Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Bokaro,1.1,Total number of pregnant women Registered for ANC,TOTAL,4544.0,4642.0,4777.0,4909.0,4332.0,3832.0,3877.0,3818.0,3600.0,4149.0,6957.0,4488.0,53925.0
Bokaro,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,835.0,925.0,1007.0,1190.0,952.0,778.0,832.0,1224.0,1089.0,1018.0,882.0,875.0,11607.0
Bokaro,1.2,Number of Pregnant women registered under JSY,TOTAL,4544.0,4637.0,4773.0,4901.0,4325.0,3827.0,3869.0,3810.0,3586.0,4149.0,4292.0,4471.0,51184.0
Bokaro,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2769.0,2748.0,2833.0,2892.0,2894.0,2569.0,2629.0,2527.0,2348.0,2496.0,2835.0,2799.0,32339.0
Bokaro,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3800.0,3581.0,3714.0,3988.0,3798.0,3274.0,3290.0,3183.0,3170.0,3442.0,6093.0,3978.0,45311.0
Bokaro,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2950.0,3181.0,3281.0,3591.0,3398.0,2896.0,3018.0,2647.0,2621.0,2613.0,4820.0,3194.0,38210.0
Bokaro,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1521.0,1364.0,1171.0,1226.0,80.0,15.0,92.0,1034.0,1223.0,1366.0,2834.0,2366.0,14292.0
Bokaro,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,153.0,150.0,121.0,110.0,134.0,153.0,152.0,124.0,133.0,109.0,242.0,82.0,1663.0
Bokaro,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,14.0,18.0,14.0,9.0,13.0,9.0,12.0,13.0,22.0,13.0,19.0,22.0,178.0
Bokaro,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,361.0,361.0,386.0,445.0,435.0,340.0,307.0,296.0,258.0,273.0,380.0,279.0,4121.0
Bokaro,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2.0,3.0,2.0,6.0,10.0,3.0,7.0,9.0,12.0,45.0,9.0,19.0,127.0
Bokaro,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Bokaro,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,206.0,197.0,209.0,227.0,193.0,195.0,163.0,198.0,189.0,245.0,207.0,150.0,2379.0
Bokaro,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,641.0,742.0,727.0,730.0,770.0,694.0,674.0,625.0,700.0,611.0,521.0,575.0,8010.0
Bokaro,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,847.0,939.0,936.0,957.0,963.0,889.0,837.0,823.0,889.0,856.0,728.0,725.0,10389.0
Bokaro,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,721.0,773.0,717.0,757.0,709.0,707.0,674.0,633.0,714.0,657.0,539.0,503.0,8104.0
Bokaro,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,69.0,49.0,67.0,45.0,48.0,87.0,57.0,52.0,34.0,31.0,11.0,18.0,568.0
Bokaro,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,759.0,767.0,880.0,871.0,919.0,1089.0,785.0,831.0,791.0,855.0,845.0,771.0,10163.0
Bokaro,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,737.0,714.0,847.0,807.0,873.0,1036.0,732.0,800.0,762.0,761.0,790.0,726.0,9585.0
Bokaro,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,462.0,515.0,428.0,536.0,343.0,403.0,244.0,300.0,275.0,464.0,439.0,396.0,4805.0
Bokaro,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,348.0,329.0,280.0,336.0,201.0,205.0,118.0,123.0,141.0,281.0,224.0,223.0,2809.0
Bokaro,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Bokaro,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,500.0,1034.0,747.0,1417.0,1420.0,945.0,1004.0,1051.0,439.0,1179.0,1116.0,916.0,11768.0
Bokaro,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,11.0,26.0,52.0
Bokaro,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,21.0,24.0,53.0
Bokaro,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,2.0
Bokaro,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,0.0,2.0,0.0,6.0
Bokaro,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bokaro,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,4.0,0.0,3.0,0.0,8.0
Bokaro,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,32.0,26.0,18.0,38.0,36.0,32.0,25.0,30.0,32.0,50.0,51.0,27.0,397.0
Bokaro,4.1.1.a,Number of male live births,TOTAL,1153.0,1492.0,1368.0,1717.0,1760.0,1527.0,1370.0,1435.0,1120.0,1556.0,1450.0,1325.0,17273.0
Bokaro,4.1.1.b,Number of female live births,TOTAL,946.0,1266.0,1183.0,1520.0,1542.0,1386.0,1248.0,1287.0,992.0,1332.0,1235.0,1224.0,15161.0
Bokaro,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2099.0,2758.0,2551.0,3237.0,3302.0,2913.0,2618.0,2722.0,2112.0,2888.0,2685.0,2549.0,32434.0
Bokaro,4.1.2,Number of still births,TOTAL,9.0,22.0,18.0,20.0,10.0,21.0,21.0,13.0,87.0,8.0,45.0,16.0,290.0
Bokaro,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,43.0,117.0,316.0,151.0,151.0,138.0,103.0,115.0,122.0,135.0,717.0,230.0,2338.0
Bokaro,4.2.1,Number of Newborns weighed at birth,TOTAL,1877.0,2513.0,2399.0,2976.0,2923.0,2636.0,2459.0,2434.0,1925.0,2664.0,2406.0,2297.0,29509.0
Bokaro,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,160.0,134.0,126.0,155.0,213.0,201.0,162.0,187.0,127.0,225.0,224.0,199.0,2113.0
Bokaro,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1808.0,2540.0,2392.0,2942.0,2856.0,2659.0,2486.0,2465.0,1945.0,2639.0,2418.0,2313.0,29463.0
Bokaro,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bokaro,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,3.0,4.0,3.0,6.0,1.0,76.0,62.0,70.0,70.0,7.0,0.0,45.0,347.0
Bokaro,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,20.0,39.0,0.0,1.0,12.0,17.0,15.0,11.0,17.0,132.0
Bokaro,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bokaro,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,3.0,4.0,3.0,27.0,40.0,76.0,63.0,82.0,87.0,22.0,11.0,62.0,480.0
Bokaro,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Bokaro,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,22.0,15.0,11.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0,82.0
Bokaro,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bokaro,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,23.0,22.0,42.0,24.0,20.0,76.0,63.0,82.0,78.0,20.0,11.0,61.0,522.0
Bokaro,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1445.0,1884.0,1816.0,2633.0,2515.0,2292.0,2122.0,1883.0,1325.0,1721.0,1901.0,1870.0,23407.0
Bokaro,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1047.0,1532.0,1292.0,2123.0,1908.0,1705.0,1907.0,1233.0,1060.0,1398.0,1049.0,1186.0,17440.0
Bokaro,6.3,PNC maternal complications attended,TOTAL,0.0,2.0,0.0,0.0,0.0,2.0,0.0,2.0,0.0,0.0,0.0,45.0,51.0
Bokaro,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,2.0,0.0,1.0,0.0,0.0,2.0,8.0
Bokaro,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,4.0,0.0,0.0,0.0,1.0,3.0,0.0,0.0,0.0,0.0,0.0,8.0
Bokaro,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,4.0,0.0,0.0,0.0,4.0,5.0,0.0,1.0,0.0,0.0,2.0,16.0
Bokaro,7.2,Number of MTPs conducted at Private Facilities,TOTAL,20.0,98.0,287.0,130.0,135.0,113.0,86.0,102.0,110.0,116.0,696.0,206.0,2099.0
Bokaro,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,245.0,194.0,193.0,20.0,22.0,17.0,19.0,13.0,18.0,28.0,11.0,6.0,786.0
Bokaro,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,181.0,139.0,150.0,27.0,32.0,26.0,38.0,32.0,21.0,53.0,14.0,4.0,717.0
Bokaro,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,426.0,333.0,343.0,47.0,54.0,43.0,57.0,45.0,39.0,81.0,25.0,10.0,1503.0
Bokaro,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,16.0,0.0,0.0,208.0,10.0,0.0,8.0,10.0,90.0,177.0,197.0,182.0,898.0
Bokaro,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,0.0,0.0,43.0,16.0,0.0,0.0,0.0,0.0,48.0,35.0,41.0,186.0
Bokaro,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bokaro,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,19.0,0.0,0.0,251.0,26.0,0.0,8.0,10.0,90.0,225.0,232.0,223.0,1084.0
Bokaro,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,3.0,1.0,1.0,114.0,0.0,3.0,3.0,42.0,197.0,488.0,336.0,208.0,1396.0
Bokaro,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bokaro,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,147.0,96.0,79.0,93.0,415.0
Bokaro,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,283.0,12.0,0.0,4.0,105.0,620.0,831.0,847.0,277.0,2979.0
Bokaro,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,6.0,0.0,0.0,40.0,1.0,0.0,2.0,83.0,332.0,354.0,499.0,0.0,1317.0
Bokaro,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bokaro,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,6.0,0.0,0.0,323.0,13.0,0.0,6.0,188.0,952.0,1185.0,1346.0,277.0,4296.0
Bokaro,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,49.0,90.0,80.0,194.0,102.0,83.0,120.0,422.0,1482.0,1163.0,1430.0,339.0,5554.0
Bokaro,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bokaro,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,82.0,0.0,82.0
Bokaro,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,218.0,185.0,180.0,522.0,304.0,205.0,176.0,157.0,157.0,233.0,203.0,168.0,2708.0
Bokaro,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,14.0,10.0,23.0,38.0,26.0,35.0,28.0,18.0,23.0,22.0,23.0,25.0,285.0
Bokaro,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,29.0,29.0,41.0,865.0,117.0,30.0,21.0,15.0,101.0,156.0,203.0,79.0,1686.0
Bokaro,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,9.0,42.0,57.0,15.0,10.0,8.0,6.0,3.0,9.0,7.0,5.0,171.0
Bokaro,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bokaro,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,261.0,233.0,286.0,1482.0,462.0,280.0,233.0,196.0,284.0,420.0,436.0,277.0,4850.0
Bokaro,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Bokaro,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,23.0,50.0,53.0,76.0,45.0,25.0,28.0,19.0,12.0,41.0,965.0,280.0,1617.0
Bokaro,9.06,Number of IUCD removals,TOTAL,153.0,126.0,86.0,173.0,135.0,106.0,109.0,104.0,100.0,158.0,185.0,149.0,1584.0
Bokaro,9.07,Number of Oral Pills cycles distributed,TOTAL,1809.0,2876.0,2389.0,6738.0,4718.0,3471.0,3614.0,4133.0,3479.0,4636.0,12944.0,3542.0,54349.0
Bokaro,9.08,Number of Condom pieces distributed,TOTAL,26258.0,27302.0,34877.0,91799.0,47056.0,34893.0,29844.0,29622.0,35699.0,37168.0,43208.0,22563.0,460289.0
Bokaro,9.09,Number of Centchroman (weekly) pills given,TOTAL,172.0,5.0,362.0,19.0,47.0,47.0,270.0,32.0,102.0,28.0,19.0,128.0,1231.0
Bokaro,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,232.0,299.0,348.0,505.0,229.0,289.0,180.0,259.0,191.0,199.0,165.0,265.0,3161.0
Bokaro,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bokaro,9.12,Number of Institutions having NSV trained doctors,TOTAL,7.0,11.0,9.0,11.0,13.0,13.0,10.0,14.0,20.0,23.0,17.0,15.0,-1.0
Bokaro,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3698.0,3751.0,3767.0,4093.0,3943.0,3853.0,3958.0,3993.0,4025.0,3855.0,3280.0,2824.0,45040.0
Bokaro,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3926.0,3533.0,3719.0,3962.0,3954.0,3701.0,3955.0,4172.0,4258.0,3911.0,5015.0,3774.0,47880.0
Bokaro,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4019.0,3704.0,3605.0,3795.0,3755.0,3409.0,3759.0,3872.0,4094.0,3807.0,4793.0,3732.0,46344.0
Bokaro,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4027.0,3826.0,3725.0,3880.0,3679.0,3235.0,3462.0,3508.0,3825.0,3696.0,4623.0,3758.0,45244.0
Bokaro,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Bokaro,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Bokaro,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Bokaro,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1362.0,1479.0,1959.0,2506.0,3028.0,1763.0,1236.0,1830.0,1400.0,1219.0,1803.0,924.0,20509.0
Bokaro,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3753.0,3670.0,3720.0,3957.0,2616.0,3434.0,2727.0,3958.0,3966.0,1875.0,3631.0,2437.0,39744.0
Bokaro,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3819.0,3811.0,3588.0,3809.0,2506.0,3154.0,2614.0,3589.0,3850.0,1804.0,3367.0,2358.0,38269.0
Bokaro,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3835.0,3816.0,3721.0,3946.0,2431.0,2997.0,2550.0,3326.0,3578.0,1779.0,3192.0,2283.0,37454.0
Bokaro,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,0.0,0.0,0.0,0.0,0.0,33.0,0.0,64.0,0.0,97.0
Bokaro,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,24.0,4.0,0.0,0.0,86.0,992.0,2413.0,3519.0
Bokaro,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,24.0,0.0,0.0,0.0,67.0,67.0,747.0,905.0
Bokaro,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,23.0,0.0,0.0,0.0,16.0,36.0,126.0,201.0
Bokaro,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3472.0,3521.0,3333.0,4238.0,4165.0,3497.0,3438.0,3431.0,2989.0,3258.0,4336.0,3549.0,43227.0
Bokaro,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,0.0,0.0,26.0,7.0,0.0,235632.0,54232.0,3.0,0.0,289900.0
Bokaro,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Bokaro,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1715.0,1823.0,1716.0,2224.0,2232.0,1849.0,1847.0,1798.0,1613.0,1661.0,2374.0,1828.0,22680.0
Bokaro,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1507.0,1651.0,1515.0,1884.0,1876.0,1611.0,1577.0,1503.0,1368.0,1488.0,1935.0,1699.0,19614.0
Bokaro,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3222.0,3474.0,3231.0,4108.0,4108.0,3460.0,3424.0,3301.0,2981.0,3149.0,4309.0,3527.0,42294.0
Bokaro,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2432.0,2286.0,2500.0,2528.0,2650.0,1969.0,2095.0,1911.0,1905.0,2299.0,2677.0,2381.0,27633.0
Bokaro,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2313.0,2290.0,2511.0,2506.0,1867.0,1822.0,1334.0,1778.0,1753.0,837.0,1647.0,1342.0,22000.0
Bokaro,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,195.0,154.0,120.0,234.0,276.0,161.0,514.0,177.0,205.0,178.0,159.0,164.0,2537.0
Bokaro,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,169.0,151.0,129.0,190.0,207.0,138.0,407.0,154.0,166.0,152.0,121.0,136.0,2120.0
Bokaro,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,364.0,305.0,249.0,424.0,483.0,299.0,921.0,331.0,371.0,330.0,280.0,300.0,4657.0
Bokaro,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,66.0,84.0,71.0,59.0,66.0,186.0,53.0,89.0,105.0,67.0,177.0,68.0,1091.0
Bokaro,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1462.0,1402.0,1469.0,1623.0,1391.0,1324.0,1419.0,1435.0,1320.0,1489.0,1651.0,1565.0,17550.0
Bokaro,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1355.0,1304.0,1549.0,1556.0,1599.0,1201.0,1349.0,1418.0,1272.0,1411.0,1671.0,1379.0,17064.0
Bokaro,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,72.0,107.0,109.0,64.0,85.0,67.0,60.0,99.0,78.0,112.0,82.0,68.0,1003.0
Bokaro,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,37.0,71.0,56.0,34.0,24.0,22.0,21.0,23.0,29.0,34.0,30.0,20.0,401.0
Bokaro,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1795.0,1842.0,1996.0,1989.0,2065.0,1875.0,1890.0,1962.0,1976.0,2049.0,1955.0,2021.0,23415.0
Bokaro,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1694.0,1723.0,1725.0,1816.0,1828.0,1792.0,1714.0,1720.0,1863.0,1888.0,1737.0,1849.0,21349.0
Bokaro,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,855.0,863.0,934.0,904.0,974.0,1019.0,1013.0,923.0,1089.0,1060.0,1041.0,1075.0,11750.0
Bokaro,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Bokaro,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2401.0,2354.0,1741.0,2161.0,12534.0,3378.0,2660.0,2661.0,2493.0,2483.0,5978.0,3372.0,44216.0
Bokaro,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,224.0,60.0,26.0,0.0,43748.0,7847.0,56.0,71.0,53.0,54.0,36485.0,4700.0,93324.0
Bokaro,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,84.0,20.0,13.0,0.0,46560.0,7725.0,26.0,24.0,18.0,10.0,40192.0,5131.0,99803.0
Bokaro,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,27.0,11.0,12.0,9.0,35.0,3.0,4.0,5.0,15.0,6.0,0.0,8.0,135.0
Bokaro,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,71.0,129.0,135.0,110.0,67.0,92.0,106.0,55.0,42.0,51.0,58.0,54.0,970.0
Bokaro,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,38.0,39.0,31.0,115.0,54.0,31.0,128.0,20.0,19.0,13.0,15.0,6.0,509.0
Bokaro,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,13.1,Number of Patients operated for cataract,TOTAL,138.0,25.0,0.0,0.0,145.0,132.0,115.0,0.0,14.0,216.0,288.0,201.0,1274.0
Bokaro,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,138.0,25.0,0.0,0.0,145.0,132.0,115.0,0.0,14.0,216.0,288.0,201.0,1274.0
Bokaro,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,27.0,0.0,0.0,153.0,32.0,55.0,267.0
Bokaro,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,27.0,0.0,0.0,0.0,0.0,20.0,47.0
Bokaro,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,8.0,7.0,10.0,8.0,9.0,7.0,6.0,10.0,9.0,9.0,7.0,-1.0
Bokaro,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,1.0,4.0,6.0,6.0,7.0,7.0,9.0,6.0,5.0,6.0,5.0,-1.0
Bokaro,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,294.0,239.0,672.0,205.0,170.0,100.0,102.0,195.0,333.0,306.0,390.0,392.0,-1.0
Bokaro,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,12.0,11.0,12.0,12.0,11.0,13.0,10.0,12.0,14.0,14.0,14.0,13.0,-1.0
Bokaro,14.05,Number of RKS meetings held during the month,TOTAL,8.0,5.0,7.0,1.0,7.0,8.0,6.0,7.0,8.0,9.0,6.0,7.0,79.0
Bokaro,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,11.0,11.0,10.0,14.0,14.0,16.0,12.0,12.0,17.0,17.0,16.0,13.0,-1.0
Bokaro,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,6.0,8.0,8.0,14.0,10.0,3.0,4.0,2.0,0.0,7.0,5.0,2.0,69.0
Bokaro,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,7.0,5.0,5.0,6.0,7.0,4.0,6.0,8.0,9.0,8.0,8.0,-1.0
Bokaro,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Bokaro,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,19.0,24.0,24.0,40.0,37.0,21.0,12.0,20.0,22.0,12.0,13.0,21.0,265.0
Bokaro,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,156.0,125.0,218.0,312.0,376.0,161.0,127.0,160.0,264.0,142.0,593.0,80.0,2714.0
Bokaro,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,27.0,30.0,22.0,32.0,29.0,19.0,25.0,30.0,21.0,13.0,14.0,19.0,281.0
Bokaro,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,281.0,353.0,482.0,566.0,604.0,464.0,351.0,489.0,830.0,1132.0,865.0,441.0,6858.0
Bokaro,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,46.0,54.0,46.0,72.0,66.0,40.0,37.0,50.0,43.0,25.0,27.0,40.0,546.0
Bokaro,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,437.0,478.0,700.0,878.0,980.0,625.0,478.0,649.0,1094.0,1274.0,1458.0,521.0,9572.0
Bokaro,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,14.11,In-Patient Head Count at midnight,TOTAL,80.0,15.0,108.0,13.0,67.0,21.0,7.0,31.0,231.0,381.0,436.0,100.0,1490.0
Bokaro,14.12.1,OPD attendance (All),TOTAL,33156.0,35139.0,35037.0,46218.0,44816.0,42840.0,38560.0,37366.0,30879.0,32971.0,33909.0,32251.0,443142.0
Bokaro,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,150.0,0.0,0.0,0.0,0.0,10.0,43.0,259.0,0.0,462.0
Bokaro,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Bokaro,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,48.0,38.0,49.0,73.0,65.0,91.0,47.0,62.0,275.0,427.0,517.0,144.0,1836.0
Bokaro,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,2.0,2.0,8.0
Bokaro,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,13.0,8.0,23.0,0.0,0.0,0.0,0.0,0.0,0.0,44.0
Bokaro,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1082.0,1048.0,1148.0,1246.0,1090.0,838.0,690.0,1011.0,1359.0,1733.0,1783.0,1202.0,14230.0
Bokaro,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,17.0,29.0,26.0,42.0,53.0,24.0,14.0,28.0,33.0,55.0,40.0,49.0,410.0
Bokaro,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,33.0,20.0,31.0,40.0,39.0,43.0,98.0,57.0,46.0,84.0,768.0,118.0,1377.0
Bokaro,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0,0.0,7.0
Bokaro,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,40.0,63.0,23.0,55.0,37.0,88.0,124.0,16.0,39.0,169.0,161.0,82.0,897.0
Bokaro,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,3.0
Bokaro,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,16.0,22.0,32.0,74.0,104.0,98.0,43.0,80.0,34.0,93.0,258.0,132.0,986.0
Bokaro,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,8.0
Bokaro,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,89.0,105.0,86.0,169.0,180.0,229.0,265.0,153.0,119.0,346.0,1187.0,332.0,3260.0
Bokaro,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,0.0,0.0,1.0,0.0,0.0,1.0,3.0,0.0,1.0,10.0,0.0,18.0
Bokaro,15.2,Number of Widal tests conducted,Number tested,24.0,13.0,0.0,40.0,62.0,0.0,2.0,37.0,47.0,33.0,25.0,58.0,341.0
Bokaro,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0
Bokaro,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0
Bokaro,15.4.1,Number of blood smears examined for Malaria,TOTAL,10488.0,8019.0,6820.0,11846.0,10420.0,8000.0,7978.0,8128.0,6507.0,7462.0,8327.0,8741.0,102736.0
Bokaro,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,102.0,53.0,87.0,202.0,90.0,104.0,62.0,98.0,175.0,145.0,106.0,105.0,1329.0
Bokaro,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,10.0,4.0,8.0,52.0,71.0,38.0,118.0,165.0,203.0,178.0,27.0,23.0,897.0
Bokaro,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,15340.0,20120.0,60.0,11380.0,16630.0,26580.0,8990.0,27360.0,8810.0,15900.0,1450.0,5280.0,157900.0
Bokaro,16.1.1,Stock position of DPT vaccines,2. Stocks Received,25000.0,0.0,30000.0,25000.0,30000.0,0.0,30000.0,0.0,30000.0,0.0,15000.0,10000.0,195000.0
Bokaro,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,10.0
Bokaro,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,20220.0,20060.0,18680.0,19750.0,20050.0,17590.0,11630.0,18550.0,22910.0,14450.0,11160.0,10240.0,205290.0
Bokaro,16.1.1,Stock position of DPT vaccines,5. Total Stock,20120.0,60.0,11380.0,16630.0,26580.0,8990.0,27360.0,8810.0,15900.0,1450.0,5280.0,5040.0,147600.0
Bokaro,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Bokaro,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Bokaro,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Bokaro,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Bokaro,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,800.0,39360.0,1580.0,9360.0,160.0,19960.0,520.0,33000.0,5520.0,80.0,0.0,0.0,110340.0
Bokaro,16.1.2,Stock position of OPV vaccines,2. Stocks Received,60000.0,0.0,40000.0,0.0,30000.0,0.0,40340.0,0.0,0.0,0.0,6000.0,0.0,176340.0
Bokaro,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Bokaro,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,21440.0,37780.0,32220.0,9200.0,10200.0,19420.0,7860.0,27480.0,5440.0,80.0,6000.0,0.0,177120.0
Bokaro,16.1.2,Stock position of OPV vaccines,5. Total Stock,39360.0,1580.0,9360.0,160.0,19960.0,520.0,33000.0,5520.0,80.0,0.0,0.0,0.0,109540.0
Bokaro,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,28270.0,24700.0,10500.0,14320.0,21420.0,24020.0,10070.0,30880.0,12580.0,22270.0,9100.0,6310.0,214440.0
Bokaro,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,0.0,20000.0,25000.0,20000.0,0.0,30000.0,0.0,30000.0,0.0,15000.0,25000.0,175000.0
Bokaro,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,20.0
Bokaro,16.1.3,Stock position of TT vaccines,4. Stock Distributed,13570.0,14200.0,16180.0,17900.0,17400.0,13950.0,9190.0,18300.0,20310.0,13150.0,17790.0,15880.0,187820.0
Bokaro,16.1.3,Stock position of TT vaccines,5. Total Stock,24700.0,10500.0,14320.0,21420.0,24020.0,10070.0,30880.0,12580.0,22270.0,9100.0,6310.0,15430.0,201600.0
Bokaro,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bokaro,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Bokaro,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bokaro,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bokaro,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,15430.0,21730.0,9170.0,15950.0,2300.0,18070.0,5960.0,18000.0,3480.0,1610.0,110.0,90.0,111900.0
Bokaro,16.1.5,Stock position of BCG vaccines,2. Stocks Received,20000.0,0.0,20000.0,0.0,25000.0,0.0,20000.0,0.0,15000.0,0.0,0.0,10000.0,110000.0
Bokaro,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,20.0
Bokaro,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,13700.0,12560.0,13220.0,13650.0,9230.0,12110.0,7960.0,14520.0,16870.0,1480.0,20.0,9820.0,125140.0
Bokaro,16.1.5,Stock position of BCG vaccines,5. Total Stock,21730.0,9170.0,15950.0,2300.0,18070.0,5960.0,18000.0,3480.0,1610.0,110.0,90.0,270.0,96740.0
Bokaro,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2340.0,3115.0,90.0,5035.0,6740.0,10815.0,4265.0,10440.0,3935.0,80185.0,38120.0,49905.0,214985.0
Bokaro,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,0.0,15000.0,10000.0,12500.0,0.0,10000.0,0.0,475000.0,0.0,32300.0,0.0,559800.0
Bokaro,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,10.0
Bokaro,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4225.0,3025.0,10055.0,8295.0,8425.0,6550.0,3825.0,6505.0,398750.0,42065.0,20515.0,18520.0,530755.0
Bokaro,16.1.6,Stock position of Measles vaccines,5. Total Stock,3115.0,90.0,5035.0,6740.0,10815.0,4265.0,10440.0,3935.0,80185.0,38120.0,49905.0,31375.0,244020.0
Bokaro,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bokaro,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Bokaro,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bokaro,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bokaro,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bokaro,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Bokaro,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bokaro,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bokaro,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1600.0,4000.0,2600.0,2200.0,1615.0,1615.0,1615.0,2900.0,2600.0,2500.0,1400.0,1400.0,26045.0
Bokaro,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,3000.0,0.0,0.0,1040.0,0.0,0.0,2400.0,0.0,0.0,0.0,0.0,0.0,6440.0
Bokaro,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,1400.0,400.0,1625.0,0.0,0.0,1115.0,300.0,100.0,1100.0,0.0,1400.0,8040.0
Bokaro,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,4000.0,2600.0,2200.0,1615.0,1615.0,1615.0,2900.0,2600.0,2500.0,1400.0,1400.0,0.0,24445.0
Bokaro,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,282000.0,156000.0,108000.0,14500.0,26500.0,8500.0,2800.0,,,,0.0,598300.0
Bokaro,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,300000.0,0.0,0.0,12000.0,48000.0,24000.0,8800.0,0.0,,,,62500.0,455300.0
Bokaro,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0
Bokaro,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,18000.0,126000.0,48000.0,105500.0,36000.0,42000.0,14500.0,2800.0,,,,5400.0,398200.0
Bokaro,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,282000.0,156000.0,108000.0,14500.0,26500.0,8500.0,2800.0,0.0,0.0,0.0,0.0,57100.0,655400.0
Bokaro,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2000.0,21000.0,14800.0,12800.0,4600.0,1600.0,1600.0,1600.0,,3000.0,1100.0,600.0,64700.0
Bokaro,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,20000.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,,0.0,0.0,3000.0,25000.0
Bokaro,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Bokaro,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1000.0,6200.0,2000.0,10200.0,3000.0,0.0,0.0,1600.0,,1900.0,500.0,3600.0,30000.0
Bokaro,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,21000.0,14800.0,12800.0,4600.0,1600.0,1600.0,1600.0,0.0,0.0,1100.0,600.0,0.0,59700.0
Bokaro,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,2650.0,1000.0,1000.0,,,185.0,,,4835.0
Bokaro,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,4000.0,0.0,0.0,0.0,,,0.0,,,4000.0
Bokaro,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,0.0,0.0,0.0,0.0,,,0.0,,,0.0
Bokaro,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,1350.0,1650.0,0.0,1000.0,,,185.0,,,4185.0
Bokaro,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,2650.0,1000.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,4650.0
Bokaro,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bokaro,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bokaro,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bokaro,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bokaro,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Bokaro,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Bokaro,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Bokaro,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Bokaro,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,0.0,675.0,675.0,1675.0,4675.0,4675.0,3875.0,4125.0,2875.0,2275.0,1325.0,26850.0
Bokaro,16.3.02,Stock Position of Gloves,2. Stocks Received,,675.0,0.0,2000.0,3000.0,0.0,0.0,2000.0,2000.0,2000.0,0.0,0.0,11675.0
Bokaro,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.3.02,Stock Position of Gloves,4. Stock Distributed,,0.0,0.0,1000.0,0.0,0.0,800.0,1750.0,3250.0,2600.0,950.0,0.0,10350.0
Bokaro,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,675.0,675.0,1675.0,4675.0,4675.0,3875.0,4125.0,2875.0,2275.0,1325.0,1325.0,28175.0
Bokaro,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Bokaro,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Bokaro,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Bokaro,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Bokaro,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bokaro,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Bokaro,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bokaro,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bokaro,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Bokaro,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Bokaro,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Bokaro,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Bokaro,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Bokaro,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Bokaro,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Bokaro,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Bokaro,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,0.0,,,,,,0.0
Bokaro,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,2658000.0,,,,,,2658000.0
Bokaro,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Bokaro,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,2658000.0,,,,,,2658000.0
Bokaro,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Bokaro,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Bokaro,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Bokaro,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Bokaro,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Bokaro,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Bokaro,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Bokaro,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Bokaro,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,0.0,129.0,95.0,69.0,69.0,39.0,34.0,236.0,186.0,857.0
Bokaro,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,3360.0,300.0,0.0,0.0,0.0,0.0,4305.0,0.0,0.0,7965.0
Bokaro,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,3231.0,334.0,26.0,0.0,30.0,5.0,4103.0,50.0,0.0,7779.0
Bokaro,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,129.0,95.0,69.0,69.0,39.0,34.0,236.0,186.0,186.0,1043.0
Bokaro,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,10100.0,10100.0,10100.0,,,,0.0,5776.0,3376.0,1776.0,800.0,800.0,42828.0
Bokaro,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,,,,5776.0,0.0,0.0,0.0,0.0,16000.0,21776.0
Bokaro,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,,,,0.0,0.0,0.0,976.0,0.0,0.0,976.0
Bokaro,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,10100.0,,,,0.0,2400.0,1600.0,,0.0,,14100.0
Bokaro,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,10100.0,10100.0,0.0,0.0,0.0,0.0,5776.0,3376.0,1776.0,800.0,800.0,16800.0,49528.0
Bokaro,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,5495.0,5495.0
Bokaro,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,3000.0,3000.0
Bokaro,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Bokaro,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,3700.0,3700.0
Bokaro,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4795.0,4795.0
Bokaro,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,11100.0,11100.0
Bokaro,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,28000.0,28000.0
Bokaro,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Bokaro,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,12700.0,12700.0
Bokaro,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26400.0,26400.0
Bokaro,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,463600.0,463600.0,463600.0,445600.0,445600.0,0.0,445600.0,445600.0,319600.0,169600.0,145600.0,145600.0,3953600.0
Bokaro,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bokaro,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,18000.0,0.0,0.0,0.0,0.0,126000.0,150000.0,24000.0,0.0,0.0,318000.0
Bokaro,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,463600.0,463600.0,445600.0,445600.0,445600.0,0.0,445600.0,319600.0,169600.0,145600.0,145600.0,145600.0,3635600.0
Bokaro,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,3.0,1.0,,3.0,,,,,,8.0
Bokaro,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bokaro,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bokaro,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Bokaro,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bokaro,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Bokaro,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,1.0,,,,1.0
Bokaro,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,1.0,3.0,,,,,,,,4.0
Bokaro,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bokaro,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,1.0,3.0,,,,,,,,4.0
Bokaro,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,1.0,2.0,,,,,,1.0,,,4.0
Bokaro,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,,1.0
Bokaro,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,1.0,2.0,,,,,,2.0,,,5.0
Bokaro,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,1.0,,1.0,1.0,,1.0,,4.0
Bokaro,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bokaro,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,1.0,,1.0,1.0,,1.0,,4.0
Bokaro,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bokaro,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bokaro,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Bokaro,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,1.0,,,,,1.0,,,,2.0
Bokaro,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Bokaro,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,1.0,,,,,2.0,,,,3.0
Bokaro,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bokaro,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bokaro,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bokaro,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,1.0,1.0,,,,,,2.0,,3.0,1.0,10.0
Bokaro,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,1.0,,1.0,,1.0,,3.0
Bokaro,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,1.0,1.0,,,,1.0,,3.0,,4.0,1.0,13.0
Bokaro,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bokaro,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Bokaro,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Bokaro,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,1.0,,,,1.0,,1.0,,3.0
Bokaro,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Bokaro,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,1.0,1.0,,,1.0,,1.0,,4.0
Bokaro,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Bokaro,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Bokaro,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,1.0,,,,,,,1.0
Bokaro,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Bokaro,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bokaro,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Bokaro,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Bokaro,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Bokaro,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,2.0,,,,,,,,2.0
Bokaro,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,,,3.0,,,,,,,,4.0
Bokaro,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Bokaro,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Bokaro,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Bokaro,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,1.0,,1.0,,2.0
Bokaro,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,2.0,,,,,,,,,2.0
Bokaro,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,2.0,,,,,1.0,,1.0,,4.0
Bokaro,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Bokaro,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Bokaro,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,1.0,1.0,,,,,,2.0
Bokaro,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bokaro,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bokaro,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bokaro,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,1.0,,,,,,,,1.0,,3.0
Bokaro,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bokaro,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,1.0,,,,,,,,1.0,,3.0
Bokaro,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Bokaro,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bokaro,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Bokaro,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,,,,,,,1.0,1.0,3.0
Bokaro,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bokaro,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,,,,,,,1.0,1.0,3.0
Bokaro,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Bokaro,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bokaro,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Bokaro,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,,1.0,3.0,3.0,,2.0,,2.0,2.0,,14.0
Bokaro,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,1.0,,,,,2.0,,,,3.0
Bokaro,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,,2.0,3.0,3.0,,2.0,2.0,2.0,2.0,,17.0
Bokaro,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Bokaro,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,2.0,1.0,1.0,1.0,,,,2.0,2.0,3.0,,12.0
Bokaro,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,,,1.0,,,,,,,1.0,3.0
Bokaro,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,3.0,1.0,1.0,3.0,,,,2.0,2.0,3.0,1.0,16.0
Bokaro,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Bokaro,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,,,1.0,,1.0,,,1.0,1.0,,,7.0
Bokaro,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Bokaro,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,,,1.0,,1.0,,,1.0,1.0,,,8.0
Bokaro,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Bokaro,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,,,,,,1.0,,,,,2.0
Bokaro,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Bokaro,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,,,1.0,,,1.0,,,,,3.0
Bokaro,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Bokaro,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,1.0,1.0,,,1.0,,,1.0,1.0,1.0,6.0
Bokaro,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,2.0,,1.0,,,,,,1.0,4.0
Bokaro,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,1.0,3.0,,1.0,1.0,,1.0,1.0,1.0,2.0,11.0
Bokaro,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,2.0,2.0,1.0,3.0,2.0,,1.0,,,2.0,,14.0
Bokaro,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,1.0,1.0,,,2.0,1.0,,4.0,1.0,10.0
Bokaro,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,2.0,2.0,2.0,4.0,2.0,,3.0,1.0,,6.0,1.0,24.0
Bokaro,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Bokaro,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,1.0,2.0,3.0,,6.0,2.0,1.0,3.0,2.0,4.0,,26.0
Bokaro,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,3.0,5.0,5.0,7.0,8.0,10.0,3.0,2.0,4.0,9.0,3.0,4.0,63.0
Bokaro,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,5.0,6.0,7.0,10.0,8.0,16.0,5.0,3.0,7.0,11.0,7.0,4.0,89.0
Chatra,1.1,Total number of pregnant women Registered for ANC,TOTAL,2168.0,1731.0,1974.0,2128.0,1717.0,1750.0,1819.0,1552.0,1660.0,1435.0,1570.0,1361.0,20865.0
Chatra,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,426.0,329.0,393.0,530.0,303.0,265.0,341.0,349.0,430.0,367.0,426.0,239.0,4398.0
Chatra,1.2,Number of Pregnant women registered under JSY,TOTAL,1653.0,1255.0,1636.0,1842.0,1369.0,1532.0,1648.0,1349.0,1421.0,1201.0,1231.0,1121.0,17258.0
Chatra,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1131.0,1074.0,1102.0,1248.0,1172.0,999.0,1121.0,1008.0,1086.0,858.0,906.0,648.0,12353.0
Chatra,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1970.0,1590.0,1897.0,2021.0,1495.0,1610.0,1717.0,1461.0,1565.0,1328.0,1488.0,1322.0,19464.0
Chatra,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1682.0,1541.0,1561.0,1605.0,1347.0,1288.0,1376.0,1296.0,1264.0,1045.0,1082.0,1046.0,16133.0
Chatra,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1150.0,1056.0,514.0,517.0,513.0,891.0,1584.0,1423.0,1560.0,1342.0,1394.0,1165.0,13109.0
Chatra,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,135.0,173.0,165.0,311.0,277.0,22.0,55.0,30.0,12.0,49.0,62.0,40.0,1331.0
Chatra,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,42.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,44.0
Chatra,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,253.0,90.0,107.0,135.0,160.0,84.0,189.0,152.0,124.0,177.0,119.0,63.0,1653.0
Chatra,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,14.0,0.0,4.0,0.0,0.0,0.0,2.0,2.0,3.0,2.0,0.0,31.0
Chatra,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Chatra,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,276.0,207.0,169.0,131.0,177.0,158.0,186.0,178.0,192.0,184.0,194.0,124.0,2176.0
Chatra,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,301.0,344.0,332.0,419.0,370.0,354.0,293.0,306.0,276.0,277.0,205.0,337.0,3814.0
Chatra,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,577.0,551.0,501.0,550.0,547.0,512.0,479.0,484.0,468.0,461.0,399.0,461.0,5990.0
Chatra,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,309.0,371.0,313.0,357.0,316.0,310.0,339.0,321.0,275.0,243.0,228.0,287.0,3669.0
Chatra,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,87.0,86.0,54.0,39.0,29.0,34.0,73.0,40.0,63.0,55.0,34.0,88.0,682.0
Chatra,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,769.0,621.0,804.0,896.0,917.0,794.0,914.0,763.0,777.0,747.0,722.0,612.0,9336.0
Chatra,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,626.0,479.0,626.0,894.0,915.0,793.0,905.0,757.0,759.0,742.0,712.0,600.0,8808.0
Chatra,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,458.0,626.0,529.0,786.0,357.0,544.0,376.0,526.0,267.0,305.0,236.0,238.0,5248.0
Chatra,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,370.0,567.0,445.0,605.0,277.0,361.0,249.0,320.0,171.0,189.0,160.0,340.0,4054.0
Chatra,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,11.0,18.0,0.0,6.0,11.0,9.0,59.0,0.0,0.0,0.0,3.0,3.0,120.0
Chatra,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Chatra,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Chatra,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Chatra,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Chatra,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Chatra,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chatra,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Chatra,4.1.1.a,Number of male live births,TOTAL,764.0,690.0,778.0,809.0,790.0,694.0,849.0,721.0,657.0,623.0,585.0,593.0,8553.0
Chatra,4.1.1.b,Number of female live births,TOTAL,693.0,522.0,632.0,734.0,706.0,647.0,658.0,640.0,590.0,579.0,565.0,467.0,7433.0
Chatra,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1457.0,1212.0,1410.0,1543.0,1496.0,1341.0,1507.0,1361.0,1247.0,1202.0,1150.0,1060.0,15986.0
Chatra,4.1.2,Number of still births,TOTAL,17.0,17.0,23.0,38.0,33.0,34.0,34.0,19.0,22.0,31.0,10.0,17.0,295.0
Chatra,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,11.0,2.0,24.0,30.0,6.0,63.0,5.0,4.0,8.0,4.0,2.0,8.0,167.0
Chatra,4.2.1,Number of Newborns weighed at birth,TOTAL,1157.0,978.0,1119.0,1291.0,1221.0,1073.0,1181.0,1181.0,1046.0,999.0,911.0,875.0,13032.0
Chatra,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,79.0,32.0,58.0,51.0,61.0,62.0,64.0,89.0,212.0,99.0,63.0,50.0,920.0
Chatra,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1209.0,1032.0,1233.0,1442.0,1382.0,1215.0,1283.0,1269.0,1099.0,1137.0,1059.0,977.0,14337.0
Chatra,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0,31.0
Chatra,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,2.0,2.0,3.0,5.0,2.0,0.0,0.0,0.0,14.0
Chatra,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chatra,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chatra,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,1.0,0.0,2.0,2.0,3.0,5.0,2.0,0.0,0.0,30.0,45.0
Chatra,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Chatra,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,1.0,4.0,0.0,7.0,9.0,2.0,0.0,7.0,0.0,30.0,60.0
Chatra,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Chatra,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,1.0,4.0,1.0,2.0,0.0,0.0,5.0,0.0,13.0
Chatra,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,856.0,816.0,979.0,1120.0,830.0,1043.0,931.0,1006.0,968.0,896.0,838.0,746.0,11029.0
Chatra,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,854.0,430.0,785.0,863.0,613.0,552.0,783.0,851.0,812.0,844.0,718.0,729.0,8834.0
Chatra,6.3,PNC maternal complications attended,TOTAL,10.0,10.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,25.0
Chatra,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,8.0,0.0,57.0,2.0,2.0,0.0,0.0,0.0,0.0,69.0
Chatra,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,5.0,6.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,13.0
Chatra,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,5.0,14.0,0.0,57.0,3.0,2.0,0.0,0.0,0.0,1.0,82.0
Chatra,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chatra,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,4.0,4.0,0.0,0.0,4.0,6.0,4.0,5.0,0.0,0.0,0.0,0.0,27.0
Chatra,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,4.0,5.0,0.0,2.0,4.0,2.0,9.0,9.0,0.0,0.0,0.0,0.0,35.0
Chatra,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,8.0,9.0,0.0,2.0,8.0,8.0,13.0,14.0,0.0,0.0,0.0,0.0,62.0
Chatra,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,49.0,0.0,0.0,0.0,0.0,0.0,49.0
Chatra,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,850.0,4.0,6.0,0.0,2.0,2.0,44.0,21.0,0.0,929.0
Chatra,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,,3.0,107.0,,10.0,,,,27.0,8.0,,157.0
Chatra,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chatra,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,0.0,3.0,957.0,4.0,16.0,0.0,2.0,2.0,71.0,29.0,0.0,1086.0
Chatra,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chatra,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chatra,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chatra,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chatra,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,3.0,460.0,0.0,20.0,0.0,53.0,95.0,1484.0,533.0,0.0,2648.0
Chatra,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,195.0,,,,,,396.0,90.0,,681.0
Chatra,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chatra,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,3.0,655.0,0.0,20.0,0.0,53.0,95.0,1880.0,623.0,0.0,3329.0
Chatra,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chatra,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,11.0,45.0,0.0,0.0,0.0,0.0,56.0
Chatra,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chatra,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chatra,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,11.0,45.0,0.0,0.0,0.0,0.0,56.0
Chatra,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chatra,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,67.0,64.0,37.0,109.0,91.0,64.0,46.0,64.0,36.0,41.0,46.0,26.0,691.0
Chatra,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,5.0,2.0,4.0,5.0,4.0,10.0,8.0,1.0,0.0,0.0,2.0,0.0,41.0
Chatra,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,27.0,0.0,9.0,155.0,4.0,3.0,0.0,0.0,1.0,1.0,16.0,1.0,217.0
Chatra,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,33.0,25.0,30.0,32.0,,32.0,21.0,25.0,40.0,50.0,22.0,5.0,315.0
Chatra,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chatra,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,132.0,91.0,80.0,301.0,99.0,109.0,75.0,90.0,77.0,92.0,86.0,32.0,1264.0
Chatra,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Chatra,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chatra,9.06,Number of IUCD removals,TOTAL,37.0,110.0,21.0,378.0,41.0,77.0,31.0,47.0,62.0,149.0,40.0,105.0,1098.0
Chatra,9.07,Number of Oral Pills cycles distributed,TOTAL,898.0,643.0,1186.0,10925.0,1353.0,1292.0,1079.0,1183.0,757.0,1111.0,592.0,588.0,21607.0
Chatra,9.08,Number of Condom pieces distributed,TOTAL,8768.0,6546.0,6424.0,31299.0,6022.0,5752.0,6247.0,8238.0,3016.0,3888.0,4394.0,4223.0,94817.0
Chatra,9.09,Number of Centchroman (weekly) pills given,TOTAL,29.0,24.0,143.0,0.0,5.0,4.0,3.0,14.0,5.0,0.0,285.0,14.0,526.0
Chatra,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,218.0,124.0,78.0,131.0,169.0,107.0,101.0,282.0,115.0,124.0,145.0,69.0,1663.0
Chatra,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,2.0,27.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,51.0
Chatra,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,8.0,0.0,12.0,2.0,38.0
Chatra,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,35.0,0.0,0.0,0.0,44.0
Chatra,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,9.0
Chatra,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,9.12,Number of Institutions having NSV trained doctors,TOTAL,7.0,4.0,3.0,4.0,3.0,2.0,4.0,8.0,6.0,4.0,6.0,8.0,-1.0
Chatra,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1960.0,1556.0,2173.0,2364.0,1411.0,2499.0,2001.0,1906.0,1916.0,1962.0,1313.0,1172.0,22233.0
Chatra,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1955.0,1485.0,2190.0,2364.0,1971.0,2379.0,1827.0,2292.0,2176.0,1855.0,1939.0,1347.0,23780.0
Chatra,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1999.0,1537.0,2046.0,2176.0,1851.0,1975.0,1591.0,1984.0,2002.0,1791.0,1738.0,1316.0,22006.0
Chatra,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2050.0,1629.0,2190.0,2124.0,1632.0,1813.0,1581.0,1799.0,1637.0,1722.0,1584.0,1123.0,20884.0
Chatra,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Chatra,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Chatra,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Chatra,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,792.0,713.0,633.0,1006.0,674.0,1222.0,698.0,977.0,120.0,813.0,638.0,229.0,8515.0
Chatra,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1825.0,1488.0,1284.0,2617.0,1361.0,1892.0,1477.0,2116.0,297.0,1523.0,1706.0,696.0,18282.0
Chatra,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1845.0,1551.0,1147.0,2128.0,1268.0,1572.0,1298.0,1799.0,286.0,1458.0,1483.0,703.0,16538.0
Chatra,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1840.0,1623.0,1225.0,1940.0,1118.0,1511.0,1172.0,1633.0,225.0,1280.0,1341.0,621.0,15529.0
Chatra,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,0.0,0.0,,0.0,23.0,47.0,0.0,177.0,201.0,103.0,551.0
Chatra,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,20.0,14.0,168.0,0.0,1789.0,2227.0,1973.0,6191.0
Chatra,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,106.0,984.0,1210.0,2303.0
Chatra,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,11.0,0.0,0.0,6.0,12.0,0.0,160.0,311.0,664.0,1164.0
Chatra,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2252.0,1853.0,2367.0,2337.0,1760.0,2047.0,1510.0,1125.0,2871.0,2346.0,1359.0,1370.0,23197.0
Chatra,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,0.0,4.0,,2.0,30.0,21.0,4.0,49.0,21.0,16.0,147.0
Chatra,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Chatra,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1111.0,943.0,1158.0,1144.0,862.0,1025.0,732.0,571.0,692.0,683.0,596.0,541.0,10058.0
Chatra,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,928.0,791.0,1095.0,1008.0,838.0,926.0,692.0,523.0,696.0,648.0,547.0,492.0,9184.0
Chatra,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2039.0,1734.0,2253.0,2152.0,1700.0,1951.0,1424.0,1094.0,1388.0,1331.0,1143.0,1033.0,19242.0
Chatra,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1256.0,1057.0,1520.0,1270.0,992.0,1010.0,868.0,1004.0,893.0,953.0,1010.0,821.0,12654.0
Chatra,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1126.0,1074.0,854.0,1245.0,828.0,876.0,691.0,888.0,106.0,751.0,838.0,358.0,9635.0
Chatra,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,361.0,457.0,334.0,247.0,325.0,448.0,311.0,303.0,387.0,233.0,406.0,226.0,4038.0
Chatra,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,267.0,315.0,255.0,233.0,291.0,413.0,285.0,315.0,351.0,217.0,382.0,188.0,3512.0
Chatra,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,628.0,772.0,589.0,480.0,616.0,861.0,596.0,618.0,738.0,450.0,788.0,414.0,7550.0
Chatra,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,51.0,154.0,198.0,135.0,124.0,78.0,130.0,103.0,86.0,96.0,69.0,116.0,1340.0
Chatra,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,850.0,646.0,848.0,796.0,685.0,775.0,665.0,781.0,483.0,669.0,583.0,486.0,8267.0
Chatra,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,884.0,701.0,781.0,815.0,721.0,698.0,634.0,722.0,527.0,673.0,573.0,409.0,8138.0
Chatra,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,10.0,0.0,0.0,6.0,2.0,19.0,6.0,34.0,1.0,14.0,19.0,0.0,111.0
Chatra,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,6.0,3.0,0.0,0.0,0.0,5.0,0.0,0.0,1.0,1.0,0.0,20.0
Chatra,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1073.0,931.0,2332.0,1145.0,952.0,983.0,1029.0,1105.0,973.0,920.0,910.0,959.0,13312.0
Chatra,10.4.2,Number of Immunisation sessions held during the month,TOTAL,960.0,856.0,1027.0,1036.0,881.0,902.0,925.0,1022.0,832.0,812.0,819.0,795.0,10867.0
Chatra,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,676.0,679.0,902.0,906.0,745.0,763.0,757.0,854.0,702.0,661.0,686.0,694.0,9025.0
Chatra,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,0.0,0.0,,6.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Chatra,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,792.0,541.0,663.0,677.0,5016.0,2449.0,1260.0,741.0,592.0,577.0,3673.0,918.0,17899.0
Chatra,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,79.0,38.0,93.0,132.0,6742.0,2796.0,1323.0,423.0,227.0,211.0,8100.0,1191.0,21355.0
Chatra,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,45.0,48.0,65.0,124.0,6833.0,3529.0,1356.0,366.0,278.0,178.0,8322.0,779.0,21923.0
Chatra,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chatra,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,122.0,143.0,0.0,116.0,2.0,0.0,49.0,18.0,1.0,6.0,7.0,6.0,470.0
Chatra,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,85.0,91.0,161.0,192.0,175.0,120.0,90.0,108.0,24.0,77.0,95.0,95.0,1313.0
Chatra,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,22.0,40.0,347.0,1094.0,345.0,375.0,278.0,171.0,87.0,136.0,219.0,47.0,3161.0
Chatra,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,23.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0
Chatra,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Chatra,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Chatra,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,5.0,0.0,2561.0,2561.0,0.0,0.0,0.0,0.0,0.0,5127.0
Chatra,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,4.0,2.0,3.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Chatra,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,4.0,3.0,1.0,3.0,3.0,2.0,3.0,4.0,5.0,3.0,3.0,3.0,-1.0
Chatra,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,606.0,537.0,461.0,438.0,382.0,428.0,470.0,512.0,441.0,491.0,458.0,562.0,-1.0
Chatra,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,5.0,3.0,4.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Chatra,14.05,Number of RKS meetings held during the month,TOTAL,2.0,3.0,0.0,1.0,0.0,1.0,3.0,3.0,2.0,1.0,0.0,2.0,18.0
Chatra,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,7.0,7.0,5.0,6.0,5.0,3.0,4.0,3.0,4.0,4.0,4.0,4.0,-1.0
Chatra,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,31.0,4.0,3.0,7.0,4.0,22.0,11.0,0.0,0.0,16.0,0.0,98.0
Chatra,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,3.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,3.0,-1.0
Chatra,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Chatra,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,871.0,781.0,1011.0,1194.0,1249.0,743.0,738.0,700.0,579.0,540.0,543.0,511.0,9460.0
Chatra,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,532.0,701.0,1136.0,971.0,1061.0,918.0,926.0,972.0,791.0,755.0,731.0,671.0,10165.0
Chatra,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,466.0,441.0,650.0,831.0,896.0,889.0,808.0,671.0,615.0,575.0,550.0,531.0,7923.0
Chatra,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,681.0,612.0,812.0,794.0,958.0,1096.0,938.0,890.0,704.0,662.0,717.0,589.0,9453.0
Chatra,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1337.0,1222.0,1661.0,2025.0,2145.0,1632.0,1546.0,1371.0,1194.0,1115.0,1093.0,1042.0,17383.0
Chatra,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1213.0,1313.0,1948.0,1765.0,2019.0,2014.0,1864.0,1862.0,1495.0,1417.0,1448.0,1260.0,19618.0
Chatra,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Chatra,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Chatra,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Chatra,14.11,In-Patient Head Count at midnight,TOTAL,87.0,212.0,168.0,149.0,313.0,144.0,212.0,641.0,505.0,521.0,488.0,1050.0,4490.0
Chatra,14.12.1,OPD attendance (All),TOTAL,22176.0,16362.0,24303.0,51968.0,26183.0,23915.0,20123.0,24688.0,17332.0,17052.0,22407.0,21357.0,287866.0
Chatra,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,565.0,565.0
Chatra,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Chatra,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,417.0,0.0,417.0
Chatra,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,14.14.c,Number of Adolescents counselled,TOTAL,0.0,16.0,10.0,10.0,5.0,0.0,0.0,199.0,0.0,5.0,0.0,0.0,245.0
Chatra,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,971.0,867.0,1172.0,1460.0,659.0,1022.0,1063.0,1060.0,538.0,1643.0,1414.0,655.0,12524.0
Chatra,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,41.0,24.0,57.0,41.0,34.0,42.0,34.0,142.0,19.0,40.0,40.0,19.0,533.0
Chatra,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,45.0,24.0,62.0,57.0,43.0,49.0,29.0,74.0,51.0,41.0,82.0,40.0,597.0
Chatra,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,3.0,7.0
Chatra,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,20.0,14.0,34.0,43.0,24.0,23.0,21.0,26.0,24.0,199.0,192.0,15.0,635.0
Chatra,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,5.0,5.0,4.0,2.0,1.0,1.0,15.0,16.0,1.0,0.0,0.0,54.0
Chatra,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,33.0,23.0,39.0,30.0,8.0,31.0,17.0,30.0,57.0,31.0,47.0,23.0,369.0
Chatra,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,4.0,4.0,5.0,5.0,0.0,0.0,16.0,15.0,11.0,0.0,0.0,0.0,60.0
Chatra,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,98.0,61.0,135.0,130.0,75.0,103.0,67.0,130.0,132.0,271.0,321.0,78.0,1601.0
Chatra,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8.0,9.0,11.0,9.0,2.0,1.0,17.0,31.0,29.0,1.0,0.0,3.0,121.0
Chatra,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,3.0
Chatra,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,12.0,0.0,0.0,0.0,0.0,6.0,6.0,6.0,6.0,0.0,0.0,0.0,36.0
Chatra,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,7.0,0.0,2.0,2.0,2.0,13.0,29.0,13.0,13.0,0.0,0.0,0.0,81.0
Chatra,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,19.0,0.0,2.0,2.0,2.0,19.0,35.0,19.0,19.0,0.0,0.0,0.0,117.0
Chatra,15.4.1,Number of blood smears examined for Malaria,TOTAL,1805.0,1656.0,1699.0,2707.0,4319.0,2667.0,2646.0,3328.0,1891.0,1015.0,1805.0,2316.0,27854.0
Chatra,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,108.0,87.0,117.0,210.0,209.0,222.0,241.0,270.0,132.0,89.0,93.0,141.0,1919.0
Chatra,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,0.0,1.0,2.0,1.0,5.0,4.0,65.0,59.0,2.0,0.0,2.0,143.0
Chatra,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,3000.0,12780.0,14260.0,7040.0,11710.0,,4390.0,8990.0,10080.0,10010.0,,82260.0
Chatra,16.1.1,Stock position of DPT vaccines,2. Stocks Received,15000.0,25000.0,16500.0,8300.0,20000.0,,12000.0,19000.0,13000.0,14000.0,5000.0,15000.0,162800.0
Chatra,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,12000.0,15220.0,15020.0,15520.0,15330.0,11710.0,7610.0,14400.0,11910.0,14070.0,15010.0,4720.0,152520.0
Chatra,16.1.1,Stock position of DPT vaccines,5. Total Stock,3000.0,12780.0,14260.0,7040.0,11710.0,0.0,4390.0,8990.0,10080.0,10010.0,0.0,10280.0,92540.0
Chatra,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Chatra,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,12920.0,18360.0,1640.0,13920.0,,3900.0,,10960.0,,10000.0,10000.0,440.0,82140.0
Chatra,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,,20000.0,,20000.0,,20000.0,,10000.0,10000.0,262000.0,,362000.0
Chatra,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,14560.0,16720.0,7720.0,13920.0,16100.0,3900.0,9040.0,10960.0,,10000.0,271560.0,440.0,374920.0
Chatra,16.1.2,Stock position of OPV vaccines,5. Total Stock,18360.0,1640.0,13920.0,0.0,3900.0,0.0,10960.0,0.0,10000.0,10000.0,440.0,0.0,69220.0
Chatra,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4880.0,3500.0,8450.0,8970.0,4620.0,1760.0,5950.0,9990.0,5320.0,6750.0,14530.0,6160.0,80880.0
Chatra,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,10000.0,10000.0,7700.0,10000.0,12000.0,12000.0,7000.0,10000.0,19500.0,5000.0,14000.0,127200.0
Chatra,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.1.3,Stock position of TT vaccines,4. Stock Distributed,11380.0,5050.0,9480.0,12050.0,12860.0,7810.0,7960.0,11670.0,8570.0,11720.0,13370.0,6380.0,118300.0
Chatra,16.1.3,Stock position of TT vaccines,5. Total Stock,3500.0,8450.0,8970.0,4620.0,1760.0,5950.0,9990.0,5320.0,6750.0,14530.0,6160.0,13780.0,89780.0
Chatra,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chatra,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1000.0,3500.0,5550.0,8400.0,,1640.0,3250.0,5690.0,4510.0,4780.0,1550.0,,39870.0
Chatra,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,10000.0,,10000.0,10000.0,10000.0,6000.0,10000.0,6500.0,,13000.0,95500.0
Chatra,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7500.0,8500.0,7150.0,8400.0,8360.0,8390.0,7560.0,7180.0,9730.0,9730.0,1550.0,5780.0,89830.0
Chatra,16.1.5,Stock position of BCG vaccines,5. Total Stock,3500.0,5000.0,8400.0,0.0,1640.0,3250.0,5690.0,4510.0,4780.0,1550.0,0.0,7220.0,45540.0
Chatra,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,4000.0,4005.0,4885.0,300.0,995.0,1775.0,,9150.0,340.0,7180.0,3335.0,35965.0
Chatra,16.1.6,Stock position of Measles vaccines,2. Stocks Received,8000.0,4000.0,5000.0,750.0,5000.0,5000.0,,75000.0,163600.0,9000.0,,5500.0,280850.0
Chatra,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4000.0,3995.0,4120.0,5335.0,4305.0,4220.0,1775.0,65850.0,172410.0,2160.0,3845.0,2825.0,274840.0
Chatra,16.1.6,Stock position of Measles vaccines,5. Total Stock,4000.0,4005.0,4885.0,300.0,995.0,1775.0,0.0,9150.0,340.0,7180.0,3335.0,6010.0,41975.0
Chatra,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Chatra,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,15750.0,8070.0,23820.0
Chatra,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,29600.0,,,29600.0
Chatra,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,13850.0,7680.0,4230.0,25760.0
Chatra,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15750.0,8070.0,3840.0,27660.0
Chatra,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,2000.0,,,,,,,,,2000.0
Chatra,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chatra,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Chatra,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,52500.0,,,,,,,,,52500.0
Chatra,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,52500.0,48000.0,,,,,,,,,100500.0
Chatra,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,100500.0,,,,,,,,,100500.0
Chatra,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,52500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,52500.0
Chatra,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chatra,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chatra,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chatra,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Chatra,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.3.02,Stock Position of Gloves,2. Stocks Received,3175.0,,,,,,,,,,,,3175.0
Chatra,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.3.02,Stock Position of Gloves,4. Stock Distributed,3175.0,,,,,,,,,,,,3175.0
Chatra,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Chatra,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Chatra,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Chatra,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Chatra,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Chatra,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Chatra,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Chatra,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Chatra,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Chatra,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Chatra,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Chatra,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,2000.0,,1000.0,,,1200.0,1200.0,,,5400.0
Chatra,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2000.0,,2000.0,3000.0,3000.0,3000.0,3000.0,1800.0,3000.0,,,,20800.0
Chatra,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2000.0,,,5000.0,2000.0,4000.0,3000.0,600.0,3000.0,,,,19600.0
Chatra,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,2000.0,0.0,1000.0,0.0,0.0,1200.0,1200.0,1200.0,0.0,0.0,6600.0
Chatra,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,4000.0,,2000.0,2000.0,12000.0,,32400.0,1815.0,,,54215.0
Chatra,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,28000.0,,30000.0,,69600.0,172800.0,32200.0,,,332600.0
Chatra,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,4000.0,26000.0,,20000.0,12000.0,37200.0,203385.0,33200.0,,,335785.0
Chatra,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,2000.0,2000.0,12000.0,0.0,32400.0,1815.0,815.0,0.0,0.0,51030.0
Chatra,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1000.0,,,,,,,,,,,,1000.0
Chatra,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2600.0,,,,,,,,,,,,2600.0
Chatra,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Chatra,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3600.0,,,,,,,,,,,,3600.0
Chatra,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chatra,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,2.0,2.0,,,,,,4.0
Chatra,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Chatra,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chatra,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Chatra,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Chatra,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chatra,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Chatra,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Chatra,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chatra,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Chatra,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,1.0,,,,,,1.0
Chatra,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chatra,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,1.0,,,,,,1.0
Chatra,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chatra,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chatra,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Chatra,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chatra,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chatra,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Chatra,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chatra,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chatra,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Chatra,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chatra,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chatra,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Chatra,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Chatra,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Chatra,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Chatra,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Chatra,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Chatra,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Chatra,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Chatra,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,1.0,,,,,,1.0
Chatra,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,2.0,,,,,,2.0
Chatra,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,2.0,,,,,,2.0
Chatra,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Chatra,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Chatra,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Chatra,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Chatra,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Chatra,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Chatra,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Chatra,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Chatra,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Chatra,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Chatra,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Chatra,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Chatra,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Chatra,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Chatra,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Chatra,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Chatra,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Chatra,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Chatra,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Chatra,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Chatra,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Chatra,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Chatra,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Chatra,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Chatra,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Chatra,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Chatra,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Chatra,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Chatra,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Chatra,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Deoghar,1.1,Total number of pregnant women Registered for ANC,TOTAL,3816.0,3254.0,3315.0,2104.0,2469.0,2918.0,2643.0,2837.0,2744.0,2891.0,2568.0,2589.0,34148.0
Deoghar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,941.0,626.0,536.0,375.0,855.0,504.0,622.0,556.0,653.0,558.0,650.0,553.0,7429.0
Deoghar,1.2,Number of Pregnant women registered under JSY,TOTAL,3031.0,2837.0,2835.0,1814.0,2327.0,2645.0,2436.0,2552.0,2446.0,2650.0,2448.0,2427.0,30448.0
Deoghar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1974.0,1916.0,2125.0,1335.0,1267.0,1620.0,1624.0,1754.0,1778.0,1387.0,1366.0,1410.0,19556.0
Deoghar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3285.0,2965.0,3046.0,1951.0,2283.0,2827.0,2406.0,2718.0,2596.0,2652.0,2362.0,2377.0,31468.0
Deoghar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3102.0,3228.0,3098.0,2070.0,2243.0,2786.0,1852.0,2677.0,2469.0,2146.0,2244.0,2252.0,30167.0
Deoghar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,951.0,686.0,348.0,849.0,363.0,130.0,594.0,5127.0,1657.0,1499.0,1410.0,1926.0,15540.0
Deoghar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,46.0,68.0,67.0,38.0,11.0,45.0,63.0,27.0,50.0,39.0,23.0,17.0,494.0
Deoghar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,5.0,17.0
Deoghar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,183.0,123.0,131.0,91.0,87.0,142.0,244.0,147.0,195.0,195.0,158.0,143.0,1839.0
Deoghar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,4.0,0.0,12.0,0.0,18.0
Deoghar,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Deoghar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,213.0,215.0,250.0,203.0,229.0,265.0,289.0,287.0,280.0,229.0,233.0,210.0,2903.0
Deoghar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,401.0,544.0,497.0,327.0,369.0,553.0,460.0,486.0,414.0,422.0,402.0,338.0,5213.0
Deoghar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,614.0,759.0,747.0,530.0,598.0,818.0,749.0,773.0,694.0,651.0,635.0,548.0,8116.0
Deoghar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,390.0,506.0,427.0,343.0,366.0,506.0,536.0,560.0,455.0,411.0,478.0,384.0,5362.0
Deoghar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,133.0,141.0,47.0,48.0,83.0,80.0,75.0,94.0,102.0,67.0,44.0,21.0,935.0
Deoghar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1707.0,1597.0,1548.0,1705.0,1576.0,1747.0,1762.0,1599.0,1673.0,1239.0,1092.0,1283.0,18528.0
Deoghar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1584.0,1232.0,1224.0,1282.0,895.0,1237.0,1110.0,1016.0,1474.0,1162.0,1084.0,1278.0,14578.0
Deoghar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,826.0,803.0,855.0,628.0,644.0,1280.0,701.0,769.0,684.0,371.0,491.0,746.0,8798.0
Deoghar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,773.0,786.0,825.0,624.0,594.0,1230.0,720.0,739.0,658.0,339.0,485.0,742.0,8515.0
Deoghar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,12.0,5.0,0.0,6.0,113.0,72.0,58.0,33.0,0.0,37.0,3.0,339.0
Deoghar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Deoghar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Deoghar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Deoghar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Deoghar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,4.0,2.0,0.0,4.0,4.0,3.0,1.0,12.0,0.0,0.0,0.0,4.0,34.0
Deoghar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Deoghar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,4.0,2.0,0.0,4.0,4.0,3.0,1.0,12.0,0.0,0.0,0.0,4.0,34.0
Deoghar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Deoghar,4.1.1.a,Number of male live births,TOTAL,1199.0,1261.0,1189.0,1161.0,1151.0,1295.0,1314.0,1275.0,1263.0,1023.0,884.0,955.0,13970.0
Deoghar,4.1.1.b,Number of female live births,TOTAL,1105.0,1112.0,1085.0,1076.0,1067.0,1241.0,1159.0,1088.0,1093.0,876.0,844.0,857.0,12603.0
Deoghar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2304.0,2373.0,2274.0,2237.0,2218.0,2536.0,2473.0,2363.0,2356.0,1899.0,1728.0,1812.0,26573.0
Deoghar,4.1.2,Number of still births,TOTAL,51.0,77.0,97.0,74.0,59.0,51.0,84.0,40.0,31.0,29.0,25.0,31.0,649.0
Deoghar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,53.0,40.0,50.0,25.0,67.0,49.0,36.0,50.0,38.0,40.0,37.0,34.0,519.0
Deoghar,4.2.1,Number of Newborns weighed at birth,TOTAL,2063.0,1916.0,1918.0,1930.0,1736.0,2201.0,2275.0,2241.0,2154.0,1615.0,1562.0,1693.0,23304.0
Deoghar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,234.0,137.0,119.0,50.0,122.0,162.0,66.0,237.0,102.0,101.0,51.0,76.0,1457.0
Deoghar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2156.0,2062.0,2019.0,2039.0,1848.0,2449.0,2337.0,2280.0,2237.0,1711.0,1653.0,1754.0,24545.0
Deoghar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Deoghar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,3.0,208.0,97.0,2.0,0.0,0.0,130.0,50.0,50.0,4.0,7.0,4.0,555.0
Deoghar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,355.0,252.0,273.0,293.0,350.0,349.0,65.0,192.0,9.0,0.0,3.0,6.0,2147.0
Deoghar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Deoghar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,358.0,460.0,371.0,295.0,350.0,349.0,195.0,242.0,59.0,4.0,10.0,10.0,2703.0
Deoghar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Deoghar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,404.0,253.0,171.0,80.0,117.0,65.0,256.0,125.0,59.0,2.0,4.0,41.0,1577.0
Deoghar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,81.0,4.0,3.0,6.0,5.0,10.0,4.0,40.0,7.0,0.0,3.0,5.0,168.0
Deoghar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,820.0,100.0,195.0,203.0,217.0,289.0,475.0,72.0,9.0,0.0,3.0,485.0,2868.0
Deoghar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,6.0,6.0,1.0,6.0,11.0,0.0,12.0,20.0,2.0,0.0,3.0,6.0,73.0
Deoghar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1051.0,1555.0,1204.0,1147.0,890.0,1715.0,1542.0,1491.0,1814.0,1040.0,1036.0,956.0,15441.0
Deoghar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1108.0,1371.0,1253.0,766.0,749.0,1461.0,1356.0,1373.0,1220.0,1016.0,1031.0,988.0,13692.0
Deoghar,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,2.0,2.0,65.0,38.0,0.0,0.0,0.0,0.0,107.0
Deoghar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,3.0,7.0,0.0,3.0,1.0,0.0,12.0,1.0,7.0,13.0,7.0,54.0
Deoghar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,20.0,3.0,7.0,0.0,0.0,14.0,0.0,0.0,3.0,2.0,3.0,0.0,52.0
Deoghar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,20.0,6.0,14.0,0.0,3.0,15.0,0.0,12.0,4.0,9.0,16.0,7.0,106.0
Deoghar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,1.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,2.0,0.0,0.0,7.0
Deoghar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,252.0,195.0,128.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,575.0
Deoghar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,390.0,171.0,123.0,1.0,0.0,0.0,0.0,0.0,4.0,0.0,4.0,4.0,697.0
Deoghar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,642.0,366.0,251.0,1.0,0.0,0.0,0.0,0.0,4.0,0.0,4.0,4.0,1272.0
Deoghar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,5.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Deoghar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Deoghar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,67.0,4.0,0.0,3.0,10.0,4.0,2.0,91.0
Deoghar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,0.0,0.0,1.0,0.0,14.0,0.0,0.0,0.0,6.0,2.0,12.0,37.0
Deoghar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Deoghar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,0.0,0.0,1.0,0.0,81.0,4.0,0.0,3.0,17.0,6.0,14.0,129.0
Deoghar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Deoghar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,3.0
Deoghar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Deoghar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,3.0
Deoghar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Deoghar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0,44.0,0.0,0.0,89.0
Deoghar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,44.0,12.0,1.0,0.0,0.0,302.0,62.0,160.0,716.0,1880.0,1381.0,281.0,4839.0
Deoghar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,10.0,2.0,0.0,0.0,0.0,58.0,15.0,71.0,304.0,1697.0,779.0,424.0,3360.0
Deoghar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Deoghar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,54.0,14.0,1.0,0.0,0.0,360.0,77.0,231.0,1065.0,3621.0,2160.0,705.0,8288.0
Deoghar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Deoghar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,3.0
Deoghar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Deoghar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,3.0
Deoghar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Deoghar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,88.0,125.0,109.0,63.0,77.0,89.0,101.0,151.0,197.0,212.0,144.0,120.0,1476.0
Deoghar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,7.0,0.0,0.0,1.0,0.0,4.0,3.0,3.0,5.0,7.0,3.0,3.0,36.0
Deoghar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,48.0,36.0,35.0,11.0,48.0,380.0,131.0,102.0,153.0,212.0,164.0,119.0,1439.0
Deoghar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,20.0,18.0,10.0,11.0,4.0,23.0,38.0,45.0,55.0,29.0,38.0,46.0,337.0
Deoghar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Deoghar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,163.0,179.0,154.0,86.0,129.0,496.0,273.0,301.0,410.0,460.0,349.0,288.0,3288.0
Deoghar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Deoghar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Deoghar,9.06,Number of IUCD removals,TOTAL,70.0,67.0,55.0,48.0,48.0,71.0,83.0,81.0,110.0,126.0,110.0,110.0,979.0
Deoghar,9.07,Number of Oral Pills cycles distributed,TOTAL,155.0,131.0,98.0,35.0,57.0,437.0,789.0,1077.0,2187.0,2125.0,2149.0,2312.0,11552.0
Deoghar,9.08,Number of Condom pieces distributed,TOTAL,3438.0,671.0,511.0,816.0,116.0,1778.0,2684.0,4678.0,6589.0,7192.0,8500.0,10916.0,47889.0
Deoghar,9.09,Number of Centchroman (weekly) pills given,TOTAL,25.0,57.0,31.0,4.0,4.0,19.0,45.0,62.0,46.0,43.0,206.0,89.0,631.0
Deoghar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,206.0,234.0,169.0,106.0,135.0,218.0,353.0,277.0,544.0,352.0,316.0,322.0,3232.0
Deoghar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,5.0,0.0,9.0
Deoghar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,12.0,2.0,0.0,29.0,12.0,24.0,2.0,81.0
Deoghar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Deoghar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,2.0,16.0,0.0,0.0,21.0
Deoghar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Deoghar,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,9.0,10.0,11.0,11.0,7.0,11.0,11.0,12.0,10.0,9.0,8.0,-1.0
Deoghar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2675.0,2564.0,3214.0,2627.0,3332.0,3642.0,3954.0,3741.0,3869.0,2793.0,611.0,521.0,33543.0
Deoghar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2708.0,2452.0,3035.0,2063.0,2464.0,3631.0,3758.0,3690.0,3603.0,3109.0,2691.0,2497.0,35701.0
Deoghar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3178.0,2630.0,2884.0,1960.0,1898.0,2837.0,3099.0,3608.0,3628.0,2995.0,3004.0,2653.0,34374.0
Deoghar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3332.0,2871.0,2999.0,1849.0,2070.0,2515.0,2561.0,2973.0,3334.0,3018.0,2956.0,2788.0,33266.0
Deoghar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Deoghar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Deoghar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Deoghar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2000.0,2012.0,3706.0,2001.0,2312.0,2499.0,2225.0,2511.0,2108.0,1027.0,847.0,592.0,23840.0
Deoghar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2718.0,2442.0,2998.0,2058.0,2460.0,3642.0,3658.0,3754.0,2419.0,793.0,1581.0,525.0,29048.0
Deoghar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3145.0,2615.0,2880.0,1951.0,1900.0,2838.0,3049.0,3627.0,2460.0,669.0,1699.0,431.0,27264.0
Deoghar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3290.0,2866.0,2995.0,1819.0,2068.0,2551.0,2478.0,2953.0,2200.0,735.0,1632.0,411.0,25998.0
Deoghar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,7.0,0.0,,,,0.0,6.0,202.0,629.0,696.0,396.0,380.0,2316.0
Deoghar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,19.0,4.0,48.0,8.0,15.0,12.0,15.0,2250.0,3460.0,2815.0,1037.0,196.0,9879.0
Deoghar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,9.0,0.0,5.0,0.0,0.0,0.0,0.0,104.0,1491.0,2462.0,982.0,170.0,5223.0
Deoghar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,9.0,0.0,17.0,0.0,0.0,0.0,0.0,81.0,400.0,1147.0,885.0,220.0,2759.0
Deoghar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2807.0,2753.0,3349.0,2148.0,1946.0,2790.0,3347.0,3054.0,2860.0,2534.0,2427.0,2434.0,32449.0
Deoghar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,0.0,,,,12.0,21.0,78.0,48.0,40.0,280.0,289.0,768.0
Deoghar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Deoghar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1406.0,1417.0,1672.0,987.0,1020.0,1411.0,1680.0,1595.0,1474.0,1230.0,1160.0,1181.0,16233.0
Deoghar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1298.0,1271.0,1535.0,957.0,893.0,1293.0,1578.0,1328.0,1348.0,1140.0,1110.0,1097.0,14848.0
Deoghar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2704.0,2688.0,3207.0,1944.0,1913.0,2704.0,3258.0,2923.0,2822.0,2370.0,2270.0,2278.0,31081.0
Deoghar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1923.0,1852.0,2267.0,1523.0,1377.0,1802.0,1584.0,1721.0,1785.0,1786.0,1791.0,1790.0,21201.0
Deoghar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1926.0,1903.0,2254.0,1314.0,1377.0,1768.0,1550.0,1647.0,1187.0,446.0,1035.0,470.0,16877.0
Deoghar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Deoghar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,638.0,773.0,842.0,445.0,416.0,484.0,466.0,616.0,428.0,557.0,561.0,442.0,6668.0
Deoghar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,612.0,741.0,868.0,420.0,432.0,401.0,408.0,534.0,350.0,491.0,531.0,429.0,6217.0
Deoghar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1250.0,1514.0,1710.0,865.0,848.0,885.0,874.0,1150.0,778.0,1048.0,1092.0,871.0,12885.0
Deoghar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,377.0,309.0,423.0,314.0,212.0,368.0,225.0,310.0,294.0,233.0,312.0,233.0,3610.0
Deoghar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,972.0,1141.0,1169.0,788.0,738.0,1028.0,780.0,755.0,781.0,801.0,629.0,715.0,10297.0
Deoghar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,990.0,927.0,1135.0,663.0,690.0,1032.0,769.0,786.0,803.0,703.0,627.0,650.0,9775.0
Deoghar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,46.0,58.0,30.0,36.0,31.0,26.0,21.0,19.0,22.0,12.0,10.0,6.0,317.0
Deoghar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,5.0,2.0,4.0,2.0,4.0,6.0,2.0,5.0,6.0,3.0,2.0,45.0
Deoghar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1623.0,1771.0,1952.0,1806.0,1752.0,1770.0,1795.0,1831.0,1804.0,1622.0,1597.0,1576.0,20899.0
Deoghar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1588.0,1771.0,1938.0,1425.0,1479.0,1743.0,1736.0,1747.0,1773.0,1568.0,1556.0,1556.0,19880.0
Deoghar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1311.0,1373.0,1544.0,1005.0,1132.0,1426.0,1328.0,1407.0,1512.0,1267.0,1324.0,1286.0,15915.0
Deoghar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1960.0,1982.0,1733.0,1155.0,1052.0,442.0,383.0,215.0,88.0,77.0,3604.0,1985.0,14676.0
Deoghar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,295.0,348.0,284.0,182.0,225.0,84.0,62.0,17.0,32.0,16.0,10464.0,832.0,12841.0
Deoghar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,144.0,151.0,143.0,65.0,60.0,46.0,34.0,0.0,0.0,21.0,11487.0,1016.0,13167.0
Deoghar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Deoghar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,4.0
Deoghar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Deoghar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,62.0,55.0,74.0,156.0,26.0,20.0,13.0,12.0,14.0,10.0,33.0,25.0,500.0
Deoghar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,256.0,316.0,255.0,273.0,187.0,272.0,153.0,169.0,124.0,150.0,190.0,190.0,2535.0
Deoghar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,285.0,109.0,89.0,85.0,140.0,53.0,25.0,68.0,98.0,69.0,23.0,12.0,1056.0
Deoghar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,18.0,0.0,0.0,0.0,0.0,0.0,18.0
Deoghar,13.1,Number of Patients operated for cataract,TOTAL,0.0,470.0,85.0,75.0,75.0,75.0,135.0,299.0,584.0,831.0,1319.0,799.0,4747.0
Deoghar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,76.0,76.0,67.0,67.0,67.0,0.0,269.0,525.0,797.0,1157.0,719.0,3820.0
Deoghar,13.3,Number of School children detected with Refractive errors,TOTAL,2.0,50.0,82.0,79.0,191.0,8618.0,131.0,1186.0,645.0,432.0,504.0,561.0,12481.0
Deoghar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,155.0,0.0,0.0,0.0,0.0,0.0,0.0,155.0
Deoghar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,3.0,6.0,5.0,6.0,4.0,6.0,6.0,7.0,5.0,6.0,6.0,-1.0
Deoghar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,2.0,1.0,2.0,1.0,2.0,3.0,2.0,2.0,1.0,1.0,2.0,-1.0
Deoghar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,573.0,349.0,353.0,291.0,247.0,540.0,506.0,459.0,426.0,584.0,304.0,217.0,-1.0
Deoghar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,5.0,8.0,6.0,7.0,5.0,6.0,6.0,6.0,6.0,7.0,7.0,-1.0
Deoghar,14.05,Number of RKS meetings held during the month,TOTAL,2.0,3.0,3.0,1.0,3.0,2.0,2.0,1.0,3.0,2.0,4.0,2.0,28.0
Deoghar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,9.0,8.0,9.0,7.0,9.0,7.0,10.0,10.0,10.0,9.0,10.0,10.0,-1.0
Deoghar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,26.0,17.0,21.0,12.0,18.0,14.0,28.0,17.0,14.0,23.0,17.0,20.0,227.0
Deoghar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,2.0,5.0,4.0,5.0,3.0,6.0,6.0,6.0,6.0,6.0,5.0,-1.0
Deoghar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,-1.0
Deoghar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,440.0,282.0,244.0,339.0,348.0,341.0,83.0,325.0,339.0,305.0,260.0,351.0,3657.0
Deoghar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,478.0,327.0,271.0,456.0,452.0,364.0,533.0,259.0,201.0,217.0,322.0,293.0,4173.0
Deoghar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,418.0,298.0,225.0,292.0,310.0,324.0,43.0,239.0,303.0,252.0,230.0,301.0,3235.0
Deoghar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1239.0,582.0,873.0,1215.0,1160.0,1042.0,1152.0,984.0,944.0,1094.0,1352.0,1004.0,12641.0
Deoghar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,858.0,580.0,469.0,631.0,658.0,665.0,126.0,564.0,642.0,557.0,490.0,652.0,6892.0
Deoghar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1717.0,909.0,1144.0,1671.0,1612.0,1406.0,1685.0,1243.0,1145.0,1311.0,1674.0,1297.0,16814.0
Deoghar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,28.0,32.0,26.0,35.0,26.0,34.0,31.0,21.0,18.0,20.0,18.0,19.0,308.0
Deoghar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,32.0,25.0,9.0,21.0,19.0,13.0,17.0,20.0,10.0,11.0,26.0,20.0,223.0
Deoghar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,60.0,57.0,35.0,56.0,45.0,47.0,48.0,41.0,28.0,31.0,44.0,39.0,531.0
Deoghar,14.11,In-Patient Head Count at midnight,TOTAL,3681.0,1968.0,1786.0,1473.0,1861.0,1350.0,1633.0,2436.0,2173.0,2923.0,1691.0,1526.0,24501.0
Deoghar,14.12.1,OPD attendance (All),TOTAL,40390.0,41375.0,43456.0,35024.0,34496.0,41990.0,38183.0,34971.0,37170.0,35298.0,32008.0,32580.0,446941.0
Deoghar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,16.0,6.0,3.0,5.0,5.0,9.0,4.0,7.0,0.0,2.0,16.0,13.0,86.0
Deoghar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Deoghar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,16.0,3.0,1.0,1.0,1.0,67.0,6.0,16.0,217.0,263.0,189.0,163.0,943.0
Deoghar,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,488.0,219.0,161.0,0.0,161.0,252.0,153.0,110.0,146.0,146.0,171.0,189.0,2196.0
Deoghar,14.14.c,Number of Adolescents counselled,TOTAL,16.0,4.0,0.0,0.0,0.0,12.0,0.0,0.0,0.0,6.0,75.0,0.0,113.0
Deoghar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2246.0,1373.0,1256.0,1053.0,1058.0,1390.0,1035.0,1297.0,1447.0,1534.0,1911.0,1774.0,17374.0
Deoghar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,108.0,53.0,67.0,44.0,49.0,56.0,52.0,78.0,42.0,34.0,46.0,69.0,698.0
Deoghar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,306.0,112.0,126.0,137.0,155.0,184.0,148.0,221.0,6.0,39.0,299.0,177.0,1910.0
Deoghar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,3.0,1.0,3.0,1.0,5.0,0.0,2.0,0.0,0.0,3.0,7.0,27.0
Deoghar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,406.0,123.0,147.0,201.0,181.0,240.0,209.0,300.0,76.0,24.0,354.0,193.0,2454.0
Deoghar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,0.0,2.0,2.0,3.0,2.0,2.0,0.0,0.0,2.0,2.0,16.0
Deoghar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,598.0,403.0,286.0,301.0,258.0,249.0,216.0,301.0,52.0,98.0,340.0,331.0,3433.0
Deoghar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Deoghar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1310.0,638.0,559.0,639.0,594.0,673.0,573.0,822.0,134.0,161.0,993.0,701.0,7797.0
Deoghar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4.0,4.0,1.0,5.0,3.0,8.0,2.0,4.0,0.0,0.0,5.0,9.0,45.0
Deoghar,15.2,Number of Widal tests conducted,Number tested,232.0,99.0,148.0,181.0,191.0,347.0,0.0,173.0,0.0,84.0,107.0,190.0,1752.0
Deoghar,15.3.a,Number of VDRL tests conducted on males,Number tested,76.0,10.0,11.0,14.0,24.0,51.0,37.0,51.0,101.0,8.0,12.0,11.0,406.0
Deoghar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,130.0,74.0,96.0,65.0,49.0,36.0,82.0,64.0,14.0,10.0,47.0,24.0,691.0
Deoghar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,292.0,142.0,164.0,135.0,166.0,176.0,158.0,108.0,98.0,38.0,78.0,52.0,1607.0
Deoghar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,498.0,226.0,271.0,214.0,239.0,263.0,277.0,223.0,213.0,56.0,137.0,87.0,2704.0
Deoghar,15.4.1,Number of blood smears examined for Malaria,TOTAL,7281.0,7475.0,13647.0,10815.0,8503.0,14578.0,17577.0,22975.0,24350.0,11080.0,15368.0,22666.0,176315.0
Deoghar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,6.0,7.0,7.0,9.0,6.0,8.0,4.0,4.0,4.0,3.0,3.0,4.0,65.0
Deoghar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,12.0,1.0,8.0,10.0,24.0,16.0,8.0,10.0,16.0,1.0,0.0,1.0,107.0
Deoghar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3151.0,1352.0,3457.0,4848.0,3620.0,2025.0,3321.0,3321.0,1699.0,3999.0,4729.0,2884.0,38406.0
Deoghar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,4000.0,3300.0,0.0,0.0,3000.0,,0.0,4000.0,3000.0,0.0,0.0,17300.0
Deoghar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0
Deoghar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1799.0,1895.0,1909.0,1228.0,1595.0,2010.0,1622.0,1622.0,1700.0,2270.0,1845.0,1290.0,20785.0
Deoghar,16.1.1,Stock position of DPT vaccines,5. Total Stock,1352.0,3457.0,4848.0,3620.0,2025.0,3015.0,1699.0,1699.0,3999.0,4729.0,2884.0,1594.0,34921.0
Deoghar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Deoghar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Deoghar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Deoghar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Deoghar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1792.0,226.0,1948.0,3359.0,2101.0,597.0,1749.0,1749.0,439.0,39.0,409.0,304.0,14712.0
Deoghar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,3500.0,3000.0,0.0,0.0,1800.0,,0.0,0.0,1000.0,18700.0,0.0,28000.0
Deoghar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0,0.0
Deoghar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1566.0,1778.0,1589.0,1258.0,1504.0,1533.0,1310.0,1310.0,400.0,630.0,18805.0,50.0,31733.0
Deoghar,16.1.2,Stock position of OPV vaccines,5. Total Stock,226.0,1948.0,3359.0,2101.0,597.0,864.0,439.0,439.0,39.0,409.0,304.0,254.0,10979.0
Deoghar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2596.0,880.0,2935.0,4133.0,2985.0,1341.0,2913.0,2913.0,1248.0,3968.0,4898.0,3468.0,34278.0
Deoghar,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,3500.0,3000.0,0.0,0.0,0.0,,0.0,4000.0,3000.0,0.0,0.0,13500.0
Deoghar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0
Deoghar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1716.0,1445.0,1802.0,1148.0,1644.0,954.0,1665.0,1665.0,1280.0,2070.0,1430.0,1240.0,18059.0
Deoghar,16.1.3,Stock position of TT vaccines,5. Total Stock,880.0,2935.0,4133.0,2985.0,1341.0,387.0,1248.0,1248.0,3968.0,4898.0,3468.0,2228.0,29719.0
Deoghar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2873.0,1232.0,3020.0,3670.0,2837.0,1383.0,2339.0,2339.0,768.0,693.0,63.0,13.0,21230.0
Deoghar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,3000.0,2200.0,0.0,0.0,3000.0,,0.0,1000.0,0.0,0.0,0.0,9200.0
Deoghar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0
Deoghar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1641.0,1212.0,1550.0,833.0,1454.0,1879.0,1571.0,1571.0,1075.0,630.0,50.0,10.0,13476.0
Deoghar,16.1.5,Stock position of BCG vaccines,5. Total Stock,1232.0,3020.0,3670.0,2837.0,1383.0,2504.0,768.0,768.0,693.0,63.0,13.0,3.0,16954.0
Deoghar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3125.0,1925.0,925.0,1375.0,677.0,78.0,2266.0,2266.0,711.0,2636.0,3666.0,2346.0,21996.0
Deoghar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,1200.0,0.0,0.0,4000.0,,0.0,3000.0,3000.0,,0.0,11200.0
Deoghar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,1555.0,0.0,,,1320.0,,2875.0
Deoghar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1200.0,1000.0,750.0,698.0,599.0,1732.0,711.0,1555.0,1075.0,1970.0,2346.0,1040.0,14676.0
Deoghar,16.1.6,Stock position of Measles vaccines,5. Total Stock,1925.0,925.0,1375.0,677.0,78.0,2346.0,0.0,711.0,2636.0,3666.0,0.0,1306.0,15645.0
Deoghar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0
Deoghar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,2150.0,2150.0,670.0,1660.0,250.0,100.0,6980.0
Deoghar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,2150.0,,0.0,0.0,2150.0
Deoghar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0
Deoghar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,1480.0,1480.0,1160.0,1410.0,150.0,90.0,5770.0
Deoghar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,670.0,670.0,1660.0,250.0,100.0,10.0,3360.0
Deoghar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,,,0.0,0.0,,0.0,0.0,0.0,0.0
Deoghar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,,,,0.0,,0.0,0.0,,0.0
Deoghar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,,0.0,,0.0,0.0,0.0,0.0
Deoghar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,,,,0.0,0.0,,0.0,0.0,0.0,0.0
Deoghar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,,,27720.0,27720.0,10080.0,10080.0,10080.0,10080.0,95760.0
Deoghar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,,,,0.0,,,0.0,0.0,0.0
Deoghar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,,0.0,,,0.0,0.0,0.0
Deoghar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,,,,,17640.0,,,0.0,0.0,17640.0
Deoghar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,27720.0,10080.0,10080.0,10080.0,10080.0,10080.0,78120.0
Deoghar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,,,3600.0,3600.0,3600.0,3600.0,3600.0,3600.0,21600.0
Deoghar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,,,,0.0,,,0.0,0.0,0.0
Deoghar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,,0.0,,,0.0,0.0,0.0
Deoghar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,,,,,0.0,,,0.0,0.0,0.0
Deoghar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,3600.0,3600.0,3600.0,3600.0,3600.0,3600.0,21600.0
Deoghar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,,,400.0,400.0,400.0,400.0,400.0,400.0,2400.0
Deoghar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,,,,,,,0.0,0.0,0.0
Deoghar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,0.0,0.0,0.0
Deoghar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,,,,,,,,0.0,0.0,0.0
Deoghar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,400.0,400.0,400.0,400.0,400.0,400.0,2400.0
Deoghar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,,,,0.0,0.0,,,,0.0
Deoghar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,,,,0.0,0.0,,,,0.0
Deoghar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,,0.0,0.0,,,,0.0
Deoghar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,,,,,0.0,0.0,,,,0.0
Deoghar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,0.0,,,,0.0
Deoghar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Deoghar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Deoghar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Deoghar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Deoghar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Deoghar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Deoghar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Deoghar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Deoghar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Deoghar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Deoghar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Deoghar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Deoghar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Deoghar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Deoghar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Deoghar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Deoghar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Deoghar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Deoghar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Deoghar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Deoghar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Deoghar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Deoghar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Deoghar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Deoghar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Deoghar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Deoghar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Deoghar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Deoghar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Deoghar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Deoghar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Deoghar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Deoghar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Deoghar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Deoghar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Deoghar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,0.0,0.0,0.0,880.0,370.0,1250.0
Deoghar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,0.0,0.0,3980.0,0.0,0.0,3980.0
Deoghar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Deoghar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,0.0,0.0,3100.0,510.0,40.0,3650.0
Deoghar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,880.0,370.0,330.0,1580.0
Deoghar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Deoghar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Deoghar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Deoghar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Deoghar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Deoghar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,5600.0,2800.0,1000.0,7800.0,5800.0,3200.0,7300.0,7300.0,4400.0,4400.0,2300.0,2100.0,54000.0
Deoghar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,8000.0,0.0,0.0,9000.0,,0.0,3000.0,0.0,0.0,0.0,20000.0
Deoghar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0
Deoghar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2800.0,1800.0,1200.0,2000.0,2600.0,4200.0,2900.0,2900.0,3000.0,2100.0,200.0,300.0,26000.0
Deoghar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2800.0,1000.0,7800.0,5800.0,3200.0,8000.0,4400.0,4400.0,4400.0,2300.0,2100.0,1800.0,48000.0
Deoghar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,52900.0,35200.0,51200.0,48800.0,38200.0,27600.0,38000.0,38000.0,18000.0,44000.0,58000.0,40000.0,489900.0
Deoghar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,30000.0,20000.0,0.0,0.0,20000.0,,,50000.0,40000.0,0.0,0.0,160000.0
Deoghar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0
Deoghar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,17700.0,14000.0,22400.0,10600.0,10600.0,20000.0,20000.0,20000.0,24000.0,26000.0,18000.0,14000.0,217300.0
Deoghar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,35200.0,51200.0,48800.0,38200.0,27600.0,27600.0,18000.0,18000.0,44000.0,58000.0,40000.0,26000.0,432600.0
Deoghar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,6890.0,3790.0,2590.0,790.0,690.0,590.0,4200.0,4200.0,1800.0,3300.0,3500.0,2000.0,34340.0
Deoghar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,4000.0,3000.0,0.0,0.0,7000.0
Deoghar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0
Deoghar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3100.0,1200.0,1800.0,100.0,100.0,390.0,2400.0,2400.0,2500.0,2800.0,1500.0,800.0,19090.0
Deoghar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3790.0,2590.0,790.0,690.0,590.0,200.0,1800.0,1800.0,3300.0,3500.0,2000.0,1200.0,22250.0
Deoghar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,1.0,,,,4.0,,5.0
Deoghar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Deoghar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Deoghar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Deoghar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Deoghar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Deoghar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,1.0,,,,1.0
Deoghar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Deoghar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Deoghar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,1.0,,,,,,1.0
Deoghar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Deoghar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,1.0,1.0,,1.0,1.0,,4.0
Deoghar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,1.0,1.0,,1.0,1.0,,4.0
Deoghar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Deoghar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Deoghar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,1.0,,,,1.0
Deoghar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,1.0,1.0,,,,2.0
Deoghar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Deoghar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,1.0,1.0,,,,2.0
Deoghar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Deoghar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Deoghar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,1.0,1.0
Deoghar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Deoghar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Deoghar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Deoghar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Deoghar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Deoghar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,1.0,,,,,,1.0
Deoghar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Deoghar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Deoghar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Deoghar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,1.0,1.0
Deoghar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Deoghar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Deoghar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Deoghar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Deoghar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Deoghar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,2.0,2.0
Deoghar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Deoghar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Deoghar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Deoghar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Deoghar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Deoghar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Deoghar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Deoghar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Deoghar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Deoghar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Deoghar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Deoghar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Deoghar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Deoghar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Deoghar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Deoghar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Deoghar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Deoghar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Deoghar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Deoghar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Deoghar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Deoghar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,2.0,2.0
Deoghar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Deoghar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Deoghar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Deoghar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,2.0,2.0
Deoghar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Deoghar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,3.0,3.0
Deoghar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Deoghar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Deoghar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Dhanbad,1.1,Total number of pregnant women Registered for ANC,TOTAL,3665.0,3783.0,3597.0,3045.0,3281.0,3827.0,3429.0,2905.0,3947.0,4253.0,4349.0,3714.0,43795.0
Dhanbad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1267.0,1322.0,1309.0,843.0,905.0,983.0,755.0,598.0,715.0,648.0,863.0,739.0,10947.0
Dhanbad,1.2,Number of Pregnant women registered under JSY,TOTAL,3114.0,3078.0,2858.0,2343.0,2487.0,2464.0,2784.0,2282.0,2437.0,3556.0,3478.0,3381.0,34262.0
Dhanbad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2375.0,2326.0,2036.0,1789.0,1731.0,1886.0,1428.0,1480.0,1343.0,1284.0,1460.0,1513.0,20651.0
Dhanbad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3223.0,2864.0,3044.0,2521.0,2752.0,2707.0,3181.0,2653.0,3736.0,3829.0,4014.0,3569.0,38093.0
Dhanbad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2828.0,2614.0,2637.0,2215.0,2501.0,2377.0,2324.0,3095.0,3186.0,3494.0,3585.0,2979.0,33835.0
Dhanbad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3122.0,1937.0,1292.0,918.0,771.0,787.0,420.0,1450.0,1369.0,1648.0,2539.0,2540.0,18793.0
Dhanbad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,218.0,231.0,246.0,173.0,160.0,128.0,109.0,86.0,138.0,135.0,107.0,94.0,1825.0
Dhanbad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,16.0,2.0,1.0,26.0
Dhanbad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,257.0,265.0,304.0,261.0,246.0,248.0,254.0,216.0,333.0,251.0,328.0,343.0,3306.0
Dhanbad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,7.0,56.0,72.0
Dhanbad,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Dhanbad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,267.0,249.0,238.0,183.0,283.0,202.0,321.0,168.0,178.0,246.0,170.0,143.0,2648.0
Dhanbad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,462.0,548.0,612.0,603.0,549.0,570.0,421.0,412.0,555.0,531.0,503.0,493.0,6259.0
Dhanbad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,729.0,797.0,850.0,786.0,832.0,772.0,742.0,580.0,733.0,777.0,673.0,636.0,8907.0
Dhanbad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,523.0,656.0,642.0,576.0,674.0,629.0,617.0,511.0,618.0,599.0,565.0,593.0,7203.0
Dhanbad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,313.0,315.0,343.0,343.0,359.0,407.0,274.0,240.0,219.0,169.0,249.0,183.0,3414.0
Dhanbad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,834.0,933.0,908.0,910.0,876.0,952.0,741.0,690.0,677.0,634.0,633.0,637.0,9425.0
Dhanbad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,818.0,874.0,850.0,871.0,850.0,930.0,691.0,673.0,610.0,621.0,598.0,615.0,9001.0
Dhanbad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,593.0,668.0,915.0,652.0,637.0,509.0,439.0,395.0,423.0,437.0,612.0,588.0,6868.0
Dhanbad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,407.0,549.0,726.0,464.0,462.0,413.0,326.0,307.0,324.0,322.0,514.0,498.0,5312.0
Dhanbad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,35.0,15.0,14.0,29.0,10.0,21.0,15.0,12.0,8.0,11.0,206.0,0.0,376.0
Dhanbad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,92.0,1514.0,1717.0,386.0,927.0,924.0,1448.0,1357.0,871.0,1226.0,1160.0,1867.0,13489.0
Dhanbad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,118.0,0.0,118.0
Dhanbad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,118.0,0.0,118.0
Dhanbad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Dhanbad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhanbad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,43.0,81.0,27.0,70.0,61.0,215.0,451.0,437.0,35.0,270.0,321.0,679.0,2690.0
Dhanbad,4.1.1.a,Number of male live births,TOTAL,991.0,1884.0,1971.0,1178.0,1497.0,1556.0,1611.0,1564.0,1167.0,1429.0,1432.0,1691.0,17971.0
Dhanbad,4.1.1.b,Number of female live births,TOTAL,880.0,1513.0,1609.0,1061.0,1401.0,1309.0,1529.0,1238.0,1076.0,1326.0,1144.0,1481.0,15567.0
Dhanbad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1871.0,3397.0,3580.0,2239.0,2898.0,2865.0,3140.0,2802.0,2243.0,2755.0,2576.0,3172.0,33538.0
Dhanbad,4.1.2,Number of still births,TOTAL,4.0,37.0,33.0,43.0,24.0,49.0,30.0,10.0,5.0,24.0,9.0,10.0,278.0
Dhanbad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,20.0,45.0,38.0,37.0,28.0,36.0,35.0,27.0,22.0,20.0,16.0,78.0,402.0
Dhanbad,4.2.1,Number of Newborns weighed at birth,TOTAL,1610.0,1961.0,2642.0,1755.0,2435.0,2154.0,2938.0,2635.0,1810.0,2162.0,2438.0,3144.0,27684.0
Dhanbad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,205.0,196.0,138.0,145.0,236.0,193.0,120.0,120.0,90.0,234.0,151.0,113.0,1941.0
Dhanbad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1697.0,1987.0,2725.0,1815.0,2507.0,2115.0,3036.0,2603.0,2012.0,2154.0,2435.0,3143.0,28229.0
Dhanbad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,2.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,7.0,4.0,3.0,19.0
Dhanbad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,20.0,21.0,1.0,0.0,45.0
Dhanbad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Dhanbad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhanbad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,2.0,0.0,0.0,0.0,3.0,3.0,0.0,20.0,28.0,5.0,3.0,64.0
Dhanbad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,43.0,37.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,80.0
Dhanbad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,23.0,97.0,2.0,22.0,2.0,9.0,24.0,553.0,4.0,1.0,737.0
Dhanbad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Dhanbad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,7.0,7.0,0.0,78.0,3.0,7.0,0.0,0.0,0.0,1.0,0.0,0.0,103.0
Dhanbad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1354.0,1659.0,2279.0,1514.0,1488.0,1787.0,1413.0,1440.0,1428.0,2146.0,2324.0,1992.0,20824.0
Dhanbad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1209.0,1417.0,1834.0,1480.0,1341.0,1575.0,1186.0,1425.0,1730.0,1579.0,1565.0,1267.0,17608.0
Dhanbad,6.3,PNC maternal complications attended,TOTAL,23.0,7.0,17.0,0.0,0.0,33.0,0.0,0.0,26.0,25.0,0.0,0.0,131.0
Dhanbad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,2.0,0.0,0.0,2.0,2.0,2.0,4.0,0.0,0.0,2.0,14.0
Dhanbad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,6.0
Dhanbad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,3.0,0.0,0.0,3.0,3.0,3.0,4.0,0.0,1.0,3.0,20.0
Dhanbad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,63.0,63.0
Dhanbad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,33.0,99.0,68.0,87.0,88.0,74.0,93.0,71.0,69.0,66.0,105.0,91.0,944.0
Dhanbad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,46.0,102.0,81.0,79.0,76.0,62.0,76.0,62.0,68.0,75.0,132.0,105.0,964.0
Dhanbad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,79.0,201.0,149.0,166.0,164.0,136.0,169.0,133.0,137.0,141.0,237.0,196.0,1908.0
Dhanbad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,19.0,2.0,8.0,2.0,5.0,10.0,0.0,0.0,9.0,55.0
Dhanbad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,13.0,6.0,4.0,186.0,9.0,2.0,2.0,8.0,26.0,50.0,19.0,135.0,460.0
Dhanbad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Dhanbad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhanbad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,13.0,6.0,4.0,205.0,11.0,10.0,4.0,13.0,36.0,50.0,19.0,144.0,515.0
Dhanbad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,18.0,3.0,8.0,16.0,2.0,0.0,12.0,156.0,44.0,26.0,10.0,8.0,303.0
Dhanbad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,2.0,0.0,0.0,6.0,0.0,0.0,0.0,10.0
Dhanbad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,0.0,122.0,0.0,0.0,136.0
Dhanbad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Dhanbad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhanbad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,16.0,0.0,2.0,0.0,0.0,6.0,122.0,0.0,0.0,146.0
Dhanbad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,2.0,27.0,12.0,0.0,171.0,311.0,397.0,0.0,40.0,960.0
Dhanbad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,7.0,0.0,0.0,45.0,0.0,0.0,0.0,12.0,78.0,163.0,0.0,0.0,305.0
Dhanbad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,45.0,61.0,15.0,222.0,33.0,19.0,32.0,183.0,775.0,1536.0,902.0,120.0,3943.0
Dhanbad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Dhanbad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhanbad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,52.0,61.0,15.0,267.0,33.0,19.0,32.0,195.0,853.0,1699.0,902.0,120.0,4248.0
Dhanbad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,147.0,160.0,177.0,141.0,148.0,198.0,165.0,0.0,1362.0,496.0,465.0,425.0,3884.0
Dhanbad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Dhanbad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Dhanbad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhanbad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Dhanbad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,274.0,233.0,207.0,551.0,338.0,308.0,211.0,152.0,167.0,147.0,203.0,209.0,3000.0
Dhanbad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,57.0,85.0,90.0,132.0,75.0,82.0,50.0,47.0,47.0,34.0,53.0,52.0,804.0
Dhanbad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,7.0,77.0,13.0,371.0,15.0,15.0,19.0,22.0,18.0,339.0,538.0,15.0,1449.0
Dhanbad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Dhanbad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhanbad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,338.0,395.0,310.0,1054.0,428.0,405.0,280.0,221.0,232.0,520.0,794.0,276.0,5253.0
Dhanbad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Dhanbad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,6.0,23.0,0.0,0.0,0.0,33.0,14.0,22.0,98.0
Dhanbad,9.06,Number of IUCD removals,TOTAL,233.0,218.0,275.0,347.0,437.0,178.0,204.0,176.0,147.0,130.0,109.0,100.0,2554.0
Dhanbad,9.07,Number of Oral Pills cycles distributed,TOTAL,5055.0,7098.0,5640.0,9796.0,7768.0,4854.0,3881.0,3613.0,4189.0,4447.0,4814.0,3644.0,64799.0
Dhanbad,9.08,Number of Condom pieces distributed,TOTAL,27925.0,39348.0,28017.0,57164.0,43576.0,39363.0,27153.0,16708.0,14915.0,16617.0,15796.0,8775.0,335357.0
Dhanbad,9.09,Number of Centchroman (weekly) pills given,TOTAL,224.0,122.0,21.0,182.0,513.0,53.0,632.0,866.0,473.0,46.0,1058.0,568.0,4758.0
Dhanbad,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,81.0,87.0,261.0,530.0,255.0,252.0,205.0,320.0,279.0,240.0,294.0,335.0,3139.0
Dhanbad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,3.0,13.0,11.0,2.0,30.0,0.0,1.0,0.0,2.0,7.0,0.0,69.0
Dhanbad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,4.0,25.0,4.0,6.0,3.0,2.0,1.0,3.0,7.0,15.0,3.0,0.0,73.0
Dhanbad,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Dhanbad,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,5.0,1.0,9.0
Dhanbad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,9.12,Number of Institutions having NSV trained doctors,TOTAL,17.0,17.0,16.0,16.0,15.0,15.0,14.0,14.0,12.0,12.0,12.0,13.0,-1.0
Dhanbad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3310.0,3153.0,4337.0,2852.0,4131.0,3875.0,3761.0,4345.0,4219.0,5152.0,1908.0,5217.0,46260.0
Dhanbad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3344.0,3379.0,4314.0,2803.0,3763.0,3817.0,3617.0,3801.0,3900.0,3975.0,4342.0,3997.0,45052.0
Dhanbad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3264.0,3329.0,4210.0,2690.0,3541.0,3529.0,3528.0,3565.0,3884.0,3736.0,4221.0,4121.0,43618.0
Dhanbad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3402.0,3330.0,4220.0,2610.0,3395.0,3515.0,3225.0,3309.0,3546.0,3607.0,3974.0,4335.0,42468.0
Dhanbad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Dhanbad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Dhanbad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Dhanbad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1771.0,2176.0,2192.0,1955.0,2296.0,2585.0,884.0,1081.0,1998.0,966.0,1469.0,1185.0,20558.0
Dhanbad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3311.0,3258.0,4330.0,2762.0,3555.0,3460.0,1509.0,3513.0,3624.0,1748.0,3732.0,3370.0,38172.0
Dhanbad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3273.0,3203.0,4208.0,2640.0,3011.0,3309.0,1480.0,3275.0,3637.0,1686.0,3545.0,3543.0,36810.0
Dhanbad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3314.0,3259.0,4230.0,2609.0,2882.0,3230.0,1246.0,2552.0,3387.0,1681.0,3225.0,3747.0,35362.0
Dhanbad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,0.0,6.0,0.0,9.0,28.0,61.0,256.0,360.0
Dhanbad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,16.0,57.0,22.0,0.0,37.0,19.0,0.0,0.0,11.0,0.0,2246.0,2168.0,4576.0
Dhanbad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,5.0,18.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,138.0,1952.0,2113.0
Dhanbad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,7.0,13.0,0.0,0.0,0.0,49.0,10.0,0.0,5.0,0.0,101.0,76.0,261.0
Dhanbad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3035.0,1532.0,4280.0,3115.0,2863.0,3529.0,2763.0,3160.0,2335.0,3927.0,5147.0,11226.0,46912.0
Dhanbad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,20.0,10.0,25.0,0.0,84.0,20.0,9.0,168.0
Dhanbad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Dhanbad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1581.0,784.0,1951.0,1444.0,1477.0,1762.0,1232.0,1635.0,994.0,2030.0,2629.0,5890.0,23409.0
Dhanbad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1342.0,611.0,1698.0,1305.0,1338.0,1592.0,1082.0,1429.0,849.0,1778.0,2217.0,5273.0,20514.0
Dhanbad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2923.0,1395.0,3649.0,2749.0,2815.0,3354.0,2314.0,3064.0,1843.0,3808.0,4846.0,11163.0,43923.0
Dhanbad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2262.0,2085.0,2289.0,1820.0,2557.0,2722.0,1906.0,1915.0,1666.0,1647.0,2315.0,2284.0,25468.0
Dhanbad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2229.0,2081.0,2275.0,1793.0,2252.0,2564.0,860.0,1317.0,1543.0,791.0,1870.0,1781.0,21356.0
Dhanbad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1832.0,659.0,936.0,797.0,659.0,797.0,815.0,662.0,625.0,453.0,498.0,375.0,9108.0
Dhanbad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1602.0,614.0,776.0,656.0,641.0,666.0,780.0,558.0,562.0,419.0,424.0,330.0,8028.0
Dhanbad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3434.0,1273.0,1712.0,1453.0,1300.0,1463.0,1595.0,1220.0,1187.0,872.0,922.0,705.0,17136.0
Dhanbad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,3.0,58.0,37.0,35.0,57.0,17.0,15.0,9.0,51.0,45.0,196.0,225.0,748.0
Dhanbad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1298.0,1128.0,1195.0,971.0,1097.0,991.0,963.0,894.0,988.0,851.0,954.0,979.0,12309.0
Dhanbad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1257.0,1085.0,1270.0,1085.0,1099.0,1071.0,937.0,807.0,881.0,860.0,899.0,1027.0,12278.0
Dhanbad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,116.0,42.0,58.0,75.0,60.0,83.0,68.0,53.0,45.0,72.0,66.0,48.0,786.0
Dhanbad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,31.0,7.0,29.0,37.0,12.0,38.0,15.0,15.0,30.0,18.0,26.0,17.0,275.0
Dhanbad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2080.0,2146.0,2178.0,2036.0,2136.0,2071.0,2186.0,1977.0,2099.0,2164.0,2314.0,2359.0,25746.0
Dhanbad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2057.0,2120.0,2157.0,2021.0,2114.0,2038.0,2178.0,1878.0,1957.0,2072.0,2237.0,2317.0,25146.0
Dhanbad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1448.0,1485.0,1476.0,1176.0,1382.0,1207.0,1356.0,1137.0,1224.0,1356.0,1501.0,1501.0,16249.0
Dhanbad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,0.0,6.0,0.0,3.0,7.0,0.0,21.0,37.0
Dhanbad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1905.0,540.0,2437.0,977.0,5805.0,2602.0,1928.0,2149.0,1140.0,1194.0,6232.0,2609.0,29518.0
Dhanbad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,100.0,89.0,67.0,135.0,24161.0,4382.0,337.0,252.0,102.0,98.0,19992.0,3696.0,53411.0
Dhanbad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,96.0,61.0,51.0,73.0,27112.0,2920.0,245.0,138.0,90.0,109.0,22349.0,4068.0,57312.0
Dhanbad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Dhanbad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Dhanbad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Dhanbad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Dhanbad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,65.0,61.0,48.0,16.0,43.0,38.0,35.0,57.0,409.0,125.0,376.0,116.0,1389.0
Dhanbad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,52.0,71.0,102.0,63.0,100.0,111.0,70.0,49.0,76.0,50.0,110.0,126.0,980.0
Dhanbad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,56.0,53.0,44.0,16.0,32.0,39.0,25.0,33.0,34.0,12.0,20.0,20.0,384.0
Dhanbad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,13.1,Number of Patients operated for cataract,TOTAL,1326.0,82.0,5.0,0.0,0.0,0.0,82.0,0.0,182.0,0.0,240.0,202.0,2119.0
Dhanbad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,1326.0,82.0,0.0,0.0,0.0,0.0,0.0,0.0,182.0,0.0,240.0,177.0,2007.0
Dhanbad,13.3,Number of School children detected with Refractive errors,TOTAL,13.0,28.0,28.0,1304.0,102.0,85.0,119.0,0.0,110.0,0.0,0.0,0.0,1789.0
Dhanbad,13.4,Number of children provided free glasses,TOTAL,0.0,15.0,15.0,18.0,52.0,40.0,0.0,0.0,27.0,0.0,0.0,0.0,167.0
Dhanbad,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Dhanbad,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,4.0,3.0,5.0,4.0,5.0,3.0,3.0,1.0,2.0,2.0,2.0,-1.0
Dhanbad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,7.0,8.0,8.0,8.0,10.0,9.0,4.0,6.0,5.0,8.0,8.0,9.0,-1.0
Dhanbad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,697.0,684.0,567.0,425.0,718.0,496.0,574.0,462.0,574.0,523.0,918.0,815.0,-1.0
Dhanbad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,6.0,6.0,8.0,7.0,7.0,5.0,4.0,5.0,5.0,5.0,5.0,-1.0
Dhanbad,14.05,Number of RKS meetings held during the month,TOTAL,6.0,4.0,5.0,2.0,2.0,13.0,5.0,3.0,6.0,9.0,10.0,10.0,75.0
Dhanbad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,11.0,13.0,16.0,13.0,16.0,14.0,7.0,9.0,9.0,11.0,12.0,13.0,-1.0
Dhanbad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1.0,15.0,19.0,20.0,19.0,18.0,21.0,20.0,36.0,37.0,37.0,16.0,259.0
Dhanbad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,5.0,3.0,6.0,6.0,6.0,3.0,3.0,2.0,3.0,3.0,4.0,-1.0
Dhanbad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,-1.0
Dhanbad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1.0,1.0,2.0,19.0,45.0,57.0,25.0,6.0,2.0,25.0,23.0,37.0,243.0
Dhanbad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,22.0,17.0,41.0,36.0,56.0,74.0,61.0,30.0,137.0,45.0,154.0,175.0,848.0
Dhanbad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,24.0,0.0,0.0,14.0,36.0,48.0,29.0,13.0,42.0,17.0,28.0,73.0,324.0
Dhanbad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,78.0,137.0,92.0,77.0,124.0,148.0,88.0,97.0,510.0,135.0,839.0,385.0,2710.0
Dhanbad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,25.0,1.0,2.0,33.0,81.0,105.0,54.0,19.0,44.0,42.0,51.0,110.0,567.0
Dhanbad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,100.0,154.0,133.0,113.0,180.0,222.0,149.0,127.0,647.0,180.0,993.0,560.0,3558.0
Dhanbad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,10.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,15.0
Dhanbad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,9.0
Dhanbad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,16.0,0.0,3.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0,0.0,1.0,24.0
Dhanbad,14.11,In-Patient Head Count at midnight,TOTAL,32.0,18.0,17.0,26.0,67.0,56.0,25.0,33.0,0.0,251.0,506.0,90.0,1121.0
Dhanbad,14.12.1,OPD attendance (All),TOTAL,46537.0,44907.0,41746.0,41954.0,44618.0,43504.0,35569.0,31585.0,25650.0,31598.0,35395.0,31893.0,454956.0
Dhanbad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,4.0,0.0,0.0,0.0,21.0,108.0,0.0,0.0,304.0,394.0,598.0,346.0,1775.0
Dhanbad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Dhanbad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,8.0,0.0,50.0,22.0,0.0,10.0,9.0,33.0,115.0,0.0,242.0,44.0,533.0
Dhanbad,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,4.0,6.0,47.0,47.0,98.0,95.0,0.0,0.0,297.0
Dhanbad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Dhanbad,14.14.c,Number of Adolescents counselled,TOTAL,11.0,45.0,24.0,0.0,24.0,43.0,90.0,55.0,175.0,15.0,12.0,127.0,621.0
Dhanbad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,878.0,736.0,692.0,759.0,926.0,719.0,1663.0,714.0,616.0,973.0,1537.0,957.0,11170.0
Dhanbad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,51.0,34.0,40.0,55.0,86.0,48.0,57.0,42.0,30.0,38.0,39.0,41.0,561.0
Dhanbad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,83.0,71.0,129.0,45.0,4.0,147.0,57.0,193.0,221.0,234.0,374.0,211.0,1769.0
Dhanbad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,8.0,1.0,1.0,0.0,4.0,0.0,1.0,0.0,0.0,3.0,0.0,21.0
Dhanbad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,68.0,160.0,134.0,62.0,0.0,56.0,42.0,142.0,60.0,270.0,728.0,100.0,1822.0
Dhanbad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,5.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Dhanbad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,63.0,85.0,180.0,100.0,5.0,96.0,49.0,109.0,376.0,83.0,371.0,91.0,1608.0
Dhanbad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,6.0,12.0,7.0,0.0,0.0,0.0,4.0,0.0,2.0,0.0,0.0,0.0,31.0
Dhanbad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,214.0,316.0,443.0,207.0,9.0,299.0,148.0,444.0,657.0,587.0,1473.0,402.0,5199.0
Dhanbad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,12.0,25.0,8.0,3.0,0.0,5.0,4.0,1.0,2.0,0.0,3.0,0.0,63.0
Dhanbad,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Dhanbad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,17.0,1.0,13.0,0.0,0.0,0.0,0.0,0.0,0.0,31.0
Dhanbad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,2.0,0.0,14.0,4.0,0.0,9.0,0.0,0.0,15.0,44.0
Dhanbad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,19.0,3.0,27.0,4.0,0.0,9.0,0.0,0.0,15.0,77.0
Dhanbad,15.4.1,Number of blood smears examined for Malaria,TOTAL,13286.0,7222.0,9880.0,9107.0,11085.0,8341.0,3738.0,1862.0,10634.0,5566.0,9062.0,12484.0,102267.0
Dhanbad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,18.0,6.0,7.0,118.0,15.0,16.0,23.0,7.0,9.0,21.0,21.0,205.0,466.0
Dhanbad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,36.0,10.0,17.0,9.0,54.0,11.0,51.0,3.0,370.0,14.0,21.0,13.0,609.0
Dhanbad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,26200.0,8200.0,12200.0,35700.0,16930.0,64930.0,47930.0,49430.0,28930.0,9930.0,18930.0,2000.0,321310.0
Dhanbad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,40000.0,50000.0,0.0,80000.0,0.0,20000.0,0.0,0.0,30000.0,0.0,13300.0,233300.0
Dhanbad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Dhanbad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,18000.0,36000.0,26500.0,18770.0,32000.0,17000.0,18500.0,20500.0,19000.0,21000.0,16930.0,12800.0,257000.0
Dhanbad,16.1.1,Stock position of DPT vaccines,5. Total Stock,8200.0,12200.0,35700.0,16930.0,64930.0,47930.0,49430.0,28930.0,9930.0,18930.0,2000.0,2500.0,297610.0
Dhanbad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Dhanbad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Dhanbad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Dhanbad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Dhanbad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,43000.0,22600.0,31842.0,36464.0,8040.0,22000.0,800.0,13300.0,9800.0,100.0,5600.0,100.0,193646.0
Dhanbad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,60000.0,40000.0,0.0,30000.0,0.0,20000.0,20000.0,0.0,20000.0,0.0,0.0,190000.0
Dhanbad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Dhanbad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,22400.0,50758.0,35378.0,28424.0,16040.0,21200.0,7500.0,23500.0,9700.0,14500.0,5500.0,100.0,235000.0
Dhanbad,16.1.2,Stock position of OPV vaccines,5. Total Stock,20600.0,31842.0,36464.0,8040.0,22000.0,800.0,13300.0,9800.0,100.0,5600.0,100.0,0.0,148646.0
Dhanbad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,18750.0,4550.0,24292.0,64572.0,49220.0,56620.0,49620.0,59620.0,43620.0,30620.0,29620.0,16220.0,447324.0
Dhanbad,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,40000.0,60000.0,0.0,30000.0,0.0,30000.0,0.0,0.0,20000.0,0.0,20000.0,200000.0
Dhanbad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Dhanbad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,14200.0,20258.0,19720.0,15352.0,22600.0,7000.0,20000.0,16000.0,13000.0,21000.0,13400.0,15500.0,198030.0
Dhanbad,16.1.3,Stock position of TT vaccines,5. Total Stock,4550.0,24292.0,64572.0,49220.0,56620.0,49620.0,59620.0,43620.0,30620.0,29620.0,16220.0,20720.0,449294.0
Dhanbad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,,,,0.0,,0.0,,0.0,0.0,0.0,0.0
Dhanbad,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,,,,0.0,,0.0,,0.0,0.0,0.0,0.0
Dhanbad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Dhanbad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,,,,0.0,,0.0,,0.0,0.0,0.0,0.0
Dhanbad,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,14000.0,2000.0,19590.0,45740.0,34230.0,34030.0,20380.0,20380.0,5380.0,380.0,0.0,0.0,196110.0
Dhanbad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,40000.0,40000.0,0.0,20000.0,0.0,20000.0,0.0,0.0,10000.0,0.0,25000.0,155000.0
Dhanbad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Dhanbad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,12000.0,22410.0,13850.0,11510.0,20200.0,13650.0,20000.0,15000.0,5000.0,10380.0,0.0,20000.0,164000.0
Dhanbad,16.1.5,Stock position of BCG vaccines,5. Total Stock,2000.0,19590.0,45740.0,34230.0,34030.0,20380.0,20380.0,5380.0,380.0,0.0,0.0,5000.0,187110.0
Dhanbad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1750.0,250.0,6335.0,4460.0,425.0,7000.0,2400.0,6500.0,1000.0,0.0,0.0,49485.0,79605.0
Dhanbad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,15000.0,5000.0,0.0,15000.0,0.0,10000.0,0.0,0.0,0.0,53235.0,0.0,98235.0
Dhanbad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Dhanbad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1500.0,8915.0,6875.0,4035.0,8425.0,4600.0,5900.0,5500.0,1000.0,0.0,3750.0,4000.0,54500.0
Dhanbad,16.1.6,Stock position of Measles vaccines,5. Total Stock,250.0,6335.0,4460.0,425.0,7000.0,2400.0,6500.0,1000.0,0.0,0.0,49485.0,45485.0,123340.0
Dhanbad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,,,,,,,,0.0,0.0,,0.0
Dhanbad,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,,,,,,,,0.0,0.0,,0.0
Dhanbad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Dhanbad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,,,,,,,,0.0,0.0,,0.0
Dhanbad,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,,,,,,,,0.0,45830.0,32440.0,78270.0
Dhanbad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,,,,,,,,88400.0,0.0,0.0,88400.0
Dhanbad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Dhanbad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,,,,,,,,42570.0,13390.0,8500.0,64460.0
Dhanbad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45830.0,32440.0,23940.0,102210.0
Dhanbad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1000.0,1000.0,1000.0,1000.0,185.0,185.0,185.0,185.0,235.0,0.0,50.0,50.0,5075.0
Dhanbad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,2400.0,0.0,0.0,0.0,50.0,0.0,300.0,0.0,6000.0,8750.0
Dhanbad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,3215.0,0.0,0.0,0.0,0.0,235.0,250.0,,3000.0,6700.0
Dhanbad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1000.0,1000.0,1000.0,185.0,185.0,185.0,185.0,235.0,0.0,50.0,50.0,3050.0,7125.0
Dhanbad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,16500.0,16500.0,16500.0,16500.0,10500.0,10500.0,10500.0,10500.0,10500.0,0.0,0.0,0.0,118500.0
Dhanbad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,136000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,81500.0,217500.0
Dhanbad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,142000.0,0.0,0.0,0.0,0.0,10500.0,0.0,0.0,44000.0,196500.0
Dhanbad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,16500.0,16500.0,16500.0,10500.0,10500.0,10500.0,10500.0,10500.0,0.0,0.0,0.0,37500.0,139500.0
Dhanbad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1000.0,1000.0,1000.0,1000.0,4500.0,4500.0,4500.0,4500.0,4500.0,0.0,0.0,0.0,26500.0
Dhanbad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,33500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,27000.0,60500.0
Dhanbad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,30000.0,0.0,0.0,0.0,0.0,4500.0,0.0,0.0,15000.0,49500.0
Dhanbad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1000.0,1000.0,1000.0,4500.0,4500.0,4500.0,4500.0,4500.0,0.0,0.0,0.0,12000.0,37500.0
Dhanbad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,7269.0,7269.0,7269.0,7269.0,400.0,400.0,400.0,400.0,400.0,0.0,0.0,0.0,31076.0
Dhanbad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,7000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7000.0
Dhanbad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,13869.0,0.0,0.0,0.0,0.0,400.0,0.0,0.0,0.0,14269.0
Dhanbad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,7269.0,7269.0,7269.0,400.0,400.0,400.0,400.0,400.0,0.0,0.0,0.0,0.0,23807.0
Dhanbad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,1000.0,1000.0,1000.0,1000.0,1000.0,19000.0
Dhanbad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,1000.0
Dhanbad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,18000.0
Dhanbad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Dhanbad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Dhanbad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Dhanbad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Dhanbad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Dhanbad,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Dhanbad,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Dhanbad,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Dhanbad,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Dhanbad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Dhanbad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Dhanbad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Dhanbad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Dhanbad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Dhanbad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Dhanbad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Dhanbad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Dhanbad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Dhanbad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Dhanbad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Dhanbad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Dhanbad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Dhanbad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Dhanbad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Dhanbad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Dhanbad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Dhanbad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Dhanbad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Dhanbad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Dhanbad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Dhanbad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Dhanbad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Dhanbad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Dhanbad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Dhanbad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Dhanbad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Dhanbad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,157.0,,25.0,,0.0,0.0,,182.0
Dhanbad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,4350.0,237.0,0.0,,0.0,,5562.0,0.0,,10149.0
Dhanbad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Dhanbad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,4350.0,80.0,132.0,,25.0,,5562.0,0.0,,10149.0
Dhanbad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,157.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,182.0
Dhanbad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Dhanbad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Dhanbad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Dhanbad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Dhanbad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhanbad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,6000.0,0.0,3600.0,400.0,1200.0,0.0,0.0,0.0,0.0,11200.0
Dhanbad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,4000.0,8000.0,0.0,6000.0,0.0,6000.0,0.0,0.0,3000.0,0.0,7500.0,34500.0
Dhanbad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Dhanbad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,4000.0,2000.0,6000.0,2400.0,3200.0,5200.0,1200.0,0.0,3000.0,0.0,5400.0,32400.0
Dhanbad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,6000.0,0.0,3600.0,400.0,1200.0,0.0,0.0,0.0,0.0,2100.0,13300.0
Dhanbad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,6600.0,0.0,400.0,0.0,0.0,36000.0,16000.0,14000.0,330410.0,151806.0,108451.0,104701.0,768368.0
Dhanbad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,24000.0,0.0,0.0,64000.0,0.0,24000.0,652800.0,0.0,0.0,0.0,20000.0,784800.0
Dhanbad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,0.0,,0.0,,0.0
Dhanbad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,6600.0,23600.0,400.0,0.0,28000.0,20000.0,26000.0,336390.0,178604.0,43355.0,3750.0,17000.0,683699.0
Dhanbad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,400.0,0.0,0.0,36000.0,16000.0,14000.0,330410.0,151806.0,108451.0,104701.0,107701.0,869469.0
Dhanbad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2600.0,2000.0,400.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,5000.0
Dhanbad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,21121.0,21121.0
Dhanbad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Dhanbad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,600.0,1600.0,400.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,800.0,3400.0
Dhanbad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2000.0,400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20321.0,22721.0
Dhanbad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,2.0,4.0,2.0,,1.0,,,,2.0,,11.0
Dhanbad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,1.0,1.0
Dhanbad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dhanbad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,1.0,1.0
Dhanbad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Dhanbad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dhanbad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Dhanbad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,1.0,,1.0
Dhanbad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,,1.0
Dhanbad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,1.0,,,,,1.0,,2.0
Dhanbad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Dhanbad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Dhanbad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,1.0,,,,,,1.0
Dhanbad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dhanbad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,1.0,,,1.0,,,,2.0
Dhanbad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,1.0,,,1.0,,,,2.0
Dhanbad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dhanbad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dhanbad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Dhanbad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dhanbad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,1.0,1.0,,,1.0,3.0
Dhanbad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,1.0,1.0,,,1.0,3.0
Dhanbad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dhanbad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dhanbad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dhanbad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,1.0,,,,,,,,,1.0
Dhanbad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,,1.0,1.0,,2.0,4.0,2.0,,11.0
Dhanbad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,2.0,,1.0,1.0,,2.0,4.0,2.0,,12.0
Dhanbad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Dhanbad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,1.0,1.0,,,,,,,2.0
Dhanbad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,1.0,1.0,,,,,,,2.0
Dhanbad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Dhanbad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,1.0,,,1.0
Dhanbad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Dhanbad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,1.0,,,,,,,1.0
Dhanbad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Dhanbad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,,,,1.0,,,,,,,,4.0
Dhanbad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,3.0,,,1.0,1.0,,,,,,,,5.0
Dhanbad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Dhanbad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,1.0,1.0,1.0,,1.0,2.0,1.0,,,7.0
Dhanbad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,1.0,2.0,,,,,,,,3.0
Dhanbad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,2.0,3.0,1.0,,1.0,2.0,1.0,,,10.0
Dhanbad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,1.0,1.0,,,,,,,2.0
Dhanbad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,1.0,1.0,,,,,,,2.0
Dhanbad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Dhanbad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,1.0,,,,,,,1.0
Dhanbad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,2.0,,,,,,,2.0
Dhanbad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,2.0,,,,,,,2.0
Dhanbad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Dhanbad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,1.0,,,1.0
Dhanbad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Dhanbad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Dhanbad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Dhanbad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Dhanbad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,6.0,2.0,2.0,,,2.0,2.0,1.0,,,1.0,16.0
Dhanbad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,2.0,5.0,,,2.0,,,,,9.0
Dhanbad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,6.0,2.0,4.0,5.0,,2.0,4.0,1.0,,,1.0,25.0
Dhanbad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Dhanbad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,,1.0,4.0,,2.0,2.0,,2.0,,1.0,1.0,14.0
Dhanbad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,1.0,1.0,1.0,,,,,,,3.0
Dhanbad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,,1.0,6.0,1.0,3.0,2.0,,2.0,,1.0,1.0,18.0
Dhanbad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,1.0,1.0,,,,,1.0,,,4.0
Dhanbad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,1.0,1.0,1.0,,,,,1.0,,,4.0
Dhanbad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Dhanbad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,,1.0,,,,,,,,,2.0
Dhanbad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Dhanbad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,1.0,1.0,,,,,,,,,3.0
Dhanbad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,1.0,6.0,2.0,4.0,,,,,2.0,1.0,17.0
Dhanbad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,2.0,,,,1.0,,,,,,3.0
Dhanbad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,3.0,6.0,2.0,4.0,1.0,,,,2.0,1.0,20.0
Dhanbad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,1.0,1.0,,,,,,,2.0
Dhanbad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,1.0,3.0,,2.0,2.0,,2.0,2.0,,1.0,13.0
Dhanbad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,3.0,,3.0,2.0,,,,,,8.0
Dhanbad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,1.0,6.0,1.0,6.0,4.0,,2.0,2.0,,1.0,23.0
Dhanbad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Dhanbad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,1.0,4.0,4.0,,2.0,2.0,4.0,4.0,5.0,4.0,30.0
Dhanbad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,,13.0,16.0,10.0,1.0,6.0,,,,,,47.0
Dhanbad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,1.0,,14.0,20.0,14.0,1.0,8.0,2.0,4.0,4.0,5.0,4.0,77.0
Dumka,1.1,Total number of pregnant women Registered for ANC,TOTAL,3074.0,3000.0,3019.0,2263.0,2357.0,2731.0,2432.0,2430.0,1760.0,3008.0,2838.0,2714.0,31626.0
Dumka,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,603.0,520.0,485.0,450.0,497.0,484.0,483.0,444.0,319.0,612.0,512.0,490.0,5899.0
Dumka,1.2,Number of Pregnant women registered under JSY,TOTAL,3028.0,2938.0,2993.0,2263.0,2330.0,2731.0,2432.0,2409.0,1741.0,3008.0,2834.0,2704.0,31411.0
Dumka,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1589.0,1637.0,1658.0,1473.0,1673.0,1546.0,1454.0,1452.0,1272.0,1360.0,1522.0,1577.0,18213.0
Dumka,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2804.0,2731.0,2770.0,2068.0,2145.0,2528.0,2184.0,2161.0,1521.0,2744.0,2533.0,2416.0,28605.0
Dumka,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2423.0,2766.0,2431.0,2015.0,2012.0,2056.0,1869.0,1868.0,1390.0,1847.0,2408.0,2282.0,25367.0
Dumka,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1499.0,1174.0,307.0,492.0,115.0,21.0,109.0,232.0,310.0,1073.0,991.0,1010.0,7333.0
Dumka,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,46.0,51.0,66.0,121.0,94.0,57.0,79.0,51.0,32.0,104.0,80.0,57.0,838.0
Dumka,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,1.0,2.0,1.0,1.0,3.0,1.0,2.0,1.0,1.0,1.0,1.0,15.0
Dumka,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,338.0,450.0,463.0,471.0,586.0,367.0,487.0,549.0,302.0,429.0,548.0,652.0,5642.0
Dumka,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,7.0,6.0,22.0,10.0,10.0,0.0,3.0,1.0,5.0,0.0,3.0,2.0,69.0
Dumka,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Dumka,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,117.0,108.0,122.0,122.0,151.0,137.0,146.0,131.0,116.0,108.0,75.0,80.0,1413.0
Dumka,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,950.0,957.0,1021.0,922.0,1041.0,1050.0,941.0,890.0,839.0,707.0,681.0,681.0,10680.0
Dumka,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1067.0,1065.0,1143.0,1044.0,1192.0,1187.0,1087.0,1021.0,955.0,815.0,756.0,761.0,12093.0
Dumka,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,434.0,509.0,449.0,413.0,486.0,386.0,448.0,351.0,365.0,296.0,313.0,304.0,4754.0
Dumka,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,183.0,227.0,214.0,128.0,238.0,138.0,209.0,219.0,162.0,140.0,172.0,115.0,2145.0
Dumka,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,858.0,1039.0,1101.0,1297.0,1275.0,1223.0,1230.0,1236.0,1094.0,1077.0,936.0,1109.0,13475.0
Dumka,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,855.0,1021.0,1098.0,1294.0,1269.0,1219.0,1226.0,1233.0,1093.0,1069.0,932.0,1102.0,13411.0
Dumka,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,759.0,820.0,792.0,987.0,825.0,914.0,837.0,958.0,856.0,907.0,784.0,918.0,10357.0
Dumka,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,579.0,662.0,601.0,724.0,601.0,731.0,679.0,828.0,724.0,724.0,677.0,837.0,8367.0
Dumka,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,2.0,2.0,3.0,0.0,1.0,4.0,1.0,1.0,2.0,16.0,0.0,2.0,34.0
Dumka,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,118.0,107.0,97.0,100.0,98.0,111.0,118.0,87.0,67.0,111.0,36.0,31.0,1081.0
Dumka,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,1.0,2.0,1.0,0.0,3.0,4.0,0.0,1.0,0.0,0.0,3.0,0.0,15.0
Dumka,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dumka,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,1.0,2.0,1.0,0.0,3.0,4.0,0.0,1.0,0.0,0.0,3.0,0.0,15.0
Dumka,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,43.0,54.0,57.0,57.0,53.0,70.0,82.0,59.0,45.0,45.0,7.0,0.0,572.0
Dumka,4.1.1.a,Number of male live births,TOTAL,1098.0,1095.0,1167.0,1318.0,1300.0,1334.0,1249.0,1223.0,1134.0,1020.0,876.0,1003.0,13817.0
Dumka,4.1.1.b,Number of female live births,TOTAL,935.0,1098.0,1149.0,1115.0,1250.0,1176.0,1176.0,1109.0,968.0,973.0,833.0,886.0,12668.0
Dumka,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2033.0,2193.0,2316.0,2433.0,2550.0,2510.0,2425.0,2332.0,2102.0,1993.0,1709.0,1889.0,26485.0
Dumka,4.1.2,Number of still births,TOTAL,28.0,31.0,39.0,25.0,31.0,27.0,28.0,23.0,21.0,22.0,26.0,27.0,328.0
Dumka,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,36.0,37.0,27.0,77.0,90.0,63.0,54.0,65.0,84.0,109.0,151.0,84.0,877.0
Dumka,4.2.1,Number of Newborns weighed at birth,TOTAL,1536.0,1883.0,1989.0,2080.0,2212.0,2114.0,2011.0,1870.0,1718.0,1704.0,1491.0,1705.0,22313.0
Dumka,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,62.0,92.0,111.0,118.0,149.0,146.0,128.0,176.0,114.0,139.0,92.0,136.0,1463.0
Dumka,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1758.0,2059.0,2070.0,2235.0,2297.0,2149.0,2154.0,2026.0,1869.0,1831.0,1610.0,1789.0,23847.0
Dumka,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,1.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Dumka,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,46.0,53.0
Dumka,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,2.0,4.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,10.0
Dumka,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dumka,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,2.0,5.0,4.0,0.0,0.0,0.0,0.0,7.0,0.0,3.0,46.0,67.0
Dumka,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Dumka,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,2.0,4.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,10.0
Dumka,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,2.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,9.0
Dumka,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,2.0,5.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,12.0
Dumka,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,2.0,4.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,10.0
Dumka,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1000.0,1167.0,1237.0,1383.0,1361.0,1309.0,1451.0,1305.0,1196.0,1162.0,1000.0,1167.0,14738.0
Dumka,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,945.0,926.0,1047.0,907.0,1041.0,1062.0,999.0,855.0,782.0,728.0,678.0,740.0,10710.0
Dumka,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,2.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Dumka,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,4.0,6.0,1.0,0.0,0.0,0.0,0.0,2.0,1.0,7.0,5.0,4.0,30.0
Dumka,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Dumka,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,5.0,6.0,3.0,0.0,0.0,0.0,0.0,2.0,1.0,7.0,5.0,4.0,33.0
Dumka,7.2,Number of MTPs conducted at Private Facilities,TOTAL,13.0,55.0,52.0,52.0,53.0,31.0,30.0,40.0,65.0,82.0,125.0,58.0,656.0
Dumka,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,35.0,34.0,56.0,63.0,70.0,114.0,107.0,105.0,75.0,131.0,101.0,125.0,1016.0
Dumka,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,81.0,96.0,71.0,77.0,80.0,90.0,72.0,80.0,105.0,110.0,120.0,139.0,1121.0
Dumka,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,116.0,130.0,127.0,140.0,150.0,204.0,179.0,185.0,180.0,241.0,221.0,264.0,2137.0
Dumka,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,40.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,42.0
Dumka,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,6.0,4.0,0.0,39.0,6.0,3.0,2.0,0.0,1.0,7.0,9.0,3.0,80.0
Dumka,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,5.0,0.0,2.0,0.0,0.0,3.0,1.0,3.0,0.0,2.0,3.0,1.0,20.0
Dumka,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dumka,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,11.0,4.0,2.0,79.0,6.0,6.0,3.0,3.0,1.0,9.0,14.0,4.0,142.0
Dumka,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Dumka,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dumka,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,71.0,0.0,0.0,0.0,0.0,37.0,86.0,150.0,7.0,351.0
Dumka,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,29.0,8.0,0.0,62.0,31.0,55.0,44.0,84.0,278.0,871.0,835.0,443.0,2740.0
Dumka,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,9.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,105.0,0.0,119.0
Dumka,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dumka,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,38.0,8.0,0.0,133.0,36.0,55.0,44.0,84.0,315.0,957.0,1090.0,450.0,3210.0
Dumka,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,7.0,6.0,16.0,16.0,15.0,12.0,14.0,14.0,11.0,8.0,2.0,8.0,129.0
Dumka,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,27.0,21.0,0.0,44.0,100.0
Dumka,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dumka,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,27.0,21.0,0.0,44.0,100.0
Dumka,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,89.0,75.0,59.0,165.0,77.0,52.0,62.0,53.0,48.0,62.0,52.0,75.0,869.0
Dumka,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,21.0,17.0,11.0,16.0,10.0,12.0,10.0,6.0,10.0,13.0,26.0,8.0,160.0
Dumka,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,50.0,28.0,24.0,806.0,17.0,36.0,25.0,8.0,2.0,79.0,26.0,177.0,1278.0
Dumka,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,5.0,1.0,10.0,10.0,3.0,5.0,2.0,4.0,3.0,4.0,16.0,4.0,67.0
Dumka,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dumka,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,165.0,121.0,104.0,997.0,107.0,105.0,99.0,71.0,63.0,158.0,120.0,264.0,2374.0
Dumka,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,0.0,,,,,0.0
Dumka,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,10.0,4.0,11.0,11.0,4.0,28.0,28.0,0.0,0.0,38.0,45.0,11.0,190.0
Dumka,9.06,Number of IUCD removals,TOTAL,62.0,67.0,65.0,74.0,85.0,50.0,58.0,77.0,57.0,56.0,80.0,129.0,860.0
Dumka,9.07,Number of Oral Pills cycles distributed,TOTAL,2444.0,2514.0,2782.0,8125.0,3418.0,2235.0,2349.0,1844.0,1894.0,1927.0,1725.0,2159.0,33416.0
Dumka,9.08,Number of Condom pieces distributed,TOTAL,18425.0,16537.0,13929.0,68635.0,11893.0,11203.0,8911.0,8490.0,11346.0,11006.0,9339.0,8788.0,198502.0
Dumka,9.09,Number of Centchroman (weekly) pills given,TOTAL,11.0,38.0,15.0,113.0,19.0,415.0,364.0,13.0,9.0,510.0,6.0,66.0,1579.0
Dumka,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,626.0,504.0,509.0,375.0,203.0,146.0,241.0,168.0,184.0,184.0,169.0,189.0,3498.0
Dumka,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Dumka,9.12,Number of Institutions having NSV trained doctors,TOTAL,21.0,24.0,24.0,9.0,18.0,15.0,16.0,17.0,19.0,11.0,12.0,12.0,-1.0
Dumka,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2108.0,2414.0,2641.0,2691.0,2934.0,2839.0,2564.0,2279.0,1780.0,1396.0,1353.0,1843.0,26842.0
Dumka,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1815.0,2131.0,2201.0,2150.0,2509.0,2741.0,2718.0,2810.0,2173.0,2383.0,2406.0,2126.0,28163.0
Dumka,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2073.0,2123.0,2043.0,1809.0,2262.0,2511.0,2328.0,2735.0,2287.0,2321.0,2593.0,2294.0,27379.0
Dumka,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2352.0,2384.0,2118.0,1755.0,1962.0,2266.0,2044.0,2430.0,2116.0,2451.0,2468.0,2384.0,26730.0
Dumka,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Dumka,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Dumka,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Dumka,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1518.0,1587.0,1732.0,1934.0,1577.0,1181.0,1077.0,1461.0,960.0,974.0,699.0,341.0,15041.0
Dumka,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1766.0,2103.0,2220.0,2157.0,1913.0,1405.0,1959.0,2801.0,1409.0,1525.0,887.0,226.0,20371.0
Dumka,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2034.0,2112.0,2032.0,1824.0,1800.0,1206.0,1510.0,2635.0,1419.0,1420.0,857.0,192.0,19041.0
Dumka,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2367.0,2422.0,2131.0,1750.0,1522.0,1095.0,1258.0,2233.0,1349.0,1440.0,792.0,206.0,18565.0
Dumka,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,276.0,389.0,665.0
Dumka,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,20.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2195.0,2236.0,4455.0
Dumka,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0,1147.0,1182.0
Dumka,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,56.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,19.0,246.0,326.0
Dumka,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3336.0,1969.0,2381.0,2277.0,2119.0,2942.0,1515.0,1893.0,2020.0,1842.0,2243.0,2303.0,26840.0
Dumka,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,4.0
Dumka,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Dumka,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1240.0,1012.0,1086.0,1149.0,1104.0,1514.0,749.0,985.0,1004.0,929.0,1111.0,1132.0,13015.0
Dumka,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1142.0,879.0,1005.0,1067.0,978.0,1414.0,738.0,872.0,897.0,871.0,1070.0,1054.0,11987.0
Dumka,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2382.0,1891.0,2091.0,2216.0,2082.0,2928.0,1487.0,1857.0,1901.0,1800.0,2181.0,2186.0,25002.0
Dumka,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1611.0,1684.0,1630.0,1206.0,1338.0,1483.0,1323.0,1449.0,983.0,1495.0,1867.0,1834.0,17903.0
Dumka,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1576.0,1658.0,1623.0,1206.0,1041.0,692.0,864.0,1409.0,698.0,1019.0,668.0,139.0,12593.0
Dumka,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,416.0,324.0,452.0,301.0,299.0,315.0,243.0,356.0,223.0,346.0,350.0,306.0,3931.0
Dumka,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,361.0,335.0,387.0,290.0,314.0,290.0,255.0,336.0,224.0,297.0,313.0,320.0,3722.0
Dumka,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,777.0,659.0,839.0,591.0,613.0,605.0,498.0,692.0,447.0,643.0,663.0,626.0,7653.0
Dumka,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,57.0,47.0,58.0,0.0,20.0,15.0,41.0,5.0,12.0,6.0,6.0,13.0,280.0
Dumka,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,844.0,1146.0,1111.0,856.0,1050.0,985.0,918.0,965.0,686.0,754.0,765.0,840.0,10920.0
Dumka,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,799.0,908.0,1046.0,728.0,868.0,862.0,801.0,867.0,516.0,649.0,754.0,712.0,9510.0
Dumka,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,115.0,98.0,123.0,128.0,90.0,93.0,119.0,104.0,63.0,44.0,49.0,57.0,1083.0
Dumka,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,93.0,51.0,85.0,65.0,67.0,58.0,60.0,78.0,55.0,49.0,50.0,50.0,761.0
Dumka,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1856.0,1897.0,1881.0,1840.0,1893.0,1889.0,1850.0,1870.0,1846.0,1860.0,1869.0,1902.0,22453.0
Dumka,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1753.0,1880.0,1853.0,1670.0,1777.0,1840.0,1687.0,1822.0,1738.0,1726.0,1836.0,1864.0,21446.0
Dumka,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1466.0,1584.0,1565.0,1436.0,1513.0,1586.0,1482.0,1615.0,1539.0,1545.0,1653.0,1643.0,18627.0
Dumka,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1726.0,1331.0,1132.0,1084.0,792.0,388.0,128.0,74.0,60.0,65.0,5222.0,2164.0,14166.0
Dumka,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,307.0,132.0,147.0,190.0,291.0,445.0,6.0,5.0,6.0,0.0,14947.0,6041.0,22517.0
Dumka,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,457.0,123.0,49.0,135.0,253.0,3.0,2.0,3.0,3.0,9.0,14505.0,5698.0,21240.0
Dumka,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,12.0,6.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,6.0,0.0,0.0,30.0
Dumka,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,2.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,6.0
Dumka,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,48.0,39.0,108.0,17.0,17.0,27.0,26.0,29.0,8.0,25.0,33.0,18.0,395.0
Dumka,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,413.0,386.0,423.0,332.0,345.0,357.0,271.0,290.0,130.0,212.0,202.0,138.0,3499.0
Dumka,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,292.0,322.0,325.0,293.0,296.0,234.0,182.0,321.0,116.0,161.0,112.0,209.0,2863.0
Dumka,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,8.0,12.0,8.0,0.0,0.0,2.0,4.0,8.0,13.0,5.0,0.0,0.0,60.0
Dumka,13.1,Number of Patients operated for cataract,TOTAL,0.0,2.0,2.0,2.0,2.0,2.0,2.0,0.0,1.0,1.0,0.0,2.0,16.0
Dumka,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,12.0,11.0,6.0,18.0,53.0
Dumka,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,6.0,7.0,5.0,6.0,5.0,3.0,4.0,5.0,3.0,3.0,3.0,-1.0
Dumka,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,17.0,16.0,18.0,2.0,11.0,11.0,12.0,13.0,12.0,9.0,4.0,7.0,-1.0
Dumka,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1559.0,1427.0,1424.0,1153.0,1432.0,1484.0,1394.0,1451.0,1435.0,1496.0,1552.0,1597.0,-1.0
Dumka,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,9.0,10.0,8.0,10.0,10.0,7.0,8.0,8.0,8.0,8.0,8.0,-1.0
Dumka,14.05,Number of RKS meetings held during the month,TOTAL,10.0,3.0,3.0,3.0,5.0,6.0,4.0,2.0,4.0,2.0,5.0,3.0,50.0
Dumka,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,23.0,22.0,21.0,5.0,16.0,12.0,17.0,17.0,16.0,12.0,8.0,10.0,-1.0
Dumka,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,51.0,41.0,49.0,17.0,26.0,23.0,23.0,19.0,27.0,24.0,21.0,33.0,354.0
Dumka,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,4.0,4.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,2.0,3.0,-1.0
Dumka,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Dumka,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,82.0,80.0,97.0,63.0,118.0,115.0,141.0,155.0,155.0,37.0,56.0,42.0,1141.0
Dumka,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,391.0,398.0,460.0,481.0,511.0,471.0,475.0,464.0,476.0,183.0,324.0,223.0,4857.0
Dumka,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,66.0,71.0,59.0,119.0,68.0,71.0,61.0,68.0,69.0,24.0,35.0,28.0,739.0
Dumka,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,857.0,801.0,992.0,1186.0,1195.0,1181.0,1138.0,905.0,1134.0,1148.0,1241.0,828.0,12606.0
Dumka,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,148.0,151.0,156.0,182.0,186.0,186.0,202.0,223.0,224.0,61.0,91.0,70.0,1880.0
Dumka,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1248.0,1199.0,1452.0,1667.0,1706.0,1652.0,1613.0,1369.0,1610.0,1331.0,1565.0,1051.0,17463.0
Dumka,14.10.2.a,Number of death cases of Inpatient males,TOTAL,16.0,26.0,18.0,7.0,15.0,26.0,24.0,18.0,15.0,14.0,14.0,18.0,211.0
Dumka,14.10.2.b,Number of death cases of Inpatient females,TOTAL,10.0,11.0,10.0,9.0,10.0,13.0,9.0,11.0,8.0,11.0,10.0,6.0,118.0
Dumka,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,26.0,37.0,28.0,16.0,25.0,39.0,33.0,29.0,23.0,25.0,24.0,24.0,329.0
Dumka,14.11,In-Patient Head Count at midnight,TOTAL,370.0,418.0,340.0,463.0,438.0,371.0,461.0,376.0,576.0,527.0,599.0,388.0,5327.0
Dumka,14.12.1,OPD attendance (All),TOTAL,46759.0,58626.0,54180.0,55622.0,55710.0,53353.0,50176.0,45675.0,43261.0,39025.0,42971.0,42939.0,588297.0
Dumka,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,265.0,14.0,5.0,80.0,11.0,15.0,37.0,30.0,131.0,230.0,277.0,139.0,1234.0
Dumka,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Dumka,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,138.0,181.0,104.0,123.0,100.0,62.0,81.0,85.0,127.0,122.0,67.0,65.0,1255.0
Dumka,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,59.0,63.0,66.0,91.0,88.0,89.0,70.0,64.0,71.0,81.0,81.0,78.0,901.0
Dumka,14.14.c,Number of Adolescents counselled,TOTAL,92.0,91.0,99.0,447.0,458.0,101.0,71.0,76.0,51.0,63.0,42.0,51.0,1642.0
Dumka,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2011.0,2174.0,2005.0,2403.0,2521.0,2364.0,2629.0,3036.0,1981.0,2638.0,2717.0,3263.0,29742.0
Dumka,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,78.0,61.0,58.0,92.0,80.0,95.0,87.0,80.0,38.0,97.0,108.0,198.0,1072.0
Dumka,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,85.0,151.0,144.0,172.0,166.0,230.0,196.0,202.0,67.0,214.0,255.0,254.0,2136.0
Dumka,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,0.0,2.0,0.0,3.0,0.0,0.0,1.0,1.0,2.0,2.0,12.0
Dumka,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,45.0,85.0,69.0,166.0,96.0,194.0,84.0,130.0,216.0,306.0,378.0,202.0,1971.0
Dumka,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Dumka,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,78.0,112.0,115.0,136.0,135.0,179.0,171.0,145.0,141.0,144.0,124.0,144.0,1624.0
Dumka,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0
Dumka,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,208.0,348.0,328.0,474.0,397.0,603.0,451.0,477.0,424.0,664.0,757.0,600.0,5731.0
Dumka,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,2.0,4.0,2.0,0.0,3.0,0.0,0.0,1.0,1.0,2.0,3.0,19.0
Dumka,15.2,Number of Widal tests conducted,Number tested,102.0,114.0,61.0,187.0,169.0,100.0,50.0,38.0,22.0,23.0,38.0,37.0,941.0
Dumka,15.3.a,Number of VDRL tests conducted on males,Number tested,14.0,30.0,98.0,143.0,120.0,202.0,165.0,217.0,107.0,191.0,174.0,242.0,1703.0
Dumka,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,12.0,37.0,71.0,97.0,88.0,180.0,75.0,157.0,141.0,281.0,190.0,189.0,1518.0
Dumka,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,30.0,0.0,35.0,133.0,125.0,179.0,147.0,164.0,124.0,140.0,77.0,144.0,1298.0
Dumka,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,56.0,67.0,204.0,373.0,333.0,561.0,387.0,538.0,372.0,612.0,441.0,575.0,4519.0
Dumka,15.4.1,Number of blood smears examined for Malaria,TOTAL,7125.0,7056.0,7744.0,10053.0,6073.0,6732.0,3433.0,9365.0,6863.0,5344.0,4274.0,6210.0,80272.0
Dumka,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,145.0,150.0,110.0,223.0,179.0,137.0,41.0,96.0,111.0,74.0,59.0,56.0,1381.0
Dumka,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,91.0,184.0,134.0,131.0,169.0,338.0,194.0,762.0,627.0,243.0,68.0,64.0,3005.0
Dumka,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,18990.0,28970.0,9730.0,10750.0,23630.0,21700.0,30580.0,21760.0,3690.0,15600.0,19430.0,4500.0,209330.0
Dumka,16.1.1,Stock position of DPT vaccines,2. Stocks Received,27000.0,0.0,20000.0,30000.0,30000.0,20000.0,10000.0,0.0,25000.0,20000.0,10000.0,26000.0,218000.0
Dumka,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,17020.0,19240.0,18980.0,17120.0,31930.0,11120.0,18820.0,18070.0,13090.0,16170.0,24930.0,4150.0,210640.0
Dumka,16.1.1,Stock position of DPT vaccines,5. Total Stock,28970.0,9730.0,10750.0,23630.0,21700.0,30580.0,21760.0,3690.0,15600.0,19430.0,4500.0,26350.0,216690.0
Dumka,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Dumka,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Dumka,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Dumka,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Dumka,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1520.0,50920.0,13980.0,13700.0,1640.0,640.0,8340.0,14800.0,6000.0,2800.0,1500.0,200.0,116040.0
Dumka,16.1.2,Stock position of OPV vaccines,2. Stocks Received,80000.0,0.0,40000.0,0.0,26000.0,20000.0,40000.0,10000.0,10000.0,20000.0,0.0,16000.0,262000.0
Dumka,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,30600.0,36940.0,40280.0,12060.0,27000.0,12300.0,33540.0,18800.0,13200.0,21300.0,1300.0,500.0,247820.0
Dumka,16.1.2,Stock position of OPV vaccines,5. Total Stock,50920.0,13980.0,13700.0,1640.0,640.0,8340.0,14800.0,6000.0,2800.0,1500.0,200.0,15700.0,130220.0
Dumka,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,16530.0,27210.0,8180.0,9440.0,16590.0,19920.0,28700.0,16840.0,110.0,15210.0,20690.0,13670.0,193090.0
Dumka,16.1.3,Stock position of TT vaccines,2. Stocks Received,25000.0,0.0,20000.0,27500.0,35000.0,20000.0,10000.0,0.0,25000.0,25000.0,20000.0,25000.0,232500.0
Dumka,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.1.3,Stock position of TT vaccines,4. Stock Distributed,14320.0,19030.0,18740.0,20350.0,31670.0,11220.0,21860.0,16730.0,9900.0,19520.0,27020.0,7720.0,218080.0
Dumka,16.1.3,Stock position of TT vaccines,5. Total Stock,27210.0,8180.0,9440.0,16590.0,19920.0,28700.0,16840.0,110.0,15210.0,20690.0,13670.0,30950.0,207510.0
Dumka,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Dumka,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Dumka,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dumka,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Dumka,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,19920.0,32370.0,14020.0,19610.0,7400.0,15800.0,19730.0,1790.0,8500.0,1640.0,580.0,80.0,141440.0
Dumka,16.1.5,Stock position of BCG vaccines,2. Stocks Received,25000.0,0.0,20000.0,0.0,35000.0,15000.0,0.0,10000.0,0.0,10000.0,0.0,16000.0,131000.0
Dumka,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,12550.0,18350.0,14410.0,12210.0,26600.0,11070.0,17940.0,3290.0,6860.0,11060.0,500.0,7500.0,142340.0
Dumka,16.1.5,Stock position of BCG vaccines,5. Total Stock,32370.0,14020.0,19610.0,7400.0,15800.0,19730.0,1790.0,8500.0,1640.0,580.0,80.0,8580.0,130100.0
Dumka,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0.0,0.0,0.0,2690.0,1150.0,4485.0,0.0,5000.0,0.0,0.0,52395.0,46290.0,112010.0
Dumka,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10395.0,,10000.0,5000.0,15000.0,0.0,10000.0,0.0,0.0,53395.0,0.0,0.0,103790.0
Dumka,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,10395.0,,7310.0,6540.0,11665.0,4485.0,5000.0,5000.0,0.0,1000.0,6105.0,1100.0,58600.0
Dumka,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,2690.0,1150.0,4485.0,0.0,5000.0,0.0,0.0,52395.0,46290.0,45190.0,157200.0
Dumka,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Dumka,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Dumka,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Dumka,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Dumka,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,,,,,,,,0.0,41200.0,23370.0,64570.0
Dumka,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,,,,,,,,44200.0,0.0,0.0,44200.0
Dumka,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,0.0,0.0,0.0
Dumka,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,,,,,,,,3000.0,17830.0,1450.0,22280.0
Dumka,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,41200.0,23370.0,21920.0,86490.0
Dumka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,290.0,290.0,290.0,290.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,2760.0
Dumka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,2800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2800.0
Dumka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,2890.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2890.0
Dumka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,290.0,290.0,290.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,2670.0
Dumka,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,5900.0,2900.0,2900.0,1900.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,29600.0
Dumka,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,66500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,66500.0
Dumka,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,3000.0,0.0,1000.0,66400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,70400.0
Dumka,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,2900.0,2900.0,1900.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,25700.0
Dumka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,470.0,470.0,470.0,370.0,970.0,970.0,970.0,970.0,970.0,970.0,970.0,970.0,9540.0
Dumka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,16500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16500.0
Dumka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,100.0,15900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16000.0
Dumka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,470.0,470.0,370.0,970.0,970.0,970.0,970.0,970.0,970.0,970.0,970.0,970.0,10040.0
Dumka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,18.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,216.0
Dumka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,18.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,216.0
Dumka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Dumka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Dumka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Dumka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Dumka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0
Dumka,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,25200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25200.0
Dumka,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,20200.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25200.0
Dumka,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0
Dumka,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,2700.0,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4200.0
Dumka,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0
Dumka,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,300.0,1200.0,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0
Dumka,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,2700.0,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4200.0
Dumka,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,1000.0,0.0,1200.0,3000.0,300.0,1600.0,300.0,2500.0,0.0,0.0,0.0,9900.0
Dumka,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,4000.0,0.0,4000.0,7000.0,0.0,4500.0,1000.0,3000.0,0.0,3000.0,0.0,4800.0,31300.0
Dumka,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3000.0,1000.0,2800.0,5200.0,2700.0,3200.0,2300.0,800.0,2500.0,3000.0,0.0,2200.0,28700.0
Dumka,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1000.0,0.0,1200.0,3000.0,300.0,1600.0,300.0,2500.0,0.0,0.0,0.0,2600.0,12500.0
Dumka,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,25000.0,53430.0,21200.0,4200.0,16200.0,0.0,10000.0,14000.0,0.0,29200.0,37500.0,38100.0,248830.0
Dumka,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,51000.0,0.0,0.0,20000.0,10000.0,20000.0,20000.0,0.0,40000.0,26000.0,24000.0,44000.0,255000.0
Dumka,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,22570.0,32230.0,17000.0,8000.0,26200.0,10000.0,16000.0,14000.0,10800.0,17700.0,23400.0,9900.0,207800.0
Dumka,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,53430.0,21200.0,4200.0,16200.0,0.0,10000.0,14000.0,0.0,29200.0,37500.0,38100.0,72200.0,296030.0
Dumka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,585.0,2635.0,0.0,0.0,0.0,0.0,12300.0,7000.0,3830.0,4654.0,2554.0,1554.0,35112.0
Dumka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,6000.0,0.0,0.0,0.0,0.0,15000.0,0.0,0.0,5000.0,0.0,2000.0,20000.0,48000.0
Dumka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dumka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3950.0,2635.0,0.0,0.0,0.0,2700.0,5300.0,3170.0,4176.0,2100.0,3000.0,1320.0,28351.0
Dumka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2635.0,0.0,0.0,0.0,0.0,12300.0,7000.0,3830.0,4654.0,2554.0,1554.0,20234.0,54761.0
Dumka,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,1.0,,,,1.0,,,,2.0,,4.0
Dumka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Dumka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dumka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Dumka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Dumka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dumka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Dumka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,1.0,,,,,,1.0
Dumka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dumka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,1.0,,,,,,1.0
Dumka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,,1.0,,,,,,,,,3.0
Dumka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,2.0,,,,,,,,,,,3.0
Dumka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,3.0,,1.0,,,,,,,,,6.0
Dumka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,2.0,1.0,,,,,,,,3.0
Dumka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dumka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,2.0,1.0,,,,,,,,3.0
Dumka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Dumka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dumka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,1.0,,,,,,,,,,,,1.0
Dumka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,1.0,,,,,1.0,,,2.0
Dumka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,,,,,,,,,,1.0
Dumka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,1.0,,,,,1.0,,,3.0
Dumka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dumka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dumka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dumka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,1.0,1.0,,,,,,,2.0
Dumka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,,1.0,,,1.0,1.0,1.0,,5.0
Dumka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,1.0,1.0,2.0,,,1.0,1.0,1.0,,7.0
Dumka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Dumka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,1.0,,,1.0,,1.0,1.0,,1.0,,,,5.0
Dumka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,1.0,1.0,,,,1.0,,,1.0,,4.0
Dumka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,1.0,2.0,,1.0,1.0,1.0,1.0,,1.0,,9.0
Dumka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Dumka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,,,,,2.0,,,,,,,4.0
Dumka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Dumka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,,,,,3.0,,,,,,,5.0
Dumka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,1.0,1.0,,1.0,,,3.0
Dumka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,3.0,,1.0,,1.0,2.0,4.0,2.0,1.0,3.0,6.0,3.0,26.0
Dumka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,3.0,,1.0,2.0,,1.0,3.0,1.0,2.0,,2.0,1.0,16.0
Dumka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,6.0,,2.0,2.0,1.0,3.0,8.0,4.0,3.0,4.0,8.0,4.0,45.0
Dumka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,1.0,,,,,,1.0,,,,2.0
Dumka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,,1.0,,,,1.0,,2.0,,,,5.0
Dumka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Dumka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,,2.0,,,,1.0,,3.0,,,,7.0
Dumka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,2.0,,,,,,,2.0
Dumka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,3.0,,1.0,1.0,,3.0,5.0,3.0,2.0,1.0,2.0,3.0,24.0
Dumka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,1.0,2.0,1.0,6.0,3.0,1.0,2.0,,,1.0,18.0
Dumka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,4.0,,2.0,3.0,1.0,11.0,8.0,4.0,4.0,1.0,2.0,4.0,44.0
Dumka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Dumka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Dumka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Dumka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,,,,,,,,,1.0
Dumka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Dumka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,4.0,,3.0,6.0,,1.0,4.0,2.0,2.0,2.0,1.0,4.0,29.0
Dumka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,2.0,4.0,,,,3.0,1.0,1.0,1.0,3.0,15.0
Dumka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,,5.0,10.0,,1.0,4.0,5.0,3.0,3.0,2.0,7.0,44.0
Dumka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Dumka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,2.0,,,,,,,,,,2.0
Dumka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,2.0,,,1.0,,,,,,,3.0
Dumka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,4.0,,,1.0,,,,,,,5.0
Dumka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dumka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,1.0,,,1.0,,,2.0
Dumka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dumka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,1.0,,,1.0,,,2.0
Dumka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dumka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,1.0,,,,,,1.0,1.0,3.0
Dumka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dumka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,1.0,,,,,,1.0,1.0,3.0
Dumka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dumka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,,,,,1.0,,,,,2.0
Dumka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dumka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,,,,,1.0,,,,,2.0
Dumka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dumka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Dumka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dumka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Dumka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dumka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,1.0,,,,,,,1.0,,,,,2.0
Dumka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dumka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,1.0,,,,,,,1.0,,,,,2.0
Dumka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dumka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,3.0,1.0,2.0,2.0,1.0,3.0,,2.0,,1.0,,16.0
Dumka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,1.0,,2.0,,,,,,,,3.0
Dumka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,3.0,2.0,2.0,4.0,1.0,3.0,,2.0,,1.0,,19.0
Dumka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,1.0,,,,,,,,,3.0
Dumka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,2.0,4.0,4.0,1.0,2.0,4.0,1.0,,3.0,,1.0,25.0
Dumka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,1.0,,1.0,,1.0,3.0
Dumka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,3.0,5.0,5.0,1.0,2.0,4.0,2.0,,4.0,,2.0,31.0
Dumka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Dumka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,,,,,,4.0,,,,,,7.0
Dumka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Dumka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,,,,,,4.0,,,,,,7.0
Dumka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Dumka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,1.0,4.0,2.0,1.0,1.0,,,,,10.0
Dumka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Dumka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,2.0,1.0,5.0,2.0,1.0,1.0,,,,,12.0
Dumka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,,,,3.0,1.0,,,,,5.0
Dumka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,2.0,,4.0,1.0,1.0,2.0,3.0,2.0,1.0,1.0,,19.0
Dumka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,1.0,,,1.0,,2.0,3.0,1.0,1.0,1.0,1.0,12.0
Dumka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,4.0,3.0,,4.0,2.0,1.0,7.0,7.0,3.0,2.0,2.0,1.0,36.0
Dumka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,1.0,1.0,,,,,,,,,,3.0
Dumka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,4.0,2.0,2.0,,1.0,1.0,,1.0,1.0,1.0,,15.0
Dumka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,2.0,,2.0,3.0,2.0,2.0,1.0,,,,,12.0
Dumka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,7.0,3.0,4.0,3.0,3.0,3.0,1.0,1.0,1.0,1.0,,30.0
Dumka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,1.0,1.0,3.0,1.0,,,,,1.0,8.0
Dumka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,4.0,5.0,7.0,6.0,13.0,9.0,6.0,8.0,9.0,13.0,11.0,93.0
Dumka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,3.0,2.0,7.0,3.0,4.0,8.0,1.0,2.0,2.0,5.0,3.0,2.0,42.0
Dumka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,6.0,6.0,12.0,11.0,11.0,24.0,11.0,8.0,10.0,14.0,16.0,14.0,143.0
Garhwa,1.1,Total number of pregnant women Registered for ANC,TOTAL,2537.0,2863.0,2794.0,3153.0,2510.0,2204.0,2059.0,1951.0,1913.0,2229.0,2866.0,2783.0,29862.0
Garhwa,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,405.0,393.0,387.0,407.0,346.0,288.0,286.0,276.0,276.0,350.0,403.0,386.0,4203.0
Garhwa,1.2,Number of Pregnant women registered under JSY,TOTAL,2536.0,2863.0,2794.0,3153.0,2507.0,2204.0,2059.0,1949.0,1906.0,2229.0,2858.0,2783.0,29841.0
Garhwa,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1191.0,1385.0,1332.0,1388.0,1359.0,1316.0,1121.0,1141.0,1123.0,1115.0,1180.0,1224.0,14875.0
Garhwa,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2189.0,2476.0,2335.0,2711.0,2149.0,1847.0,1707.0,1612.0,1622.0,1973.0,2515.0,2413.0,25549.0
Garhwa,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1810.0,2309.0,2027.0,2320.0,2104.0,1920.0,1728.0,1633.0,1473.0,1485.0,1854.0,2231.0,22894.0
Garhwa,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,950.0,736.0,229.0,201.0,95.0,1.0,89.0,279.0,916.0,1382.0,2409.0,1538.0,8825.0
Garhwa,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,3.0,5.0,9.0,2.0,39.0,22.0,2.0,9.0,9.0,8.0,8.0,5.0,121.0
Garhwa,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,3.0,3.0,2.0,1.0,2.0,1.0,0.0,0.0,0.0,0.0,12.0
Garhwa,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,516.0,460.0,347.0,384.0,426.0,383.0,219.0,366.0,311.0,386.0,667.0,642.0,5107.0
Garhwa,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,8.0,15.0,21.0,7.0,9.0,7.0,5.0,33.0,19.0,9.0,9.0,36.0,178.0
Garhwa,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Garhwa,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,64.0,67.0,77.0,91.0,68.0,111.0,76.0,57.0,76.0,56.0,75.0,75.0,893.0
Garhwa,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,454.0,460.0,457.0,502.0,506.0,561.0,484.0,458.0,421.0,453.0,420.0,369.0,5545.0
Garhwa,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,518.0,527.0,534.0,593.0,574.0,672.0,560.0,515.0,497.0,509.0,495.0,444.0,6438.0
Garhwa,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,322.0,319.0,398.0,375.0,398.0,394.0,379.0,311.0,325.0,296.0,315.0,227.0,4059.0
Garhwa,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,14.0,0.0,0.0,5.0,8.0,16.0,43.0
Garhwa,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,835.0,985.0,1167.0,1531.0,1647.0,1473.0,1462.0,1254.0,1229.0,1174.0,995.0,909.0,14661.0
Garhwa,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,835.0,984.0,1164.0,1527.0,1581.0,1451.0,1439.0,1224.0,1154.0,1097.0,968.0,885.0,14309.0
Garhwa,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,670.0,426.0,1089.0,1391.0,1751.0,1221.0,1107.0,1385.0,1099.0,888.0,639.0,696.0,12362.0
Garhwa,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,661.0,515.0,659.0,1205.0,623.0,1112.0,1068.0,882.0,784.0,873.0,443.0,490.0,9315.0
Garhwa,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,86.0,78.0,62.0,195.0,132.0,172.0,232.0,198.0,80.0,212.0,190.0,122.0,1759.0
Garhwa,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,86.0,78.0,62.0,195.0,132.0,172.0,232.0,198.0,80.0,212.0,190.0,122.0,1759.0
Garhwa,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,86.0,78.0,62.0,195.0,132.0,172.0,232.0,198.0,80.0,212.0,190.0,122.0,1759.0
Garhwa,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Garhwa,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,7.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,6.0,12.0,5.0,37.0
Garhwa,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwa,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,7.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,6.0,12.0,5.0,37.0
Garhwa,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,4.1.1.a,Number of male live births,TOTAL,796.0,794.0,848.0,1137.0,1204.0,1191.0,1196.0,1002.0,883.0,951.0,833.0,729.0,11564.0
Garhwa,4.1.1.b,Number of female live births,TOTAL,641.0,767.0,889.0,1138.0,1156.0,1091.0,1038.0,939.0,894.0,919.0,832.0,721.0,11025.0
Garhwa,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1437.0,1561.0,1737.0,2275.0,2360.0,2282.0,2234.0,1941.0,1777.0,1870.0,1665.0,1450.0,22589.0
Garhwa,4.1.2,Number of still births,TOTAL,39.0,37.0,50.0,62.0,67.0,52.0,39.0,34.0,37.0,35.0,23.0,44.0,519.0
Garhwa,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,6.0,11.0,9.0,10.0,7.0,8.0,8.0,6.0,12.0,11.0,15.0,3.0,106.0
Garhwa,4.2.1,Number of Newborns weighed at birth,TOTAL,1321.0,1433.0,1608.0,2137.0,2128.0,2052.0,2122.0,1807.0,1653.0,1757.0,1545.0,1281.0,20844.0
Garhwa,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,55.0,83.0,135.0,139.0,172.0,146.0,159.0,147.0,91.0,122.0,59.0,64.0,1372.0
Garhwa,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1377.0,1517.0,1665.0,2184.0,2209.0,2217.0,2188.0,1900.0,1729.0,1815.0,1631.0,1370.0,21802.0
Garhwa,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,1.0,0.0,20.0,0.0,38.0,34.0,54.0,28.0,27.0,13.0,0.0,0.0,215.0
Garhwa,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,130.0,5.0,0.0,68.0,400.0,500.0,300.0,60.0,115.0,2.0,13.0,5.0,1598.0
Garhwa,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwa,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,131.0,5.0,20.0,68.0,438.0,534.0,354.0,88.0,142.0,15.0,13.0,5.0,1813.0
Garhwa,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,131.0,3.0,20.0,68.0,438.0,534.0,354.0,88.0,142.0,13.0,0.0,5.0,1796.0
Garhwa,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,40.0,0.0,0.0,0.0,50.0,100.0,100.0,40.0,45.0,0.0,13.0,0.0,388.0
Garhwa,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,10.0,2.0,0.0,12.0,8.0,6.0,4.0,6.0,6.0,2.0,1.0,5.0,62.0
Garhwa,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1005.0,1033.0,1267.0,1274.0,1501.0,1166.0,1007.0,1271.0,1192.0,1237.0,967.0,880.0,13800.0
Garhwa,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,547.0,627.0,642.0,713.0,636.0,757.0,723.0,589.0,547.0,950.0,508.0,425.0,7664.0
Garhwa,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,17.0
Garhwa,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Garhwa,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Garhwa,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,50.0,1.0,54.0,3.0,0.0,0.0,6.0,13.0,18.0,69.0,78.0,63.0,355.0
Garhwa,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,60.0,2.0,51.0,3.0,2.0,0.0,11.0,16.0,5.0,125.0,141.0,117.0,533.0
Garhwa,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,110.0,3.0,105.0,6.0,2.0,0.0,17.0,29.0,23.0,194.0,219.0,180.0,888.0
Garhwa,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,0.0,17.0,0.0,0.0,0.0,2.0,0.0,4.0,3.0,0.0,27.0
Garhwa,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,8.0
Garhwa,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwa,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,0.0,0.0,20.0,0.0,0.0,0.0,2.0,0.0,8.0,3.0,0.0,35.0
Garhwa,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,5.0,1.0,0.0,0.0,2.0,2.0,8.0,0.0,0.0,18.0
Garhwa,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwa,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,2.0,0.0,0.0,139.0,0.0,0.0,0.0,72.0,94.0,943.0,368.0,0.0,1618.0
Garhwa,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,25.0,0.0,0.0,0.0,7.0,262.0,244.0,24.0,10.0,572.0
Garhwa,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwa,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,2.0,0.0,0.0,164.0,0.0,0.0,0.0,79.0,356.0,1187.0,392.0,10.0,2190.0
Garhwa,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,692.0,5.0,0.0,0.0,201.0,369.0,2731.0,2679.0,0.0,6677.0
Garhwa,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,2.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Garhwa,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,24.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0
Garhwa,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwa,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,2.0,24.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0
Garhwa,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,59.0,48.0,44.0,99.0,118.0,114.0,90.0,92.0,75.0,78.0,82.0,83.0,982.0
Garhwa,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,16.0,14.0,15.0,6.0,8.0,9.0,12.0,8.0,9.0,4.0,5.0,6.0,112.0
Garhwa,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,9.0,9.0,9.0,150.0,12.0,16.0,16.0,12.0,12.0,60.0,27.0,13.0,345.0
Garhwa,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,27.0,11.0,7.0,3.0,5.0,12.0,9.0,13.0,5.0,11.0,14.0,7.0,124.0
Garhwa,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwa,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,111.0,82.0,75.0,258.0,143.0,151.0,127.0,125.0,101.0,153.0,128.0,109.0,1563.0
Garhwa,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Garhwa,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.06,Number of IUCD removals,TOTAL,61.0,69.0,52.0,65.0,56.0,96.0,42.0,57.0,59.0,47.0,48.0,63.0,715.0
Garhwa,9.07,Number of Oral Pills cycles distributed,TOTAL,664.0,647.0,598.0,1872.0,1281.0,1213.0,1303.0,1358.0,1160.0,2565.0,1216.0,1603.0,15480.0
Garhwa,9.08,Number of Condom pieces distributed,TOTAL,4457.0,3084.0,4683.0,12741.0,14180.0,10652.0,9215.0,6367.0,3859.0,7274.0,6365.0,3240.0,86117.0
Garhwa,9.09,Number of Centchroman (weekly) pills given,TOTAL,16.0,11.0,17.0,20.0,20.0,30.0,0.0,0.0,0.0,0.0,4.0,0.0,118.0
Garhwa,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,254.0,248.0,205.0,269.0,274.0,243.0,199.0,235.0,147.0,171.0,129.0,140.0,2514.0
Garhwa,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,9.12,Number of Institutions having NSV trained doctors,TOTAL,9.0,10.0,10.0,7.0,8.0,11.0,16.0,16.0,17.0,17.0,17.0,17.0,-1.0
Garhwa,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1580.0,2249.0,2218.0,2118.0,1642.0,3722.0,2930.0,2788.0,2761.0,2476.0,1485.0,1970.0,27939.0
Garhwa,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1723.0,1972.0,1805.0,2294.0,2508.0,2689.0,2930.0,3076.0,2717.0,2604.0,2859.0,2553.0,29730.0
Garhwa,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2094.0,2150.0,1826.0,2037.0,2414.0,2275.0,2207.0,2712.0,2624.0,2437.0,2916.0,2679.0,28371.0
Garhwa,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2311.0,2412.0,2033.0,2215.0,2403.0,2178.0,1979.0,2100.0,2290.0,2257.0,2665.0,2498.0,27341.0
Garhwa,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Garhwa,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Garhwa,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Garhwa,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,616.0,964.0,1116.0,1218.0,892.0,1576.0,1171.0,794.0,508.0,861.0,744.0,618.0,11078.0
Garhwa,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1704.0,1972.0,1807.0,2286.0,2507.0,2594.0,2889.0,2310.0,335.0,1892.0,2393.0,2109.0,24798.0
Garhwa,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2094.0,2157.0,1827.0,2042.0,2398.0,2215.0,2172.0,1983.0,308.0,1642.0,2338.0,2183.0,23359.0
Garhwa,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2314.0,2438.0,2042.0,2228.0,2404.0,2139.0,1944.0,1561.0,299.0,1490.0,2114.0,2012.0,22985.0
Garhwa,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,0.0,0.0,0.0,38.0,409.0,454.0,522.0,470.0,1893.0
Garhwa,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,298.0,2843.0,3254.0,3339.0,1462.0,11196.0
Garhwa,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,230.0,1587.0,2288.0,1109.0,5221.0
Garhwa,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,29.0,0.0,0.0,0.0,14.0,105.0,310.0,1232.0,799.0,2489.0
Garhwa,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1708.0,2960.0,2580.0,2920.0,2218.0,2966.0,2316.0,2150.0,1833.0,1754.0,2157.0,2026.0,27588.0
Garhwa,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,9.0,0.0,0.0,0.0,256910.0,0.0,12.0,0.0,256931.0
Garhwa,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Garhwa,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,856.0,1476.0,1333.0,1418.0,1029.0,1457.0,1143.0,988.0,874.0,810.0,1057.0,958.0,13399.0
Garhwa,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,801.0,1353.0,1145.0,1214.0,1096.0,1291.0,1013.0,954.0,819.0,770.0,1014.0,965.0,12435.0
Garhwa,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1657.0,2829.0,2478.0,2632.0,2125.0,2748.0,2156.0,1942.0,1693.0,1580.0,2071.0,1923.0,25834.0
Garhwa,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1384.0,1742.0,1614.0,1721.0,2043.0,1713.0,1394.0,1565.0,1441.0,1659.0,2245.0,2032.0,20553.0
Garhwa,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1384.0,1743.0,1615.0,1721.0,2041.0,1691.0,1373.0,1252.0,264.0,1106.0,1817.0,1668.0,17675.0
Garhwa,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,561.0,616.0,681.0,678.0,725.0,625.0,501.0,449.0,399.0,571.0,731.0,542.0,7079.0
Garhwa,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,494.0,580.0,672.0,594.0,697.0,587.0,455.0,411.0,383.0,542.0,704.0,469.0,6588.0
Garhwa,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1055.0,1196.0,1353.0,1272.0,1422.0,1212.0,956.0,860.0,782.0,1113.0,1435.0,1011.0,13667.0
Garhwa,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,546.0,766.0,236.0,316.0,434.0,609.0,495.0,526.0,388.0,425.0,555.0,394.0,5690.0
Garhwa,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,688.0,670.0,684.0,792.0,753.0,685.0,643.0,687.0,736.0,586.0,688.0,638.0,8250.0
Garhwa,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,613.0,615.0,582.0,687.0,751.0,725.0,703.0,699.0,622.0,665.0,831.0,635.0,8128.0
Garhwa,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,8.0,10.0,8.0,4.0,6.0,8.0,3.0,2.0,3.0,4.0,6.0,0.0,62.0
Garhwa,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,11.0,0.0,0.0,0.0,4.0,0.0,1.0,1.0,0.0,0.0,0.0,17.0
Garhwa,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1182.0,1208.0,1203.0,1199.0,1202.0,1219.0,1182.0,1202.0,1209.0,1194.0,1201.0,1232.0,14433.0
Garhwa,10.4.2,Number of Immunisation sessions held during the month,TOTAL,947.0,1156.0,1066.0,1091.0,1191.0,1169.0,1090.0,1136.0,1119.0,1061.0,1130.0,1198.0,13354.0
Garhwa,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,826.0,988.0,954.0,1001.0,1042.0,1036.0,979.0,1023.0,1015.0,936.0,1028.0,1099.0,11927.0
Garhwa,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1097.0,1821.0,575.0,1414.0,7236.0,2537.0,1907.0,1589.0,763.0,807.0,7636.0,2424.0,29806.0
Garhwa,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,308.0,120.0,0.0,443.0,23610.0,5882.0,142.0,66.0,28.0,76.0,23026.0,3356.0,57057.0
Garhwa,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,490.0,154.0,0.0,396.0,29075.0,8145.0,104.0,10.0,27.0,3.0,30693.0,5098.0,74195.0
Garhwa,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,0.0,0.0,0.0,12.0
Garhwa,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,46.0,49.0,73.0,33.0,80.0,38.0,22.0,33.0,13.0,10.0,8.0,14.0,419.0
Garhwa,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,155.0,217.0,211.0,268.0,423.0,258.0,108.0,110.0,74.0,64.0,67.0,63.0,2018.0
Garhwa,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,218.0,182.0,319.0,439.0,704.0,836.0,252.0,288.0,122.0,138.0,556.0,676.0,4730.0
Garhwa,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,7.0,16.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0
Garhwa,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,29.0,0.0,0.0,0.0,1012.0,30.0,201.0,18.0,0.0,1290.0
Garhwa,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1012.0,30.0,94.0,0.0,0.0,1136.0
Garhwa,13.3,Number of School children detected with Refractive errors,TOTAL,282.0,1424.0,529.0,1226.0,4717.0,3760.0,140.0,57.0,21.0,11.0,4.0,99.0,12270.0
Garhwa,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,13.0,84.0,28.0,34.0,38.0,21.0,10.0,11.0,0.0,97.0,336.0
Garhwa,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,7.0,7.0,5.0,5.0,4.0,4.0,3.0,4.0,3.0,3.0,3.0,-1.0
Garhwa,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,3.0,3.0,2.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Garhwa,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,592.0,735.0,756.0,790.0,787.0,759.0,641.0,658.0,583.0,635.0,653.0,706.0,-1.0
Garhwa,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,8.0,9.0,6.0,6.0,8.0,8.0,9.0,9.0,9.0,8.0,9.0,-1.0
Garhwa,14.05,Number of RKS meetings held during the month,TOTAL,0.0,1.0,1.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,1.0,6.0
Garhwa,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,13.0,12.0,12.0,13.0,11.0,9.0,10.0,9.0,9.0,10.0,9.0,-1.0
Garhwa,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,34.0,38.0,42.0,32.0,41.0,18.0,24.0,24.0,18.0,31.0,30.0,32.0,364.0
Garhwa,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,6.0,6.0,5.0,5.0,4.0,4.0,5.0,5.0,5.0,6.0,5.0,-1.0
Garhwa,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Garhwa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,81.0,92.0,62.0,97.0,132.0,123.0,40.0,67.0,52.0,65.0,44.0,33.0,888.0
Garhwa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,288.0,540.0,529.0,431.0,465.0,468.0,339.0,256.0,593.0,148.0,411.0,416.0,4884.0
Garhwa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,47.0,70.0,61.0,72.0,138.0,87.0,38.0,63.0,59.0,66.0,36.0,34.0,771.0
Garhwa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,584.0,829.0,798.0,912.0,857.0,908.0,922.0,737.0,1033.0,1050.0,832.0,760.0,10222.0
Garhwa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,128.0,162.0,123.0,169.0,270.0,210.0,78.0,130.0,111.0,131.0,80.0,67.0,1659.0
Garhwa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,872.0,1369.0,1327.0,1343.0,1322.0,1376.0,1261.0,993.0,1626.0,1198.0,1243.0,1176.0,15106.0
Garhwa,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,15.0,14.0,8.0,22.0,17.0,16.0,12.0,14.0,10.0,12.0,4.0,149.0
Garhwa,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,11.0,18.0,17.0,16.0,12.0,14.0,19.0,12.0,8.0,12.0,4.0,150.0
Garhwa,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12.0,26.0,32.0,25.0,38.0,29.0,30.0,31.0,26.0,18.0,24.0,8.0,299.0
Garhwa,14.11,In-Patient Head Count at midnight,TOTAL,593.0,414.0,415.0,451.0,529.0,596.0,737.0,670.0,932.0,536.0,221.0,82.0,6176.0
Garhwa,14.12.1,OPD attendance (All),TOTAL,39253.0,41135.0,35908.0,47086.0,47745.0,47747.0,37477.0,35461.0,22872.0,30126.0,28760.0,30967.0,444537.0
Garhwa,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,56.0,0.0,0.0,0.0,55.0,137.0,245.0,87.0,0.0,580.0
Garhwa,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Garhwa,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,103.0,75.0,74.0,428.0,172.0,133.0,125.0,121.0,227.0,190.0,227.0,235.0,2110.0
Garhwa,14.14.a,Number of patients given AYUSH treatment,TOTAL,304.0,254.0,245.0,269.0,0.0,0.0,1.0,232.0,1.0,238.0,202.0,170.0,1916.0
Garhwa,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,209.0,174.0,93.0,93.0,176.0,159.0,167.0,109.0,167.0,147.0,0.0,0.0,1494.0
Garhwa,14.14.c,Number of Adolescents counselled,TOTAL,330.0,23.0,62.0,92.0,38.0,552.0,94.0,194.0,246.0,287.0,82.0,68.0,2068.0
Garhwa,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,350.0,437.0,487.0,583.0,524.0,448.0,339.0,414.0,252.0,353.0,408.0,388.0,4983.0
Garhwa,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,20.0,21.0,34.0,18.0,46.0,30.0,34.0,33.0,19.0,9.0,25.0,38.0,327.0
Garhwa,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,85.0,145.0,127.0,140.0,145.0,149.0,156.0,150.0,195.0,180.0,302.0,168.0,1942.0
Garhwa,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,1.0,0.0,2.0,0.0,1.0,0.0,0.0,102.0,0.0,106.0
Garhwa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,50.0,180.0,119.0,154.0,118.0,135.0,36.0,125.0,114.0,176.0,221.0,138.0,1566.0
Garhwa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,54.0,0.0,57.0
Garhwa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,56.0,186.0,147.0,155.0,91.0,155.0,132.0,158.0,143.0,165.0,274.0,167.0,1829.0
Garhwa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,123.0,0.0,125.0
Garhwa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,191.0,511.0,393.0,449.0,354.0,439.0,324.0,433.0,452.0,521.0,797.0,473.0,5337.0
Garhwa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,1.0,0.0,1.0,1.0,3.0,0.0,1.0,0.0,2.0,279.0,0.0,288.0
Garhwa,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,21.0,0.0,0.0,35.0,40.0,42.0,52.0,190.0
Garhwa,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,34.0,37.0,24.0,17.0,118.0
Garhwa,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,32.0,0.0,0.0,56.0,62.0,85.0,100.0,335.0
Garhwa,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,59.0,0.0,0.0,125.0,139.0,151.0,169.0,643.0
Garhwa,15.4.1,Number of blood smears examined for Malaria,TOTAL,5835.0,6967.0,4917.0,4651.0,8777.0,14751.0,8000.0,6635.0,5489.0,4522.0,7367.0,5228.0,83139.0
Garhwa,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,616.0,609.0,558.0,755.0,946.0,1139.0,873.0,757.0,561.0,288.0,435.0,537.0,8074.0
Garhwa,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,16.0,4.0,9.0,59.0,179.0,228.0,132.0,177.0,58.0,69.0,30.0,18.0,979.0
Garhwa,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1120.0,11460.0,0.0,10000.0,14500.0,21500.0,10500.0,26000.0,28500.0,39500.0,36500.0,18500.0,218080.0
Garhwa,16.1.1,Stock position of DPT vaccines,2. Stocks Received,25500.0,0.0,30000.0,20000.0,30000.0,0.0,25000.0,20000.0,25000.0,10000.0,0.0,4000.0,189500.0
Garhwa,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Garhwa,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,15160.0,11460.0,20000.0,15500.0,23000.0,11000.0,9500.0,17500.0,14000.0,13000.0,18000.0,14000.0,182120.0
Garhwa,16.1.1,Stock position of DPT vaccines,5. Total Stock,11460.0,0.0,10000.0,14500.0,21500.0,10500.0,26000.0,28500.0,39500.0,36500.0,18500.0,8500.0,225460.0
Garhwa,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Garhwa,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,18200.0,25040.0,12040.0,22040.0,25040.0,21040.0,9540.0,10440.0,0.0,6440.0,11940.0,4440.0,166200.0
Garhwa,16.1.2,Stock position of OPV vaccines,2. Stocks Received,24000.0,0.0,30000.0,20000.0,20000.0,0.0,9900.0,0.0,10000.0,10000.0,0.0,4420.0,128320.0
Garhwa,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Garhwa,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,17160.0,13000.0,20000.0,17000.0,24000.0,11500.0,9000.0,10440.0,3560.0,4500.0,7500.0,8000.0,145660.0
Garhwa,16.1.2,Stock position of OPV vaccines,5. Total Stock,25040.0,12040.0,22040.0,25040.0,21040.0,9540.0,10440.0,0.0,6440.0,11940.0,4440.0,860.0,148860.0
Garhwa,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2420.0,15220.0,7220.0,3720.0,12420.0,15920.0,8920.0,20920.0,20920.0,31920.0,22920.0,9920.0,172440.0
Garhwa,16.1.3,Stock position of TT vaccines,2. Stocks Received,22000.0,0.0,10000.0,20000.0,20000.0,0.0,20000.0,10000.0,20000.0,0.0,0.0,20000.0,142000.0
Garhwa,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Garhwa,16.1.3,Stock position of TT vaccines,4. Stock Distributed,9200.0,8000.0,13500.0,11300.0,16500.0,7000.0,8000.0,10000.0,9000.0,9000.0,13000.0,9000.0,123500.0
Garhwa,16.1.3,Stock position of TT vaccines,5. Total Stock,15220.0,7220.0,3720.0,12420.0,15920.0,8920.0,20920.0,20920.0,31920.0,22920.0,9920.0,20920.0,190940.0
Garhwa,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Garhwa,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Garhwa,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0.0,10170.0,2670.0,670.0,0.0,12500.0,3500.0,3850.0,3900.0,12400.0,3900.0,1900.0,55460.0
Garhwa,16.1.5,Stock position of BCG vaccines,2. Stocks Received,22000.0,0.0,10000.0,4000.0,24000.0,0.0,5000.0,10000.0,20000.0,0.0,0.0,18000.0,113000.0
Garhwa,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Garhwa,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,11830.0,7500.0,12000.0,4670.0,11500.0,9000.0,4650.0,9950.0,11500.0,8500.0,2000.0,11000.0,104100.0
Garhwa,16.1.5,Stock position of BCG vaccines,5. Total Stock,10170.0,2670.0,670.0,0.0,12500.0,3500.0,3850.0,3900.0,12400.0,3900.0,1900.0,8900.0,64360.0
Garhwa,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0.0,7000.0,1750.0,4250.0,1750.0,11275.0,7275.0,4525.0,7775.0,14275.0,12027.0,8777.0,80679.0
Garhwa,16.1.6,Stock position of Measles vaccines,2. Stocks Received,14000.0,0.0,10000.0,0.0,15500.0,0.0,0.0,10000.0,10000.0,0.0,0.0,0.0,59500.0
Garhwa,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Garhwa,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,7000.0,5250.0,7500.0,2500.0,5975.0,4000.0,2750.0,6750.0,3500.0,2248.0,3250.0,,50723.0
Garhwa,16.1.6,Stock position of Measles vaccines,5. Total Stock,7000.0,1750.0,4250.0,1750.0,11275.0,7275.0,4525.0,7775.0,14275.0,12027.0,8777.0,8777.0,89456.0
Garhwa,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5800.0,21100.0,11200.0,2500.0,40600.0
Garhwa,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19300.0,19300.0,0.0,0.0,0.0,38600.0
Garhwa,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Garhwa,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,13500.0,4000.0,9900.0,8700.0,900.0,37000.0
Garhwa,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5800.0,21100.0,11200.0,2500.0,1600.0,42200.0
Garhwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,64000.0,64000.0,64000.0,192000.0
Garhwa,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,96000.0,0.0,0.0,0.0,96000.0
Garhwa,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Garhwa,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,32000.0,0.0,0.0,0.0,32000.0
Garhwa,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,64000.0,64000.0,64000.0,64000.0,256000.0
Garhwa,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Garhwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,960.0,20.0,20.0,20.0,20.0,20.0,1513.0,936.0,3509.0
Garhwa,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,2760.0,0.0,0.0,0.0,0.0,0.0,3537.0,0.0,0.0,6297.0
Garhwa,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Garhwa,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,1800.0,940.0,0.0,0.0,0.0,0.0,2044.0,577.0,786.0,6147.0
Garhwa,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,960.0,20.0,20.0,20.0,20.0,20.0,1513.0,936.0,150.0,3659.0
Garhwa,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Garhwa,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Garhwa,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Garhwa,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1050.0,6005.0,3505.0,2705.0,7805.0,10405.0,7605.0,7805.0,8705.0,11305.0,9805.0,8705.0,85405.0
Garhwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,7200.0,0.0,2000.0,6000.0,6000.0,0.0,1500.0,3000.0,6000.0,0.0,0.0,5400.0,37100.0
Garhwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Garhwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2245.0,2500.0,2800.0,900.0,3400.0,2800.0,1300.0,2100.0,3400.0,1500.0,1100.0,3300.0,27345.0
Garhwa,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,6005.0,3505.0,2705.0,7805.0,10405.0,7605.0,7805.0,8705.0,11305.0,9805.0,8705.0,10805.0,95160.0
Garhwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,33300.0,27900.0,9900.0,30700.0,58200.0,82300.0,62400.0,88000.0,91800.0,69600.0,43800.0,12400.0,610300.0
Garhwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,10000.0,0.0,40000.0,50000.0,60000.0,0.0,45000.0,36000.0,0.0,0.0,0.0,33900.0,274900.0
Garhwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Garhwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,15400.0,18000.0,19200.0,22500.0,35900.0,19900.0,19400.0,32200.0,22200.0,25800.0,31400.0,24200.0,286100.0
Garhwa,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,27900.0,9900.0,30700.0,58200.0,82300.0,62400.0,88000.0,91800.0,69600.0,43800.0,12400.0,22100.0,599100.0
Garhwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1200.0,2300.0,500.0,700.0,500.0,3700.0,2300.0,7200.0,4400.0,3700.0,2600.0,1800.0,30900.0
Garhwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,1500.0,0.0,1500.0,0.0,6000.0,0.0,6000.0,0.0,900.0,0.0,0.0,11500.0,27400.0
Garhwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Garhwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,400.0,1800.0,1300.0,200.0,2800.0,1400.0,1100.0,2800.0,1600.0,1100.0,800.0,1600.0,16900.0
Garhwa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2300.0,500.0,700.0,500.0,3700.0,2300.0,7200.0,4400.0,3700.0,2600.0,1800.0,11700.0,41400.0
Garhwa,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,1.0,,,1.0,1.0,3.0
Garhwa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Garhwa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Garhwa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Garhwa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,1.0,1.0
Garhwa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,,1.0
Garhwa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,1.0,,1.0,2.0
Garhwa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Garhwa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,1.0,1.0,3.0
Garhwa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,1.0,1.0,1.0,3.0
Garhwa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,3.0,,,,,3.0
Garhwa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,1.0,,2.0
Garhwa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,3.0,,1.0,1.0,,5.0
Garhwa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,1.0,,,1.0,,,2.0
Garhwa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Garhwa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,1.0,,,1.0,,,2.0
Garhwa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,1.0,,,,,1.0
Garhwa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Garhwa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,1.0,,,,,1.0
Garhwa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,2.0,,2.0,1.0,,,5.0
Garhwa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,1.0,2.0,1.0,1.0,2.0,1.0,8.0
Garhwa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,3.0,2.0,3.0,2.0,2.0,1.0,13.0
Garhwa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Garhwa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Garhwa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Garhwa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,1.0,,1.0,,,2.0
Garhwa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,1.0,,1.0,2.0,,4.0
Garhwa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,2.0,,2.0,2.0,,6.0
Garhwa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Garhwa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Garhwa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Garhwa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,1.0,,,1.0,,2.0
Garhwa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Garhwa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,1.0,,,1.0,,2.0
Garhwa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,3.0,1.0,4.0
Garhwa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,2.0,,,,2.0
Garhwa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,2.0,,3.0,1.0,6.0
Garhwa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Garhwa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Garhwa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,1.0,,1.0
Garhwa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Garhwa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,4.0,2.0,,,1.0,7.0
Garhwa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Garhwa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,4.0,2.0,,1.0,1.0,8.0
Garhwa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Garhwa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Garhwa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Garhwa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,1.0,,,,2.0,1.0,4.0
Garhwa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,6.0,,6.0
Garhwa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,1.0,,,,8.0,1.0,10.0
Garhwa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,1.0,1.0,2.0
Garhwa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Garhwa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,1.0,1.0,2.0
Garhwa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Garhwa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Garhwa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Garhwa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Garhwa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Garhwa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Garhwa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,3.0,,,,,,3.0
Garhwa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Garhwa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,3.0,,,,,,3.0
Garhwa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Garhwa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Garhwa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,1.0,,,,,1.0
Garhwa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,2.0,,2.0
Garhwa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Garhwa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,2.0,,2.0
Garhwa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,2.0,1.0,,,1.0,1.0,5.0
Garhwa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,1.0,,,,1.0
Garhwa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,2.0,1.0,1.0,,1.0,1.0,6.0
Garhwa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,2.0,,,4.0,,1.0,1.0,2.0,10.0
Garhwa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,1.0,,,1.0,,2.0
Garhwa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,2.0,,,5.0,,1.0,2.0,2.0,12.0
Garhwa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,2.0,,,,,1.0,3.0
Garhwa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Garhwa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,2.0,,,,,1.0,3.0
Garhwa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,1.0,1.0,1.0,1.0,1.0,5.0
Garhwa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Garhwa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,2.0,1.0,1.0,1.0,1.0,6.0
Garhwa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Garhwa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,3.0,1.0,,,,4.0
Garhwa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,3.0,1.0,,,,4.0
Garhwa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Garhwa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Garhwa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,1.0,1.0,2.0,1.0,,,5.0
Garhwa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,1.0,1.0,2.0,1.0,,1.0,6.0
Garhwa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,1.0,1.0,1.0,,,3.0
Garhwa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,4.0,,2.0,1.0,,8.0,1.0,4.0,20.0
Garhwa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,1.0,9.0,8.0,1.0,,,19.0
Garhwa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,4.0,,3.0,11.0,9.0,10.0,1.0,4.0,42.0
Giridih,1.1,Total number of pregnant women Registered for ANC,TOTAL,4024.0,3289.0,3936.0,3414.0,3154.0,3517.0,3047.0,3368.0,3040.0,3655.0,3780.0,4050.0,42274.0
Giridih,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,588.0,591.0,586.0,481.0,649.0,547.0,505.0,521.0,509.0,729.0,681.0,653.0,7040.0
Giridih,1.2,Number of Pregnant women registered under JSY,TOTAL,3605.0,2980.0,3723.0,3145.0,2827.0,3241.0,2963.0,3178.0,2826.0,3220.0,3484.0,3735.0,38927.0
Giridih,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2138.0,1932.0,2007.0,1822.0,1751.0,1904.0,1764.0,1809.0,1612.0,1782.0,1826.0,2026.0,22373.0
Giridih,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3570.0,2928.0,3596.0,3161.0,2734.0,3221.0,2798.0,3033.0,2779.0,3137.0,3335.0,3562.0,37854.0
Giridih,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2976.0,2919.0,3116.0,2989.0,2832.0,2714.0,2637.0,2900.0,2510.0,2304.0,2611.0,2921.0,33429.0
Giridih,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1659.0,1278.0,1139.0,882.0,354.0,332.0,2056.0,2436.0,2229.0,1905.0,2018.0,2202.0,18490.0
Giridih,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,88.0,74.0,83.0,71.0,70.0,57.0,38.0,118.0,37.0,54.0,40.0,60.0,790.0
Giridih,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,16.0,2.0,1.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,22.0
Giridih,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,475.0,488.0,590.0,536.0,362.0,580.0,416.0,580.0,379.0,457.0,456.0,523.0,5842.0
Giridih,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,5.0,3.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,11.0
Giridih,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Giridih,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,347.0,286.0,302.0,342.0,306.0,319.0,275.0,310.0,264.0,348.0,276.0,304.0,3679.0
Giridih,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1155.0,1087.0,1221.0,1067.0,922.0,1307.0,992.0,1218.0,981.0,938.0,993.0,950.0,12831.0
Giridih,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1502.0,1373.0,1523.0,1409.0,1228.0,1626.0,1267.0,1528.0,1245.0,1286.0,1269.0,1254.0,16510.0
Giridih,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,937.0,831.0,786.0,825.0,807.0,983.0,707.0,871.0,758.0,857.0,850.0,791.0,10003.0
Giridih,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,93.0,76.0,91.0,93.0,65.0,43.0,74.0,97.0,87.0,104.0,56.0,55.0,934.0
Giridih,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1464.0,1383.0,1263.0,1668.0,1481.0,1098.0,848.0,1757.0,1425.0,1439.0,1346.0,1455.0,16627.0
Giridih,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1429.0,1363.0,1233.0,1579.0,1449.0,1093.0,811.0,1261.0,1396.0,953.0,835.0,822.0,14224.0
Giridih,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,594.0,671.0,749.0,700.0,806.0,675.0,693.0,771.0,924.0,930.0,798.0,903.0,9214.0
Giridih,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,757.0,518.0,554.0,397.0,389.0,253.0,531.0,468.0,521.0,554.0,598.0,682.0,6222.0
Giridih,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,28.0,0.0,6.0,2.0,21.0,0.0,9.0,11.0,7.0,4.0,5.0,21.0,114.0
Giridih,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,442.0,442.0
Giridih,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Giridih,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Giridih,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Giridih,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,16.0,5.0,2.0,5.0,6.0,,,11.0,4.0,1.0,9.0,5.0,64.0
Giridih,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Giridih,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,16.0,5.0,2.0,5.0,6.0,0.0,0.0,11.0,4.0,1.0,9.0,5.0,64.0
Giridih,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,132.0,132.0
Giridih,4.1.1.a,Number of male live births,TOTAL,1535.0,1466.0,1531.0,1726.0,1473.0,1445.0,1099.0,1765.0,1430.0,1364.0,1369.0,1645.0,17848.0
Giridih,4.1.1.b,Number of female live births,TOTAL,1428.0,1312.0,1386.0,1514.0,1281.0,1290.0,1046.0,1512.0,1283.0,1318.0,1275.0,1514.0,16159.0
Giridih,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2963.0,2778.0,2917.0,3240.0,2754.0,2735.0,2145.0,3277.0,2713.0,2682.0,2644.0,3159.0,34007.0
Giridih,4.1.2,Number of still births,TOTAL,107.0,135.0,58.0,49.0,93.0,31.0,44.0,52.0,34.0,40.0,28.0,78.0,749.0
Giridih,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,76.0,37.0,40.0,49.0,54.0,52.0,28.0,59.0,58.0,30.0,30.0,36.0,549.0
Giridih,4.2.1,Number of Newborns weighed at birth,TOTAL,2489.0,2267.0,2255.0,2517.0,2340.0,2071.0,1698.0,2305.0,2229.0,1869.0,1789.0,1748.0,25577.0
Giridih,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,85.0,131.0,67.0,115.0,90.0,49.0,84.0,67.0,65.0,92.0,41.0,62.0,948.0
Giridih,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2294.0,2406.0,2383.0,2612.0,2463.0,2319.0,1793.0,2026.0,1955.0,1980.0,2019.0,1884.0,26134.0
Giridih,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,5.0,0.0,2.0,0.0,10.0,4.0,4.0,0.0,0.0,0.0,25.0
Giridih,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,5.0,4.0,35.0,29.0,29.0,4.0,0.0,10.0,7.0,123.0
Giridih,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,0.0,0.0,0.0,,,,,,,,0.0
Giridih,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Giridih,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,5.0,5.0,6.0,35.0,39.0,33.0,8.0,0.0,10.0,7.0,148.0
Giridih,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Giridih,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,3.0,5.0,2.0,6.0,0.0,5.0,0.0,5.0,0.0,5.0,5.0,36.0
Giridih,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Giridih,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,7.0,9.0,2.0,2.0,2.0,4.0,2.0,6.0,4.0,270.0,182.0,490.0
Giridih,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1640.0,1437.0,1384.0,1777.0,1573.0,1761.0,1415.0,1347.0,1313.0,1397.0,1374.0,1317.0,17735.0
Giridih,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1500.0,1353.0,1151.0,1124.0,1108.0,1469.0,1020.0,1082.0,1082.0,1175.0,1276.0,1065.0,14405.0
Giridih,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,61.0,4.0,4.0,4.0,4.0,0.0,0.0,77.0
Giridih,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,25.0,0.0,3.0,0.0,17.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0
Giridih,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,25.0,0.0,3.0,0.0,17.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0
Giridih,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,2.0,1.0,1.0,1.0,1.0,1.0,7.0,7.0,7.0,7.0,1.0,1.0,37.0
Giridih,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,2.0,1.0,1.0,1.0,1.0,1.0,7.0,7.0,7.0,7.0,1.0,1.0,37.0
Giridih,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,10.0
Giridih,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,3.0,0.0,1.0,85.0,17.0,34.0,12.0,4.0,15.0,198.0,121.0,60.0,550.0
Giridih,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,,114.0,5.0,,,,,,,,119.0
Giridih,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Giridih,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,0.0,1.0,199.0,22.0,34.0,12.0,4.0,15.0,198.0,121.0,60.0,669.0
Giridih,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Giridih,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Giridih,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Giridih,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Giridih,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,67.0,53.0,35.0,230.0,154.0,83.0,64.0,80.0,232.0,1000.0,956.0,30.0,2984.0
Giridih,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,30.0,,,45.0,6.0,,,,,,,,81.0
Giridih,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Giridih,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,97.0,53.0,35.0,275.0,160.0,83.0,64.0,80.0,232.0,1000.0,956.0,30.0,3065.0
Giridih,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Giridih,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,16.0,0.0,0.0,0.0,25.0,0.0,80.0,0.0,0.0,121.0
Giridih,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,,0.0,0.0,0.0,,,,,,,,0.0
Giridih,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Giridih,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,16.0,0.0,0.0,0.0,25.0,0.0,80.0,0.0,0.0,121.0
Giridih,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Giridih,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,305.0,263.0,259.0,418.0,308.0,266.0,241.0,216.0,188.0,263.0,189.0,178.0,3094.0
Giridih,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,22.0,19.0,15.0,18.0,16.0,15.0,6.0,14.0,14.0,27.0,30.0,25.0,221.0
Giridih,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,28.0,75.0,23.0,709.0,167.0,15.0,27.0,15.0,56.0,290.0,184.0,92.0,1681.0
Giridih,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4.0,5.0,7.0,10.0,5.0,7.0,4.0,6.0,10.0,12.0,13.0,5.0,88.0
Giridih,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Giridih,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,359.0,362.0,304.0,1155.0,496.0,303.0,278.0,251.0,268.0,592.0,416.0,300.0,5084.0
Giridih,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Giridih,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Giridih,9.06,Number of IUCD removals,TOTAL,149.0,125.0,142.0,173.0,206.0,136.0,134.0,132.0,203.0,150.0,156.0,135.0,1841.0
Giridih,9.07,Number of Oral Pills cycles distributed,TOTAL,1504.0,1528.0,1765.0,4635.0,2399.0,1954.0,1986.0,2009.0,1899.0,1969.0,2102.0,2114.0,25864.0
Giridih,9.08,Number of Condom pieces distributed,TOTAL,9604.0,9109.0,8468.0,22922.0,15385.0,7265.0,8270.0,11144.0,9906.0,14232.0,9349.0,10637.0,136291.0
Giridih,9.09,Number of Centchroman (weekly) pills given,TOTAL,4.0,4.0,12.0,52.0,16.0,29.0,234.0,37.0,13.0,89.0,150.0,131.0,771.0
Giridih,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,42.0,86.0,159.0,182.0,95.0,131.0,129.0,172.0,216.0,265.0,284.0,168.0,1929.0
Giridih,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,4.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,46.0,4.0,58.0
Giridih,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,2.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,5.0,2.0,21.0,9.0,51.0
Giridih,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,6.0,1.0,12.0,0.0,25.0
Giridih,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,2.0,2.0,0.0,0.0,1.0,3.0,15.0,7.0,1.0,31.0
Giridih,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,9.12,Number of Institutions having NSV trained doctors,TOTAL,12.0,14.0,10.0,12.0,11.0,12.0,12.0,12.0,16.0,15.0,17.0,11.0,-1.0
Giridih,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3683.0,3670.0,4136.0,3524.0,1051.0,6071.0,4495.0,4725.0,3555.0,3157.0,2163.0,4212.0,44442.0
Giridih,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3784.0,3724.0,4090.0,3912.0,3925.0,4713.0,4541.0,4964.0,4610.0,4127.0,4649.0,4600.0,51639.0
Giridih,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4052.0,3851.0,3845.0,3528.0,3911.0,3948.0,3631.0,4428.0,4415.0,4238.0,4493.0,4690.0,49030.0
Giridih,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4007.0,4019.0,3915.0,3325.0,3571.0,3626.0,3395.0,3813.0,3873.0,4038.0,4189.0,4321.0,46092.0
Giridih,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Giridih,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Giridih,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Giridih,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,641.0,817.0,1071.0,916.0,401.0,213.0,611.0,1095.0,424.0,696.0,463.0,540.0,7888.0
Giridih,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2178.0,5922.0,4140.0,5103.0,1237.0,309.0,2769.0,4436.0,1417.0,2080.0,2072.0,1703.0,33366.0
Giridih,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2395.0,3457.0,3898.0,3316.0,1210.0,288.0,2085.0,3848.0,1267.0,2094.0,1994.0,1666.0,27518.0
Giridih,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2212.0,3553.0,3945.0,3145.0,1113.0,277.0,1937.0,3295.0,1076.0,1845.0,1957.0,1557.0,25912.0
Giridih,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,179.0,179.0
Giridih,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,38.0,0.0,5.0,20.0,0.0,4.0,90.0,487.0,1642.0,1717.0,4003.0
Giridih,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,272.0,1188.0,1470.0
Giridih,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,10.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,18.0,240.0,278.0
Giridih,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3521.0,3302.0,4420.0,2213.0,3917.0,4388.0,932.0,3608.0,3500.0,4127.0,3622.0,3958.0,41508.0
Giridih,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Giridih,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1573.0,1684.0,2236.0,1114.0,1775.0,2232.0,434.0,1767.0,1712.0,1961.0,1765.0,1881.0,20134.0
Giridih,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1373.0,1540.0,1920.0,1004.0,1601.0,2011.0,403.0,1636.0,1581.0,1729.0,1563.0,1610.0,17971.0
Giridih,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2946.0,3224.0,4156.0,2118.0,3376.0,4243.0,837.0,3403.0,3293.0,3690.0,3328.0,3491.0,38105.0
Giridih,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2469.0,2438.0,2736.0,2263.0,2676.0,2246.0,2073.0,2593.0,2139.0,2375.0,2868.0,2762.0,29638.0
Giridih,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1315.0,2146.0,2733.0,2139.0,1043.0,244.0,1327.0,2186.0,799.0,1144.0,1231.0,1076.0,17383.0
Giridih,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,338.0,450.0,484.0,563.0,579.0,300.0,278.0,509.0,435.0,301.0,414.0,559.0,5210.0
Giridih,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,323.0,407.0,406.0,495.0,523.0,277.0,229.0,490.0,402.0,246.0,335.0,473.0,4606.0
Giridih,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,661.0,857.0,890.0,1058.0,1102.0,577.0,507.0,999.0,837.0,547.0,749.0,1032.0,9816.0
Giridih,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,90.0,52.0,72.0,19.0,54.0,30.0,69.0,49.0,47.0,32.0,98.0,89.0,701.0
Giridih,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1155.0,1252.0,1354.0,1291.0,1222.0,1227.0,1407.0,1415.0,1235.0,1229.0,1041.0,1180.0,15008.0
Giridih,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1041.0,1116.0,1417.0,1462.0,1266.0,1355.0,1341.0,1469.0,1203.0,1130.0,967.0,1191.0,14958.0
Giridih,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,261.0,100.0,182.0,203.0,160.0,155.0,84.0,100.0,104.0,92.0,111.0,236.0,1788.0
Giridih,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Giridih,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,139.0,62.0,185.0,98.0,91.0,150.0,94.0,97.0,101.0,85.0,112.0,133.0,1347.0
Giridih,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1957.0,2114.0,2128.0,2093.0,2138.0,2152.0,2036.0,2103.0,2133.0,2098.0,2142.0,2183.0,25277.0
Giridih,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1791.0,1980.0,2016.0,1922.0,2001.0,1955.0,1891.0,1985.0,3610.0,1886.0,1998.0,2094.0,25129.0
Giridih,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1021.0,1062.0,1038.0,991.0,947.0,1020.0,993.0,1051.0,1069.0,1028.0,1129.0,1218.0,12567.0
Giridih,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,8.0,8.0
Giridih,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2782.0,2427.0,2948.0,1588.0,8613.0,3742.0,914.0,2893.0,1162.0,2191.0,5849.0,3300.0,38409.0
Giridih,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,493.0,205.0,234.0,249.0,29124.0,4061.0,137.0,585.0,226.0,197.0,11861.0,1828.0,49200.0
Giridih,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,448.0,106.0,89.0,51.0,43584.0,4942.0,82.0,646.0,46.0,40.0,16737.0,1341.0,68112.0
Giridih,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,130.0,57.0,43.0,27.0,174.0,36.0,60.0,38.0,62.0,6.0,22.0,27.0,682.0
Giridih,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,75.0,94.0,92.0,90.0,92.0,79.0,57.0,33.0,44.0,59.0,56.0,56.0,827.0
Giridih,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,164.0,141.0,140.0,255.0,236.0,118.0,116.0,113.0,111.0,93.0,103.0,150.0,1740.0
Giridih,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Giridih,13.1,Number of Patients operated for cataract,TOTAL,284.0,131.0,87.0,0.0,0.0,0.0,0.0,0.0,97.0,0.0,0.0,0.0,599.0
Giridih,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,284.0,131.0,87.0,0.0,0.0,0.0,0.0,0.0,91.0,0.0,0.0,0.0,593.0
Giridih,13.3,Number of School children detected with Refractive errors,TOTAL,14.0,653.0,63.0,1460.0,7.0,960.0,968.0,1463.0,12.0,9.0,22.0,24.0,5655.0
Giridih,13.4,Number of children provided free glasses,TOTAL,142.0,0.0,155.0,0.0,0.0,7.0,13.0,0.0,0.0,58.0,7.0,25.0,407.0
Giridih,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,4.0,7.0,7.0,6.0,6.0,6.0,7.0,7.0,7.0,8.0,8.0,-1.0
Giridih,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,4.0,6.0,4.0,6.0,6.0,7.0,7.0,7.0,6.0,6.0,6.0,7.0,-1.0
Giridih,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,662.0,370.0,667.0,489.0,422.0,694.0,477.0,601.0,400.0,602.0,710.0,660.0,-1.0
Giridih,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,7.0,9.0,9.0,9.0,9.0,9.0,10.0,10.0,9.0,9.0,9.0,-1.0
Giridih,14.05,Number of RKS meetings held during the month,TOTAL,5.0,4.0,6.0,4.0,7.0,2.0,3.0,8.0,3.0,3.0,2.0,2.0,49.0
Giridih,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,11.0,13.0,13.0,14.0,13.0,11.0,12.0,15.0,15.0,14.0,14.0,14.0,-1.0
Giridih,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,6.0,12.0,13.0,11.0,9.0,6.0,10.0,18.0,0.0,0.0,12.0,8.0,105.0
Giridih,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,4.0,5.0,6.0,7.0,8.0,8.0,9.0,10.0,10.0,10.0,10.0,-1.0
Giridih,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,-1.0
Giridih,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,5.0,34.0,18.0,16.0,25.0,17.0,28.0,10.0,26.0,22.0,14.0,18.0,233.0
Giridih,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,177.0,163.0,154.0,257.0,238.0,297.0,73.0,53.0,97.0,66.0,77.0,85.0,1737.0
Giridih,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,7.0,7.0,9.0,5.0,21.0,15.0,6.0,7.0,13.0,22.0,24.0,12.0,148.0
Giridih,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,274.0,484.0,329.0,413.0,304.0,421.0,486.0,419.0,431.0,1415.0,1013.0,508.0,6497.0
Giridih,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,12.0,41.0,27.0,21.0,46.0,32.0,34.0,17.0,39.0,44.0,38.0,30.0,381.0
Giridih,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,451.0,647.0,483.0,670.0,542.0,718.0,559.0,472.0,528.0,1481.0,1090.0,593.0,8234.0
Giridih,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Giridih,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Giridih,14.11,In-Patient Head Count at midnight,TOTAL,143.0,192.0,148.0,214.0,165.0,156.0,110.0,101.0,88.0,389.0,252.0,115.0,2073.0
Giridih,14.12.1,OPD attendance (All),TOTAL,21409.0,20973.0,25897.0,35894.0,29174.0,27964.0,21689.0,23993.0,17382.0,20385.0,21466.0,22906.0,289132.0
Giridih,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,5.0,6.0,0.0,0.0,0.0,520.0,520.0,0.0,0.0,1051.0
Giridih,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Giridih,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,0.0,23.0,172.0,31.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,226.0
Giridih,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,31.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31.0
Giridih,14.14.c,Number of Adolescents counselled,TOTAL,230.0,212.0,45.0,73.0,30.0,59.0,46.0,63.0,63.0,63.0,62.0,35.0,981.0
Giridih,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1750.0,1410.0,1647.0,1531.0,1087.0,1557.0,4806.0,2038.0,1124.0,1731.0,1756.0,1641.0,22078.0
Giridih,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,81.0,35.0,38.0,41.0,24.0,24.0,51.0,52.0,33.0,84.0,51.0,54.0,568.0
Giridih,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,51.0,63.0,0.0,53.0,0.0,0.0,0.0,0.0,0.0,0.0,39.0,57.0,263.0
Giridih,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,5.0
Giridih,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,35.0,26.0,0.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,113.0,42.0,241.0
Giridih,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,5.0
Giridih,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,76.0,74.0,0.0,41.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,48.0,254.0
Giridih,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Giridih,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,162.0,163.0,0.0,119.0,0.0,0.0,0.0,0.0,0.0,0.0,167.0,147.0,758.0
Giridih,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,6.0,11.0
Giridih,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Giridih,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Giridih,15.4.1,Number of blood smears examined for Malaria,TOTAL,4675.0,4833.0,6425.0,7719.0,5451.0,7918.0,7130.0,7178.0,4349.0,4539.0,5138.0,7889.0,73244.0
Giridih,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,215.0,214.0,282.0,533.0,346.0,425.0,444.0,416.0,217.0,213.0,163.0,204.0,3672.0
Giridih,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,10.0,13.0,4.0,27.0,16.0,27.0,25.0,25.0,6.0,3.0,2.0,2.0,160.0
Giridih,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,38160.0,34740.0,10850.0,29840.0,46900.0,,37680.0,21560.0,,10360.0,,,230090.0
Giridih,16.1.1,Stock position of DPT vaccines,2. Stocks Received,20000.0,0.0,40000.0,40000.0,20000.0,,0.0,20000.0,,0.0,,,140000.0
Giridih,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,,,0.0
Giridih,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,23420.0,23890.0,21010.0,22940.0,27220.0,,16120.0,26850.0,,3160.0,,,164610.0
Giridih,16.1.1,Stock position of DPT vaccines,5. Total Stock,34740.0,10850.0,29840.0,46900.0,39680.0,0.0,21560.0,14710.0,0.0,7200.0,0.0,0.0,205480.0
Giridih,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Giridih,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Giridih,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Giridih,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Giridih,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0.0,52000.0,10020.0,12680.0,0.0,,16000.0,100.0,,0.0,,,90800.0
Giridih,16.1.2,Stock position of OPV vaccines,2. Stocks Received,60000.0,0.0,40000.0,12000.0,0.0,,0.0,30000.0,,20000.0,,,162000.0
Giridih,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,,,0.0
Giridih,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,8000.0,41980.0,37340.0,24680.0,0.0,,15900.0,29900.0,,19920.0,,,177720.0
Giridih,16.1.2,Stock position of OPV vaccines,5. Total Stock,52000.0,10020.0,12680.0,0.0,0.0,0.0,100.0,200.0,0.0,80.0,0.0,0.0,75080.0
Giridih,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,8260.0,29260.0,11690.0,12650.0,11590.0,,16050.0,1790.0,,100.0,,,91390.0
Giridih,16.1.3,Stock position of TT vaccines,2. Stocks Received,30000.0,0.0,20000.0,20000.0,20000.0,,0.0,20000.0,,20000.0,,,130000.0
Giridih,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,,,0.0
Giridih,16.1.3,Stock position of TT vaccines,4. Stock Distributed,9000.0,17570.0,19040.0,21060.0,20500.0,,14260.0,19390.0,,17660.0,,,138480.0
Giridih,16.1.3,Stock position of TT vaccines,5. Total Stock,29260.0,11690.0,12650.0,11590.0,11090.0,0.0,1790.0,2400.0,0.0,2440.0,0.0,0.0,82910.0
Giridih,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,,,0.0
Giridih,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,,0.0,,0.0,,,0.0,,,0.0
Giridih,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,,0.0,,,0.0,,,0.0
Giridih,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,,0.0,,0.0,,,0.0,,,0.0
Giridih,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,17200.0,20450.0,2430.0,5790.0,870.0,,14010.0,20.0,,30.0,,,60800.0
Giridih,16.1.5,Stock position of BCG vaccines,2. Stocks Received,20000.0,0.0,20000.0,0.0,20000.0,,0.0,10000.0,,10000.0,,,80000.0
Giridih,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,260.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,,,260.0
Giridih,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,16490.0,18020.0,16640.0,4920.0,13420.0,,13990.0,9950.0,,10030.0,,,103460.0
Giridih,16.1.5,Stock position of BCG vaccines,5. Total Stock,20450.0,2430.0,5790.0,870.0,7450.0,0.0,20.0,70.0,0.0,0.0,0.0,0.0,37080.0
Giridih,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2530.0,5390.0,7100.0,0.0,2345.0,,85.0,0.0,,10360.0,,,27810.0
Giridih,16.1.6,Stock position of Measles vaccines,2. Stocks Received,6700.0,10000.0,0.0,9000.0,10000.0,,0.0,90000.0,,0.0,,,125700.0
Giridih,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,3160.0,,,3160.0
Giridih,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3840.0,8290.0,7100.0,6655.0,9225.0,,85.0,52370.0,,,,,87565.0
Giridih,16.1.6,Stock position of Measles vaccines,5. Total Stock,5390.0,7100.0,0.0,2345.0,3120.0,0.0,0.0,37630.0,0.0,7200.0,0.0,0.0,62785.0
Giridih,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Giridih,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,,,,0.0,,,,,,0.0
Giridih,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,0.0,,,,,,0.0
Giridih,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,,,,0.0,,,,,,0.0
Giridih,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Giridih,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,,,,0.0,,,,,,0.0
Giridih,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,0.0,,,,,,0.0
Giridih,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,,,,0.0,,,,,,0.0
Giridih,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1100.0,1050.0,1050.0,4740.0,3320.0,,3220.0,,,,,,14480.0
Giridih,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,4800.0,0.0,0.0,,0.0,,,,,,4800.0
Giridih,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Giridih,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,50.0,0.0,1110.0,1420.0,0.0,,50.0,,,,,,2630.0
Giridih,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1050.0,1050.0,4740.0,3320.0,3320.0,0.0,3170.0,0.0,0.0,0.0,0.0,0.0,16650.0
Giridih,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,120000.0,108000.0,102000.0,105153.0,39653.0,,0.0,,,,,,474806.0
Giridih,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,65553.0,0.0,0.0,,100800.0,,,,,,166353.0
Giridih,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Giridih,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,12000.0,6000.0,62400.0,65500.0,20300.0,,47880.0,,,,,,214080.0
Giridih,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,108000.0,102000.0,105153.0,39653.0,19353.0,0.0,52920.0,0.0,0.0,0.0,0.0,0.0,427079.0
Giridih,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,23800.0,21500.0,21000.0,23500.0,13500.0,,9600.0,,,,,,112900.0
Giridih,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,10000.0,0.0,0.0,,0.0,,,,,,10000.0
Giridih,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Giridih,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,2300.0,500.0,7500.0,10000.0,2900.0,,1000.0,,,,,,24200.0
Giridih,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,21500.0,21000.0,23500.0,13500.0,10600.0,0.0,8600.0,0.0,0.0,0.0,0.0,0.0,98700.0
Giridih,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2974.0,2274.0,2274.0,774.0,,,0.0,,,,,,8296.0
Giridih,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,,9300.0,,,,,,9300.0
Giridih,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Giridih,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,700.0,0.0,1500.0,774.0,,,4500.0,,,,,,7474.0
Giridih,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,2274.0,2274.0,774.0,0.0,0.0,0.0,4800.0,0.0,0.0,0.0,0.0,0.0,10122.0
Giridih,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Giridih,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,,,,,,,,,,,0.0
Giridih,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Giridih,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Giridih,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,430.0,230.0,230.0,50.0,50.0,,,,,,,,990.0
Giridih,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Giridih,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Giridih,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,200.0,0.0,180.0,0.0,50.0,,,,,,,,430.0
Giridih,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,230.0,230.0,50.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,560.0
Giridih,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,2500.0,2000.0,2000.0,800.0,150.0,,,,,,,,7450.0
Giridih,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Giridih,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Giridih,16.3.02,Stock Position of Gloves,4. Stock Distributed,500.0,0.0,1200.0,650.0,150.0,,,,,,,,2500.0
Giridih,16.3.02,Stock Position of Gloves,5. Total Stock,2000.0,2000.0,800.0,150.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4950.0
Giridih,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Giridih,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,,,3550000.0,,,,,,3550000.0
Giridih,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Giridih,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,,,808000.0,,,,,,808000.0
Giridih,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,2742000.0,0.0,0.0,0.0,0.0,0.0,2742000.0
Giridih,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Giridih,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Giridih,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,74.0,,,,,,,,74.0
Giridih,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,5330.0,900.0,,,,,,,,6230.0
Giridih,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Giridih,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,5256.0,600.0,,,,,,,,5856.0
Giridih,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,74.0,374.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,448.0
Giridih,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Giridih,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,,,26409.0,,,,,,26409.0
Giridih,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Giridih,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,,,2100.0,,,,,,2100.0
Giridih,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,24309.0,0.0,0.0,0.0,0.0,0.0,24309.0
Giridih,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,410.0,11485.0,4565.0,4085.0,14795.0,,11365.0,7175.0,,,,,53880.0
Giridih,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,12000.0,0.0,4000.0,12000.0,0.0,,0.0,3000.0,,,,,31000.0
Giridih,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Giridih,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,925.0,6920.0,4480.0,1290.0,5380.0,,4290.0,7260.0,,,,,30545.0
Giridih,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,11485.0,4565.0,4085.0,14795.0,9415.0,0.0,7075.0,2915.0,0.0,0.0,0.0,0.0,54335.0
Giridih,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,16873.0,13000.0,8780.0,28780.0,42200.0,,47250.0,25830.0,,,,,182713.0
Giridih,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,16000.0,0.0,40000.0,40000.0,36000.0,,0.0,142400.0,,,,,274400.0
Giridih,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Giridih,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,19873.0,4220.0,20000.0,26580.0,34600.0,,21420.0,88440.0,,,,,215133.0
Giridih,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,13000.0,8780.0,28780.0,42200.0,43600.0,0.0,25830.0,79790.0,0.0,0.0,0.0,0.0,241980.0
Giridih,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,806.0,2400.0,1649.0,149.0,101.0,,5143.0,4022.0,,,,,14270.0
Giridih,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2500.0,0.0,0.0,0.0,4000.0,,0.0,24000.0,,,,,30500.0
Giridih,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,0.0
Giridih,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,906.0,751.0,1500.0,48.0,1248.0,,1121.0,12260.0,,,,,17834.0
Giridih,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2400.0,1649.0,149.0,101.0,2853.0,0.0,4022.0,15762.0,0.0,0.0,0.0,0.0,26936.0
Giridih,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,,1.0,,,,,,,2.0
Giridih,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Giridih,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Giridih,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Giridih,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Giridih,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Giridih,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Giridih,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,1.0,,,,,,1.0
Giridih,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Giridih,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,1.0,,,,,,1.0
Giridih,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Giridih,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,,1.0
Giridih,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,,,,,,,,,,,1.0
Giridih,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Giridih,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Giridih,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Giridih,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Giridih,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Giridih,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Giridih,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Giridih,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Giridih,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Giridih,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Giridih,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Giridih,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Giridih,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,2.0,1.0,1.0,,,,,,,,4.0
Giridih,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Giridih,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,2.0,1.0,1.0,,,,,,,,4.0
Giridih,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Giridih,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Giridih,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Giridih,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,1.0,1.0,,,,,,,2.0
Giridih,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Giridih,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,1.0,1.0,,,,,,,2.0
Giridih,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Giridih,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Giridih,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Giridih,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Giridih,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,2.0,,,,,,,,,,,,2.0
Giridih,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Giridih,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,3.0,,,,,,,,,,,,3.0
Giridih,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,1.0,,,,,,,1.0,,,2.0
Giridih,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Giridih,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Giridih,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,1.0,,,,,,,1.0,,,3.0
Giridih,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Giridih,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Giridih,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Giridih,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Giridih,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Giridih,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,2.0,,,,,,,,,,,2.0
Giridih,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Giridih,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Giridih,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Giridih,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Giridih,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Giridih,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Giridih,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Giridih,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Giridih,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Giridih,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Giridih,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Giridih,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Giridih,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,1.0,,,,,,,,,,2.0
Giridih,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Giridih,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,1.0,,,,,,,,,,2.0
Giridih,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Giridih,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Giridih,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,1.0,,,,,,,,1.0
Giridih,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,1.0,1.0,,,,,,,,,3.0
Giridih,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,1.0,,,1.0,,,,,,,2.0
Giridih,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,2.0,1.0,,1.0,,,,,,,5.0
Giridih,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Giridih,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,1.0,,1.0,1.0,,,1.0,,1.0,,,6.0
Giridih,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,1.0,,1.0,,,,,,2.0
Giridih,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,1.0,,2.0,2.0,,1.0,1.0,,1.0,,,9.0
Giridih,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,,1.0,,,,,,,,2.0
Giridih,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Giridih,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,1.0,,1.0,,,,,,,,2.0
Giridih,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Giridih,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Giridih,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,3.0,,,3.0
Giridih,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,,,,,,3.0,,,4.0
Giridih,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,,,,1.0,1.0,1.0,,,1.0,,,6.0
Giridih,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,1.0,,,1.0,,,1.0,,3.0
Giridih,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,,,,2.0,1.0,1.0,1.0,,1.0,1.0,,9.0
Giridih,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Giridih,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,1.0,,,1.0,,,,,2.0,,5.0
Giridih,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,1.0,,,2.0,,,3.0,,6.0
Giridih,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,1.0,1.0,,1.0,1.0,,2.0,,,5.0,,11.0
Giridih,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Giridih,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Giridih,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,1.0,1.0,,1.0,2.0,,,1.0,1.0,1.0,1.0,10.0
Giridih,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,1.0,1.0,1.0,,1.0,3.0,1.0,,1.0,1.0,1.0,1.0,12.0
Godda,1.1,Total number of pregnant women Registered for ANC,TOTAL,3166.0,3170.0,3456.0,3103.0,2782.0,2387.0,2518.0,2067.0,1765.0,2388.0,2349.0,2742.0,31893.0
Godda,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,788.0,808.0,811.0,792.0,675.0,574.0,610.0,568.0,479.0,591.0,604.0,691.0,7991.0
Godda,1.2,Number of Pregnant women registered under JSY,TOTAL,2146.0,2514.0,2675.0,2305.0,2175.0,1890.0,2181.0,1809.0,1457.0,2075.0,1885.0,2141.0,25253.0
Godda,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1392.0,1492.0,1857.0,1650.0,1981.0,1810.0,1600.0,1583.0,1406.0,1440.0,1470.0,1582.0,19263.0
Godda,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3144.0,2934.0,3190.0,2927.0,2680.0,2264.0,2417.0,1960.0,1656.0,2286.0,2254.0,2630.0,30342.0
Godda,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2365.0,2563.0,2679.0,2597.0,2383.0,1986.0,2057.0,1720.0,1416.0,1762.0,1727.0,1850.0,25105.0
Godda,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2333.0,2045.0,1795.0,1564.0,2558.0,1120.0,1898.0,977.0,737.0,739.0,1313.0,1744.0,18823.0
Godda,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,4.0,30.0,20.0,28.0,15.0,373.0,41.0,65.0,64.0,56.0,47.0,118.0,861.0
Godda,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,5.0,6.0,16.0,13.0,14.0,14.0,12.0,16.0,8.0,13.0,54.0,174.0
Godda,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,42.0,99.0,166.0,167.0,185.0,334.0,135.0,206.0,152.0,261.0,286.0,354.0,2387.0
Godda,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2.0,7.0,2.0,15.0,16.0,8.0,2.0,1.0,8.0,13.0,13.0,16.0,103.0
Godda,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Godda,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,96.0,78.0,111.0,115.0,115.0,66.0,121.0,98.0,122.0,149.0,154.0,159.0,1384.0
Godda,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,603.0,634.0,757.0,835.0,967.0,814.0,904.0,715.0,720.0,716.0,612.0,528.0,8805.0
Godda,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,699.0,712.0,868.0,950.0,1082.0,880.0,1025.0,813.0,842.0,865.0,766.0,687.0,10189.0
Godda,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,502.0,454.0,552.0,602.0,683.0,643.0,723.0,613.0,582.0,597.0,567.0,505.0,7023.0
Godda,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,130.0,91.0,128.0,115.0,129.0,125.0,117.0,90.0,89.0,81.0,85.0,71.0,1251.0
Godda,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,715.0,805.0,883.0,1107.0,1545.0,1373.0,1683.0,1739.0,1526.0,1335.0,1326.0,1111.0,15148.0
Godda,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,506.0,578.0,665.0,764.0,1169.0,1349.0,1667.0,1288.0,1464.0,1233.0,1297.0,1096.0,13076.0
Godda,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,765.0,663.0,770.0,520.0,1161.0,1297.0,1333.0,1048.0,899.0,780.0,642.0,613.0,10491.0
Godda,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,459.0,408.0,540.0,497.0,659.0,941.0,1048.0,1350.0,890.0,792.0,950.0,939.0,9473.0
Godda,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,1.0,12.0,3.0,0.0,13.0,178.0,30.0,1.0,7.0,6.0,0.0,251.0
Godda,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Godda,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Godda,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Godda,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Godda,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,8.0,7.0,8.0,8.0,19.0,5.0,4.0,1.0,18.0,10.0,1.0,3.0,92.0
Godda,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,1.0,0.0,0.0,1.0
Godda,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Godda,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,8.0,7.0,8.0,8.0,19.0,5.0,4.0,1.0,18.0,11.0,1.0,3.0,93.0
Godda,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Godda,4.1.1.a,Number of male live births,TOTAL,754.0,809.0,982.0,1117.0,1545.0,1125.0,1679.0,1275.0,1214.0,1101.0,1043.0,1009.0,13653.0
Godda,4.1.1.b,Number of female live births,TOTAL,674.0,731.0,838.0,920.0,1218.0,1112.0,1372.0,1265.0,1260.0,1103.0,1049.0,879.0,12421.0
Godda,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1428.0,1540.0,1820.0,2037.0,2763.0,2237.0,3051.0,2540.0,2474.0,2204.0,2092.0,1888.0,26074.0
Godda,4.1.2,Number of still births,TOTAL,17.0,23.0,16.0,33.0,38.0,39.0,24.0,31.0,29.0,31.0,24.0,21.0,326.0
Godda,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,28.0,25.0,28.0,22.0,18.0,33.0,12.0,14.0,12.0,12.0,23.0,6.0,233.0
Godda,4.2.1,Number of Newborns weighed at birth,TOTAL,1248.0,1264.0,1447.0,1633.0,2213.0,1868.0,2421.0,2199.0,2051.0,1794.0,1835.0,1665.0,21638.0
Godda,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,58.0,284.0,124.0,97.0,83.0,106.0,119.0,85.0,278.0,353.0,104.0,108.0,1799.0
Godda,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1363.0,1463.0,1630.0,1867.0,2497.0,2070.0,2752.0,2455.0,2253.0,2109.0,1994.0,1821.0,24274.0
Godda,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,7.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Godda,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,8.0,7.0,26.0,2.0,3.0,5.0,4.0,1.0,2.0,0.0,0.0,0.0,58.0
Godda,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,6.0,0.0,10.0,78.0,0.0,20.0,,,4.0,5.0,0.0,123.0
Godda,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Godda,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,8.0,13.0,33.0,16.0,81.0,5.0,24.0,1.0,2.0,4.0,5.0,0.0,192.0
Godda,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Godda,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,172.0,7.0,8.0,292.0,355.0,348.0,24.0,1.0,600.0,606.0,100.0,30.0,2543.0
Godda,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,60.0,0.0,0.0,0.0,36.0,100.0,20.0,0.0,0.0,50.0,0.0,300.0,566.0
Godda,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,10.0,0.0,25.0,600.0,0.0,303.0,310.0,352.0,1600.0
Godda,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,5.0,0.0,9.0
Godda,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1000.0,1071.0,1236.0,1575.0,2110.0,1905.0,2140.0,1885.0,1389.0,1438.0,1607.0,1654.0,19010.0
Godda,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,814.0,744.0,1047.0,1175.0,1587.0,1307.0,1984.0,1601.0,1406.0,1554.0,1193.0,1257.0,15669.0
Godda,6.3,PNC maternal complications attended,TOTAL,46.0,0.0,0.0,6.0,3.0,98.0,10.0,3.0,0.0,325.0,255.0,315.0,1061.0
Godda,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3.0,2.0,3.0,3.0,3.0,2.0,2.0,6.0,2.0,4.0,3.0,3.0,36.0
Godda,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Godda,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3.0,4.0,3.0,3.0,3.0,2.0,2.0,6.0,2.0,4.0,3.0,3.0,38.0
Godda,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,10.0,89.0,49.0,51.0,59.0,109.0,57.0,55.0,8.0,64.0,103.0,86.0,740.0
Godda,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,7.0,125.0,63.0,64.0,62.0,101.0,80.0,79.0,17.0,162.0,114.0,148.0,1022.0
Godda,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,17.0,214.0,112.0,115.0,121.0,210.0,137.0,134.0,25.0,226.0,217.0,234.0,1762.0
Godda,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,2.0,437.0,19.0,2.0,27.0,3.0,26.0,66.0,66.0,26.0,674.0
Godda,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,19.0,0.0,0.0,0.0,0.0,,,7.0,2.0,28.0
Godda,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Godda,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,2.0,456.0,19.0,2.0,27.0,3.0,26.0,66.0,73.0,28.0,702.0
Godda,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Godda,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Godda,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Godda,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Godda,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,113.0,22.0,0.0,135.0
Godda,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,21.0,31.0,0.0,641.0,68.0,29.0,45.0,180.0,687.0,1209.0,1280.0,178.0,4369.0
Godda,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,9.0,0.0,0.0,0.0,12.0,,,83.0,26.0,130.0
Godda,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Godda,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,21.0,31.0,0.0,650.0,68.0,29.0,45.0,192.0,687.0,1322.0,1385.0,204.0,4634.0
Godda,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Godda,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,90.0,0.0,90.0
Godda,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Godda,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,90.0,0.0,90.0
Godda,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Godda,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,80.0,58.0,60.0,173.0,79.0,69.0,55.0,46.0,39.0,113.0,145.0,103.0,1020.0
Godda,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,8.0,4.0,47.0,6.0,5.0,17.0,6.0,10.0,12.0,14.0,5.0,135.0
Godda,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,80.0,48.0,121.0,1973.0,83.0,66.0,66.0,95.0,88.0,470.0,65.0,356.0,3511.0
Godda,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,2.0,2.0,4.0,33.0,2.0,0.0,,0.0,2.0,1.0,3.0,8.0,57.0
Godda,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Godda,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,163.0,116.0,189.0,2226.0,170.0,140.0,138.0,147.0,139.0,596.0,227.0,472.0,4723.0
Godda,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Godda,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Godda,9.06,Number of IUCD removals,TOTAL,48.0,43.0,46.0,472.0,82.0,157.0,46.0,89.0,48.0,129.0,93.0,92.0,1345.0
Godda,9.07,Number of Oral Pills cycles distributed,TOTAL,2188.0,2040.0,3044.0,12253.0,3550.0,3603.0,3606.0,3236.0,2910.0,3163.0,2262.0,1953.0,43808.0
Godda,9.08,Number of Condom pieces distributed,TOTAL,11525.0,17846.0,21589.0,112247.0,22500.0,20404.0,28188.0,18330.0,18130.0,17809.0,10728.0,11478.0,310774.0
Godda,9.09,Number of Centchroman (weekly) pills given,TOTAL,6.0,14.0,124.0,43.0,403.0,76.0,104.0,69.0,0.0,57.0,77.0,47.0,1020.0
Godda,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,103.0,374.0,353.0,572.0,455.0,679.0,559.0,226.0,273.0,844.0,157.0,141.0,4736.0
Godda,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,1.0,0.0,2.0,21.0,0.0,4.0,0.0,1.0,18.0,6.0,4.0,0.0,57.0
Godda,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,55.0,0.0,5.0,12.0,4.0,80.0,36.0,5.0,0.0,197.0
Godda,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Godda,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Godda,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,4.0,7.0,6.0,5.0,,1.0,2.0,2.0,2.0,2.0,1.0,-1.0
Godda,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2207.0,2067.0,2436.0,2870.0,2859.0,2012.0,3593.0,1792.0,2714.0,3184.0,2580.0,1323.0,29637.0
Godda,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2346.0,2132.0,2246.0,2127.0,2579.0,2471.0,2728.0,2728.0,2733.0,2996.0,2952.0,2766.0,30804.0
Godda,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2570.0,2299.0,2288.0,1973.0,2427.0,2165.0,2064.0,2066.0,2453.0,2361.0,2579.0,2899.0,28144.0
Godda,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2541.0,2544.0,2450.0,1983.0,2300.0,2130.0,1910.0,1772.0,1810.0,1982.0,2166.0,2435.0,26023.0
Godda,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Godda,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Godda,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Godda,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,729.0,1174.0,1009.0,1449.0,1221.0,702.0,1073.0,907.0,877.0,509.0,156.0,14.0,9820.0
Godda,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2347.0,2160.0,2240.0,2095.0,2554.0,2132.0,2446.0,2733.0,2625.0,1241.0,616.0,79.0,23268.0
Godda,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2583.0,2287.0,2274.0,1967.0,2399.0,1911.0,1819.0,2105.0,2394.0,934.0,426.0,107.0,21206.0
Godda,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2564.0,2549.0,2454.0,1959.0,2373.0,1891.0,1676.0,1800.0,1743.0,832.0,394.0,80.0,20315.0
Godda,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,2.0,42.0,47.0,11.0,109.0
Godda,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,15.0,3.0,18.0,0.0,13.0,0.0,0.0,815.0,2472.0,2736.0,6072.0
Godda,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,4.0,0.0,2.0,0.0,0.0,0.0,0.0,8.0,784.0,2278.0,3076.0
Godda,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,142.0,1125.0,1269.0
Godda,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2772.0,1933.0,2725.0,2509.0,3395.0,2525.0,2151.0,1569.0,1579.0,1627.0,2208.0,2149.0,27142.0
Godda,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,40.0,1510.0,11.0,0.0,9.0,1.0,1571.0
Godda,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Godda,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1452.0,999.0,1348.0,1292.0,1716.0,1292.0,1128.0,660.0,828.0,822.0,1113.0,929.0,13579.0
Godda,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1226.0,879.0,1281.0,1081.0,1587.0,1171.0,1005.0,544.0,700.0,730.0,1049.0,845.0,12098.0
Godda,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2678.0,1878.0,2629.0,2373.0,3303.0,2463.0,2133.0,1204.0,1528.0,1552.0,2162.0,1774.0,25677.0
Godda,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1495.0,1335.0,1487.0,1103.0,1701.0,1290.0,1032.0,741.0,803.0,850.0,1500.0,1461.0,14798.0
Godda,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1493.0,1342.0,1355.0,1056.0,1681.0,1084.0,913.0,711.0,793.0,337.0,192.0,22.0,10979.0
Godda,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,598.0,463.0,415.0,348.0,498.0,391.0,332.0,232.0,234.0,253.0,323.0,233.0,4320.0
Godda,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,510.0,422.0,375.0,353.0,463.0,309.0,276.0,158.0,228.0,196.0,297.0,219.0,3806.0
Godda,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1108.0,885.0,790.0,701.0,961.0,700.0,608.0,390.0,462.0,449.0,620.0,452.0,8126.0
Godda,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,103.0,85.0,99.0,87.0,275.0,145.0,112.0,78.0,56.0,70.0,65.0,67.0,1242.0
Godda,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,633.0,633.0,564.0,649.0,668.0,527.0,656.0,621.0,463.0,477.0,486.0,474.0,6851.0
Godda,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,560.0,533.0,533.0,567.0,701.0,506.0,602.0,570.0,448.0,488.0,469.0,427.0,6404.0
Godda,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,59.0,60.0,99.0,102.0,99.0,91.0,99.0,91.0,103.0,96.0,93.0,107.0,1099.0
Godda,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,54.0,87.0,87.0,82.0,77.0,80.0,77.0,79.0,72.0,84.0,79.0,59.0,917.0
Godda,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1452.0,1508.0,1468.0,1560.0,1498.0,1522.0,1480.0,1486.0,1430.0,1430.0,1549.0,1500.0,17883.0
Godda,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1296.0,1398.0,1422.0,1456.0,1428.0,1463.0,1365.0,1306.0,1334.0,1289.0,1427.0,1416.0,16600.0
Godda,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,846.0,1013.0,1006.0,1119.0,1111.0,1147.0,1060.0,988.0,1060.0,1010.0,1119.0,1127.0,12606.0
Godda,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,23.0,11.0,15.0,0.0,8.0,26.0,83.0
Godda,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2121.0,1549.0,2290.0,1931.0,4392.0,2432.0,2193.0,1062.0,1159.0,1077.0,2910.0,2163.0,25279.0
Godda,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,401.0,345.0,344.0,264.0,16104.0,1654.0,169.0,159.0,115.0,113.0,11205.0,5571.0,36444.0
Godda,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,92.0,111.0,120.0,154.0,16651.0,1887.0,46.0,42.0,25.0,34.0,11415.0,5472.0,36049.0
Godda,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,39.0,34.0,17.0,24.0,24.0,143.0,29.0,15.0,29.0,19.0,23.0,27.0,423.0
Godda,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,299.0,331.0,352.0,353.0,439.0,476.0,327.0,181.0,189.0,202.0,216.0,227.0,3592.0
Godda,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,114.0,215.0,61.0,71.0,78.0,108.0,68.0,67.0,74.0,106.0,64.0,53.0,1079.0
Godda,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,13.1,Number of Patients operated for cataract,TOTAL,74.0,0.0,0.0,0.0,0.0,149.0,170.0,183.0,376.0,326.0,525.0,9.0,1812.0
Godda,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,67.0,0.0,0.0,0.0,0.0,149.0,170.0,180.0,371.0,367.0,340.0,0.0,1644.0
Godda,13.3,Number of School children detected with Refractive errors,TOTAL,1241.0,1087.0,1786.0,416.0,1456.0,4055.0,232.0,693.0,841.0,1596.0,708.0,469.0,14580.0
Godda,13.4,Number of children provided free glasses,TOTAL,2.0,0.0,6.0,48.0,3.0,41.0,2.0,332.0,392.0,2.0,29.0,0.0,857.0
Godda,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,3.0,3.0,3.0,2.0,2.0,5.0,3.0,2.0,2.0,2.0,-1.0
Godda,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,-1.0
Godda,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,169.0,244.0,207.0,353.0,372.0,412.0,397.0,318.0,575.0,457.0,573.0,641.0,-1.0
Godda,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,6.0,4.0,4.0,4.0,3.0,2.0,4.0,3.0,3.0,4.0,4.0,-1.0
Godda,14.05,Number of RKS meetings held during the month,TOTAL,11.0,12.0,10.0,7.0,7.0,4.0,4.0,6.0,8.0,6.0,6.0,7.0,88.0
Godda,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,6.0,4.0,4.0,4.0,3.0,5.0,5.0,4.0,4.0,5.0,4.0,-1.0
Godda,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,128.0,159.0,142.0,134.0,37.0,36.0,35.0,35.0,30.0,36.0,52.0,58.0,882.0
Godda,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,3.0,3.0,4.0,2.0,2.0,3.0,2.0,2.0,3.0,3.0,-1.0
Godda,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,1.0,0.0,6.0,-1.0
Godda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,321.0,405.0,319.0,503.0,756.0,373.0,254.0,190.0,251.0,92.0,118.0,102.0,3684.0
Godda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1441.0,1258.0,1265.0,1755.0,1552.0,1340.0,1557.0,1254.0,1214.0,381.0,167.0,128.0,13312.0
Godda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,390.0,474.0,482.0,695.0,596.0,900.0,493.0,835.0,714.0,336.0,342.0,419.0,6676.0
Godda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1466.0,1639.0,1591.0,2829.0,1694.0,2041.0,2657.0,2182.0,2432.0,754.0,1506.0,1007.0,21798.0
Godda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,711.0,879.0,801.0,1198.0,1352.0,1273.0,747.0,1025.0,965.0,428.0,460.0,521.0,10360.0
Godda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2907.0,2897.0,2856.0,4584.0,3246.0,3381.0,4214.0,3436.0,3646.0,1135.0,1673.0,1135.0,35110.0
Godda,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,7.0,7.0,14.0,0.0,6.0,14.0,13.0,12.0,33.0,13.0,10.0,129.0
Godda,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,6.0,8.0,12.0,2.0,12.0,20.0,7.0,8.0,12.0,4.0,6.0,97.0
Godda,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,13.0,15.0,26.0,2.0,18.0,34.0,20.0,20.0,45.0,17.0,16.0,226.0
Godda,14.11,In-Patient Head Count at midnight,TOTAL,833.0,1103.0,1003.0,1430.0,312.0,163.0,173.0,191.0,230.0,246.0,219.0,195.0,6098.0
Godda,14.12.1,OPD attendance (All),TOTAL,28593.0,30398.0,26804.0,35406.0,22769.0,29313.0,29807.0,27924.0,20763.0,22318.0,25015.0,24324.0,323434.0
Godda,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,44.0,21.0,26.0,23.0,7.0,43.0,30.0,66.0,67.0,217.0,474.0,24.0,1042.0
Godda,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Godda,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,33.0,14.0,26.0,19.0,1.0,18.0,23.0,17.0,25.0,20.0,21.0,13.0,230.0
Godda,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,206.0,189.0,395.0
Godda,14.14.c,Number of Adolescents counselled,TOTAL,69.0,0.0,150.0,17.0,10.0,10.0,11.0,9.0,9.0,54.0,140.0,107.0,586.0
Godda,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,240.0,420.0,387.0,475.0,609.0,454.0,1380.0,680.0,571.0,1073.0,974.0,943.0,8206.0
Godda,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,6.0,19.0,49.0,15.0,34.0,24.0,21.0,16.0,13.0,34.0,44.0,35.0,310.0
Godda,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,0.0,0.0,0.0,74.0,0.0,111.0,86.0,67.0,85.0,81.0,133.0,178.0,815.0
Godda,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,0.0,0.0,0.0,54.0,0.0,91.0,65.0,109.0,105.0,104.0,156.0,165.0,849.0
Godda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Godda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,0.0,0.0,0.0,78.0,0.0,109.0,92.0,42.0,111.0,100.0,191.0,185.0,908.0
Godda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Godda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,0.0,0.0,0.0,206.0,0.0,311.0,243.0,218.0,301.0,285.0,480.0,528.0,2572.0
Godda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Godda,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,79.0,79.0
Godda,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,99.0,44.0,0.0,0.0,54.0,94.0,137.0,428.0
Godda,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,88.0,61.0,0.0,0.0,74.0,100.0,160.0,483.0
Godda,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,109.0,92.0,0.0,0.0,94.0,156.0,371.0,822.0
Godda,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,296.0,197.0,0.0,0.0,222.0,350.0,668.0,1733.0
Godda,15.4.1,Number of blood smears examined for Malaria,TOTAL,5821.0,6605.0,5685.0,6054.0,7991.0,6319.0,5403.0,3783.0,4347.0,4784.0,4812.0,6518.0,68122.0
Godda,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,238.0,225.0,151.0,205.0,147.0,174.0,149.0,112.0,119.0,83.0,100.0,82.0,1785.0
Godda,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,32.0,25.0,27.0,48.0,73.0,85.0,45.0,32.0,77.0,48.0,29.0,13.0,534.0
Godda,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,39520.0,27120.0,20120.0,29500.0,12500.0,2520.0,,,,,,,131280.0
Godda,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,40000.0,40000.0,0.0,0.0,60000.0,,,,,,,140000.0
Godda,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,12400.0,47000.0,30600.0,17000.0,10000.0,13500.0,,,,,,,130500.0
Godda,16.1.1,Stock position of DPT vaccines,5. Total Stock,27120.0,20120.0,29520.0,12500.0,2500.0,49020.0,0.0,0.0,0.0,0.0,0.0,0.0,140780.0
Godda,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Godda,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Godda,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Godda,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Godda,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,40500.0,11100.0,0.0,12500.0,20000.0,7300.0,,,,,,,91400.0
Godda,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,60000.0,60000.0,35000.0,0.0,0.0,,,,,,,155000.0
Godda,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,29400.0,71100.0,47500.0,27500.0,12700.0,6700.0,,,,,,,194900.0
Godda,16.1.2,Stock position of OPV vaccines,5. Total Stock,11100.0,0.0,12500.0,20000.0,7300.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,51500.0
Godda,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,25920.0,13020.0,6020.0,12720.0,11520.0,5270.0,,,,,,,74470.0
Godda,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,30000.0,30000.0,10000.0,0.0,30000.0,,,,,,,100000.0
Godda,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.3,Stock position of TT vaccines,4. Stock Distributed,12900.0,37000.0,23300.0,11200.0,6250.0,16250.0,,,,,,,106900.0
Godda,16.1.3,Stock position of TT vaccines,5. Total Stock,13020.0,6020.0,12720.0,11520.0,5270.0,19020.0,0.0,0.0,0.0,0.0,0.0,0.0,67570.0
Godda,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,22940.0,12040.0,6540.0,17400.0,6440.0,4190.0,,,,,,,69550.0
Godda,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,30000.0,30000.0,0.0,0.0,20000.0,,,,,,,80000.0
Godda,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,10900.0,35500.0,19100.0,11000.0,2250.0,11500.0,,,,,,,90250.0
Godda,16.1.5,Stock position of BCG vaccines,5. Total Stock,12040.0,6540.0,17440.0,6400.0,4190.0,12690.0,0.0,0.0,0.0,0.0,0.0,0.0,59300.0
Godda,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,10000.0,5900.0,3650.0,9400.0,8150.0,5650.0,,,,,,,42750.0
Godda,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,15000.0,15000.0,4000.0,0.0,7500.0,,,,,,,41500.0
Godda,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4100.0,17250.0,9250.0,5250.0,2500.0,9650.0,,,,,,,48000.0
Godda,16.1.6,Stock position of Measles vaccines,5. Total Stock,5900.0,3650.0,9400.0,8150.0,5650.0,3500.0,0.0,0.0,0.0,0.0,0.0,0.0,36250.0
Godda,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,,0.0,0.0,,,,,,,,0.0
Godda,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,200.0,0.0,0.0,200.0,0.0,,,,,,,,400.0
Godda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,1200.0,0.0,3000.0,0.0,0.0,,,,,,,,4200.0
Godda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,1400.0,0.0,2800.0,200.0,0.0,,,,,,,,4400.0
Godda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0
Godda,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,4000.0,0.0,0.0,0.0,0.0,,,,,,,,4000.0
Godda,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,150000.0,0.0,0.0,66000.0,0.0,,,,,,,,216000.0
Godda,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,154000.0,0.0,0.0,66000.0,0.0,,,,,,,,220000.0
Godda,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,500.0,0.0,0.0,0.0,0.0,,,,,,,,500.0
Godda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,15000.0,0.0,75000.0,16000.0,0.0,,,,,,,,106000.0
Godda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,15500.0,,75000.0,16000.0,0.0,,,,,,,,106500.0
Godda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,,0.0,0.0,,,,,,,,0.0
Godda,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,100000.0,,,,,,,,100000.0
Godda,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,100000.0,,,,,,,,100000.0
Godda,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,4000.0,,,,,,,,4000.0
Godda,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,4000.0,,,,,,,,4000.0
Godda,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Godda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Godda,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Godda,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Godda,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Godda,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Godda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Godda,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,2.0,2.0,1.0,,,,,,,,5.0
Godda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Godda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Godda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Godda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Godda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Godda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Godda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Godda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Godda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Godda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Godda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Godda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Godda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Godda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Godda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Godda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Godda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Godda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Godda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Godda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Godda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Godda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Godda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Godda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Godda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Godda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Godda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Godda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Godda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Godda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Godda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Godda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Godda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Godda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Godda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Godda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Godda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Godda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Godda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Godda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Godda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,1.0,,,,,,,,,,1.0
Godda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Godda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Godda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Godda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Godda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Godda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,3.0,,,,,,,,,3.0
Godda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Godda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,3.0,,,,,,,,,3.0
Godda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Godda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Godda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Godda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Godda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Godda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Godda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Godda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Godda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Godda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Godda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Godda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,,,,,,,,,,1.0
Godda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Godda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Godda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Godda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Godda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Godda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Godda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Godda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Godda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Godda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Godda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Godda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,1.0,,,,,,,,,1.0
Godda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Godda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Godda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Godda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,1.0,1.0,,,,,,,,,2.0
Gumla,1.1,Total number of pregnant women Registered for ANC,TOTAL,2210.0,2305.0,2322.0,2573.0,1941.0,1814.0,1819.0,1915.0,1672.0,1798.0,1617.0,1391.0,23377.0
Gumla,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,397.0,532.0,517.0,458.0,334.0,328.0,365.0,378.0,326.0,325.0,315.0,251.0,4526.0
Gumla,1.2,Number of Pregnant women registered under JSY,TOTAL,1714.0,1795.0,1759.0,2193.0,1640.0,1613.0,1639.0,1724.0,1531.0,1709.0,1462.0,1305.0,20084.0
Gumla,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1378.0,1418.0,1653.0,1519.0,1409.0,1345.0,1280.0,1430.0,1318.0,1167.0,1224.0,1241.0,16382.0
Gumla,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1843.0,1985.0,1939.0,2446.0,1846.0,1728.0,1741.0,1816.0,1612.0,1752.0,1562.0,1352.0,21622.0
Gumla,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1611.0,1790.0,1939.0,1868.0,2139.0,1673.0,1666.0,1716.0,1565.0,1425.0,1663.0,1503.0,20558.0
Gumla,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1379.0,1130.0,749.0,488.0,234.0,102.0,401.0,652.0,615.0,1492.0,1761.0,1413.0,10416.0
Gumla,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,48.0,67.0,58.0,70.0,57.0,33.0,42.0,51.0,45.0,60.0,55.0,58.0,644.0
Gumla,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,7.0,2.0,1.0,1.0,3.0,2.0,2.0,1.0,1.0,2.0,2.0,24.0
Gumla,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,725.0,777.0,885.0,790.0,688.0,779.0,762.0,854.0,779.0,803.0,805.0,831.0,9478.0
Gumla,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,12.0,20.0,15.0,21.0,15.0,8.0,13.0,12.0,16.0,13.0,13.0,18.0,176.0
Gumla,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Gumla,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,142.0,133.0,139.0,137.0,141.0,157.0,132.0,133.0,117.0,99.0,104.0,66.0,1500.0
Gumla,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,537.0,475.0,490.0,595.0,597.0,585.0,569.0,538.0,483.0,471.0,359.0,306.0,6005.0
Gumla,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,679.0,608.0,629.0,732.0,738.0,742.0,701.0,671.0,600.0,570.0,463.0,372.0,7505.0
Gumla,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,497.0,436.0,439.0,488.0,492.0,525.0,525.0,527.0,440.0,362.0,306.0,236.0,5273.0
Gumla,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,68.0,69.0,62.0,78.0,44.0,19.0,49.0,107.0,47.0,75.0,42.0,8.0,668.0
Gumla,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,967.0,1043.0,1127.0,1310.0,1163.0,1040.0,1070.0,1260.0,1032.0,984.0,966.0,1052.0,13014.0
Gumla,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,704.0,819.0,885.0,1070.0,1134.0,823.0,956.0,1135.0,1020.0,982.0,916.0,1034.0,11478.0
Gumla,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1012.0,980.0,1177.0,1200.0,1232.0,1449.0,1057.0,910.0,867.0,986.0,1049.0,1173.0,13092.0
Gumla,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,764.0,719.0,870.0,1004.0,973.0,1188.0,622.0,640.0,640.0,601.0,265.0,640.0,8926.0
Gumla,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,5.0,17.0,33.0,5.0,6.0,24.0,15.0,3.0,4.0,5.0,10.0,3.0,130.0
Gumla,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,70.0,79.0,84.0,101.0,75.0,81.0,73.0,81.0,69.0,49.0,57.0,78.0,897.0
Gumla,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,53.0,43.0,50.0,45.0,31.0,30.0,38.0,7.0,4.0,0.0,0.0,14.0,315.0
Gumla,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,18.0,29.0,28.0,45.0,16.0,18.0,5.0,3.0,3.0,0.0,0.0,5.0,170.0
Gumla,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,20.0,6.0,13.0,10.0,10.0,9.0,15.0,10.0,6.0,6.0,12.0,7.0,124.0
Gumla,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gumla,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,20.0,6.0,13.0,10.0,10.0,9.0,15.0,10.0,6.0,6.0,12.0,7.0,124.0
Gumla,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,27.0,22.0,22.0,34.0,24.0,16.0,21.0,13.0,26.0,23.0,15.0,25.0,268.0
Gumla,4.1.1.a,Number of male live births,TOTAL,881.0,945.0,972.0,1141.0,1060.0,974.0,943.0,1035.0,878.0,832.0,756.0,766.0,11183.0
Gumla,4.1.1.b,Number of female live births,TOTAL,834.0,832.0,925.0,1039.0,928.0,908.0,908.0,1030.0,819.0,771.0,739.0,731.0,10464.0
Gumla,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1715.0,1777.0,1897.0,2180.0,1988.0,1882.0,1851.0,2065.0,1697.0,1603.0,1495.0,1497.0,21647.0
Gumla,4.1.2,Number of still births,TOTAL,21.0,75.0,46.0,66.0,76.0,29.0,54.0,66.0,25.0,34.0,50.0,31.0,573.0
Gumla,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,87.0,50.0,56.0,51.0,39.0,153.0,130.0,169.0,159.0,163.0,140.0,133.0,1330.0
Gumla,4.2.1,Number of Newborns weighed at birth,TOTAL,1576.0,1627.0,1700.0,2049.0,1860.0,1713.0,1739.0,1934.0,1618.0,1449.0,1364.0,1375.0,20004.0
Gumla,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,107.0,105.0,151.0,175.0,145.0,155.0,127.0,171.0,104.0,155.0,88.0,106.0,1589.0
Gumla,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1440.0,1486.0,1587.0,1898.0,1935.0,1596.0,1808.0,1994.0,1582.0,1552.0,1336.0,1426.0,19640.0
Gumla,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Gumla,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,21.0,11.0,17.0,3.0,14.0,12.0,16.0,10.0,7.0,6.0,14.0,7.0,138.0
Gumla,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gumla,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,21.0,11.0,17.0,3.0,14.0,12.0,17.0,10.0,7.0,6.0,14.0,7.0,139.0
Gumla,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,30.0,26.0,16.0,21.0,15.0,26.0,23.0,13.0,23.0,193.0
Gumla,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,21.0,11.0,17.0,33.0,40.0,28.0,37.0,25.0,33.0,29.0,35.0,40.0,349.0
Gumla,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,1.0,0.0,1.0,2.0,0.0,1.0,2.0,1.0,0.0,2.0,2.0,12.0
Gumla,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,21.0,11.0,0.0,33.0,37.0,25.0,37.0,22.0,29.0,27.0,27.0,30.0,299.0
Gumla,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,1.0,0.0,4.0,5.0,7.0,5.0,5.0,11.0,9.0,17.0,7.0,71.0
Gumla,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1249.0,1316.0,1328.0,1252.0,1442.0,1202.0,1391.0,1403.0,1003.0,1128.0,1176.0,1047.0,14937.0
Gumla,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,903.0,746.0,896.0,1102.0,986.0,916.0,1089.0,911.0,767.0,702.0,618.0,543.0,10179.0
Gumla,6.3,PNC maternal complications attended,TOTAL,27.0,0.0,1.0,22.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Gumla,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,16.0,15.0,14.0,8.0,7.0,26.0,19.0,20.0,18.0,12.0,19.0,18.0,192.0
Gumla,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,5.0,1.0,2.0,3.0,6.0,4.0,2.0,2.0,3.0,0.0,0.0,0.0,28.0
Gumla,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,21.0,16.0,16.0,11.0,13.0,30.0,21.0,22.0,21.0,12.0,19.0,18.0,220.0
Gumla,7.2,Number of MTPs conducted at Private Facilities,TOTAL,83.0,120.0,88.0,91.0,62.0,84.0,80.0,100.0,101.0,118.0,101.0,102.0,1130.0
Gumla,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,6.0,1.0,0.0,6.0,46.0,67.0,39.0,26.0,48.0,28.0,41.0,60.0,368.0
Gumla,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,25.0,2.0,15.0,7.0,74.0,137.0,68.0,67.0,66.0,77.0,66.0,101.0,705.0
Gumla,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,31.0,3.0,15.0,13.0,120.0,204.0,107.0,93.0,114.0,105.0,107.0,161.0,1073.0
Gumla,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,8.0,10.0
Gumla,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,5.0,8.0,2.0,476.0,16.0,90.0,68.0,95.0,92.0,246.0,114.0,57.0,1269.0
Gumla,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,,13.0,0.0,,,1.0,1.0,2.0,3.0,1.0,22.0
Gumla,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gumla,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,5.0,9.0,2.0,489.0,16.0,90.0,68.0,96.0,93.0,248.0,117.0,58.0,1291.0
Gumla,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,6.0
Gumla,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Gumla,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gumla,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,33.0,35.0,5.0,425.0,16.0,102.0,69.0,196.0,255.0,798.0,375.0,99.0,2408.0
Gumla,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,1.0,,3.0,0.0,1.0,,0.0,,6.0,3.0,4.0,18.0
Gumla,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gumla,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,33.0,36.0,5.0,428.0,16.0,103.0,69.0,196.0,255.0,804.0,378.0,103.0,2426.0
Gumla,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,9.0
Gumla,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Gumla,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gumla,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,9.0
Gumla,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,180.0,214.0,212.0,1702.0,231.0,211.0,170.0,206.0,208.0,313.0,255.0,212.0,4114.0
Gumla,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,35.0,62.0,31.0,658.0,78.0,245.0,71.0,252.0,481.0,290.0,292.0,668.0,3163.0
Gumla,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,8.0,7.0,8.0,17.0,13.0,3.0,5.0,0.0,57.0,6.0,3.0,16.0,143.0
Gumla,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gumla,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,223.0,283.0,251.0,2377.0,322.0,459.0,246.0,458.0,746.0,609.0,550.0,896.0,7420.0
Gumla,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Gumla,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,17.0,36.0,49.0,59.0,108.0,31.0,35.0,310.0,152.0,46.0,41.0,30.0,914.0
Gumla,9.06,Number of IUCD removals,TOTAL,148.0,99.0,142.0,297.0,182.0,95.0,154.0,135.0,103.0,102.0,153.0,143.0,1753.0
Gumla,9.07,Number of Oral Pills cycles distributed,TOTAL,3438.0,3588.0,3570.0,13117.0,3874.0,4346.0,4952.0,3319.0,8136.0,6610.0,4238.0,7984.0,67172.0
Gumla,9.08,Number of Condom pieces distributed,TOTAL,30909.0,21542.0,23554.0,67932.0,20019.0,22313.0,23262.0,14664.0,25174.0,50969.0,28471.0,42650.0,371459.0
Gumla,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,27.0,75.0,3.0,0.0,0.0,21.0,1.0,0.0,0.0,5.0,18.0,150.0
Gumla,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,857.0,199.0,377.0,316.0,138.0,172.0,144.0,85.0,166.0,202.0,209.0,397.0,3262.0
Gumla,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,1.0,4.0
Gumla,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Gumla,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,9.12,Number of Institutions having NSV trained doctors,TOTAL,11.0,10.0,12.0,10.0,8.0,8.0,12.0,12.0,14.0,11.0,10.0,12.0,-1.0
Gumla,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1703.0,1800.0,1823.0,2224.0,1841.0,1943.0,1973.0,2015.0,1770.0,1527.0,1377.0,1259.0,21255.0
Gumla,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1629.0,1830.0,1823.0,2075.0,1849.0,1858.0,2106.0,1906.0,1735.0,1616.0,1509.0,1320.0,21256.0
Gumla,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1610.0,1679.0,1792.0,1828.0,2111.0,1861.0,1734.0,2166.0,1812.0,1574.0,1585.0,1432.0,21184.0
Gumla,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1764.0,1650.0,1694.0,1817.0,1865.0,2026.0,1750.0,1843.0,1994.0,1652.0,1498.0,1497.0,21050.0
Gumla,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Gumla,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Gumla,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Gumla,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1087.0,1234.0,1143.0,1484.0,1315.0,826.0,1134.0,1325.0,519.0,818.0,866.0,536.0,12287.0
Gumla,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1653.0,1819.0,1805.0,2067.0,1844.0,1256.0,1964.0,1884.0,516.0,1203.0,1316.0,442.0,17769.0
Gumla,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1607.0,1679.0,1780.0,1819.0,2107.0,1271.0,1624.0,2100.0,555.0,1110.0,1293.0,473.0,17418.0
Gumla,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1775.0,1640.0,1643.0,1800.0,1867.0,1295.0,1732.0,1780.0,581.0,1122.0,1179.0,498.0,16912.0
Gumla,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,0.0,0.0,119.0,106.0,68.0,43.0,5.0,341.0
Gumla,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,2.0,0.0,15.0,13.0,0.0,1598.0,1647.0,1288.0,368.0,472.0,5403.0
Gumla,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,6.0,0.0,16.0,0.0,0.0,78.0,972.0,1176.0,370.0,348.0,2966.0
Gumla,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,12.0,10.0,1.0,14.0,0.0,0.0,54.0,83.0,623.0,252.0,376.0,1425.0
Gumla,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1819.0,1964.0,1975.0,2131.0,2133.0,1795.0,1700.0,1652.0,1475.0,1523.0,1630.0,1497.0,21294.0
Gumla,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,0.0,9.0,71.0,494.0,513.0,638.0,627.0,2352.0
Gumla,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Gumla,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,860.0,985.0,962.0,1014.0,945.0,900.0,813.0,745.0,697.0,762.0,800.0,733.0,10216.0
Gumla,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,874.0,929.0,901.0,976.0,931.0,802.0,791.0,740.0,671.0,683.0,707.0,721.0,9726.0
Gumla,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1734.0,1914.0,1863.0,1990.0,1876.0,1702.0,1604.0,1485.0,1368.0,1445.0,1507.0,1454.0,19942.0
Gumla,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1335.0,1514.0,1488.0,1504.0,1485.0,1223.0,1323.0,1359.0,1336.0,1321.0,1545.0,1338.0,16771.0
Gumla,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1342.0,1495.0,1456.0,1502.0,1577.0,821.0,1275.0,1311.0,515.0,1055.0,1224.0,454.0,14027.0
Gumla,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,96.0,133.0,124.0,160.0,160.0,108.0,77.0,106.0,120.0,114.0,107.0,108.0,1413.0
Gumla,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,99.0,118.0,141.0,146.0,146.0,94.0,68.0,103.0,94.0,92.0,92.0,91.0,1284.0
Gumla,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,195.0,251.0,265.0,306.0,306.0,202.0,145.0,209.0,214.0,206.0,199.0,199.0,2697.0
Gumla,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,366.0,361.0,366.0,384.0,395.0,322.0,296.0,265.0,262.0,333.0,412.0,281.0,4043.0
Gumla,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1065.0,1309.0,1217.0,1094.0,1315.0,1151.0,1141.0,986.0,839.0,741.0,697.0,634.0,12189.0
Gumla,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1041.0,1196.0,1482.0,1738.0,1807.0,1701.0,1463.0,1453.0,1293.0,1058.0,930.0,905.0,16067.0
Gumla,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,12.0,9.0,14.0,5.0,9.0,20.0,12.0,13.0,9.0,8.0,13.0,10.0,134.0
Gumla,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,9.0,7.0,3.0,12.0,5.0,9.0,9.0,8.0,3.0,14.0,5.0,4.0,88.0
Gumla,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1577.0,1587.0,1649.0,1642.0,1635.0,1649.0,1617.0,1630.0,1631.0,1470.0,1436.0,1471.0,18994.0
Gumla,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1486.0,1557.0,1632.0,1618.0,1610.0,1617.0,1568.0,1621.0,1605.0,1446.0,1431.0,1458.0,18649.0
Gumla,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1223.0,1313.0,1392.0,1375.0,1398.0,1426.0,1376.0,1424.0,1390.0,1277.0,1249.0,1275.0,16118.0
Gumla,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1635.0,1727.0,1727.0,1777.0,2908.0,1785.0,1604.0,1697.0,1310.0,1398.0,2164.0,1433.0,21165.0
Gumla,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,288.0,246.0,222.0,587.0,8817.0,579.0,223.0,342.0,234.0,221.0,10690.0,889.0,23338.0
Gumla,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,220.0,172.0,165.0,575.0,9913.0,553.0,124.0,210.0,146.0,110.0,11644.0,838.0,24670.0
Gumla,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,13.0,0.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,0.0,0.0,27.0
Gumla,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,39.0,16.0,5.0,34.0,31.0,32.0,1.0,16.0,17.0,1.0,25.0,24.0,241.0
Gumla,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,54.0,86.0,108.0,114.0,171.0,65.0,45.0,50.0,74.0,95.0,84.0,98.0,1044.0
Gumla,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,27.0,47.0,40.0,70.0,78.0,51.0,32.0,79.0,107.0,33.0,92.0,96.0,752.0
Gumla,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,8.0,5.0,8.0,0.0,0.0,2.0,2.0,6.0,8.0,20.0,6.0,65.0
Gumla,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,108.0,93.0,65.0,6.0,0.0,230.0,253.0,1062.0,33.0,1850.0
Gumla,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,99.0,93.0,65.0,6.0,0.0,202.0,250.0,4.0,23.0,742.0
Gumla,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,40.0,17.0,28.0,541.0,403.0,403.0,8.0,305.0,0.0,1745.0
Gumla,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,6.0,11.0,6.0,84.0,0.0,0.0,0.0,0.0,0.0,107.0
Gumla,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Gumla,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,1.0,1.0,2.0,2.0,1.0,2.0,3.0,3.0,3.0,3.0,3.0,-1.0
Gumla,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1500.0,1377.0,1408.0,1423.0,1408.0,1488.0,1411.0,1480.0,1431.0,1300.0,1241.0,1281.0,-1.0
Gumla,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,11.0,10.0,11.0,11.0,10.0,10.0,10.0,8.0,10.0,11.0,11.0,10.0,-1.0
Gumla,14.05,Number of RKS meetings held during the month,TOTAL,1.0,2.0,2.0,1.0,4.0,4.0,4.0,3.0,3.0,3.0,4.0,3.0,34.0
Gumla,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,10.0,12.0,13.0,12.0,10.0,14.0,14.0,13.0,14.0,14.0,13.0,-1.0
Gumla,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,69.0,27.0,29.0,49.0,67.0,96.0,55.0,66.0,35.0,65.0,87.0,91.0,736.0
Gumla,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,3.0,5.0,5.0,5.0,1.0,5.0,5.0,5.0,1.0,5.0,3.0,-1.0
Gumla,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,2.0,1.0,2.0,2.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,-1.0
Gumla,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,103.0,158.0,192.0,206.0,277.0,174.0,122.0,138.0,117.0,144.0,138.0,144.0,1913.0
Gumla,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,441.0,507.0,517.0,490.0,532.0,553.0,456.0,417.0,463.0,441.0,359.0,388.0,5564.0
Gumla,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,94.0,125.0,156.0,195.0,267.0,225.0,140.0,123.0,102.0,89.0,121.0,125.0,1762.0
Gumla,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,397.0,611.0,882.0,1134.0,934.0,961.0,772.0,859.0,895.0,1108.0,823.0,1039.0,10415.0
Gumla,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,197.0,283.0,348.0,401.0,544.0,399.0,262.0,261.0,219.0,233.0,259.0,269.0,3675.0
Gumla,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,838.0,1118.0,1399.0,1624.0,1466.0,1514.0,1228.0,1276.0,1358.0,1549.0,1182.0,1427.0,15979.0
Gumla,14.10.2.a,Number of death cases of Inpatient males,TOTAL,21.0,23.0,20.0,17.0,20.0,26.0,18.0,19.0,19.0,10.0,19.0,19.0,231.0
Gumla,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,8.0,21.0,11.0,19.0,16.0,19.0,15.0,18.0,5.0,13.0,6.0,157.0
Gumla,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,27.0,31.0,41.0,28.0,39.0,42.0,37.0,34.0,37.0,15.0,32.0,25.0,388.0
Gumla,14.11,In-Patient Head Count at midnight,TOTAL,927.0,1046.0,1160.0,529.0,1423.0,408.0,332.0,1139.0,987.0,1178.0,838.0,1612.0,11579.0
Gumla,14.12.1,OPD attendance (All),TOTAL,36652.0,39373.0,40456.0,47736.0,48434.0,39149.0,33921.0,33459.0,27018.0,30068.0,29384.0,28723.0,434373.0
Gumla,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,21.0,6.0,29.0,75.0,31.0,25.0,36.0,30.0,45.0,132.0,12.0,41.0,483.0
Gumla,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Gumla,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,93.0,51.0,43.0,508.0,120.0,108.0,64.0,115.0,105.0,230.0,183.0,112.0,1732.0
Gumla,14.14.a,Number of patients given AYUSH treatment,TOTAL,1.0,2.0,1.0,2.0,2.0,0.0,801.0,312.0,475.0,277.0,238.0,164.0,2275.0
Gumla,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,34.0,272.0,8.0,9.0,323.0
Gumla,14.14.c,Number of Adolescents counselled,TOTAL,0.0,207.0,558.0,42.0,73.0,173.0,25.0,171.0,58.0,133.0,130.0,198.0,1768.0
Gumla,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1702.0,2055.0,2061.0,3235.0,2719.0,2479.0,3863.0,2397.0,1971.0,2649.0,2533.0,2412.0,30076.0
Gumla,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,169.0,132.0,133.0,126.0,131.0,109.0,92.0,68.0,71.0,41.0,110.0,102.0,1284.0
Gumla,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,99.0,148.0,86.0,213.0,205.0,215.0,138.0,175.0,168.0,256.0,288.0,358.0,2349.0
Gumla,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,55.0,0.0,1.0,1.0,6.0,0.0,5.0,0.0,13.0,1.0,2.0,24.0,108.0
Gumla,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,80.0,144.0,80.0,158.0,112.0,160.0,110.0,120.0,94.0,208.0,205.0,177.0,1648.0
Gumla,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,66.0,1.0,17.0,12.0,3.0,0.0,0.0,0.0,3.0,0.0,1.0,7.0,110.0
Gumla,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,83.0,160.0,116.0,247.0,298.0,312.0,220.0,277.0,318.0,411.0,379.0,368.0,3189.0
Gumla,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,55.0,1.0,0.0,94.0,29.0,0.0,3.0,14.0,19.0,0.0,0.0,0.0,215.0
Gumla,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,262.0,452.0,282.0,618.0,615.0,687.0,468.0,572.0,580.0,875.0,872.0,903.0,7186.0
Gumla,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,176.0,2.0,18.0,107.0,38.0,0.0,8.0,14.0,35.0,1.0,3.0,31.0,433.0
Gumla,15.2,Number of Widal tests conducted,Number tested,64.0,95.0,38.0,157.0,314.0,258.0,204.0,270.0,188.0,115.0,220.0,325.0,2248.0
Gumla,15.3.a,Number of VDRL tests conducted on males,Number tested,46.0,58.0,55.0,103.0,130.0,111.0,113.0,72.0,154.0,99.0,143.0,123.0,1207.0
Gumla,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,52.0,70.0,62.0,86.0,55.0,87.0,77.0,55.0,88.0,71.0,76.0,95.0,874.0
Gumla,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,28.0,65.0,114.0,143.0,174.0,139.0,124.0,141.0,129.0,129.0,192.0,176.0,1554.0
Gumla,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,126.0,193.0,231.0,332.0,359.0,337.0,314.0,268.0,371.0,299.0,411.0,394.0,3635.0
Gumla,15.4.1,Number of blood smears examined for Malaria,TOTAL,2502.0,5053.0,4956.0,8409.0,9777.0,6133.0,8117.0,6976.0,5331.0,6915.0,7706.0,7378.0,79253.0
Gumla,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,10.0,7.0,13.0,24.0,49.0,49.0,20.0,22.0,44.0,4.0,42.0,46.0,330.0
Gumla,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,68.0,126.0,159.0,275.0,294.0,214.0,193.0,178.0,145.0,101.0,111.0,156.0,2020.0
Gumla,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2965.0,3765.0,3145.0,1595.0,1960.0,2285.0,2675.0,1665.0,1650.0,2530.0,2680.0,1670.0,28585.0
Gumla,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,1000.0,,2000.0,2000.0,2000.0,100.0,2000.0,2000.0,2000.0,500.0,2000.0,17600.0
Gumla,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1200.0,1620.0,1550.0,1635.0,1675.0,1610.0,1110.0,2015.0,1120.0,1850.0,1510.0,1270.0,18165.0
Gumla,16.1.1,Stock position of DPT vaccines,5. Total Stock,3765.0,3145.0,1595.0,1960.0,2285.0,2675.0,1665.0,1650.0,2530.0,2680.0,1670.0,2400.0,28020.0
Gumla,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Gumla,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2053.0,3088.0,1393.0,0.0,300.0,100.0,525.0,792.0,0.0,450.0,200.0,2.0,8903.0
Gumla,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000.0,,,1000.0,1000.0,1000.0,1500.0,,500.0,1000.0,9630.0,102.0,17732.0
Gumla,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,965.0,1695.0,1393.0,700.0,1200.0,575.0,1233.0,792.0,50.0,1250.0,9828.0,,19681.0
Gumla,16.1.2,Stock position of OPV vaccines,5. Total Stock,3088.0,1393.0,0.0,300.0,100.0,525.0,792.0,0.0,450.0,200.0,2.0,104.0,6954.0
Gumla,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1611.0,2386.0,2666.0,1166.0,480.0,1895.0,2355.0,610.0,0.0,2230.0,2200.0,1239.0,18838.0
Gumla,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,2000.0,,2000.0,3200.0,2000.0,100.0,,4000.0,2000.0,500.0,1000.0,18800.0
Gumla,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1225.0,1720.0,1500.0,2686.0,1785.0,1540.0,1845.0,610.0,1770.0,2030.0,1461.0,1475.0,19647.0
Gumla,16.1.3,Stock position of TT vaccines,5. Total Stock,2386.0,2666.0,1166.0,480.0,1895.0,2355.0,610.0,0.0,2230.0,2200.0,1239.0,764.0,17991.0
Gumla,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Gumla,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2300.0,3280.0,2660.0,1310.0,0.0,1825.0,1698.0,1238.0,838.0,518.0,350.0,,16017.0
Gumla,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,1000.0,,3000.0,3000.0,1500.0,1000.0,1000.0,600.0,1000.0,0.0,1200.0,15300.0
Gumla,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1020.0,1620.0,1350.0,4310.0,1175.0,1627.0,1460.0,1400.0,920.0,1168.0,350.0,800.0,17200.0
Gumla,16.1.5,Stock position of BCG vaccines,5. Total Stock,3280.0,2660.0,1310.0,0.0,1825.0,1698.0,1238.0,838.0,518.0,350.0,0.0,400.0,14117.0
Gumla,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3800.0,2937.0,2337.0,1037.0,1337.0,2637.0,1147.0,1747.0,2447.0,2977.0,2370.0,1370.0,26143.0
Gumla,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,1000.0,,2000.0,2750.0,,2000.0,2000.0,1500.0,1000.0,500.0,2000.0,14750.0
Gumla,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,863.0,1600.0,1300.0,1700.0,1450.0,1490.0,1400.0,1300.0,970.0,1607.0,1500.0,1260.0,16440.0
Gumla,16.1.6,Stock position of Measles vaccines,5. Total Stock,2937.0,2337.0,1037.0,1337.0,2637.0,1147.0,1747.0,2447.0,2977.0,2370.0,1370.0,2110.0,24453.0
Gumla,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Gumla,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,0.0,1170.0,1090.0,600.0,0.0,,2860.0
Gumla,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,1500.0,1000.0,500.0,,500.0,500.0,4000.0
Gumla,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,330.0,1080.0,990.0,600.0,500.0,500.0,4000.0
Gumla,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1170.0,1090.0,600.0,0.0,0.0,0.0,2860.0
Gumla,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gumla,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gumla,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gumla,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gumla,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gumla,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Gumla,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Gumla,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Gumla,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Gumla,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Gumla,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Gumla,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Gumla,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Gumla,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Gumla,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Gumla,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Gumla,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Gumla,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Gumla,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gumla,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2700.0,1700.0,300.0,300.0,4900.0,1900.0,5150.0,2350.0,2600.0,2600.0,500.0,1800.0,26800.0
Gumla,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,11800.0,,4500.0,0.0,3000.0,1800.0,3000.0,1800.0,1800.0,27700.0
Gumla,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1000.0,1400.0,,7200.0,3000.0,1250.0,2800.0,2750.0,1800.0,5100.0,500.0,,26800.0
Gumla,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1700.0,300.0,300.0,4900.0,1900.0,5150.0,2350.0,2600.0,2600.0,500.0,1800.0,3600.0,27700.0
Gumla,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,21900.0,51300.0,50300.0,40300.0,40325.0,11325.0,35325.0,20000.0,14000.0,42000.0,36000.0,28000.0,390775.0
Gumla,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,32000.0,,,36000.0,,30000.0,0.0,,38000.0,36000.0,16000.0,,188000.0
Gumla,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,2600.0,1000.0,10000.0,35975.0,29000.0,6000.0,15325.0,6000.0,10000.0,42000.0,24000.0,,181900.0
Gumla,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,51300.0,50300.0,40300.0,40325.0,11325.0,35325.0,20000.0,14000.0,42000.0,36000.0,28000.0,28000.0,396875.0
Gumla,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,7538.0,9038.0,9038.0,7538.0,2778.0,5223.0,3823.0,2300.0,1400.0,,,,48676.0
Gumla,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2000.0,,,,4000.0,,0.0,,,,,,6000.0
Gumla,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Gumla,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,500.0,,1500.0,4760.0,1555.0,1400.0,1523.0,900.0,1400.0,,,,13538.0
Gumla,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,9038.0,9038.0,7538.0,2778.0,5223.0,3823.0,2300.0,1400.0,0.0,0.0,0.0,0.0,41138.0
Gumla,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,1.0,,,1.0,,2.0
Gumla,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gumla,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,1.0,,1.0
Gumla,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,1.0,,1.0
Gumla,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,1.0,,,,,,,,,1.0
Gumla,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Gumla,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,1.0,,,,1.0,,,,,2.0
Gumla,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,1.0,1.0
Gumla,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gumla,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,1.0,1.0
Gumla,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,,,,1.0,,,2.0,,1.0,2.0,7.0
Gumla,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,1.0,,,,2.0
Gumla,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,2.0,,,,1.0,,,3.0,,1.0,2.0,9.0
Gumla,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,1.0,,,,,1.0
Gumla,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Gumla,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,1.0,,1.0,,,2.0
Gumla,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gumla,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gumla,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Gumla,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gumla,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,1.0,1.0,2.0
Gumla,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,1.0,1.0,2.0
Gumla,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gumla,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gumla,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Gumla,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,1.0,4.0,1.0,1.0,7.0
Gumla,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,2.0,,2.0,1.0,2.0,,7.0
Gumla,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,2.0,,3.0,5.0,3.0,1.0,14.0
Gumla,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Gumla,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Gumla,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,1.0,,,1.0
Gumla,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,1.0,,,,,,4.0,1.0,,1.0,7.0
Gumla,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Gumla,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,,,,,,4.0,1.0,,1.0,7.0
Gumla,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,1.0,,,1.0,,,,,,,,2.0
Gumla,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,,,2.0,2.0,2.0,1.0,1.0,2.0,,11.0
Gumla,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,,,1.0,,,,,,,,2.0
Gumla,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,2.0,1.0,,2.0,2.0,2.0,2.0,1.0,1.0,2.0,,15.0
Gumla,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Gumla,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,2.0,1.0,,1.0,1.0,,,,,,5.0
Gumla,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Gumla,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,2.0,1.0,2.0,1.0,1.0,,,,,,7.0
Gumla,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,1.0,,,,,,,,,2.0
Gumla,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,2.0,4.0,2.0,2.0,2.0,2.0,7.0,4.0,2.0,4.0,1.0,32.0
Gumla,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,,1.0,,,,,,,,2.0
Gumla,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,3.0,5.0,3.0,3.0,2.0,2.0,7.0,4.0,2.0,4.0,1.0,36.0
Gumla,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Gumla,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Gumla,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Gumla,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,1.0,,1.0,,1.0,,,1.0,1.0,1.0,6.0
Gumla,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,2.0,,1.0,2.0,,,,,,,,5.0
Gumla,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,2.0,1.0,1.0,3.0,,1.0,,,1.0,1.0,1.0,11.0
Gumla,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,1.0,,,,1.0,,,2.0
Gumla,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Gumla,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,1.0,,,,1.0,,,2.0
Gumla,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Gumla,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Gumla,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,1.0,,1.0
Gumla,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,2.0,,,1.0,,,,,,,,3.0
Gumla,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Gumla,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,2.0,,,1.0,,,,,,,,3.0
Gumla,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,2.0,,,,,,2.0
Gumla,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Gumla,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,2.0,,,,,,2.0
Gumla,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,1.0,2.0,3.0
Gumla,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Gumla,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,1.0,2.0,3.0
Gumla,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Gumla,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Gumla,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Gumla,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,1.0,1.0,3.0,,1.0,,1.0,1.0,9.0
Gumla,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Gumla,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,1.0,1.0,3.0,,1.0,,1.0,1.0,9.0
Gumla,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,1.0,2.0,,3.0,5.0,7.0,8.0,8.0,3.0,5.0,42.0
Gumla,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,2.0,2.0,,,,,,,,4.0
Gumla,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,1.0,4.0,2.0,3.0,5.0,7.0,8.0,8.0,3.0,5.0,46.0
Gumla,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,3.0,1.0,,1.0,,2.0,4.0,1.0,3.0,,15.0
Gumla,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Gumla,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,3.0,1.0,,1.0,,2.0,4.0,1.0,3.0,,15.0
Gumla,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Gumla,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,,,,,1.0,,1.0,1.0,4.0
Gumla,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Gumla,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,2.0,,,,,,1.0,,1.0,1.0,5.0
Gumla,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,1.0,,2.0,3.0,1.0,,2.0,9.0
Gumla,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Gumla,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,,,,1.0,,2.0,3.0,1.0,,2.0,10.0
Gumla,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Gumla,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,,,,,2.0,1.0,,2.0,1.0,1.0,8.0
Gumla,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Gumla,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,1.0,,,1.0,,2.0,1.0,,2.0,1.0,1.0,9.0
Gumla,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,4.0,,,,,,,,4.0
Gumla,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,3.0,3.0,5.0,3.0,4.0,18.0,12.0,13.0,9.0,8.0,15.0,93.0
Gumla,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,3.0,1.0,1.0,3.0,,,,,,,,8.0
Gumla,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,6.0,4.0,6.0,10.0,4.0,18.0,12.0,13.0,9.0,8.0,15.0,105.0
Hazaribagh,1.1,Total number of pregnant women Registered for ANC,TOTAL,3319.0,3209.0,4365.0,4499.0,3951.0,3904.0,3101.0,3027.0,3260.0,3039.0,3167.0,3531.0,42372.0
Hazaribagh,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,600.0,786.0,1037.0,946.0,907.0,1136.0,704.0,913.0,855.0,929.0,878.0,1100.0,10791.0
Hazaribagh,1.2,Number of Pregnant women registered under JSY,TOTAL,3164.0,3047.0,4148.0,4235.0,3684.0,3785.0,2930.0,2802.0,3039.0,2970.0,3115.0,3506.0,40425.0
Hazaribagh,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1757.0,1599.0,2505.0,2004.0,2184.0,2399.0,1647.0,1688.0,1944.0,1885.0,1651.0,2038.0,23301.0
Hazaribagh,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2706.0,2219.0,3253.0,3758.0,3391.0,3239.0,2683.0,2586.0,2588.0,2200.0,2574.0,2545.0,33742.0
Hazaribagh,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2060.0,2562.0,2654.0,2388.0,2284.0,2435.0,1978.0,2152.0,2287.0,1898.0,2242.0,2330.0,27270.0
Hazaribagh,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,720.0,639.0,442.0,317.0,74.0,397.0,861.0,900.0,1006.0,907.0,2846.0,622.0,9731.0
Hazaribagh,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,53.0,65.0,88.0,91.0,33.0,45.0,32.0,22.0,395.0,88.0,84.0,82.0,1078.0
Hazaribagh,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,9.0,3.0,0.0,9.0,5.0,4.0,0.0,1.0,0.0,61.0,263.0,358.0
Hazaribagh,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,927.0,429.0,453.0,557.0,489.0,420.0,469.0,455.0,466.0,521.0,566.0,604.0,6356.0
Hazaribagh,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,6.0,7.0,5.0,9.0,8.0,12.0,6.0,5.0,9.0,59.0,11.0,10.0,147.0
Hazaribagh,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Hazaribagh,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,59.0,84.0,136.0,137.0,168.0,172.0,138.0,193.0,178.0,189.0,166.0,148.0,1768.0
Hazaribagh,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,737.0,940.0,1010.0,927.0,980.0,910.0,765.0,739.0,781.0,694.0,677.0,709.0,9869.0
Hazaribagh,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,796.0,1024.0,1146.0,1064.0,1148.0,1082.0,903.0,932.0,959.0,883.0,843.0,857.0,11637.0
Hazaribagh,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,564.0,702.0,897.0,766.0,826.0,783.0,648.0,629.0,663.0,604.0,603.0,559.0,8244.0
Hazaribagh,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,41.0,43.0,34.0,48.0,21.0,43.0,34.0,111.0,68.0,12.0,15.0,18.0,488.0
Hazaribagh,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2191.0,1341.0,2228.0,2370.0,1605.0,1461.0,1335.0,1450.0,1445.0,1427.0,1380.0,1464.0,19697.0
Hazaribagh,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2092.0,1315.0,2097.0,2242.0,1549.0,1455.0,1319.0,1340.0,1299.0,1382.0,1368.0,1444.0,18902.0
Hazaribagh,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1309.0,1068.0,1190.0,1781.0,2603.0,641.0,540.0,742.0,698.0,794.0,1985.0,1108.0,14459.0
Hazaribagh,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1202.0,918.0,1008.0,1673.0,2635.0,505.0,472.0,579.0,581.0,594.0,1702.0,822.0,12691.0
Hazaribagh,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Hazaribagh,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,989.0,908.0,117.0,267.0,430.0,366.0,,589.0,3666.0
Hazaribagh,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Hazaribagh,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Hazaribagh,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Hazaribagh,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0,4.0
Hazaribagh,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,13.0,15.0,37.0,126.0,16.0,14.0,19.0,20.0,29.0,23.0,13.0,17.0,342.0
Hazaribagh,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hazaribagh,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,13.0,15.0,37.0,126.0,16.0,14.0,19.0,20.0,29.0,25.0,13.0,19.0,346.0
Hazaribagh,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Hazaribagh,4.1.1.a,Number of male live births,TOTAL,1531.0,1249.0,1955.0,1814.0,1964.0,1862.0,1246.0,1403.0,1481.0,1458.0,1184.0,1519.0,18666.0
Hazaribagh,4.1.1.b,Number of female live births,TOTAL,1453.0,1139.0,1885.0,1614.0,1816.0,1632.0,1106.0,1227.0,1353.0,1244.0,1034.0,1388.0,16891.0
Hazaribagh,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2984.0,2388.0,3840.0,3428.0,3780.0,3494.0,2352.0,2630.0,2834.0,2702.0,2218.0,2907.0,35557.0
Hazaribagh,4.1.2,Number of still births,TOTAL,32.0,41.0,65.0,50.0,46.0,46.0,45.0,27.0,152.0,28.0,30.0,46.0,608.0
Hazaribagh,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,39.0,32.0,33.0,63.0,42.0,69.0,40.0,26.0,38.0,36.0,32.0,37.0,487.0
Hazaribagh,4.2.1,Number of Newborns weighed at birth,TOTAL,2659.0,2115.0,3548.0,3092.0,3366.0,3071.0,2108.0,2333.0,2493.0,2431.0,2026.0,2682.0,31924.0
Hazaribagh,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,92.0,84.0,276.0,151.0,168.0,240.0,150.0,226.0,166.0,217.0,160.0,143.0,2073.0
Hazaribagh,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2843.0,2251.0,3707.0,3243.0,3508.0,3328.0,2107.0,2496.0,2701.0,2553.0,2148.0,2823.0,33708.0
Hazaribagh,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,17.0,25.0,47.0,65.0,6.0,4.0,2.0,9.0,1.0,0.0,3.0,179.0
Hazaribagh,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,45.0,38.0,65.0,45.0,54.0,54.0,62.0,30.0,27.0,49.0,3.0,4.0,476.0
Hazaribagh,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,13.0,20.0,10.0,52.0,25.0,19.0,33.0,0.0,36.0,4.0,8.0,1.0,221.0
Hazaribagh,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hazaribagh,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,58.0,75.0,100.0,144.0,144.0,79.0,99.0,32.0,72.0,54.0,11.0,8.0,876.0
Hazaribagh,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Hazaribagh,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,13.0,62.0,100.0,144.0,115.0,79.0,99.0,27.0,65.0,55.0,11.0,39.0,809.0
Hazaribagh,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,13.0,37.0,66.0,107.0,116.0,41.0,39.0,0.0,43.0,18.0,5.0,3.0,488.0
Hazaribagh,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,58.0,62.0,93.0,118.0,113.0,79.0,93.0,26.0,62.0,25.0,11.0,12.0,752.0
Hazaribagh,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1365.0,1590.0,1727.0,2620.0,1817.0,1773.0,1718.0,1701.0,1254.0,1189.0,1148.0,1120.0,19022.0
Hazaribagh,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,741.0,990.0,1161.0,1186.0,1115.0,1037.0,1074.0,1091.0,980.0,985.0,965.0,931.0,12256.0
Hazaribagh,6.3,PNC maternal complications attended,TOTAL,15.0,25.0,3.0,4.0,3.0,3.0,2.0,4.0,9.0,4.0,3.0,3.0,78.0
Hazaribagh,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,8.0,6.0,4.0,30.0,7.0,12.0,11.0,0.0,9.0,0.0,0.0,7.0,94.0
Hazaribagh,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,8.0,6.0,0.0,14.0,2.0,0.0,1.0,1.0,5.0,0.0,37.0
Hazaribagh,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,8.0,6.0,12.0,36.0,7.0,26.0,13.0,0.0,10.0,1.0,5.0,7.0,131.0
Hazaribagh,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0
Hazaribagh,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,9.0,10.0,6.0,13.0,15.0,0.0,12.0,7.0,6.0,9.0,9.0,8.0,104.0
Hazaribagh,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,9.0,7.0,7.0,15.0,12.0,4.0,14.0,10.0,8.0,11.0,6.0,10.0,113.0
Hazaribagh,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,18.0,17.0,13.0,28.0,27.0,4.0,26.0,17.0,14.0,20.0,15.0,18.0,217.0
Hazaribagh,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,47.0,2.0,5.0,1.0,2.0,4.0,23.0,19.0,1.0,104.0
Hazaribagh,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,9.0,2.0,2.0,11.0,0.0,1.0,13.0,0.0,2.0,40.0
Hazaribagh,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hazaribagh,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,56.0,4.0,7.0,12.0,2.0,5.0,36.0,19.0,3.0,144.0
Hazaribagh,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Hazaribagh,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,20.0,0.0,0.0,0.0,0.0,0.0,135.0,118.0,0.0,273.0
Hazaribagh,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,0.0,,,0.0,0.0,,,0.0,0.0
Hazaribagh,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hazaribagh,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,20.0,0.0,0.0,0.0,0.0,0.0,135.0,118.0,0.0,273.0
Hazaribagh,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Hazaribagh,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,29.0,0.0,11.0,6.0,0.0,26.0,80.0,57.0,8.0,217.0
Hazaribagh,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,28.0,5.0,1.0,417.0,95.0,248.0,169.0,129.0,749.0,1505.0,1340.0,147.0,4833.0
Hazaribagh,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,134.0,37.0,32.0,15.0,49.0,2765.0,1404.0,823.0,138.0,5397.0
Hazaribagh,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hazaribagh,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,28.0,5.0,1.0,580.0,132.0,291.0,190.0,178.0,3540.0,2989.0,2220.0,293.0,10447.0
Hazaribagh,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Hazaribagh,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,6.0,6.0,4.0,20.0
Hazaribagh,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,,0.0,2.0,,,,0.0,0.0,0.0,0.0,0.0,2.0
Hazaribagh,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hazaribagh,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,4.0,6.0,6.0,4.0,22.0
Hazaribagh,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Hazaribagh,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,99.0,107.0,109.0,638.0,138.0,108.0,76.0,82.0,91.0,206.0,325.0,154.0,2133.0
Hazaribagh,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,17.0,12.0,30.0,133.0,23.0,24.0,23.0,20.0,21.0,50.0,77.0,35.0,465.0
Hazaribagh,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,66.0,32.0,10.0,360.0,103.0,47.0,22.0,27.0,45.0,238.0,290.0,49.0,1289.0
Hazaribagh,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,23.0,,20.0,89.0,27.0,20.0,16.0,7.0,21.0,22.0,79.0,0.0,324.0
Hazaribagh,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hazaribagh,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,205.0,151.0,169.0,1220.0,291.0,199.0,137.0,136.0,178.0,516.0,771.0,238.0,4211.0
Hazaribagh,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Hazaribagh,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Hazaribagh,9.06,Number of IUCD removals,TOTAL,61.0,53.0,47.0,95.0,171.0,62.0,67.0,58.0,67.0,65.0,63.0,68.0,877.0
Hazaribagh,9.07,Number of Oral Pills cycles distributed,TOTAL,2109.0,2091.0,2366.0,9273.0,3448.0,2906.0,2846.0,3390.0,3010.0,5284.0,5934.0,3762.0,46419.0
Hazaribagh,9.08,Number of Condom pieces distributed,TOTAL,17853.0,19191.0,19613.0,78956.0,22761.0,21662.0,22903.0,28533.0,24559.0,59763.0,69627.0,48733.0,434154.0
Hazaribagh,9.09,Number of Centchroman (weekly) pills given,TOTAL,6.0,552.0,23.0,0.0,75.0,96.0,46.0,20.0,36.0,27.0,165.0,67.0,1113.0
Hazaribagh,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,68.0,97.0,86.0,86.0,323.0,393.0,378.0,246.0,385.0,719.0,491.0,550.0,3822.0
Hazaribagh,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Hazaribagh,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,8.0,0.0,0.0,12.0,0.0,16.0,0.0,0.0,12.0,7.0,7.0,0.0,62.0
Hazaribagh,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,10.0,2.0,0.0,15.0
Hazaribagh,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Hazaribagh,9.12,Number of Institutions having NSV trained doctors,TOTAL,10.0,7.0,8.0,5.0,8.0,9.0,11.0,10.0,11.0,9.0,8.0,8.0,-1.0
Hazaribagh,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2304.0,2661.0,3103.0,3237.0,3430.0,3197.0,2904.0,3841.0,3086.0,2929.0,2162.0,2895.0,35749.0
Hazaribagh,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2189.0,3056.0,3515.0,3115.0,3569.0,3472.0,3264.0,3936.0,3290.0,3048.0,3189.0,3032.0,38675.0
Hazaribagh,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2321.0,2803.0,3192.0,3034.0,3478.0,3201.0,2904.0,3870.0,3422.0,2869.0,3127.0,3076.0,37297.0
Hazaribagh,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2577.0,2830.0,3152.0,2847.0,3449.0,3051.0,2718.0,3408.0,3216.0,2959.0,3092.0,3041.0,36340.0
Hazaribagh,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Hazaribagh,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Hazaribagh,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Hazaribagh,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1653.0,1919.0,2111.0,2189.0,2293.0,2038.0,1555.0,2667.0,1969.0,1448.0,1411.0,860.0,22113.0
Hazaribagh,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2190.0,3088.0,3544.0,3096.0,3580.0,3183.0,2712.0,3867.0,2983.0,2113.0,2655.0,1451.0,34462.0
Hazaribagh,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2335.0,2825.0,3208.0,3018.0,3482.0,2942.0,2418.0,3782.0,3083.0,2127.0,2578.0,1439.0,33237.0
Hazaribagh,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2613.0,2843.0,3168.0,2794.0,3445.0,2801.0,2221.0,3321.0,2974.0,2185.0,2490.0,1386.0,32241.0
Hazaribagh,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,0.0,0.0,10.0,0.0,0.0,27.0,31.0,68.0
Hazaribagh,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,574.0,1540.0,2251.0,2641.0,2694.0,9700.0
Hazaribagh,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,399.0,1121.0,2069.0,2364.0,5962.0
Hazaribagh,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,22.0,0.0,0.0,0.0,0.0,0.0,46.0,474.0,1094.0,1928.0,3564.0
Hazaribagh,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2979.0,3010.0,3740.0,3202.0,3822.0,3117.0,2718.0,2909.0,1863.0,2486.0,3103.0,2816.0,35765.0
Hazaribagh,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Hazaribagh,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1525.0,1573.0,1986.0,1682.0,2001.0,1544.0,1334.0,1529.0,960.0,1351.0,1641.0,1475.0,18601.0
Hazaribagh,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1438.0,1438.0,1710.0,1455.0,1743.0,1494.0,1333.0,1262.0,862.0,1108.0,1453.0,1312.0,16608.0
Hazaribagh,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2963.0,3011.0,3696.0,3137.0,3744.0,3038.0,2667.0,2791.0,1822.0,2459.0,3094.0,2787.0,35209.0
Hazaribagh,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2038.0,2121.0,2586.0,2231.0,2504.0,2141.0,2030.0,2353.0,2099.0,2229.0,2674.0,2514.0,27520.0
Hazaribagh,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1903.0,2155.0,2590.0,2220.0,2479.0,1877.0,1689.0,2307.0,1975.0,1636.0,2232.0,1311.0,24374.0
Hazaribagh,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,194.0,209.0,306.0,191.0,253.0,426.0,423.0,273.0,263.0,570.0,614.0,242.0,3964.0
Hazaribagh,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,162.0,211.0,274.0,169.0,236.0,385.0,383.0,218.0,213.0,497.0,542.0,215.0,3505.0
Hazaribagh,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,356.0,420.0,580.0,360.0,489.0,811.0,806.0,491.0,476.0,1067.0,1156.0,457.0,7469.0
Hazaribagh,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,183.0,267.0,410.0,249.0,1051.0,629.0,572.0,603.0,478.0,535.0,699.0,632.0,6308.0
Hazaribagh,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,968.0,1214.0,1316.0,1236.0,1153.0,1337.0,1164.0,1612.0,1003.0,1079.0,1035.0,1088.0,14205.0
Hazaribagh,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1104.0,1249.0,1318.0,1438.0,1520.0,1549.0,1589.0,1655.0,1182.0,1125.0,1163.0,1200.0,16092.0
Hazaribagh,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,111.0,154.0,111.0,170.0,120.0,142.0,112.0,100.0,87.0,78.0,68.0,71.0,1324.0
Hazaribagh,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,17.0,39.0,23.0,29.0,44.0,11.0,17.0,17.0,20.0,19.0,19.0,36.0,291.0
Hazaribagh,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1483.0,1557.0,1519.0,1530.0,1571.0,1499.0,1508.0,1583.0,1553.0,1513.0,1514.0,1537.0,18367.0
Hazaribagh,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1257.0,1434.0,1488.0,1423.0,1500.0,1447.0,1387.0,1562.0,1494.0,1364.0,1447.0,1464.0,17267.0
Hazaribagh,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,963.0,1084.0,1208.0,1075.0,1125.0,1091.0,1094.0,1188.0,1218.0,1207.0,1301.0,1312.0,13866.0
Hazaribagh,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2280.0,2399.0,2488.0,1210.0,5191.0,3404.0,2425.0,2570.0,1573.0,2069.0,6052.0,2520.0,34181.0
Hazaribagh,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,105.0,114.0,93.0,223.0,16094.0,3685.0,113.0,105.0,113.0,113.0,14645.0,1439.0,36842.0
Hazaribagh,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,50.0,57.0,25.0,250.0,16080.0,3905.0,56.0,66.0,67.0,45.0,17770.0,1767.0,40138.0
Hazaribagh,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,3.0
Hazaribagh,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Hazaribagh,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,17.0,26.0,43.0,44.0,96.0,22.0,37.0,6.0,31.0,13.0,12.0,13.0,360.0
Hazaribagh,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,79.0,71.0,82.0,105.0,105.0,95.0,59.0,64.0,64.0,71.0,58.0,79.0,932.0
Hazaribagh,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,66.0,50.0,103.0,68.0,81.0,73.0,78.0,69.0,66.0,54.0,63.0,40.0,811.0
Hazaribagh,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,13.1,Number of Patients operated for cataract,TOTAL,71.0,143.0,114.0,142.0,146.0,309.0,309.0,0.0,0.0,755.0,1774.0,980.0,4743.0
Hazaribagh,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,71.0,143.0,114.0,142.0,146.0,309.0,309.0,0.0,0.0,755.0,1774.0,980.0,4743.0
Hazaribagh,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,10.0,0.0,12.0
Hazaribagh,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,2.0,3.0,2.0,2.0,2.0,3.0,3.0,6.0,4.0,3.0,3.0,-1.0
Hazaribagh,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,6.0,4.0,3.0,4.0,5.0,2.0,3.0,5.0,3.0,3.0,3.0,-1.0
Hazaribagh,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,848.0,804.0,968.0,941.0,1022.0,1021.0,961.0,1105.0,1098.0,998.0,1083.0,1017.0,-1.0
Hazaribagh,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,6.0,7.0,7.0,7.0,10.0,9.0,10.0,10.0,9.0,8.0,8.0,-1.0
Hazaribagh,14.05,Number of RKS meetings held during the month,TOTAL,3.0,5.0,4.0,3.0,3.0,3.0,5.0,8.0,4.0,5.0,6.0,9.0,58.0
Hazaribagh,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,9.0,7.0,6.0,4.0,5.0,5.0,5.0,5.0,9.0,4.0,4.0,4.0,-1.0
Hazaribagh,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,43.0,31.0,23.0,35.0,26.0,33.0,27.0,26.0,18.0,23.0,27.0,28.0,340.0
Hazaribagh,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,1.0,4.0,3.0,5.0,4.0,4.0,6.0,6.0,5.0,4.0,4.0,-1.0
Hazaribagh,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,-1.0
Hazaribagh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,114.0,713.0,621.0,514.0,868.0,1062.0,847.0,815.0,197.0,797.0,812.0,764.0,8124.0
Hazaribagh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1084.0,7033.0,6639.0,4902.0,7114.0,7519.0,8467.0,8359.0,3733.0,8423.0,8943.0,9087.0,81303.0
Hazaribagh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,100.0,638.0,473.0,458.0,731.0,923.0,705.0,779.0,94.0,654.0,646.0,788.0,6989.0
Hazaribagh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,647.0,4597.0,4301.0,4949.0,4638.0,5155.0,5663.0,5444.0,6846.0,6118.0,6829.0,5491.0,60678.0
Hazaribagh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,214.0,1351.0,1094.0,972.0,1599.0,1985.0,1552.0,1594.0,291.0,1451.0,1458.0,1552.0,15113.0
Hazaribagh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1731.0,11630.0,10940.0,9851.0,11752.0,12674.0,14130.0,13803.0,10579.0,14541.0,15772.0,14578.0,141981.0
Hazaribagh,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,4.0
Hazaribagh,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Hazaribagh,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,6.0
Hazaribagh,14.11,In-Patient Head Count at midnight,TOTAL,1196.0,1314.0,1383.0,9359.0,1277.0,1565.0,1362.0,1347.0,1585.0,474.0,419.0,268.0,21549.0
Hazaribagh,14.12.1,OPD attendance (All),TOTAL,28280.0,30200.0,30806.0,37364.0,36485.0,40949.0,38703.0,35982.0,41193.0,21264.0,22569.0,37935.0,401730.0
Hazaribagh,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,14.0,30.0,81.0,459.0,0.0,14.0,0.0,0.0,0.0,0.0,0.0,0.0,598.0
Hazaribagh,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Hazaribagh,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,6.0,109.0,256.0,869.0,0.0,34.0,0.0,0.0,0.0,0.0,0.0,0.0,1274.0
Hazaribagh,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,5.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0
Hazaribagh,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,14.14.c,Number of Adolescents counselled,TOTAL,0.0,12.0,0.0,32.0,20.0,31.0,16.0,46.0,38.0,9.0,15.0,63.0,282.0
Hazaribagh,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1982.0,1664.0,1835.0,3404.0,1733.0,1682.0,3056.0,1834.0,2280.0,2908.0,2490.0,2623.0,27491.0
Hazaribagh,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,31.0,31.0,53.0,51.0,45.0,55.0,71.0,36.0,39.0,54.0,54.0,66.0,586.0
Hazaribagh,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,345.0,257.0,222.0,401.0,282.0,503.0,307.0,254.0,217.0,145.0,246.0,645.0,3824.0
Hazaribagh,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,17.0,27.0,10.0,27.0,5.0,22.0,3.0,9.0,7.0,54.0,15.0,19.0,215.0
Hazaribagh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,360.0,311.0,171.0,411.0,420.0,388.0,658.0,340.0,541.0,998.0,885.0,753.0,6236.0
Hazaribagh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,27.0,20.0,9.0,33.0,7.0,18.0,5.0,6.0,5.0,77.0,72.0,28.0,307.0
Hazaribagh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,298.0,235.0,245.0,364.0,209.0,261.0,285.0,263.0,355.0,142.0,417.0,708.0,3782.0
Hazaribagh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,26.0,0.0,2.0,1.0,2.0,1.0,1.0,0.0,51.0,0.0,0.0,86.0
Hazaribagh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1003.0,803.0,638.0,1176.0,911.0,1152.0,1250.0,857.0,1113.0,1285.0,1548.0,2106.0,13842.0
Hazaribagh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,46.0,73.0,19.0,62.0,13.0,42.0,9.0,16.0,12.0,182.0,87.0,47.0,608.0
Hazaribagh,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,15.4.1,Number of blood smears examined for Malaria,TOTAL,8559.0,3548.0,7270.0,8949.0,4705.0,5472.0,4462.0,7617.0,3820.0,4840.0,5243.0,4906.0,69391.0
Hazaribagh,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,416.0,140.0,296.0,815.0,392.0,415.0,526.0,588.0,344.0,162.0,286.0,380.0,4760.0
Hazaribagh,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,29.0,8.0,9.0,68.0,47.0,45.0,48.0,192.0,85.0,14.0,18.0,18.0,581.0
Hazaribagh,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2420.0,6770.0,11200.0,17240.0,19300.0,21940.0,35970.0,37730.0,19400.0,21040.0,21430.0,7030.0,221470.0
Hazaribagh,16.1.1,Stock position of DPT vaccines,2. Stocks Received,20000.0,25000.0,25000.0,25000.0,20000.0,40000.0,20000.0,0.0,10000.0,20000.0,5000.0,30000.0,240000.0
Hazaribagh,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,15650.0,20570.0,18960.0,22940.0,17360.0,25970.0,18240.0,18330.0,8360.0,19610.0,19400.0,20540.0,225930.0
Hazaribagh,16.1.1,Stock position of DPT vaccines,5. Total Stock,6770.0,11200.0,17240.0,19300.0,21940.0,35970.0,37730.0,19400.0,21040.0,21430.0,7030.0,16490.0,235540.0
Hazaribagh,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Hazaribagh,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Hazaribagh,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Hazaribagh,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,22640.0,35240.0,43880.0,43920.0,25860.0,14000.0,12640.0,18160.0,19360.0,11340.0,15920.0,80.0,263040.0
Hazaribagh,16.1.2,Stock position of OPV vaccines,2. Stocks Received,40000.0,40000.0,30000.0,12000.0,20000.0,20000.0,30000.0,20000.0,10000.0,20000.0,0.0,0.0,242000.0
Hazaribagh,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,27400.0,31360.0,29960.0,30060.0,31860.0,21360.0,24480.0,18800.0,18020.0,15420.0,15840.0,80.0,264640.0
Hazaribagh,16.1.2,Stock position of OPV vaccines,5. Total Stock,35240.0,43880.0,43920.0,25860.0,14000.0,12640.0,18160.0,19360.0,11340.0,15920.0,80.0,0.0,240400.0
Hazaribagh,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,15050.0,13110.0,14370.0,10570.0,17730.0,22810.0,21290.0,17060.0,6310.0,32910.0,26120.0,24530.0,221860.0
Hazaribagh,16.1.3,Stock position of TT vaccines,2. Stocks Received,15000.0,15000.0,10000.0,25000.0,20000.0,20000.0,10000.0,0.0,40000.0,10000.0,20000.0,10000.0,195000.0
Hazaribagh,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.1.3,Stock position of TT vaccines,4. Stock Distributed,16940.0,13740.0,13800.0,17840.0,14920.0,21520.0,14230.0,10750.0,13400.0,16790.0,21590.0,19170.0,194690.0
Hazaribagh,16.1.3,Stock position of TT vaccines,5. Total Stock,13110.0,14370.0,10570.0,17730.0,22810.0,21290.0,17060.0,6310.0,32910.0,26120.0,24530.0,15360.0,222170.0
Hazaribagh,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0
Hazaribagh,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0
Hazaribagh,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0
Hazaribagh,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3510.0,10690.0,0.0,17130.0,2610.0,11870.0,22750.0,19510.0,17560.0,16240.0,5320.0,7870.0,135060.0
Hazaribagh,16.1.5,Stock position of BCG vaccines,2. Stocks Received,20000.0,0.0,30000.0,0.0,18000.0,30000.0,10000.0,10000.0,10000.0,0.0,5000.0,11000.0,144000.0
Hazaribagh,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,12820.0,10690.0,12870.0,14520.0,8740.0,19120.0,13240.0,11950.0,11320.0,10920.0,2450.0,16280.0,144920.0
Hazaribagh,16.1.5,Stock position of BCG vaccines,5. Total Stock,10690.0,0.0,17130.0,2610.0,11870.0,22750.0,19510.0,17560.0,16240.0,5320.0,7870.0,2590.0,134140.0
Hazaribagh,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1975.0,1225.0,3000.0,1295.0,6010.0,3695.0,3815.0,7400.0,68180.0,34505.0,33315.0,33065.0,197480.0
Hazaribagh,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,10000.0,4500.0,12000.0,5000.0,10000.0,10000.0,350000.0,58260.0,0.0,0.0,0.0,464760.0
Hazaribagh,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5750.0,8225.0,6205.0,7285.0,7315.0,9880.0,6415.0,289220.0,91935.0,1190.0,19400.0,2325.0,455145.0
Hazaribagh,16.1.6,Stock position of Measles vaccines,5. Total Stock,1225.0,3000.0,1295.0,6010.0,3695.0,3815.0,7400.0,68180.0,34505.0,33315.0,13915.0,30740.0,207095.0
Hazaribagh,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Hazaribagh,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Hazaribagh,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Hazaribagh,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,0.0,12350.0,12060.0,120.0,17800.0,42330.0
Hazaribagh,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,26900.0,0.0,0.0,19600.0,0.0,46500.0
Hazaribagh,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,14550.0,290.0,11940.0,1920.0,14480.0,43180.0
Hazaribagh,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12350.0,12060.0,120.0,17800.0,3320.0,45650.0
Hazaribagh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,,,,0.0,,,,,0.0
Hazaribagh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,,,,0.0,,,,,0.0
Hazaribagh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,,,,,0.0,,,,,0.0
Hazaribagh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Hazaribagh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,,,,,,,,,,,0.0
Hazaribagh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Hazaribagh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Hazaribagh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,,,,,,,,,,,0.0
Hazaribagh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Hazaribagh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,,,,,,0.0,,,,,0.0
Hazaribagh,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,,,,,,,0.0,,,,,0.0
Hazaribagh,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Hazaribagh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Hazaribagh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Hazaribagh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Hazaribagh,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hazaribagh,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2002.0,3018.0,1508.0,4188.0,3824.0,2804.0,9538.0,8866.0,9001.0,8755.0,5629.0,6069.0,65202.0
Hazaribagh,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,4000.0,0.0,6000.0,0.0,3000.0,11000.0,3000.0,3000.0,3000.0,0.0,1500.0,3300.0,37800.0
Hazaribagh,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2984.0,1510.0,3320.0,364.0,4020.0,4266.0,3672.0,2865.0,3246.0,3126.0,1060.0,4929.0,35362.0
Hazaribagh,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3018.0,1508.0,4188.0,3824.0,2804.0,9538.0,8866.0,9001.0,8755.0,5629.0,6069.0,4440.0,67640.0
Hazaribagh,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,150.0,8150.0,18150.0,6950.0,53750.0,18550.0,33950.0,20500.0,38280.0,39080.0,20000.0,23480.0,280990.0
Hazaribagh,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,32000.0,40000.0,28000.0,50000.0,30000.0,52000.0,20000.0,330800.0,99200.0,0.0,18000.0,20000.0,720000.0
Hazaribagh,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,24000.0,30000.0,39200.0,3200.0,65200.0,36600.0,33450.0,313020.0,98400.0,17600.0,23480.0,24640.0,708790.0
Hazaribagh,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,8150.0,18150.0,6950.0,53750.0,18550.0,33950.0,20500.0,38280.0,39080.0,21480.0,14520.0,18840.0,292200.0
Hazaribagh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2450.0,4250.0,2270.0,0.0,0.0,0.0,0.0,0.0,0.0,9200.0,2040.0,2040.0,22250.0
Hazaribagh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,3000.0,3000.0,0.0,0.0,0.0,0.0,0.0,38000.0,22000.0,0.0,0.0,0.0,66000.0
Hazaribagh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Hazaribagh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1200.0,4980.0,2270.0,0.0,0.0,0.0,0.0,38000.0,12800.0,7160.0,0.0,2000.0,68410.0
Hazaribagh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4250.0,2270.0,0.0,0.0,0.0,0.0,0.0,0.0,9200.0,2040.0,2040.0,40.0,19840.0
Hazaribagh,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,,1.0,1.0,1.0,,,4.0,3.0,,1.0,1.0,15.0
Hazaribagh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Hazaribagh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Hazaribagh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,1.0,,,,,,,,,1.0
Hazaribagh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Hazaribagh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Hazaribagh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,1.0,,,,1.0
Hazaribagh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,1.0,,,,,,,,,1.0,2.0
Hazaribagh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,1.0,2.0,,,4.0
Hazaribagh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,1.0,,,,1.0,,1.0,2.0,,1.0,6.0
Hazaribagh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,1.0,,,,,,,1.0,,,2.0
Hazaribagh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,2.0,,1.0,,,3.0
Hazaribagh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,1.0,,,,,2.0,,2.0,,,5.0
Hazaribagh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,1.0,1.0,2.0,,4.0
Hazaribagh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
Hazaribagh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,,,,1.0,1.0,2.0,,5.0
Hazaribagh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hazaribagh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hazaribagh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Hazaribagh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,2.0,,,,,,,,,3.0
Hazaribagh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Hazaribagh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,2.0,,,,,1.0,,,,4.0
Hazaribagh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hazaribagh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hazaribagh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Hazaribagh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,,,,2.0,3.0,1.0,3.0,,3.0,1.0,14.0
Hazaribagh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,1.0,2.0,1.0,,1.0,,3.0,2.0,,11.0
Hazaribagh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,1.0,1.0,2.0,3.0,3.0,2.0,3.0,3.0,5.0,1.0,25.0
Hazaribagh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Hazaribagh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Hazaribagh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Hazaribagh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,1.0,1.0,,,,,2.0
Hazaribagh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,2.0,,,,,,2.0,4.0,4.0,1.0,13.0
Hazaribagh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,1.0,1.0,,2.0
Hazaribagh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,2.0,,,,,,2.0,5.0,5.0,1.0,15.0
Hazaribagh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,,,,1.0,,,,,,2.0
Hazaribagh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Hazaribagh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,1.0,,,,1.0,,,,,,2.0
Hazaribagh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,2.0,,,,,2.0
Hazaribagh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Hazaribagh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Hazaribagh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,2.0,,,,1.0,3.0
Hazaribagh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,,2.0,,1.0,,,,1.0,,,5.0
Hazaribagh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,2.0,,1.0,1.0,,,3.0,3.0,1.0,1.0,12.0
Hazaribagh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,2.0,2.0,1.0,2.0,,,3.0,4.0,1.0,1.0,17.0
Hazaribagh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,1.0,3.0,,,3.0,1.0,,8.0
Hazaribagh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Hazaribagh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,1.0,4.0,,,3.0,1.0,,9.0
Hazaribagh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,1.0,1.0,1.0,1.0,1.0,,3.0,2.0,1.0,1.0,,13.0
Hazaribagh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,,,,3.0,1.0,1.0,3.0,4.0,1.0,,14.0
Hazaribagh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,2.0,1.0,1.0,1.0,4.0,1.0,4.0,5.0,5.0,2.0,,27.0
Hazaribagh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,1.0,,,,,,,,,,,2.0
Hazaribagh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,1.0,1.0,1.0,,3.0
Hazaribagh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,1.0,,,1.0,2.0
Hazaribagh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,1.0,,,,,,,2.0,1.0,1.0,1.0,7.0
Hazaribagh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,2.0,,,1.0,,,1.0,,,,4.0
Hazaribagh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Hazaribagh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,2.0,,,1.0,,,1.0,,,,4.0
Hazaribagh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,1.0,,,1.0,,1.0,1.0,4.0
Hazaribagh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Hazaribagh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,1.0,,,1.0,,1.0,1.0,4.0
Hazaribagh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Hazaribagh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,1.0,,,,1.0,,2.0
Hazaribagh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,1.0,,,,2.0,,3.0
Hazaribagh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Hazaribagh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Hazaribagh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,,,,,,,,,1.0
Hazaribagh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,1.0,1.0,,,,1.0,1.0,,4.0
Hazaribagh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,1.0,,,,,1.0
Hazaribagh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,1.0,1.0,,1.0,,1.0,1.0,,5.0
Hazaribagh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,3.0,,2.0,,2.0,1.0,,3.0,1.0,3.0,,16.0
Hazaribagh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,1.0,1.0,,3.0,2.0,1.0,,,8.0
Hazaribagh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,3.0,,2.0,1.0,3.0,1.0,3.0,5.0,2.0,3.0,,24.0
Hazaribagh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,2.0,1.0,1.0,,,1.0,,1.0,,,7.0
Hazaribagh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,2.0,5.0,3.0,3.0,6.0,6.0,7.0,4.0,7.0,8.0,3.0,58.0
Hazaribagh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,2.0,,,,,1.0,1.0,1.0,2.0,1.0,8.0
Hazaribagh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,3.0,9.0,4.0,4.0,6.0,6.0,9.0,5.0,9.0,10.0,4.0,73.0
Hazaribagh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,1.0,,2.0,,2.0,,2.0,3.0,,3.0,,17.0
Hazaribagh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,1.0,1.0,,,,1.0,,,,,4.0
Hazaribagh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,5.0,1.0,1.0,3.0,,2.0,,3.0,3.0,,3.0,,21.0
Hazaribagh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Hazaribagh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,,2.0,,1.0,1.0,,,,,6.0
Hazaribagh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,,,,,,1.0,,2.0
Hazaribagh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,1.0,1.0,3.0,,1.0,1.0,,,1.0,,9.0
Hazaribagh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,1.0,1.0,,,1.0,,1.0,,4.0
Hazaribagh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,5.0,3.0,1.0,1.0,2.0,4.0,4.0,3.0,,3.0,26.0
Hazaribagh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,1.0,1.0,1.0,4.0,,1.0,2.0,6.0,3.0,1.0,3.0,24.0
Hazaribagh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,1.0,6.0,4.0,6.0,2.0,3.0,6.0,11.0,6.0,2.0,6.0,54.0
Hazaribagh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Hazaribagh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,5.0,2.0,3.0,,3.0,,1.0,1.0,6.0,3.0,1.0,3.0,28.0
Hazaribagh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,2.0,3.0,3.0,5.0,1.0,1.0,8.0,10.0,7.0,,2.0,42.0
Hazaribagh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,4.0,6.0,3.0,8.0,1.0,2.0,9.0,16.0,10.0,1.0,5.0,70.0
Hazaribagh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,1.0,,1.0,1.0,1.0,,1.0,,,1.0,,7.0
Hazaribagh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,5.0,3.0,1.0,5.0,4.0,1.0,3.0,5.0,3.0,5.0,4.0,7.0,46.0
Hazaribagh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,9.0,11.0,21.0,4.0,18.0,5.0,7.0,14.0,19.0,23.0,13.0,5.0,149.0
Hazaribagh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,15.0,15.0,22.0,10.0,23.0,7.0,10.0,20.0,22.0,28.0,18.0,12.0,202.0
Jamtara,1.1,Total number of pregnant women Registered for ANC,TOTAL,1577.0,1505.0,1500.0,1418.0,1237.0,1281.0,1204.0,1349.0,1405.0,1325.0,1289.0,1362.0,16452.0
Jamtara,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,243.0,280.0,269.0,241.0,271.0,218.0,211.0,236.0,264.0,248.0,277.0,300.0,3058.0
Jamtara,1.2,Number of Pregnant women registered under JSY,TOTAL,1028.0,994.0,1013.0,968.0,933.0,982.0,807.0,984.0,1111.0,982.0,1091.0,1048.0,11941.0
Jamtara,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1073.0,1006.0,1056.0,1029.0,1017.0,975.0,920.0,917.0,999.0,990.0,889.0,937.0,11808.0
Jamtara,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1475.0,1438.0,1421.0,1326.0,1034.0,1160.0,1099.0,1246.0,1287.0,1226.0,1108.0,1248.0,15068.0
Jamtara,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1388.0,1352.0,1675.0,1329.0,1188.0,1154.0,1022.0,1140.0,1120.0,1169.0,902.0,1144.0,14583.0
Jamtara,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,876.0,810.0,775.0,434.0,585.0,381.0,528.0,565.0,852.0,1023.0,1106.0,1073.0,9008.0
Jamtara,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,51.0,45.0,60.0,74.0,74.0,26.0,31.0,27.0,48.0,42.0,24.0,20.0,522.0
Jamtara,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,9.0,11.0,0.0,5.0,1.0,4.0,2.0,1.0,0.0,2.0,1.0,1.0,37.0
Jamtara,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,126.0,204.0,201.0,180.0,106.0,117.0,139.0,101.0,133.0,117.0,89.0,68.0,1581.0
Jamtara,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Jamtara,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,91.0,99.0,57.0,102.0,90.0,103.0,107.0,113.0,66.0,47.0,68.0,50.0,993.0
Jamtara,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,515.0,501.0,592.0,670.0,606.0,616.0,562.0,645.0,624.0,586.0,545.0,496.0,6958.0
Jamtara,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,606.0,600.0,649.0,772.0,696.0,719.0,669.0,758.0,690.0,633.0,613.0,546.0,7951.0
Jamtara,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,526.0,474.0,540.0,613.0,556.0,543.0,537.0,596.0,551.0,490.0,403.0,411.0,6240.0
Jamtara,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,49.0,13.0,36.0,26.0,33.0,6.0,24.0,38.0,17.0,24.0,8.0,20.0,294.0
Jamtara,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,574.0,526.0,667.0,696.0,623.0,720.0,689.0,727.0,651.0,711.0,585.0,611.0,7780.0
Jamtara,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,485.0,517.0,581.0,639.0,572.0,701.0,615.0,662.0,612.0,701.0,504.0,605.0,7194.0
Jamtara,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,455.0,427.0,382.0,532.0,314.0,549.0,856.0,780.0,507.0,410.0,386.0,542.0,6140.0
Jamtara,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,376.0,344.0,304.0,373.0,201.0,396.0,592.0,578.0,387.0,360.0,320.0,448.0,4679.0
Jamtara,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,3.0,0.0,0.0,0.0,10.0,1.0,0.0,0.0,0.0,6.0,0.0,20.0
Jamtara,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,75.0,59.0,78.0,47.0,56.0,0.0,9.0,0.0,51.0,36.0,31.0,28.0,470.0
Jamtara,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Jamtara,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamtara,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,0.0,,0.0,0.0,,,,0.0
Jamtara,4.1.1.a,Number of male live births,TOTAL,666.0,626.0,720.0,795.0,679.0,779.0,724.0,763.0,645.0,693.0,639.0,616.0,8345.0
Jamtara,4.1.1.b,Number of female live births,TOTAL,610.0,543.0,680.0,733.0,673.0,687.0,661.0,753.0,729.0,702.0,611.0,580.0,7962.0
Jamtara,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1276.0,1169.0,1400.0,1528.0,1352.0,1466.0,1385.0,1516.0,1374.0,1395.0,1250.0,1196.0,16307.0
Jamtara,4.1.2,Number of still births,TOTAL,32.0,20.0,22.0,27.0,32.0,30.0,76.0,55.0,42.0,52.0,19.0,19.0,426.0
Jamtara,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,23.0,11.0,16.0,20.0,18.0,10.0,15.0,16.0,14.0,13.0,8.0,18.0,182.0
Jamtara,4.2.1,Number of Newborns weighed at birth,TOTAL,1122.0,1013.0,1208.0,1384.0,1203.0,1362.0,1316.0,1410.0,1212.0,1263.0,1109.0,1086.0,14688.0
Jamtara,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,68.0,165.0,97.0,81.0,60.0,83.0,94.0,85.0,82.0,63.0,76.0,86.0,1040.0
Jamtara,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1140.0,1018.0,1211.0,1425.0,1247.0,1399.0,1325.0,1442.0,1270.0,1320.0,1178.0,1001.0,14976.0
Jamtara,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,1.0,1.0,1.0,1.0,2.0,1.0,3.0,2.0,0.0,22.0,34.0
Jamtara,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Jamtara,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamtara,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,1.0,1.0,1.0,1.0,2.0,1.0,3.0,2.0,0.0,22.0,34.0
Jamtara,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,70.0,0.0,0.0,0.0,0.0,0.0,3.0,1.0,0.0,0.0,74.0
Jamtara,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,70.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,72.0
Jamtara,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,943.0,845.0,1012.0,1235.0,1089.0,1227.0,1082.0,1292.0,1116.0,1182.0,868.0,909.0,12800.0
Jamtara,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,489.0,464.0,420.0,540.0,556.0,598.0,658.0,530.0,416.0,477.0,467.0,427.0,6042.0
Jamtara,6.3,PNC maternal complications attended,TOTAL,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,6.0
Jamtara,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Jamtara,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Jamtara,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,10.0,10.0,10.0,40.0
Jamtara,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,5.0,6.0,3.0,2.0,0.0,2.0,1.0,2.0,0.0,0.0,0.0,0.0,21.0
Jamtara,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,17.0,8.0,6.0,11.0,0.0,7.0,4.0,3.0,2.0,2.0,2.0,2.0,64.0
Jamtara,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,22.0,14.0,9.0,13.0,0.0,9.0,5.0,5.0,2.0,2.0,2.0,2.0,85.0
Jamtara,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,5.0
Jamtara,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,56.0,0.0,0.0,0.0,2.0,0.0,4.0,2.0,7.0,71.0
Jamtara,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,24.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0
Jamtara,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamtara,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,80.0,0.0,0.0,0.0,2.0,0.0,4.0,2.0,7.0,95.0
Jamtara,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamtara,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,8.0,0.0,16.0
Jamtara,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,98.0,0.0,0.0,0.0,20.0,351.0,627.0,1113.0,185.0,2394.0
Jamtara,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,5.0,0.0,0.0,8.0,0.0,0.0,0.0,16.0,74.0,0.0,0.0,0.0,103.0
Jamtara,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamtara,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,5.0,0.0,0.0,106.0,0.0,0.0,0.0,36.0,425.0,635.0,1121.0,185.0,2513.0
Jamtara,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,18.0,7.0,17.0,11.0,2.0,0.0,21.0,25.0,59.0,60.0,70.0,46.0,336.0
Jamtara,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamtara,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,38.0,54.0,44.0,137.0,63.0,93.0,39.0,35.0,44.0,87.0,117.0,53.0,804.0
Jamtara,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,15.0,12.0,10.0,16.0,2.0,17.0,16.0,10.0,25.0,24.0,16.0,14.0,177.0
Jamtara,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,5.0,5.0,10.0,81.0,7.0,10.0,8.0,31.0,22.0,38.0,34.0,25.0,276.0
Jamtara,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,71.0,24.0,27.0,19.0,24.0,13.0,0.0,42.0,40.0,260.0
Jamtara,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jamtara,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,58.0,71.0,64.0,305.0,96.0,147.0,82.0,100.0,104.0,149.0,209.0,132.0,1517.0
Jamtara,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Jamtara,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.06,Number of IUCD removals,TOTAL,46.0,226.0,39.0,92.0,38.0,79.0,62.0,75.0,57.0,104.0,56.0,46.0,920.0
Jamtara,9.07,Number of Oral Pills cycles distributed,TOTAL,618.0,450.0,296.0,1729.0,1289.0,1657.0,1542.0,1669.0,1698.0,1879.0,1898.0,1387.0,16112.0
Jamtara,9.08,Number of Condom pieces distributed,TOTAL,9046.0,9345.0,8665.0,20056.0,12154.0,12191.0,11622.0,9167.0,25045.0,17567.0,9326.0,9182.0,153366.0
Jamtara,9.09,Number of Centchroman (weekly) pills given,TOTAL,30.0,150.0,18.0,197.0,58.0,59.0,126.0,100.0,17.0,138.0,151.0,5.0,1049.0
Jamtara,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,134.0,108.0,121.0,126.0,77.0,86.0,66.0,72.0,112.0,159.0,99.0,113.0,1273.0
Jamtara,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Jamtara,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,6.0,7.0,22.0
Jamtara,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Jamtara,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,12.0,13.0,6.0,14.0,9.0,14.0,12.0,12.0,12.0,13.0,13.0,-1.0
Jamtara,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1312.0,1302.0,1590.0,1677.0,919.0,1678.0,1605.0,1788.0,1546.0,1644.0,1196.0,1258.0,17515.0
Jamtara,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1277.0,1159.0,1389.0,1386.0,1204.0,1409.0,1383.0,1591.0,1626.0,1387.0,1168.0,1407.0,16386.0
Jamtara,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1319.0,1092.0,1338.0,1303.0,1074.0,1451.0,1165.0,1410.0,1548.0,1442.0,1097.0,1420.0,15659.0
Jamtara,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1366.0,1207.0,1362.0,1212.0,1004.0,1290.0,1123.0,1275.0,1420.0,1397.0,1170.0,1400.0,15226.0
Jamtara,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Jamtara,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Jamtara,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Jamtara,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,792.0,704.0,1103.0,951.0,300.0,180.0,188.0,919.0,659.0,656.0,612.0,518.0,7582.0
Jamtara,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1267.0,1148.0,1391.0,1155.0,220.0,60.0,50.0,1602.0,1265.0,831.0,1203.0,980.0,11172.0
Jamtara,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1321.0,1098.0,1339.0,1119.0,227.0,40.0,60.0,1210.0,1204.0,960.0,1081.0,996.0,10655.0
Jamtara,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1359.0,1205.0,1348.0,1006.0,219.0,70.0,40.0,1033.0,861.0,814.0,1042.0,897.0,9894.0
Jamtara,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,113.0,106.0,9.0,228.0
Jamtara,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,20.0,14.0,6.0,0.0,0.0,0.0,6.0,0.0,965.0,1578.0,1183.0,3772.0
Jamtara,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,663.0,815.0,1484.0
Jamtara,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,6.0,77.0,426.0,512.0
Jamtara,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1424.0,1197.0,1410.0,1445.0,1262.0,1401.0,1163.0,1165.0,1136.0,1081.0,1003.0,1274.0,14961.0
Jamtara,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,11.0,0.0,154.0,188.0,182.0,535.0
Jamtara,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Jamtara,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,719.0,638.0,728.0,726.0,627.0,718.0,591.0,619.0,599.0,569.0,483.0,616.0,7633.0
Jamtara,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,677.0,549.0,644.0,686.0,630.0,675.0,543.0,527.0,529.0,509.0,447.0,579.0,6995.0
Jamtara,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1396.0,1187.0,1372.0,1412.0,1257.0,1393.0,1134.0,1146.0,1128.0,1078.0,930.0,1195.0,14628.0
Jamtara,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,982.0,898.0,1088.0,980.0,707.0,888.0,1048.0,983.0,977.0,892.0,835.0,1024.0,11302.0
Jamtara,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,983.0,896.0,1088.0,901.0,170.0,20.0,19.0,948.0,951.0,756.0,813.0,806.0,8351.0
Jamtara,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,160.0,176.0,197.0,134.0,178.0,131.0,110.0,149.0,193.0,117.0,205.0,165.0,1915.0
Jamtara,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,153.0,138.0,158.0,91.0,193.0,133.0,90.0,130.0,144.0,109.0,184.0,132.0,1655.0
Jamtara,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,313.0,314.0,355.0,225.0,371.0,264.0,200.0,279.0,337.0,226.0,389.0,297.0,3570.0
Jamtara,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,127.0,68.0,120.0,200.0,173.0,198.0,138.0,176.0,166.0,97.0,132.0,169.0,1764.0
Jamtara,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,549.0,547.0,594.0,649.0,599.0,606.0,607.0,582.0,542.0,471.0,525.0,534.0,6805.0
Jamtara,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,711.0,653.0,787.0,859.0,608.0,675.0,699.0,706.0,665.0,546.0,500.0,595.0,8004.0
Jamtara,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,79.0,54.0,75.0,72.0,16.0,54.0,61.0,59.0,39.0,58.0,31.0,45.0,643.0
Jamtara,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,4.0,0.0,0.0,0.0,4.0,0.0,1.0,0.0,4.0,0.0,0.0,15.0
Jamtara,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,994.0,878.0,987.0,1049.0,990.0,1056.0,1020.0,1048.0,1045.0,1058.0,1066.0,1082.0,12273.0
Jamtara,10.4.2,Number of Immunisation sessions held during the month,TOTAL,918.0,831.0,935.0,996.0,964.0,1038.0,885.0,1000.0,1014.0,947.0,1042.0,1046.0,11616.0
Jamtara,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,780.0,728.0,811.0,831.0,841.0,887.0,771.0,864.0,882.0,824.0,910.0,914.0,10043.0
Jamtara,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,,4.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Jamtara,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1118.0,1022.0,1102.0,1130.0,1435.0,1271.0,1003.0,1025.0,959.0,883.0,1801.0,1115.0,13864.0
Jamtara,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,64.0,99.0,85.0,267.0,3623.0,127.0,111.0,124.0,210.0,221.0,4807.0,933.0,10671.0
Jamtara,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,23.0,60.0,63.0,297.0,4912.0,71.0,56.0,71.0,74.0,42.0,4785.0,829.0,11283.0
Jamtara,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,8.0,7.0,5.0,0.0,12.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0
Jamtara,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,2.0,0.0,2.0,0.0,7.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0
Jamtara,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,10.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Jamtara,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,24.0,47.0,25.0,18.0,29.0,10.0,5.0,6.0,8.0,13.0,9.0,18.0,212.0
Jamtara,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,58.0,63.0,34.0,50.0,66.0,53.0,53.0,99.0,42.0,28.0,46.0,64.0,656.0
Jamtara,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,126.0,40.0,3.0,4.0,8.0,1.0,0.0,0.0,29.0,44.0,8.0,9.0,272.0
Jamtara,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,7.0,7.0,0.0,0.0,0.0,0.0,0.0,14.0
Jamtara,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,264.0,161.0,145.0,365.0,337.0,1272.0
Jamtara,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,264.0,161.0,145.0,354.0,337.0,1261.0
Jamtara,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,37.0,102.0,20.0,0.0,258.0,51.0,25.0,21.0,17.0,35.0,6.0,572.0
Jamtara,13.4,Number of children provided free glasses,TOTAL,0.0,29.0,71.0,5.0,0.0,63.0,48.0,25.0,21.0,17.0,17.0,6.0,302.0
Jamtara,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,4.0,5.0,4.0,4.0,3.0,4.0,4.0,5.0,5.0,5.0,5.0,-1.0
Jamtara,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,9.0,10.0,4.0,10.0,6.0,11.0,10.0,10.0,11.0,11.0,11.0,-1.0
Jamtara,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,530.0,615.0,594.0,671.0,556.0,478.0,497.0,515.0,475.0,443.0,555.0,422.0,-1.0
Jamtara,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,4.0,5.0,5.0,5.0,3.0,4.0,5.0,5.0,5.0,5.0,5.0,-1.0
Jamtara,14.05,Number of RKS meetings held during the month,TOTAL,2.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,1.0,1.0,1.0,1.0,13.0
Jamtara,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,16.0,14.0,8.0,16.0,8.0,13.0,14.0,12.0,13.0,13.0,13.0,-1.0
Jamtara,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,16.0,7.0,18.0,20.0,13.0,16.0,4.0,5.0,24.0,4.0,9.0,0.0,136.0
Jamtara,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,3.0,4.0,4.0,4.0,4.0,5.0,4.0,5.0,5.0,5.0,5.0,-1.0
Jamtara,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,-1.0
Jamtara,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,325.0,347.0,230.0,623.0,362.0,388.0,382.0,321.0,329.0,234.0,257.0,239.0,4037.0
Jamtara,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,634.0,768.0,715.0,1036.0,1050.0,655.0,939.0,837.0,677.0,700.0,1063.0,596.0,9670.0
Jamtara,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,224.0,221.0,125.0,349.0,123.0,251.0,132.0,240.0,279.0,194.0,246.0,135.0,2519.0
Jamtara,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,863.0,816.0,941.0,970.0,716.0,1035.0,1016.0,942.0,982.0,1134.0,922.0,858.0,11195.0
Jamtara,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,549.0,568.0,355.0,972.0,485.0,639.0,514.0,561.0,608.0,428.0,503.0,374.0,6556.0
Jamtara,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1497.0,1584.0,1656.0,2006.0,1766.0,1690.0,1955.0,1779.0,1659.0,1834.0,1985.0,1454.0,20865.0
Jamtara,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,3.0,5.0,8.0,17.0,3.0,3.0,2.0,2.0,43.0
Jamtara,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,2.0,1.0,3.0,5.0,2.0,1.0,20.0
Jamtara,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,0.0,3.0,11.0,10.0,18.0,6.0,8.0,4.0,3.0,63.0
Jamtara,14.11,In-Patient Head Count at midnight,TOTAL,10.0,12.0,10.0,7.0,8.0,5.0,8.0,9.0,15.0,19.0,63.0,30.0,196.0
Jamtara,14.12.1,OPD attendance (All),TOTAL,21665.0,20599.0,21535.0,26167.0,21052.0,23421.0,19777.0,20821.0,21913.0,21416.0,20921.0,20465.0,259752.0
Jamtara,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Jamtara,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,7.0,15.0,12.0,8.0,0.0,5.0,53.0
Jamtara,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,322.0,0.0,0.0,0.0,0.0,96.0,375.0,280.0,320.0,188.0,177.0,290.0,2048.0
Jamtara,14.14.c,Number of Adolescents counselled,TOTAL,9.0,6.0,10.0,0.0,0.0,4.0,0.0,0.0,4.0,0.0,0.0,0.0,33.0
Jamtara,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,642.0,596.0,691.0,348.0,444.0,432.0,1194.0,711.0,763.0,902.0,1534.0,617.0,8874.0
Jamtara,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,15.0,24.0,45.0,24.0,17.0,22.0,29.0,11.0,30.0,30.0,31.0,32.0,310.0
Jamtara,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,80.0,0.0,0.0,0.0,81.0,0.0,71.0,76.0,107.0,102.0,0.0,155.0,672.0
Jamtara,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Jamtara,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,17.0,0.0,0.0,0.0,16.0,0.0,58.0,84.0,120.0,132.0,0.0,210.0,637.0
Jamtara,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,95.0,0.0,0.0,0.0,57.0,0.0,45.0,48.0,56.0,65.0,0.0,77.0,443.0
Jamtara,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,192.0,0.0,0.0,0.0,154.0,0.0,174.0,208.0,283.0,299.0,0.0,442.0,1752.0
Jamtara,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Jamtara,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,22.0,34.0
Jamtara,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,64.0,0.0,0.0,8.0,0.0,72.0
Jamtara,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,68.0,0.0,0.0,4.0,0.0,72.0
Jamtara,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,2.0,0.0,33.0,0.0,0.0,0.0,0.0,35.0
Jamtara,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,2.0,0.0,165.0,0.0,0.0,12.0,0.0,179.0
Jamtara,15.4.1,Number of blood smears examined for Malaria,TOTAL,292.0,177.0,320.0,283.0,3894.0,4199.0,264.0,4490.0,4633.0,3759.0,4474.0,4504.0,31289.0
Jamtara,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Jamtara,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,18.0,0.0,0.0,2.0,23.0
Jamtara,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,12500.0,25500.0,14500.0,20000.0,10000.0,15500.0,6000.0,29500.0,19500.0,19000.0,16000.0,5500.0,193500.0
Jamtara,16.1.1,Stock position of DPT vaccines,2. Stocks Received,25000.0,0.0,15000.0,0.0,20000.0,0.0,30000.0,0.0,10000.0,8000.0,0.0,31000.0,139000.0
Jamtara,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,12000.0,11000.0,9500.0,10000.0,14500.0,9500.0,6500.0,10000.0,10500.0,11000.0,10500.0,12500.0,127500.0
Jamtara,16.1.1,Stock position of DPT vaccines,5. Total Stock,25500.0,14500.0,20000.0,10000.0,15500.0,6000.0,29500.0,19500.0,19000.0,16000.0,5500.0,24000.0,205000.0
Jamtara,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Jamtara,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Jamtara,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Jamtara,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Jamtara,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,17040.0,45240.0,22740.0,1500.0,500.0,500.0,0.0,25500.0,4500.0,0.0,15000.0,2300.0,134820.0
Jamtara,16.1.2,Stock position of OPV vaccines,2. Stocks Received,50000.0,0.0,0.0,0.0,0.0,0.0,30000.0,0.0,0.0,30000.0,166800.0,0.0,276800.0
Jamtara,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,21800.0,22500.0,21240.0,1000.0,0.0,500.0,4500.0,21000.0,4500.0,15000.0,179500.0,2300.0,293840.0
Jamtara,16.1.2,Stock position of OPV vaccines,5. Total Stock,45240.0,22740.0,1500.0,500.0,500.0,0.0,25500.0,4500.0,0.0,15000.0,2300.0,0.0,117780.0
Jamtara,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,13500.0,27000.0,17500.0,10500.0,19000.0,24000.0,15000.0,28500.0,18500.0,19500.0,26000.0,15000.0,234000.0
Jamtara,16.1.3,Stock position of TT vaccines,2. Stocks Received,25000.0,0.0,2500.0,18000.0,20000.0,0.0,20000.0,0.0,10000.0,17000.0,0.0,22000.0,134500.0
Jamtara,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.3,Stock position of TT vaccines,4. Stock Distributed,11500.0,9500.0,9500.0,9500.0,15000.0,9000.0,6500.0,10000.0,9000.0,10500.0,11000.0,14500.0,125500.0
Jamtara,16.1.3,Stock position of TT vaccines,5. Total Stock,27000.0,17500.0,10500.0,19000.0,24000.0,15000.0,28500.0,18500.0,19500.0,26000.0,15000.0,22500.0,243000.0
Jamtara,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,15500.0,26000.0,16400.0,7900.0,400.0,25000.0,14500.0,7500.0,500.0,9000.0,10500.0,3500.0,136700.0
Jamtara,16.1.5,Stock position of BCG vaccines,2. Stocks Received,20000.0,0.0,0.0,0.0,32000.0,0.0,0.0,0.0,20000.0,10000.0,0.0,6000.0,88000.0
Jamtara,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,9500.0,9600.0,8500.0,7500.0,7400.0,10500.0,7000.0,7000.0,11500.0,8500.0,7000.0,8000.0,102000.0
Jamtara,16.1.5,Stock position of BCG vaccines,5. Total Stock,26000.0,16400.0,7900.0,400.0,25000.0,14500.0,7500.0,500.0,9000.0,10500.0,3500.0,1500.0,122700.0
Jamtara,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,13050.0,13550.0,11050.0,10800.0,8300.0,16550.0,12300.0,14800.0,10300.0,11800.0,13050.0,8800.0,144350.0
Jamtara,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2500.0,0.0,5500.0,2500.0,15000.0,0.0,5000.0,0.0,5000.0,600.0,0.0,9500.0,45600.0
Jamtara,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2000.0,2500.0,5750.0,5000.0,6750.0,4250.0,2500.0,4500.0,3500.0,4750.0,4250.0,5500.0,51250.0
Jamtara,16.1.6,Stock position of Measles vaccines,5. Total Stock,13550.0,11050.0,10800.0,8300.0,16550.0,12300.0,14800.0,10300.0,11800.0,7650.0,8800.0,12800.0,138700.0
Jamtara,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11000.0,11000.0,11000.0,8200.0,1300.0,42500.0
Jamtara,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,11000.0,0.0,0.0,11000.0,0.0,200.0,22200.0
Jamtara,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13800.0,6900.0,1500.0,22200.0
Jamtara,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,11000.0,11000.0,11000.0,8200.0,1300.0,0.0,42500.0
Jamtara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,50.0,3500.0,2400.0,1300.0,5250.0,12150.0,9950.0,8350.0,6550.0,15100.0,9600.0,7900.0,82100.0
Jamtara,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,4000.0,0.0,0.0,4800.0,9600.0,0.0,0.0,0.0,10550.0,3000.0,0.0,1800.0,33750.0
Jamtara,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,550.0,1100.0,1100.0,850.0,2700.0,2200.0,1600.0,1800.0,2000.0,1950.0,1700.0,2500.0,20050.0
Jamtara,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3500.0,2400.0,1300.0,5250.0,12150.0,9950.0,8350.0,6550.0,15100.0,16150.0,7900.0,7200.0,95800.0
Jamtara,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,44700.0,59300.0,39300.0,54100.0,70100.0,76100.0,72100.0,70100.0,46500.0,44500.0,32500.0,16500.0,625800.0
Jamtara,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,26000.0,0.0,24000.0,30000.0,26000.0,0.0,10000.0,0.0,20000.0,10000.0,0.0,20000.0,166000.0
Jamtara,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,11400.0,20000.0,9200.0,14000.0,20000.0,4000.0,12000.0,23600.0,22000.0,22000.0,16000.0,22500.0,196700.0
Jamtara,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,59300.0,39300.0,54100.0,70100.0,76100.0,72100.0,70100.0,46500.0,44500.0,32500.0,16500.0,14000.0,595100.0
Jamtara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,6650.0,6150.0,4150.0,4050.0,2650.0,950.0,550.0,14450.0,12450.0,11700.0,20100.0,17700.0,101550.0
Jamtara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2500.0,0.0,0.0,0.0,0.0,0.0,14000.0,0.0,0.0,10000.0,0.0,0.0,26500.0
Jamtara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jamtara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3000.0,2000.0,100.0,1400.0,1700.0,400.0,100.0,2000.0,900.0,1600.0,2400.0,3900.0,19500.0
Jamtara,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,6150.0,4150.0,4050.0,2650.0,950.0,550.0,14450.0,12450.0,11550.0,20100.0,17700.0,13800.0,108550.0
Jamtara,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,1.0,,,,1.0
Jamtara,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,,,1.0
Jamtara,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jamtara,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,1.0,,,,,,,,1.0
Jamtara,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jamtara,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Jamtara,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,1.0,,,,,,,,,1.0
Jamtara,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jamtara,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,2.0,,,1.0,3.0
Jamtara,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,2.0,,,1.0,3.0
Jamtara,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jamtara,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,1.0,1.0
Jamtara,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,1.0,1.0
Jamtara,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
Jamtara,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamtara,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,,,,,,,,,,1.0
Jamtara,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jamtara,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamtara,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Jamtara,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,1.0,,,,,,,,1.0
Jamtara,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamtara,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,1.0,,,,,,,,1.0
Jamtara,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jamtara,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jamtara,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Jamtara,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,1.0,2.0,,,1.0,,,,4.0
Jamtara,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,,,,,,1.0,,,1.0,3.0
Jamtara,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,,,,1.0,2.0,,,2.0,,,1.0,7.0
Jamtara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Jamtara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Jamtara,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Jamtara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,3.0,,,,,,,,,3.0
Jamtara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Jamtara,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,3.0,,,,,,,,,3.0
Jamtara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Jamtara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Jamtara,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,,1.0,,,,,,,,,2.0
Jamtara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,1.0,1.0,,,,,,2.0
Jamtara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Jamtara,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,1.0,1.0,,,,,,2.0
Jamtara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Jamtara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Jamtara,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,,,1.0,,,,,,,,2.0
Jamtara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Jamtara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Jamtara,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Jamtara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,1.0,1.0,,,,,,,1.0,3.0
Jamtara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,,,1.0,,,,,,,,2.0
Jamtara,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,,,1.0,2.0,,,,,,,1.0,5.0
Jamtara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Jamtara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Jamtara,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Jamtara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Jamtara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Jamtara,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Jamtara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Jamtara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Jamtara,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Jamtara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Jamtara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Jamtara,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Jamtara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Jamtara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Jamtara,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Jamtara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Jamtara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Jamtara,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Jamtara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,2.0,,,,,,,,,,,2.0
Jamtara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Jamtara,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,2.0,,,,,,,,,,,2.0
Jamtara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,1.0,,,,1.0,,,,,,,2.0
Jamtara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Jamtara,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,2.0,,,,1.0,,,,,,,3.0
Jamtara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Jamtara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Jamtara,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,1.0,,,,,1.0
Jamtara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Jamtara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Jamtara,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Jamtara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,3.0,,,1.0,,,,,,,,4.0
Jamtara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,3.0,,,,,,,,,,,3.0
Jamtara,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,6.0,,,1.0,,,,,,,,7.0
Jamtara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,1.0,,2.0,3.0,3.0,1.0,,,,,1.0,12.0
Jamtara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,4.0,,,,,,,,4.0
Jamtara,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,1.0,,2.0,7.0,3.0,1.0,,,,,1.0,16.0
Jamtara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Jamtara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,3.0,1.0,,,2.0,2.0,1.0,,3.0,12.0
Jamtara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,3.0,,,1.0,,,,,,,,4.0
Jamtara,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,3.0,,3.0,2.0,,,2.0,2.0,1.0,,3.0,16.0
Khunti,1.1,Total number of pregnant women Registered for ANC,TOTAL,1016.0,1018.0,947.0,1176.0,926.0,1103.0,1099.0,873.0,800.0,991.0,1214.0,1037.0,12200.0
Khunti,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,207.0,236.0,152.0,252.0,163.0,258.0,253.0,196.0,158.0,199.0,225.0,182.0,2481.0
Khunti,1.2,Number of Pregnant women registered under JSY,TOTAL,1011.0,1018.0,917.0,1176.0,907.0,1023.0,1026.0,859.0,788.0,984.0,1197.0,996.0,11902.0
Khunti,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,721.0,774.0,758.0,764.0,782.0,790.0,710.0,760.0,807.0,795.0,757.0,703.0,9121.0
Khunti,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,997.0,986.0,924.0,1167.0,918.0,1079.0,1093.0,858.0,794.0,942.0,1176.0,985.0,11919.0
Khunti,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,888.0,935.0,835.0,844.0,899.0,837.0,947.0,897.0,801.0,707.0,801.0,985.0,10376.0
Khunti,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,246.0,289.0,178.0,277.0,127.0,136.0,454.0,787.0,670.0,845.0,976.0,862.0,5847.0
Khunti,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,48.0,35.0,81.0,40.0,32.0,35.0,31.0,31.0,37.0,42.0,40.0,60.0,512.0
Khunti,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,12.0
Khunti,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,228.0,255.0,267.0,246.0,214.0,223.0,264.0,233.0,176.0,323.0,310.0,354.0,3093.0
Khunti,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,10.0,31.0,12.0,2.0,9.0,0.0,3.0,3.0,4.0,4.0,0.0,3.0,81.0
Khunti,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Khunti,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,231.0,188.0,138.0,143.0,118.0,139.0,221.0,123.0,127.0,109.0,85.0,70.0,1692.0
Khunti,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,348.0,291.0,280.0,322.0,320.0,308.0,284.0,266.0,270.0,291.0,290.0,264.0,3534.0
Khunti,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,579.0,479.0,418.0,465.0,438.0,447.0,505.0,389.0,397.0,400.0,375.0,334.0,5226.0
Khunti,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,468.0,395.0,395.0,418.0,406.0,432.0,431.0,348.0,359.0,368.0,309.0,299.0,4628.0
Khunti,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,96.0,96.0,153.0,193.0,180.0,191.0,254.0,125.0,128.0,39.0,39.0,19.0,1513.0
Khunti,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,486.0,477.0,372.0,493.0,428.0,415.0,435.0,433.0,404.0,389.0,402.0,476.0,5210.0
Khunti,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,485.0,476.0,371.0,483.0,428.0,411.0,435.0,433.0,402.0,389.0,405.0,474.0,5192.0
Khunti,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,349.0,331.0,167.0,303.0,332.0,341.0,336.0,308.0,298.0,382.0,298.0,467.0,3912.0
Khunti,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,282.0,346.0,135.0,325.0,266.0,292.0,295.0,233.0,349.0,447.0,321.0,385.0,3676.0
Khunti,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Khunti,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Khunti,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Khunti,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Khunti,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khunti,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Khunti,4.1.1.a,Number of male live births,TOTAL,590.0,508.0,374.0,498.0,454.0,434.0,478.0,414.0,407.0,383.0,380.0,401.0,5321.0
Khunti,4.1.1.b,Number of female live births,TOTAL,494.0,444.0,428.0,477.0,408.0,422.0,456.0,406.0,387.0,418.0,398.0,404.0,5142.0
Khunti,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1084.0,952.0,802.0,975.0,862.0,856.0,934.0,820.0,794.0,801.0,778.0,805.0,10463.0
Khunti,4.1.2,Number of still births,TOTAL,15.0,10.0,2.0,11.0,9.0,9.0,12.0,9.0,10.0,6.0,10.0,9.0,112.0
Khunti,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,17.0,13.0,8.0,13.0,11.0,13.0,8.0,14.0,19.0,36.0,27.0,36.0,215.0
Khunti,4.2.1,Number of Newborns weighed at birth,TOTAL,1025.0,833.0,752.0,878.0,832.0,812.0,915.0,789.0,776.0,771.0,712.0,787.0,9882.0
Khunti,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,209.0,29.0,26.0,53.0,48.0,42.0,54.0,23.0,35.0,20.0,24.0,31.0,594.0
Khunti,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1041.0,893.0,765.0,879.0,843.0,821.0,861.0,708.0,777.0,782.0,752.0,801.0,9923.0
Khunti,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,8.0,3.0,0.0,0.0,16.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0
Khunti,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khunti,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,8.0,3.0,0.0,0.0,16.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0
Khunti,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Khunti,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,8.0,3.0,0.0,0.0,16.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0
Khunti,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Khunti,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,8.0,3.0,0.0,0.0,16.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0
Khunti,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,854.0,679.0,650.0,720.0,749.0,732.0,733.0,648.0,623.0,547.0,548.0,619.0,8102.0
Khunti,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,741.0,711.0,622.0,762.0,680.0,748.0,679.0,511.0,497.0,405.0,387.0,373.0,7116.0
Khunti,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,9.0,5.0,3.0,3.0,0.0,2.0,0.0,3.0,1.0,8.0,6.0,16.0,56.0
Khunti,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,3.0,4.0,3.0,1.0,1.0,12.0,12.0,7.0,43.0
Khunti,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,9.0,5.0,3.0,3.0,3.0,6.0,3.0,4.0,2.0,20.0,18.0,23.0,99.0
Khunti,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,21.0,30.0,27.0,16.0,29.0,28.0,20.0,15.0,22.0,21.0,39.0,42.0,310.0
Khunti,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,37.0,45.0,46.0,30.0,52.0,46.0,53.0,49.0,55.0,55.0,54.0,44.0,566.0
Khunti,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,58.0,75.0,73.0,46.0,81.0,74.0,73.0,64.0,77.0,76.0,93.0,86.0,876.0
Khunti,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,64.0,77.0,0.0,93.0,0.0,234.0
Khunti,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,91.0,16.0,4.0,0.0,1.0,13.0,62.0,45.0,12.0,244.0
Khunti,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,1.0,2.0,35.0,5.0,1.0,0.0,46.0
Khunti,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khunti,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,91.0,18.0,4.0,1.0,3.0,48.0,67.0,46.0,12.0,290.0
Khunti,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Khunti,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Khunti,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khunti,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Khunti,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,164.0,12.0,11.0,0.0,23.0,128.0,345.0,286.0,24.0,993.0
Khunti,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,5.0,2.0,0.0,0.0,24.0,0.0,17.0,14.0,0.0,62.0
Khunti,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khunti,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,169.0,14.0,11.0,0.0,47.0,128.0,362.0,300.0,24.0,1055.0
Khunti,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Khunti,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khunti,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Khunti,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,91.0,91.0,108.0,436.0,116.0,116.0,96.0,94.0,91.0,251.0,126.0,104.0,1720.0
Khunti,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,37.0,54.0,49.0,449.0,31.0,120.0,131.0,36.0,61.0,1060.0,110.0,101.0,2239.0
Khunti,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,15.0,12.0,10.0,70.0,15.0,10.0,12.0,10.0,10.0,32.0,41.0,10.0,247.0
Khunti,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Khunti,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,143.0,157.0,167.0,955.0,162.0,246.0,239.0,140.0,162.0,1343.0,277.0,215.0,4206.0
Khunti,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Khunti,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Khunti,9.06,Number of IUCD removals,TOTAL,38.0,50.0,42.0,89.0,65.0,51.0,62.0,47.0,59.0,98.0,67.0,88.0,756.0
Khunti,9.07,Number of Oral Pills cycles distributed,TOTAL,371.0,1043.0,699.0,3903.0,1893.0,1004.0,930.0,643.0,597.0,6862.0,995.0,525.0,19465.0
Khunti,9.08,Number of Condom pieces distributed,TOTAL,1271.0,2425.0,3221.0,28800.0,10737.0,5373.0,4548.0,2595.0,1461.0,9263.0,5461.0,2862.0,78017.0
Khunti,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,50.0,0.0,0.0,1.0,1.0,2.0,0.0,0.0,7.0,42.0,12.0,115.0
Khunti,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,8.0,467.0,423.0,237.0,117.0,117.0,147.0,547.0,159.0,59.0,2281.0
Khunti,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,9.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Khunti,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,11.0
Khunti,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0
Khunti,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,9.12,Number of Institutions having NSV trained doctors,TOTAL,7.0,8.0,8.0,8.0,8.0,10.0,8.0,8.0,7.0,7.0,7.0,7.0,-1.0
Khunti,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1163.0,1023.0,810.0,987.0,987.0,915.0,1013.0,897.0,836.0,941.0,938.0,730.0,11240.0
Khunti,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,980.0,1052.0,1008.0,1124.0,946.0,947.0,952.0,875.0,929.0,918.0,913.0,845.0,11489.0
Khunti,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,918.0,997.0,990.0,1235.0,1039.0,878.0,982.0,929.0,864.0,903.0,959.0,908.0,11602.0
Khunti,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1002.0,1053.0,918.0,1316.0,1089.0,982.0,959.0,876.0,880.0,824.0,872.0,932.0,11703.0
Khunti,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Khunti,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Khunti,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Khunti,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,978.0,975.0,735.0,916.0,899.0,876.0,947.0,830.0,800.0,762.0,725.0,553.0,9996.0
Khunti,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,893.0,1056.0,1008.0,1124.0,946.0,916.0,899.0,873.0,929.0,885.0,902.0,622.0,11053.0
Khunti,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,841.0,997.0,989.0,1231.0,1039.0,855.0,930.0,929.0,864.0,861.0,941.0,685.0,11162.0
Khunti,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,908.0,928.0,914.0,1314.0,1090.0,949.0,913.0,873.0,883.0,764.0,882.0,666.0,11084.0
Khunti,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,3.0,11.0,0.0,0.0,64.0,84.0,168.0,330.0
Khunti,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,5.0,0.0,0.0,10.0,171.0,403.0,278.0,734.0,1601.0
Khunti,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,100.0,199.0,368.0,679.0
Khunti,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,39.0,70.0,250.0,362.0
Khunti,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1000.0,974.0,891.0,1066.0,1199.0,997.0,820.0,879.0,951.0,989.0,1059.0,897.0,11722.0
Khunti,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,2.0,0.0,36.0,368.0,509.0,542.0,619.0,2076.0
Khunti,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Khunti,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,524.0,454.0,441.0,514.0,596.0,478.0,416.0,430.0,443.0,495.0,527.0,416.0,5734.0
Khunti,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,456.0,440.0,411.0,467.0,575.0,457.0,353.0,409.0,467.0,471.0,494.0,439.0,5439.0
Khunti,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,980.0,894.0,852.0,981.0,1171.0,935.0,769.0,839.0,910.0,966.0,1021.0,855.0,11173.0
Khunti,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,756.0,680.0,713.0,853.0,995.0,841.0,803.0,772.0,806.0,803.0,988.0,877.0,9887.0
Khunti,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,648.0,700.0,708.0,853.0,992.0,814.0,794.0,778.0,804.0,776.0,984.0,703.0,9554.0
Khunti,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,151.0,117.0,118.0,146.0,149.0,184.0,202.0,110.0,152.0,152.0,177.0,97.0,1755.0
Khunti,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,157.0,101.0,118.0,160.0,162.0,176.0,200.0,123.0,156.0,187.0,134.0,104.0,1778.0
Khunti,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,308.0,218.0,236.0,306.0,311.0,360.0,402.0,233.0,308.0,339.0,311.0,201.0,3533.0
Khunti,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,252.0,328.0,283.0,261.0,255.0,299.0,293.0,233.0,281.0,342.0,605.0,548.0,3980.0
Khunti,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,994.0,884.0,942.0,1007.0,1012.0,1052.0,1042.0,969.0,877.0,882.0,839.0,883.0,11383.0
Khunti,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1001.0,991.0,1042.0,1157.0,1258.0,1114.0,1073.0,937.0,851.0,907.0,948.0,883.0,12162.0
Khunti,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,15.0,6.0,6.0,29.0
Khunti,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Khunti,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Khunti,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,781.0,788.0,868.0,877.0,791.0,872.0,808.0,791.0,803.0,799.0,802.0,805.0,9785.0
Khunti,10.4.2,Number of Immunisation sessions held during the month,TOTAL,780.0,788.0,843.0,834.0,788.0,861.0,757.0,778.0,798.0,782.0,770.0,788.0,9567.0
Khunti,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,725.0,728.0,779.0,771.0,720.0,793.0,681.0,678.0,708.0,707.0,688.0,695.0,8673.0
Khunti,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,937.0,810.0,729.0,982.0,1976.0,939.0,796.0,855.0,939.0,958.0,1450.0,898.0,12269.0
Khunti,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,105.0,69.0,87.0,217.0,11215.0,306.0,116.0,150.0,107.0,14.0,8818.0,797.0,22001.0
Khunti,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,86.0,86.0,61.0,173.0,12511.0,309.0,88.0,128.0,75.0,9.0,9112.0,853.0,23491.0
Khunti,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Khunti,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,15.0,52.0,0.0,41.0,0.0,46.0,21.0,0.0,0.0,0.0,0.0,0.0,175.0
Khunti,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,25.0,13.0,14.0,5.0,0.0,13.0,5.0,0.0,13.0,0.0,0.0,0.0,88.0
Khunti,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,109.0,115.0,113.0,111.0,143.0,176.0,133.0,105.0,121.0,73.0,72.0,69.0,1340.0
Khunti,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,115.0,110.0,74.0,115.0,91.0,146.0,128.0,96.0,105.0,103.0,96.0,72.0,1251.0
Khunti,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,147.0,0.0,0.0,57.0,116.0,320.0
Khunti,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,13.3,Number of School children detected with Refractive errors,TOTAL,212.0,472.0,16.0,2566.0,36.0,702.0,544.0,12.0,23.0,35.0,44.0,18.0,4680.0
Khunti,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,178.0,0.0,18.0,196.0
Khunti,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,6.0,5.0,6.0,5.0,5.0,5.0,6.0,6.0,5.0,5.0,6.0,-1.0
Khunti,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Khunti,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,699.0,713.0,698.0,715.0,714.0,709.0,675.0,593.0,558.0,566.0,654.0,698.0,-1.0
Khunti,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,6.0,6.0,6.0,6.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,-1.0
Khunti,14.05,Number of RKS meetings held during the month,TOTAL,3.0,3.0,6.0,6.0,6.0,6.0,6.0,123.0,4.0,4.0,4.0,3.0,174.0
Khunti,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,7.0,7.0,7.0,7.0,7.0,6.0,6.0,7.0,7.0,7.0,7.0,7.0,-1.0
Khunti,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,51.0,47.0,70.0,66.0,56.0,63.0,66.0,78.0,52.0,74.0,69.0,59.0,751.0
Khunti,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,3.0,4.0,5.0,5.0,5.0,5.0,7.0,7.0,7.0,7.0,-1.0
Khunti,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,-1.0
Khunti,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,19.0,30.0,8.0,16.0,21.0,12.0,21.0,15.0,23.0,13.0,36.0,18.0,232.0
Khunti,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,78.0,60.0,60.0,75.0,59.0,96.0,88.0,72.0,57.0,51.0,64.0,84.0,844.0
Khunti,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,20.0,20.0,14.0,20.0,25.0,26.0,29.0,21.0,15.0,19.0,25.0,18.0,252.0
Khunti,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,474.0,376.0,316.0,442.0,309.0,404.0,375.0,354.0,387.0,532.0,440.0,507.0,4916.0
Khunti,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,39.0,50.0,22.0,36.0,46.0,38.0,50.0,36.0,38.0,32.0,61.0,36.0,484.0
Khunti,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,552.0,436.0,376.0,517.0,368.0,500.0,463.0,426.0,444.0,583.0,504.0,591.0,5760.0
Khunti,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0,1.0,0.0,7.0
Khunti,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,6.0
Khunti,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,4.0,0.0,0.0,2.0,0.0,0.0,3.0,0.0,0.0,2.0,2.0,0.0,13.0
Khunti,14.11,In-Patient Head Count at midnight,TOTAL,517.0,549.0,354.0,437.0,410.0,483.0,174.0,246.0,530.0,801.0,603.0,569.0,5673.0
Khunti,14.12.1,OPD attendance (All),TOTAL,15969.0,16852.0,17866.0,20277.0,21365.0,20403.0,19275.0,18579.0,16950.0,15338.0,15525.0,15408.0,213807.0
Khunti,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Khunti,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,8.0,8.0,38.0,60.0,63.0,53.0,47.0,30.0,307.0
Khunti,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,598.0,578.0,591.0,628.0,489.0,660.0,1069.0,783.0,622.0,883.0,894.0,915.0,8710.0
Khunti,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,62.0,72.0,47.0,49.0,32.0,48.0,56.0,31.0,38.0,46.0,28.0,34.0,543.0
Khunti,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,45.0,69.0,80.0,58.0,70.0,67.0,55.0,60.0,57.0,63.0,96.0,95.0,815.0
Khunti,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,2.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,6.0
Khunti,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,53.0,46.0,59.0,42.0,55.0,55.0,59.0,57.0,57.0,77.0,71.0,57.0,688.0
Khunti,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,2.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,4.0
Khunti,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,72.0,72.0,82.0,77.0,77.0,69.0,66.0,82.0,70.0,73.0,79.0,106.0,925.0
Khunti,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,170.0,187.0,221.0,177.0,202.0,191.0,180.0,199.0,184.0,213.0,246.0,258.0,2428.0
Khunti,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,4.0,0.0,0.0,3.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,10.0
Khunti,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,55.0,55.0
Khunti,15.3.a,Number of VDRL tests conducted on males,Number tested,11.0,0.0,29.0,25.0,30.0,34.0,35.0,30.0,28.0,32.0,49.0,48.0,351.0
Khunti,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,29.0,0.0,30.0,30.0,53.0,51.0,58.0,65.0,57.0,57.0,66.0,104.0,600.0
Khunti,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,64.0,0.0,44.0,77.0,77.0,69.0,66.0,82.0,70.0,73.0,79.0,207.0,908.0
Khunti,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,104.0,0.0,103.0,132.0,160.0,154.0,159.0,177.0,155.0,162.0,194.0,359.0,1859.0
Khunti,15.4.1,Number of blood smears examined for Malaria,TOTAL,3329.0,3532.0,3689.0,4500.0,4905.0,4836.0,3618.0,5403.0,4668.0,4397.0,4250.0,4066.0,51193.0
Khunti,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,15.0,21.0,64.0,28.0,24.0,79.0,25.0,36.0,37.0,28.0,48.0,81.0,486.0
Khunti,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,121.0,122.0,72.0,158.0,188.0,138.0,161.0,396.0,228.0,194.0,179.0,105.0,2062.0
Khunti,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,5560.0,7000.0,9310.0,12490.0,6430.0,7760.0,10820.0,12560.0,13890.0,16360.0,20520.0,8480.0,131180.0
Khunti,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,10000.0,10000.0,0.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,0.0,10000.0,100000.0
Khunti,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,8560.0,7690.0,6820.0,6060.0,8670.0,6940.0,8260.0,8670.0,7530.0,5840.0,12040.0,5580.0,92660.0
Khunti,16.1.1,Stock position of DPT vaccines,5. Total Stock,7000.0,9310.0,12490.0,6430.0,7760.0,10820.0,12560.0,13890.0,16360.0,20520.0,8480.0,12900.0,138520.0
Khunti,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Khunti,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0.0,11240.0,14960.0,19180.0,7280.0,9920.0,8820.0,14980.0,8540.0,140.0,11160.0,0.0,106220.0
Khunti,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,20000.0,20000.0,0.0,20000.0,10000.0,20000.0,10000.0,0.0,20000.0,0.0,0.0,140000.0
Khunti,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,240.0,0.0,0.0,0.0,0.0,500.0,0.0,0.0,740.0
Khunti,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,8760.0,16280.0,15780.0,11900.0,17120.0,11100.0,13880.0,16440.0,8400.0,8480.0,11160.0,0.0,139300.0
Khunti,16.1.2,Stock position of OPV vaccines,5. Total Stock,11240.0,14960.0,19180.0,7280.0,9920.0,8820.0,14940.0,8540.0,140.0,11160.0,0.0,0.0,106180.0
Khunti,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,3590.0,5620.0,8880.0,9610.0,2800.0,4580.0,9330.0,9920.0,1880.0,4400.0,6360.0,4700.0,71670.0
Khunti,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,10000.0,10000.0,0.0,10000.0,10000.0,10000.0,0.0,10000.0,10000.0,10000.0,10000.0,100000.0
Khunti,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,130.0,200.0,170.0,100.0,50.0,0.0,20.0,100.0,770.0
Khunti,16.1.3,Stock position of TT vaccines,4. Stock Distributed,7970.0,6740.0,9270.0,6810.0,8090.0,5050.0,8240.0,7940.0,7430.0,8040.0,11640.0,4220.0,91440.0
Khunti,16.1.3,Stock position of TT vaccines,5. Total Stock,5620.0,8880.0,9610.0,2800.0,4580.0,9330.0,10920.0,1880.0,4400.0,6360.0,4700.0,10380.0,79460.0
Khunti,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,5560.0,7000.0,9310.0,12490.0,6430.0,,,,,,,,40790.0
Khunti,16.1.4,Stock position of DT vaccines,2. Stocks Received,10000.0,10000.0,10000.0,0.0,10000.0,,,,,,,,40000.0
Khunti,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Khunti,16.1.4,Stock position of DT vaccines,4. Stock Distributed,8560.0,7690.0,6820.0,6060.0,8670.0,,,,,,,,37800.0
Khunti,16.1.4,Stock position of DT vaccines,5. Total Stock,7000.0,9310.0,12490.0,6430.0,7760.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,42990.0
Khunti,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,6730.0,4190.0,7110.0,10770.0,5740.0,8250.0,18250.0,10250.0,8110.0,7080.0,4890.0,50.0,91420.0
Khunti,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,10000.0,10000.0,0.0,10000.0,10000.0,5000.0,5000.0,6000.0,5000.0,0.0,3500.0,69500.0
Khunti,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,0.0,0.0,200.0
Khunti,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7540.0,7080.0,6340.0,5030.0,7490.0,,6410.0,7140.0,7030.0,6990.0,4840.0,1100.0,66990.0
Khunti,16.1.5,Stock position of BCG vaccines,5. Total Stock,4190.0,7110.0,10770.0,5740.0,8250.0,18250.0,16840.0,8110.0,7080.0,4890.0,50.0,2450.0,93730.0
Khunti,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,3380.0,5690.0,6095.0,3045.0,4665.0,,,5100.0,3840.0,5320.0,4540.0,41675.0
Khunti,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,5000.0,4000.0,0.0,5000.0,0.0,,,2500.0,5000.0,4500.0,5000.0,31000.0
Khunti,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0
Khunti,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,2690.0,3595.0,3050.0,3380.0,,,,3760.0,3520.0,5280.0,2270.0,27545.0
Khunti,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,5690.0,6095.0,3045.0,4665.0,4665.0,0.0,0.0,3840.0,5320.0,4540.0,7270.0,45130.0
Khunti,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Khunti,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,0.0,4400.0,2490.0,400.0,6640.0,13930.0
Khunti,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,5000.0,0.0,0.0,11800.0,0.0,16800.0
Khunti,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,40.0,0.0,0.0,40.0
Khunti,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,600.0,1910.0,2050.0,5560.0,5740.0,15860.0
Khunti,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4400.0,2490.0,400.0,6640.0,900.0,14830.0
Khunti,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khunti,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khunti,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khunti,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khunti,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Khunti,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Khunti,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Khunti,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Khunti,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Khunti,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Khunti,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Khunti,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Khunti,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Khunti,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Khunti,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Khunti,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Khunti,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Khunti,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Khunti,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Khunti,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,600.0,0.0,2000.0,200.0,0.0,2400.0,1700.0,1900.0,400.0,1030.0,30.0,10260.0
Khunti,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,1000.0,0.0,2000.0,0.0,0.0,3000.0,1500.0,1500.0,1800.0,1500.0,0.0,1050.0,13350.0
Khunti,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,0.0,10.0,30.0
Khunti,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,400.0,600.0,0.0,1800.0,200.0,600.0,2200.0,1300.0,3300.0,850.0,1000.0,600.0,12850.0
Khunti,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,600.0,0.0,2000.0,200.0,0.0,2400.0,1700.0,1900.0,400.0,1030.0,30.0,470.0,10730.0
Khunti,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,5000.0,1000.0,2500.0,4900.0,10500.0,7500.0,900.0,2500.0,1885.0,36685.0
Khunti,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,5000.0,5000.0,10000.0,0.0,0.0,5000.0,6000.0,10000.0,41000.0
Khunti,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Khunti,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,4000.0,3500.0,2600.0,4400.0,3000.0,6600.0,3400.0,6615.0,6800.0,40915.0
Khunti,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,1000.0,2500.0,4900.0,10500.0,7500.0,900.0,2500.0,1885.0,5085.0,36770.0
Khunti,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,1900.0,1100.0,800.0,255.0,1930.0,8985.0
Khunti,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,3000.0,3000.0,9000.0
Khunti,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0,25.0,0.0,55.0
Khunti,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,1100.0,800.0,300.0,515.0,1300.0,1800.0,5815.0
Khunti,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,3000.0,1900.0,1100.0,800.0,255.0,1930.0,3130.0,12115.0
Khunti,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,1.0,2.0,,,,1.0,1.0,1.0,,,,8.0
Khunti,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Khunti,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khunti,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Khunti,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Khunti,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Khunti,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Khunti,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,1.0,,,,,,,,,,1.0
Khunti,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,,,,,,,,,,1.0
Khunti,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,2.0,,,,,,,,,,2.0
Khunti,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,,,7.0
Khunti,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,,,1.0,,1.0,,,,,3.0
Khunti,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,,,,,10.0
Khunti,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khunti,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,1.0,,,8.0
Khunti,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,1.0,,,8.0
Khunti,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khunti,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khunti,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Khunti,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khunti,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,1.0,1.0,,,,2.0,,,,,,5.0
Khunti,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,1.0,,,,2.0,,,,,,5.0
Khunti,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Khunti,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Khunti,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Khunti,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,3.0,3.0,1.0,1.0,,1.0,1.0,2.0,,,1.0,14.0
Khunti,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,,,3.0,,,,1.0,,,5.0
Khunti,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,3.0,4.0,1.0,1.0,3.0,1.0,1.0,2.0,1.0,,1.0,19.0
Khunti,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Khunti,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Khunti,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Khunti,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Khunti,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Khunti,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,1.0,,,,,,,,,1.0
Khunti,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Khunti,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Khunti,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Khunti,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,,,1.0,1.0,12.0
Khunti,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Khunti,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,,1.0,1.0,1.0,13.0
Khunti,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,2.0,,,,,,,,,,3.0
Khunti,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,4.0,1.0,,2.0,,3.0,1.0,3.0,1.0,1.0,,,16.0
Khunti,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,2.0,,2.0,1.0,,,,,,6.0
Khunti,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,4.0,2.0,3.0,4.0,,5.0,2.0,3.0,1.0,1.0,,,25.0
Khunti,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Khunti,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Khunti,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,,,,,,,,,1.0
Khunti,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,,,,,1.0,,,,1.0,1.0,4.0
Khunti,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Khunti,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,1.0,,,,,1.0,,,1.0,1.0,1.0,5.0
Khunti,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,,,7.0
Khunti,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,,,7.0
Khunti,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Khunti,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,2.0,2.0,2.0,2.0,2.0,2.0,,,,,,14.0
Khunti,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Khunti,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Khunti,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Khunti,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,1.0,,1.0,,,,,,,,3.0
Khunti,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Khunti,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,1.0,,1.0,,,,,,,,3.0
Khunti,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,,,7.0
Khunti,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Khunti,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,,,7.0
Khunti,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Khunti,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Khunti,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Khunti,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,3.0,,1.0,,,,,,,,,,4.0
Khunti,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Khunti,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,3.0,,1.0,,,,,,,,,,4.0
Khunti,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,2.0,,1.0,,,,1.0,,,,6.0
Khunti,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Khunti,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,2.0,,1.0,,,,1.0,,,,6.0
Khunti,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,,,,,,,,,,2.0
Khunti,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,3.0,4.0,,2.0,2.0,,,,,,,12.0
Khunti,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Khunti,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,4.0,6.0,,2.0,2.0,,,,,,,15.0
Khunti,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,1.0,,,,1.0,,,,,,3.0
Khunti,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Khunti,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,1.0,,,,1.0,,,,,,3.0
Khunti,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Khunti,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,1.0,1.0,,,,,,,3.0
Khunti,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Khunti,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,,1.0,1.0,1.0,1.0,,,,,,5.0
Khunti,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,2.0,3.0,1.0,,,,,,,,,7.0
Khunti,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,2.0,1.0,1.0,1.0,1.0,1.0,,,,,,9.0
Khunti,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,4.0,4.0,2.0,1.0,1.0,1.0,,,,,,16.0
Khunti,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Khunti,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,1.0,2.0,3.0,2.0,,,,,,8.0
Khunti,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,1.0,,3.0,2.0,1.0,1.0,,,,,,8.0
Khunti,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,1.0,,4.0,4.0,4.0,3.0,,,,,,16.0
Khunti,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,2.0,,,,,2.0
Khunti,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,10.0,4.0,4.0,4.0,5.0,11.0,5.0,2.0,3.0,2.0,,,50.0
Khunti,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,7.0,6.0,6.0,3.0,2.0,3.0,4.0,1.0,,1.0,,1.0,34.0
Khunti,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,17.0,10.0,10.0,7.0,7.0,14.0,9.0,5.0,3.0,3.0,,1.0,86.0
Kodarma,1.1,Total number of pregnant women Registered for ANC,TOTAL,936.0,1156.0,1733.0,1217.0,1244.0,1127.0,1045.0,900.0,1092.0,959.0,995.0,923.0,13327.0
Kodarma,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,149.0,164.0,281.0,173.0,207.0,180.0,207.0,138.0,165.0,135.0,141.0,149.0,2089.0
Kodarma,1.2,Number of Pregnant women registered under JSY,TOTAL,911.0,1123.0,1700.0,1162.0,1225.0,1060.0,956.0,872.0,998.0,912.0,979.0,910.0,12808.0
Kodarma,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,515.0,557.0,729.0,649.0,744.0,719.0,683.0,594.0,642.0,540.0,524.0,411.0,7307.0
Kodarma,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,767.0,928.0,1393.0,1007.0,986.0,901.0,816.0,753.0,821.0,776.0,793.0,785.0,10726.0
Kodarma,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,778.0,766.0,1234.0,921.0,1038.0,995.0,830.0,718.0,787.0,761.0,669.0,614.0,10111.0
Kodarma,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,29.0,4.0,47.0,3.0,0.0,0.0,0.0,193.0,1384.0,416.0,616.0,753.0,3445.0
Kodarma,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,52.0,8.0,26.0,7.0,26.0,29.0,18.0,12.0,45.0,29.0,2.0,3.0,257.0
Kodarma,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,147.0,91.0,95.0,105.0,130.0,115.0,150.0,92.0,108.0,82.0,104.0,41.0,1260.0
Kodarma,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,19.0,25.0,0.0,0.0,0.0,0.0,0.0,18.0,0.0,0.0,0.0,0.0,62.0
Kodarma,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Kodarma,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,37.0,68.0,75.0,33.0,43.0,34.0,23.0,25.0,34.0,21.0,34.0,29.0,456.0
Kodarma,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,150.0,193.0,283.0,238.0,230.0,187.0,175.0,166.0,180.0,135.0,136.0,99.0,2172.0
Kodarma,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,187.0,261.0,358.0,271.0,273.0,221.0,198.0,191.0,214.0,156.0,170.0,128.0,2628.0
Kodarma,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,128.0,198.0,257.0,150.0,221.0,162.0,156.0,143.0,149.0,112.0,103.0,111.0,1890.0
Kodarma,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,11.0,8.0,16.0,18.0,14.0,3.0,33.0,9.0,0.0,18.0,8.0,11.0,149.0
Kodarma,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,362.0,455.0,534.0,604.0,786.0,704.0,618.0,612.0,658.0,569.0,590.0,464.0,6956.0
Kodarma,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,360.0,448.0,397.0,444.0,626.0,704.0,603.0,612.0,658.0,517.0,583.0,458.0,6410.0
Kodarma,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,70.0,121.0,93.0,139.0,150.0,520.0,219.0,424.0,171.0,115.0,240.0,144.0,2406.0
Kodarma,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,44.0,31.0,22.0,25.0,34.0,75.0,52.0,12.0,49.0,101.0,126.0,108.0,679.0
Kodarma,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,414.0,500.0,538.0,540.0,581.0,522.0,497.0,385.0,261.0,406.0,401.0,,5045.0
Kodarma,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,414.0,,0.0,540.0,581.0,522.0,497.0,385.0,,,,,2939.0
Kodarma,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Kodarma,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Kodarma,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0,0.0
Kodarma,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodarma,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,111.0,170.0,154.0,178.0,185.0,169.0,195.0,162.0,168.0,125.0,110.0,,1727.0
Kodarma,4.1.1.a,Number of male live births,TOTAL,538.0,725.0,796.0,787.0,875.0,761.0,732.0,642.0,687.0,524.0,591.0,324.0,7982.0
Kodarma,4.1.1.b,Number of female live births,TOTAL,419.0,500.0,619.0,613.0,748.0,675.0,628.0,625.0,592.0,590.0,553.0,268.0,6830.0
Kodarma,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,957.0,1225.0,1415.0,1400.0,1623.0,1436.0,1360.0,1267.0,1279.0,1114.0,1144.0,592.0,14812.0
Kodarma,4.1.2,Number of still births,TOTAL,10.0,147.0,87.0,29.0,24.0,21.0,158.0,92.0,50.0,20.0,23.0,2.0,663.0
Kodarma,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0.0,1.0,7.0,9.0,5.0,9.0,11.0,13.0,2.0,5.0,2.0,3.0,67.0
Kodarma,4.2.1,Number of Newborns weighed at birth,TOTAL,902.0,1129.0,1335.0,1301.0,1532.0,1344.0,1123.0,1207.0,1229.0,1076.0,1132.0,582.0,13892.0
Kodarma,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,23.0,24.0,28.0,36.0,50.0,28.0,28.0,50.0,37.0,43.0,37.0,15.0,399.0
Kodarma,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,903.0,1129.0,1331.0,1297.0,1545.0,1345.0,734.0,757.0,806.0,684.0,739.0,586.0,11856.0
Kodarma,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,4.0,9.0
Kodarma,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,,0.0,0.0
Kodarma,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodarma,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,4.0,9.0
Kodarma,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Kodarma,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,196.0,356.0,464.0,410.0,632.0,489.0,396.0,361.0,438.0,340.0,403.0,302.0,4787.0
Kodarma,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,273.0,335.0,453.0,415.0,599.0,489.0,325.0,360.0,366.0,326.0,404.0,291.0,4636.0
Kodarma,6.3,PNC maternal complications attended,TOTAL,0.0,2.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Kodarma,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Kodarma,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Kodarma,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,22.0,29.0,27.0,18.0,32.0,35.0,0.0,13.0,25.0,31.0,20.0,24.0,276.0
Kodarma,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,99.0,45.0,68.0,67.0,89.0,70.0,0.0,89.0,111.0,82.0,70.0,85.0,875.0
Kodarma,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,121.0,74.0,95.0,85.0,121.0,105.0,0.0,102.0,136.0,113.0,90.0,109.0,1151.0
Kodarma,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,85.0,121.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,206.0
Kodarma,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Kodarma,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,3.0,0.0,0.0,63.0,15.0,4.0,3.0,0.0,2.0,7.0,1.0,1.0,99.0
Kodarma,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,4.0,1.0,0.0,0.0,1.0,2.0,3.0,1.0,0.0,13.0
Kodarma,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodarma,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,0.0,1.0,67.0,16.0,4.0,3.0,2.0,4.0,10.0,2.0,1.0,113.0
Kodarma,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,20.0,0.0,0.0,,0.0,,1.0,0.0,0.0,21.0
Kodarma,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodarma,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0
Kodarma,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,24.0,0.0,2.0,11.0,0.0,0.0,0.0,0.0,37.0
Kodarma,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,15.0,5.0,1.0,504.0,61.0,67.0,39.0,20.0,115.0,788.0,302.0,71.0,1988.0
Kodarma,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,17.0,5.0,0.0,15.0,1.0,12.0,4.0,71.0,86.0,159.0,115.0,0.0,485.0
Kodarma,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodarma,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,32.0,10.0,1.0,519.0,86.0,79.0,45.0,102.0,201.0,947.0,417.0,71.0,2510.0
Kodarma,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,54.0,73.0,73.0,505.0,38.0,64.0,88.0,227.0,,400.0,617.0,474.0,2613.0
Kodarma,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodarma,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0
Kodarma,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,40.0,41.0,29.0,115.0,116.0,60.0,48.0,43.0,28.0,47.0,36.0,10.0,613.0
Kodarma,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,8.0,5.0,5.0,4.0,1.0,4.0,3.0,3.0,4.0,5.0,4.0,0.0,46.0
Kodarma,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,16.0,2.0,3.0,421.0,12.0,4.0,0.0,0.0,0.0,54.0,6.0,0.0,518.0
Kodarma,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Kodarma,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodarma,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,64.0,48.0,37.0,556.0,129.0,68.0,51.0,46.0,32.0,106.0,46.0,10.0,1193.0
Kodarma,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Kodarma,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,16.0,0.0,,0.0,19.0,,35.0
Kodarma,9.06,Number of IUCD removals,TOTAL,42.0,31.0,30.0,44.0,48.0,39.0,26.0,27.0,25.0,34.0,25.0,5.0,376.0
Kodarma,9.07,Number of Oral Pills cycles distributed,TOTAL,521.0,928.0,727.0,3494.0,1413.0,1119.0,1060.0,1032.0,1354.0,1680.0,952.0,682.0,14962.0
Kodarma,9.08,Number of Condom pieces distributed,TOTAL,6766.0,6521.0,7422.0,98330.0,14021.0,11959.0,10842.0,9681.0,9509.0,14068.0,10326.0,4077.0,203522.0
Kodarma,9.09,Number of Centchroman (weekly) pills given,TOTAL,32.0,53.0,1300.0,0.0,0.0,62.0,192.0,0.0,0.0,13.0,20.0,109.0,1781.0
Kodarma,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,7.0,15.0,31.0,77.0,83.0,33.0,39.0,32.0,38.0,55.0,62.0,58.0,530.0
Kodarma,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Kodarma,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,104.0,16.0,0.0,122.0
Kodarma,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,6.0,3.0,7.0,7.0,6.0,6.0,8.0,6.0,9.0,8.0,5.0,-1.0
Kodarma,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,923.0,1178.0,1598.0,1598.0,1964.0,883.0,1848.0,1573.0,1663.0,393.0,30.0,411.0,14062.0
Kodarma,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,749.0,962.0,1260.0,1197.0,1476.0,1454.0,1280.0,1268.0,1423.0,1127.0,952.0,1209.0,14357.0
Kodarma,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,885.0,1029.0,1266.0,1056.0,1230.0,1255.0,1183.0,1059.0,1371.0,1215.0,908.0,963.0,13420.0
Kodarma,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,904.0,1008.0,1342.0,1044.0,1168.0,1168.0,948.0,940.0,1103.0,998.0,946.0,881.0,12450.0
Kodarma,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Kodarma,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Kodarma,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Kodarma,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,153.0,287.0,435.0,492.0,398.0,257.0,113.0,4.0,285.0,217.0,59.0,76.0,2776.0
Kodarma,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,755.0,893.0,1258.0,1217.0,1458.0,1395.0,418.0,113.0,1089.0,1113.0,985.0,979.0,11673.0
Kodarma,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,883.0,943.0,1266.0,1059.0,1237.0,1209.0,423.0,86.0,1043.0,1184.0,925.0,780.0,11038.0
Kodarma,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,902.0,1049.0,1332.0,1062.0,1176.0,1136.0,305.0,53.0,838.0,960.0,918.0,742.0,10473.0
Kodarma,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,,,,,0.0,1.0,0.0,0.0,44.0,28.0,117.0,190.0
Kodarma,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,3.0,15.0,0.0,1.0,0.0,0.0,112.0,561.0,826.0,1518.0
Kodarma,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,186.0,298.0,487.0
Kodarma,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,16.0,0.0,86.0,535.0,638.0
Kodarma,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,797.0,420.0,1437.0,1357.0,1557.0,1314.0,1229.0,913.0,1020.0,824.0,750.0,854.0,12472.0
Kodarma,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,,,,,20.0,6.0,0.0,9289.0,0.0,9.0,21.0,9345.0
Kodarma,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Kodarma,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,443.0,191.0,732.0,698.0,808.0,651.0,613.0,468.0,510.0,443.0,382.0,451.0,6390.0
Kodarma,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,352.0,180.0,675.0,643.0,733.0,641.0,583.0,410.0,496.0,366.0,341.0,402.0,5822.0
Kodarma,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,795.0,371.0,1407.0,1341.0,1541.0,1292.0,1196.0,878.0,1006.0,809.0,723.0,853.0,12212.0
Kodarma,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,509.0,590.0,897.0,692.0,965.0,703.0,653.0,526.0,716.0,636.0,644.0,647.0,8178.0
Kodarma,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,508.0,591.0,908.0,685.0,956.0,675.0,184.0,59.0,494.0,618.0,638.0,515.0,6831.0
Kodarma,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,46.0,38.0,52.0,70.0,66.0,42.0,47.0,49.0,64.0,49.0,46.0,23.0,592.0
Kodarma,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,67.0,31.0,48.0,73.0,50.0,51.0,42.0,51.0,48.0,48.0,46.0,17.0,572.0
Kodarma,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,113.0,69.0,100.0,143.0,116.0,93.0,89.0,100.0,112.0,97.0,92.0,40.0,1164.0
Kodarma,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,17.0,15.0,47.0,43.0,61.0,79.0,39.0,43.0,32.0,24.0,57.0,20.0,477.0
Kodarma,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,222.0,227.0,324.0,258.0,359.0,275.0,308.0,275.0,240.0,264.0,203.0,203.0,3158.0
Kodarma,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,195.0,173.0,253.0,253.0,310.0,250.0,290.0,224.0,206.0,195.0,199.0,136.0,2684.0
Kodarma,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,18.0,22.0,14.0,9.0,23.0,22.0,23.0,12.0,8.0,11.0,2.0,8.0,172.0
Kodarma,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,2.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,6.0
Kodarma,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,456.0,640.0,721.0,571.0,716.0,607.0,640.0,600.0,610.0,569.0,578.0,605.0,7313.0
Kodarma,10.4.2,Number of Immunisation sessions held during the month,TOTAL,355.0,500.0,658.0,530.0,779.0,558.0,571.0,497.0,540.0,482.0,431.0,413.0,6314.0
Kodarma,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,230.0,314.0,399.0,356.0,486.0,388.0,395.0,349.0,395.0,358.0,343.0,346.0,4359.0
Kodarma,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,,,,,0.0,16.0,1.0,0.0,0.0,0.0,0.0,17.0
Kodarma,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,443.0,144.0,494.0,482.0,2069.0,1570.0,1205.0,871.0,990.0,765.0,978.0,1008.0,11019.0
Kodarma,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,0.0,3412.0,3059.0,84.0,12.0,7.0,0.0,2162.0,1267.0,10003.0
Kodarma,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,4059.0,3334.0,44.0,0.0,0.0,3.0,2895.0,1411.0,11746.0
Kodarma,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,10.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,12.0
Kodarma,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,7.0,9.0,22.0,16.0,18.0,5.0,6.0,6.0,15.0,10.0,0.0,1.0,115.0
Kodarma,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,57.0,61.0,197.0,183.0,97.0,94.0,192.0,112.0,60.0,34.0,3.0,4.0,1094.0
Kodarma,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,29.0,90.0,70.0,61.0,240.0,67.0,120.0,120.0,78.0,38.0,37.0,1.0,951.0
Kodarma,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,252.0,0.0,0.0,0.0,152.0,0.0,0.0,0.0,0.0,404.0
Kodarma,13.1,Number of Patients operated for cataract,TOTAL,51.0,19.0,10.0,25.0,21.0,0.0,40.0,152.0,0.0,0.0,0.0,0.0,318.0
Kodarma,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,6.0,0.0,0.0,0.0,0.0,0.0,40.0,152.0,0.0,0.0,0.0,0.0,198.0
Kodarma,13.3,Number of School children detected with Refractive errors,TOTAL,28.0,45.0,133.0,328.0,111.0,0.0,139.0,197.0,567.0,0.0,0.0,2900.0,4448.0
Kodarma,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,87.0,87.0
Kodarma,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,2.0,2.0,2.0,,4.0,3.0,1.0,1.0,2.0,2.0,3.0,-1.0
Kodarma,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,2.0,3.0,4.0,4.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,-1.0
Kodarma,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,153.0,197.0,291.0,198.0,179.0,121.0,187.0,111.0,240.0,193.0,213.0,188.0,-1.0
Kodarma,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,4.0,5.0,5.0,4.0,5.0,5.0,3.0,4.0,4.0,4.0,6.0,-1.0
Kodarma,14.05,Number of RKS meetings held during the month,TOTAL,2.0,1.0,4.0,1.0,3.0,3.0,1.0,2.0,2.0,0.0,0.0,0.0,19.0
Kodarma,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,5.0,5.0,4.0,4.0,8.0,9.0,9.0,7.0,7.0,7.0,8.0,-1.0
Kodarma,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,12.0,22.0,12.0,24.0,56.0,17.0,50.0,38.0,4.0,53.0,43.0,13.0,344.0
Kodarma,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,,3.0,4.0,2.0,2.0,1.0,,1.0,2.0,2.0,4.0,-1.0
Kodarma,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,-1.0
Kodarma,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,24.0,28.0,16.0,23.0,27.0,19.0,25.0,23.0,18.0,12.0,10.0,19.0,244.0
Kodarma,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,88.0,70.0,125.0,180.0,178.0,128.0,67.0,65.0,38.0,51.0,36.0,54.0,1080.0
Kodarma,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,13.0,26.0,20.0,13.0,13.0,21.0,21.0,11.0,11.0,7.0,9.0,166.0,331.0
Kodarma,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,300.0,309.0,441.0,637.0,562.0,469.0,429.0,439.0,300.0,610.0,583.0,416.0,5495.0
Kodarma,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,37.0,54.0,36.0,36.0,40.0,40.0,46.0,34.0,29.0,19.0,19.0,185.0,575.0
Kodarma,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,388.0,379.0,566.0,817.0,740.0,597.0,496.0,504.0,338.0,661.0,619.0,470.0,6575.0
Kodarma,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,1.0,2.0,2.0,3.0,3.0,1.0,2.0,1.0,3.0,7.0,2.0,28.0
Kodarma,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,2.0,3.0,3.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,11.0
Kodarma,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,1.0,1.0,4.0,5.0,6.0,3.0,3.0,2.0,1.0,4.0,7.0,2.0,39.0
Kodarma,14.11,In-Patient Head Count at midnight,TOTAL,322.0,400.0,351.0,421.0,421.0,398.0,435.0,384.0,160.0,327.0,173.0,382.0,4174.0
Kodarma,14.12.1,OPD attendance (All),TOTAL,12738.0,12931.0,15476.0,18267.0,20622.0,14753.0,18890.0,12918.0,12446.0,11727.0,13621.0,11035.0,175424.0
Kodarma,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Kodarma,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,225.0,0.0,225.0
Kodarma,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,18.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0
Kodarma,14.14.c,Number of Adolescents counselled,TOTAL,13.0,33.0,24.0,41.0,7.0,7.0,25.0,78.0,120.0,146.0,130.0,0.0,624.0
Kodarma,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,317.0,419.0,489.0,998.0,536.0,394.0,411.0,495.0,425.0,488.0,570.0,350.0,5892.0
Kodarma,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,4.0,4.0,6.0,30.0,16.0,10.0,7.0,9.0,11.0,5.0,10.0,6.0,118.0
Kodarma,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,114.0,84.0,143.0,143.0,149.0,182.0,116.0,94.0,346.0,142.0,196.0,163.0,1872.0
Kodarma,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,4.0,3.0,5.0,5.0,2.0,5.0,5.0,4.0,2.0,8.0,6.0,56.0
Kodarma,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,138.0,114.0,201.0,183.0,136.0,213.0,125.0,161.0,224.0,326.0,285.0,264.0,2370.0
Kodarma,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,1.0,4.0,3.0,2.0,5.0,5.0,4.0,3.0,4.0,5.0,6.0,45.0
Kodarma,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,117.0,145.0,166.0,166.0,129.0,146.0,159.0,125.0,130.0,152.0,156.0,216.0,1807.0
Kodarma,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,3.0
Kodarma,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,369.0,343.0,510.0,492.0,414.0,541.0,400.0,380.0,700.0,620.0,637.0,643.0,6049.0
Kodarma,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,11.0,5.0,7.0,8.0,8.0,7.0,10.0,9.0,7.0,6.0,14.0,12.0,104.0
Kodarma,15.2,Number of Widal tests conducted,Number tested,2.0,0.0,3.0,27.0,30.0,22.0,30.0,21.0,12.0,6.0,14.0,17.0,184.0
Kodarma,15.3.a,Number of VDRL tests conducted on males,Number tested,2.0,0.0,4.0,12.0,25.0,31.0,34.0,12.0,31.0,46.0,29.0,30.0,256.0
Kodarma,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,2.0,0.0,8.0,25.0,27.0,23.0,65.0,31.0,57.0,75.0,70.0,37.0,420.0
Kodarma,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,10.0,0.0,16.0,86.0,76.0,82.0,95.0,83.0,88.0,54.0,77.0,64.0,731.0
Kodarma,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,14.0,0.0,28.0,123.0,128.0,136.0,194.0,126.0,176.0,175.0,176.0,131.0,1407.0
Kodarma,15.4.1,Number of blood smears examined for Malaria,TOTAL,567.0,901.0,1015.0,1774.0,2380.0,1970.0,1490.0,1234.0,394.0,310.0,307.0,175.0,12517.0
Kodarma,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,21.0,35.0,46.0,161.0,185.0,133.0,108.0,46.0,17.0,9.0,9.0,8.0,778.0
Kodarma,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,1.0,0.0,24.0,25.0,7.0,12.0,47.0,8.0,0.0,2.0,3.0,131.0
Kodarma,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1355.0,2631.0,2030.0,1308.0,2509.0,1729.0,1451.0,812.0,431.0,1608.0,1038.0,481.0,17383.0
Kodarma,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,0.0,0.0,2000.0,0.0,500.0,0.0,300.0,2000.0,,,1000.0,7800.0
Kodarma,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Kodarma,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,724.0,601.0,722.0,799.0,780.0,778.0,639.0,681.0,823.0,570.0,557.0,715.0,8389.0
Kodarma,16.1.1,Stock position of DPT vaccines,5. Total Stock,2631.0,2030.0,1308.0,2509.0,1729.0,1451.0,812.0,431.0,1608.0,1038.0,481.0,766.0,16794.0
Kodarma,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Kodarma,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Kodarma,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Kodarma,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Kodarma,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,699.0,2033.0,1848.0,1157.0,202.0,125.0,0.0,0.0,1785.0,1207.0,599.0,5.0,9660.0
Kodarma,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000.0,500.0,0.0,0.0,700.0,0.0,0.0,2000.0,0.0,,9040.0,0.0,14240.0
Kodarma,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,25.0,0.0,25.0
Kodarma,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,666.0,585.0,691.0,955.0,777.0,125.0,,215.0,578.0,608.0,9609.0,5.0,14814.0
Kodarma,16.1.2,Stock position of OPV vaccines,5. Total Stock,2033.0,1948.0,1157.0,202.0,125.0,0.0,0.0,1785.0,1207.0,599.0,5.0,0.0,9061.0
Kodarma,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,700.0,1655.0,1402.0,765.0,1304.0,1675.0,1440.0,904.0,246.0,1175.0,578.0,126.0,11970.0
Kodarma,16.1.3,Stock position of TT vaccines,2. Stocks Received,1500.0,300.0,0.0,1300.0,1000.0,500.0,0.0,,1500.0,,,500.0,6600.0
Kodarma,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0
Kodarma,16.1.3,Stock position of TT vaccines,4. Stock Distributed,545.0,553.0,637.0,761.0,629.0,735.0,536.0,658.0,571.0,597.0,452.0,398.0,7072.0
Kodarma,16.1.3,Stock position of TT vaccines,5. Total Stock,1655.0,1402.0,765.0,1304.0,1675.0,1440.0,904.0,246.0,1175.0,578.0,126.0,228.0,11498.0
Kodarma,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0,,,0.0
Kodarma,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0,,,0.0
Kodarma,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,673.0,1269.0,1271.0,666.0,315.0,0.0,1507.0,905.0,223.0,13.0,0.0,0.0,6842.0
Kodarma,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1200.0,500.0,0.0,300.0,,2000.0,0.0,,0.0,,,500.0,4500.0
Kodarma,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,,,,0.0
Kodarma,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,604.0,498.0,605.0,651.0,315.0,493.0,602.0,682.0,210.0,13.0,0.0,156.0,4829.0
Kodarma,16.1.5,Stock position of BCG vaccines,5. Total Stock,1269.0,1271.0,666.0,315.0,0.0,1507.0,905.0,223.0,13.0,0.0,0.0,344.0,6513.0
Kodarma,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,499.0,0.0,1800.0,1200.0,543.0,654.0,976.0,484.0,236.0,1934.0,258.0,191.0,8775.0
Kodarma,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,2000.0,0.0,0.0,800.0,1000.0,0.0,300.0,28160.0,,0.0,,32260.0
Kodarma,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0
Kodarma,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,499.0,200.0,600.0,657.0,689.0,678.0,492.0,548.0,26462.0,1676.0,67.0,156.0,32724.0
Kodarma,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,1800.0,1200.0,543.0,654.0,976.0,484.0,236.0,1934.0,258.0,191.0,35.0,8311.0
Kodarma,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,,,0.0
Kodarma,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,,,0.0
Kodarma,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,1900.0,1900.0,1646.0,1121.0,6567.0
Kodarma,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,,1900.0,0.0,,,,1900.0
Kodarma,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,,,,0.0
Kodarma,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,254.0,525.0,448.0,1227.0
Kodarma,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1900.0,1900.0,1646.0,1121.0,673.0,7240.0
Kodarma,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1180.0,1130.0,20.0,20.0,,0.0,0.0,0.0,1000.0,800.0,800.0,780.0,5730.0
Kodarma,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1500.0,,0.0,0.0,1200.0,0.0,,0.0,,2700.0
Kodarma,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,,0.0,,0.0
Kodarma,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,50.0,1110.0,0.0,1520.0,,0.0,0.0,200.0,200.0,,20.0,,3100.0
Kodarma,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1130.0,20.0,20.0,0.0,0.0,0.0,0.0,1000.0,800.0,800.0,780.0,780.0,5330.0
Kodarma,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,60000.0,36000.0,3500.0,2000.0,26000.0,27660.0,15660.0,10620.0,5100.0,0.0,21500.0,208040.0
Kodarma,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,60000.0,30000.0,0.0,36000.0,60000.0,74480.0,0.0,0.0,0.0,,21500.0,,281980.0
Kodarma,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0
Kodarma,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,54000.0,32500.0,37500.0,36000.0,72820.0,12000.0,5040.0,5520.0,5100.0,0.0,18000.0,278480.0
Kodarma,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,60000.0,36000.0,3500.0,2000.0,26000.0,27660.0,15660.0,10620.0,5100.0,0.0,21500.0,3500.0,211540.0
Kodarma,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,1900.0,1500.0,2000.0,0.0,13200.0,11900.0,4700.0,4700.0,5000.0,44900.0
Kodarma,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,8900.0,2000.0,0.0,13200.0,0.0,0.0,,5000.0,,29100.0
Kodarma,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0
Kodarma,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,9300.0,1500.0,2000.0,0.0,1300.0,7200.0,,4700.0,2100.0,28100.0
Kodarma,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,1500.0,2000.0,0.0,13200.0,11900.0,4700.0,4700.0,5000.0,2900.0,45900.0
Kodarma,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,2700.0,3100.0,900.0,900.0,,7600.0
Kodarma,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,2700.0,1000.0,0.0,,0.0,,3700.0
Kodarma,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,,0.0,,0.0
Kodarma,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,600.0,2200.0,,900.0,,3700.0
Kodarma,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,2700.0,3100.0,900.0,900.0,0.0,0.0,7600.0
Kodarma,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,,,,,,,0.0
Kodarma,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,1000.0,0.0,0.0,1000.0,,0.0,0.0,,,,,,2000.0
Kodarma,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,1000.0,,0.0,0.0,,,,,,1000.0
Kodarma,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Kodarma,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,1000.0,200.0,0.0,,0.0,0.0,,,,,,1200.0
Kodarma,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,800.0,200.0,0.0,,0.0,0.0,,,,,,1000.0
Kodarma,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0
Kodarma,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Kodarma,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Kodarma,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,2000.0,18000.0,15000.0,12000.0,223000.0,270000.0
Kodarma,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,75000.0,103000.0,0.0,,1672000.0,,1850000.0
Kodarma,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,,,0.0,,0.0,,0.0
Kodarma,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,73000.0,87000.0,3000.0,3000.0,1461000.0,205000.0,1832000.0
Kodarma,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,18000.0,15000.0,12000.0,223000.0,18000.0,288000.0
Kodarma,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Kodarma,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodarma,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,609.0,5.0,38.0,28.0,8.0,8.0,645.0,201.0,1542.0
Kodarma,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,1520.0,0.0,100.0,0.0,0.0,,1945.0,0.0,,3565.0
Kodarma,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0
Kodarma,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,0.0,911.0,604.0,67.0,10.0,20.0,,1308.0,444.0,19.0,3383.0
Kodarma,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,609.0,5.0,38.0,28.0,8.0,8.0,645.0,201.0,182.0,1724.0
Kodarma,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,8998.0,3923.0,1461.0,1361.0,1361.0,1361.0,1311.0,19776.0
Kodarma,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,12000.0,0.0,0.0,0.0,,,0.0,,12000.0
Kodarma,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0
Kodarma,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,3002.0,5075.0,2462.0,100.0,,,50.0,870.0,11559.0
Kodarma,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,8998.0,3923.0,1461.0,1361.0,1361.0,1361.0,1311.0,441.0,20217.0
Kodarma,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,2800.0,1590.0,4361.0,3791.0,7756.0,6499.0,4599.0,3746.0,3716.0,3716.0,42574.0
Kodarma,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,3100.0,0.0,4300.0,0.0,5000.0,0.0,0.0,0.0,0.0,,1500.0,13900.0
Kodarma,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Kodarma,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,300.0,1210.0,1529.0,570.0,1035.0,1257.0,1900.0,853.0,30.0,,1409.0,10093.0
Kodarma,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,2800.0,1590.0,4361.0,3791.0,7756.0,6499.0,4599.0,3746.0,3716.0,3716.0,3807.0,46381.0
Kodarma,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,30000.0,26200.0,10955.0,13385.0,0.0,9600.0,0.0,1000.0,1595.0,0.0,0.0,92735.0
Kodarma,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,30000.0,10000.0,0.0,20000.0,0.0,15000.0,0.0,4000.0,139200.0,0.0,,0.0,218200.0
Kodarma,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Kodarma,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,13800.0,15245.0,17570.0,13385.0,5400.0,9600.0,3000.0,138605.0,1595.0,,0.0,218200.0
Kodarma,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,30000.0,26200.0,10955.0,13385.0,0.0,9600.0,0.0,1000.0,1595.0,0.0,0.0,0.0,92735.0
Kodarma,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,395401.0,395201.0,392201.0,388201.0,385771.0,377271.0,365271.0,363071.0,360771.0,337185.0,328585.0,326585.0,4415514.0
Kodarma,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28000.0,0.0,,0.0,28000.0
Kodarma,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Kodarma,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,200.0,3000.0,4000.0,2430.0,8500.0,12000.0,2200.0,2300.0,51586.0,8600.0,2000.0,500.0,97316.0
Kodarma,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,395201.0,392201.0,388201.0,385771.0,377271.0,365271.0,363071.0,360771.0,337185.0,328585.0,326585.0,326085.0,4346198.0
Kodarma,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,3.0,,1.0,,2.0,1.0,,,,,7.0
Kodarma,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kodarma,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kodarma,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Kodarma,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kodarma,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kodarma,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Kodarma,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kodarma,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kodarma,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Kodarma,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kodarma,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,1.0,,,3.0,,1.0,,,,5.0
Kodarma,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,1.0,,,3.0,,1.0,,,,5.0
Kodarma,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kodarma,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kodarma,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Kodarma,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kodarma,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,3.0,,,,,,3.0
Kodarma,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,3.0,,,,,,3.0
Kodarma,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kodarma,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kodarma,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Kodarma,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kodarma,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kodarma,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kodarma,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,1.0,1.0,,,,,,,,,2.0
Kodarma,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Kodarma,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,1.0,1.0,,,,,,,,,2.0
Kodarma,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,1.0,,,1.0,,1.0,3.0
Kodarma,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Kodarma,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,,,,1.0,,,1.0,,1.0,4.0
Kodarma,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Kodarma,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Kodarma,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Kodarma,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,,,,,1.0,,,,,2.0
Kodarma,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,2.0,,,1.0,,1.0,,,1.0,,5.0
Kodarma,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Kodarma,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,2.0,,,1.0,,1.0,,,2.0,,6.0
Kodarma,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Kodarma,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Kodarma,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,1.0,,,,,,,1.0
Kodarma,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Kodarma,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Kodarma,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Kodarma,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Kodarma,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kodarma,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Kodarma,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,1.0,1.0,,2.0
Kodarma,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,1.0,,1.0,2.0,,1.0,,1.0,1.0,,7.0
Kodarma,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,1.0,,1.0,2.0,,1.0,,2.0,2.0,,9.0
Kodarma,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Kodarma,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Kodarma,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Kodarma,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Kodarma,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kodarma,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,1.0,,,,,,,1.0
Kodarma,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,1.0,,1.0,,,,2.0
Kodarma,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kodarma,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,1.0,,1.0,,,,2.0
Kodarma,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Kodarma,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,1.0,,,,1.0,,,,,2.0
Kodarma,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,1.0,,,,1.0,,,,,2.0
Kodarma,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Kodarma,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kodarma,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,1.0,,,,,,,,1.0
Kodarma,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kodarma,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kodarma,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kodarma,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,1.0,1.0,1.0,2.0,,,,,5.0
Kodarma,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,2.0,,,,,,2.0
Kodarma,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,1.0,1.0,3.0,2.0,,,,,7.0
Kodarma,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,1.0,1.0,2.0,3.0,2.0,3.0,,2.0,4.0,3.0,,22.0
Kodarma,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,2.0,2.0,,1.0,1.0,,,,,,7.0
Kodarma,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,2.0,3.0,4.0,3.0,3.0,4.0,,2.0,4.0,3.0,,29.0
Kodarma,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Kodarma,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Kodarma,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,1.0,,,,,,,,,,2.0
Kodarma,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Kodarma,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Kodarma,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Kodarma,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,1.0,,1.0,,,,,,2.0
Kodarma,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,3.0,2.0,3.0,3.0,1.0,2.0,,1.0,,15.0
Kodarma,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,1.0,3.0,3.0,,1.0,1.0,,,,,9.0
Kodarma,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,1.0,6.0,5.0,3.0,4.0,2.0,2.0,,1.0,,24.0
Kodarma,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Kodarma,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,1.0,1.0,,5.0,1.0,1.0,1.0,,,10.0
Kodarma,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,3.0,1.0,1.0,2.0,,1.0,,,,8.0
Kodarma,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,4.0,2.0,1.0,7.0,1.0,2.0,1.0,,,18.0
Kodarma,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Kodarma,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,1.0,3.0,2.0,,,,1.0,,7.0
Kodarma,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,3.0,4.0,1.0,1.0,1.0,,,,,,10.0
Kodarma,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,3.0,4.0,2.0,5.0,3.0,,,,1.0,,18.0
Latehar,1.1,Total number of pregnant women Registered for ANC,TOTAL,1970.0,1581.0,1835.0,2021.0,1395.0,1433.0,1234.0,1217.0,1305.0,1653.0,1599.0,1376.0,18619.0
Latehar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,467.0,378.0,452.0,461.0,302.0,400.0,295.0,227.0,306.0,390.0,325.0,281.0,4284.0
Latehar,1.2,Number of Pregnant women registered under JSY,TOTAL,1746.0,1491.0,1746.0,2021.0,1392.0,1433.0,1228.0,1195.0,1280.0,1635.0,1570.0,1345.0,18082.0
Latehar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1321.0,1124.0,1317.0,1360.0,1199.0,1197.0,1069.0,1078.0,995.0,1084.0,1070.0,1034.0,13848.0
Latehar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1754.0,1401.0,1721.0,1872.0,1273.0,1341.0,1206.0,1141.0,1229.0,1546.0,1532.0,1253.0,17269.0
Latehar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1500.0,1564.0,1559.0,1646.0,1582.0,1269.0,1169.0,1152.0,1103.0,1147.0,1503.0,1430.0,16624.0
Latehar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,271.0,287.0,317.0,1141.0,1454.0,78.0,83.0,786.0,1809.0,1071.0,1440.0,1127.0,9864.0
Latehar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,17.0,4.0,3.0,2.0,2.0,1.0,5.0,0.0,5.0,14.0,0.0,0.0,53.0
Latehar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
Latehar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,46.0,64.0,56.0,96.0,69.0,79.0,56.0,116.0,88.0,114.0,100.0,106.0,990.0
Latehar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,2.0,1.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,2.0,5.0,14.0
Latehar,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Latehar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,74.0,86.0,170.0,183.0,203.0,160.0,111.0,91.0,81.0,99.0,175.0,116.0,1549.0
Latehar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,753.0,693.0,732.0,831.0,622.0,551.0,631.0,680.0,567.0,670.0,560.0,437.0,7727.0
Latehar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,827.0,779.0,902.0,1014.0,825.0,711.0,742.0,771.0,648.0,769.0,735.0,553.0,9276.0
Latehar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,625.0,620.0,771.0,910.0,661.0,613.0,612.0,672.0,570.0,652.0,585.0,437.0,7728.0
Latehar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,22.0,9.0,1.0,0.0,0.0,7.0,0.0,7.0,3.0,0.0,0.0,49.0
Latehar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,664.0,516.0,614.0,860.0,807.0,809.0,773.0,840.0,689.0,733.0,527.0,626.0,8458.0
Latehar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,598.0,417.0,477.0,663.0,629.0,679.0,609.0,656.0,601.0,534.0,416.0,449.0,6728.0
Latehar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,393.0,526.0,609.0,779.0,741.0,796.0,742.0,814.0,652.0,661.0,493.0,573.0,7779.0
Latehar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,261.0,360.0,515.0,577.0,423.0,553.0,587.0,658.0,558.0,547.0,423.0,526.0,5988.0
Latehar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,2.0,0.0,6.0,0.0,0.0,0.0,0.0,51.0,0.0,0.0,0.0,0.0,59.0
Latehar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Latehar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Latehar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Latehar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Latehar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,0.0,0.0,0.0,0.0,,0.0,0.0
Latehar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Latehar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Latehar,4.1.1.a,Number of male live births,TOTAL,798.0,701.0,809.0,1007.0,869.0,770.0,812.0,825.0,686.0,830.0,679.0,640.0,9426.0
Latehar,4.1.1.b,Number of female live births,TOTAL,714.0,629.0,755.0,883.0,770.0,783.0,704.0,783.0,642.0,666.0,584.0,545.0,8458.0
Latehar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1512.0,1330.0,1564.0,1890.0,1639.0,1553.0,1516.0,1608.0,1328.0,1496.0,1263.0,1185.0,17884.0
Latehar,4.1.2,Number of still births,TOTAL,14.0,10.0,17.0,14.0,35.0,15.0,16.0,11.0,14.0,30.0,27.0,23.0,226.0
Latehar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,19.0,10.0,16.0,20.0,12.0,18.0,10.0,14.0,16.0,18.0,24.0,20.0,197.0
Latehar,4.2.1,Number of Newborns weighed at birth,TOTAL,1379.0,1166.0,1480.0,1636.0,1412.0,1326.0,1310.0,1375.0,1153.0,1290.0,1091.0,1021.0,15639.0
Latehar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,83.0,50.0,65.0,72.0,37.0,34.0,54.0,66.0,51.0,44.0,14.0,50.0,620.0
Latehar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1460.0,1261.0,1511.0,1829.0,1545.0,1468.0,1465.0,1549.0,1273.0,1436.0,1200.0,1122.0,17119.0
Latehar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,10.0,0.0,7.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,22.0
Latehar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Latehar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,10.0,0.0,7.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0
Latehar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Latehar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,29.0,0.0,4.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,38.0
Latehar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,14.0,0.0,2.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0
Latehar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1178.0,903.0,1058.0,1115.0,1027.0,1034.0,1062.0,1154.0,1021.0,1127.0,761.0,775.0,12215.0
Latehar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,702.0,575.0,484.0,722.0,491.0,485.0,408.0,384.0,331.0,397.0,466.0,399.0,5844.0
Latehar,6.3,PNC maternal complications attended,TOTAL,0.0,1.0,0.0,7.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Latehar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,5.0,5.0,0.0,9.0,25.0
Latehar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,5.0,5.0,0.0,9.0,25.0
Latehar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,0.0,0.0,2.0,12.0,2.0,2.0,4.0,2.0,0.0,0.0,0.0,24.0
Latehar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,0.0,0.0,0.0,1.0,38.0,2.0,1.0,2.0,1.0,1.0,4.0,0.0,50.0
Latehar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,0.0,0.0,0.0,3.0,50.0,4.0,3.0,6.0,3.0,1.0,4.0,0.0,74.0
Latehar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,3.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Latehar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,2.0,0.0,131.0,1.0,0.0,0.0,16.0,47.0,92.0,27.0,8.0,324.0
Latehar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Latehar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Latehar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,2.0,0.0,134.0,4.0,0.0,0.0,16.0,47.0,92.0,27.0,8.0,330.0
Latehar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Latehar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,138.0,0.0,0.0,0.0,0.0,0.0,27.0,0.0,0.0,165.0
Latehar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Latehar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Latehar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,138.0,0.0,0.0,0.0,0.0,0.0,27.0,0.0,0.0,165.0
Latehar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Latehar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,12.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0
Latehar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,33.0,0.0,0.0,380.0,5.0,16.0,0.0,216.0,987.0,1079.0,340.0,3.0,3059.0
Latehar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Latehar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Latehar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,33.0,0.0,0.0,392.0,12.0,16.0,0.0,216.0,987.0,1079.0,340.0,3.0,3078.0
Latehar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Latehar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Latehar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Latehar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Latehar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,113.0,151.0,156.0,258.0,151.0,84.0,122.0,129.0,91.0,138.0,144.0,88.0,1625.0
Latehar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,14.0,9.0,3.0,24.0,4.0,7.0,10.0,8.0,9.0,13.0,8.0,0.0,109.0
Latehar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,18.0,28.0,7.0,229.0,9.0,18.0,49.0,20.0,43.0,86.0,32.0,9.0,548.0
Latehar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4.0,2.0,2.0,0.0,3.0,2.0,2.0,3.0,3.0,3.0,,2.0,26.0
Latehar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Latehar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,149.0,190.0,168.0,511.0,167.0,111.0,183.0,160.0,146.0,240.0,184.0,99.0,2308.0
Latehar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Latehar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Latehar,9.06,Number of IUCD removals,TOTAL,60.0,53.0,241.0,136.0,97.0,92.0,46.0,107.0,73.0,101.0,104.0,73.0,1183.0
Latehar,9.07,Number of Oral Pills cycles distributed,TOTAL,1254.0,1128.0,1215.0,5120.0,1183.0,967.0,1305.0,1133.0,943.0,2081.0,1348.0,1051.0,18728.0
Latehar,9.08,Number of Condom pieces distributed,TOTAL,7993.0,7484.0,7870.0,23841.0,6656.0,6895.0,7383.0,6641.0,7016.0,8435.0,7066.0,6098.0,103378.0
Latehar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,78.0,25.0,6.0,30.0,1.0,24.0,2.0,0.0,166.0
Latehar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,50.0,73.0,148.0,136.0,119.0,103.0,83.0,81.0,94.0,144.0,91.0,1122.0
Latehar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Latehar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Latehar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,9.12,Number of Institutions having NSV trained doctors,TOTAL,11.0,10.0,10.0,9.0,9.0,9.0,8.0,8.0,8.0,9.0,8.0,8.0,-1.0
Latehar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1362.0,1386.0,1538.0,2075.0,1717.0,1243.0,1948.0,1636.0,605.0,1409.0,1365.0,333.0,16617.0
Latehar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1424.0,1244.0,1376.0,1809.0,1666.0,1747.0,1694.0,1767.0,1784.0,1533.0,1538.0,1538.0,19120.0
Latehar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1498.0,1383.0,1337.0,1492.0,1663.0,1652.0,1628.0,1700.0,1845.0,1601.0,2033.0,1489.0,19321.0
Latehar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1672.0,1461.0,1397.0,1403.0,1473.0,1550.0,1453.0,1548.0,1816.0,1615.0,1690.0,1604.0,18682.0
Latehar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Latehar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Latehar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Latehar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,693.0,664.0,730.0,960.0,780.0,681.0,904.0,453.0,119.0,513.0,124.0,138.0,6759.0
Latehar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1377.0,1253.0,1380.0,1797.0,1593.0,1549.0,1699.0,876.0,292.0,1144.0,360.0,378.0,13698.0
Latehar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1420.0,1374.0,1343.0,1496.0,1539.0,1357.0,1612.0,833.0,336.0,1139.0,387.0,295.0,13131.0
Latehar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1644.0,1446.0,1391.0,1392.0,1351.0,1331.0,1433.0,755.0,301.0,1076.0,397.0,383.0,12900.0
Latehar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,20.0
Latehar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,5.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0,1481.0,1231.0,2759.0
Latehar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24.0,991.0,1015.0
Latehar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,72.0,82.0
Latehar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2856.0,2477.0,2196.0,2083.0,1755.0,1689.0,1532.0,986.0,1028.0,1214.0,1625.0,1506.0,20947.0
Latehar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,,,,0.0,6.0,0.0,0.0,0.0,0.0,10.0,0.0,16.0
Latehar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Latehar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1434.0,1219.0,1121.0,1019.0,798.0,850.0,777.0,451.0,359.0,581.0,807.0,634.0,10050.0
Latehar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1335.0,1202.0,1055.0,990.0,671.0,764.0,693.0,463.0,319.0,548.0,756.0,591.0,9387.0
Latehar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2769.0,2421.0,2176.0,2009.0,1469.0,1614.0,1470.0,914.0,678.0,1129.0,1563.0,1225.0,19437.0
Latehar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1144.0,1127.0,1097.0,1127.0,1170.0,1085.0,1016.0,920.0,1119.0,1244.0,1510.0,1408.0,13967.0
Latehar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1118.0,1126.0,1069.0,1101.0,1106.0,927.0,970.0,465.0,359.0,871.0,410.0,307.0,9829.0
Latehar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,421.0,518.0,587.0,481.0,535.0,469.0,286.0,239.0,239.0,312.0,252.0,287.0,4626.0
Latehar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,386.0,470.0,507.0,419.0,513.0,387.0,282.0,185.0,227.0,291.0,250.0,248.0,4165.0
Latehar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,807.0,988.0,1094.0,900.0,1048.0,856.0,568.0,424.0,466.0,603.0,502.0,535.0,8791.0
Latehar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,119.0,114.0,99.0,238.0,106.0,142.0,94.0,113.0,122.0,142.0,113.0,1402.0
Latehar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,901.0,870.0,887.0,747.0,879.0,738.0,730.0,686.0,830.0,663.0,658.0,876.0,9465.0
Latehar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1090.0,883.0,892.0,794.0,885.0,796.0,645.0,635.0,755.0,1098.0,686.0,815.0,9974.0
Latehar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,0.0,0.0,0.0,0.0,3.0,0.0,1.0,0.0,1.0,4.0,0.0,11.0
Latehar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1041.0,1017.0,1021.0,1030.0,1028.0,1033.0,984.0,1001.0,974.0,1005.0,987.0,1011.0,12132.0
Latehar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,993.0,970.0,988.0,993.0,993.0,1012.0,945.0,958.0,941.0,948.0,959.0,959.0,11659.0
Latehar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,838.0,842.0,779.0,865.0,797.0,808.0,725.0,807.0,796.0,787.0,838.0,842.0,9724.0
Latehar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1152.0,1164.0,1294.0,1234.0,3406.0,1335.0,1486.0,846.0,563.0,694.0,3016.0,1589.0,17779.0
Latehar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,12.0,0.0,0.0,11172.0,593.0,967.0,37.0,31.0,49.0,12415.0,449.0,25725.0
Latehar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,14160.0,734.0,1515.0,6.0,0.0,12.0,13469.0,500.0,30396.0
Latehar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,7.0,0.0,0.0,6.0,0.0,17.0,0.0,3.0,5.0,0.0,39.0,24.0,101.0
Latehar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,43.0,51.0,29.0,47.0,48.0,56.0,24.0,12.0,46.0,20.0,247.0,32.0,655.0
Latehar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,176.0,86.0,52.0,54.0,36.0,106.0,17.0,11.0,34.0,8.0,420.0,8.0,1008.0
Latehar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,2449.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2449.0
Latehar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,3.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,2.0,4.0,-1.0
Latehar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,4.0,3.0,5.0,4.0,3.0,3.0,4.0,3.0,4.0,3.0,5.0,-1.0
Latehar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,545.0,587.0,743.0,780.0,744.0,761.0,708.0,688.0,712.0,732.0,711.0,728.0,-1.0
Latehar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,6.0,8.0,7.0,8.0,8.0,8.0,8.0,7.0,8.0,7.0,8.0,-1.0
Latehar,14.05,Number of RKS meetings held during the month,TOTAL,5.0,3.0,3.0,4.0,5.0,5.0,9.0,10.0,10.0,7.0,7.0,8.0,76.0
Latehar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,9.0,8.0,9.0,10.0,8.0,9.0,8.0,7.0,7.0,6.0,7.0,-1.0
Latehar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,112.0,32.0,28.0,28.0,32.0,14.0,17.0,54.0,54.0,74.0,3.0,18.0,466.0
Latehar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,3.0,4.0,3.0,4.0,5.0,3.0,4.0,4.0,5.0,5.0,4.0,-1.0
Latehar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Latehar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,25.0,46.0,44.0,68.0,44.0,25.0,25.0,18.0,23.0,30.0,21.0,27.0,396.0
Latehar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,358.0,226.0,197.0,193.0,243.0,163.0,98.0,109.0,106.0,103.0,63.0,114.0,1973.0
Latehar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,18.0,37.0,29.0,55.0,40.0,18.0,25.0,14.0,14.0,19.0,18.0,18.0,305.0
Latehar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,690.0,331.0,327.0,449.0,335.0,238.0,323.0,291.0,321.0,907.0,136.0,242.0,4590.0
Latehar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,43.0,83.0,73.0,123.0,84.0,43.0,50.0,32.0,37.0,49.0,39.0,45.0,701.0
Latehar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1048.0,557.0,524.0,642.0,578.0,401.0,421.0,400.0,427.0,1010.0,199.0,356.0,6563.0
Latehar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,9.0,0.0,2.0,0.0,4.0,39.0,0.0,1.0,1.0,0.0,0.0,0.0,56.0
Latehar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,2.0,3.0,2.0,1.0,25.0,0.0,0.0,3.0,1.0,0.0,0.0,43.0
Latehar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,15.0,2.0,5.0,2.0,5.0,64.0,0.0,1.0,4.0,1.0,0.0,0.0,99.0
Latehar,14.11,In-Patient Head Count at midnight,TOTAL,952.0,579.0,458.0,636.0,590.0,372.0,344.0,393.0,408.0,819.0,149.0,387.0,6087.0
Latehar,14.12.1,OPD attendance (All),TOTAL,41550.0,30770.0,31008.0,31011.0,33348.0,32890.0,29196.0,27804.0,21340.0,21826.0,21531.0,22869.0,345143.0
Latehar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,13.0,9.0,200.0,7.0,0.0,0.0,8.0,721.0,90.0,45.0,0.0,1093.0
Latehar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Latehar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,33.0,23.0,29.0,66.0,64.0,0.0,0.0,0.0,20.0,0.0,0.0,0.0,235.0
Latehar,14.14.a,Number of patients given AYUSH treatment,TOTAL,12162.0,45.0,21.0,21.0,12.0,635.0,0.0,600.0,0.0,479.0,0.0,458.0,14433.0
Latehar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,291.0,620.0,123.0,239.0,253.0,903.0,0.0,0.0,0.0,462.0,0.0,0.0,2891.0
Latehar,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,164.0,173.0,131.0,0.0,0.0,0.0,0.0,0.0,0.0,71.0,539.0
Latehar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,207.0,186.0,251.0,661.0,359.0,313.0,425.0,670.0,1083.0,780.0,347.0,377.0,5659.0
Latehar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1.0,8.0,4.0,29.0,6.0,7.0,3.0,3.0,14.0,3.0,8.0,3.0,89.0
Latehar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,111.0,24.0,36.0,32.0,28.0,28.0,30.0,40.0,18.0,28.0,0.0,0.0,375.0
Latehar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,64.0,67.0
Latehar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,69.0,24.0,24.0,23.0,22.0,22.0,62.0,13.0,35.0,23.0,0.0,0.0,317.0
Latehar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,76.0,77.0
Latehar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,210.0,81.0,93.0,118.0,72.0,81.0,81.0,69.0,62.0,57.0,0.0,0.0,924.0
Latehar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,10.0
Latehar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,390.0,129.0,153.0,173.0,122.0,131.0,173.0,122.0,115.0,108.0,0.0,0.0,1616.0
Latehar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,150.0,154.0
Latehar,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,15.4.1,Number of blood smears examined for Malaria,TOTAL,3746.0,4027.0,4489.0,8455.0,6628.0,20709.0,4263.0,7224.0,6472.0,4944.0,2523.0,1764.0,75244.0
Latehar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,464.0,474.0,455.0,842.0,731.0,881.0,447.0,802.0,649.0,512.0,276.0,236.0,6769.0
Latehar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,29.0,13.0,24.0,84.0,75.0,186.0,150.0,385.0,266.0,50.0,11.0,10.0,1283.0
Latehar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,22510.0,29790.0,11750.0,7100.0,18200.0,39610.0,51920.0,43160.0,49390.0,39210.0,23430.0,12730.0,348800.0
Latehar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,15000.0,0.0,0.0,25000.0,26000.0,25000.0,,20000.0,0.0,0.0,0.0,25000.0,136000.0
Latehar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,7720.0,12040.0,10650.0,8750.0,8620.0,12690.0,8760.0,13770.0,10180.0,15780.0,15700.0,5010.0,129670.0
Latehar,16.1.1,Stock position of DPT vaccines,5. Total Stock,29790.0,17750.0,1100.0,23350.0,35580.0,51920.0,43160.0,49390.0,39210.0,23430.0,7730.0,32720.0,355130.0
Latehar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Latehar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Latehar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Latehar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Latehar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0.0,52320.0,34240.0,18020.0,1660.0,14960.0,10800.0,1380.0,980.0,7080.0,1300.0,580.0,143320.0
Latehar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,60000.0,0.0,0.0,0.0,20000.0,10000.0,,0.0,9500.0,0.0,181000.0,0.0,280500.0
Latehar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7680.0,18080.0,16220.0,11860.0,20460.0,14160.0,9420.0,400.0,3400.0,5780.0,181720.0,0.0,289180.0
Latehar,16.1.2,Stock position of OPV vaccines,5. Total Stock,52320.0,34240.0,18020.0,6160.0,1200.0,10800.0,1380.0,980.0,7080.0,1300.0,580.0,580.0,134640.0
Latehar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,11950.0,26330.0,15540.0,6340.0,7980.0,23290.0,34320.0,25360.0,13840.0,33090.0,19090.0,9600.0,226730.0
Latehar,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,0.0,0.0,16500.0,18000.0,25000.0,,0.0,25000.0,0.0,0.0,10000.0,114500.0
Latehar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5620.0,10790.0,9200.0,8700.0,12310.0,13970.0,8960.0,11520.0,5350.0,14000.0,12990.0,4210.0,117620.0
Latehar,16.1.3,Stock position of TT vaccines,5. Total Stock,26330.0,15540.0,6340.0,14140.0,13670.0,34320.0,25360.0,13840.0,33490.0,19090.0,6100.0,15390.0,223610.0
Latehar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,14770.0,30220.0,20460.0,13050.0,3510.0,4460.0,18480.0,6940.0,5700.0,12835.0,3160.0,0.0,133585.0
Latehar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,20000.0,0.0,0.0,0.0,3000.0,20000.0,,0.0,0.0,0.0,0.0,5000.0,48000.0
Latehar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4550.0,9760.0,7410.0,6110.0,3500.0,5980.0,11540.0,1240.0,250.0,3500.0,1850.0,2200.0,57890.0
Latehar,16.1.5,Stock position of BCG vaccines,5. Total Stock,30220.0,20460.0,13050.0,6940.0,3010.0,18480.0,6940.0,5700.0,5450.0,9335.0,1310.0,2800.0,123695.0
Latehar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,6800.0,14000.0,7595.0,3580.0,115.0,3005.0,5610.0,1630.0,6065.0,15085.0,9485.0,5950.0,78920.0
Latehar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,0.0,0.0,750.0,5000.0,7500.0,,7500.0,173900.0,0.0,0.0,10000.0,214650.0
Latehar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2800.0,6405.0,4015.0,3175.0,4100.0,4895.0,3980.0,3065.0,164880.0,3350.0,5535.0,2840.0,209040.0
Latehar,16.1.6,Stock position of Measles vaccines,5. Total Stock,14000.0,7595.0,3580.0,1155.0,1015.0,5610.0,1630.0,6065.0,15085.0,11735.0,3950.0,13110.0,84530.0
Latehar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13900.0,11500.0,25400.0
Latehar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22000.0,0.0,0.0,22000.0
Latehar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,8100.0,2400.0,4500.0,15000.0
Latehar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13900.0,11500.0,7000.0,32400.0
Latehar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,950.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,950.0
Latehar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,950.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,950.0
Latehar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,46000.0,28000.0,22000.0,0.0,0.0,0.0,102000.0,90000.0,90000.0,30000.0,18000.0,18000.0,444000.0
Latehar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,18000.0,0.0,120000.0,,0.0,0.0,0.0,0.0,22000.0,160000.0
Latehar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,18000.0,6000.0,22000.0,18000.0,0.0,18000.0,12000.0,0.0,60000.0,12000.0,6000.0,22000.0,194000.0
Latehar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,28000.0,22000.0,0.0,0.0,0.0,102000.0,90000.0,90000.0,30000.0,18000.0,12000.0,18000.0,410000.0
Latehar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,3000.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,3000.0
Latehar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0
Latehar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1700.0,0.0,0.0,,0.0,0.0,0.0,0.0,7000.0,8700.0
Latehar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,1700.0,0.0,0.0,,0.0,0.0,0.0,0.0,7000.0,8700.0
Latehar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,2000.0,2000.0,2000.0,1500.0,1300.0,800.0,800.0,800.0,800.0,0.0,0.0,0.0,12000.0
Latehar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,,500.0,200.0,500.0,0.0,,0.0,0.0,0.0,0.0,0.0,1200.0
Latehar,16.3.02,Stock Position of Gloves,5. Total Stock,2000.0,2000.0,1500.0,1300.0,800.0,800.0,800.0,800.0,800.0,0.0,0.0,0.0,10800.0
Latehar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,5.0,5.0,0.0,5.0,5.0,5.0,5.0,5.0,5.0,0.0,5.0,5.0,50.0
Latehar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,5.0,0.0,,5.0,0.0,0.0,0.0,0.0,10.0
Latehar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,5.0,5.0,0.0,5.0,0.0,5.0,5.0,0.0,5.0,0.0,5.0,5.0,40.0
Latehar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,20000.0,10000.0,10000.0,5000.0,0.0,45000.0
Latehar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,30000.0,30000.0,0.0,0.0,0.0,0.0,60000.0
Latehar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,40000.0,0.0,5000.0,0.0,0.0,55000.0
Latehar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,10000.0,10000.0,5000.0,5000.0,0.0,50000.0
Latehar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,770.0,0.0,,0.0,50.0,50.0,50.0,0.0,920.0
Latehar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,1570.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,1570.0
Latehar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,800.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,800.0
Latehar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,770.0,770.0,0.0,0.0,0.0,50.0,50.0,50.0,0.0,1690.0
Latehar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1500.0,200.0,0.0,600.0,400.0,100.0,3500.0,2700.0,1700.0,1700.0,800.0,0.0,13200.0
Latehar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,4000.0,0.0,1000.0,0.0,0.0,6900.0,,0.0,,0.0,0.0,1500.0,13400.0
Latehar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5300.0,200.0,400.0,200.0,100.0,3500.0,800.0,1000.0,0.0,900.0,0.0,1200.0,13600.0
Latehar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,200.0,0.0,600.0,400.0,300.0,3500.0,2700.0,1700.0,1700.0,800.0,800.0,300.0,13000.0
Latehar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,29400.0,45400.0,35400.0,29400.0,29400.0,19400.0,17800.0,11800.0,5800.0,57000.0,51000.0,4000.0,335800.0
Latehar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,36000.0,0.0,0.0,0.0,0.0,0.0,,0.0,58400.0,0.0,0.0,36000.0,130400.0
Latehar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,20000.0,10000.0,6000.0,0.0,10000.0,1600.0,6000.0,6000.0,7200.0,6000.0,2000.0,30000.0,104800.0
Latehar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,45400.0,35400.0,29400.0,29400.0,19400.0,17800.0,11800.0,5800.0,57000.0,51000.0,49000.0,10000.0,361400.0
Latehar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,500.0,2500.0,2500.0,2500.0,2500.0,2000.0,2000.0,20000.0,2000.0,4000.0,0.0,6000.0,46500.0
Latehar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000.0,0.0,0.0,0.0,0.0,0.0,,0.0,3000.0,0.0,4000.0,0.0,11000.0
Latehar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Latehar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2000.0,0.0,0.0,0.0,500.0,0.0,0.0,0.0,1000.0,4000.0,2000.0,3000.0,12500.0
Latehar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2500.0,2500.0,2500.0,2500.0,2000.0,2000.0,2000.0,20000.0,4000.0,0.0,2000.0,3000.0,45000.0
Latehar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Latehar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Latehar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Latehar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Latehar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Latehar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Latehar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Latehar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Latehar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Latehar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Latehar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,1.0,1.0
Latehar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Latehar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,1.0,1.0
Latehar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Latehar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Latehar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Latehar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Latehar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Latehar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Latehar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Latehar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Latehar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Latehar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Latehar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Latehar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Latehar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Latehar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Latehar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Latehar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Latehar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Latehar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Latehar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Latehar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Latehar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Latehar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Latehar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Latehar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Latehar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Latehar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Latehar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Latehar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Latehar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Latehar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Latehar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Latehar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Latehar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Latehar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Latehar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Latehar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Latehar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,1.0,,,,,,,,,1.0
Latehar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Latehar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Latehar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Latehar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Latehar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Latehar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Latehar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Latehar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Latehar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Latehar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Latehar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Latehar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Latehar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Latehar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Latehar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Latehar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Latehar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Latehar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Latehar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Latehar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,1.0,1.0
Latehar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Latehar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Latehar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,1.0,1.0
Latehar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Latehar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Latehar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Latehar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,1.0,,,,,,,,,1.0
Lohardaga,1.1,Total number of pregnant women Registered for ANC,TOTAL,982.0,1022.0,980.0,1141.0,817.0,915.0,948.0,918.0,756.0,923.0,1001.0,777.0,11180.0
Lohardaga,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,190.0,154.0,212.0,185.0,146.0,143.0,155.0,182.0,160.0,173.0,238.0,161.0,2099.0
Lohardaga,1.2,Number of Pregnant women registered under JSY,TOTAL,915.0,986.0,938.0,1099.0,757.0,867.0,921.0,854.0,756.0,912.0,982.0,691.0,10678.0
Lohardaga,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,605.0,597.0,585.0,614.0,588.0,610.0,617.0,659.0,560.0,606.0,598.0,621.0,7260.0
Lohardaga,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,851.0,932.0,890.0,1055.0,769.0,821.0,895.0,786.0,702.0,834.0,927.0,682.0,10144.0
Lohardaga,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,720.0,882.0,823.0,779.0,856.0,643.0,752.0,861.0,665.0,665.0,803.0,768.0,9217.0
Lohardaga,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,517.0,534.0,379.0,235.0,156.0,74.0,196.0,413.0,553.0,615.0,752.0,635.0,5059.0
Lohardaga,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,31.0,7.0,11.0,21.0,24.0,11.0,39.0,168.0,12.0,13.0,15.0,9.0,361.0
Lohardaga,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,0.0,2.0,1.0,1.0,0.0,1.0,2.0,1.0,1.0,0.0,0.0,10.0
Lohardaga,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,149.0,108.0,99.0,56.0,216.0,164.0,277.0,201.0,301.0,245.0,223.0,202.0,2241.0
Lohardaga,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,5.0,15.0,0.0,11.0,11.0,11.0,13.0,11.0,5.0,11.0,7.0,101.0
Lohardaga,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Lohardaga,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,13.0,23.0,19.0,27.0,28.0,14.0,11.0,14.0,12.0,19.0,5.0,24.0,209.0
Lohardaga,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,240.0,235.0,227.0,279.0,230.0,243.0,229.0,227.0,185.0,190.0,147.0,119.0,2551.0
Lohardaga,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,253.0,258.0,246.0,306.0,258.0,257.0,240.0,241.0,197.0,209.0,152.0,143.0,2760.0
Lohardaga,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,235.0,162.0,161.0,205.0,161.0,156.0,134.0,188.0,167.0,202.0,112.0,126.0,2009.0
Lohardaga,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,11.0,25.0,11.0,2.0,4.0,2.0,13.0,8.0,11.0,0.0,3.0,0.0,90.0
Lohardaga,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,464.0,508.0,452.0,518.0,489.0,551.0,546.0,531.0,499.0,573.0,461.0,509.0,6101.0
Lohardaga,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,443.0,476.0,452.0,518.0,487.0,551.0,543.0,526.0,497.0,573.0,457.0,506.0,6029.0
Lohardaga,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,667.0,316.0,588.0,631.0,447.0,502.0,802.0,532.0,550.0,634.0,397.0,530.0,6596.0
Lohardaga,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,224.0,305.0,417.0,340.0,361.0,387.0,342.0,465.0,285.0,754.0,359.0,425.0,4664.0
Lohardaga,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,15.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,19.0
Lohardaga,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,133.0,135.0,122.0,142.0,160.0,150.0,133.0,127.0,111.0,90.0,495.0,104.0,1902.0
Lohardaga,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0,32.0,35.0,89.0
Lohardaga,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,9.0,20.0
Lohardaga,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Lohardaga,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,2.0,1.0,1.0,2.0,3.0,5.0,1.0,3.0,1.0,3.0,22.0
Lohardaga,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohardaga,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,2.0,1.0,1.0,2.0,3.0,5.0,1.0,3.0,1.0,3.0,22.0
Lohardaga,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,58.0,53.0,43.0,50.0,72.0,54.0,65.0,63.0,66.0,57.0,81.0,59.0,721.0
Lohardaga,4.1.1.a,Number of male live births,TOTAL,441.0,467.0,432.0,483.0,464.0,508.0,479.0,461.0,415.0,433.0,587.0,410.0,5580.0
Lohardaga,4.1.1.b,Number of female live births,TOTAL,401.0,407.0,384.0,467.0,457.0,456.0,446.0,441.0,392.0,431.0,515.0,341.0,5138.0
Lohardaga,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,842.0,874.0,816.0,950.0,921.0,964.0,925.0,902.0,807.0,864.0,1102.0,751.0,10718.0
Lohardaga,4.1.2,Number of still births,TOTAL,9.0,15.0,9.0,24.0,12.0,13.0,10.0,11.0,10.0,9.0,7.0,6.0,135.0
Lohardaga,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,17.0,16.0,20.0,22.0,19.0,18.0,24.0,20.0,61.0,17.0,83.0,16.0,333.0
Lohardaga,4.2.1,Number of Newborns weighed at birth,TOTAL,839.0,843.0,812.0,920.0,900.0,955.0,902.0,860.0,755.0,842.0,973.0,725.0,10326.0
Lohardaga,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,128.0,122.0,115.0,148.0,122.0,305.0,122.0,115.0,118.0,122.0,106.0,102.0,1625.0
Lohardaga,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,839.0,851.0,810.0,944.0,913.0,963.0,907.0,887.0,791.0,852.0,1097.0,735.0,10589.0
Lohardaga,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,25.0,0.0,0.0,34.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,59.0
Lohardaga,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,1.0,1.0,147.0,17.0,161.0,21.0,162.0,18.0,12.0,14.0,12.0,23.0,589.0
Lohardaga,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohardaga,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,1.0,26.0,147.0,17.0,195.0,21.0,162.0,18.0,12.0,14.0,12.0,23.0,648.0
Lohardaga,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,54.0,65.0,63.0,66.0,57.0,59.0,59.0,423.0
Lohardaga,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1.0,26.0,51.0,160.0,195.0,203.0,162.0,162.0,179.0,179.0,140.0,184.0,1642.0
Lohardaga,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,0.0,2.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,7.0
Lohardaga,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1.0,26.0,147.0,160.0,195.0,203.0,162.0,159.0,179.0,179.0,140.0,184.0,1735.0
Lohardaga,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,1.0,0.0,7.0,6.0,10.0,6.0,11.0,7.0,7.0,55.0
Lohardaga,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,696.0,673.0,659.0,728.0,715.0,318.0,404.0,604.0,549.0,666.0,501.0,517.0,7030.0
Lohardaga,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,384.0,349.0,425.0,475.0,447.0,295.0,247.0,208.0,241.0,305.0,280.0,145.0,3801.0
Lohardaga,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,5.0,0.0,6.0,2.0,2.0,4.0,21.0
Lohardaga,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,12.0,8.0,14.0,12.0,13.0,13.0,1.0,6.0,8.0,8.0,10.0,14.0,119.0
Lohardaga,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,13.0,7.0,0.0,0.0,0.0,0.0,20.0
Lohardaga,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,12.0,8.0,14.0,12.0,13.0,13.0,14.0,13.0,8.0,8.0,10.0,14.0,139.0
Lohardaga,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0,0.0,69.0,0.0,114.0
Lohardaga,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,0.0,16.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,15.0,13.0,53.0
Lohardaga,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,3.0,0.0,180.0,2.0,4.0,1.0,165.0,1.0,0.0,1.0,110.0,87.0,554.0
Lohardaga,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,3.0,0.0,196.0,2.0,4.0,1.0,174.0,1.0,0.0,1.0,125.0,100.0,607.0
Lohardaga,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,35.0,0.0,0.0,0.0,1.0,2.0,14.0,3.0,0.0,55.0
Lohardaga,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,0.0,150.0,10.0,8.0,8.0,9.0,7.0,46.0,45.0,5.0,289.0
Lohardaga,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,12.0,2.0,1.0,2.0,2.0,3.0,8.0,16.0,8.0,55.0
Lohardaga,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohardaga,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,1.0,0.0,197.0,12.0,9.0,10.0,12.0,12.0,68.0,64.0,13.0,399.0
Lohardaga,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohardaga,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,53.0,0.0,0.0,37.0,9.0,37.0,83.0,41.0,3.0,263.0
Lohardaga,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,13.0,0.0,0.0,204.0,9.0,49.0,81.0,72.0,159.0,330.0,149.0,25.0,1091.0
Lohardaga,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,3.0,5.0,62.0,6.0,19.0,39.0,18.0,10.0,13.0,26.0,10.0,211.0
Lohardaga,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohardaga,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,13.0,3.0,5.0,319.0,15.0,68.0,157.0,99.0,206.0,426.0,216.0,38.0,1565.0
Lohardaga,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0,0.0,23.0
Lohardaga,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,3.0
Lohardaga,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohardaga,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,3.0
Lohardaga,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,13.0,7.0,11.0,16.0,12.0,16.0,14.0,15.0,13.0,10.0,9.0,12.0,148.0
Lohardaga,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,36.0,26.0,23.0,138.0,35.0,46.0,27.0,49.0,51.0,108.0,42.0,49.0,630.0
Lohardaga,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,6.0,6.0,8.0,0.0,6.0,4.0,9.0,0.0,0.0,10.0,0.0,0.0,49.0
Lohardaga,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,7.0,7.0,8.0,83.0,11.0,15.0,16.0,24.0,21.0,54.0,21.0,23.0,290.0
Lohardaga,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,7.0,7.0,6.0,30.0,0.0,3.0,3.0,12.0,18.0,3.0,4.0,3.0,96.0
Lohardaga,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lohardaga,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,56.0,46.0,45.0,251.0,52.0,68.0,55.0,85.0,90.0,175.0,67.0,75.0,1065.0
Lohardaga,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Lohardaga,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,7.0,3.0,9.0,8.0,7.0,6.0,5.0,6.0,5.0,4.0,70.0,8.0,138.0
Lohardaga,9.06,Number of IUCD removals,TOTAL,20.0,17.0,17.0,44.0,26.0,30.0,27.0,30.0,40.0,25.0,21.0,23.0,320.0
Lohardaga,9.07,Number of Oral Pills cycles distributed,TOTAL,1455.0,1721.0,1699.0,3228.0,2012.0,2109.0,1817.0,1798.0,2038.0,2358.0,2372.0,2030.0,24637.0
Lohardaga,9.08,Number of Condom pieces distributed,TOTAL,4062.0,6352.0,5935.0,30365.0,12230.0,11853.0,10888.0,11469.0,13737.0,16178.0,7875.0,8227.0,139171.0
Lohardaga,9.09,Number of Centchroman (weekly) pills given,TOTAL,3.0,11.0,0.0,52.0,100.0,10.0,2.0,0.0,120.0,20.0,43.0,31.0,392.0
Lohardaga,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,49.0,64.0,47.0,113.0,172.0,186.0,208.0,96.0,183.0,197.0,307.0,148.0,1770.0
Lohardaga,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Lohardaga,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,8.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Lohardaga,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,9.0,9.0,11.0,12.0,10.0,16.0,16.0,14.0,8.0,7.0,8.0,-1.0
Lohardaga,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,933.0,977.0,895.0,1049.0,956.0,927.0,985.0,1001.0,940.0,921.0,819.0,671.0,11074.0
Lohardaga,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,741.0,828.0,845.0,1034.0,955.0,927.0,1045.0,1043.0,835.0,940.0,925.0,799.0,10917.0
Lohardaga,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,734.0,787.0,787.0,877.0,1024.0,915.0,852.0,1006.0,940.0,890.0,935.0,835.0,10582.0
Lohardaga,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,769.0,832.0,736.0,873.0,888.0,940.0,907.0,900.0,853.0,892.0,935.0,898.0,10423.0
Lohardaga,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Lohardaga,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Lohardaga,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Lohardaga,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,576.0,680.0,419.0,715.0,701.0,572.0,593.0,479.0,472.0,501.0,506.0,457.0,6671.0
Lohardaga,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,737.0,826.0,828.0,1044.0,957.0,912.0,1024.0,1048.0,852.0,898.0,925.0,794.0,10845.0
Lohardaga,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,734.0,788.0,796.0,879.0,1024.0,920.0,847.0,999.0,940.0,866.0,935.0,835.0,10563.0
Lohardaga,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,769.0,830.0,734.0,863.0,887.0,948.0,901.0,905.0,850.0,866.0,941.0,898.0,10392.0
Lohardaga,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,179.0,106.0,92.0,161.0,549.0
Lohardaga,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,20.0,5.0,0.0,0.0,23.0,2.0,143.0,592.0,719.0,750.0,658.0,2912.0
Lohardaga,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,11.0,48.0,469.0,668.0,593.0,1791.0
Lohardaga,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,10.0,0.0,0.0,1.0,12.0,0.0,55.0,507.0,595.0,1180.0
Lohardaga,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,771.0,821.0,850.0,1052.0,1050.0,732.0,890.0,773.0,674.0,1019.0,901.0,776.0,10309.0
Lohardaga,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,33.0,269.0,324.0,427.0,494.0,1549.0
Lohardaga,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Lohardaga,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,406.0,420.0,428.0,519.0,493.0,370.0,441.0,377.0,339.0,498.0,442.0,417.0,5150.0
Lohardaga,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,344.0,387.0,399.0,492.0,497.0,345.0,417.0,378.0,325.0,502.0,420.0,343.0,4849.0
Lohardaga,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,750.0,807.0,827.0,1011.0,990.0,715.0,858.0,755.0,664.0,1000.0,862.0,760.0,9999.0
Lohardaga,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,575.0,609.0,681.0,794.0,681.0,612.0,608.0,588.0,661.0,617.0,824.0,728.0,7978.0
Lohardaga,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,573.0,608.0,670.0,774.0,682.0,612.0,595.0,615.0,661.0,591.0,824.0,708.0,7913.0
Lohardaga,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,159.0,232.0,225.0,268.0,151.0,148.0,127.0,140.0,141.0,163.0,215.0,172.0,2141.0
Lohardaga,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,133.0,199.0,209.0,234.0,120.0,142.0,97.0,116.0,123.0,165.0,217.0,141.0,1896.0
Lohardaga,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,292.0,431.0,434.0,502.0,271.0,290.0,224.0,256.0,264.0,328.0,432.0,313.0,4037.0
Lohardaga,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,31.0,44.0,91.0,97.0,143.0,124.0,124.0,137.0,121.0,158.0,164.0,144.0,1378.0
Lohardaga,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,350.0,538.0,373.0,412.0,402.0,334.0,331.0,374.0,315.0,315.0,313.0,299.0,4356.0
Lohardaga,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,429.0,597.0,812.0,562.0,396.0,410.0,426.0,381.0,336.0,370.0,393.0,373.0,5485.0
Lohardaga,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,11.0,10.0,14.0,34.0,11.0,9.0,4.0,11.0,0.0,3.0,20.0,0.0,127.0
Lohardaga,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,37.0,56.0,50.0,67.0,63.0,69.0,39.0,50.0,0.0,1.0,17.0,5.0,454.0
Lohardaga,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,677.0,685.0,667.0,671.0,661.0,684.0,678.0,672.0,678.0,681.0,665.0,688.0,8107.0
Lohardaga,10.4.2,Number of Immunisation sessions held during the month,TOTAL,607.0,633.0,610.0,616.0,621.0,614.0,603.0,630.0,601.0,637.0,630.0,664.0,7466.0
Lohardaga,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,477.0,487.0,477.0,487.0,486.0,490.0,509.0,490.0,464.0,493.0,504.0,520.0,5884.0
Lohardaga,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,588.0,577.0,548.0,711.0,2155.0,665.0,785.0,762.0,487.0,690.0,1169.0,673.0,9810.0
Lohardaga,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,134.0,152.0,180.0,390.0,4664.0,553.0,272.0,374.0,246.0,235.0,5374.0,439.0,13013.0
Lohardaga,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,101.0,103.0,84.0,250.0,5246.0,493.0,213.0,235.0,103.0,80.0,8391.0,499.0,15798.0
Lohardaga,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,9.0,0.0,5.0,8.0,4.0,0.0,11.0,5.0,7.0,8.0,8.0,0.0,65.0
Lohardaga,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,9.0,39.0,235.0,33.0,41.0,32.0,28.0,15.0,24.0,24.0,22.0,26.0,528.0
Lohardaga,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,3.0,9.0,28.0,42.0,56.0,36.0,13.0,5.0,32.0,5.0,20.0,5.0,254.0
Lohardaga,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,13.1,Number of Patients operated for cataract,TOTAL,44.0,14.0,39.0,27.0,20.0,39.0,41.0,0.0,159.0,130.0,333.0,0.0,846.0
Lohardaga,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,14.0,0.0,27.0,20.0,39.0,0.0,0.0,0.0,0.0,333.0,0.0,433.0
Lohardaga,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,55.0,40.0,0.0,0.0,0.0,0.0,0.0,0.0,58.0,0.0,153.0
Lohardaga,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,58.0,0.0,58.0
Lohardaga,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Lohardaga,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,3.0,1.0,4.0,5.0,2.0,7.0,5.0,4.0,1.0,1.0,,-1.0
Lohardaga,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,422.0,421.0,464.0,434.0,433.0,410.0,448.0,442.0,510.0,476.0,526.0,495.0,-1.0
Lohardaga,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Lohardaga,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,4.0,0.0,0.0,1.0,0.0,7.0
Lohardaga,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,7.0,6.0,9.0,10.0,7.0,12.0,9.0,8.0,7.0,7.0,6.0,-1.0
Lohardaga,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,10.0,7.0,39.0,68.0,17.0,8.0,15.0,14.0,23.0,31.0,32.0,43.0,307.0
Lohardaga,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,1.0,,,,,1.0,-1.0
Lohardaga,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Lohardaga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,446.0,254.0,22.0,553.0,693.0,708.0,19.0,14.0,13.0,18.0,16.0,19.0,2775.0
Lohardaga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,355.0,722.0,119.0,532.0,734.0,499.0,94.0,78.0,87.0,98.0,88.0,60.0,3466.0
Lohardaga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,419.0,248.0,12.0,525.0,659.0,674.0,9.0,0.0,21.0,18.0,28.0,21.0,2634.0
Lohardaga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,683.0,1058.0,462.0,928.0,1069.0,697.0,610.0,629.0,639.0,694.0,645.0,538.0,8652.0
Lohardaga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,865.0,502.0,34.0,1078.0,1352.0,1382.0,28.0,14.0,34.0,36.0,44.0,40.0,5409.0
Lohardaga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1038.0,1780.0,581.0,1460.0,1803.0,1196.0,704.0,707.0,726.0,792.0,733.0,598.0,12118.0
Lohardaga,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,1.0,3.0,7.0,5.0,4.0,8.0,8.0,6.0,3.0,4.0,4.0,58.0
Lohardaga,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,2.0,7.0,6.0,5.0,5.0,4.0,1.0,2.0,2.0,1.0,1.0,38.0
Lohardaga,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,7.0,3.0,10.0,13.0,10.0,9.0,12.0,9.0,8.0,5.0,5.0,5.0,96.0
Lohardaga,14.11,In-Patient Head Count at midnight,TOTAL,8372.0,8372.0,8395.0,12440.0,8372.0,9461.0,8418.0,28.0,190.0,78.0,5605.0,37.0,69768.0
Lohardaga,14.12.1,OPD attendance (All),TOTAL,18020.0,17886.0,17780.0,21167.0,25531.0,18464.0,15560.0,9724.0,17390.0,16371.0,15667.0,13952.0,207512.0
Lohardaga,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,6.0,6.0,2.0,137.0,25.0,33.0,68.0,41.0,138.0,229.0,101.0,73.0,859.0
Lohardaga,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Lohardaga,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,14.0,14.0,248.0,0.0,0.0,0.0,0.0,0.0,79.0,0.0,0.0,355.0
Lohardaga,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,646.0,299.0,209.0,1018.0,235.0,282.0,538.0,662.0,387.0,1108.0,1069.0,850.0,7303.0
Lohardaga,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,38.0,3.0,5.0,32.0,8.0,7.0,6.0,2.0,1.0,30.0,17.0,18.0,167.0
Lohardaga,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,40.0,48.0,65.0,84.0,45.0,53.0,30.0,33.0,28.0,144.0,62.0,56.0,688.0
Lohardaga,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0
Lohardaga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,70.0,39.0,6.0,135.0,75.0,97.0,124.0,91.0,121.0,198.0,210.0,117.0,1283.0
Lohardaga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Lohardaga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,231.0,267.0,53.0,254.0,199.0,249.0,254.0,232.0,164.0,128.0,227.0,213.0,2471.0
Lohardaga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Lohardaga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,341.0,354.0,124.0,473.0,319.0,399.0,408.0,356.0,313.0,470.0,499.0,386.0,4442.0
Lohardaga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,5.0
Lohardaga,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,15.4.1,Number of blood smears examined for Malaria,TOTAL,2958.0,2493.0,3389.0,4027.0,2708.0,3932.0,4849.0,0.0,3968.0,3933.0,3448.0,272.0,35977.0
Lohardaga,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,7.0,55.0,13.0,25.0,13.0,14.0,7.0,0.0,4.0,4.0,1.0,0.0,143.0
Lohardaga,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,42.0,4.0,166.0,247.0,172.0,198.0,104.0,0.0,128.0,128.0,0.0,3.0,1192.0
Lohardaga,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,12000.0,7780.0,4580.0,5280.0,1040.0,4590.0,8890.0,10740.0,10090.0,11860.0,8710.0,8010.0,93570.0
Lohardaga,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,4000.0,6000.0,0.0,10000.0,10000.0,8000.0,6000.0,5000.0,4000.0,6000.0,10000.0,69000.0
Lohardaga,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4220.0,7200.0,5300.0,4240.0,6450.0,5700.0,6150.0,6650.0,3230.0,7150.0,6700.0,4950.0,67940.0
Lohardaga,16.1.1,Stock position of DPT vaccines,5. Total Stock,7780.0,4580.0,5280.0,1040.0,4590.0,8890.0,10740.0,10090.0,11860.0,8710.0,8010.0,13060.0,94630.0
Lohardaga,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Lohardaga,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Lohardaga,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Lohardaga,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Lohardaga,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,11540.0,3060.0,6000.0,12600.0,4140.0,9140.0,1240.0,11720.0,2220.0,5280.0,12620.0,5900.0,85460.0
Lohardaga,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,16000.0,16000.0,0.0,16000.0,0.0,16000.0,0.0,10000.0,20000.0,102000.0,720.0,196720.0
Lohardaga,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,8480.0,13060.0,9400.0,8460.0,11000.0,7900.0,5520.0,9500.0,6940.0,12660.0,108720.0,3060.0,204700.0
Lohardaga,16.1.2,Stock position of OPV vaccines,5. Total Stock,3060.0,6000.0,12600.0,4140.0,9140.0,1240.0,11720.0,2220.0,5280.0,12620.0,5900.0,3560.0,77480.0
Lohardaga,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,10570.0,5720.0,4340.0,5140.0,460.0,5040.0,8840.0,11580.0,3270.0,8400.0,8680.0,10290.0,82330.0
Lohardaga,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,6000.0,6000.0,0.0,10000.0,10000.0,8000.0,0.0,8000.0,8000.0,8000.0,12000.0,76000.0
Lohardaga,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.3,Stock position of TT vaccines,4. Stock Distributed,4850.0,7380.0,5200.0,4680.0,5420.0,6200.0,5260.0,8310.0,2870.0,7720.0,6390.0,4200.0,68480.0
Lohardaga,16.1.3,Stock position of TT vaccines,5. Total Stock,5720.0,4340.0,5140.0,460.0,5040.0,8840.0,11580.0,3270.0,8400.0,8680.0,10290.0,18090.0,89850.0
Lohardaga,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,7780.0,4510.0,7500.0,8250.0,5020.0,4820.0,7570.0,9820.0,4570.0,8340.0,2820.0,20.0,71020.0
Lohardaga,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,8000.0,6000.0,0.0,5000.0,8000.0,6000.0,0.0,6000.0,0.0,0.0,6000.0,45000.0
Lohardaga,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,3270.0,5010.0,5250.0,3230.0,5200.0,5250.0,3750.0,5250.0,2230.0,5520.0,2800.0,3150.0,49910.0
Lohardaga,16.1.5,Stock position of BCG vaccines,5. Total Stock,4510.0,7500.0,8250.0,5020.0,4820.0,7570.0,9820.0,4570.0,8340.0,2820.0,20.0,2870.0,66110.0
Lohardaga,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3790.0,1630.0,4480.0,6080.0,4290.0,1790.0,4490.0,2440.0,5690.0,8375.0,7325.0,7300.0,57680.0
Lohardaga,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,6000.0,4000.0,0.0,0.0,5000.0,0.0,6000.0,4000.0,2000.0,3000.0,2000.0,32000.0
Lohardaga,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2160.0,3150.0,2400.0,1790.0,2500.0,2300.0,2050.0,2750.0,1315.0,3050.0,3025.0,2810.0,29300.0
Lohardaga,16.1.6,Stock position of Measles vaccines,5. Total Stock,1630.0,4480.0,6080.0,4290.0,1790.0,4490.0,2440.0,5690.0,8375.0,7325.0,7300.0,6490.0,60380.0
Lohardaga,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,0.0,0.0,0.0
Lohardaga,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Lohardaga,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Lohardaga,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,0.0,0.0,0.0
Lohardaga,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,0.0,,,,0.0,0.0,10800.0,8290.0,5490.0,1190.0,25770.0
Lohardaga,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,0.0,,,,0.0,13800.0,0.0,0.0,0.0,0.0,13800.0
Lohardaga,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,0.0,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,0.0,,,,0.0,3000.0,2510.0,2800.0,4300.0,1140.0,13750.0
Lohardaga,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10800.0,8290.0,5490.0,1190.0,50.0,25820.0
Lohardaga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,400.0,0.0,0.0,0.0,0.0,400.0
Lohardaga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,950.0,0.0,0.0,0.0,0.0,0.0,950.0
Lohardaga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,550.0,0.0,0.0,0.0,0.0,0.0,550.0
Lohardaga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,400.0,400.0,0.0,0.0,0.0,0.0,800.0
Lohardaga,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5040.0,0.0,0.0,0.0,0.0,5040.0
Lohardaga,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,46320.0,0.0,0.0,0.0,0.0,0.0,46320.0
Lohardaga,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,41280.0,0.0,0.0,0.0,0.0,0.0,41280.0
Lohardaga,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,5040.0,5040.0,0.0,0.0,0.0,0.0,10080.0
Lohardaga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,2000.0
Lohardaga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,13400.0,0.0,0.0,0.0,0.0,0.0,13400.0
Lohardaga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,11400.0,0.0,0.0,0.0,0.0,0.0,11400.0
Lohardaga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,2000.0,0.0,0.0,0.0,0.0,4000.0
Lohardaga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200700.0,0.0,0.0,0.0,0.0,1200700.0
Lohardaga,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200700.0,0.0,0.0,0.0,0.0,1200700.0
Lohardaga,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,126.0,126.0
Lohardaga,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1146.0,0.0,1146.0
Lohardaga,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1020.0,0.0,1020.0
Lohardaga,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,126.0,126.0,252.0
Lohardaga,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2128.0,628.0,0.0,1000.0,900.0,0.0,1700.0,2400.0,2100.0,3200.0,2300.0,1500.0,17856.0
Lohardaga,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,1200.0,0.0,0.0,2400.0,1800.0,0.0,1800.0,0.0,0.0,1800.0,9000.0
Lohardaga,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1500.0,628.0,200.0,100.0,900.0,700.0,1100.0,300.0,700.0,900.0,800.0,700.0,8528.0
Lohardaga,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,628.0,0.0,1000.0,900.0,0.0,1700.0,2400.0,2100.0,3200.0,2300.0,1500.0,2600.0,18328.0
Lohardaga,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,76780.0,56780.0,54180.0,67180.0,67180.0,43180.0,55180.0,43180.0,43180.0,0.0,10000.0,8800.0,525620.0
Lohardaga,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,2000.0,13000.0,13000.0,0.0,0.0,20000.0,0.0,0.0,14000.0,12000.0,7200.0,19200.0,100400.0
Lohardaga,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,22000.0,15600.0,0.0,0.0,24000.0,8000.0,12000.0,0.0,57180.0,2000.0,8400.0,5200.0,154380.0
Lohardaga,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,56780.0,54180.0,67180.0,67180.0,43180.0,55180.0,43180.0,43180.0,0.0,10000.0,8800.0,22800.0,471640.0
Lohardaga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,7857.0,7857.0,1857.0,1857.0,1857.0,1857.0,1857.0,1857.0,0.0,0.0,0.0,0.0,26856.0
Lohardaga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8000.0,8000.0
Lohardaga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lohardaga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,1857.0,0.0,0.0,0.0,0.0,7857.0
Lohardaga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,7857.0,1857.0,1857.0,1857.0,1857.0,1857.0,1857.0,0.0,0.0,0.0,0.0,8000.0,26999.0
Lohardaga,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,1.0,3.0,,1.0,1.0,,,,,,,8.0
Lohardaga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lohardaga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lohardaga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Lohardaga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lohardaga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lohardaga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Lohardaga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lohardaga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lohardaga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Lohardaga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lohardaga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Lohardaga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,1.0,,,,,1.0
Lohardaga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lohardaga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lohardaga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Lohardaga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lohardaga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lohardaga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Lohardaga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lohardaga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lohardaga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Lohardaga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lohardaga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lohardaga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Lohardaga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Lohardaga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Lohardaga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Lohardaga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Lohardaga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,1.0,1.0
Lohardaga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Lohardaga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Lohardaga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,1.0,,,,,,,,,1.0
Lohardaga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Lohardaga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,,1.0,,,,,,,2.0
Lohardaga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,3.0,1.0,,1.0,,3.0,,,,9.0
Lohardaga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,1.0,1.0,2.0,,,1.0,1.0,,,6.0
Lohardaga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,,5.0,2.0,3.0,1.0,,4.0,1.0,,,17.0
Lohardaga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Lohardaga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Lohardaga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,,,,,,,,,,,,1.0
Lohardaga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Lohardaga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Lohardaga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Lohardaga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Lohardaga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Lohardaga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Lohardaga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Lohardaga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Lohardaga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,,,,,,,,,1.0
Lohardaga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Lohardaga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Lohardaga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Lohardaga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Lohardaga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,3.0,,,,,,,,,4.0
Lohardaga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,1.0,2.0,2.0,,,,,,,,,5.0
Lohardaga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Lohardaga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,1.0,3.0,5.0,,,,,,,1.0,,10.0
Lohardaga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Lohardaga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Lohardaga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,2.0,,,,,2.0
Lohardaga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,1.0,,,,,,2.0
Lohardaga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Lohardaga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,1.0,1.0,,1.0,,,,3.0
Lohardaga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Lohardaga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Lohardaga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Lohardaga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,1.0,1.0,1.0,,,3.0,,,,,7.0
Lohardaga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,1.0,1.0,1.0,,,,,,,,3.0
Lohardaga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,,2.0,2.0,2.0,,,3.0,,,,,10.0
Lohardaga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,1.0,,,,,1.0,,2.0
Lohardaga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,1.0,3.0,5.0,5.0,2.0,6.0,3.0,3.0,2.0,2.0,,33.0
Lohardaga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,5.0,,,,1.0,,,,2.0,2.0,3.0,14.0
Lohardaga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,2.0,6.0,3.0,5.0,5.0,4.0,6.0,3.0,3.0,4.0,5.0,3.0,49.0
Pakaur,1.1,Total number of pregnant women Registered for ANC,TOTAL,2247.0,2406.0,2009.0,1717.0,2008.0,2394.0,2136.0,1722.0,2097.0,2125.0,2093.0,2099.0,25053.0
Pakaur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,334.0,382.0,260.0,226.0,314.0,329.0,328.0,288.0,384.0,376.0,375.0,328.0,3924.0
Pakaur,1.2,Number of Pregnant women registered under JSY,TOTAL,2247.0,2406.0,2009.0,1717.0,2008.0,2394.0,2136.0,1722.0,2097.0,2125.0,2093.0,2099.0,25053.0
Pakaur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,865.0,1000.0,991.0,874.0,1017.0,1030.0,1067.0,1068.0,1189.0,1076.0,1039.0,1035.0,12251.0
Pakaur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2177.0,2350.0,1985.0,1700.0,1982.0,2278.0,2078.0,1694.0,2051.0,2090.0,2067.0,2070.0,24522.0
Pakaur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1658.0,1917.0,1798.0,1494.0,1504.0,1690.0,1740.0,1466.0,1564.0,1466.0,1458.0,1523.0,19278.0
Pakaur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,335.0,286.0,91.0,53.0,186.0,1198.0,2096.0,1729.0,1840.0,1696.0,1549.0,1179.0,12238.0
Pakaur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,9.0,7.0,8.0,12.0,14.0,44.0,23.0,22.0,29.0,23.0,34.0,24.0,249.0
Pakaur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,99.0,125.0,135.0,68.0,85.0,70.0,85.0,58.0,46.0,58.0,39.0,29.0,897.0
Pakaur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Pakaur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,258.0,216.0,231.0,183.0,212.0,152.0,190.0,178.0,204.0,215.0,127.0,75.0,2241.0
Pakaur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,578.0,539.0,460.0,546.0,848.0,886.0,780.0,723.0,538.0,1067.0,691.0,674.0,8330.0
Pakaur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,836.0,755.0,691.0,729.0,1060.0,1038.0,970.0,901.0,742.0,1282.0,818.0,749.0,10571.0
Pakaur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,505.0,558.0,492.0,518.0,524.0,561.0,554.0,480.0,453.0,579.0,483.0,419.0,6126.0
Pakaur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,29.0,77.0,72.0,7.0,25.0,55.0,3.0,12.0,9.0,3.0,3.0,2.0,297.0
Pakaur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,396.0,434.0,513.0,525.0,633.0,603.0,580.0,660.0,645.0,634.0,774.0,781.0,7178.0
Pakaur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,279.0,370.0,357.0,378.0,432.0,492.0,441.0,645.0,540.0,543.0,774.0,781.0,6032.0
Pakaur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,220.0,163.0,446.0,486.0,484.0,616.0,494.0,672.0,645.0,558.0,762.0,728.0,6274.0
Pakaur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,176.0,91.0,446.0,484.0,475.0,595.0,492.0,663.0,645.0,558.0,740.0,715.0,6080.0
Pakaur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,345.0,10.0,15.0,0.0,370.0
Pakaur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Pakaur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pakaur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,130.0,2.0,0.0,0.0,132.0
Pakaur,4.1.1.a,Number of male live births,TOTAL,654.0,612.0,647.0,661.0,942.0,894.0,820.0,850.0,912.0,1016.0,786.0,822.0,9616.0
Pakaur,4.1.1.b,Number of female live births,TOTAL,573.0,565.0,555.0,575.0,725.0,738.0,729.0,703.0,845.0,914.0,809.0,709.0,8440.0
Pakaur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1227.0,1177.0,1202.0,1236.0,1667.0,1632.0,1549.0,1553.0,1757.0,1930.0,1595.0,1531.0,18056.0
Pakaur,4.1.2,Number of still births,TOTAL,11.0,13.0,4.0,19.0,28.0,10.0,15.0,14.0,11.0,3.0,14.0,4.0,146.0
Pakaur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,5.0,7.0,3.0,7.0,4.0,5.0,12.0,4.0,6.0,5.0,3.0,1.0,62.0
Pakaur,4.2.1,Number of Newborns weighed at birth,TOTAL,954.0,1022.0,1064.0,1071.0,1340.0,1412.0,1410.0,1488.0,1672.0,1546.0,1489.0,1382.0,15850.0
Pakaur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,42.0,57.0,64.0,52.0,147.0,144.0,83.0,82.0,49.0,51.0,36.0,30.0,837.0
Pakaur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1011.0,1133.0,1082.0,1196.0,1444.0,1536.0,1479.0,1534.0,1707.0,1685.0,1560.0,1432.0,16799.0
Pakaur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Pakaur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pakaur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Pakaur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,584.0,667.0,518.0,866.0,795.0,761.0,859.0,772.0,1069.0,721.0,899.0,913.0,9424.0
Pakaur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,594.0,474.0,519.0,392.0,809.0,815.0,660.0,822.0,572.0,1012.0,582.0,535.0,7786.0
Pakaur,6.3,PNC maternal complications attended,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Pakaur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,74.0,67.0,62.0,70.0,42.0,61.0,62.0,62.0,152.0,41.0,53.0,29.0,775.0
Pakaur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,157.0,107.0,83.0,85.0,48.0,68.0,105.0,112.0,233.0,88.0,82.0,43.0,1211.0
Pakaur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,231.0,174.0,145.0,155.0,90.0,129.0,167.0,174.0,385.0,129.0,135.0,72.0,1986.0
Pakaur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,98.0,18.0,0.0,0.0,0.0,0.0,2.0,13.0,0.0,131.0
Pakaur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Pakaur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pakaur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,100.0,18.0,0.0,0.0,0.0,0.0,2.0,13.0,0.0,133.0
Pakaur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Pakaur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pakaur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,9.0,0.0,0.0,321.0,14.0,27.0,0.0,0.0,187.0,700.0,449.0,92.0,1799.0
Pakaur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,11.0
Pakaur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pakaur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,9.0,0.0,0.0,324.0,14.0,27.0,0.0,0.0,187.0,708.0,449.0,92.0,1810.0
Pakaur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,98.0,22.0,22.0,16.0,158.0
Pakaur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pakaur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,118.0,127.0,93.0,213.0,100.0,90.0,98.0,59.0,58.0,248.0,176.0,103.0,1483.0
Pakaur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,10.0,20.0,9.0,27.0,9.0,4.0,7.0,6.0,5.0,12.0,1.0,1.0,111.0
Pakaur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,27.0,21.0,29.0,1021.0,15.0,9.0,25.0,36.0,14.0,147.0,667.0,28.0,2039.0
Pakaur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,6.0,4.0,5.0,42.0,4.0,5.0,0.0,6.0,8.0,7.0,3.0,3.0,93.0
Pakaur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pakaur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,161.0,172.0,136.0,1303.0,128.0,108.0,130.0,107.0,85.0,414.0,847.0,135.0,3726.0
Pakaur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Pakaur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.06,Number of IUCD removals,TOTAL,50.0,95.0,79.0,107.0,81.0,50.0,53.0,32.0,41.0,58.0,79.0,62.0,787.0
Pakaur,9.07,Number of Oral Pills cycles distributed,TOTAL,992.0,950.0,761.0,5231.0,976.0,1004.0,1324.0,1547.0,1290.0,1995.0,2525.0,1379.0,19974.0
Pakaur,9.08,Number of Condom pieces distributed,TOTAL,8885.0,10888.0,11882.0,177626.0,11912.0,13292.0,12498.0,13400.0,10015.0,16519.0,30945.0,15191.0,333053.0
Pakaur,9.09,Number of Centchroman (weekly) pills given,TOTAL,19.0,303.0,34.0,26.0,491.0,114.0,238.0,114.0,32.0,76.0,104.0,54.0,1605.0
Pakaur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,67.0,108.0,87.0,112.0,238.0,227.0,165.0,219.0,268.0,278.0,146.0,116.0,2031.0
Pakaur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,9.0,8.0,12.0,10.0,8.0,6.0,9.0,7.0,8.0,10.0,10.0,-1.0
Pakaur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1768.0,1812.0,1480.0,1626.0,2057.0,2184.0,1963.0,1561.0,1592.0,2870.0,1686.0,1673.0,22272.0
Pakaur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1751.0,2053.0,1646.0,1441.0,2083.0,2043.0,1942.0,2136.0,2423.0,2044.0,2145.0,1983.0,23690.0
Pakaur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1847.0,1933.0,1773.0,1511.0,1834.0,1835.0,1729.0,1850.0,2130.0,2057.0,2010.0,1874.0,22383.0
Pakaur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1688.0,1914.0,1719.0,1529.0,1773.0,1795.0,1518.0,1754.0,1910.0,1918.0,1867.0,1868.0,21253.0
Pakaur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Pakaur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Pakaur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Pakaur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,856.0,958.0,906.0,959.0,1216.0,1335.0,1227.0,1156.0,905.0,1438.0,691.0,122.0,11769.0
Pakaur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1714.0,2079.0,1642.0,1434.0,2024.0,1917.0,1881.0,2082.0,2295.0,1597.0,335.0,192.0,19192.0
Pakaur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1786.0,2073.0,1819.0,1529.0,1816.0,1736.0,1684.0,1874.0,1982.0,1605.0,292.0,196.0,18392.0
Pakaur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1593.0,1966.0,1764.0,1555.0,1766.0,1676.0,1442.0,1745.0,1754.0,1484.0,278.0,203.0,17226.0
Pakaur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,207.0,344.0,285.0,844.0
Pakaur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,346.0,1579.0,1741.0,1846.0,5512.0
Pakaur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,257.0,1032.0,1310.0,2604.0
Pakaur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,97.0,210.0,744.0,1058.0
Pakaur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1380.0,1265.0,1604.0,1545.0,2186.0,2025.0,1746.0,1580.0,1436.0,1610.0,1321.0,1702.0,19400.0
Pakaur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Pakaur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Pakaur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,688.0,619.0,789.0,769.0,1127.0,1044.0,685.0,740.0,678.0,752.0,485.0,542.0,8918.0
Pakaur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,666.0,595.0,728.0,710.0,1010.0,912.0,633.0,605.0,619.0,618.0,418.0,536.0,8050.0
Pakaur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1354.0,1214.0,1517.0,1479.0,2137.0,1956.0,1318.0,1345.0,1297.0,1370.0,903.0,1078.0,16968.0
Pakaur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1111.0,1187.0,1022.0,800.0,1326.0,1130.0,922.0,869.0,972.0,1102.0,1517.0,1249.0,13207.0
Pakaur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1066.0,1226.0,1009.0,779.0,1305.0,955.0,900.0,831.0,920.0,886.0,309.0,144.0,10330.0
Pakaur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,3.0,32.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,38.0
Pakaur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,553.0,550.0,596.0,478.0,777.0,541.0,483.0,443.0,560.0,504.0,679.0,505.0,6669.0
Pakaur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,523.0,547.0,588.0,492.0,779.0,509.0,472.0,448.0,530.0,458.0,575.0,469.0,6390.0
Pakaur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1076.0,1097.0,1184.0,970.0,1556.0,1050.0,955.0,891.0,1090.0,962.0,1254.0,974.0,13059.0
Pakaur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,88.0,30.0,30.0,35.0,62.0,42.0,12.0,29.0,13.0,71.0,92.0,74.0,578.0
Pakaur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,524.0,665.0,663.0,567.0,728.0,579.0,688.0,641.0,708.0,716.0,765.0,626.0,7870.0
Pakaur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,481.0,611.0,611.0,589.0,623.0,588.0,652.0,707.0,748.0,622.0,725.0,602.0,7559.0
Pakaur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,5.0,5.0,1.0,4.0,4.0,3.0,0.0,2.0,4.0,5.0,0.0,0.0,33.0
Pakaur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,14.0,5.0,0.0,3.0,14.0,7.0,0.0,3.0,10.0,0.0,0.0,0.0,56.0
Pakaur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1088.0,1101.0,1102.0,1129.0,1214.0,1128.0,1110.0,1144.0,1134.0,1115.0,1133.0,1137.0,13535.0
Pakaur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,926.0,1019.0,1036.0,881.0,1153.0,1063.0,968.0,1074.0,1080.0,1064.0,1081.0,1050.0,12395.0
Pakaur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,706.0,635.0,659.0,527.0,767.0,666.0,632.0,723.0,758.0,726.0,731.0,678.0,8208.0
Pakaur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Pakaur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,651.0,600.0,413.0,342.0,5520.0,2193.0,1338.0,1129.0,883.0,1259.0,3798.0,1688.0,19814.0
Pakaur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,16.0,18.0,0.0,0.0,19148.0,2812.0,31.0,84.0,48.0,8.0,14147.0,2039.0,38351.0
Pakaur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,9.0,6.0,0.0,0.0,19736.0,3312.0,6.0,7.0,12.0,7.0,17434.0,2439.0,42968.0
Pakaur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,12.0,12.0,2.0,10.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,42.0
Pakaur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,63.0,156.0,39.0,19.0,63.0,41.0,43.0,56.0,52.0,74.0,33.0,57.0,696.0
Pakaur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,54.0,48.0,20.0,32.0,54.0,16.0,34.0,45.0,62.0,23.0,9.0,17.0,414.0
Pakaur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,2.0,5.0
Pakaur,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,62.0,0.0,54.0,216.0,514.0,0.0,186.0,1032.0
Pakaur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,62.0,0.0,54.0,216.0,514.0,0.0,186.0,1032.0
Pakaur,13.3,Number of School children detected with Refractive errors,TOTAL,54.0,96.0,137.0,75.0,148.0,153.0,112.0,74.0,91.0,44.0,38.0,42.0,1064.0
Pakaur,13.4,Number of children provided free glasses,TOTAL,13.0,39.0,54.0,36.0,42.0,51.0,41.0,20.0,25.0,6.0,8.0,10.0,345.0
Pakaur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,2.0,3.0,2.0,3.0,2.0,2.0,5.0,2.0,3.0,3.0,3.0,-1.0
Pakaur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,3.0,1.0,5.0,4.0,1.0,,1.0,2.0,2.0,4.0,5.0,-1.0
Pakaur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,228.0,216.0,147.0,130.0,141.0,152.0,225.0,205.0,223.0,232.0,347.0,435.0,-1.0
Pakaur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,6.0,5.0,4.0,5.0,7.0,7.0,6.0,7.0,7.0,7.0,-1.0
Pakaur,14.05,Number of RKS meetings held during the month,TOTAL,10.0,8.0,10.0,9.0,10.0,12.0,8.0,6.0,10.0,9.0,5.0,3.0,100.0
Pakaur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,7.0,7.0,5.0,12.0,10.0,6.0,4.0,7.0,7.0,7.0,8.0,8.0,-1.0
Pakaur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,6.0,6.0,5.0,9.0,5.0,12.0,2.0,2.0,1.0,1.0,1.0,0.0,50.0
Pakaur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,2.0,3.0,2.0,4.0,2.0,3.0,4.0,2.0,3.0,3.0,4.0,-1.0
Pakaur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,-1.0
Pakaur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,69.0,78.0,57.0,27.0,29.0,32.0,24.0,18.0,26.0,8.0,9.0,26.0,403.0
Pakaur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,38.0,35.0,29.0,61.0,69.0,45.0,113.0,98.0,37.0,57.0,48.0,65.0,695.0
Pakaur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,290.0,54.0,117.0,19.0,21.0,20.0,17.0,17.0,17.0,11.0,18.0,6.0,607.0
Pakaur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,309.0,361.0,299.0,438.0,352.0,497.0,592.0,615.0,841.0,911.0,779.0,673.0,6667.0
Pakaur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,359.0,132.0,174.0,46.0,50.0,52.0,41.0,35.0,43.0,19.0,27.0,32.0,1010.0
Pakaur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,347.0,396.0,328.0,499.0,421.0,542.0,705.0,713.0,878.0,968.0,827.0,738.0,7362.0
Pakaur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2.0,3.0,0.0,0.0,0.0,3.0,3.0,0.0,5.0,0.0,0.0,7.0,23.0
Pakaur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Pakaur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,2.0,3.0,0.0,0.0,0.0,4.0,3.0,0.0,5.0,0.0,0.0,7.0,24.0
Pakaur,14.11,In-Patient Head Count at midnight,TOTAL,0.0,0.0,0.0,0.0,0.0,19.0,0.0,0.0,138.0,97.0,61.0,103.0,418.0
Pakaur,14.12.1,OPD attendance (All),TOTAL,17993.0,20210.0,19605.0,24322.0,20902.0,21688.0,21302.0,20151.0,18704.0,18685.0,20769.0,22177.0,246508.0
Pakaur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,67.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,67.0
Pakaur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Pakaur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,2.0,0.0,10.0
Pakaur,14.14.a,Number of patients given AYUSH treatment,TOTAL,203.0,105.0,115.0,106.0,112.0,119.0,121.0,119.0,121.0,132.0,101.0,0.0,1354.0
Pakaur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,63.0,55.0,76.0,82.0,77.0,72.0,40.0,42.0,37.0,61.0,67.0,43.0,715.0
Pakaur,14.14.c,Number of Adolescents counselled,TOTAL,234.0,163.0,162.0,183.0,162.0,211.0,297.0,356.0,183.0,505.0,448.0,357.0,3261.0
Pakaur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,216.0,266.0,366.0,346.0,282.0,394.0,594.0,562.0,473.0,678.0,657.0,580.0,5414.0
Pakaur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,22.0,32.0,21.0,25.0,3.0,13.0,52.0,33.0,17.0,40.0,17.0,11.0,286.0
Pakaur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,66.0,87.0,68.0,0.0,89.0,61.0,56.0,82.0,50.0,68.0,87.0,90.0,804.0
Pakaur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,1.0,0.0,0.0,2.0,1.0,1.0,1.0,0.0,2.0,1.0,1.0,13.0
Pakaur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,58.0,71.0,39.0,0.0,70.0,118.0,140.0,146.0,153.0,222.0,199.0,151.0,1367.0
Pakaur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,3.0
Pakaur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,64.0,63.0,55.0,0.0,72.0,51.0,100.0,127.0,39.0,209.0,158.0,114.0,1052.0
Pakaur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Pakaur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,188.0,221.0,162.0,0.0,231.0,230.0,296.0,355.0,242.0,499.0,444.0,355.0,3223.0
Pakaur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4.0,1.0,0.0,0.0,2.0,1.0,1.0,1.0,0.0,3.0,1.0,3.0,17.0
Pakaur,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Pakaur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Pakaur,15.4.1,Number of blood smears examined for Malaria,TOTAL,9989.0,9163.0,10303.0,6945.0,9190.0,9957.0,9730.0,9061.0,19099.0,11513.0,11007.0,6320.0,122277.0
Pakaur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,79.0,58.0,83.0,82.0,102.0,106.0,105.0,32.0,69.0,49.0,43.0,57.0,865.0
Pakaur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,63.0,10.0,109.0,94.0,87.0,106.0,61.0,94.0,129.0,46.0,23.0,6.0,828.0
Pakaur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,20570.0,22210.0,23810.0,10520.0,17140.0,23540.0,8030.0,21970.0,14970.0,19970.0,5970.0,6970.0,195670.0
Pakaur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,15000.0,0.0,20000.0,20000.0,0.0,25000.0,0.0,20000.0,0.0,10000.0,20000.0,140000.0
Pakaur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,250.0,260.0,250.0,350.0,0.0,50.0,60.0,0.0,0.0,0.0,0.0,10.0,1230.0
Pakaur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,8110.0,13140.0,13040.0,13030.0,13600.0,15460.0,11000.0,7000.0,15000.0,14000.0,9000.0,12040.0,144420.0
Pakaur,16.1.1,Stock position of DPT vaccines,5. Total Stock,22210.0,23810.0,10520.0,17140.0,23540.0,8030.0,21970.0,14970.0,19970.0,5970.0,6970.0,14920.0,190020.0
Pakaur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Pakaur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Pakaur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Pakaur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Pakaur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,14260.0,38340.0,12940.0,31460.0,13900.0,14400.0,5160.0,26620.0,10960.0,700.0,0.0,0.0,168740.0
Pakaur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,40000.0,0.0,40000.0,0.0,20000.0,20000.0,40000.0,0.0,0.0,10000.0,0.0,0.0,170000.0
Pakaur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,440.0,500.0,400.0,0.0,0.0,20.0,80.0,160.0,0.0,0.0,0.0,0.0,1600.0
Pakaur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,15480.0,24900.0,21080.0,17560.0,19500.0,29220.0,18460.0,15500.0,10260.0,10700.0,0.0,0.0,182660.0
Pakaur,16.1.2,Stock position of OPV vaccines,5. Total Stock,38340.0,12940.0,31460.0,13900.0,14400.0,5160.0,26620.0,10960.0,700.0,0.0,0.0,0.0,154480.0
Pakaur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,14480.0,18520.0,16610.0,4790.0,10790.0,21960.0,6790.0,16860.0,10240.0,16090.0,21010.0,10510.0,168650.0
Pakaur,16.1.3,Stock position of TT vaccines,2. Stocks Received,12500.0,10000.0,0.0,20000.0,25000.0,0.0,20000.0,0.0,20000.0,20000.0,0.0,10000.0,137500.0
Pakaur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,120.0,170.0,180.0,120.0,180.0,160.0,130.0,120.0,50.0,80.0,0.0,100.0,1410.0
Pakaur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,8340.0,11740.0,11640.0,13880.0,13650.0,15010.0,9800.0,6500.0,14100.0,15000.0,10500.0,11070.0,141230.0
Pakaur,16.1.3,Stock position of TT vaccines,5. Total Stock,18520.0,16610.0,4790.0,10790.0,21960.0,6790.0,16860.0,10240.0,16090.0,21010.0,10510.0,9340.0,163510.0
Pakaur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,15000.0,23190.0,22180.0,13080.0,6300.0,12550.0,4620.0,820.0,0.0,1500.0,900.0,0.0,100140.0
Pakaur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,15000.0,10000.0,0.0,0.0,20000.0,5000.0,5240.0,0.0,10000.0,10000.0,0.0,12000.0,87240.0
Pakaur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,270.0,220.0,210.0,0.0,30.0,30.0,40.0,0.0,0.0,0.0,0.0,20.0,820.0
Pakaur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6540.0,10790.0,8890.0,6780.0,13720.0,12900.0,9000.0,820.0,8500.0,10600.0,900.0,10510.0,99950.0
Pakaur,16.1.5,Stock position of BCG vaccines,5. Total Stock,23190.0,22180.0,13080.0,6300.0,12550.0,4620.0,820.0,0.0,1500.0,900.0,0.0,1470.0,86610.0
Pakaur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5420.0,2215.0,9520.0,4320.0,2545.0,6300.0,1005.0,6935.0,5685.0,3635.0,0.0,1269.0,48849.0
Pakaur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,10000.0,0.0,2750.0,10000.0,1350.0,10000.0,0.0,0.0,0.0,2019.0,1500.0,37619.0
Pakaur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,75.0,80.0,260.0,345.0,70.0,80.0,0.0,0.0,0.0,0.0,0.0,910.0
Pakaur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3205.0,2620.0,5120.0,4265.0,5900.0,6575.0,3990.0,1250.0,2050.0,3635.0,750.0,1306.0,40666.0
Pakaur,16.1.6,Stock position of Measles vaccines,5. Total Stock,2215.0,9520.0,4320.0,2545.0,6300.0,1005.0,6935.0,5685.0,3635.0,0.0,1269.0,1463.0,44892.0
Pakaur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,0.0,0.0,0.0
Pakaur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,0.0,0.0,0.0
Pakaur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,0.0,0.0,0.0
Pakaur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,0.0,0.0,0.0
Pakaur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,0.0,,,,,,0.0,13300.0,6590.0,90.0,675.0,20655.0
Pakaur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,0.0,,,,,,13300.0,0.0,0.0,1330.0,0.0,14630.0
Pakaur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,0.0,,,,,,0.0,10.0,0.0,0.0,3.0,13.0
Pakaur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,0.0,,,,,,0.0,6700.0,6500.0,745.0,580.0,14525.0
Pakaur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13300.0,6590.0,90.0,675.0,92.0,20747.0
Pakaur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,69.0,69.0,69.0,69.0,69.0,69.0,160.0,0.0,0.0,0.0,0.0,4200.0,4774.0
Pakaur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,841.0,0.0,0.0,0.0,0.0,5000.0,0.0,5841.0
Pakaur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,750.0,160.0,0.0,0.0,0.0,800.0,1500.0,3210.0
Pakaur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,69.0,69.0,69.0,69.0,69.0,160.0,0.0,0.0,0.0,0.0,4200.0,2700.0,7405.0
Pakaur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,14500.0,13500.0,13500.0,13500.0,1500.0,49000.0,24000.0,98600.0,10205.0,1000.0,0.0,24000.0,263305.0
Pakaur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,45000.0,48000.0,0.0,75600.0,0.0,0.0,0.0,30000.0,0.0,198600.0
Pakaur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,1000.0,0.0,0.0,57000.0,500.0,25000.0,1000.0,88395.0,9205.0,1000.0,6000.0,10000.0,199100.0
Pakaur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,13500.0,13500.0,13500.0,1500.0,49000.0,24000.0,98600.0,10205.0,1000.0,0.0,24000.0,14000.0,262805.0
Pakaur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,500.0,500.0,500.0,500.0,3000.0,2000.0,1000.0,16900.0,1594.0,0.0,0.0,3500.0,29994.0
Pakaur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,11000.0,2000.0,0.0,16200.0,0.0,0.0,0.0,4000.0,0.0,33200.0
Pakaur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,8500.0,3000.0,1000.0,300.0,15306.0,1594.0,0.0,500.0,1300.0,31500.0
Pakaur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,500.0,500.0,500.0,3000.0,2000.0,1000.0,16900.0,1594.0,0.0,0.0,3500.0,2200.0,31694.0
Pakaur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1081.0,1081.0,1081.0,1081.0,2031.0,500.0,500.0,3800.0,810.0,499.0,0.0,0.0,12464.0
Pakaur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,2050.0,0.0,0.0,3300.0,0.0,0.0,0.0,0.0,0.0,5350.0
Pakaur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,1100.0,1531.0,0.0,0.0,2990.0,311.0,499.0,0.0,0.0,6431.0
Pakaur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1081.0,1081.0,1081.0,2031.0,500.0,500.0,3800.0,810.0,499.0,0.0,0.0,0.0,11383.0
Pakaur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,570.0,570.0,570.0,570.0,,,,,0.0,0.0,0.0,0.0,2280.0
Pakaur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,570.0,,,,,,0.0,0.0,0.0,570.0
Pakaur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,570.0,570.0,570.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1710.0
Pakaur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0,0.0
Pakaur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,76236.0,58236.0,20000.0,0.0,0.0,1220000.0,1374472.0
Pakaur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,,1500000.0,0.0,0.0,0.0,0.0,1305000.0,45000.0,2850000.0
Pakaur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,,1423764.0,18000.0,38236.0,20000.0,0.0,85000.0,231000.0,1816000.0
Pakaur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,76236.0,58236.0,20000.0,0.0,0.0,1220000.0,1034000.0,2408472.0
Pakaur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,500.0,400.0,100.0,100.0,100.0,1365.0,2565.0
Pakaur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,,1450.0,0.0,0.0,0.0,0.0,1365.0,0.0,2815.0
Pakaur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,,950.0,100.0,300.0,0.0,0.0,100.0,400.0,1850.0
Pakaur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,500.0,400.0,100.0,100.0,100.0,1365.0,965.0,3530.0
Pakaur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Pakaur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Pakaur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Pakaur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,1369.0,1369.0,0.0,0.0,0.0,0.0,220.0,220.0,3178.0
Pakaur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,2080.0,0.0,0.0,0.0,0.0,,2655.0,0.0,0.0,4735.0
Pakaur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Pakaur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,711.0,0.0,1369.0,0.0,0.0,,2435.0,0.0,0.0,4515.0
Pakaur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,1369.0,1369.0,0.0,0.0,0.0,0.0,220.0,220.0,220.0,3398.0
Pakaur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,,30000.0,0.0,0.0,,0.0,0.0,0.0,30000.0
Pakaur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Pakaur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,,30000.0,0.0,0.0,,0.0,0.0,0.0,30000.0
Pakaur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pakaur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2150.0,4030.0,2900.0,2475.0,6150.0,2520.0,950.0,1350.0,350.0,950.0,520.0,0.0,24345.0
Pakaur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,0.0,0.0,7500.0,0.0,1500.0,3000.0,0.0,3000.0,3000.0,0.0,1800.0,22800.0
Pakaur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,20.0,30.0,25.0,25.0,30.0,20.0,0.0,0.0,0.0,30.0,0.0,20.0,200.0
Pakaur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1100.0,1100.0,400.0,3800.0,3600.0,3050.0,2600.0,1000.0,2400.0,3400.0,520.0,900.0,23870.0
Pakaur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4030.0,2900.0,2475.0,6150.0,2520.0,950.0,1350.0,350.0,950.0,520.0,0.0,880.0,23075.0
Pakaur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,38000.0,23970.0,17900.0,3880.0,,0.0,18000.0,2000.0,600.0,13600.0,3880.0,5480.0,127310.0
Pakaur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,20000.0,0.0,0.0,20000.0,0.0,9000.0,8000.0,57000.0
Pakaur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,30.0,70.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,140.0
Pakaur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,14000.0,6000.0,14000.0,3880.0,0.0,2000.0,16000.0,1400.0,7000.0,9700.0,7400.0,12000.0,93380.0
Pakaur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,23970.0,17900.0,3880.0,0.0,0.0,18000.0,2000.0,600.0,13600.0,3880.0,5480.0,1480.0,90790.0
Pakaur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,12525.0,12525.0,6175.0,6175.0,9675.0,13600.0,9170.0,1570.0,0.0,6000.0,4000.0,4033.0,85448.0
Pakaur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,4000.0,5000.0,2000.0,0.0,0.0,6000.0,0.0,133.0,6000.0,23133.0
Pakaur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,50.0,0.0,0.0,75.0,30.0,0.0,0.0,0.0,0.0,0.0,22.0,177.0
Pakaur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,6300.0,0.0,500.0,1000.0,6400.0,7600.0,1570.0,0.0,2000.0,100.0,11.0,25481.0
Pakaur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,12525.0,6175.0,6175.0,9675.0,13600.0,9170.0,1570.0,0.0,6000.0,4000.0,4033.0,10000.0,82923.0
Pakaur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Pakaur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Pakaur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Pakaur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Pakaur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Pakaur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Pakaur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Pakaur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Pakaur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Pakaur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Pakaur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Pakaur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Pakaur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Pakaur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Pakaur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Pakaur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Pakaur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Pakaur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Pakaur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Pakaur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Pakaur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Pakaur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Pakaur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Pakaur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Pakaur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Pakaur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Pakaur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Pakaur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,1.0,1.0
Pakaur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Pakaur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Pakaur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,,,,,,,1.0,4.0,,,,7.0
Pakaur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,1.0,1.0,,,,2.0
Pakaur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,,,,,,,2.0,5.0,,,,9.0
Pakaur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Pakaur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Pakaur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Pakaur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,2.0,,,,,,2.0
Pakaur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,2.0,,,,,,2.0
Pakaur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Pakaur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Pakaur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Pakaur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Pakaur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Pakaur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Pakaur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,1.0,,,,,,,1.0
Pakaur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Pakaur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Pakaur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,1.0,,,,,,1.0
Pakaur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Pakaur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Pakaur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Pakaur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Pakaur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Pakaur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Pakaur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Pakaur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Pakaur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Pakaur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Pakaur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Pakaur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Pakaur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Pakaur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Pakaur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Pakaur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,1.0,,,1.0
Pakaur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Pakaur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,2.0,1.0,,,,,,3.0
Pakaur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,2.0,,,,,2.0
Pakaur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,2.0,1.0,2.0,,,,,5.0
Palamu,1.1,Total number of pregnant women Registered for ANC,TOTAL,4896.0,3890.0,3930.0,4309.0,3355.0,3200.0,2906.0,2540.0,2619.0,3262.0,3301.0,3577.0,41785.0
Palamu,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,928.0,793.0,922.0,973.0,792.0,877.0,787.0,610.0,674.0,724.0,737.0,781.0,9598.0
Palamu,1.2,Number of Pregnant women registered under JSY,TOTAL,4562.0,3797.0,3908.0,4231.0,3308.0,3102.0,2868.0,2512.0,2558.0,3191.0,3216.0,3545.0,40798.0
Palamu,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2731.0,2715.0,2825.0,2820.0,2824.0,2705.0,2413.0,2384.0,2325.0,2278.0,2189.0,2395.0,30604.0
Palamu,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4101.0,3053.0,3377.0,3683.0,2906.0,2763.0,2448.0,2155.0,2260.0,2776.0,2882.0,2938.0,35342.0
Palamu,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3550.0,3760.0,3374.0,3552.0,3634.0,2932.0,2808.0,2385.0,2281.0,2461.0,3099.0,2940.0,36776.0
Palamu,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1032.0,697.0,594.0,264.0,243.0,79.0,318.0,1198.0,1458.0,1607.0,1946.0,3481.0,12917.0
Palamu,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,98.0,123.0,43.0,33.0,92.0,25.0,60.0,30.0,49.0,43.0,42.0,11.0,649.0
Palamu,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,4.0,7.0,6.0,0.0,0.0,0.0,0.0,14.0,0.0,0.0,0.0,32.0
Palamu,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,815.0,671.0,844.0,905.0,762.0,550.0,389.0,548.0,555.0,615.0,697.0,868.0,8219.0
Palamu,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,16.0,25.0,11.0,9.0,1.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,66.0
Palamu,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Palamu,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,317.0,252.0,288.0,381.0,348.0,329.0,360.0,320.0,281.0,329.0,253.0,228.0,3686.0
Palamu,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,592.0,675.0,651.0,798.0,759.0,835.0,728.0,706.0,586.0,659.0,542.0,467.0,7998.0
Palamu,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,909.0,927.0,939.0,1179.0,1107.0,1164.0,1088.0,1026.0,867.0,988.0,795.0,695.0,11684.0
Palamu,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,622.0,616.0,697.0,885.0,833.0,823.0,717.0,651.0,565.0,576.0,524.0,475.0,7984.0
Palamu,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,86.0,50.0,41.0,55.0,31.0,73.0,56.0,20.0,8.0,6.0,29.0,15.0,470.0
Palamu,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1006.0,1158.0,1336.0,1855.0,1936.0,1786.0,1672.0,1524.0,1505.0,1392.0,1181.0,1042.0,17393.0
Palamu,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,914.0,1052.0,1247.0,1775.0,1893.0,1661.0,1624.0,1476.0,1473.0,1360.0,1150.0,1035.0,16660.0
Palamu,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1015.0,1008.0,1130.0,1511.0,1707.0,1756.0,1568.0,1598.0,1397.0,2045.0,1218.0,998.0,16951.0
Palamu,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,882.0,816.0,934.0,1093.0,1084.0,1335.0,1117.0,1199.0,941.0,948.0,1513.0,1194.0,13056.0
Palamu,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,476.0,611.0,641.0,733.0,850.0,189.0,0.0,0.0,0.0,0.0,0.0,0.0,3500.0
Palamu,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,10.0,611.0,641.0,729.0,850.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2841.0
Palamu,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,10.0,611.0,641.0,729.0,563.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2554.0
Palamu,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,5.0,23.0,12.0,6.0,11.0,16.0,15.0,6.0,20.0,27.0,24.0,11.0,176.0
Palamu,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Palamu,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,5.0,23.0,12.0,6.0,11.0,16.0,15.0,6.0,20.0,27.0,24.0,11.0,176.0
Palamu,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,206.0,12.0,0.0,4.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,223.0
Palamu,4.1.1.a,Number of male live births,TOTAL,1253.0,1452.0,1542.0,1884.0,2022.0,1618.0,1419.0,1313.0,1198.0,1195.0,1020.0,883.0,16799.0
Palamu,4.1.1.b,Number of female live births,TOTAL,1113.0,1244.0,1334.0,1819.0,1818.0,1493.0,1310.0,1236.0,1152.0,1163.0,935.0,836.0,15453.0
Palamu,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2366.0,2696.0,2876.0,3703.0,3840.0,3111.0,2729.0,2549.0,2350.0,2358.0,1955.0,1719.0,32252.0
Palamu,4.1.2,Number of still births,TOTAL,59.0,59.0,61.0,84.0,71.0,60.0,55.0,76.0,97.0,54.0,29.0,30.0,735.0
Palamu,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,106.0,33.0,29.0,20.0,23.0,16.0,4.0,20.0,16.0,17.0,6.0,6.0,296.0
Palamu,4.2.1,Number of Newborns weighed at birth,TOTAL,1972.0,2415.0,2585.0,3432.0,3503.0,2685.0,2399.0,2245.0,2047.0,2061.0,1689.0,1545.0,28578.0
Palamu,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,172.0,148.0,167.0,213.0,227.0,178.0,177.0,169.0,129.0,122.0,79.0,64.0,1845.0
Palamu,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2201.0,2496.0,2719.0,3598.0,3717.0,2921.0,2586.0,2414.0,2178.0,2214.0,1841.0,1647.0,30532.0
Palamu,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,4.0,0.0,2.0,84.0,0.0,2.0,75.0,15.0,0.0,0.0,1.0,0.0,183.0
Palamu,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,3.0,115.0,80.0,0.0,4.0,0.0,0.0,2.0,74.0,5.0,0.0,283.0
Palamu,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,65.0,80.0,0.0,0.0,0.0,0.0,0.0,72.0,0.0,0.0,217.0
Palamu,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Palamu,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,4.0,3.0,182.0,244.0,0.0,6.0,75.0,15.0,2.0,146.0,6.0,0.0,683.0
Palamu,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,4.0,0.0,4.0,0.0,0.0,4.0,0.0,0.0,2.0,2.0,5.0,0.0,21.0
Palamu,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,0.0,2.0,0.0,0.0,3.0,0.0,0.0,0.0,2.0,3.0,0.0,11.0
Palamu,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,4.0,0.0,66.0,156.0,0.0,1.0,70.0,14.0,0.0,72.0,0.0,0.0,383.0
Palamu,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1263.0,1423.0,1482.0,2069.0,2037.0,2082.0,1817.0,1827.0,1716.0,1768.0,1397.0,1201.0,20082.0
Palamu,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1117.0,1229.0,1270.0,1616.0,1532.0,1717.0,1428.0,1550.0,1437.0,1440.0,1294.0,1065.0,16695.0
Palamu,6.3,PNC maternal complications attended,TOTAL,83.0,30.0,97.0,2.0,1.0,0.0,0.0,1.0,3.0,1.0,43.0,1.0,262.0
Palamu,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,49.0,14.0,6.0,3.0,11.0,3.0,0.0,5.0,0.0,3.0,0.0,0.0,94.0
Palamu,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,27.0,4.0,2.0,6.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,43.0
Palamu,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,76.0,18.0,8.0,9.0,11.0,3.0,0.0,6.0,1.0,4.0,1.0,0.0,137.0
Palamu,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,30.0,23.0,52.0,18.0,28.0,16.0,9.0,0.0,0.0,0.0,0.0,0.0,176.0
Palamu,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,223.0,163.0,201.0,144.0,133.0,113.0,167.0,8.0,0.0,0.0,2.0,8.0,1162.0
Palamu,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,253.0,186.0,253.0,162.0,161.0,129.0,176.0,8.0,0.0,0.0,2.0,8.0,1338.0
Palamu,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,6.0
Palamu,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,7.0,5.0,0.0,20.0
Palamu,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,13.0,0.0,0.0,85.0,3.0,6.0,7.0,11.0,11.0,91.0,111.0,57.0,395.0
Palamu,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,11.0,0.0,1.0,32.0,3.0,0.0,4.0,2.0,13.0,8.0,18.0,3.0,95.0
Palamu,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Palamu,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,24.0,0.0,1.0,125.0,6.0,6.0,11.0,13.0,24.0,106.0,134.0,60.0,510.0
Palamu,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,60.0,60.0,66.0,0.0,7.0,4.0,0.0,197.0
Palamu,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Palamu,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,23.0,0.0,0.0,0.0,0.0,0.0,82.0,24.0,0.0,129.0
Palamu,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,1.0,0.0,0.0,215.0,9.0,14.0,74.0,129.0,392.0,2457.0,1937.0,632.0,5860.0
Palamu,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,3.0,8.0,4.0,20.0,1.0,7.0,38.0,31.0,262.0,927.0,503.0,20.0,1824.0
Palamu,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Palamu,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,4.0,8.0,4.0,258.0,10.0,21.0,112.0,160.0,654.0,3466.0,2464.0,652.0,7813.0
Palamu,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,92.0,118.0,75.0,98.0,58.0,89.0,900.0,200.0,0.0,538.0,247.0,797.0,3212.0
Palamu,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Palamu,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,10.0,0.0,0.0,25.0,0.0,0.0,0.0,0.0,0.0,35.0
Palamu,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Palamu,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,0.0,0.0,10.0,0.0,0.0,25.0,0.0,0.0,0.0,0.0,0.0,37.0
Palamu,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,229.0,281.0,283.0,378.0,290.0,315.0,269.0,264.0,238.0,362.0,248.0,266.0,3423.0
Palamu,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,27.0,26.0,29.0,52.0,31.0,16.0,29.0,24.0,18.0,28.0,19.0,21.0,320.0
Palamu,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,56.0,53.0,29.0,882.0,145.0,48.0,49.0,64.0,51.0,355.0,154.0,69.0,1955.0
Palamu,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,16.0,12.0,12.0,344.0,19.0,14.0,18.0,22.0,23.0,26.0,25.0,29.0,560.0
Palamu,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Palamu,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,328.0,372.0,353.0,1656.0,485.0,393.0,365.0,374.0,330.0,771.0,446.0,385.0,6258.0
Palamu,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Palamu,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,8.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
Palamu,9.06,Number of IUCD removals,TOTAL,138.0,139.0,125.0,160.0,168.0,128.0,102.0,97.0,116.0,115.0,114.0,164.0,1566.0
Palamu,9.07,Number of Oral Pills cycles distributed,TOTAL,2830.0,3097.0,3084.0,6041.0,2603.0,2245.0,2045.0,2244.0,2336.0,3918.0,3590.0,1946.0,35979.0
Palamu,9.08,Number of Condom pieces distributed,TOTAL,17047.0,18575.0,17258.0,72627.0,18928.0,15329.0,14772.0,79002.0,14971.0,23275.0,17941.0,9871.0,319596.0
Palamu,9.09,Number of Centchroman (weekly) pills given,TOTAL,26.0,73.0,16.0,1258.0,27.0,26.0,44.0,1.0,75.0,3.0,10.0,5.0,1564.0
Palamu,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,107.0,1347.0,98.0,412.0,367.0,138.0,87.0,322.0,165.0,203.0,137.0,84.0,3467.0
Palamu,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,1.0,0.0,0.0,20.0,6.0,0.0,2.0,0.0,0.0,3.0,0.0,0.0,32.0
Palamu,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,6.0,46.0,20.0,0.0,74.0
Palamu,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,4.0,6.0,0.0,11.0
Palamu,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,9.12,Number of Institutions having NSV trained doctors,TOTAL,18.0,19.0,18.0,20.0,21.0,26.0,26.0,24.0,24.0,23.0,23.0,25.0,-1.0
Palamu,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2933.0,2707.0,3221.0,4176.0,4270.0,4528.0,4420.0,3854.0,3505.0,3971.0,2724.0,1076.0,41385.0
Palamu,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3265.0,2826.0,2957.0,3255.0,3637.0,4007.0,4465.0,4129.0,3838.0,4079.0,3549.0,3199.0,43206.0
Palamu,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3598.0,3269.0,3080.0,2959.0,3562.0,3375.0,3634.0,4130.0,3955.0,3993.0,3756.0,3393.0,42704.0
Palamu,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3959.0,3489.0,3297.0,3103.0,3269.0,3156.0,3161.0,3412.0,3895.0,3974.0,3630.0,3584.0,41929.0
Palamu,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Palamu,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Palamu,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Palamu,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1712.0,1867.0,2200.0,2866.0,1890.0,3082.0,2559.0,2419.0,696.0,1155.0,947.0,210.0,21603.0
Palamu,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3224.0,2828.0,2832.0,3272.0,1602.0,4037.0,4163.0,4062.0,894.0,1839.0,1999.0,732.0,31484.0
Palamu,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3587.0,3244.0,2947.0,2964.0,1608.0,3245.0,3432.0,4031.0,812.0,1671.0,1938.0,743.0,30222.0
Palamu,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3875.0,3504.0,3087.0,3270.0,1452.0,3045.0,2914.0,3590.0,753.0,1639.0,1821.0,827.0,29777.0
Palamu,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,,,,,0.0,0.0,0.0,0.0,1101.0,216.0,182.0,1499.0
Palamu,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,5.0,3.0,15.0,6.0,22.0,23.0,17.0,0.0,0.0,2285.0,3595.0,1863.0,7834.0
Palamu,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,122.0,1985.0,1736.0,3843.0
Palamu,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,56.0,97.0,1025.0,1178.0
Palamu,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3880.0,3661.0,3900.0,3861.0,1570.0,4367.0,3552.0,2884.0,1921.0,2848.0,2821.0,2808.0,38073.0
Palamu,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,,,,,0.0,9.0,0.0,88659.0,0.0,13.0,0.0,88681.0
Palamu,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Palamu,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1906.0,1801.0,1985.0,1953.0,772.0,2167.0,1676.0,1428.0,866.0,1341.0,1293.0,1284.0,18472.0
Palamu,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1766.0,1727.0,1878.0,1813.0,669.0,2000.0,1432.0,1330.0,793.0,1198.0,1130.0,1183.0,16919.0
Palamu,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3672.0,3528.0,3863.0,3766.0,1441.0,4167.0,3108.0,2758.0,1659.0,2539.0,2423.0,2467.0,35391.0
Palamu,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2443.0,2104.0,2227.0,2227.0,2216.0,1961.0,1856.0,1865.0,1893.0,2361.0,2967.0,2496.0,26616.0
Palamu,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2405.0,2087.0,2209.0,2221.0,1117.0,1900.0,1764.0,1857.0,511.0,1320.0,1873.0,732.0,19996.0
Palamu,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,424.0,439.0,177.0,71.0,58.0,99.0,36.0,125.0,29.0,95.0,118.0,87.0,1758.0
Palamu,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,391.0,400.0,135.0,63.0,40.0,86.0,31.0,128.0,26.0,81.0,103.0,70.0,1554.0
Palamu,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,815.0,839.0,312.0,134.0,98.0,185.0,67.0,253.0,55.0,176.0,221.0,157.0,3312.0
Palamu,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,103.0,131.0,44.0,0.0,43.0,43.0,28.0,23.0,12.0,22.0,37.0,42.0,528.0
Palamu,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1098.0,955.0,948.0,945.0,981.0,1061.0,1025.0,886.0,800.0,1013.0,862.0,852.0,11426.0
Palamu,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1018.0,987.0,1099.0,995.0,1084.0,1185.0,1088.0,900.0,867.0,1095.0,1032.0,970.0,12320.0
Palamu,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,102.0,96.0,7.0,0.0,4.0,1.0,0.0,0.0,1.0,1.0,9.0,1.0,222.0
Palamu,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,20.0
Palamu,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1668.0,1819.0,1818.0,1799.0,1867.0,1876.0,1833.0,1846.0,1748.0,1854.0,1827.0,1812.0,21767.0
Palamu,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1629.0,1761.0,1802.0,1729.0,1830.0,1847.0,1788.0,1790.0,1584.0,1786.0,1727.0,1704.0,20977.0
Palamu,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1376.0,1472.0,1455.0,1391.0,1425.0,1470.0,1403.0,1496.0,1355.0,1453.0,1444.0,1357.0,17097.0
Palamu,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2250.0,1753.0,1523.0,1085.0,9218.0,3378.0,3018.0,2305.0,1210.0,2670.0,5341.0,2434.0,36185.0
Palamu,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,29.0,31.0,74.0,14.0,33635.0,1221.0,140.0,50.0,66.0,141.0,37415.0,4146.0,76962.0
Palamu,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,31.0,32.0,41.0,4.0,39930.0,1768.0,294.0,0.0,32.0,38.0,36569.0,4501.0,83240.0
Palamu,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,3.0,1.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Palamu,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,2.0,3.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Palamu,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,2.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Palamu,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,16.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Palamu,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,68.0,119.0,56.0,45.0,18.0,38.0,21.0,2.0,0.0,6.0,4.0,6.0,383.0
Palamu,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,270.0,329.0,183.0,169.0,165.0,172.0,46.0,72.0,35.0,57.0,69.0,40.0,1607.0
Palamu,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,310.0,325.0,269.0,250.0,277.0,190.0,107.0,730.0,88.0,88.0,67.0,71.0,2772.0
Palamu,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,14.0,0.0,3.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0
Palamu,13.1,Number of Patients operated for cataract,TOTAL,13.0,3.0,0.0,0.0,0.0,0.0,0.0,46.0,159.0,328.0,457.0,0.0,1006.0
Palamu,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,13.0,3.0,0.0,0.0,0.0,0.0,0.0,42.0,159.0,328.0,457.0,0.0,1002.0
Palamu,13.3,Number of School children detected with Refractive errors,TOTAL,369.0,24.0,4.0,700.0,89.0,428.0,267.0,268.0,0.0,0.0,6.0,0.0,2155.0
Palamu,13.4,Number of children provided free glasses,TOTAL,19.0,4.0,4.0,11.0,69.0,260.0,162.0,204.0,0.0,0.0,2.0,0.0,735.0
Palamu,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Palamu,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,2.0,2.0,3.0,4.0,2.0,4.0,3.0,4.0,3.0,2.0,3.0,-1.0
Palamu,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,11.0,12.0,13.0,12.0,13.0,18.0,15.0,10.0,12.0,11.0,11.0,10.0,-1.0
Palamu,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1125.0,1103.0,1023.0,969.0,1044.0,1012.0,1006.0,1029.0,1043.0,1041.0,1040.0,1089.0,-1.0
Palamu,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,10.0,11.0,10.0,10.0,11.0,10.0,8.0,8.0,8.0,8.0,8.0,-1.0
Palamu,14.05,Number of RKS meetings held during the month,TOTAL,18.0,17.0,14.0,15.0,12.0,13.0,15.0,13.0,13.0,14.0,20.0,18.0,182.0
Palamu,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,17.0,14.0,13.0,16.0,13.0,20.0,20.0,15.0,16.0,16.0,15.0,15.0,-1.0
Palamu,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,47.0,52.0,37.0,43.0,41.0,46.0,40.0,45.0,25.0,72.0,49.0,50.0,547.0
Palamu,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,3.0,3.0,3.0,4.0,6.0,7.0,6.0,7.0,5.0,5.0,-1.0
Palamu,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,-1.0
Palamu,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,186.0,97.0,72.0,637.0,179.0,60.0,476.0,143.0,234.0,1351.0,1289.0,328.0,5052.0
Palamu,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1072.0,933.0,1209.0,2971.0,1249.0,1161.0,2653.0,2907.0,1833.0,697.0,803.0,735.0,18223.0
Palamu,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,195.0,75.0,119.0,554.0,212.0,75.0,420.0,139.0,303.0,141.0,225.0,176.0,2634.0
Palamu,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1048.0,1121.0,1562.0,1804.0,2008.0,1542.0,1958.0,2108.0,1828.0,2647.0,2322.0,1082.0,21030.0
Palamu,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,381.0,172.0,191.0,1191.0,391.0,135.0,896.0,282.0,537.0,1492.0,1514.0,504.0,7686.0
Palamu,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2120.0,2054.0,2771.0,4775.0,3257.0,2703.0,4611.0,5015.0,3661.0,3344.0,3125.0,1817.0,39253.0
Palamu,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,3.0
Palamu,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0
Palamu,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,6.0
Palamu,14.11,In-Patient Head Count at midnight,TOTAL,209.0,794.0,314.0,645.0,690.0,480.0,534.0,486.0,686.0,1310.0,1260.0,603.0,8011.0
Palamu,14.12.1,OPD attendance (All),TOTAL,55634.0,57739.0,54968.0,103934.0,73023.0,69283.0,61934.0,62327.0,42973.0,56644.0,55612.0,62018.0,756089.0
Palamu,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,7.0,18.0,27.0,31.0,41.0,36.0,29.0,166.0,22.0,23.0,193.0,53.0,646.0
Palamu,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Palamu,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,84.0,54.0,54.0,45.0,61.0,48.0,64.0,69.0,60.0,58.0,107.0,106.0,810.0
Palamu,14.14.a,Number of patients given AYUSH treatment,TOTAL,81.0,42.0,46.0,47.0,43.0,1650.0,53.0,2347.0,1986.0,2370.0,2436.0,2153.0,13254.0
Palamu,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Palamu,14.14.c,Number of Adolescents counselled,TOTAL,96.0,58.0,72.0,94.0,106.0,133.0,64.0,567.0,843.0,727.0,716.0,279.0,3755.0
Palamu,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4292.0,3367.0,3346.0,4004.0,3472.0,3093.0,26440.0,7376.0,2471.0,4474.0,3664.0,3218.0,69217.0
Palamu,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,187.0,127.0,145.0,179.0,152.0,121.0,126.0,135.0,100.0,95.0,88.0,93.0,1548.0
Palamu,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,165.0,174.0,211.0,255.0,105.0,233.0,203.0,232.0,49.0,187.0,218.0,308.0,2340.0
Palamu,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,3.0,3.0,0.0,0.0,10.0,0.0,2.0,1.0,0.0,0.0,0.0,23.0
Palamu,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,152.0,141.0,110.0,163.0,60.0,220.0,240.0,318.0,59.0,328.0,331.0,490.0,2612.0
Palamu,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,4.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,1.0,1.0,11.0
Palamu,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,67.0,87.0,152.0,164.0,464.0,158.0,130.0,127.0,55.0,46.0,50.0,85.0,1585.0
Palamu,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,2.0,5.0,2.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Palamu,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,384.0,402.0,473.0,582.0,629.0,611.0,573.0,677.0,163.0,561.0,599.0,883.0,6537.0
Palamu,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5.0,6.0,12.0,2.0,6.0,12.0,1.0,2.0,1.0,0.0,1.0,1.0,49.0
Palamu,15.2,Number of Widal tests conducted,Number tested,112.0,96.0,45.0,135.0,163.0,147.0,130.0,89.0,34.0,30.0,44.0,102.0,1127.0
Palamu,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,19.0,40.0,26.0,0.0,0.0,0.0,0.0,0.0,0.0,85.0
Palamu,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,4.0,50.0,109.0,144.0,0.0,0.0,0.0,0.0,0.0,0.0,307.0
Palamu,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,102.0,141.0,96.0,0.0,0.0,0.0,0.0,0.0,0.0,339.0
Palamu,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,4.0,171.0,290.0,266.0,0.0,0.0,0.0,0.0,0.0,0.0,731.0
Palamu,15.4.1,Number of blood smears examined for Malaria,TOTAL,13596.0,11376.0,14666.0,18468.0,18429.0,23128.0,20457.0,17783.0,12338.0,7007.0,9154.0,13740.0,180142.0
Palamu,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1208.0,802.0,1153.0,1590.0,1547.0,2134.0,2162.0,1954.0,1059.0,430.0,771.0,686.0,15496.0
Palamu,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,108.0,11.0,11.0,30.0,65.0,72.0,152.0,560.0,146.0,32.0,31.0,13.0,1231.0
Palamu,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,13600.0,21240.0,41470.0,34510.0,12070.0,19200.0,24560.0,33540.0,19940.0,30890.0,12740.0,18620.0,282380.0
Palamu,16.1.1,Stock position of DPT vaccines,2. Stocks Received,25000.0,40000.0,0.0,0.0,40500.0,25000.0,30000.0,15000.0,25000.0,10000.0,30000.0,30000.0,270500.0
Palamu,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,17360.0,19770.0,6960.0,22440.0,33370.0,19640.0,21020.0,28600.0,14050.0,28150.0,24120.0,24940.0,260420.0
Palamu,16.1.1,Stock position of DPT vaccines,5. Total Stock,21240.0,41470.0,34510.0,12070.0,19200.0,24560.0,33540.0,19940.0,30890.0,12740.0,18620.0,23680.0,292460.0
Palamu,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Palamu,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Palamu,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Palamu,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Palamu,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,18360.0,35940.0,12760.0,32760.0,1280.0,10340.0,14120.0,18840.0,0.0,0.0,4960.0,0.0,149360.0
Palamu,16.1.2,Stock position of OPV vaccines,2. Stocks Received,40000.0,0.0,30000.0,0.0,30000.0,20000.0,30000.0,0.0,0.0,20000.0,0.0,0.0,170000.0
Palamu,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,22420.0,23180.0,10000.0,31480.0,20940.0,16220.0,25280.0,18840.0,0.0,15040.0,4960.0,0.0,188360.0
Palamu,16.1.2,Stock position of OPV vaccines,5. Total Stock,35940.0,12760.0,32760.0,1280.0,10340.0,14120.0,18840.0,0.0,0.0,4960.0,0.0,0.0,131000.0
Palamu,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,19890.0,25660.0,36680.0,35020.0,16660.0,19010.0,27570.0,29750.0,15880.0,37180.0,14370.0,21040.0,298710.0
Palamu,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,25000.0,20000.0,0.0,24500.0,20000.0,15000.0,6000.0,30000.0,0.0,20000.0,30000.0,210500.0
Palamu,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.3,Stock position of TT vaccines,4. Stock Distributed,14230.0,13980.0,21660.0,18360.0,22150.0,11440.0,12820.0,19870.0,8700.0,22810.0,13330.0,15870.0,195220.0
Palamu,16.1.3,Stock position of TT vaccines,5. Total Stock,25660.0,36680.0,35020.0,16660.0,19010.0,27570.0,29750.0,15880.0,37180.0,14370.0,21040.0,35170.0,313990.0
Palamu,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,25030.0,28860.0,26180.0,32350.0,18500.0,13980.0,21480.0,16930.0,0.0,10460.0,2570.0,0.0,196340.0
Palamu,16.1.5,Stock position of BCG vaccines,2. Stocks Received,15000.0,10000.0,20000.0,0.0,20000.0,20000.0,10000.0,0.0,20000.0,10000.0,0.0,13000.0,138000.0
Palamu,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,11170.0,12680.0,13830.0,13850.0,24520.0,12500.0,14550.0,16930.0,9540.0,17890.0,2570.0,5630.0,155660.0
Palamu,16.1.5,Stock position of BCG vaccines,5. Total Stock,28860.0,26180.0,32350.0,18500.0,13980.0,21480.0,16930.0,0.0,10460.0,2570.0,0.0,7370.0,178680.0
Palamu,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,7740.0,6665.0,12960.0,4935.0,0.0,10130.0,10050.0,10665.0,2180.0,38855.0,35425.0,31195.0,170800.0
Palamu,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,12500.0,0.0,0.0,20000.0,5000.0,10000.0,0.0,38145.0,0.0,0.0,0.0,90645.0
Palamu,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,6075.0,6205.0,8025.0,4935.0,9870.0,5080.0,9385.0,8485.0,1470.0,3430.0,4230.0,6615.0,73805.0
Palamu,16.1.6,Stock position of Measles vaccines,5. Total Stock,6665.0,12960.0,4935.0,0.0,10130.0,10050.0,10665.0,2180.0,38855.0,35425.0,31195.0,24580.0,187640.0
Palamu,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28000.0,28000.0,10550.0,670.0,67220.0
Palamu,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28000.0,0.0,0.0,200.0,0.0,28200.0
Palamu,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17450.0,10080.0,670.0,28200.0
Palamu,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28000.0,28000.0,10550.0,670.0,0.0,67220.0
Palamu,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3036.0,3036.0,2436.0,1836.0,4996.0,4396.0,4396.0,4396.0,4384.0,4384.0,3884.0,3284.0,44464.0
Palamu,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,4110.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4110.0
Palamu,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,600.0,600.0,950.0,600.0,0.0,0.0,12.0,0.0,500.0,600.0,2500.0,6362.0
Palamu,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,3036.0,2436.0,1836.0,4996.0,4396.0,4396.0,4396.0,4384.0,4384.0,3884.0,3284.0,784.0,42212.0
Palamu,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,74400.0,44400.0,32400.0,9900.0,79500.0,41500.0,35500.0,123140.0,23500.0,23500.0,13500.0,8500.0,509740.0
Palamu,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,97500.0,0.0,0.0,88200.0,0.0,0.0,0.0,0.0,30000.0,215700.0
Palamu,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,30000.0,12000.0,22500.0,27900.0,38000.0,6000.0,560.0,99640.0,0.0,10000.0,5000.0,19500.0,271100.0
Palamu,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,44400.0,32400.0,9900.0,79500.0,41500.0,35500.0,123140.0,23500.0,23500.0,13500.0,8500.0,19000.0,454340.0
Palamu,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,12900.0,9900.0,8900.0,5600.0,11200.0,7900.0,7900.0,43100.0,42890.0,42890.0,32890.0,22890.0,248960.0
Palamu,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,10000.0,0.0,0.0,35400.0,0.0,0.0,0.0,0.0,0.0,45400.0
Palamu,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,3000.0,1000.0,3300.0,4400.0,3300.0,0.0,200.0,210.0,0.0,10000.0,10000.0,1290.0,36700.0
Palamu,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,9900.0,8900.0,5600.0,11200.0,7900.0,7900.0,43100.0,42890.0,42890.0,32890.0,22890.0,21600.0,257660.0
Palamu,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1632.0,1632.0,1132.0,5000.0,4350.0,4300.0,3900.0,9300.0,9250.0,9250.0,8250.0,7250.0,65246.0
Palamu,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,4350.0,0.0,0.0,0.0,7500.0,0.0,0.0,0.0,0.0,0.0,11850.0
Palamu,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,500.0,482.0,650.0,50.0,400.0,2100.0,50.0,0.0,1000.0,1000.0,4900.0,11132.0
Palamu,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1632.0,1132.0,5000.0,4350.0,4300.0,3900.0,9300.0,9250.0,9250.0,8250.0,7250.0,2350.0,65964.0
Palamu,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Palamu,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Palamu,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Palamu,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Palamu,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,50.0,50.0,0.0,300.0,300.0,300.0,200.0,200.0,200.0,0.0,0.0,1600.0
Palamu,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,100.0,0.0,0.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0
Palamu,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,50.0,0.0,50.0,200.0,0.0,0.0,100.0,0.0,0.0,200.0,0.0,0.0,600.0
Palamu,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,50.0,50.0,0.0,300.0,300.0,300.0,200.0,200.0,200.0,0.0,0.0,0.0,1600.0
Palamu,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,4030.0,2830.0,1830.0,558.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9248.0
Palamu,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Palamu,16.3.02,Stock Position of Gloves,4. Stock Distributed,1200.0,1000.0,500.0,558.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3258.0
Palamu,16.3.02,Stock Position of Gloves,5. Total Stock,2830.0,1830.0,1330.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5990.0
Palamu,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Palamu,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,2070.0,2070.0,87.0,0.0,0.0,0.0,0.0,0.0,0.0,4227.0
Palamu,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,3750.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3750.0
Palamu,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,1680.0,0.0,1983.0,87.0,0.0,0.0,0.0,0.0,0.0,0.0,3750.0
Palamu,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,2070.0,2070.0,87.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4227.0
Palamu,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4619.0,5721.0,2980.0,6119.0,3196.0,4258.0,6912.0,5427.0,296.0,3038.0,618.0,0.0,43184.0
Palamu,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,0.0,5000.0,0.0,6000.0,6000.0,3000.0,0.0,6000.0,3000.0,0.0,4000.0,36000.0
Palamu,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1898.0,2741.0,1861.0,2923.0,4938.0,3346.0,4485.0,5131.0,3258.0,5420.0,618.0,1689.0,38308.0
Palamu,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,5721.0,2980.0,6119.0,3196.0,4258.0,6912.0,5427.0,296.0,3038.0,618.0,0.0,2311.0,40876.0
Palamu,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,30172.0,76972.0,111972.0,70400.0,33600.0,48800.0,86200.0,64000.0,21600.0,31200.0,36500.0,57300.0,668716.0
Palamu,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,60000.0,60000.0,0.0,0.0,38000.0,58000.0,0.0,0.0,38800.0,30000.0,38400.0,0.0,323200.0
Palamu,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,13200.0,25000.0,41572.0,36800.0,22800.0,20600.0,22200.0,42400.0,29200.0,24700.0,17600.0,26800.0,322872.0
Palamu,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,76972.0,111972.0,70400.0,33600.0,48800.0,86200.0,64000.0,21600.0,31200.0,36500.0,57300.0,30500.0,669044.0
Palamu,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3326.0,4051.0,1721.0,0.0,4940.0,2560.0,7110.0,5180.0,1780.0,5780.0,4254.0,12634.0,53336.0
Palamu,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2500.0,0.0,0.0,6000.0,0.0,6000.0,0.0,0.0,4300.0,0.0,10000.0,0.0,28800.0
Palamu,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Palamu,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1775.0,2330.0,1721.0,1060.0,2380.0,1450.0,1930.0,3400.0,300.0,1526.0,1620.0,1670.0,21162.0
Palamu,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4051.0,1721.0,0.0,4940.0,2560.0,7110.0,5180.0,1780.0,5780.0,4254.0,12634.0,10964.0,60974.0
Palamu,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Palamu,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Palamu,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Palamu,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Palamu,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Palamu,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Palamu,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Palamu,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Palamu,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Palamu,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Palamu,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,,,,,,,,,,,1.0
Palamu,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,,1.0
Palamu,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,,,,,,,,,,,,2.0
Palamu,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,1.0,,1.0,,,,2.0
Palamu,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Palamu,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,1.0,,1.0,,,,2.0
Palamu,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Palamu,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Palamu,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Palamu,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Palamu,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Palamu,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Palamu,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Palamu,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Palamu,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,1.0,,,,,,,,1.0
Palamu,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Palamu,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
Palamu,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,1.0,,,,1.0,,2.0
Palamu,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Palamu,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Palamu,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Palamu,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Palamu,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Palamu,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Palamu,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Palamu,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Palamu,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Palamu,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,1.0,,,,1.0
Palamu,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Palamu,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Palamu,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Palamu,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Palamu,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Palamu,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Palamu,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Palamu,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Palamu,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Palamu,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Palamu,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Palamu,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Palamu,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Palamu,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Palamu,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Palamu,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Palamu,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Palamu,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Palamu,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Palamu,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Palamu,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Palamu,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Palamu,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Palamu,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,1.0,,,,,,1.0
Palamu,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Palamu,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Palamu,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Palamu,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Palamu,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Palamu,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Palamu,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Palamu,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Palamu,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Palamu,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Palamu,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Palamu,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,4.0,,1.0,,,,,5.0
Palamu,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Palamu,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,4.0,,1.0,,,,,5.0
Pashchimi Singhbhum,1.1,Total number of pregnant women Registered for ANC,TOTAL,3668.0,3794.0,3654.0,3743.0,3514.0,2850.0,3384.0,3378.0,3485.0,3359.0,3345.0,3617.0,41791.0
Pashchimi Singhbhum,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,880.0,805.0,686.0,831.0,822.0,828.0,808.0,825.0,738.0,717.0,715.0,767.0,9422.0
Pashchimi Singhbhum,1.2,Number of Pregnant women registered under JSY,TOTAL,3112.0,3081.0,2948.0,3243.0,2897.0,2640.0,3018.0,3054.0,3344.0,3111.0,3182.0,3110.0,36740.0
Pashchimi Singhbhum,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2251.0,2320.0,2330.0,2235.0,2315.0,2266.0,2294.0,2595.0,2434.0,2675.0,2491.0,2846.0,29052.0
Pashchimi Singhbhum,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3139.0,3301.0,3071.0,3308.0,3160.0,2749.0,3129.0,3204.0,3333.0,3187.0,3211.0,3109.0,37901.0
Pashchimi Singhbhum,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2293.0,2886.0,2939.0,2600.0,3029.0,2665.0,2658.0,2976.0,2982.0,3030.0,2957.0,3114.0,34129.0
Pashchimi Singhbhum,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2372.0,2245.0,1644.0,1369.0,694.0,310.0,250.0,770.0,1226.0,1482.0,1985.0,1837.0,16184.0
Pashchimi Singhbhum,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,117.0,144.0,81.0,80.0,45.0,55.0,63.0,51.0,109.0,54.0,51.0,87.0,937.0
Pashchimi Singhbhum,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,16.0,0.0,5.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0
Pashchimi Singhbhum,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,550.0,565.0,575.0,588.0,593.0,531.0,614.0,596.0,512.0,609.0,604.0,589.0,6926.0
Pashchimi Singhbhum,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,5.0,13.0,3.0,2.0,0.0,2.0,2.0,2.0,4.0,4.0,2.0,18.0,57.0
Pashchimi Singhbhum,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,369.0,400.0,413.0,368.0,360.0,297.0,406.0,440.0,420.0,422.0,349.0,487.0,4731.0
Pashchimi Singhbhum,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,811.0,813.0,733.0,879.0,963.0,847.0,929.0,1058.0,1077.0,978.0,807.0,632.0,10527.0
Pashchimi Singhbhum,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1180.0,1213.0,1146.0,1247.0,1323.0,1144.0,1335.0,1498.0,1497.0,1400.0,1156.0,1119.0,15258.0
Pashchimi Singhbhum,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,996.0,1085.0,1017.0,1064.0,1195.0,988.0,1084.0,1198.0,1221.0,1078.0,929.0,905.0,12760.0
Pashchimi Singhbhum,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,136.0,261.0,194.0,142.0,204.0,119.0,166.0,201.0,200.0,193.0,148.0,238.0,2202.0
Pashchimi Singhbhum,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1200.0,1208.0,1122.0,1261.0,1354.0,1302.0,1435.0,1544.0,1503.0,1422.0,1537.0,1618.0,16506.0
Pashchimi Singhbhum,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1189.0,1208.0,1100.0,1262.0,1334.0,1286.0,1427.0,1445.0,1405.0,1410.0,1415.0,1508.0,15989.0
Pashchimi Singhbhum,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1078.0,963.0,1327.0,1040.0,1215.0,1173.0,1085.0,1223.0,1178.0,1339.0,1152.0,1432.0,14205.0
Pashchimi Singhbhum,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,871.0,814.0,1066.0,837.0,960.0,723.0,656.0,888.0,871.0,1011.0,913.0,1135.0,10745.0
Pashchimi Singhbhum,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,3.0,11.0,0.0,0.0,7.0,11.0,5.0,1.0,6.0,94.0,2.0,0.0,140.0
Pashchimi Singhbhum,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,6.0
Pashchimi Singhbhum,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,6.0
Pashchimi Singhbhum,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,4.1.1.a,Number of male live births,TOTAL,1278.0,1286.0,1142.0,1321.0,1426.0,1236.0,1390.0,1544.0,1491.0,1494.0,1401.0,1432.0,16441.0
Pashchimi Singhbhum,4.1.1.b,Number of female live births,TOTAL,1211.0,1139.0,1108.0,1224.0,1270.0,1225.0,1426.0,1513.0,1490.0,1363.0,1296.0,1289.0,15554.0
Pashchimi Singhbhum,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2489.0,2425.0,2250.0,2545.0,2696.0,2461.0,2816.0,3057.0,2981.0,2857.0,2697.0,2721.0,31995.0
Pashchimi Singhbhum,4.1.2,Number of still births,TOTAL,47.0,26.0,23.0,38.0,25.0,49.0,50.0,43.0,25.0,32.0,52.0,55.0,465.0
Pashchimi Singhbhum,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,35.0,26.0,33.0,32.0,26.0,26.0,41.0,36.0,26.0,37.0,49.0,46.0,413.0
Pashchimi Singhbhum,4.2.1,Number of Newborns weighed at birth,TOTAL,2430.0,2145.0,2154.0,2443.0,2616.0,2388.0,2665.0,2852.0,2836.0,2718.0,2550.0,2295.0,30092.0
Pashchimi Singhbhum,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,205.0,122.0,107.0,133.0,77.0,117.0,181.0,133.0,146.0,115.0,156.0,92.0,1584.0
Pashchimi Singhbhum,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2441.0,2213.0,2183.0,2485.0,2628.0,2438.0,2699.0,2968.0,2895.0,2789.0,2636.0,2242.0,30617.0
Pashchimi Singhbhum,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,2.0,0.0,3.0,0.0,0.0,0.0,5.0,2.0,0.0,2.0,14.0
Pashchimi Singhbhum,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4.0,0.0,0.0,0.0,2.0,71.0,79.0,112.0,80.0,73.0,66.0,56.0,543.0
Pashchimi Singhbhum,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,42.0,75.0,102.0,70.0,67.0,48.0,46.0,450.0
Pashchimi Singhbhum,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,4.0,0.0,2.0,0.0,5.0,113.0,154.0,214.0,155.0,142.0,114.0,104.0,1007.0
Pashchimi Singhbhum,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,4.0,0.0,0.0,6.0,2.0,45.0,79.0,112.0,80.0,70.0,52.0,8.0,458.0
Pashchimi Singhbhum,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,1.0,5.0
Pashchimi Singhbhum,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,4.0,0.0,0.0,2.0,0.0,42.0,154.0,109.0,63.0,72.0,56.0,48.0,550.0
Pashchimi Singhbhum,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1758.0,1806.0,1787.0,1798.0,2178.0,1862.0,2033.0,2241.0,2011.0,2150.0,2057.0,2032.0,23713.0
Pashchimi Singhbhum,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1481.0,1236.0,1327.0,1384.0,1632.0,1106.0,1343.0,1565.0,1400.0,1675.0,1488.0,1369.0,17006.0
Pashchimi Singhbhum,6.3,PNC maternal complications attended,TOTAL,23.0,24.0,0.0,0.0,0.0,7.0,0.0,5.0,0.0,2.0,0.0,1.0,62.0
Pashchimi Singhbhum,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2.0,8.0,4.0,10.0,0.0,6.0,4.0,13.0,6.0,6.0,12.0,8.0,79.0
Pashchimi Singhbhum,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2.0,8.0,4.0,10.0,0.0,6.0,4.0,13.0,6.0,6.0,12.0,8.0,79.0
Pashchimi Singhbhum,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,50.0,41.0,50.0,261.0,39.0,33.0,94.0,26.0,17.0,26.0,34.0,30.0,701.0
Pashchimi Singhbhum,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,54.0,44.0,63.0,160.0,55.0,41.0,165.0,22.0,12.0,22.0,46.0,34.0,718.0
Pashchimi Singhbhum,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,104.0,85.0,113.0,421.0,94.0,74.0,259.0,48.0,29.0,48.0,80.0,64.0,1419.0
Pashchimi Singhbhum,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Pashchimi Singhbhum,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,53.0,22.0,18.0,188.0,98.0,86.0,87.0,50.0,59.0,120.0,55.0,44.0,880.0
Pashchimi Singhbhum,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,11.0,0.0,0.0,28.0,4.0,13.0,8.0,3.0,6.0,8.0,8.0,3.0,92.0
Pashchimi Singhbhum,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,64.0,22.0,18.0,217.0,102.0,99.0,95.0,53.0,65.0,128.0,63.0,47.0,973.0
Pashchimi Singhbhum,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,25.0,2.0,15.0,315.0,94.0,58.0,44.0,14.0,8.0,331.0,285.0,194.0,1385.0
Pashchimi Singhbhum,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,10.0,0.0,0.0,36.0,5.0,0.0,0.0,2.0,0.0,0.0,12.0,6.0,71.0
Pashchimi Singhbhum,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,35.0,2.0,15.0,351.0,99.0,58.0,44.0,16.0,8.0,331.0,297.0,200.0,1456.0
Pashchimi Singhbhum,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Pashchimi Singhbhum,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,11.0,0.0,0.0,46.0,9.0,17.0,10.0,14.0,15.0,75.0,62.0,0.0,259.0
Pashchimi Singhbhum,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,10.0,0.0,0.0,36.0,5.0,8.0,9.0,0.0,15.0,52.0,44.0,0.0,179.0
Pashchimi Singhbhum,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,21.0,0.0,0.0,86.0,14.0,25.0,19.0,14.0,30.0,127.0,106.0,0.0,442.0
Pashchimi Singhbhum,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Pashchimi Singhbhum,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Pashchimi Singhbhum,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,2.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Pashchimi Singhbhum,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,159.0,185.0,183.0,836.0,197.0,135.0,152.0,187.0,180.0,390.0,402.0,274.0,3280.0
Pashchimi Singhbhum,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,13.0,8.0,10.0,31.0,27.0,7.0,7.0,12.0,16.0,16.0,37.0,15.0,199.0
Pashchimi Singhbhum,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,72.0,24.0,31.0,396.0,45.0,38.0,35.0,21.0,78.0,238.0,133.0,160.0,1271.0
Pashchimi Singhbhum,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,13.0,3.0,0.0,183.0,4.0,3.0,0.0,0.0,2.0,136.0,22.0,105.0,471.0
Pashchimi Singhbhum,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,257.0,220.0,224.0,1446.0,273.0,183.0,194.0,220.0,276.0,780.0,594.0,554.0,5221.0
Pashchimi Singhbhum,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,9.06,Number of IUCD removals,TOTAL,87.0,85.0,83.0,99.0,356.0,298.0,129.0,90.0,265.0,154.0,121.0,130.0,1897.0
Pashchimi Singhbhum,9.07,Number of Oral Pills cycles distributed,TOTAL,4110.0,3762.0,3686.0,6894.0,4188.0,4888.0,4858.0,3872.0,4956.0,5457.0,5199.0,4303.0,56173.0
Pashchimi Singhbhum,9.08,Number of Condom pieces distributed,TOTAL,22552.0,20668.0,22895.0,52952.0,25002.0,20650.0,23756.0,24382.0,22528.0,29021.0,25757.0,24563.0,314726.0
Pashchimi Singhbhum,9.09,Number of Centchroman (weekly) pills given,TOTAL,161.0,25.0,106.0,31.0,21.0,133.0,23.0,12.0,128.0,100.0,88.0,237.0,1065.0
Pashchimi Singhbhum,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,169.0,110.0,92.0,230.0,125.0,110.0,103.0,94.0,157.0,290.0,276.0,317.0,2073.0
Pashchimi Singhbhum,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,8.0,1.0,0.0,29.0,0.0,2.0,8.0,0.0,2.0,3.0,3.0,13.0,69.0
Pashchimi Singhbhum,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,4.0,0.0,0.0,13.0,1.0,26.0,12.0,6.0,7.0,30.0,25.0,21.0,145.0
Pashchimi Singhbhum,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Pashchimi Singhbhum,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,3.0,5.0,0.0,11.0
Pashchimi Singhbhum,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,9.12,Number of Institutions having NSV trained doctors,TOTAL,17.0,20.0,21.0,21.0,22.0,19.0,21.0,19.0,19.0,20.0,18.0,17.0,-1.0
Pashchimi Singhbhum,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2673.0,2904.0,2571.0,2811.0,2883.0,2524.0,3269.0,3384.0,3019.0,3240.0,1572.0,1440.0,32290.0
Pashchimi Singhbhum,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2726.0,2730.0,2786.0,2789.0,3540.0,2570.0,3042.0,3273.0,3541.0,3705.0,3568.0,3683.0,37953.0
Pashchimi Singhbhum,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2686.0,2800.0,2736.0,2683.0,2772.0,2489.0,2848.0,2892.0,3487.0,3333.0,3596.0,3795.0,36117.0
Pashchimi Singhbhum,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2818.0,2785.0,2902.0,2667.0,2648.0,2511.0,2740.0,2670.0,3028.0,3299.0,3196.0,3710.0,34974.0
Pashchimi Singhbhum,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,885.0,1222.0,1234.0,1441.0,585.0,911.0,451.0,1599.0,1304.0,1327.0,563.0,123.0,11645.0
Pashchimi Singhbhum,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1743.0,2560.0,2691.0,2743.0,1058.0,1735.0,588.0,3443.0,2536.0,2242.0,1137.0,227.0,22703.0
Pashchimi Singhbhum,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1946.0,2425.0,2760.0,2820.0,1090.0,1386.0,482.0,2451.0,2420.0,1991.0,955.0,201.0,20927.0
Pashchimi Singhbhum,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1795.0,2631.0,2746.0,2818.0,985.0,1402.0,498.0,2295.0,2124.0,1842.0,905.0,223.0,20264.0
Pashchimi Singhbhum,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,3.0,,,,0.0,0.0,0.0,0.0,6.0,87.0,289.0,99.0,484.0
Pashchimi Singhbhum,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,27.0,33.0,6.0,1.0,9.0,8.0,0.0,17.0,408.0,49.0,5117.0,4415.0,10090.0
Pashchimi Singhbhum,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,8.0,12.0,0.0,0.0,7.0,2.0,0.0,4.0,224.0,13.0,509.0,4233.0,5012.0
Pashchimi Singhbhum,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3.0,2.0,0.0,0.0,14.0,2.0,0.0,44.0,16.0,13.0,210.0,644.0,948.0
Pashchimi Singhbhum,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2715.0,2726.0,2892.0,2716.0,3031.0,2063.0,2315.0,2748.0,2066.0,2778.0,3108.0,3026.0,32184.0
Pashchimi Singhbhum,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,,,,0.0,24.0,2.0,39.0,0.0,24.0,0.0,2.0,91.0
Pashchimi Singhbhum,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1354.0,1385.0,1412.0,1348.0,1449.0,1013.0,1171.0,1326.0,1035.0,1359.0,1480.0,1505.0,15837.0
Pashchimi Singhbhum,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1286.0,1281.0,1350.0,1285.0,1398.0,1012.0,1113.0,1302.0,922.0,1358.0,1417.0,1406.0,15130.0
Pashchimi Singhbhum,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2640.0,2666.0,2762.0,2633.0,2847.0,2025.0,2284.0,2628.0,1957.0,2717.0,2897.0,2911.0,30967.0
Pashchimi Singhbhum,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2002.0,2326.0,2318.0,1951.0,2318.0,1720.0,1914.0,1952.0,1869.0,2042.0,2404.0,2586.0,25402.0
Pashchimi Singhbhum,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1370.0,1989.0,2160.0,1891.0,895.0,1067.0,380.0,1804.0,1364.0,1227.0,659.0,151.0,14957.0
Pashchimi Singhbhum,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,378.0,494.0,624.0,481.0,503.0,409.0,463.0,513.0,574.0,704.0,819.0,517.0,6479.0
Pashchimi Singhbhum,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,344.0,479.0,602.0,471.0,484.0,413.0,357.0,480.0,595.0,645.0,742.0,502.0,6114.0
Pashchimi Singhbhum,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,722.0,973.0,1226.0,952.0,987.0,822.0,820.0,993.0,1169.0,1349.0,1561.0,1019.0,12593.0
Pashchimi Singhbhum,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,255.0,519.0,760.0,644.0,941.0,675.0,599.0,654.0,610.0,652.0,718.0,865.0,7892.0
Pashchimi Singhbhum,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1400.0,1485.0,1397.0,1339.0,1529.0,1379.0,1524.0,1579.0,1409.0,1410.0,1555.0,1773.0,17779.0
Pashchimi Singhbhum,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1315.0,1474.0,1371.0,1436.0,1579.0,1500.0,1667.0,1597.0,1582.0,1567.0,1494.0,1811.0,18393.0
Pashchimi Singhbhum,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,6.0,0.0,0.0,0.0,0.0,0.0,17.0,22.0,32.0,17.0,25.0,119.0
Pashchimi Singhbhum,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,72.0,77.0,97.0,42.0,81.0,105.0,98.0,142.0,166.0,162.0,151.0,106.0,1299.0
Pashchimi Singhbhum,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2229.0,2218.0,2090.0,2093.0,2074.0,1912.0,2264.0,2336.0,2264.0,2335.0,2311.0,2510.0,26636.0
Pashchimi Singhbhum,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2009.0,2110.0,2022.0,1960.0,2007.0,1876.0,2133.0,2174.0,2241.0,2241.0,2272.0,2422.0,25467.0
Pashchimi Singhbhum,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1674.0,1744.0,1666.0,1709.0,1667.0,1569.0,1834.0,1870.0,1909.0,1927.0,1991.0,2118.0,21678.0
Pashchimi Singhbhum,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,,,,0.0,0.0,0.0,55.0,109.0,63.0,46.0,9.0,282.0
Pashchimi Singhbhum,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2496.0,2462.0,2669.0,1835.0,4376.0,2038.0,2136.0,2305.0,1604.0,1818.0,4758.0,2709.0,31206.0
Pashchimi Singhbhum,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,457.0,741.0,690.0,460.0,13089.0,1270.0,777.0,590.0,433.0,274.0,13686.0,1369.0,33836.0
Pashchimi Singhbhum,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,340.0,428.0,339.0,321.0,15321.0,1436.0,641.0,482.0,252.0,138.0,16497.0,1414.0,37609.0
Pashchimi Singhbhum,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Pashchimi Singhbhum,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0
Pashchimi Singhbhum,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,92.0,53.0,29.0,50.0,79.0,16.0,35.0,12.0,25.0,32.0,25.0,20.0,468.0
Pashchimi Singhbhum,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,268.0,320.0,376.0,298.0,302.0,259.0,189.0,308.0,214.0,216.0,258.0,230.0,3238.0
Pashchimi Singhbhum,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,407.0,372.0,418.0,286.0,281.0,271.0,190.0,253.0,291.0,558.0,267.0,271.0,3865.0
Pashchimi Singhbhum,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,6.0
Pashchimi Singhbhum,13.1,Number of Patients operated for cataract,TOTAL,0.0,54.0,0.0,0.0,0.0,0.0,875.0,0.0,0.0,0.0,0.0,160.0,1089.0
Pashchimi Singhbhum,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,54.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,54.0
Pashchimi Singhbhum,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,650.0,54.0,0.0,0.0,0.0,12.0,25.0,0.0,0.0,0.0,2.0,743.0
Pashchimi Singhbhum,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,0.0,0.0,0.0,2.0,14.0
Pashchimi Singhbhum,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,7.0,7.0,8.0,7.0,5.0,5.0,9.0,10.0,9.0,6.0,5.0,-1.0
Pashchimi Singhbhum,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,6.0,6.0,8.0,7.0,8.0,7.0,8.0,8.0,7.0,6.0,4.0,-1.0
Pashchimi Singhbhum,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1764.0,1905.0,1741.0,1832.0,1756.0,1608.0,1770.0,1901.0,1858.0,1853.0,1948.0,1864.0,-1.0
Pashchimi Singhbhum,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,14.0,14.0,14.0,12.0,14.0,14.0,13.0,15.0,15.0,13.0,10.0,12.0,-1.0
Pashchimi Singhbhum,14.05,Number of RKS meetings held during the month,TOTAL,11.0,9.0,6.0,6.0,5.0,5.0,7.0,5.0,3.0,6.0,6.0,8.0,77.0
Pashchimi Singhbhum,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,17.0,18.0,20.0,20.0,20.0,17.0,19.0,21.0,22.0,18.0,14.0,15.0,-1.0
Pashchimi Singhbhum,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,34.0,23.0,26.0,48.0,40.0,30.0,44.0,18.0,20.0,33.0,21.0,38.0,375.0
Pashchimi Singhbhum,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,6.0,7.0,7.0,6.0,8.0,6.0,5.0,7.0,7.0,7.0,5.0,6.0,-1.0
Pashchimi Singhbhum,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,6.0,6.0,6.0,-1.0
Pashchimi Singhbhum,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,47.0,35.0,33.0,18.0,26.0,29.0,34.0,25.0,18.0,26.0,26.0,22.0,339.0
Pashchimi Singhbhum,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,383.0,500.0,395.0,103.0,384.0,441.0,130.0,118.0,51.0,40.0,488.0,495.0,3528.0
Pashchimi Singhbhum,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,32.0,32.0,23.0,10.0,14.0,18.0,31.0,75.0,14.0,17.0,27.0,25.0,318.0
Pashchimi Singhbhum,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,435.0,627.0,566.0,476.0,586.0,766.0,511.0,416.0,185.0,296.0,613.0,735.0,6212.0
Pashchimi Singhbhum,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,79.0,67.0,56.0,28.0,40.0,47.0,65.0,100.0,32.0,43.0,53.0,47.0,657.0
Pashchimi Singhbhum,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,818.0,1127.0,961.0,579.0,970.0,1207.0,641.0,534.0,236.0,336.0,1101.0,1230.0,9740.0
Pashchimi Singhbhum,14.10.2.a,Number of death cases of Inpatient males,TOTAL,4.0,1.0,3.0,1.0,8.0,8.0,7.0,8.0,2.0,4.0,6.0,5.0,57.0
Pashchimi Singhbhum,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,3.0,3.0,0.0,5.0,4.0,10.0,4.0,3.0,5.0,1.0,2.0,44.0
Pashchimi Singhbhum,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,8.0,4.0,6.0,1.0,13.0,12.0,17.0,12.0,5.0,9.0,7.0,7.0,101.0
Pashchimi Singhbhum,14.11,In-Patient Head Count at midnight,TOTAL,622.0,24.0,575.0,6.0,5.0,46.0,170.0,28.0,7.0,36.0,71.0,26.0,1616.0
Pashchimi Singhbhum,14.12.1,OPD attendance (All),TOTAL,51236.0,50531.0,50297.0,52088.0,61217.0,55404.0,61114.0,58052.0,45809.0,47917.0,51318.0,49354.0,634337.0
Pashchimi Singhbhum,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,2.0,2.0,6.0,1.0,2.0,0.0,0.0,1.0,29.0,0.0,6.0,49.0
Pashchimi Singhbhum,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Pashchimi Singhbhum,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,29.0,20.0,28.0,29.0,169.0,99.0,91.0,28.0,32.0,42.0,3.0,7.0,577.0
Pashchimi Singhbhum,14.14.a,Number of patients given AYUSH treatment,TOTAL,879.0,616.0,687.0,697.0,316.0,358.0,141.0,60.0,146.0,133.0,95.0,80.0,4208.0
Pashchimi Singhbhum,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,13.0
Pashchimi Singhbhum,14.14.c,Number of Adolescents counselled,TOTAL,0.0,33.0,2.0,386.0,239.0,197.0,17.0,107.0,146.0,93.0,124.0,33.0,1377.0
Pashchimi Singhbhum,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1582.0,2042.0,1937.0,1856.0,1910.0,1817.0,2163.0,1809.0,1849.0,1838.0,2738.0,1927.0,23468.0
Pashchimi Singhbhum,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,88.0,87.0,88.0,68.0,95.0,69.0,83.0,61.0,58.0,68.0,86.0,77.0,928.0
Pashchimi Singhbhum,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,172.0,141.0,241.0,135.0,277.0,308.0,249.0,205.0,226.0,338.0,339.0,183.0,2814.0
Pashchimi Singhbhum,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,1.0,0.0,2.0,0.0,0.0,1.0,0.0,1.0,2.0,0.0,8.0
Pashchimi Singhbhum,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,90.0,77.0,213.0,162.0,157.0,185.0,107.0,59.0,187.0,149.0,260.0,26.0,1672.0
Pashchimi Singhbhum,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,4.0
Pashchimi Singhbhum,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,92.0,124.0,166.0,59.0,141.0,194.0,142.0,89.0,198.0,187.0,213.0,80.0,1685.0
Pashchimi Singhbhum,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,55.0,0.0,0.0,55.0
Pashchimi Singhbhum,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,354.0,342.0,620.0,356.0,575.0,687.0,498.0,353.0,611.0,674.0,812.0,289.0,6171.0
Pashchimi Singhbhum,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,1.0,2.0,0.0,4.0,0.0,0.0,1.0,1.0,56.0,2.0,0.0,67.0
Pashchimi Singhbhum,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,9.0
Pashchimi Singhbhum,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,9.0
Pashchimi Singhbhum,15.4.1,Number of blood smears examined for Malaria,TOTAL,6248.0,6703.0,5640.0,7831.0,12108.0,8560.0,10346.0,10026.0,8925.0,7532.0,7901.0,7531.0,99351.0
Pashchimi Singhbhum,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,130.0,142.0,111.0,237.0,404.0,173.0,212.0,230.0,300.0,244.0,211.0,221.0,2615.0
Pashchimi Singhbhum,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,471.0,464.0,296.0,622.0,1490.0,518.0,839.0,1203.0,1401.0,611.0,431.0,579.0,8925.0
Pashchimi Singhbhum,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,65460.0,67620.0,69410.0,62700.0,92280.0,86440.0,70650.0,70990.0,67540.0,72920.0,67870.0,57350.0,851230.0
Pashchimi Singhbhum,16.1.1,Stock position of DPT vaccines,2. Stocks Received,20000.0,20000.0,15000.0,50000.0,20000.0,0.0,20000.0,20000.0,20000.0,20000.0,20000.0,15000.0,240000.0
Pashchimi Singhbhum,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,17840.0,18210.0,21710.0,20420.0,25840.0,15790.0,19660.0,23450.0,14620.0,25050.0,30520.0,16980.0,250090.0
Pashchimi Singhbhum,16.1.1,Stock position of DPT vaccines,5. Total Stock,67620.0,69410.0,62700.0,92280.0,86440.0,70650.0,70990.0,67540.0,72920.0,67870.0,57350.0,55370.0,841140.0
Pashchimi Singhbhum,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Pashchimi Singhbhum,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Pashchimi Singhbhum,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Pashchimi Singhbhum,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Pashchimi Singhbhum,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2140.0,22120.0,24480.0,30960.0,0.0,18060.0,0.0,16660.0,10440.0,0.0,700.0,700.0,126260.0
Pashchimi Singhbhum,16.1.2,Stock position of OPV vaccines,2. Stocks Received,30000.0,30000.0,40000.0,6000.0,20000.0,0.0,30000.0,20000.0,20000.0,20000.0,0.0,0.0,216000.0
Pashchimi Singhbhum,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,120.0,0.0,0.0,700.0,820.0
Pashchimi Singhbhum,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,10020.0,27640.0,33520.0,36960.0,1940.0,18060.0,13340.0,26220.0,30320.0,19300.0,0.0,0.0,217320.0
Pashchimi Singhbhum,16.1.2,Stock position of OPV vaccines,5. Total Stock,22120.0,24480.0,30960.0,0.0,18060.0,0.0,16660.0,10440.0,0.0,700.0,700.0,0.0,124120.0
Pashchimi Singhbhum,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,18800.0,30270.0,43200.0,33880.0,18920.0,32740.0,18180.0,28850.0,11610.0,26960.0,27040.0,28910.0,319360.0
Pashchimi Singhbhum,16.1.3,Stock position of TT vaccines,2. Stocks Received,30000.0,30000.0,10000.0,2500.0,39100.0,0.0,30000.0,0.0,30000.0,25000.0,20000.0,10000.0,226600.0
Pashchimi Singhbhum,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.1.3,Stock position of TT vaccines,4. Stock Distributed,18530.0,17070.0,19320.0,17460.0,25280.0,14560.0,19330.0,17240.0,14650.0,24920.0,18130.0,15050.0,221540.0
Pashchimi Singhbhum,16.1.3,Stock position of TT vaccines,5. Total Stock,30270.0,43200.0,33880.0,18920.0,32740.0,18180.0,28850.0,11610.0,26960.0,27040.0,28910.0,23860.0,324420.0
Pashchimi Singhbhum,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,37060.0,41230.0,46780.0,53500.0,35840.0,32490.0,19050.0,3770.0,5120.0,2310.0,340.0,20.0,277510.0
Pashchimi Singhbhum,16.1.5,Stock position of BCG vaccines,2. Stocks Received,20000.0,20000.0,20000.0,0.0,20000.0,0.0,0.0,10000.0,7000.0,10000.0,0.0,10000.0,117000.0
Pashchimi Singhbhum,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Pashchimi Singhbhum,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,15830.0,14450.0,13280.0,17660.0,23350.0,13440.0,15280.0,8650.0,9810.0,11970.0,320.0,,144040.0
Pashchimi Singhbhum,16.1.5,Stock position of BCG vaccines,5. Total Stock,41230.0,46780.0,53500.0,35840.0,32490.0,19050.0,3770.0,5120.0,2310.0,340.0,20.0,10020.0,250470.0
Pashchimi Singhbhum,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,8685.0,4685.0,8920.0,4415.0,5000.0,9485.0,2390.0,6845.0,245.0,8120.0,7435.0,10160.0,76385.0
Pashchimi Singhbhum,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,10000.0,5000.0,6370.0,10000.0,0.0,10000.0,0.0,10000.0,10000.0,10000.0,20000.0,96370.0
Pashchimi Singhbhum,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,9000.0,5765.0,9505.0,5785.0,5515.0,7095.0,5545.0,6600.0,2125.0,10685.0,7275.0,7150.0,82045.0
Pashchimi Singhbhum,16.1.6,Stock position of Measles vaccines,5. Total Stock,4685.0,8920.0,4415.0,5000.0,9485.0,2390.0,6845.0,245.0,8120.0,7435.0,10160.0,23010.0,90710.0
Pashchimi Singhbhum,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Pashchimi Singhbhum,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Pashchimi Singhbhum,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pashchimi Singhbhum,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Pashchimi Singhbhum,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,0.0,23770.0,7520.0,31290.0
Pashchimi Singhbhum,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,31700.0,0.0,12300.0,44000.0
Pashchimi Singhbhum,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,7930.0,16250.0,11660.0,35840.0
Pashchimi Singhbhum,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23770.0,7520.0,8160.0,39450.0
Pashchimi Singhbhum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,171.0,119.0,3019.0,2209.0,1197.0,847.0,797.0,497.0,497.0,547.0,497.0,840.0,11237.0
Pashchimi Singhbhum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,3000.0,0.0,600.0,0.0,0.0,0.0,0.0,200.0,200.0,4200.0,2000.0,10200.0
Pashchimi Singhbhum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,52.0,100.0,810.0,1612.0,350.0,50.0,300.0,0.0,150.0,250.0,3857.0,520.0,8051.0
Pashchimi Singhbhum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,119.0,3019.0,2209.0,1197.0,847.0,797.0,497.0,497.0,547.0,497.0,840.0,2320.0,13386.0
Pashchimi Singhbhum,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,20600.0,0.0,81000.0,16000.0,14000.0,8500.0,0.0,0.0,21354.0,21354.0,15153.0,3033.0,200994.0
Pashchimi Singhbhum,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,90000.0,0.0,75500.0,0.0,0.0,0.0,128520.0,0.0,0.0,0.0,7000.0,301020.0
Pashchimi Singhbhum,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,20600.0,9000.0,65000.0,77500.0,5500.0,8500.0,0.0,107166.0,0.0,6201.0,12120.0,6200.0,317787.0
Pashchimi Singhbhum,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,81000.0,16000.0,14000.0,8500.0,0.0,0.0,21354.0,21354.0,15153.0,3033.0,3833.0,184227.0
Pashchimi Singhbhum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,6528.0,2628.0,15628.0,7928.0,7428.0,3428.0,2928.0,1628.0,1528.0,1378.0,1878.0,441.0,53349.0
Pashchimi Singhbhum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,15000.0,0.0,18700.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,15000.0,50700.0
Pashchimi Singhbhum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,3900.0,2000.0,7700.0,19200.0,4000.0,500.0,1300.0,100.0,150.0,1500.0,1437.0,269.0,42056.0
Pashchimi Singhbhum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,2628.0,15628.0,7928.0,7428.0,3428.0,2928.0,1628.0,1528.0,1378.0,1878.0,441.0,15172.0,61993.0
Pashchimi Singhbhum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,700.0,700.0,1500.0,1130.0,1513.0,1513.0,1513.0,1513.0,1513.0,1513.0,1513.0,1513.0,16134.0
Pashchimi Singhbhum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,1000.0,0.0,3400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4400.0
Pashchimi Singhbhum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,200.0,370.0,3017.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,550.0,4137.0
Pashchimi Singhbhum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,700.0,1500.0,1130.0,1513.0,1513.0,1513.0,1513.0,1513.0,1513.0,1513.0,1513.0,963.0,16397.0
Pashchimi Singhbhum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,465.0,465.0,100.0,100.0,,,0.0,,0.0,1130.0
Pashchimi Singhbhum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,465.0,0.0,0.0,0.0,0.0,,,0.0,,0.0,465.0
Pashchimi Singhbhum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0
Pashchimi Singhbhum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,365.0,0.0,100.0,,,0.0,,0.0,465.0
Pashchimi Singhbhum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,465.0,465.0,100.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,1130.0
Pashchimi Singhbhum,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,113.0,141.0,128.0,49.0,49.0,49.0,49.0,,,,,,578.0
Pashchimi Singhbhum,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,153.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,153.0
Pashchimi Singhbhum,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,125.0,13.0,79.0,0.0,0.0,0.0,49.0,,,,,,266.0
Pashchimi Singhbhum,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,141.0,128.0,49.0,49.0,49.0,49.0,0.0,0.0,0.0,0.0,0.0,0.0,465.0
Pashchimi Singhbhum,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,960.0,35.0,0.0,5000.0,1530.0,1530.0,1530.0,1530.0,1530.0,1530.0,0.0,,15175.0
Pashchimi Singhbhum,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,5000.0
Pashchimi Singhbhum,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Pashchimi Singhbhum,16.3.02,Stock Position of Gloves,4. Stock Distributed,925.0,35.0,0.0,3470.0,0.0,0.0,0.0,0.0,0.0,1530.0,0.0,,5960.0
Pashchimi Singhbhum,16.3.02,Stock Position of Gloves,5. Total Stock,35.0,0.0,5000.0,1530.0,1530.0,1530.0,1530.0,1530.0,1530.0,0.0,0.0,0.0,14215.0
Pashchimi Singhbhum,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,298.0,0.0,0.0,,,,,,298.0
Pashchimi Singhbhum,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,,,,,,3000.0
Pashchimi Singhbhum,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,2702.0,298.0,0.0,0.0,,,,,,3000.0
Pashchimi Singhbhum,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,298.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,298.0
Pashchimi Singhbhum,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Pashchimi Singhbhum,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1270.0,3220.0,3320.0,4420.0,11620.0,12920.0,10120.0,5920.0,5320.0,5420.0,4943.0,2742.0,71235.0
Pashchimi Singhbhum,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,4000.0,4000.0,4000.0,9900.0,6000.0,0.0,0.0,3000.0,2100.0,3000.0,0.0,3000.0,39000.0
Pashchimi Singhbhum,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2050.0,3900.0,2900.0,2700.0,4700.0,2800.0,4200.0,3600.0,2000.0,3477.0,2201.0,1700.0,36228.0
Pashchimi Singhbhum,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3220.0,3320.0,4420.0,11620.0,12920.0,10120.0,5920.0,5320.0,5420.0,4943.0,2742.0,4042.0,74007.0
Pashchimi Singhbhum,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,182510.0,198460.0,177460.0,149960.0,137160.0,116560.0,113560.0,96060.0,81060.0,122800.0,110300.0,136700.0,1622590.0
Pashchimi Singhbhum,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,45000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,70240.0,0.0,40800.0,0.0,156040.0
Pashchimi Singhbhum,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,29050.0,21000.0,27500.0,12800.0,20600.0,3000.0,17500.0,15000.0,28500.0,12500.0,14400.0,14300.0,216150.0
Pashchimi Singhbhum,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,198460.0,177460.0,149960.0,137160.0,116560.0,113560.0,96060.0,81060.0,122800.0,110300.0,136700.0,122400.0,1562480.0
Pashchimi Singhbhum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,22100.0,23100.0,25100.0,23100.0,15600.0,8900.0,6400.0,4400.0,1400.0,372.0,272.0,172.0,130916.0
Pashchimi Singhbhum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,3000.0,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,522.0,0.0,0.0,0.0,7522.0
Pashchimi Singhbhum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pashchimi Singhbhum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2000.0,2000.0,2000.0,7500.0,6700.0,2500.0,2000.0,3000.0,1550.0,100.0,100.0,100.0,29550.0
Pashchimi Singhbhum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,23100.0,25100.0,23100.0,15600.0,8900.0,6400.0,4400.0,1400.0,372.0,272.0,172.0,72.0,108888.0
Pashchimi Singhbhum,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,2.0,2.0,2.0,2.0,2.0,1.0,4.0,4.0,4.0,3.0,26.0
Pashchimi Singhbhum,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Pashchimi Singhbhum,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Pashchimi Singhbhum,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Pashchimi Singhbhum,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,1.0,,,,1.0
Pashchimi Singhbhum,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,,1.0
Pashchimi Singhbhum,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,1.0,1.0,,,2.0
Pashchimi Singhbhum,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,1.0,,2.0,1.0,1.0,,4.0,1.0,10.0
Pashchimi Singhbhum,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,1.0,1.0,1.0,,1.0,,3.0,,7.0
Pashchimi Singhbhum,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,2.0,1.0,3.0,1.0,2.0,,7.0,1.0,17.0
Pashchimi Singhbhum,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,2.0,2.0,3.0,3.0,3.0,2.0,1.0,5.0,21.0
Pashchimi Singhbhum,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,1.0,,3.0,2.0,7.0
Pashchimi Singhbhum,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,2.0,2.0,3.0,4.0,4.0,2.0,4.0,7.0,28.0
Pashchimi Singhbhum,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Pashchimi Singhbhum,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Pashchimi Singhbhum,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Pashchimi Singhbhum,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Pashchimi Singhbhum,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Pashchimi Singhbhum,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Pashchimi Singhbhum,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,1.0,1.0,,,1.0,,,,1.0,5.0
Pashchimi Singhbhum,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,1.0,1.0,3.0,,,1.0,6.0
Pashchimi Singhbhum,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,1.0,1.0,,1.0,2.0,3.0,,,2.0,11.0
Pashchimi Singhbhum,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Pashchimi Singhbhum,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Pashchimi Singhbhum,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Pashchimi Singhbhum,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,3.0,8.0,3.0,2.0,7.0,1.0,3.0,,27.0
Pashchimi Singhbhum,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,1.0,3.0,6.0,9.0,4.0,1.0,4.0,,28.0
Pashchimi Singhbhum,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,4.0,11.0,9.0,11.0,11.0,2.0,7.0,,55.0
Pashchimi Singhbhum,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Pashchimi Singhbhum,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,1.0,,,,,,1.0
Pashchimi Singhbhum,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,1.0,1.0,,,,1.0,1.0,1.0,5.0
Pashchimi Singhbhum,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,1.0,1.0,,,,1.0,1.0,1.0,5.0
Pashchimi Singhbhum,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Pashchimi Singhbhum,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,1.0,1.0
Pashchimi Singhbhum,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,3.0,3.0,1.0,,7.0
Pashchimi Singhbhum,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,3.0,3.0,1.0,,7.0
Pashchimi Singhbhum,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Pashchimi Singhbhum,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,3.0,1.0,1.0,,7.0,3.0,2.0,17.0
Pashchimi Singhbhum,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Pashchimi Singhbhum,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,3.0,3.0,1.0,,7.0,3.0,2.0,19.0
Pashchimi Singhbhum,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,2.0,1.0,3.0
Pashchimi Singhbhum,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,2.0,1.0,3.0
Pashchimi Singhbhum,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Pashchimi Singhbhum,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,1.0,,1.0
Pashchimi Singhbhum,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,1.0,,1.0,,,1.0,2.0,,,5.0
Pashchimi Singhbhum,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,1.0,,1.0,,,1.0,2.0,,,5.0
Pashchimi Singhbhum,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Pashchimi Singhbhum,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,1.0,1.0
Pashchimi Singhbhum,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Pashchimi Singhbhum,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,1.0,,,,,1.0
Pashchimi Singhbhum,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,2.0,,2.0,4.0,5.0,1.0,14.0
Pashchimi Singhbhum,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,2.0,4.0,,,,,,,,,6.0
Pashchimi Singhbhum,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,2.0,4.0,,,2.0,,2.0,4.0,5.0,1.0,20.0
Pashchimi Singhbhum,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Pashchimi Singhbhum,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,1.0,4.0,2.0,2.0,1.0,1.0,11.0
Pashchimi Singhbhum,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,2.0,4.0,2.0,2.0,1.0,1.0,12.0
Pashchimi Singhbhum,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Pashchimi Singhbhum,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,1.0,,1.0
Pashchimi Singhbhum,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Pashchimi Singhbhum,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,1.0,,,,,,,1.0
Pashchimi Singhbhum,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,1.0,3.0,1.0,,2.0,1.0,1.0,2.0,3.0,2.0,16.0
Pashchimi Singhbhum,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,1.0,1.0,,1.0,,1.0,,,,,4.0
Pashchimi Singhbhum,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,2.0,4.0,1.0,1.0,2.0,2.0,1.0,2.0,3.0,2.0,20.0
Pashchimi Singhbhum,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Pashchimi Singhbhum,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,2.0,1.0,,,,,,1.0,2.0,2.0,8.0
Pashchimi Singhbhum,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,3.0,,,,,,,,,3.0
Pashchimi Singhbhum,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,2.0,4.0,,,,,,1.0,2.0,2.0,11.0
Pashchimi Singhbhum,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,2.0,,,,,,,,2.0
Pashchimi Singhbhum,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,1.0,3.0,7.0,2.0,7.0,6.0,5.0,5.0,36.0
Pashchimi Singhbhum,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,3.0,8.0,2.0,7.0,1.0,,,,21.0
Pashchimi Singhbhum,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,6.0,11.0,9.0,9.0,8.0,6.0,5.0,5.0,59.0
Purbi Singhbhum,1.1,Total number of pregnant women Registered for ANC,TOTAL,4477.0,4828.0,4798.0,4979.0,4712.0,3868.0,5574.0,4646.0,4398.0,4478.0,4411.0,4456.0,55625.0
Purbi Singhbhum,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,857.0,924.0,1003.0,898.0,966.0,761.0,888.0,896.0,836.0,905.0,879.0,886.0,10699.0
Purbi Singhbhum,1.2,Number of Pregnant women registered under JSY,TOTAL,4386.0,4812.0,4653.0,4489.0,4644.0,3798.0,5529.0,4543.0,4286.0,4303.0,4297.0,4291.0,54031.0
Purbi Singhbhum,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2678.0,3084.0,3095.0,3216.0,2765.0,2453.0,3523.0,2992.0,2970.0,2893.0,2925.0,3097.0,35691.0
Purbi Singhbhum,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3038.0,3066.0,2714.0,3119.0,2866.0,2600.0,2801.0,2688.0,2509.0,2581.0,2693.0,2552.0,33227.0
Purbi Singhbhum,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3093.0,3458.0,2916.0,2900.0,3339.0,2799.0,2862.0,2902.0,2817.0,2725.0,2620.0,2890.0,35321.0
Purbi Singhbhum,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1173.0,1059.0,786.0,937.0,688.0,570.0,727.0,1673.0,1893.0,2928.0,2141.0,2097.0,16672.0
Purbi Singhbhum,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,401.0,106.0,120.0,85.0,97.0,76.0,120.0,73.0,104.0,148.0,373.0,89.0,1792.0
Purbi Singhbhum,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,3.0,3.0,4.0,3.0,5.0,4.0,15.0,7.0,12.0,9.0,65.0
Purbi Singhbhum,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,587.0,613.0,511.0,569.0,570.0,521.0,506.0,521.0,506.0,526.0,524.0,501.0,6455.0
Purbi Singhbhum,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,22.0,19.0,51.0,50.0,61.0,6.0,78.0,48.0,48.0,24.0,8.0,8.0,423.0
Purbi Singhbhum,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,17.0,8.0,15.0,28.0,29.0,20.0,17.0,28.0,12.0,16.0,18.0,9.0,217.0
Purbi Singhbhum,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,640.0,639.0,646.0,745.0,673.0,565.0,606.0,646.0,628.0,561.0,470.0,469.0,7288.0
Purbi Singhbhum,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,657.0,647.0,661.0,773.0,702.0,585.0,623.0,674.0,640.0,577.0,488.0,478.0,7505.0
Purbi Singhbhum,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,436.0,401.0,451.0,499.0,442.0,399.0,432.0,440.0,416.0,364.0,291.0,278.0,4849.0
Purbi Singhbhum,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,45.0,15.0,24.0,26.0,31.0,54.0,33.0,29.0,9.0,30.0,21.0,32.0,349.0
Purbi Singhbhum,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,972.0,1337.0,1305.0,1448.0,1410.0,1355.0,1480.0,1530.0,1433.0,1471.0,1267.0,1376.0,16384.0
Purbi Singhbhum,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,947.0,1263.0,1082.0,1305.0,1346.0,1298.0,1435.0,1475.0,1325.0,1347.0,1205.0,1312.0,15340.0
Purbi Singhbhum,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,890.0,1182.0,1150.0,1389.0,1352.0,1042.0,1258.0,1448.0,1530.0,1289.0,2668.0,1711.0,16909.0
Purbi Singhbhum,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,319.0,1096.0,876.0,896.0,861.0,873.0,950.0,944.0,1059.0,1003.0,1424.0,1459.0,11760.0
Purbi Singhbhum,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,3.0,2.0,6.0,3.0,0.0,0.0,1.0,0.0,15.0
Purbi Singhbhum,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,745.0,1163.0,1167.0,1324.0,1359.0,1210.0,1027.0,1332.0,1697.0,1157.0,672.0,1130.0,13983.0
Purbi Singhbhum,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,3.0
Purbi Singhbhum,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,3.0,4.0,0.0,0.0,0.0,2.0,1.0,0.0,10.0
Purbi Singhbhum,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,136.0,190.0,302.0,249.0,391.0,217.0,342.0,199.0,199.0,244.0,228.0,247.0,2944.0
Purbi Singhbhum,4.1.1.a,Number of male live births,TOTAL,1319.0,1699.0,1583.0,1879.0,1821.0,1619.0,1711.0,1912.0,1951.0,1597.0,1300.0,1567.0,19958.0
Purbi Singhbhum,4.1.1.b,Number of female live births,TOTAL,1087.0,1421.0,1527.0,1687.0,1622.0,1505.0,1485.0,1631.0,1803.0,1487.0,1108.0,1403.0,17766.0
Purbi Singhbhum,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2406.0,3120.0,3110.0,3566.0,3443.0,3124.0,3196.0,3543.0,3754.0,3084.0,2408.0,2970.0,37724.0
Purbi Singhbhum,4.1.2,Number of still births,TOTAL,42.0,84.0,51.0,74.0,53.0,56.0,34.0,34.0,44.0,44.0,39.0,39.0,594.0
Purbi Singhbhum,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,76.0,108.0,85.0,84.0,106.0,100.0,156.0,159.0,121.0,147.0,83.0,105.0,1330.0
Purbi Singhbhum,4.2.1,Number of Newborns weighed at birth,TOTAL,2029.0,2951.0,2906.0,3221.0,3155.0,2962.0,3096.0,3436.0,3647.0,2848.0,2189.0,2851.0,35291.0
Purbi Singhbhum,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,206.0,238.0,269.0,292.0,326.0,305.0,444.0,392.0,317.0,313.0,291.0,284.0,3677.0
Purbi Singhbhum,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1761.0,2929.0,2902.0,3153.0,2992.0,2810.0,2817.0,3365.0,3612.0,2684.0,2083.0,2767.0,33875.0
Purbi Singhbhum,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,9.0,68.0,10.0,19.0,19.0,30.0,82.0,43.0,34.0,38.0,102.0,32.0,486.0
Purbi Singhbhum,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,9.0,68.0,10.0,19.0,19.0,30.0,82.0,43.0,34.0,38.0,102.0,32.0,486.0
Purbi Singhbhum,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,34.0,22.0,24.0,208.0,83.0,68.0,40.0,68.0,37.0,49.0,60.0,693.0
Purbi Singhbhum,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,19.0,55.0,28.0,84.0,28.0,30.0,103.0,53.0,82.0,29.0,80.0,97.0,688.0
Purbi Singhbhum,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,10.0,0.0,0.0,1.0,0.0,15.0,17.0,36.0,4.0,15.0,15.0,113.0
Purbi Singhbhum,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,49.0,51.0,35.0,20.0,27.0,30.0,88.0,62.0,238.0,18.0,59.0,66.0,743.0
Purbi Singhbhum,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,7.0,14.0,10.0,17.0,0.0,68.0,5.0,38.0,32.0,39.0,42.0,272.0
Purbi Singhbhum,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1506.0,2047.0,1881.0,2343.0,1995.0,2131.0,2188.0,2047.0,2897.0,1846.0,1420.0,2175.0,24476.0
Purbi Singhbhum,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1048.0,1052.0,1488.0,1969.0,974.0,1036.0,999.0,1069.0,979.0,744.0,547.0,492.0,12397.0
Purbi Singhbhum,6.3,PNC maternal complications attended,TOTAL,0.0,4.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Purbi Singhbhum,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Purbi Singhbhum,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Purbi Singhbhum,7.2,Number of MTPs conducted at Private Facilities,TOTAL,26.0,48.0,35.0,26.0,35.0,40.0,110.0,84.0,65.0,68.0,49.0,65.0,651.0
Purbi Singhbhum,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,57.0,205.0,161.0,344.0,383.0,374.0,356.0,143.0,208.0,97.0,10.0,6.0,2344.0
Purbi Singhbhum,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,107.0,199.0,230.0,35.0,233.0,276.0,149.0,126.0,233.0,85.0,111.0,72.0,1856.0
Purbi Singhbhum,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,164.0,404.0,391.0,379.0,616.0,650.0,505.0,269.0,441.0,182.0,121.0,78.0,4200.0
Purbi Singhbhum,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,3.0
Purbi Singhbhum,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,1.0,,,,,,,,,,1.0
Purbi Singhbhum,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,4.0
Purbi Singhbhum,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,14.0,11.0,21.0,54.0,10.0,14.0,8.0,17.0,15.0,15.0,17.0,10.0,206.0
Purbi Singhbhum,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,2.0
Purbi Singhbhum,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,282.0,0.0,0.0,286.0
Purbi Singhbhum,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,282.0,0.0,1.0,288.0
Purbi Singhbhum,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,83.0,59.0,61.0,988.0,69.0,136.0,130.0,635.0,467.0,1128.0,1461.0,398.0,5615.0
Purbi Singhbhum,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,91.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,91.0
Purbi Singhbhum,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,2.0,,,,,,,,,,2.0
Purbi Singhbhum,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,2.0,91.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,93.0
Purbi Singhbhum,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,2.0,10.0,13.0,18.0,0.0,39.0,19.0,31.0,39.0,2.0,4.0,4.0,181.0
Purbi Singhbhum,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,16.0,26.0,35.0,25.0,37.0,5.0,32.0,11.0,37.0,101.0,37.0,64.0,426.0
Purbi Singhbhum,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,214.0,231.0,198.0,589.0,171.0,128.0,116.0,126.0,112.0,324.0,260.0,163.0,2632.0
Purbi Singhbhum,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,3.0,3.0,111.0,6.0,5.0,6.0,4.0,5.0,14.0,3.0,6.0,167.0
Purbi Singhbhum,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,18.0,24.0,13.0,525.0,19.0,16.0,11.0,15.0,19.0,45.0,179.0,17.0,901.0
Purbi Singhbhum,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,1.0,4.0,7.0,6.0,2.0,1.0,6.0,9.0,4.0,,,10.0,50.0
Purbi Singhbhum,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,234.0,262.0,221.0,1231.0,198.0,150.0,139.0,154.0,140.0,383.0,442.0,196.0,3750.0
Purbi Singhbhum,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,34.0,59.0,104.0,129.0,49.0,62.0,59.0,48.0,56.0,35.0,60.0,52.0,747.0
Purbi Singhbhum,9.06,Number of IUCD removals,TOTAL,81.0,123.0,106.0,178.0,119.0,122.0,95.0,93.0,98.0,177.0,178.0,142.0,1512.0
Purbi Singhbhum,9.07,Number of Oral Pills cycles distributed,TOTAL,2933.0,3967.0,4259.0,10782.0,4788.0,7728.0,12528.0,20524.0,17496.0,4872.0,3759.0,2980.0,96616.0
Purbi Singhbhum,9.08,Number of Condom pieces distributed,TOTAL,34649.0,47138.0,43962.0,127263.0,52597.0,51618.0,51516.0,40478.0,35227.0,43483.0,33782.0,26243.0,587956.0
Purbi Singhbhum,9.09,Number of Centchroman (weekly) pills given,TOTAL,257.0,22.0,5.0,3.0,139.0,126.0,802.0,44.0,50.0,2148.0,610.0,400.0,4606.0
Purbi Singhbhum,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,162.0,152.0,145.0,153.0,235.0,175.0,152.0,1255.0,933.0,727.0,93.0,162.0,4344.0
Purbi Singhbhum,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,6.0
Purbi Singhbhum,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,4.0,0.0,0.0,22.0,1.0,0.0,0.0,13.0,2.0,15.0,3.0,0.0,60.0
Purbi Singhbhum,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,5.0,5.0,0.0,0.0,1.0,0.0,5.0,0.0,0.0,17.0
Purbi Singhbhum,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,9.12,Number of Institutions having NSV trained doctors,TOTAL,13.0,11.0,9.0,13.0,10.0,9.0,10.0,12.0,9.0,10.0,10.0,9.0,-1.0
Purbi Singhbhum,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3328.0,3710.0,3698.0,4261.0,4141.0,3814.0,4061.0,3760.0,4641.0,3926.0,2803.0,3605.0,45748.0
Purbi Singhbhum,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3010.0,3069.0,3135.0,3698.0,3701.0,3427.0,3917.0,3745.0,3737.0,3817.0,3471.0,3536.0,42263.0
Purbi Singhbhum,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3247.0,3376.0,3087.0,3274.0,3379.0,3251.0,3566.0,3612.0,3766.0,3596.0,3638.0,3770.0,41562.0
Purbi Singhbhum,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3615.0,3573.0,3003.0,3039.0,3103.0,2990.0,3434.0,3323.0,3694.0,3369.0,3812.0,3734.0,40689.0
Purbi Singhbhum,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2309.0,2768.0,3048.0,3228.0,3083.0,2674.0,2797.0,2152.0,3140.0,2079.0,1928.0,1211.0,30417.0
Purbi Singhbhum,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3009.0,3279.0,3328.0,3583.0,3568.0,2687.0,3978.0,3537.0,3422.0,3156.0,2592.0,1417.0,37556.0
Purbi Singhbhum,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3476.0,3469.0,3291.0,3165.0,3187.0,2373.0,3497.0,3578.0,3467.0,2978.0,2566.0,1451.0,36498.0
Purbi Singhbhum,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3951.0,3929.0,3273.0,3114.0,3047.0,2219.0,3377.0,3328.0,3424.0,2814.0,2613.0,1411.0,36500.0
Purbi Singhbhum,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,1.0,0.0,0.0,0.0,149.0,20.0,123.0,293.0
Purbi Singhbhum,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,10.0,0.0,0.0,6.0,2.0,0.0,2.0,0.0,213.0,0.0,340.0,573.0
Purbi Singhbhum,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,259.0,0.0,261.0,530.0
Purbi Singhbhum,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,5.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,208.0,0.0,278.0,506.0
Purbi Singhbhum,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3646.0,2717.0,3843.0,3816.0,4239.0,3304.0,3406.0,2530.0,4018.0,2978.0,3410.0,3659.0,41566.0
Purbi Singhbhum,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,0.0,9.0,148339.0,56647.0,2574.0,284.0,207853.0
Purbi Singhbhum,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1817.0,1467.0,1803.0,1966.0,2206.0,1679.0,1753.0,1225.0,1422.0,1549.0,1732.0,1914.0,20533.0
Purbi Singhbhum,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1759.0,1250.0,1780.0,1773.0,2013.0,1569.0,1632.0,1149.0,1335.0,1374.0,1631.0,1653.0,18918.0
Purbi Singhbhum,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3576.0,2717.0,3583.0,3739.0,4219.0,3248.0,3385.0,2374.0,2757.0,2923.0,3363.0,3567.0,39451.0
Purbi Singhbhum,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3920.0,3741.0,3398.0,3631.0,3253.0,2467.0,3024.0,2762.0,2710.0,2990.0,3301.0,3345.0,38542.0
Purbi Singhbhum,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3708.0,3761.0,3360.0,3209.0,2942.0,1890.0,2953.0,2825.0,2566.0,2571.0,2679.0,1327.0,33791.0
Purbi Singhbhum,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,27.0,0.0,0.0,16.0,0.0,12.0,27.0,13.0,17.0,0.0,3.0,115.0
Purbi Singhbhum,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,51.0,146.0,54.0,86.0,144.0,125.0,209.0,81.0,157.0,191.0,105.0,123.0,1472.0
Purbi Singhbhum,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,57.0,135.0,34.0,92.0,127.0,96.0,169.0,73.0,146.0,151.0,86.0,114.0,1280.0
Purbi Singhbhum,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,108.0,281.0,88.0,178.0,271.0,221.0,378.0,154.0,303.0,342.0,191.0,237.0,2752.0
Purbi Singhbhum,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1.0,0.0,9.0,96.0,264.0,274.0,253.0,265.0,314.0,255.0,306.0,246.0,2283.0
Purbi Singhbhum,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1589.0,1660.0,1590.0,1573.0,1802.0,1705.0,1792.0,1465.0,1676.0,1729.0,1775.0,1737.0,20093.0
Purbi Singhbhum,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1740.0,1903.0,1725.0,2018.0,2095.0,1971.0,1837.0,1680.0,1773.0,2091.0,1708.0,1719.0,22260.0
Purbi Singhbhum,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,17.0,11.0,19.0,13.0,6.0,14.0,6.0,4.0,9.0,8.0,20.0,8.0,135.0
Purbi Singhbhum,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,72.0,90.0,94.0,114.0,104.0,91.0,85.0,96.0,67.0,86.0,60.0,61.0,1020.0
Purbi Singhbhum,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2064.0,1868.0,1927.0,1936.0,1877.0,1855.0,1945.0,1654.0,1934.0,1893.0,1889.0,1916.0,22758.0
Purbi Singhbhum,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2029.0,1863.0,1873.0,1889.0,1852.0,1835.0,1908.0,1646.0,1904.0,1871.0,1861.0,1886.0,22417.0
Purbi Singhbhum,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1506.0,1446.0,1418.0,1394.0,1430.0,1408.0,1414.0,1412.0,1427.0,1419.0,1428.0,1429.0,17131.0
Purbi Singhbhum,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,3.0,0.0,0.0,10.0,0.0,13.0
Purbi Singhbhum,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2097.0,1562.0,1607.0,1359.0,7385.0,3877.0,2866.0,1993.0,1643.0,1761.0,3365.0,2778.0,32293.0
Purbi Singhbhum,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,350.0,290.0,321.0,225.0,13603.0,3697.0,685.0,475.0,518.0,504.0,12186.0,1030.0,33884.0
Purbi Singhbhum,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,297.0,213.0,210.0,152.0,12618.0,3428.0,145.0,89.0,130.0,175.0,12834.0,617.0,30908.0
Purbi Singhbhum,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Purbi Singhbhum,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,20.0,16.0,24.0,43.0,64.0,6.0,17.0,1.0,12.0,17.0,79.0,38.0,337.0
Purbi Singhbhum,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,340.0,464.0,449.0,496.0,598.0,367.0,322.0,309.0,328.0,351.0,342.0,232.0,4598.0
Purbi Singhbhum,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,50.0,45.0,68.0,76.0,95.0,46.0,48.0,59.0,76.0,32.0,209.0,73.0,877.0
Purbi Singhbhum,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,9.0,6.0,11.0,10.0,17.0,3.0,13.0,10.0,33.0,36.0,40.0,35.0,223.0
Purbi Singhbhum,13.1,Number of Patients operated for cataract,TOTAL,682.0,474.0,313.0,348.0,216.0,373.0,456.0,121.0,101.0,117.0,178.0,178.0,3557.0
Purbi Singhbhum,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,614.0,452.0,315.0,350.0,216.0,364.0,441.0,99.0,126.0,94.0,149.0,176.0,3396.0
Purbi Singhbhum,13.3,Number of School children detected with Refractive errors,TOTAL,3.0,8.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
Purbi Singhbhum,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,6.0,6.0,6.0,5.0,5.0,6.0,5.0,3.0,4.0,4.0,4.0,-1.0
Purbi Singhbhum,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,7.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,5.0,6.0,6.0,6.0,-1.0
Purbi Singhbhum,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1335.0,1560.0,1444.0,1290.0,1424.0,1354.0,1403.0,1393.0,1407.0,1470.0,1589.0,1507.0,-1.0
Purbi Singhbhum,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,9.0,10.0,9.0,7.0,9.0,9.0,9.0,10.0,9.0,10.0,10.0,-1.0
Purbi Singhbhum,14.05,Number of RKS meetings held during the month,TOTAL,5.0,11.0,9.0,6.0,7.0,11.0,10.0,7.0,9.0,5.0,11.0,6.0,97.0
Purbi Singhbhum,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,20.0,16.0,16.0,16.0,15.0,13.0,13.0,14.0,16.0,13.0,13.0,13.0,-1.0
Purbi Singhbhum,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,28.0,48.0,24.0,18.0,30.0,13.0,44.0,29.0,22.0,14.0,5.0,21.0,296.0
Purbi Singhbhum,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,2.0,3.0,4.0,2.0,1.0,4.0,4.0,2.0,2.0,2.0,-1.0
Purbi Singhbhum,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,-1.0
Purbi Singhbhum,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,109.0,202.0,3383.0,659.0,596.0,537.0,625.0,213.0,478.0,408.0,441.0,214.0,7865.0
Purbi Singhbhum,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,273.0,595.0,6718.0,1360.0,1063.0,806.0,628.0,566.0,718.0,748.0,631.0,560.0,14666.0
Purbi Singhbhum,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,73.0,138.0,3447.0,563.0,628.0,441.0,1083.0,181.0,461.0,433.0,419.0,193.0,8060.0
Purbi Singhbhum,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1021.0,1962.0,7980.0,2515.0,2028.0,2040.0,1429.0,1803.0,1704.0,1853.0,1919.0,1678.0,27932.0
Purbi Singhbhum,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,182.0,340.0,6830.0,1222.0,1224.0,978.0,1708.0,394.0,939.0,841.0,860.0,407.0,15925.0
Purbi Singhbhum,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1294.0,2557.0,14698.0,3875.0,3091.0,2846.0,2057.0,2369.0,2422.0,2601.0,2550.0,2238.0,42598.0
Purbi Singhbhum,14.10.2.a,Number of death cases of Inpatient males,TOTAL,18.0,16.0,69.0,77.0,126.0,84.0,106.0,29.0,97.0,101.0,93.0,20.0,836.0
Purbi Singhbhum,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,14.0,51.0,70.0,80.0,65.0,63.0,8.0,57.0,49.0,52.0,23.0,539.0
Purbi Singhbhum,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,25.0,30.0,120.0,147.0,206.0,149.0,169.0,37.0,154.0,150.0,145.0,43.0,1375.0
Purbi Singhbhum,14.11,In-Patient Head Count at midnight,TOTAL,1696.0,2134.0,2291.0,2786.0,2876.0,214.0,3510.0,2228.0,2122.0,2172.0,2174.0,2330.0,26533.0
Purbi Singhbhum,14.12.1,OPD attendance (All),TOTAL,87439.0,112515.0,124805.0,184755.0,160694.0,86490.0,162738.0,127517.0,124688.0,130985.0,131540.0,129600.0,1563766.0
Purbi Singhbhum,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,503.0,496.0,1101.0,3032.0,901.0,457.0,1230.0,454.0,721.0,677.0,970.0,743.0,11285.0
Purbi Singhbhum,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Purbi Singhbhum,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,165.0,474.0,1281.0,1473.0,2520.0,1690.0,1768.0,320.0,1783.0,1889.0,2236.0,402.0,16001.0
Purbi Singhbhum,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Purbi Singhbhum,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,60.0,60.0,472.0,19.0,13.0,202.0,287.0,45.0,489.0,200.0,1847.0
Purbi Singhbhum,14.14.c,Number of Adolescents counselled,TOTAL,130.0,200.0,149.0,363.0,353.0,331.0,345.0,298.0,288.0,132.0,285.0,286.0,3160.0
Purbi Singhbhum,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,20757.0,18796.0,20347.0,14564.0,12699.0,2949.0,22740.0,11954.0,10190.0,9754.0,8315.0,10919.0,163984.0
Purbi Singhbhum,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,2162.0,2564.0,2200.0,2879.0,2691.0,350.0,4736.0,2362.0,1951.0,1937.0,1684.0,2058.0,27574.0
Purbi Singhbhum,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1946.0,1864.0,2197.0,2272.0,2406.0,537.0,2047.0,1823.0,2021.0,1898.0,1939.0,1788.0,22738.0
Purbi Singhbhum,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,6.0,19.0,24.0,17.0,21.0,117.0,5.0,18.0,18.0,91.0,6.0,346.0
Purbi Singhbhum,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,641.0,523.0,886.0,1081.0,1032.0,627.0,772.0,535.0,710.0,820.0,871.0,653.0,9151.0
Purbi Singhbhum,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,4.0,9.0,12.0,10.0,5.0,235.0,3.0,14.0,8.0,11.0,1.0,313.0
Purbi Singhbhum,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,225.0,229.0,814.0,436.0,790.0,669.0,661.0,297.0,654.0,748.0,843.0,327.0,6693.0
Purbi Singhbhum,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,0.0,1.0,2.0,3.0,50.0,0.0,0.0,4.0,1.0,1.0,63.0
Purbi Singhbhum,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2812.0,2616.0,3897.0,3789.0,4228.0,1833.0,3480.0,2655.0,3385.0,3466.0,3653.0,2768.0,38582.0
Purbi Singhbhum,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5.0,11.0,28.0,37.0,29.0,29.0,402.0,8.0,32.0,30.0,103.0,8.0,722.0
Purbi Singhbhum,15.2,Number of Widal tests conducted,Number tested,677.0,1064.0,1092.0,1018.0,1869.0,714.0,2642.0,1611.0,1613.0,1251.0,1411.0,1459.0,16421.0
Purbi Singhbhum,15.3.a,Number of VDRL tests conducted on males,Number tested,105.0,77.0,370.0,84.0,90.0,33.0,117.0,51.0,455.0,546.0,232.0,55.0,2215.0
Purbi Singhbhum,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,90.0,96.0,249.0,144.0,724.0,143.0,845.0,410.0,319.0,150.0,287.0,392.0,3849.0
Purbi Singhbhum,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,382.0,121.0,528.0,148.0,190.0,198.0,271.0,217.0,198.0,151.0,196.0,170.0,2770.0
Purbi Singhbhum,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,577.0,294.0,1147.0,376.0,1004.0,374.0,1233.0,678.0,972.0,847.0,715.0,617.0,8834.0
Purbi Singhbhum,15.4.1,Number of blood smears examined for Malaria,TOTAL,14741.0,14532.0,16747.0,17058.0,16208.0,9055.0,25786.0,17251.0,17724.0,15360.0,16492.0,18610.0,199564.0
Purbi Singhbhum,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,43.0,65.0,72.0,124.0,110.0,55.0,116.0,99.0,81.0,47.0,148.0,37.0,997.0
Purbi Singhbhum,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,97.0,164.0,282.0,224.0,313.0,359.0,444.0,1100.0,840.0,298.0,162.0,121.0,4404.0
Purbi Singhbhum,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,28340.0,4140.0,31240.0,8340.0,28440.0,30680.0,43980.0,35080.0,8670.0,9700.0,24500.0,600.0,253710.0
Purbi Singhbhum,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,50000.0,2000.0,40000.0,30000.0,30000.0,10000.0,0.0,40000.0,30000.0,0.0,52500.0,284500.0
Purbi Singhbhum,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,24200.0,22900.0,24900.0,19900.0,27760.0,16700.0,18900.0,26410.0,38970.0,15200.0,23900.0,18400.0,278140.0
Purbi Singhbhum,16.1.1,Stock position of DPT vaccines,5. Total Stock,4140.0,31240.0,8340.0,28440.0,30680.0,43980.0,35080.0,8670.0,9700.0,24500.0,600.0,34700.0,260070.0
Purbi Singhbhum,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Purbi Singhbhum,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Purbi Singhbhum,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Purbi Singhbhum,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,40000.0,0.0,41900.0,3600.0,0.0,700.0,18800.0,40200.0,11740.0,4140.0,6740.0,9980.0,177800.0
Purbi Singhbhum,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,80000.0,5000.0,40000.0,40000.0,40000.0,40000.0,20000.0,10000.0,34000.0,452600.0,26000.0,787600.0
Purbi Singhbhum,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,1920.0,,1920.0
Purbi Singhbhum,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,40000.0,38100.0,43300.0,43600.0,39300.0,21900.0,18600.0,48460.0,17600.0,31400.0,447440.0,540.0,790240.0
Purbi Singhbhum,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,41900.0,3600.0,0.0,700.0,18800.0,40200.0,11740.0,4140.0,6740.0,9980.0,35440.0,173240.0
Purbi Singhbhum,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,20000.0,0.0,30800.0,7650.0,14450.0,12340.0,13940.0,22040.0,0.0,17700.0,22900.0,2850.0,164670.0
Purbi Singhbhum,16.1.3,Stock position of TT vaccines,2. Stocks Received,,50000.0,0.0,20000.0,20000.0,18000.0,22000.0,0.0,40000.0,22000.0,0.0,30000.0,222000.0
Purbi Singhbhum,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.1.3,Stock position of TT vaccines,4. Stock Distributed,20000.0,19200.0,23150.0,13200.0,22110.0,16400.0,13900.0,22040.0,22300.0,16800.0,20050.0,9950.0,219100.0
Purbi Singhbhum,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,30800.0,7650.0,14450.0,12340.0,13940.0,22040.0,0.0,17700.0,22900.0,2850.0,22900.0,167570.0
Purbi Singhbhum,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Purbi Singhbhum,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,20000.0,5500.0,22700.0,7950.0,13750.0,20410.0,16910.0,19110.0,1470.0,11590.0,0.0,2300.0,141690.0
Purbi Singhbhum,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,30000.0,0.0,16000.0,25000.0,10000.0,15000.0,0.0,25000.0,0.0,5000.0,15000.0,141000.0
Purbi Singhbhum,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,14500.0,12800.0,14750.0,10200.0,18340.0,13500.0,12800.0,17640.0,14880.0,11590.0,2700.0,9950.0,153650.0
Purbi Singhbhum,16.1.5,Stock position of BCG vaccines,5. Total Stock,5500.0,22700.0,7950.0,13750.0,20410.0,16910.0,19110.0,1470.0,11590.0,0.0,2300.0,7350.0,129040.0
Purbi Singhbhum,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,10150.0,0.0,10000.0,0.0,5350.0,18680.0,12180.0,13580.0,151170.0,133240.0,102290.0,66840.0,523480.0
Purbi Singhbhum,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,10000.0,0.0,14500.0,27500.0,0.0,10000.0,225000.0,160000.0,50000.0,0.0,0.0,497000.0
Purbi Singhbhum,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,10150.0,0.0,10000.0,9150.0,14170.0,6500.0,8600.0,87410.0,177930.0,80950.0,35450.0,22870.0,463180.0
Purbi Singhbhum,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,10000.0,0.0,5350.0,18680.0,12180.0,13580.0,151170.0,133240.0,102290.0,66840.0,43970.0,557300.0
Purbi Singhbhum,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,,0.0
Purbi Singhbhum,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Purbi Singhbhum,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,20000.0,20000.0,20000.0,20000.0,20000.0,100000.0
Purbi Singhbhum,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,3900.0,3900.0
Purbi Singhbhum,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,20000.0,20000.0,20000.0,16100.0,96100.0
Purbi Singhbhum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,3650.0,1250.0,650.0,4200.0,4100.0,4100.0,4100.0,2900.0,2800.0,900.0,3300.0,31950.0
Purbi Singhbhum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,5000.0,0.0,0.0,4800.0,0.0,0.0,0.0,0.0,0.0,0.0,2400.0,0.0,12200.0
Purbi Singhbhum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,1350.0,2400.0,600.0,1250.0,100.0,0.0,0.0,1200.0,100.0,1900.0,0.0,1200.0,10100.0
Purbi Singhbhum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,3650.0,1250.0,650.0,4200.0,4100.0,4100.0,4100.0,2900.0,2800.0,900.0,3300.0,2100.0,34050.0
Purbi Singhbhum,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,1000.0,60000.0,116400.0,98400.0,78000.0,18000.0,12000.0,194040.0,123120.0,115560.0,72720.0,4140.0,893380.0
Purbi Singhbhum,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,132000.0,200400.0,0.0,114500.0,0.0,0.0,194040.0,0.0,0.0,0.0,0.0,30000.0,670940.0
Purbi Singhbhum,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,73000.0,144000.0,18000.0,134900.0,60000.0,6000.0,12000.0,70920.0,7560.0,42840.0,68580.0,6000.0,643800.0
Purbi Singhbhum,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,60000.0,116400.0,98400.0,78000.0,18000.0,12000.0,194040.0,123120.0,115560.0,72720.0,4140.0,28140.0,920520.0
Purbi Singhbhum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1000.0,17000.0,2000.0,0.0,3000.0,1000.0,0.0,42000.0,9855.0,9855.0,4955.0,2855.0,93520.0
Purbi Singhbhum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,21000.0,0.0,0.0,15000.0,0.0,0.0,42000.0,0.0,0.0,0.0,0.0,15000.0,93000.0
Purbi Singhbhum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,5000.0,15000.0,2000.0,12000.0,2000.0,1000.0,,32145.0,0.0,4900.0,2100.0,0.0,76145.0
Purbi Singhbhum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,17000.0,2000.0,0.0,3000.0,1000.0,0.0,42000.0,9855.0,9855.0,4955.0,2855.0,17855.0,110375.0
Purbi Singhbhum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,5800.0,4800.0,8600.0,12500.0,5845.0,5845.0,4245.0,3945.0,51580.0
Purbi Singhbhum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,0.0,5800.0,0.0,5800.0,8700.0,0.0,0.0,0.0,0.0,0.0,20300.0
Purbi Singhbhum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,1000.0,2000.0,4800.0,6655.0,0.0,1600.0,300.0,0.0,16355.0
Purbi Singhbhum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,5800.0,4800.0,8600.0,12500.0,5845.0,5845.0,4245.0,3945.0,3945.0,55525.0
Purbi Singhbhum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,5000.0,5000.0
Purbi Singhbhum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,0.0,,0.0,0.0,0.0,,10000.0,0.0,10000.0
Purbi Singhbhum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,,5000.0,5000.0,10000.0
Purbi Singhbhum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,5000.0
Purbi Singhbhum,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Purbi Singhbhum,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,,0.0
Purbi Singhbhum,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.02,Stock Position of Gloves,2. Stocks Received,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Purbi Singhbhum,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,,0.0
Purbi Singhbhum,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Purbi Singhbhum,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,,0.0
Purbi Singhbhum,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Purbi Singhbhum,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,,0.0
Purbi Singhbhum,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Purbi Singhbhum,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,,0.0
Purbi Singhbhum,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Purbi Singhbhum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,,0.0
Purbi Singhbhum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,0.0,0.0,0.0,,1360000.0,375000.0,767000.0,662000.0,0.0,64000.0,3228000.0
Purbi Singhbhum,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,0.0,0.0,0.0,,375000.0,545000.0,0.0,0.0,1300000.0,0.0,2220000.0
Purbi Singhbhum,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,0.0,0.0,0.0,,1360000.0,153000.0,105000.0,662000.0,1236000.0,64000.0,3580000.0
Purbi Singhbhum,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,375000.0,767000.0,662000.0,0.0,64000.0,0.0,1868000.0
Purbi Singhbhum,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,1238.0,0.0,0.0,0.0,0.0,1238.0
Purbi Singhbhum,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,0.0,0.0,0.0,,4000.0,0.0,0.0,,0.0,0.0,4000.0
Purbi Singhbhum,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,0.0,0.0,0.0,,2762.0,1238.0,0.0,,0.0,,4000.0
Purbi Singhbhum,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1238.0,0.0,0.0,0.0,0.0,0.0,1238.0
Purbi Singhbhum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Purbi Singhbhum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,,0.0
Purbi Singhbhum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,0.0,0.0,70.0,50.0,3.0,3.0,3.0,3.0,0.0,0.0,132.0
Purbi Singhbhum,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,0.0,3400.0,580.0,0.0,0.0,0.0,0.0,4335.0,0.0,0.0,8315.0
Purbi Singhbhum,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,0.0,3330.0,600.0,47.0,0.0,0.0,0.0,4338.0,0.0,,8315.0
Purbi Singhbhum,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,70.0,50.0,3.0,3.0,3.0,3.0,0.0,0.0,0.0,132.0
Purbi Singhbhum,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Purbi Singhbhum,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,,0.0
Purbi Singhbhum,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Purbi Singhbhum,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4000.0,4000.0,5700.0,400.0,3900.0,1000.0,2200.0,4700.0,3000.0,7790.0,3390.0,2190.0,42270.0
Purbi Singhbhum,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,4000.0,0.0,5000.0,0.0,3000.0,4500.0,0.0,7500.0,0.0,0.0,4500.0,28500.0
Purbi Singhbhum,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,2300.0,5300.0,1500.0,2900.0,1800.0,2000.0,1700.0,2710.0,4400.0,1200.0,1475.0,27285.0
Purbi Singhbhum,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4000.0,5700.0,400.0,3900.0,1000.0,2200.0,4700.0,3000.0,7790.0,3390.0,2190.0,5215.0,43485.0
Purbi Singhbhum,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,166700.0,166700.0,197200.0,179200.0,173200.0,157000.0,147000.0,147000.0,214750.0,147535.0,91435.0,59135.0,1846855.0
Purbi Singhbhum,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,49000.0,0.0,0.0,0.0,0.0,0.0,154000.0,134400.0,36000.0,0.0,26000.0,399400.0
Purbi Singhbhum,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,18500.0,18000.0,6000.0,16200.0,10000.0,0.0,86250.0,201615.0,92100.0,32300.0,16900.0,497865.0
Purbi Singhbhum,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,166700.0,197200.0,179200.0,173200.0,157000.0,147000.0,147000.0,214750.0,147535.0,91435.0,59135.0,68235.0,1748390.0
Purbi Singhbhum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4000.0,4000.0,7000.0,6900.0,6400.0,2350.0,3350.0,3950.0,60800.0,58700.0,42150.0,35700.0,235300.0
Purbi Singhbhum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,5000.0,0.0,0.0,0.0,3000.0,1800.0,74000.0,36000.0,0.0,0.0,0.0,119800.0
Purbi Singhbhum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Purbi Singhbhum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,2000.0,100.0,500.0,4050.0,2000.0,1200.0,17150.0,38100.0,16550.0,6450.0,2650.0,90750.0
Purbi Singhbhum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4000.0,7000.0,6900.0,6400.0,2350.0,3350.0,3950.0,60800.0,58700.0,42150.0,35700.0,33050.0,264350.0
Purbi Singhbhum,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,10.0,3.0,2.0,1.0,2.0,5.0,4.0,2.0,3.0,1.0,2.0,38.0
Purbi Singhbhum,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,,1.0,,,,,,,1.0,3.0
Purbi Singhbhum,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Purbi Singhbhum,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,1.0,,,,,,,1.0,3.0
Purbi Singhbhum,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,1.0,,,,1.0
Purbi Singhbhum,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Purbi Singhbhum,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,1.0,,,,,1.0,,,,2.0
Purbi Singhbhum,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,2.0,1.0,3.0,,,1.0,2.0,1.0,3.0,1.0,2.0,17.0
Purbi Singhbhum,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,3.0,4.0,2.0,2.0,,3.0,1.0,3.0,,,2.0,,20.0
Purbi Singhbhum,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,6.0,3.0,5.0,,3.0,2.0,5.0,1.0,3.0,3.0,2.0,37.0
Purbi Singhbhum,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,2.0,1.0,,1.0,1.0,2.0,2.0,4.0,,1.0,14.0
Purbi Singhbhum,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,1.0,1.0,,4.0,4.0,,,1.0,,12.0
Purbi Singhbhum,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,2.0,2.0,1.0,1.0,5.0,6.0,2.0,4.0,1.0,1.0,26.0
Purbi Singhbhum,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,1.0,,1.0,,,1.0,,,4.0
Purbi Singhbhum,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,1.0,,,,,,1.0,2.0
Purbi Singhbhum,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,1.0,1.0,1.0,,,1.0,,1.0,6.0
Purbi Singhbhum,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Purbi Singhbhum,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,1.0,,,,,1.0,2.0
Purbi Singhbhum,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,1.0,,,,,1.0,2.0
Purbi Singhbhum,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,1.0,1.0,,,1.0,,,,1.0,4.0
Purbi Singhbhum,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,2.0,1.0,3.0,,,,1.0,1.0,1.0,10.0
Purbi Singhbhum,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,,3.0,2.0,3.0,,1.0,,1.0,1.0,2.0,14.0
Purbi Singhbhum,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Purbi Singhbhum,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Purbi Singhbhum,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Purbi Singhbhum,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,3.0,,4.0,4.0,2.0,3.0,1.0,1.0,2.0,2.0,5.0,28.0
Purbi Singhbhum,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,2.0,,,2.0,2.0,2.0,1.0,3.0,1.0,,15.0
Purbi Singhbhum,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,5.0,2.0,4.0,4.0,4.0,5.0,3.0,2.0,5.0,3.0,5.0,43.0
Purbi Singhbhum,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,1.0,1.0,,,,,,,,,,,2.0
Purbi Singhbhum,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,1.0,,,,1.0,,2.0
Purbi Singhbhum,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Purbi Singhbhum,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,1.0,,,,,1.0,1.0,,,1.0,,5.0
Purbi Singhbhum,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,1.0,,,1.0,1.0,,1.0,1.0,2.0,1.0,3.0,14.0
Purbi Singhbhum,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,3.0,1.0,,1.0,1.0,,1.0,,,,7.0
Purbi Singhbhum,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,1.0,3.0,1.0,1.0,2.0,1.0,1.0,2.0,2.0,1.0,3.0,21.0
Purbi Singhbhum,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,2.0,,2.0,,,,,,,,,5.0
Purbi Singhbhum,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,2.0,,,,1.0,,,,2.0,,5.0
Purbi Singhbhum,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,2.0,2.0,2.0,,,1.0,,,,2.0,,10.0
Purbi Singhbhum,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,1.0,1.0,,,,,1.0,,,,1.0,4.0
Purbi Singhbhum,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Purbi Singhbhum,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,1.0,,,,,1.0,,,,1.0,4.0
Purbi Singhbhum,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,1.0,,,3.0,,,,4.0
Purbi Singhbhum,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,5.0,,4.0,5.0,4.0,4.0,2.0,5.0,2.0,32.0
Purbi Singhbhum,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,5.0,3.0,2.0,5.0,7.0,,1.0,1.0,1.0,,2.0,,27.0
Purbi Singhbhum,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,5.0,3.0,3.0,10.0,7.0,5.0,6.0,5.0,8.0,2.0,7.0,2.0,63.0
Purbi Singhbhum,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Purbi Singhbhum,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Purbi Singhbhum,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Purbi Singhbhum,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,5.0,3.0,2.0,1.0,,,2.0,,1.0,1.0,1.0,17.0
Purbi Singhbhum,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,1.0,3.0,1.0,2.0,,,,1.0,,1.0,,11.0
Purbi Singhbhum,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,6.0,6.0,3.0,3.0,,,2.0,1.0,1.0,2.0,1.0,28.0
Purbi Singhbhum,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,,,,,,1.0,,1.0,,3.0
Purbi Singhbhum,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,1.0,,,,1.0,,,,,,2.0
Purbi Singhbhum,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,2.0,,,,1.0,,1.0,,1.0,,5.0
Purbi Singhbhum,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Purbi Singhbhum,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Purbi Singhbhum,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,1.0,,,,,,,,,,,,1.0
Purbi Singhbhum,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,,,1.0,2.0,2.0,3.0,,,,,9.0
Purbi Singhbhum,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Purbi Singhbhum,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,,,1.0,2.0,2.0,3.0,,,,,9.0
Purbi Singhbhum,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,1.0,,,,,,,,,,1.0,3.0
Purbi Singhbhum,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Purbi Singhbhum,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,1.0,,,,,,,,,,1.0,3.0
Purbi Singhbhum,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,2.0,,,,,,,,1.0,,1.0,4.0
Purbi Singhbhum,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Purbi Singhbhum,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,2.0,,,,,,,,1.0,,1.0,4.0
Purbi Singhbhum,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,,,2.0,,,,,,3.0
Purbi Singhbhum,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Purbi Singhbhum,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,,,2.0,,,,,,3.0
Purbi Singhbhum,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,4.0,,3.0,2.0,1.0,1.0,1.0,3.0,2.0,6.0,1.0,,24.0
Purbi Singhbhum,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,3.0,,1.0,1.0,1.0,1.0,,1.0,1.0,,,9.0
Purbi Singhbhum,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,4.0,3.0,3.0,3.0,2.0,2.0,2.0,3.0,3.0,7.0,1.0,,33.0
Purbi Singhbhum,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,2.0,,,,,,,,,,2.0
Purbi Singhbhum,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,4.0,6.0,2.0,1.0,3.0,8.0,3.0,2.0,1.0,,,33.0
Purbi Singhbhum,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,1.0,,1.0,,,1.0,,,,,,4.0
Purbi Singhbhum,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,5.0,8.0,3.0,1.0,3.0,9.0,3.0,2.0,1.0,,,39.0
Purbi Singhbhum,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Purbi Singhbhum,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,4.0,1.0,,,,,1.0,,,1.0,,7.0
Purbi Singhbhum,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Purbi Singhbhum,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,4.0,2.0,,,,,1.0,,,1.0,,8.0
Purbi Singhbhum,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Purbi Singhbhum,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Purbi Singhbhum,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Purbi Singhbhum,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,1.0,,,,,,,,1.0
Purbi Singhbhum,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,,1.0,,,,,,,,2.0
Purbi Singhbhum,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,5.0,1.0,2.0,2.0,3.0,5.0,4.0,4.0,1.0,3.0,2.0,3.0,35.0
Purbi Singhbhum,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,4.0,5.0,4.0,3.0,1.0,3.0,1.0,,2.0,,,25.0
Purbi Singhbhum,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,7.0,6.0,7.0,6.0,7.0,6.0,7.0,5.0,1.0,5.0,2.0,3.0,62.0
Purbi Singhbhum,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,1.0,,,,,1.0,,,,2.0
Purbi Singhbhum,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,1.0,2.0,1.0,1.0,6.0,5.0,3.0,4.0,5.0,5.0,2.0,37.0
Purbi Singhbhum,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,6.0,5.0,7.0,6.0,8.0,1.0,4.0,4.0,4.0,,1.0,1.0,47.0
Purbi Singhbhum,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,8.0,6.0,9.0,8.0,9.0,7.0,9.0,7.0,9.0,5.0,6.0,3.0,86.0
Purbi Singhbhum,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,,,,1.0,1.0,1.0,,,,,4.0
Purbi Singhbhum,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,7.0,7.0,3.0,6.0,4.0,3.0,8.0,5.0,3.0,3.0,8.0,59.0
Purbi Singhbhum,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,6.0,,9.0,10.0,8.0,2.0,1.0,4.0,7.0,3.0,7.0,2.0,59.0
Purbi Singhbhum,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,8.0,8.0,16.0,13.0,14.0,7.0,5.0,13.0,12.0,6.0,10.0,10.0,122.0
Ramgarh,1.1,Total number of pregnant women Registered for ANC,TOTAL,1617.0,3267.0,1406.0,1261.0,1199.0,1207.0,1278.0,1230.0,1194.0,1259.0,1403.0,1295.0,17616.0
Ramgarh,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,229.0,103.0,194.0,93.0,159.0,143.0,132.0,181.0,195.0,165.0,162.0,184.0,1940.0
Ramgarh,1.2,Number of Pregnant women registered under JSY,TOTAL,1425.0,1181.0,1269.0,1219.0,1117.0,1155.0,1177.0,1186.0,1099.0,1187.0,1366.0,1266.0,14647.0
Ramgarh,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,805.0,2861.0,1003.0,959.0,903.0,832.0,903.0,843.0,921.0,888.0,911.0,892.0,12721.0
Ramgarh,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1494.0,2198.0,1310.0,1216.0,1114.0,1068.0,1180.0,1147.0,1133.0,1179.0,1311.0,1212.0,15562.0
Ramgarh,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1328.0,1208.0,1224.0,1165.0,973.0,1087.0,1005.0,986.0,911.0,1064.0,1037.0,1176.0,13164.0
Ramgarh,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,52.0,44.0,20.0,6.0,0.0,0.0,0.0,69.0,464.0,506.0,502.0,533.0,2196.0
Ramgarh,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,4.0,0.0,42.0,34.0,5.0,99.0,54.0,69.0,76.0,63.0,0.0,20.0,466.0
Ramgarh,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,7.0
Ramgarh,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,311.0,458.0,347.0,336.0,305.0,279.0,231.0,317.0,364.0,183.0,469.0,443.0,4043.0
Ramgarh,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,46.0,6.0,8.0,10.0,8.0,13.0,2.0,4.0,13.0,5.0,12.0,20.0,147.0
Ramgarh,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Ramgarh,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,54.0,344.0,46.0,70.0,62.0,17.0,82.0,107.0,74.0,108.0,41.0,40.0,1045.0
Ramgarh,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,460.0,330.0,461.0,517.0,515.0,579.0,507.0,531.0,486.0,381.0,327.0,383.0,5477.0
Ramgarh,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,514.0,674.0,507.0,587.0,577.0,596.0,589.0,638.0,560.0,489.0,368.0,423.0,6522.0
Ramgarh,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,444.0,608.0,452.0,566.0,539.0,530.0,489.0,599.0,507.0,436.0,334.0,398.0,5902.0
Ramgarh,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,39.0,0.0,78.0,0.0,64.0,33.0,14.0,16.0,20.0,27.0,0.0,10.0,301.0
Ramgarh,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,519.0,495.0,617.0,687.0,1028.0,621.0,608.0,585.0,637.0,621.0,587.0,623.0,7628.0
Ramgarh,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,400.0,490.0,559.0,548.0,977.0,571.0,587.0,551.0,609.0,592.0,556.0,613.0,7053.0
Ramgarh,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,367.0,235.0,354.0,479.0,534.0,303.0,95.0,205.0,225.0,222.0,418.0,411.0,3848.0
Ramgarh,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,249.0,229.0,435.0,478.0,528.0,299.0,166.0,188.0,219.0,221.0,354.0,408.0,3774.0
Ramgarh,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,3.0,17.0,0.0,28.0
Ramgarh,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,81.0,56.0,65.0,53.0,89.0,18.0,74.0,29.0,68.0,77.0,52.0,37.0,699.0
Ramgarh,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Ramgarh,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,3.0,3.0,6.0,14.0
Ramgarh,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,9.0,,,,,,,,9.0
Ramgarh,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramgarh,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,1.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,3.0,3.0,6.0,23.0
Ramgarh,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,29.0,17.0,24.0,7.0,18.0,2.0,28.0,10.0,10.0,16.0,15.0,17.0,193.0
Ramgarh,4.1.1.a,Number of male live births,TOTAL,569.0,663.0,590.0,688.0,843.0,610.0,690.0,641.0,649.0,609.0,540.0,566.0,7658.0
Ramgarh,4.1.1.b,Number of female live births,TOTAL,544.0,582.0,590.0,653.0,854.0,631.0,608.0,610.0,619.0,593.0,500.0,527.0,7311.0
Ramgarh,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1113.0,1245.0,1180.0,1341.0,1697.0,1241.0,1298.0,1251.0,1268.0,1202.0,1040.0,1093.0,14969.0
Ramgarh,4.1.2,Number of still births,TOTAL,7.0,10.0,13.0,10.0,42.0,3.0,10.0,6.0,3.0,9.0,2.0,7.0,122.0
Ramgarh,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,7.0,12.0,14.0,4.0,16.0,8.0,8.0,28.0,5.0,5.0,6.0,9.0,122.0
Ramgarh,4.2.1,Number of Newborns weighed at birth,TOTAL,1084.0,1071.0,1148.0,1332.0,1666.0,1217.0,1255.0,1233.0,1246.0,1189.0,997.0,998.0,14436.0
Ramgarh,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,59.0,33.0,41.0,44.0,53.0,69.0,55.0,58.0,42.0,29.0,21.0,24.0,528.0
Ramgarh,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1107.0,1072.0,1157.0,1335.0,1680.0,1225.0,1245.0,1244.0,1264.0,1179.0,1002.0,1076.0,14586.0
Ramgarh,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,7.0
Ramgarh,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,0.0,,,,,,,,0.0
Ramgarh,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramgarh,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,7.0
Ramgarh,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ramgarh,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ramgarh,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ramgarh,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,593.0,776.0,701.0,833.0,1247.0,916.0,978.0,845.0,899.0,893.0,717.0,752.0,10150.0
Ramgarh,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,375.0,581.0,515.0,543.0,534.0,593.0,673.0,685.0,593.0,560.0,429.0,524.0,6605.0
Ramgarh,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Ramgarh,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Ramgarh,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Ramgarh,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1.0,5.0,3.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,0.0,23.0
Ramgarh,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,48.0,64.0,20.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,26.0,0.0,163.0
Ramgarh,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,49.0,69.0,23.0,2.0,1.0,1.0,1.0,1.0,0.0,0.0,39.0,0.0,186.0
Ramgarh,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,21.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,103.0,0.0,124.0
Ramgarh,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,2.0
Ramgarh,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,2.0,0.0,129.0,67.0,89.0,12.0,0.0,7.0,26.0,6.0,1.0,339.0
Ramgarh,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,3.0,,,,,,,,3.0
Ramgarh,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramgarh,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,2.0,0.0,129.0,70.0,89.0,12.0,1.0,8.0,26.0,6.0,1.0,344.0
Ramgarh,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,3.0,0.0,1.0,6.0
Ramgarh,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Ramgarh,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,0.0,,,,,,,,0.0
Ramgarh,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramgarh,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Ramgarh,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,10.0,0.0,0.0,0.0,20.0
Ramgarh,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,2.0,6.0,0.0,297.0,9.0,5.0,65.0,172.0,693.0,1278.0,605.0,23.0,3155.0
Ramgarh,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,8.0,,,,,,,,8.0
Ramgarh,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramgarh,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,2.0,6.0,0.0,297.0,17.0,5.0,65.0,182.0,703.0,1278.0,605.0,23.0,3183.0
Ramgarh,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,17.0,7.0,22.0,10.0,8.0,15.0,17.0,159.0,138.0,249.0,172.0,63.0,877.0
Ramgarh,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Ramgarh,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,0.0,,,,,,,,0.0
Ramgarh,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramgarh,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Ramgarh,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,59.0,55.0,55.0,164.0,64.0,88.0,62.0,69.0,63.0,92.0,59.0,81.0,911.0
Ramgarh,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,5.0,6.0,1.0,9.0,6.0,5.0,7.0,0.0,0.0,53.0,8.0,9.0,109.0
Ramgarh,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,16.0,23.0,20.0,169.0,13.0,26.0,36.0,24.0,18.0,47.0,24.0,18.0,434.0
Ramgarh,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,0.0,,,,,,,,0.0
Ramgarh,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramgarh,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,80.0,84.0,76.0,342.0,83.0,119.0,105.0,93.0,81.0,192.0,91.0,108.0,1454.0
Ramgarh,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Ramgarh,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,18.0,18.0,42.0,18.0,31.0,13.0,11.0,14.0,16.0,13.0,29.0,9.0,232.0
Ramgarh,9.06,Number of IUCD removals,TOTAL,44.0,18.0,100.0,39.0,53.0,91.0,47.0,71.0,42.0,67.0,41.0,106.0,719.0
Ramgarh,9.07,Number of Oral Pills cycles distributed,TOTAL,966.0,739.0,1294.0,6296.0,1140.0,1267.0,1654.0,1120.0,1247.0,1899.0,1357.0,883.0,19862.0
Ramgarh,9.08,Number of Condom pieces distributed,TOTAL,2921.0,3053.0,3564.0,33023.0,4005.0,3731.0,4136.0,2675.0,2088.0,5619.0,4368.0,4530.0,73713.0
Ramgarh,9.09,Number of Centchroman (weekly) pills given,TOTAL,22.0,4.0,0.0,0.0,0.0,2.0,8.0,6.0,160.0,0.0,30.0,89.0,321.0
Ramgarh,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,142.0,133.0,112.0,115.0,114.0,208.0,263.0,153.0,80.0,156.0,137.0,148.0,1761.0
Ramgarh,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,24.0,0.0,0.0,0.0,0.0,0.0,24.0
Ramgarh,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,21.0,0.0,0.0,0.0,0.0,0.0,21.0
Ramgarh,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Ramgarh,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,9.12,Number of Institutions having NSV trained doctors,TOTAL,9.0,9.0,13.0,12.0,14.0,13.0,13.0,13.0,8.0,11.0,8.0,11.0,-1.0
Ramgarh,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1334.0,1334.0,1399.0,1537.0,1919.0,1464.0,1498.0,1561.0,1416.0,1349.0,772.0,1243.0,16826.0
Ramgarh,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1274.0,1195.0,1324.0,1294.0,1460.0,1539.0,1529.0,1521.0,1503.0,1452.0,1350.0,1268.0,16709.0
Ramgarh,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1324.0,1293.0,1150.0,1280.0,1270.0,1278.0,1449.0,1506.0,1566.0,1409.0,1436.0,1355.0,16316.0
Ramgarh,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1346.0,1537.0,1243.0,1155.0,1326.0,1185.0,1282.0,1337.0,1489.0,1434.0,1416.0,1412.0,16162.0
Ramgarh,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Ramgarh,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Ramgarh,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Ramgarh,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,930.0,999.0,1144.0,1093.0,1516.0,1098.0,1134.0,1132.0,1042.0,911.0,602.0,744.0,12345.0
Ramgarh,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1253.0,1185.0,1303.0,1291.0,1424.0,1547.0,1398.0,1498.0,1466.0,1437.0,1349.0,1248.0,16399.0
Ramgarh,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1324.0,1293.0,1161.0,1287.0,1253.0,1278.0,1335.0,1461.0,1532.0,1399.0,1428.0,1315.0,16066.0
Ramgarh,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1339.0,1535.0,1210.0,1139.0,1290.0,1185.0,1178.0,1287.0,1437.0,1387.0,1415.0,1351.0,15753.0
Ramgarh,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,72.0,394.0,235.0,302.0,407.0,1410.0
Ramgarh,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,1.0,98.0,0.0,0.0,261.0,656.0,1273.0,1203.0,1192.0,4684.0
Ramgarh,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,9.0,68.0,0.0,0.0,1.0,271.0,715.0,1113.0,1186.0,3363.0
Ramgarh,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,12.0,2.0,65.0,0.0,0.0,5.0,41.0,271.0,680.0,1098.0,2174.0
Ramgarh,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1329.0,2523.0,1407.0,1379.0,1510.0,1288.0,1188.0,1079.0,910.0,1309.0,1262.0,1333.0,16517.0
Ramgarh,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,6955.0,0.0,21.0,0.0,6978.0
Ramgarh,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Ramgarh,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,687.0,855.0,721.0,695.0,784.0,633.0,607.0,536.0,395.0,682.0,617.0,685.0,7897.0
Ramgarh,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,635.0,727.0,680.0,666.0,724.0,646.0,578.0,532.0,412.0,594.0,615.0,634.0,7443.0
Ramgarh,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1322.0,1582.0,1401.0,1361.0,1508.0,1279.0,1185.0,1068.0,807.0,1276.0,1232.0,1319.0,15340.0
Ramgarh,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1113.0,1099.0,920.0,889.0,981.0,848.0,817.0,789.0,776.0,969.0,1179.0,1103.0,11483.0
Ramgarh,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1115.0,1095.0,920.0,889.0,966.0,844.0,737.0,772.0,764.0,893.0,1181.0,1080.0,11256.0
Ramgarh,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,389.0,337.0,143.0,123.0,163.0,134.0,121.0,99.0,94.0,145.0,158.0,126.0,2032.0
Ramgarh,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,355.0,289.0,152.0,121.0,161.0,135.0,100.0,82.0,103.0,147.0,153.0,152.0,1950.0
Ramgarh,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,744.0,626.0,295.0,244.0,324.0,269.0,221.0,181.0,197.0,292.0,311.0,278.0,3982.0
Ramgarh,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,219.0,156.0,28.0,144.0,340.0,364.0,347.0,259.0,206.0,196.0,240.0,200.0,2699.0
Ramgarh,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,434.0,445.0,560.0,616.0,580.0,576.0,629.0,582.0,576.0,543.0,563.0,592.0,6696.0
Ramgarh,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,478.0,435.0,628.0,625.0,673.0,636.0,688.0,626.0,706.0,1011.0,772.0,709.0,7987.0
Ramgarh,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,43.0,11.0,18.0,9.0,13.0,8.0,25.0,14.0,3.0,7.0,22.0,30.0,203.0
Ramgarh,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ramgarh,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,9.0,7.0,5.0,7.0,8.0,18.0,17.0,13.0,10.0,12.0,20.0,9.0,135.0
Ramgarh,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,551.0,493.0,561.0,602.0,576.0,592.0,577.0,557.0,584.0,535.0,567.0,580.0,6775.0
Ramgarh,10.4.2,Number of Immunisation sessions held during the month,TOTAL,561.0,478.0,558.0,607.0,571.0,587.0,546.0,561.0,584.0,590.0,554.0,561.0,6758.0
Ramgarh,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,438.0,375.0,454.0,437.0,472.0,489.0,475.0,457.0,483.0,451.0,471.0,490.0,5492.0
Ramgarh,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,9.0
Ramgarh,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1007.0,1108.0,762.0,860.0,2113.0,1105.0,1078.0,936.0,546.0,1136.0,1813.0,1222.0,13686.0
Ramgarh,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,63.0,76.0,139.0,278.0,8538.0,393.0,104.0,90.0,100.0,10.0,7446.0,415.0,17652.0
Ramgarh,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,46.0,111.0,135.0,356.0,10955.0,298.0,58.0,83.0,12.0,34.0,10570.0,315.0,22973.0
Ramgarh,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,6.0,18.0,3.0,0.0,0.0,18.0,6.0,14.0,0.0,8.0,4.0,77.0
Ramgarh,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,30.0,15.0,19.0,24.0,47.0,20.0,16.0,17.0,13.0,11.0,10.0,8.0,230.0
Ramgarh,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,2.0,1.0,7.0,7.0,2.0,0.0,0.0,0.0,1.0,1.0,21.0
Ramgarh,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,77.0,0.0,96.0,210.0,205.0,120.0,708.0
Ramgarh,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,77.0,0.0,50.0,0.0,0.0,93.0,220.0
Ramgarh,13.3,Number of School children detected with Refractive errors,TOTAL,230.0,10.0,24.0,24.0,21.0,16.0,22.0,0.0,0.0,0.0,0.0,0.0,347.0
Ramgarh,13.4,Number of children provided free glasses,TOTAL,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Ramgarh,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,3.0,3.0,3.0,1.0,1.0,1.0,2.0,1.0,3.0,2.0,-1.0
Ramgarh,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,7.0,6.0,6.0,6.0,8.0,9.0,7.0,4.0,4.0,3.0,7.0,-1.0
Ramgarh,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,339.0,370.0,311.0,281.0,338.0,383.0,305.0,162.0,110.0,169.0,203.0,94.0,-1.0
Ramgarh,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,4.0,4.0,5.0,4.0,4.0,4.0,3.0,4.0,4.0,4.0,-1.0
Ramgarh,14.05,Number of RKS meetings held during the month,TOTAL,1.0,2.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,3.0,2.0,10.0
Ramgarh,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,10.0,11.0,13.0,12.0,12.0,12.0,11.0,11.0,6.0,6.0,3.0,8.0,-1.0
Ramgarh,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,8.0,10.0,6.0,8.0,13.0,9.0,9.0,0.0,0.0,65.0,27.0,54.0,209.0
Ramgarh,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,3.0,4.0,4.0,4.0,1.0,2.0,2.0,2.0,3.0,2.0,1.0,-1.0
Ramgarh,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,2.0,2.0,2.0,2.0,3.0,2.0,2.0,2.0,1.0,0.0,0.0,-1.0
Ramgarh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,12.0,16.0,14.0,8.0,8.0,21.0,15.0,6.0,13.0,13.0,0.0,17.0,143.0
Ramgarh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,33.0,68.0,57.0,136.0,36.0,62.0,61.0,54.0,53.0,168.0,62.0,232.0,1022.0
Ramgarh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,8.0,9.0,8.0,7.0,10.0,3.0,16.0,6.0,13.0,23.0,0.0,12.0,115.0
Ramgarh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,311.0,438.0,501.0,502.0,645.0,424.0,429.0,479.0,853.0,1141.0,632.0,367.0,6722.0
Ramgarh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,20.0,25.0,22.0,15.0,18.0,24.0,31.0,12.0,26.0,36.0,0.0,29.0,258.0
Ramgarh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,344.0,506.0,558.0,638.0,681.0,486.0,490.0,533.0,906.0,1309.0,694.0,599.0,7744.0
Ramgarh,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ramgarh,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ramgarh,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Ramgarh,14.11,In-Patient Head Count at midnight,TOTAL,87.0,138.0,168.0,80.0,393.0,165.0,65.0,142.0,376.0,240.0,864.0,132.0,2850.0
Ramgarh,14.12.1,OPD attendance (All),TOTAL,12988.0,13008.0,12631.0,13976.0,23112.0,17064.0,16953.0,15156.0,17167.0,15259.0,13848.0,12208.0,183370.0
Ramgarh,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1.0,0.0,0.0,0.0,10.0,875.0,0.0,16.0,16.0,0.0,0.0,0.0,918.0
Ramgarh,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Ramgarh,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2.0,6.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,12.0
Ramgarh,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,0.0,0.0,50.0
Ramgarh,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,982.0,593.0,651.0,1034.0,828.0,742.0,1111.0,719.0,657.0,1094.0,1155.0,932.0,10498.0
Ramgarh,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,22.0,25.0,10.0,23.0,13.0,12.0,8.0,8.0,17.0,89.0,22.0,21.0,270.0
Ramgarh,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,40.0,91.0,94.0,131.0,208.0,185.0,84.0,167.0,120.0,88.0,224.0,270.0,1702.0
Ramgarh,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,1.0,1.0,1.0,1.0,0.0,51.0,1.0,117.0,1.0,0.0,1.0,177.0
Ramgarh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,85.0,107.0,93.0,161.0,201.0,177.0,52.0,200.0,100.0,303.0,445.0,227.0,2151.0
Ramgarh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,2.0,0.0,1.0,0.0,37.0,0.0,357.0,0.0,1.0,1.0,401.0
Ramgarh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,62.0,147.0,147.0,146.0,201.0,183.0,80.0,266.0,105.0,84.0,161.0,172.0,1754.0
Ramgarh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,71.0,0.0,73.0,0.0,0.0,0.0,144.0
Ramgarh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,187.0,345.0,334.0,438.0,610.0,545.0,216.0,633.0,325.0,475.0,830.0,669.0,5607.0
Ramgarh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,2.0,3.0,1.0,2.0,0.0,159.0,1.0,547.0,1.0,1.0,2.0,722.0
Ramgarh,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Ramgarh,15.3.a,Number of VDRL tests conducted on males,Number tested,5.0,5.0,24.0,0.0,8.0,6.0,0.0,6.0,0.0,0.0,13.0,8.0,75.0
Ramgarh,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,13.0,62.0,84.0,99.0,58.0,20.0,37.0,20.0,128.0,0.0,26.0,13.0,560.0
Ramgarh,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,51.0,76.0,76.0,59.0,100.0,53.0,44.0,83.0,73.0,0.0,103.0,121.0,839.0
Ramgarh,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,69.0,143.0,184.0,158.0,166.0,79.0,81.0,109.0,201.0,0.0,142.0,142.0,1474.0
Ramgarh,15.4.1,Number of blood smears examined for Malaria,TOTAL,5070.0,2922.0,4450.0,5243.0,7840.0,10010.0,8740.0,5994.0,6852.0,3256.0,4770.0,4204.0,69351.0
Ramgarh,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,22.0,29.0,27.0,113.0,92.0,95.0,88.0,50.0,37.0,18.0,19.0,16.0,606.0
Ramgarh,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,3.0,2.0,4.0,15.0,9.0,25.0,51.0,112.0,126.0,6.0,7.0,5.0,365.0
Ramgarh,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1350.0,1450.0,1700.0,900.0,0.0,1650.0,900.0,1700.0,1050.0,250.0,1300.0,1150.0,13400.0
Ramgarh,16.1.1,Stock position of DPT vaccines,2. Stocks Received,950.0,1000.0,0.0,0.0,2500.0,0.0,1500.0,0.0,0.0,2000.0,500.0,500.0,8950.0
Ramgarh,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,850.0,750.0,800.0,900.0,850.0,750.0,700.0,650.0,800.0,950.0,650.0,1250.0,9900.0
Ramgarh,16.1.1,Stock position of DPT vaccines,5. Total Stock,1450.0,1700.0,900.0,0.0,1650.0,900.0,1700.0,1050.0,250.0,1300.0,1150.0,400.0,12450.0
Ramgarh,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Ramgarh,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Ramgarh,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Ramgarh,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Ramgarh,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,657.0,1025.0,1400.0,875.0,0.0,500.0,25.0,100.0,500.0,0.0,350.0,700.0,6132.0
Ramgarh,16.1.2,Stock position of OPV vaccines,2. Stocks Received,700.0,1140.0,0.0,0.0,1000.0,0.0,500.0,400.0,0.0,1000.0,1000.0,1000.0,6740.0
Ramgarh,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,332.0,765.0,525.0,875.0,500.0,475.0,425.0,0.0,500.0,650.0,650.0,1700.0,7397.0
Ramgarh,16.1.2,Stock position of OPV vaccines,5. Total Stock,1025.0,1400.0,875.0,0.0,500.0,25.0,100.0,500.0,0.0,350.0,700.0,0.0,5475.0
Ramgarh,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1200.0,1740.0,1100.0,500.0,2900.0,2250.0,1550.0,1250.0,800.0,200.0,800.0,1200.0,15490.0
Ramgarh,16.1.3,Stock position of TT vaccines,2. Stocks Received,1100.0,210.0,0.0,3000.0,0.0,0.0,300.0,0.0,0.0,1500.0,1000.0,1000.0,8110.0
Ramgarh,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.3,Stock position of TT vaccines,4. Stock Distributed,560.0,850.0,600.0,600.0,650.0,700.0,600.0,450.0,600.0,900.0,600.0,1450.0,8560.0
Ramgarh,16.1.3,Stock position of TT vaccines,5. Total Stock,1740.0,1100.0,500.0,2900.0,2250.0,1550.0,1250.0,800.0,200.0,800.0,1200.0,750.0,15040.0
Ramgarh,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1500.0,1530.0,850.0,300.0,800.0,1700.0,1000.0,1450.0,1050.0,450.0,100.0,0.0,10730.0
Ramgarh,16.1.5,Stock position of BCG vaccines,2. Stocks Received,530.0,0.0,0.0,1000.0,1550.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,4080.0
Ramgarh,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,500.0,680.0,550.0,500.0,650.0,700.0,550.0,400.0,600.0,350.0,100.0,0.0,5580.0
Ramgarh,16.1.5,Stock position of BCG vaccines,5. Total Stock,1530.0,850.0,300.0,800.0,1700.0,1000.0,1450.0,1050.0,450.0,100.0,0.0,0.0,9230.0
Ramgarh,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,300.0,1300.0,700.0,750.0,800.0,1850.0,1050.0,750.0,350.0,7150.0,2200.0,1850.0,19050.0
Ramgarh,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1500.0,0.0,600.0,900.0,1500.0,0.0,300.0,0.0,7500.0,0.0,0.0,0.0,12300.0
Ramgarh,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,500.0,600.0,550.0,850.0,450.0,800.0,600.0,400.0,700.0,4950.0,350.0,600.0,11350.0
Ramgarh,16.1.6,Stock position of Measles vaccines,5. Total Stock,1300.0,700.0,750.0,800.0,1850.0,1050.0,750.0,350.0,7150.0,2200.0,1850.0,1250.0,20000.0
Ramgarh,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1220.0,1050.0,660.0,1740.0,4670.0
Ramgarh,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,1570.0,0.0,3570.0
Ramgarh,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,780.0,170.0,390.0,490.0,530.0,2360.0
Ramgarh,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1220.0,1050.0,660.0,1740.0,1210.0,5880.0
Ramgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,150.0,150.0,150.0,150.0,150.0,150.0,150.0,100.0,0.0,0.0,0.0,0.0,1150.0
Ramgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,50.0,100.0,0.0,0.0,0.0,0.0,150.0
Ramgarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,150.0,150.0,150.0,150.0,150.0,150.0,100.0,0.0,0.0,0.0,0.0,0.0,1000.0
Ramgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,14000.0,26000.0,20000.0,18000.0,16000.0,16000.0,30000.0,30000.0,14000.0,184000.0
Ramgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,20000.0,20000.0,0.0,0.0,0.0,0.0,20000.0,0.0,0.0,0.0,60000.0
Ramgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,6000.0,8000.0,6000.0,2000.0,2000.0,0.0,6000.0,0.0,16000.0,0.0,46000.0
Ramgarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,14000.0,26000.0,20000.0,18000.0,16000.0,16000.0,30000.0,30000.0,14000.0,14000.0,198000.0
Ramgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,1000.0,1000.0,200.0,200.0,200.0,0.0,5000.0,5000.0,3000.0,15600.0
Ramgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,6000.0
Ramgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,800.0,0.0,0.0,200.0,0.0,0.0,2000.0,0.0,3000.0
Ramgarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,1000.0,1000.0,200.0,200.0,200.0,0.0,5000.0,5000.0,3000.0,3000.0,18600.0
Ramgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,1200.0,700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1900.0
Ramgarh,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,500.0,700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0
Ramgarh,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,700.0
Ramgarh,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,2500.0,0.0,0.0,2150.0,1500.0,700.0,0.0,0.0,150.0,150.0,0.0,7150.0
Ramgarh,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,2800.0,0.0,0.0,0.0,0.0,1500.0,0.0,0.0,0.0,4300.0
Ramgarh,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,1500.0,0.0,650.0,650.0,800.0,700.0,0.0,1350.0,0.0,150.0,0.0,5800.0
Ramgarh,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,1000.0,0.0,2150.0,1500.0,700.0,0.0,0.0,150.0,150.0,0.0,0.0,5650.0
Ramgarh,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,25200.0,16800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,42000.0
Ramgarh,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,8400.0,16800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25200.0
Ramgarh,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,16800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16800.0
Ramgarh,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,100000.0,0.0,75000.0,65000.0,11500.0,195000.0,446500.0
Ramgarh,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200000.0,0.0,0.0,360000.0,0.0,560000.0
Ramgarh,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,100000.0,125000.0,10000.0,53500.0,176500.0,25000.0,490000.0
Ramgarh,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,75000.0,65000.0,11500.0,195000.0,170000.0,516500.0
Ramgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,600.0,600.0,0.0,1800.0
Ramgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1896.0,0.0,0.0,0.0,0.0,1896.0
Ramgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1296.0,0.0,0.0,600.0,0.0,1896.0
Ramgarh,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,600.0,600.0,0.0,0.0,1800.0
Ramgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,50000.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50000.0
Ramgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,50000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50000.0
Ramgarh,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,,0.0,18.0,55.0,55.0,230.0,55.0,55.0,230.0,60.0,758.0
Ramgarh,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,,1540.0,400.0,0.0,1977.0,0.0,0.0,1977.0,0.0,0.0,5894.0
Ramgarh,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,,1522.0,363.0,0.0,1802.0,175.0,0.0,1802.0,170.0,0.0,5834.0
Ramgarh,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,18.0,55.0,55.0,230.0,55.0,55.0,230.0,60.0,60.0,818.0
Ramgarh,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,6000.0,6000.0,2000.0,2000.0,15600.0,15600.0,12800.0,11800.0,11300.0,3900.0,3300.0,3300.0,93600.0
Ramgarh,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,25000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25000.0
Ramgarh,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,4000.0,0.0,11400.0,0.0,2800.0,1000.0,500.0,7400.0,600.0,0.0,500.0,28200.0
Ramgarh,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,6000.0,2000.0,2000.0,15600.0,15600.0,12800.0,11800.0,11300.0,3900.0,3300.0,3300.0,2800.0,90400.0
Ramgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,800.0,1250.0,550.0,600.0,8700.0,7800.0,6050.0,6050.0,6350.0,4100.0,2700.0,2100.0,47050.0
Ramgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,1000.0,0.0,1000.0,9000.0,700.0,0.0,0.0,300.0,0.0,0.0,0.0,0.0,12000.0
Ramgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,550.0,700.0,950.0,900.0,1600.0,1750.0,0.0,0.0,2250.0,1400.0,600.0,450.0,11150.0
Ramgarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1250.0,550.0,600.0,8700.0,7800.0,6050.0,6050.0,6350.0,4100.0,2700.0,2100.0,1650.0,47900.0
Ramgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,63800.0,42800.0,69000.0,65000.0,63300.0,64000.0,58000.0,68000.0,68000.0,91200.0,87200.0,80800.0,821100.0
Ramgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,31200.0,0.0,10000.0,10000.0,0.0,10000.0,0.0,30000.0,0.0,0.0,0.0,91200.0
Ramgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,21000.0,5000.0,4000.0,12000.0,9000.0,6000.0,0.0,0.0,6800.0,4000.0,6400.0,12000.0,86200.0
Ramgarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,42800.0,69000.0,65000.0,63000.0,64300.0,58000.0,68000.0,68000.0,91200.0,87200.0,80800.0,68800.0,826100.0
Ramgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4400.0,5400.0,4000.0,79800.0,2600.0,53400.0,51000.0,31000.0,31300.0,22400.0,21000.0,25000.0,331300.0
Ramgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0,0.0,6000.0,0.0,9000.0
Ramgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,500.0,1400.0,1200.0,26200.0,200.0,900.0,20000.0,0.0,1500.0,1400.0,2000.0,5500.0,60800.0
Ramgarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,5400.0,4000.0,2800.0,53600.0,2400.0,52500.0,31000.0,31000.0,31300.0,21000.0,25000.0,19500.0,279500.0
Ramgarh,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,1.0,1.0
Ramgarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,1.0,,,,,1.0
Ramgarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ramgarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,1.0,,,,,1.0
Ramgarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Ramgarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ramgarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Ramgarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Ramgarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ramgarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Ramgarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Ramgarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,,1.0
Ramgarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,1.0,,,,,,,1.0
Ramgarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ramgarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ramgarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Ramgarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ramgarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ramgarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Ramgarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ramgarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ramgarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Ramgarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ramgarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ramgarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Ramgarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,1.0,,,1.0
Ramgarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Ramgarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,1.0,,,1.0
Ramgarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Ramgarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Ramgarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Ramgarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Ramgarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Ramgarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Ramgarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,1.0,,1.0
Ramgarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,1.0,,,,,1.0,,2.0
Ramgarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,2.0,,,,,,,2.0
Ramgarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,2.0,,,,,,,2.0
Ramgarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Ramgarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,1.0,,,,,,,1.0
Ramgarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Ramgarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Ramgarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Ramgarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Ramgarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,1.0,,,,,,,1.0
Ranchi,1.1,Total number of pregnant women Registered for ANC,TOTAL,4717.0,4873.0,4187.0,5048.0,4263.0,4543.0,4428.0,5574.0,4442.0,4193.0,4348.0,5770.0,56386.0
Ranchi,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1604.0,1003.0,1122.0,1485.0,1268.0,1545.0,1203.0,2056.0,1586.0,1533.0,1340.0,2652.0,18397.0
Ranchi,1.2,Number of Pregnant women registered under JSY,TOTAL,4668.0,4818.0,4130.0,3982.0,4184.0,4460.0,4384.0,5513.0,4349.0,4090.0,4237.0,5712.0,54527.0
Ranchi,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2881.0,2820.0,2946.0,2906.0,2848.0,3169.0,3056.0,3476.0,3167.0,2350.0,2859.0,3901.0,36379.0
Ranchi,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3828.0,4513.0,3880.0,4176.0,3860.0,4141.0,4194.0,5116.0,4065.0,3968.0,4111.0,4714.0,50566.0
Ranchi,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3566.0,4299.0,3853.0,3749.0,3951.0,3645.0,3791.0,5032.0,4020.0,3709.0,4306.0,4610.0,48531.0
Ranchi,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1321.0,1189.0,791.0,670.0,408.0,550.0,525.0,543.0,507.0,446.0,574.0,668.0,8192.0
Ranchi,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,112.0,114.0,111.0,123.0,77.0,100.0,93.0,104.0,109.0,90.0,93.0,72.0,1198.0
Ranchi,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Ranchi,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,360.0,371.0,364.0,309.0,376.0,195.0,322.0,310.0,315.0,367.0,270.0,390.0,3949.0
Ranchi,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,11.0,65.0,2.0,2.0,6.0,3.0,1.0,0.0,0.0,0.0,4.0,94.0
Ranchi,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Ranchi,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,254.0,242.0,287.0,254.0,206.0,155.0,185.0,150.0,181.0,188.0,203.0,192.0,2497.0
Ranchi,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,642.0,718.0,776.0,796.0,1031.0,794.0,676.0,736.0,713.0,711.0,617.0,652.0,8862.0
Ranchi,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,896.0,960.0,1063.0,1050.0,1237.0,949.0,861.0,886.0,894.0,899.0,820.0,844.0,11359.0
Ranchi,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,640.0,701.0,750.0,753.0,831.0,665.0,639.0,690.0,727.0,703.0,709.0,678.0,8486.0
Ranchi,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,77.0,85.0,109.0,63.0,99.0,70.0,64.0,92.0,79.0,49.0,34.0,51.0,872.0
Ranchi,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2284.0,2342.0,3181.0,3842.0,3219.0,4132.0,2910.0,4506.0,3374.0,2889.0,3116.0,5815.0,41610.0
Ranchi,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2248.0,2298.0,3122.0,3775.0,3171.0,4075.0,2873.0,4359.0,3334.0,2842.0,3066.0,5798.0,40961.0
Ranchi,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1457.0,1741.0,1566.0,1557.0,1916.0,1501.0,1908.0,1348.0,1862.0,1702.0,1626.0,1184.0,19368.0
Ranchi,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1010.0,1231.0,1118.0,1370.0,1329.0,1024.0,1232.0,1221.0,1289.0,1237.0,1072.0,1171.0,14304.0
Ranchi,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,27.0,0.0,0.0,72.0,3.0,11.0,1.0,3.0,0.0,6.0,0.0,48.0,171.0
Ranchi,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,56.0,,,0.0,0.0,0.0,,,,,,,56.0
Ranchi,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,53.0,,,0.0,0.0,0.0,,,,,,,53.0
Ranchi,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,53.0,,,0.0,0.0,0.0,,,,,,,53.0
Ranchi,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,0.0,0.0,0.0,,,,,,,0.0
Ranchi,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,195.0,143.0,503.0,222.0,278.0,220.0,381.0,1017.0,575.0,530.0,584.0,1607.0,6255.0
Ranchi,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranchi,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,195.0,143.0,503.0,222.0,278.0,220.0,381.0,1017.0,575.0,530.0,584.0,1607.0,6255.0
Ranchi,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,6.0,,,0.0,0.0,0.0,,,,,,,6.0
Ranchi,4.1.1.a,Number of male live births,TOTAL,1719.0,1773.0,2269.0,2556.0,2331.0,2647.0,2036.0,2807.0,2179.0,1927.0,2002.0,3446.0,27692.0
Ranchi,4.1.1.b,Number of female live births,TOTAL,1518.0,1594.0,2035.0,2406.0,2083.0,2447.0,1862.0,2613.0,2128.0,1924.0,1930.0,3132.0,25672.0
Ranchi,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3237.0,3367.0,4304.0,4962.0,4414.0,5094.0,3898.0,5420.0,4307.0,3851.0,3932.0,6578.0,53364.0
Ranchi,4.1.2,Number of still births,TOTAL,45.0,54.0,66.0,67.0,96.0,87.0,49.0,102.0,106.0,58.0,49.0,134.0,913.0
Ranchi,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,373.0,408.0,300.0,426.0,310.0,102.0,307.0,378.0,414.0,471.0,384.0,530.0,4403.0
Ranchi,4.2.1,Number of Newborns weighed at birth,TOTAL,3130.0,2907.0,3036.0,4787.0,4261.0,4924.0,3693.0,4860.0,4149.0,3646.0,3813.0,6435.0,49641.0
Ranchi,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,158.0,289.0,174.0,220.0,266.0,222.0,198.0,303.0,296.0,230.0,217.0,243.0,2816.0
Ranchi,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3160.0,2848.0,3118.0,4881.0,4328.0,5021.0,3774.0,4877.0,4207.0,3652.0,3828.0,6474.0,50168.0
Ranchi,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,3.0
Ranchi,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,16.0,27.0,127.0,182.0,16.0,26.0,17.0,60.0,56.0,7.0,18.0,0.0,552.0
Ranchi,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0
Ranchi,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranchi,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,16.0,27.0,127.0,183.0,16.0,26.0,18.0,61.0,56.0,7.0,18.0,0.0,555.0
Ranchi,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,3.0,,,0.0,0.0,0.0,,,,,,,3.0
Ranchi,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,6.0,13.0,15.0,208.0,239.0,263.0,276.0,153.0,101.0,119.0,158.0,120.0,1671.0
Ranchi,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,2.0,13.0,1.0,103.0,124.0,133.0,172.0,2.0,4.0,11.0,29.0,166.0,760.0
Ranchi,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1967.0,2079.0,2316.0,2142.0,2205.0,2013.0,1918.0,2101.0,1822.0,1731.0,1659.0,1905.0,23858.0
Ranchi,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1642.0,1658.0,1767.0,1827.0,1938.0,1864.0,1741.0,1766.0,1797.0,1932.0,1948.0,1634.0,21514.0
Ranchi,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,44.0,0.0,0.0,0.0,0.0,45.0,6.0,95.0
Ranchi,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5.0,6.0,2.0,6.0,1.0,3.0,3.0,69.0,48.0,26.0,15.0,76.0,260.0
Ranchi,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,1.0,0.0,0.0,0.0,2.0,2.0,2.0,1.0,0.0,3.0,1.0,13.0
Ranchi,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,6.0,7.0,2.0,6.0,1.0,5.0,5.0,71.0,49.0,26.0,18.0,77.0,273.0
Ranchi,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,5.0
Ranchi,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,165.0,204.0,214.0,294.0,1.0,2.0,2938.0,163.0,163.0,137.0,120.0,124.0,4525.0
Ranchi,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,97.0,104.0,115.0,512.0,1.0,1.0,3543.0,141.0,141.0,119.0,152.0,146.0,5072.0
Ranchi,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,262.0,308.0,329.0,806.0,2.0,3.0,6481.0,304.0,304.0,256.0,272.0,270.0,9597.0
Ranchi,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,520.0,0.0,0.0,0.0,0.0,0.0,20.0,230.0,244.0,1014.0
Ranchi,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,9.0,3.0,3.0,0.0,0.0,0.0,10.0,0.0,0.0,25.0
Ranchi,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,4.0,5.0,2.0,277.0,46.0,26.0,9.0,33.0,50.0,67.0,65.0,33.0,617.0
Ranchi,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,4.0,18.0,74.0,37.0,32.0,4.0,,81.0,46.0,48.0,20.0,364.0
Ranchi,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranchi,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4.0,9.0,20.0,360.0,86.0,61.0,13.0,33.0,131.0,123.0,113.0,53.0,1006.0
Ranchi,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,,,,0.0,,,,,,,,0.0
Ranchi,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,8.0,1.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,13.0
Ranchi,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,7.0,3.0,0.0,120.0,33.0,17.0,45.0,5.0,64.0,326.0,351.0,94.0,1065.0
Ranchi,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,7.0,,,46.0,,,,,,0.0,0.0,,53.0
Ranchi,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranchi,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,14.0,3.0,0.0,174.0,34.0,17.0,45.0,9.0,64.0,326.0,351.0,94.0,1131.0
Ranchi,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,2.0,,,,0.0,,,,,,,,2.0
Ranchi,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,8.0,0.0,0.0,10.0
Ranchi,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,7.0,1.0,0.0,191.0,14.0,99.0,104.0,224.0,534.0,1061.0,873.0,131.0,3239.0
Ranchi,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,135.0,82.0,215.0,106.0,125.0,108.0,3.0,10.0,293.0,683.0,873.0,2633.0
Ranchi,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranchi,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,7.0,136.0,82.0,406.0,120.0,224.0,213.0,227.0,545.0,1362.0,1556.0,1004.0,5882.0
Ranchi,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,,,,0.0,,,,,,,,0.0
Ranchi,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,6.0
Ranchi,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,6.0,19.0,0.0,0.0,66.0,12.0,103.0
Ranchi,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,0.0,75.0,33.0,,,41.0,76.0,161.0,18.0,404.0
Ranchi,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranchi,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,75.0,33.0,6.0,19.0,41.0,76.0,233.0,30.0,513.0
Ranchi,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,,,,0.0,,,,,,,,0.0
Ranchi,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,531.0,669.0,597.0,2308.0,779.0,685.0,541.0,557.0,582.0,748.0,690.0,710.0,9397.0
Ranchi,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,36.0,56.0,69.0,133.0,63.0,56.0,53.0,52.0,56.0,44.0,53.0,39.0,710.0
Ranchi,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,68.0,82.0,85.0,438.0,128.0,73.0,65.0,97.0,118.0,123.0,111.0,85.0,1473.0
Ranchi,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,20.0,433.0,282.0,561.0,423.0,375.0,310.0,20.0,494.0,591.0,627.0,774.0,4910.0
Ranchi,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ranchi,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,655.0,1240.0,1033.0,3440.0,1393.0,1189.0,969.0,726.0,1250.0,1506.0,1481.0,1608.0,16490.0
Ranchi,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Ranchi,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,,,,0.0,,,,,,,,0.0
Ranchi,9.06,Number of IUCD removals,TOTAL,276.0,362.0,228.0,411.0,284.0,379.0,648.0,416.0,307.0,334.0,312.0,1503.0,5460.0
Ranchi,9.07,Number of Oral Pills cycles distributed,TOTAL,12416.0,13069.0,13053.0,33090.0,16475.0,14702.0,14627.0,11613.0,13225.0,13211.0,11160.0,14640.0,181281.0
Ranchi,9.08,Number of Condom pieces distributed,TOTAL,136065.0,132675.0,135023.0,284840.0,135142.0,154568.0,133680.0,103380.0,113162.0,118698.0,114193.0,111430.0,1672856.0
Ranchi,9.09,Number of Centchroman (weekly) pills given,TOTAL,49.0,1097.0,40.0,115.0,56.0,6.0,932.0,252.0,19.0,261.0,14.0,423.0,3264.0
Ranchi,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,2394.0,130.0,2064.0,2891.0,89.0,76.0,3419.0,109.0,91.0,130.0,670.0,196.0,12259.0
Ranchi,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,9.0,0.0,30.0,10.0,9.0,3.0,0.0,4.0,7.0,26.0,4.0,102.0
Ranchi,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,9.0,10.0,4.0,56.0,7.0,11.0,19.0,7.0,22.0,38.0,18.0,20.0,221.0
Ranchi,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,2.0,0.0,4.0,0.0,9.0,0.0,0.0,6.0,18.0,0.0,1.0,40.0
Ranchi,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,2.0,0.0,5.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,9.0
Ranchi,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,9.12,Number of Institutions having NSV trained doctors,TOTAL,11.0,10.0,13.0,14.0,16.0,22.0,20.0,19.0,16.0,21.0,19.0,16.0,-1.0
Ranchi,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3029.0,5393.0,5148.0,4617.0,5281.0,5340.0,4855.0,6152.0,5089.0,4908.0,4422.0,5009.0,59243.0
Ranchi,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2662.0,4795.0,4779.0,4459.0,5063.0,4794.0,4905.0,5414.0,4730.0,5066.0,4811.0,4757.0,56235.0
Ranchi,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2800.0,4691.0,4465.0,3923.0,4966.0,4586.0,4685.0,5316.0,4759.0,4716.0,4659.0,4996.0,54562.0
Ranchi,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3098.0,4898.0,4376.0,3640.0,4469.0,4566.0,4544.0,5137.0,4776.0,4715.0,4494.0,5083.0,53796.0
Ranchi,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Ranchi,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Ranchi,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Ranchi,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1705.0,4524.0,3377.0,2874.0,3270.0,2110.0,2294.0,3460.0,2340.0,1647.0,1448.0,1834.0,30883.0
Ranchi,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2683.0,4803.0,4434.0,4440.0,4516.0,3107.0,3865.0,4223.0,3407.0,2980.0,2454.0,2253.0,43165.0
Ranchi,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2812.0,4663.0,4471.0,3914.0,4427.0,3029.0,3608.0,4068.0,3088.0,2738.0,2355.0,2229.0,41402.0
Ranchi,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3128.0,4901.0,4401.0,3627.0,4151.0,2885.0,3473.0,3798.0,3046.0,2753.0,2040.0,2211.0,40414.0
Ranchi,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,,,0.0,0.0,0.0,454.0,113.0,55.0,208.0,830.0
Ranchi,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,27.0,13.0,0.0,0.0,6.0,0.0,1.0,2.0,394.0,3147.0,3657.0,3185.0,10432.0
Ranchi,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,6.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,16.0,834.0,2142.0,3097.0,6097.0
Ranchi,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,7.0,4.0,0.0,0.0,0.0,0.0,1.0,2.0,22.0,220.0,423.0,2136.0,2815.0
Ranchi,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4172.0,3890.0,4878.0,5117.0,5127.0,4686.0,4397.0,13964.0,13381.0,4873.0,4534.0,4694.0,73713.0
Ranchi,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,0.0,0.0,,0.0,21.0,26.0,0.0,1.0,0.0,19.0,15.0,82.0
Ranchi,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Ranchi,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1989.0,1998.0,2502.0,2367.0,2657.0,2440.0,2216.0,6650.0,6793.0,1762.0,1915.0,2056.0,35345.0
Ranchi,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1751.0,1805.0,2271.0,2276.0,2398.0,2151.0,2115.0,6111.0,6223.0,1687.0,1679.0,1888.0,32355.0
Ranchi,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3740.0,3803.0,4773.0,4643.0,5055.0,4591.0,4331.0,12761.0,13016.0,3449.0,3594.0,3944.0,67700.0
Ranchi,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2543.0,3894.0,3623.0,3216.0,3557.0,3225.0,3403.0,3463.0,2342.0,3701.0,3817.0,3755.0,40539.0
Ranchi,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2366.0,3912.0,3611.0,3196.0,3302.0,2206.0,2736.0,2557.0,2247.0,2345.0,2117.0,1699.0,32294.0
Ranchi,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,7.0
Ranchi,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,859.0,1484.0,1283.0,958.0,1402.0,988.0,881.0,862.0,985.0,801.0,855.0,961.0,12319.0
Ranchi,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,807.0,1403.0,1167.0,830.0,1231.0,949.0,766.0,860.0,965.0,744.0,797.0,930.0,11449.0
Ranchi,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1666.0,2887.0,2450.0,1788.0,2633.0,1937.0,1647.0,1722.0,1950.0,1545.0,1652.0,1891.0,23768.0
Ranchi,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,39.0,85.0,161.0,94.0,616.0,549.0,649.0,689.0,459.0,599.0,654.0,642.0,5236.0
Ranchi,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2239.0,3385.0,2621.0,2667.0,2536.0,2781.0,2911.0,2827.0,2745.0,2475.0,2645.0,2741.0,32573.0
Ranchi,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2446.0,2545.0,2847.0,3075.0,2603.0,3164.0,2800.0,2825.0,2560.0,2554.0,2647.0,2750.0,32816.0
Ranchi,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,44.0,72.0,64.0,72.0,63.0,86.0,75.0,69.0,40.0,54.0,52.0,71.0,762.0
Ranchi,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,265.0,141.0,190.0,248.0,230.0,229.0,197.0,179.0,130.0,172.0,148.0,117.0,2246.0
Ranchi,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2532.0,2763.0,2797.0,2585.0,2795.0,2816.0,2739.0,2856.0,2807.0,2828.0,2842.0,3013.0,33373.0
Ranchi,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2308.0,2671.0,2773.0,2383.0,2749.0,2877.0,2574.0,2402.0,2349.0,2834.0,2818.0,2924.0,31662.0
Ranchi,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1750.0,1767.0,1922.0,1780.0,1811.0,1953.0,1730.0,1946.0,1947.0,1843.0,1986.0,2169.0,22604.0
Ranchi,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,,0.0,5.0,7.0,10.0,0.0,0.0,0.0,0.0,22.0
Ranchi,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3571.0,2338.0,2506.0,2691.0,6763.0,4205.0,3051.0,2168.0,2576.0,2628.0,5197.0,3596.0,41290.0
Ranchi,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,915.0,685.0,512.0,321.0,26755.0,3408.0,577.0,384.0,286.0,280.0,23245.0,4207.0,61575.0
Ranchi,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,778.0,203.0,111.0,110.0,29586.0,4153.0,333.0,191.0,72.0,88.0,27338.0,4543.0,67506.0
Ranchi,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,0.0,0.0,23.0
Ranchi,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,20.0,24.0,75.0,64.0,71.0,143.0,36.0,41.0,7.0,6.0,28.0,5.0,520.0
Ranchi,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,305.0,270.0,225.0,310.0,271.0,279.0,160.0,126.0,94.0,125.0,93.0,126.0,2384.0
Ranchi,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,203.0,186.0,163.0,424.0,356.0,482.0,383.0,453.0,256.0,340.0,248.0,201.0,3695.0
Ranchi,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,47.0,165.0,73.0,286.0
Ranchi,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,47.0,76.0,26.0,150.0
Ranchi,13.3,Number of School children detected with Refractive errors,TOTAL,50.0,410.0,612.0,3870.0,1797.0,2407.0,1920.0,711.0,918.0,120.0,116.0,100.0,13031.0
Ranchi,13.4,Number of children provided free glasses,TOTAL,51.0,0.0,14.0,92.0,36.0,13.0,34.0,3.0,2.0,0.0,41.0,0.0,286.0
Ranchi,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,5.0,4.0,5.0,6.0,4.0,6.0,6.0,7.0,7.0,7.0,7.0,-1.0
Ranchi,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,3.0,4.0,5.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Ranchi,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1628.0,1846.0,1821.0,1679.0,1836.0,1734.0,1744.0,1741.0,2097.0,1722.0,1738.0,1814.0,-1.0
Ranchi,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,13.0,10.0,10.0,11.0,12.0,11.0,14.0,12.0,12.0,13.0,13.0,11.0,-1.0
Ranchi,14.05,Number of RKS meetings held during the month,TOTAL,10.0,11.0,15.0,12.0,21.0,19.0,15.0,15.0,14.0,16.0,13.0,13.0,174.0
Ranchi,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,9.0,14.0,12.0,14.0,13.0,13.0,13.0,12.0,15.0,12.0,11.0,-1.0
Ranchi,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,37.0,33.0,48.0,42.0,61.0,45.0,38.0,44.0,52.0,43.0,57.0,64.0,564.0
Ranchi,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,5.0,4.0,3.0,2.0,4.0,4.0,3.0,4.0,5.0,5.0,-1.0
Ranchi,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,-1.0
Ranchi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,72.0,218.0,73.0,63.0,71.0,82.0,89.0,101.0,32.0,34.0,16.0,17.0,868.0
Ranchi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,55.0,153.0,192.0,151.0,189.0,33.0,96.0,989.0,917.0,721.0,1237.0,1384.0,6117.0
Ranchi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,46.0,321.0,85.0,64.0,160.0,70.0,87.0,105.0,13.0,16.0,12.0,28.0,1007.0
Ranchi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,734.0,697.0,804.0,1038.0,737.0,795.0,786.0,2274.0,1596.0,2141.0,2648.0,2166.0,16416.0
Ranchi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,118.0,539.0,158.0,127.0,231.0,152.0,176.0,206.0,45.0,50.0,28.0,45.0,1875.0
Ranchi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,789.0,850.0,996.0,1189.0,926.0,828.0,882.0,3263.0,2513.0,2862.0,3885.0,3550.0,22533.0
Ranchi,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,4.0
Ranchi,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0
Ranchi,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,7.0
Ranchi,14.11,In-Patient Head Count at midnight,TOTAL,3137.0,298.0,451.0,401.0,592.0,602.0,495.0,381.0,638.0,797.0,529.0,289.0,8610.0
Ranchi,14.12.1,OPD attendance (All),TOTAL,72924.0,72692.0,91589.0,91017.0,99101.0,104263.0,99400.0,87029.0,81749.0,89658.0,86301.0,86480.0,1062203.0
Ranchi,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,189.0,107.0,1387.0,1683.0
Ranchi,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Ranchi,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,0.0,10.0,178.0,12.0,787.0,72.0,59.0,135.0,404.0,208.0,30.0,1895.0
Ranchi,14.14.a,Number of patients given AYUSH treatment,TOTAL,257.0,237.0,210.0,280.0,652.0,218.0,645.0,0.0,302.0,229.0,217.0,279.0,3526.0
Ranchi,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,105.0,94.0,60.0,316.0,446.0,81.0,55.0,133.0,589.0,514.0,620.0,408.0,3421.0
Ranchi,14.14.c,Number of Adolescents counselled,TOTAL,89.0,29.0,432.0,42.0,126.0,642.0,1403.0,427.0,184.0,1580.0,674.0,288.0,5916.0
Ranchi,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2118.0,1615.0,1959.0,2110.0,2039.0,1501.0,5334.0,3578.0,2043.0,3225.0,2677.0,3364.0,31563.0
Ranchi,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,108.0,200.0,82.0,84.0,82.0,100.0,300.0,103.0,89.0,106.0,118.0,137.0,1509.0
Ranchi,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,46.0,35.0,45.0,66.0,238.0,0.0,,103.0,2.0,178.0,298.0,192.0,1203.0
Ranchi,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,68.0,1.0,0.0,0.0,0.0,0.0,0.0,88.0,0.0,193.0,147.0,133.0,630.0
Ranchi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,11.0,62.0,72.0,41.0,139.0,0.0,,112.0,5.0,154.0,222.0,181.0,999.0
Ranchi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,14.0,1.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,232.0,137.0,140.0,624.0
Ranchi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,61.0,72.0,73.0,131.0,281.0,0.0,,338.0,20.0,430.0,418.0,402.0,2226.0
Ranchi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,116.0,17.0,18.0,27.0,30.0,64.0,63.0,324.0,0.0,473.0,309.0,353.0,1794.0
Ranchi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,118.0,169.0,190.0,238.0,658.0,0.0,,553.0,27.0,762.0,938.0,775.0,4428.0
Ranchi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,198.0,19.0,18.0,27.0,30.0,64.0,63.0,512.0,0.0,898.0,593.0,626.0,3048.0
Ranchi,15.2,Number of Widal tests conducted,Number tested,14.0,14.0,7.0,18.0,0.0,296.0,0.0,0.0,18.0,0.0,15.0,19.0,401.0
Ranchi,15.3.a,Number of VDRL tests conducted on males,Number tested,4.0,8.0,6.0,4199.0,4316.0,2790.0,3565.0,3482.0,46.0,3492.0,3360.0,60.0,25328.0
Ranchi,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,3565.0,2099.0,3194.0,2938.0,2310.0,7.0,2540.0,2703.0,61.0,19417.0
Ranchi,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,22.0,23.0,32.0,529.0,344.0,464.0,436.0,2705.0,4.0,545.0,514.0,24.0,5642.0
Ranchi,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,26.0,31.0,38.0,8293.0,6759.0,6448.0,6939.0,8497.0,57.0,6577.0,6577.0,145.0,50387.0
Ranchi,15.4.1,Number of blood smears examined for Malaria,TOTAL,20982.0,18700.0,17920.0,21389.0,18612.0,20385.0,20526.0,17625.0,16846.0,13053.0,15713.0,17254.0,219005.0
Ranchi,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,136.0,108.0,163.0,288.0,237.0,227.0,228.0,185.0,133.0,102.0,138.0,137.0,2082.0
Ranchi,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,71.0,31.0,46.0,69.0,103.0,95.0,124.0,132.0,157.0,101.0,39.0,53.0,1021.0
Ranchi,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,65640.0,62310.0,45460.0,54890.0,7030.0,30830.0,14850.0,925.0,1880.0,1880.0,659.0,101.0,286455.0
Ranchi,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,35000.0,35000.0,20000.0,20000.0,5500.0,1500.0,1500.0,2000.0,4500.0,125000.0
Ranchi,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,28800.0,41850.0,25570.0,33110.0,11200.0,35980.0,25600.0,3374.0,2721.0,2721.0,2558.0,2647.0,216131.0
Ranchi,16.1.1,Stock position of DPT vaccines,5. Total Stock,36840.0,20460.0,19890.0,56780.0,30830.0,14850.0,9250.0,3051.0,659.0,659.0,101.0,1954.0,195324.0
Ranchi,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,78060.0,78060.0,64520.0,34860.0,4300.0,20000.0,7520.0,630.0,145.0,145.0,0.0,0.0,288240.0
Ranchi,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,40000.0,20500.0,40000.0,1000.0,1000.0,1000.0,0.0,0.0,103500.0
Ranchi,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Ranchi,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,57200.0,57200.0,29660.0,30560.0,44280.0,13000.0,34920.0,899.0,1145.0,1145.0,0.0,0.0,270009.0
Ranchi,16.1.2,Stock position of OPV vaccines,5. Total Stock,20860.0,20860.0,34860.0,4300.0,20.0,27500.0,12600.0,731.0,0.0,0.0,0.0,0.0,121731.0
Ranchi,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,51880.0,51340.0,48430.0,58510.0,24550.0,32500.0,15650.0,822.0,1877.0,1877.0,1499.0,1157.0,290092.0
Ranchi,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,35000.0,35000.0,20000.0,20000.0,3500.0,3000.0,3000.0,3000.0,4500.0,127000.0
Ranchi,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.1.3,Stock position of TT vaccines,4. Stock Distributed,35540.0,27910.0,24920.0,33960.0,27050.0,36850.0,27430.0,2794.0,3378.0,3378.0,3342.0,3401.0,229953.0
Ranchi,16.1.3,Stock position of TT vaccines,5. Total Stock,16340.0,23430.0,23510.0,59550.0,32500.0,15650.0,8220.0,1528.0,1499.0,1499.0,1157.0,2256.0,187139.0
Ranchi,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,0.0,0.0,0.0,0.0
Ranchi,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,0.0,0.0,0.0,0.0
Ranchi,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Ranchi,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,0.0,0.0,0.0,0.0
Ranchi,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,60600.0,61720.0,42990.0,23680.0,3120.0,22810.0,14530.0,616.0,949.0,949.0,57.0,1.0,232022.0
Ranchi,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,45000.0,15000.0,10000.0,5000.0,850.0,850.0,0.0,2900.0,79600.0
Ranchi,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,23880.0,43730.0,19310.0,20560.0,25310.0,23280.0,18370.0,2597.0,1742.0,1742.0,56.0,2052.0,182629.0
Ranchi,16.1.5,Stock position of BCG vaccines,5. Total Stock,36720.0,17990.0,23680.0,3120.0,22810.0,14530.0,6160.0,3019.0,57.0,57.0,1.0,849.0,128993.0
Ranchi,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,12445.0,12445.0,,28315.0,13370.0,21500.0,2115.0,10.0,652.0,652.0,47.0,2679.0,94230.0
Ranchi,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,20000.0,,,5000.0,400.0,400.0,4000.0,1000.0,30800.0
Ranchi,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,11505.0,11505.0,,14945.0,11870.0,19385.0,2115.0,2206.0,1005.0,1005.0,1368.0,1594.0,78503.0
Ranchi,16.1.6,Stock position of Measles vaccines,5. Total Stock,940.0,940.0,0.0,13370.0,21500.0,2115.0,0.0,2804.0,47.0,47.0,2679.0,2085.0,46527.0
Ranchi,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,9700.0,,,3200.0,2900.0,2900.0,2665.0,2665.0,,,24030.0
Ranchi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,1950.0,,,,,,,,,,1950.0
Ranchi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,7750.0,0.0,0.0,3200.0,2900.0,2900.0,2665.0,2665.0,0.0,0.0,22080.0
Ranchi,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,384000.0,,,325500.0,1150000.0,53000.0,4000.0,4000.0,,,1920500.0
Ranchi,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,240000.0,,,,,,,,,,240000.0
Ranchi,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,144000.0,0.0,0.0,325500.0,1150000.0,53000.0,4000.0,4000.0,0.0,0.0,1680500.0
Ranchi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,62000.0,,,,,,,,,,62000.0
Ranchi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,17600.0,,,,,,,,,,17600.0
Ranchi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,44400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,44400.0
Ranchi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Ranchi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Ranchi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ranchi,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,4600.0,1422.0,144.0,,,19.0,19.0,5140.0,573.0,11917.0
Ranchi,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,750.0,,,,5875.0,5875.0,250.0,,12750.0
Ranchi,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,0.0,0.0,,0.0
Ranchi,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,3178.0,1910.0,133.0,,,754.0,754.0,4817.0,60.0,11606.0
Ranchi,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,1422.0,262.0,11.0,0.0,0.0,5140.0,5140.0,573.0,513.0,13061.0
Ranchi,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,4384.0,,,,,,,,,4384.0
Ranchi,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Ranchi,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,2661.0,,,,,,,,,2661.0
Ranchi,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,1723.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1723.0
Ranchi,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,15991.0,15591.0,12054.0,,2225.0,2793.0,2650.0,260.0,6491.0,6491.0,4396.0,446.0,69388.0
Ranchi,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,5000.0,5000.0,,,3000.0,4500.0,3000.0,15000.0,3000.0,3000.0,0.0,8700.0,50200.0
Ranchi,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5562.0,5562.0,5634.0,,2432.0,4643.0,5390.0,4618.0,5095.0,5095.0,3950.0,4904.0,52885.0
Ranchi,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,15429.0,15029.0,6420.0,0.0,2793.0,2650.0,260.0,10642.0,4396.0,4396.0,446.0,4242.0,66703.0
Ranchi,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,25069.0,25069.0,75112.0,,9838.0,21236.0,9159.0,8553.0,39821.0,39821.0,59916.0,68796.0,382390.0
Ranchi,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,63000.0,63000.0,,,40000.0,20100.0,30000.0,30000.0,40000.0,40000.0,40000.0,40000.0,406100.0
Ranchi,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,28543.0,28543.0,34525.0,,28602.0,32177.0,35509.0,7283.0,19905.0,19905.0,31120.0,27738.0,293850.0
Ranchi,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,59526.0,59526.0,40587.0,0.0,21236.0,9159.0,3650.0,31270.0,59916.0,59916.0,68796.0,81058.0,494640.0
Ranchi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,10619.0,10619.0,6582.0,4384.0,1723.0,25062.0,22728.0,15750.0,6780.0,6780.0,4499.0,3252.0,118778.0
Ranchi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,5000.0,5000.0,,,25000.0,,,,0.0,0.0,0.0,0.0,35000.0
Ranchi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Ranchi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,10266.0,10266.0,2198.0,2661.0,1661.0,2334.0,12206.0,6618.0,2281.0,2281.0,1247.0,653.0,54672.0
Ranchi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,5353.0,5353.0,4384.0,1723.0,25062.0,22728.0,10522.0,9132.0,4499.0,4499.0,3252.0,2599.0,99106.0
Ranchi,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,1.0,,1.0,,1.0,1.0,1.0,1.0,,,7.0
Ranchi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Ranchi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ranchi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Ranchi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Ranchi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ranchi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Ranchi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,1.0,,,,,1.0
Ranchi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,1.0,1.0,,3.0
Ranchi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,2.0,,1.0,1.0,,4.0
Ranchi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,2.0,,2.0,1.0,,,,,1.0,2.0,,8.0
Ranchi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,2.0,1.0,,,1.0,,1.0,,,,,6.0
Ranchi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,4.0,1.0,2.0,1.0,1.0,,1.0,,1.0,2.0,,14.0
Ranchi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ranchi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ranchi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Ranchi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ranchi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ranchi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Ranchi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ranchi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ranchi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Ranchi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ranchi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ranchi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Ranchi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,1.0,1.0,,,,1.0,,,,,4.0
Ranchi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,1.0,,,,,,1.0,,2.0
Ranchi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,,1.0,1.0,1.0,,,1.0,,,1.0,,6.0
Ranchi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Ranchi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Ranchi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,,,,,,,,,1.0
Ranchi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Ranchi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Ranchi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,1.0,,,,,,,1.0
Ranchi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,1.0,1.0,,,2.0
Ranchi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Ranchi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,1.0,1.0,,,2.0
Ranchi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Ranchi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Ranchi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Ranchi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,,,,,1.0,,1.0,1.0,2.0,2.0,,9.0
Ranchi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Ranchi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,,,,,2.0,,1.0,1.0,2.0,2.0,,10.0
Ranchi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Ranchi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Ranchi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Ranchi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,1.0,,1.0,,,,,,2.0
Ranchi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,1.0,1.0,4.0,1.0,,1.0,,1.0,,,1.0,11.0
Ranchi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,1.0,1.0,4.0,2.0,,2.0,,1.0,,,1.0,13.0
Ranchi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Ranchi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Ranchi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,1.0,,,,,,1.0
Ranchi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Ranchi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Ranchi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Ranchi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Ranchi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Ranchi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,1.0,,,,,,,,1.0
Ranchi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Ranchi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,1.0,,,,,,,,,1.0
Ranchi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,1.0,,,,,,,,,1.0
Ranchi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Ranchi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Ranchi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,1.0,,,1.0
Ranchi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Ranchi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,1.0,,,,1.0
Ranchi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,,,1.0,,,,2.0
Ranchi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,2.0,,,2.0,1.0,1.0,,,1.0,1.0,,9.0
Ranchi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,3.0,1.0,1.0,,,,,,,,,5.0
Ranchi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,5.0,1.0,1.0,2.0,1.0,1.0,,,1.0,1.0,,14.0
Ranchi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,1.0,,,,,1.0,,,2.0
Ranchi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,3.0,3.0,3.0,1.0,3.0,1.0,1.0,1.0,1.0,,1.0,19.0
Ranchi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,3.0,,,,,,3.0
Ranchi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,3.0,3.0,3.0,2.0,3.0,4.0,1.0,1.0,2.0,,1.0,24.0
Ranchi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,,,,,3.0,2.0,,,,,,6.0
Ranchi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Ranchi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,,,,,3.0,2.0,,,,,,6.0
Ranchi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Ranchi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Ranchi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Ranchi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Ranchi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,,1.0,1.0,4.0,,,,1.0,,,8.0
Ranchi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,2.0,1.0,1.0,,,,,,,,,5.0
Ranchi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,3.0,1.0,2.0,2.0,4.0,,,,1.0,,,14.0
Ranchi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Ranchi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,,,1.0,2.0,1.0,1.0,,1.0,1.0,,8.0
Ranchi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,1.0,,2.0,3.0,1.0,,,,,,,8.0
Ranchi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,2.0,,2.0,4.0,3.0,1.0,1.0,,1.0,1.0,,16.0
Ranchi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,,,,,,,,,,,,2.0
Ranchi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,8.0,1.0,2.0,4.0,5.0,1.0,,2.0,2.0,1.0,1.0,28.0
Ranchi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,3.0,10.0,4.0,7.0,7.0,4.0,5.0,1.0,1.0,3.0,2.0,4.0,51.0
Ranchi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,6.0,18.0,5.0,9.0,11.0,9.0,6.0,1.0,3.0,5.0,3.0,5.0,81.0
Sahibganj,1.1,Total number of pregnant women Registered for ANC,TOTAL,3435.0,3887.0,2577.0,2442.0,2126.0,2875.0,2093.0,2243.0,1889.0,2117.0,2447.0,2593.0,30724.0
Sahibganj,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,726.0,805.0,544.0,530.0,467.0,676.0,503.0,505.0,439.0,471.0,551.0,632.0,6849.0
Sahibganj,1.2,Number of Pregnant women registered under JSY,TOTAL,3435.0,3703.0,2386.0,2293.0,2004.0,2778.0,1869.0,1956.0,1715.0,1862.0,2212.0,2285.0,28498.0
Sahibganj,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1062.0,1272.0,1244.0,1226.0,1074.0,1197.0,1002.0,1086.0,980.0,973.0,937.0,958.0,13011.0
Sahibganj,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2278.0,2569.0,1714.0,1522.0,1385.0,1937.0,1366.0,1369.0,1214.0,1341.0,1531.0,1629.0,19855.0
Sahibganj,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2383.0,3030.0,2306.0,1955.0,1686.0,1919.0,1503.0,1625.0,1543.0,1434.0,1691.0,1730.0,22805.0
Sahibganj,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,441.0,301.0,190.0,108.0,158.0,217.0,434.0,222.0,275.0,297.0,4235.0,2993.0,9871.0
Sahibganj,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,112.0,38.0,7.0,24.0,18.0,2.0,8.0,53.0,19.0,26.0,46.0,44.0,397.0
Sahibganj,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,1.0,5.0,11.0,16.0,13.0,7.0,5.0,9.0,2.0,4.0,9.0,83.0
Sahibganj,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,244.0,298.0,167.0,243.0,342.0,387.0,239.0,326.0,218.0,127.0,256.0,383.0,3230.0
Sahibganj,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2.0,0.0,0.0,5.0,0.0,3.0,0.0,7.0,7.0,0.0,1.0,15.0,40.0
Sahibganj,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Sahibganj,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,19.0,43.0,35.0,23.0,47.0,47.0,60.0,63.0,101.0,129.0,56.0,62.0,685.0
Sahibganj,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,885.0,1001.0,735.0,792.0,792.0,1014.0,917.0,945.0,671.0,753.0,643.0,550.0,9698.0
Sahibganj,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,904.0,1044.0,770.0,815.0,839.0,1061.0,977.0,1008.0,772.0,882.0,699.0,612.0,10383.0
Sahibganj,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,478.0,604.0,472.0,513.0,521.0,612.0,607.0,620.0,417.0,502.0,307.0,260.0,5913.0
Sahibganj,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,2.0,2.0,19.0,1.0,0.0,0.0,3.0,10.0,3.0,0.0,15.0,57.0
Sahibganj,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,548.0,569.0,566.0,787.0,1033.0,1064.0,1225.0,1114.0,906.0,906.0,936.0,1141.0,10795.0
Sahibganj,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,544.0,569.0,566.0,787.0,1033.0,1064.0,1219.0,1111.0,903.0,840.0,933.0,1091.0,10660.0
Sahibganj,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,421.0,522.0,515.0,899.0,1055.0,1039.0,1404.0,923.0,1714.0,1551.0,1040.0,827.0,11910.0
Sahibganj,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,304.0,263.0,242.0,348.0,375.0,748.0,681.0,427.0,769.0,812.0,1576.0,934.0,7479.0
Sahibganj,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,3.0
Sahibganj,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,79.0,67.0,86.0,108.0,115.0,159.0,138.0,113.0,94.0,84.0,66.0,83.0,1192.0
Sahibganj,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,47.0,68.0,80.0,68.0,73.0,115.0,34.0,33.0,70.0,40.0,26.0,26.0,680.0
Sahibganj,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,18.0,25.0,16.0,16.0,22.0,43.0,2.0,1.0,28.0,9.0,7.0,11.0,198.0
Sahibganj,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,2.0,0.0,3.0,2.0,4.0,6.0,3.0,3.0,1.0,3.0,15.0,42.0
Sahibganj,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sahibganj,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,2.0,0.0,3.0,2.0,4.0,6.0,3.0,3.0,1.0,3.0,15.0,42.0
Sahibganj,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,22.0,17.0,18.0,22.0,17.0,15.0,30.0,21.0,25.0,22.0,12.0,25.0,246.0
Sahibganj,4.1.1.a,Number of male live births,TOTAL,752.0,851.0,672.0,859.0,1002.0,1166.0,1202.0,1142.0,882.0,943.0,856.0,942.0,11269.0
Sahibganj,4.1.1.b,Number of female live births,TOTAL,751.0,800.0,722.0,806.0,942.0,1070.0,1094.0,1052.0,858.0,909.0,770.0,864.0,10638.0
Sahibganj,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1503.0,1651.0,1394.0,1665.0,1944.0,2236.0,2296.0,2194.0,1740.0,1852.0,1626.0,1806.0,21907.0
Sahibganj,4.1.2,Number of still births,TOTAL,26.0,35.0,35.0,50.0,52.0,53.0,51.0,44.0,38.0,36.0,27.0,35.0,482.0
Sahibganj,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,36.0,49.0,19.0,27.0,31.0,30.0,27.0,56.0,25.0,38.0,26.0,37.0,401.0
Sahibganj,4.2.1,Number of Newborns weighed at birth,TOTAL,1279.0,1416.0,1251.0,1485.0,1786.0,2042.0,2087.0,1997.0,1584.0,1635.0,1398.0,1595.0,19555.0
Sahibganj,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,78.0,114.0,88.0,107.0,185.0,203.0,114.0,173.0,135.0,170.0,120.0,89.0,1576.0
Sahibganj,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1389.0,1558.0,1303.0,1570.0,1878.0,2015.0,2195.0,2072.0,1675.0,1729.0,1521.0,1667.0,20572.0
Sahibganj,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Sahibganj,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Sahibganj,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,2.0,0.0,3.0,2.0,4.0,6.0,3.0,3.0,1.0,3.0,15.0,42.0
Sahibganj,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sahibganj,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,1.0,3.0,0.0,3.0,2.0,4.0,6.0,5.0,3.0,1.0,3.0,15.0,46.0
Sahibganj,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,27.0,11.0,11.0,25.0,25.0,19.0,13.0,7.0,45.0,25.0,21.0,17.0,246.0
Sahibganj,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,24.0,24.0,7.0,33.0,32.0,123.0,127.0,24.0,163.0,122.0,105.0,163.0,947.0
Sahibganj,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,2.0,5.0,11.0,15.0,13.0,15.0,34.0,22.0,14.0,12.0,21.0,166.0
Sahibganj,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,21.0,23.0,19.0,52.0,69.0,155.0,155.0,33.0,173.0,112.0,95.0,189.0,1096.0
Sahibganj,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,3.0,15.0,21.0
Sahibganj,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,909.0,1062.0,946.0,1126.0,1265.0,1541.0,1696.0,1549.0,1243.0,1319.0,1055.0,1136.0,14847.0
Sahibganj,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,655.0,741.0,626.0,698.0,785.0,985.0,918.0,916.0,739.0,746.0,580.0,465.0,8854.0
Sahibganj,6.3,PNC maternal complications attended,TOTAL,0.0,2.0,0.0,26.0,7.0,8.0,7.0,3.0,3.0,4.0,3.0,16.0,79.0
Sahibganj,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,13.0,0.0,4.0,2.0,2.0,13.0,31.0,2.0,2.0,4.0,10.0,84.0
Sahibganj,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,1.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,4.0
Sahibganj,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1.0,14.0,0.0,6.0,2.0,2.0,13.0,31.0,3.0,2.0,4.0,10.0,88.0
Sahibganj,7.2,Number of MTPs conducted at Private Facilities,TOTAL,21.0,9.0,5.0,6.0,10.0,9.0,3.0,12.0,13.0,20.0,10.0,9.0,127.0
Sahibganj,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,58.0,57.0,12.0,35.0,15.0,15.0,11.0,9.0,11.0,12.0,8.0,12.0,255.0
Sahibganj,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,52.0,92.0,31.0,10.0,21.0,10.0,24.0,42.0,37.0,48.0,78.0,52.0,497.0
Sahibganj,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,110.0,149.0,43.0,45.0,36.0,25.0,35.0,51.0,48.0,60.0,86.0,64.0,752.0
Sahibganj,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,10.0,0.0,4.0,0.0,0.0,2.0,8.0,3.0,0.0,27.0
Sahibganj,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,19.0,0.0,0.0,0.0,0.0,0.0,8.0,2.0,0.0,30.0
Sahibganj,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sahibganj,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,29.0,0.0,4.0,0.0,0.0,2.0,16.0,5.0,0.0,57.0
Sahibganj,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,3.0
Sahibganj,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sahibganj,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,121.0,0.0,37.0,100.0,244.0,298.0,730.0,426.0,110.0,2066.0
Sahibganj,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,2.0,0.0,0.0,49.0,0.0,1.0,0.0,24.0,55.0,95.0,68.0,5.0,299.0
Sahibganj,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sahibganj,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,2.0,0.0,0.0,170.0,0.0,38.0,100.0,268.0,353.0,825.0,494.0,115.0,2365.0
Sahibganj,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,25.0,11.0,9.0,9.0,25.0,17.0,16.0,68.0,84.0,51.0,53.0,61.0,429.0
Sahibganj,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sahibganj,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,2.0,3.0,6.0,5.0,6.0,4.0,2.0,6.0,3.0,1.0,2.0,40.0
Sahibganj,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,184.0,174.0,171.0,236.0,187.0,204.0,164.0,171.0,184.0,276.0,200.0,197.0,2348.0
Sahibganj,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,6.0,17.0,11.0,24.0,20.0,30.0,22.0,13.0,16.0,42.0,26.0,26.0,253.0
Sahibganj,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,23.0,26.0,41.0,221.0,12.0,53.0,22.0,16.0,12.0,144.0,95.0,50.0,715.0
Sahibganj,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,6.0,3.0,0.0,114.0,1.0,4.0,4.0,5.0,7.0,5.0,9.0,8.0,166.0
Sahibganj,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sahibganj,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,219.0,220.0,223.0,595.0,220.0,291.0,212.0,205.0,219.0,467.0,330.0,281.0,3482.0
Sahibganj,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Sahibganj,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,34.0,21.0,12.0,9.0,8.0,9.0,18.0,22.0,13.0,20.0,25.0,13.0,204.0
Sahibganj,9.06,Number of IUCD removals,TOTAL,99.0,91.0,102.0,139.0,138.0,110.0,74.0,154.0,109.0,115.0,89.0,101.0,1321.0
Sahibganj,9.07,Number of Oral Pills cycles distributed,TOTAL,2416.0,2253.0,2686.0,7915.0,3181.0,3423.0,3188.0,2986.0,3340.0,6845.0,3730.0,3292.0,45255.0
Sahibganj,9.08,Number of Condom pieces distributed,TOTAL,16508.0,15530.0,18034.0,133478.0,14164.0,15419.0,14338.0,14225.0,13271.0,28563.0,23502.0,11535.0,318567.0
Sahibganj,9.09,Number of Centchroman (weekly) pills given,TOTAL,32.0,0.0,5.0,365.0,10.0,0.0,104.0,7.0,6.0,6.0,480.0,443.0,1458.0
Sahibganj,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,59.0,30.0,105.0,604.0,257.0,188.0,91.0,150.0,134.0,317.0,113.0,84.0,2132.0
Sahibganj,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Sahibganj,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,9.12,Number of Institutions having NSV trained doctors,TOTAL,7.0,8.0,7.0,6.0,6.0,7.0,7.0,8.0,9.0,10.0,10.0,12.0,-1.0
Sahibganj,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2437.0,2920.0,1861.0,1642.0,1625.0,3025.0,2682.0,2981.0,1642.0,2638.0,1224.0,1054.0,25731.0
Sahibganj,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2358.0,2937.0,2069.0,1975.0,1707.0,2137.0,2027.0,2795.0,2779.0,2398.0,2594.0,2412.0,28188.0
Sahibganj,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2501.0,2964.0,2176.0,2098.0,1891.0,1804.0,1460.0,2005.0,2195.0,2146.0,2306.0,2140.0,25686.0
Sahibganj,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2515.0,3024.0,2218.0,2129.0,1876.0,1855.0,1417.0,1569.0,1727.0,1733.0,1984.0,2008.0,24055.0
Sahibganj,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Sahibganj,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Sahibganj,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Sahibganj,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1298.0,1512.0,1005.0,1119.0,1148.0,1814.0,1582.0,1758.0,1059.0,812.0,549.0,349.0,14005.0
Sahibganj,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2336.0,2940.0,2067.0,1976.0,1705.0,2135.0,2022.0,2754.0,2750.0,857.0,2109.0,431.0,24082.0
Sahibganj,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2445.0,2984.0,2190.0,2097.0,1885.0,1796.0,1446.0,1989.0,2173.0,798.0,1737.0,324.0,21864.0
Sahibganj,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2460.0,3013.0,2231.0,2136.0,1892.0,1852.0,1418.0,1565.0,1712.0,597.0,1510.0,310.0,20696.0
Sahibganj,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,0.0,7.0,0.0,13.0,24.0,101.0,145.0
Sahibganj,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,8.0,10.0,0.0,0.0,0.0,0.0,0.0,24.0,962.0,1784.0,2788.0
Sahibganj,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,37.0,455.0,505.0
Sahibganj,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,20.0,53.0,94.0
Sahibganj,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2344.0,2906.0,2158.0,2277.0,2457.0,2349.0,1729.0,1757.0,1525.0,1528.0,1987.0,1579.0,24596.0
Sahibganj,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,0.0,1.0,2.0,0.0,65.0,45.0,113.0
Sahibganj,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Sahibganj,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1203.0,1485.0,1096.0,1112.0,1202.0,1135.0,823.0,843.0,725.0,739.0,928.0,767.0,12058.0
Sahibganj,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1114.0,1353.0,982.0,1096.0,1167.0,1117.0,781.0,861.0,692.0,693.0,919.0,716.0,11491.0
Sahibganj,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2317.0,2838.0,2078.0,2208.0,2369.0,2252.0,1604.0,1704.0,1417.0,1432.0,1847.0,1483.0,23549.0
Sahibganj,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1611.0,2010.0,1456.0,1380.0,1439.0,1264.0,805.0,942.0,923.0,907.0,1416.0,1191.0,15344.0
Sahibganj,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1611.0,2005.0,1439.0,1380.0,1432.0,1267.0,802.0,933.0,907.0,394.0,1189.0,242.0,13601.0
Sahibganj,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,195.0,221.0,152.0,127.0,198.0,158.0,122.0,153.0,158.0,153.0,200.0,187.0,2024.0
Sahibganj,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,179.0,201.0,134.0,119.0,154.0,137.0,98.0,141.0,129.0,152.0,155.0,186.0,1785.0
Sahibganj,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,374.0,422.0,286.0,246.0,352.0,295.0,220.0,294.0,287.0,305.0,355.0,373.0,3809.0
Sahibganj,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,188.0,200.0,170.0,155.0,202.0,210.0,189.0,186.0,142.0,118.0,156.0,126.0,2042.0
Sahibganj,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,715.0,964.0,893.0,978.0,911.0,868.0,790.0,871.0,815.0,694.0,647.0,727.0,9873.0
Sahibganj,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,797.0,1045.0,796.0,847.0,903.0,910.0,766.0,934.0,806.0,786.0,745.0,812.0,10147.0
Sahibganj,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,26.0,11.0,22.0,6.0,5.0,6.0,8.0,6.0,7.0,8.0,5.0,6.0,116.0
Sahibganj,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,17.0,16.0,4.0,6.0,5.0,5.0,7.0,7.0,8.0,13.0,12.0,10.0,110.0
Sahibganj,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1293.0,1389.0,1282.0,1284.0,1293.0,1288.0,1186.0,1240.0,1234.0,1257.0,1216.0,1260.0,15222.0
Sahibganj,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1125.0,1339.0,1176.0,1190.0,1142.0,1167.0,936.0,1079.0,1087.0,977.0,1069.0,1072.0,13359.0
Sahibganj,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,657.0,766.0,689.0,699.0,655.0,666.0,546.0,672.0,693.0,636.0,667.0,688.0,8034.0
Sahibganj,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1780.0,1658.0,1140.0,1801.0,3594.0,2714.0,1556.0,1489.0,1304.0,1123.0,4106.0,1580.0,23845.0
Sahibganj,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,55.0,9.0,8.0,2080.0,17230.0,5970.0,348.0,14.0,21.0,14.0,18786.0,5787.0,50322.0
Sahibganj,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,65.0,25.0,2.0,1871.0,19399.0,6466.0,925.0,0.0,0.0,4.0,20661.0,6765.0,56183.0
Sahibganj,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,22.0,27.0,15.0,29.0,8.0,15.0,9.0,0.0,1.0,4.0,6.0,10.0,146.0
Sahibganj,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,84.0,148.0,122.0,107.0,235.0,104.0,129.0,52.0,46.0,57.0,58.0,50.0,1192.0
Sahibganj,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,66.0,94.0,93.0,149.0,95.0,47.0,39.0,44.0,32.0,22.0,12.0,16.0,709.0
Sahibganj,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,29.0,38.0,42.0,40.0,30.0,15.0,11.0,46.0,19.0,31.0,10.0,15.0,326.0
Sahibganj,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,13.3,Number of School children detected with Refractive errors,TOTAL,56.0,88.0,50.0,58.0,76.0,62.0,77.0,30.0,16.0,11.0,17.0,11.0,552.0
Sahibganj,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,25.0,31.0,0.0,10.0,22.0,28.0,0.0,87.0,203.0
Sahibganj,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,4.0,3.0,3.0,3.0,3.0,5.0,6.0,5.0,4.0,6.0,4.0,-1.0
Sahibganj,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,8.0,6.0,1.0,5.0,2.0,2.0,2.0,5.0,6.0,6.0,6.0,5.0,-1.0
Sahibganj,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,196.0,203.0,116.0,141.0,154.0,125.0,128.0,168.0,157.0,188.0,387.0,452.0,-1.0
Sahibganj,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,6.0,6.0,5.0,5.0,5.0,6.0,6.0,6.0,6.0,4.0,6.0,-1.0
Sahibganj,14.05,Number of RKS meetings held during the month,TOTAL,3.0,3.0,3.0,1.0,3.0,4.0,2.0,4.0,2.0,1.0,0.0,1.0,27.0
Sahibganj,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,13.0,14.0,9.0,11.0,8.0,9.0,6.0,5.0,6.0,7.0,7.0,6.0,-1.0
Sahibganj,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,24.0,35.0,27.0,22.0,95.0,83.0,140.0,186.0,86.0,127.0,132.0,139.0,1096.0
Sahibganj,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,3.0,3.0,6.0,6.0,5.0,2.0,3.0,3.0,3.0,3.0,2.0,-1.0
Sahibganj,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Sahibganj,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,150.0,155.0,210.0,293.0,254.0,299.0,359.0,232.0,184.0,166.0,128.0,197.0,2627.0
Sahibganj,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,248.0,477.0,417.0,407.0,566.0,584.0,563.0,431.0,364.0,408.0,468.0,471.0,5404.0
Sahibganj,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,116.0,219.0,211.0,284.0,275.0,321.0,404.0,254.0,170.0,155.0,111.0,217.0,2737.0
Sahibganj,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,582.0,1249.0,1123.0,1074.0,2233.0,1853.0,2062.0,1831.0,1611.0,1741.0,1484.0,1997.0,18840.0
Sahibganj,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,266.0,374.0,421.0,577.0,529.0,620.0,763.0,486.0,354.0,321.0,239.0,414.0,5364.0
Sahibganj,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,830.0,1726.0,1540.0,1481.0,2799.0,2437.0,2625.0,2262.0,1975.0,2149.0,1952.0,2468.0,24244.0
Sahibganj,14.10.2.a,Number of death cases of Inpatient males,TOTAL,12.0,12.0,13.0,11.0,13.0,17.0,10.0,10.0,17.0,11.0,7.0,7.0,140.0
Sahibganj,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5.0,8.0,15.0,8.0,11.0,16.0,19.0,13.0,12.0,10.0,6.0,12.0,135.0
Sahibganj,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,17.0,20.0,28.0,19.0,24.0,33.0,29.0,23.0,29.0,21.0,13.0,19.0,275.0
Sahibganj,14.11,In-Patient Head Count at midnight,TOTAL,1096.0,1083.0,1186.0,1312.0,2020.0,2052.0,2218.0,1651.0,1947.0,1959.0,1797.0,1868.0,20189.0
Sahibganj,14.12.1,OPD attendance (All),TOTAL,30266.0,39678.0,34949.0,44466.0,50507.0,44785.0,33669.0,29746.0,27387.0,28716.0,31094.0,33201.0,428464.0
Sahibganj,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,16.0,13.0,15.0,32.0,24.0,97.0,36.0,51.0,164.0,248.0,159.0,239.0,1094.0
Sahibganj,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Sahibganj,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,92.0,118.0,194.0,401.0,344.0,422.0,331.0,317.0,508.0,616.0,288.0,428.0,4059.0
Sahibganj,14.14.a,Number of patients given AYUSH treatment,TOTAL,167.0,366.0,284.0,328.0,292.0,351.0,369.0,408.0,480.0,323.0,382.0,379.0,4129.0
Sahibganj,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,267.0,273.0,252.0,224.0,247.0,225.0,175.0,251.0,184.0,308.0,368.0,306.0,3080.0
Sahibganj,14.14.c,Number of Adolescents counselled,TOTAL,1.0,0.0,0.0,0.0,0.0,9.0,75.0,52.0,73.0,0.0,31.0,56.0,297.0
Sahibganj,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,970.0,1237.0,1012.0,1055.0,916.0,1156.0,1859.0,1030.0,901.0,878.0,1435.0,1053.0,13502.0
Sahibganj,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,41.0,101.0,97.0,49.0,75.0,53.0,25.0,49.0,27.0,40.0,81.0,39.0,677.0
Sahibganj,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,145.0,182.0,152.0,135.0,162.0,136.0,53.0,120.0,128.0,82.0,182.0,201.0,1678.0
Sahibganj,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,8.0,1.0,2.0,3.0,2.0,1.0,0.0,2.0,0.0,6.0,3.0,29.0
Sahibganj,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,91.0,201.0,182.0,178.0,123.0,149.0,34.0,133.0,286.0,456.0,494.0,207.0,2534.0
Sahibganj,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,3.0,5.0,1.0,4.0,1.0,0.0,2.0,3.0,0.0,6.0,2.0,30.0
Sahibganj,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,154.0,141.0,156.0,183.0,170.0,296.0,137.0,140.0,138.0,121.0,249.0,217.0,2102.0
Sahibganj,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Sahibganj,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,390.0,524.0,490.0,496.0,455.0,581.0,224.0,393.0,552.0,659.0,925.0,625.0,6314.0
Sahibganj,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4.0,11.0,6.0,3.0,7.0,3.0,1.0,2.0,5.0,0.0,13.0,5.0,60.0
Sahibganj,15.2,Number of Widal tests conducted,Number tested,380.0,506.0,623.0,233.0,165.0,251.0,948.0,604.0,264.0,126.0,126.0,123.0,4349.0
Sahibganj,15.3.a,Number of VDRL tests conducted on males,Number tested,11.0,8.0,24.0,16.0,12.0,12.0,15.0,9.0,11.0,13.0,25.0,53.0,209.0
Sahibganj,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,13.0,23.0,36.0,51.0,30.0,23.0,31.0,36.0,32.0,67.0,54.0,78.0,474.0
Sahibganj,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,111.0,120.0,182.0,208.0,199.0,299.0,233.0,189.0,268.0,180.0,396.0,239.0,2624.0
Sahibganj,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,135.0,151.0,242.0,275.0,241.0,334.0,279.0,234.0,311.0,260.0,475.0,370.0,3307.0
Sahibganj,15.4.1,Number of blood smears examined for Malaria,TOTAL,1801.0,5231.0,8170.0,8213.0,6372.0,6117.0,7058.0,7324.0,4997.0,4192.0,4470.0,5044.0,68989.0
Sahibganj,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,22.0,58.0,49.0,73.0,74.0,70.0,62.0,123.0,81.0,29.0,25.0,42.0,708.0
Sahibganj,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,206.0,341.0,454.0,474.0,394.0,341.0,372.0,455.0,265.0,116.0,139.0,136.0,3693.0
Sahibganj,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,21490.0,21690.0,25260.0,12140.0,11800.0,19520.0,15400.0,20140.0,2580.0,12550.0,17100.0,11370.0,191040.0
Sahibganj,16.1.1,Stock position of DPT vaccines,2. Stocks Received,15000.0,20000.0,0.0,20000.0,20000.0,10000.0,15000.0,0.0,20000.0,20000.0,10000.0,10000.0,160000.0
Sahibganj,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,14800.0,16430.0,13120.0,20340.0,12280.0,14120.0,10260.0,17560.0,10030.0,15450.0,15730.0,10390.0,170510.0
Sahibganj,16.1.1,Stock position of DPT vaccines,5. Total Stock,21690.0,25260.0,12140.0,11800.0,19520.0,15400.0,20140.0,2580.0,12550.0,17100.0,11370.0,10980.0,180530.0
Sahibganj,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Sahibganj,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Sahibganj,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Sahibganj,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Sahibganj,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,45660.0,49900.0,25720.0,39080.0,19820.0,19100.0,17900.0,39080.0,9440.0,220.0,11900.0,120.0,277940.0
Sahibganj,16.1.2,Stock position of OPV vaccines,2. Stocks Received,30000.0,0.0,40000.0,14000.0,20000.0,20000.0,40000.0,0.0,0.0,20000.0,2280.0,0.0,186280.0
Sahibganj,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,25760.0,24180.0,26640.0,33260.0,20720.0,21200.0,18820.0,29640.0,9220.0,8320.0,14060.0,120.0,231940.0
Sahibganj,16.1.2,Stock position of OPV vaccines,5. Total Stock,49900.0,25720.0,39080.0,19820.0,19100.0,17900.0,39080.0,9440.0,220.0,11900.0,120.0,0.0,232280.0
Sahibganj,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,20380.0,23350.0,16390.0,4100.0,17240.0,14550.0,14810.0,18460.0,5250.0,15950.0,12660.0,9390.0,172530.0
Sahibganj,16.1.3,Stock position of TT vaccines,2. Stocks Received,15000.0,5000.0,0.0,30000.0,10000.0,10000.0,15000.0,0.0,20000.0,10000.0,10000.0,10000.0,135000.0
Sahibganj,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.1.3,Stock position of TT vaccines,4. Stock Distributed,12030.0,11960.0,12290.0,16860.0,12690.0,9740.0,11350.0,13210.0,9300.0,13290.0,13270.0,10790.0,146780.0
Sahibganj,16.1.3,Stock position of TT vaccines,5. Total Stock,23350.0,16390.0,4100.0,17240.0,14550.0,14810.0,18460.0,5250.0,15950.0,12660.0,9390.0,8600.0,160750.0
Sahibganj,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.1.4,Stock position of DT vaccines,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,19920.0,23960.0,13690.0,2970.0,2970.0,19340.0,16850.0,6000.0,1000.0,10360.0,140.0,190.0,117390.0
Sahibganj,16.1.5,Stock position of BCG vaccines,2. Stocks Received,15000.0,0.0,0.0,1660.0,24000.0,10000.0,0.0,0.0,20000.0,0.0,310.0,7780.0,78750.0
Sahibganj,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,10960.0,10270.0,10720.0,1660.0,7630.0,12490.0,10850.0,5000.0,10640.0,10220.0,260.0,7550.0,98250.0
Sahibganj,16.1.5,Stock position of BCG vaccines,5. Total Stock,23960.0,13690.0,2970.0,2970.0,19340.0,16850.0,6000.0,1000.0,10360.0,140.0,190.0,420.0,97890.0
Sahibganj,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,11460.0,7530.0,6990.0,835.0,579.0,10290.0,5105.0,10300.0,4225.0,3830.0,2280.0,9415.0,72839.0
Sahibganj,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2500.0,5000.0,0.0,9000.0,12500.0,0.0,10000.0,0.0,2500.0,0.0,10000.0,0.0,51500.0
Sahibganj,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,6430.0,5540.0,6155.0,9256.0,2789.0,5185.0,4805.0,6075.0,2895.0,1550.0,2865.0,1660.0,55205.0
Sahibganj,16.1.6,Stock position of Measles vaccines,5. Total Stock,7530.0,6990.0,835.0,579.0,10290.0,5105.0,10300.0,4225.0,3830.0,2280.0,9415.0,7755.0,69134.0
Sahibganj,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,0.0,0.0,0.0,0.0
Sahibganj,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Sahibganj,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sahibganj,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sahibganj,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,0.0,28790.0,22580.0,51370.0
Sahibganj,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,34600.0,0.0,0.0,34600.0
Sahibganj,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Sahibganj,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,5810.0,6210.0,4780.0,16800.0
Sahibganj,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28790.0,22580.0,17800.0,69170.0
Sahibganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,70.0,70.0,70.0,5070.0,4690.0,8740.0,7540.0,7540.0,7540.0,7540.0,2370.0,2370.0,53610.0
Sahibganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,5000.0,0.0,4050.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9050.0
Sahibganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,380.0,0.0,1200.0,0.0,0.0,0.0,5170.0,0.0,0.0,6750.0
Sahibganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,70.0,70.0,5070.0,4690.0,8740.0,7540.0,7540.0,7540.0,7540.0,2370.0,2370.0,2370.0,55910.0
Sahibganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,59950.0,59950.0,59950.0,59950.0,0.0,94000.0,52000.0,40000.0,40000.0,40000.0,22680.0,57680.0,586160.0
Sahibganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,50400.0,35000.0,0.0,185400.0
Sahibganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,59950.0,6000.0,42000.0,12000.0,0.0,0.0,67720.0,0.0,0.0,187670.0
Sahibganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,59950.0,59950.0,59950.0,0.0,94000.0,52000.0,40000.0,40000.0,40000.0,22680.0,57680.0,57680.0,583890.0
Sahibganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,9850.0,9850.0,9850.0,42607.0,9900.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,87057.0
Sahibganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,32757.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,37757.0
Sahibganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,32707.0,9900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,42607.0
Sahibganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,9850.0,9850.0,42607.0,9900.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,5000.0,82207.0
Sahibganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,3000.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,15000.0
Sahibganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Sahibganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,2000.0,14000.0
Sahibganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sahibganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sahibganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sahibganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sahibganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Sahibganj,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Sahibganj,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Sahibganj,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Sahibganj,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Sahibganj,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Sahibganj,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Sahibganj,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Sahibganj,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Sahibganj,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Sahibganj,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Sahibganj,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Sahibganj,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sahibganj,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Sahibganj,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sahibganj,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sahibganj,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Sahibganj,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Sahibganj,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Sahibganj,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Sahibganj,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Sahibganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Sahibganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Sahibganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Sahibganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Sahibganj,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Sahibganj,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Sahibganj,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Sahibganj,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Sahibganj,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Sahibganj,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Sahibganj,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,400.0,400.0,400.0,400.0,300.0,200.0,200.0,200.0,200.0,200.0,,,2900.0
Sahibganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Sahibganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Sahibganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,100.0,300.0,0.0,0.0,0.0,0.0,0.0,,,400.0
Sahibganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,400.0,400.0,400.0,300.0,0.0,200.0,200.0,200.0,200.0,200.0,0.0,0.0,2500.0
Sahibganj,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,435.0,0.0,0.0,0.0,0.0,270.0,0.0,705.0
Sahibganj,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,435.0,0.0,0.0,0.0,0.0,3276.0,0.0,0.0,3711.0
Sahibganj,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,435.0,0.0,0.0,0.0,3006.0,270.0,0.0,3711.0
Sahibganj,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,435.0,0.0,0.0,0.0,0.0,270.0,0.0,0.0,705.0
Sahibganj,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,3000.0,3000.0,2800.0,2800.0,2200.0,1050.0,1050.0,1050.0,1050.0,1050.0,1050.0,1050.0,21150.0
Sahibganj,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,200.0,0.0,600.0,1150.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1950.0
Sahibganj,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,3000.0,2800.0,2800.0,2200.0,1050.0,1050.0,1050.0,1050.0,1050.0,1050.0,1050.0,1050.0,19200.0
Sahibganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2000.0,3000.0,0.0,0.0,6550.0,5930.0,4260.0,1860.0,660.0,14.0,1302.0,1266.0,26842.0
Sahibganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,0.0,0.0,7000.0,0.0,0.0,0.0,0.0,0.0,1600.0,0.0,2334.0,13934.0
Sahibganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2000.0,3000.0,0.0,450.0,620.0,1670.0,2400.0,1200.0,646.0,312.0,36.0,1476.0,13810.0
Sahibganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3000.0,0.0,0.0,6550.0,5930.0,4260.0,1860.0,660.0,14.0,1302.0,1266.0,2124.0,26966.0
Sahibganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,28975.0,26675.0,24175.0,175.0,79875.0,3875.0,3575.0,975.0,675.0,17575.0,2175.0,8875.0,197600.0
Sahibganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,24000.0,24000.0,0.0,80000.0,0.0,0.0,0.0,0.0,96000.0,0.0,12000.0,16000.0,252000.0
Sahibganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,26300.0,26500.0,24000.0,300.0,76000.0,300.0,2600.0,300.0,79100.0,15400.0,5300.0,2950.0,259050.0
Sahibganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,26675.0,24175.0,175.0,79875.0,3875.0,3575.0,975.0,675.0,17575.0,2175.0,8875.0,21925.0,190550.0
Sahibganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4860.0,2560.0,160.0,160.0,160.0,160.0,160.0,60.0,60.0,17130.0,4430.0,600.0,30500.0
Sahibganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,58240.0,0.0,0.0,0.0,60240.0
Sahibganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sahibganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4300.0,2400.0,0.0,0.0,0.0,0.0,100.0,0.0,41170.0,12700.0,3830.0,400.0,64900.0
Sahibganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2560.0,160.0,160.0,160.0,160.0,160.0,60.0,60.0,17130.0,4430.0,600.0,200.0,25840.0
Sahibganj,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,1.0,1.0,,1.0,,,,,,,4.0
Sahibganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sahibganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,1.0,,,,,1.0,,,,,2.0
Sahibganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,,,,1.0,,,,,2.0
Sahibganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sahibganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sahibganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Sahibganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,1.0,,1.0
Sahibganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Sahibganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,1.0,,,,1.0,,2.0
Sahibganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,,,,,,,1.0,,1.0,,3.0
Sahibganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,2.0,2.0,,,,1.0,5.0
Sahibganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,,,,,2.0,2.0,1.0,,1.0,1.0,8.0
Sahibganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,1.0,,,2.0,,,,,3.0
Sahibganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,1.0,2.0,,,,,4.0
Sahibganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,,1.0,,1.0,4.0,,,,,7.0
Sahibganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sahibganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,1.0,,2.0,,,,3.0
Sahibganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,1.0,,2.0,,,,3.0
Sahibganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,,1.0,2.0,,,4.0
Sahibganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,2.0,,1.0,,1.0,2.0,2.0,2.0,,,,,10.0
Sahibganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,,2.0,,1.0,2.0,2.0,2.0,1.0,2.0,,,14.0
Sahibganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sahibganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sahibganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sahibganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,1.0,,1.0,5.0,2.0,,9.0
Sahibganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,1.0,,8.0
Sahibganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,1.0,1.0,1.0,1.0,1.0,2.0,,1.0,5.0,3.0,,17.0
Sahibganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Sahibganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,1.0,,,1.0,,2.0
Sahibganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,2.0,,,,,2.0
Sahibganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,3.0,,,1.0,,4.0
Sahibganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Sahibganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,2.0,1.0,1.0,1.0,1.0,2.0,8.0
Sahibganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Sahibganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,2.0,1.0,1.0,1.0,1.0,3.0,9.0
Sahibganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,1.0,,1.0,,,,,,1.0,,3.0
Sahibganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,1.0,3.0,,3.0,2.0,1.0,2.0,,1.0,2.0,16.0
Sahibganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,2.0,1.0,,,1.0,4.0,3.0,1.0,1.0,14.0
Sahibganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,3.0,5.0,2.0,3.0,2.0,2.0,6.0,3.0,3.0,3.0,33.0
Sahibganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Sahibganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,1.0,2.0,,2.0,,2.0,,,,,,7.0
Sahibganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Sahibganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,3.0,,2.0,,2.0,,,,,,8.0
Sahibganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,1.0,3.0,3.0,1.0,1.0,,,,10.0
Sahibganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,,1.0,2.0,,2.0,3.0,5.0,2.0,,2.0,3.0,22.0
Sahibganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,1.0,,,1.0,,,,,3.0,1.0,,7.0
Sahibganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,3.0,1.0,1.0,3.0,2.0,5.0,6.0,6.0,3.0,3.0,3.0,3.0,39.0
Sahibganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sahibganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Sahibganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sahibganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Sahibganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Sahibganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,1.0,,,1.0,1.0,,3.0,,2.0,1.0,9.0
Sahibganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,1.0,,,1.0,,,3.0,,1.0,2.0,8.0
Sahibganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,3.0,,,2.0,1.0,,6.0,,3.0,3.0,18.0
Sahibganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Sahibganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,2.0,,3.0,,4.0,3.0,,,1.0,1.0,14.0
Sahibganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,,3.0,4.0,1.0,1.0,1.0,,1.0,12.0
Sahibganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,2.0,,3.0,3.0,8.0,4.0,1.0,1.0,1.0,2.0,26.0
Sahibganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sahibganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,1.0,1.0,2.0
Sahibganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sahibganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,1.0,1.0,2.0
Sahibganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sahibganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,1.0,,,,,3.0,,4.0
Sahibganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sahibganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,1.0,,,,,3.0,,4.0
Sahibganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sahibganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,2.0,,,,1.0,,,,,1.0,4.0
Sahibganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sahibganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,2.0,,,,1.0,,,,,1.0,4.0
Sahibganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sahibganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,1.0,,1.0,2.0,,,1.0,,5.0
Sahibganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sahibganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,1.0,,1.0,2.0,,,1.0,,5.0
Sahibganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sahibganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Sahibganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sahibganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,1.0,,,,,,1.0
Sahibganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sahibganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,4.0,,2.0,,1.0,,1.0,8.0
Sahibganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sahibganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,4.0,,2.0,,1.0,,1.0,8.0
Sahibganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Sahibganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,2.0,,,1.0,1.0,1.0,4.0,9.0
Sahibganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Sahibganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,2.0,,,1.0,1.0,2.0,4.0,10.0
Sahibganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Sahibganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,3.0,,,,,,3.0
Sahibganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Sahibganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,3.0,,,,,,3.0
Sahibganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,,,,1.0,,,,,2.0
Sahibganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,3.0,,,1.0,,,,1.0,5.0
Sahibganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Sahibganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,3.0,,,2.0,,,,1.0,7.0
Sahibganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Sahibganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,,,1.0,1.0,3.0,2.0,5.0,9.0,6.0,3.0,31.0
Sahibganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,1.0,,,,1.0,1.0,,5.0,,1.0,9.0
Sahibganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,1.0,,1.0,1.0,5.0,3.0,5.0,14.0,6.0,4.0,41.0
Sahibganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Sahibganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,,1.0,2.0,,3.0,2.0,1.0,4.0,3.0,3.0,20.0
Sahibganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,1.0,,1.0,2.0,1.0,6.0,2.0,,13.0
Sahibganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,,,1.0,3.0,,5.0,4.0,2.0,10.0,5.0,3.0,34.0
Sahibganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Sahibganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,4.0,5.0,1.0,,1.0,3.0,4.0,2.0,1.0,3.0,2.0,7.0,33.0
Sahibganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,3.0,,,,,,2.0,1.0,2.0,3.0,2.0,1.0,14.0
Sahibganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,8.0,5.0,1.0,,1.0,3.0,6.0,3.0,3.0,6.0,4.0,8.0,48.0
Saraikela,1.1,Total number of pregnant women Registered for ANC,TOTAL,2145.0,2240.0,2361.0,2323.0,2099.0,2102.0,2172.0,2073.0,2195.0,2112.0,2096.0,2219.0,26137.0
Saraikela,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,553.0,483.0,505.0,466.0,405.0,495.0,632.0,536.0,471.0,592.0,442.0,519.0,6099.0
Saraikela,1.2,Number of Pregnant women registered under JSY,TOTAL,2045.0,2135.0,2173.0,2114.0,1834.0,2025.0,1958.0,1974.0,2065.0,2002.0,1901.0,2164.0,24390.0
Saraikela,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,984.0,1205.0,1338.0,1352.0,1374.0,1390.0,1485.0,1554.0,1326.0,1399.0,1356.0,1487.0,16250.0
Saraikela,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1957.0,2024.0,1906.0,1960.0,1705.0,1733.0,1752.0,1723.0,1779.0,1759.0,1632.0,1738.0,21668.0
Saraikela,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1182.0,1566.0,1807.0,1775.0,1912.0,1814.0,1804.0,1634.0,1678.0,1834.0,1759.0,1986.0,20751.0
Saraikela,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,617.0,1083.0,1025.0,570.0,69.0,181.0,1214.0,1333.0,793.0,812.0,2420.0,1645.0,11762.0
Saraikela,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,30.0,37.0,65.0,49.0,105.0,53.0,65.0,90.0,53.0,54.0,105.0,87.0,793.0
Saraikela,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,1.0,5.0,9.0
Saraikela,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,175.0,182.0,207.0,273.0,207.0,231.0,261.0,283.0,284.0,299.0,343.0,312.0,3057.0
Saraikela,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,1.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Saraikela,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Saraikela,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,235.0,102.0,123.0,135.0,149.0,102.0,108.0,107.0,133.0,149.0,99.0,108.0,1550.0
Saraikela,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,570.0,609.0,659.0,754.0,725.0,746.0,719.0,690.0,662.0,619.0,493.0,580.0,7826.0
Saraikela,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,805.0,711.0,782.0,889.0,874.0,848.0,827.0,797.0,795.0,768.0,592.0,688.0,9376.0
Saraikela,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,693.0,568.0,610.0,693.0,647.0,681.0,665.0,674.0,642.0,580.0,450.0,586.0,7489.0
Saraikela,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,148.0,193.0,216.0,195.0,121.0,116.0,84.0,120.0,109.0,70.0,72.0,67.0,1511.0
Saraikela,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,877.0,788.0,851.0,749.0,802.0,731.0,1005.0,1298.0,975.0,1056.0,876.0,987.0,10995.0
Saraikela,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,872.0,768.0,785.0,710.0,795.0,661.0,879.0,1269.0,886.0,1055.0,775.0,888.0,10343.0
Saraikela,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,831.0,702.0,738.0,674.0,767.0,782.0,905.0,933.0,866.0,880.0,938.0,1051.0,10067.0
Saraikela,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,555.0,644.0,637.0,618.0,636.0,676.0,738.0,811.0,814.0,854.0,735.0,776.0,8494.0
Saraikela,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,1.0,0.0,7.0,6.0,13.0,4.0,2.0,0.0,6.0,12.0,6.0,0.0,57.0
Saraikela,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,189.0,195.0,183.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,567.0
Saraikela,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,,0.0
Saraikela,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saraikela,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,0.0,7.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Saraikela,4.1.1.a,Number of male live births,TOTAL,881.0,812.0,973.0,1035.0,1049.0,798.0,929.0,1158.0,890.0,959.0,777.0,883.0,11144.0
Saraikela,4.1.1.b,Number of female live births,TOTAL,789.0,672.0,876.0,886.0,932.0,782.0,897.0,1039.0,874.0,949.0,773.0,801.0,10270.0
Saraikela,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1670.0,1484.0,1849.0,1921.0,1981.0,1580.0,1826.0,2197.0,1764.0,1908.0,1550.0,1684.0,21414.0
Saraikela,4.1.2,Number of still births,TOTAL,13.0,17.0,35.0,36.0,25.0,44.0,22.0,25.0,21.0,14.0,43.0,33.0,328.0
Saraikela,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,35.0,14.0,40.0,41.0,40.0,42.0,37.0,46.0,33.0,46.0,47.0,51.0,472.0
Saraikela,4.2.1,Number of Newborns weighed at birth,TOTAL,1310.0,1268.0,1734.0,1753.0,1840.0,1474.0,1745.0,2079.0,1661.0,1776.0,1416.0,1609.0,19665.0
Saraikela,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,63.0,62.0,116.0,111.0,105.0,82.0,98.0,439.0,91.0,138.0,139.0,78.0,1522.0
Saraikela,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1636.0,1427.0,1783.0,1816.0,1927.0,1524.0,1768.0,1858.0,1726.0,1896.0,1510.0,1633.0,20504.0
Saraikela,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Saraikela,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,14.0,0.0,0.0,0.0,0.0,1.0,0.0,3.0,0.0,0.0,18.0
Saraikela,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,18.0,16.0,0.0,0.0,0.0,18.0,0.0,0.0,15.0,30.0,97.0
Saraikela,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saraikela,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,32.0,17.0,1.0,0.0,0.0,19.0,0.0,3.0,15.0,30.0,117.0
Saraikela,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,157.0,142.0,140.0,439.0
Saraikela,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,14.0,32.0,66.0
Saraikela,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,32.0,16.0,0.0,0.0,0.0,13.0,0.0,251.0,227.0,222.0,761.0
Saraikela,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1153.0,911.0,1345.0,1318.0,1388.0,1040.0,1326.0,1712.0,1222.0,1276.0,1109.0,1310.0,15110.0
Saraikela,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,756.0,645.0,893.0,889.0,946.0,864.0,1020.0,939.0,1011.0,1046.0,854.0,835.0,10698.0
Saraikela,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Saraikela,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,1.0,1.0,0.0,1.0,0.0,2.0,0.0,2.0,0.0,0.0,7.0
Saraikela,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,1.0,0.0,3.0,1.0,0.0,0.0,1.0,1.0,0.0,7.0
Saraikela,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,1.0,2.0,0.0,4.0,1.0,2.0,0.0,3.0,1.0,0.0,14.0
Saraikela,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Saraikela,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,73.0,47.0,178.0,91.0,119.0,82.0,95.0,74.0,90.0,124.0,95.0,136.0,1204.0
Saraikela,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,70.0,35.0,127.0,106.0,144.0,126.0,112.0,92.0,126.0,102.0,94.0,109.0,1243.0
Saraikela,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,143.0,82.0,305.0,197.0,263.0,208.0,207.0,166.0,216.0,226.0,189.0,245.0,2447.0
Saraikela,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,3.0,7.0,5.0,8.0,0.0,26.0,0.0,0.0,1.0,0.0,50.0
Saraikela,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,2.0,0.0,7.0,0.0,0.0,1.0,0.0,5.0,2.0,4.0,0.0,21.0
Saraikela,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,33.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,33.0
Saraikela,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saraikela,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,2.0,3.0,47.0,5.0,8.0,1.0,26.0,5.0,2.0,5.0,0.0,104.0
Saraikela,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,11.0,0.0,1.0,13.0,0.0,0.0,2.0,131.0,8.0,19.0,63.0,25.0,273.0
Saraikela,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,1.0,3.0,63.0,4.0,3.0,0.0,8.0,7.0,82.0,207.0,96.0,474.0
Saraikela,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,143.0,0.0,,0.0,0.0,0.0,110.0,285.0,19.0,557.0
Saraikela,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saraikela,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,11.0,1.0,4.0,219.0,4.0,3.0,2.0,139.0,15.0,211.0,555.0,140.0,1304.0
Saraikela,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,2.0,0.0,41.0,9.0,4.0,4.0,125.0,12.0,0.0,67.0,33.0,297.0
Saraikela,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,59.0,251.0,293.0,112.0,718.0
Saraikela,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,14.0,0.0,,0.0,0.0,0.0,3.0,27.0,6.0,50.0
Saraikela,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saraikela,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,3.0,2.0,0.0,55.0,9.0,4.0,4.0,125.0,71.0,254.0,387.0,151.0,1065.0
Saraikela,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0,0.0,0.0,17.0
Saraikela,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,4.0
Saraikela,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,14.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,14.0
Saraikela,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saraikela,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,14.0,0.0,0.0,0.0,4.0,0.0,17.0,0.0,0.0,35.0
Saraikela,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,60.0,93.0,73.0,756.0,133.0,125.0,145.0,78.0,60.0,106.0,207.0,205.0,2041.0
Saraikela,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,2.0,11.0,32.0,131.0,49.0,36.0,33.0,20.0,16.0,7.0,38.0,23.0,398.0
Saraikela,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,8.0,38.0,16.0,238.0,32.0,16.0,6.0,4.0,54.0,2.0,12.0,23.0,449.0
Saraikela,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Saraikela,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saraikela,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,70.0,142.0,121.0,1126.0,214.0,177.0,184.0,102.0,130.0,115.0,258.0,251.0,2890.0
Saraikela,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Saraikela,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,9.06,Number of IUCD removals,TOTAL,75.0,60.0,95.0,194.0,90.0,114.0,80.0,58.0,57.0,51.0,96.0,99.0,1069.0
Saraikela,9.07,Number of Oral Pills cycles distributed,TOTAL,1294.0,1020.0,1082.0,3184.0,1774.0,1554.0,1526.0,1162.0,1515.0,859.0,1022.0,737.0,16729.0
Saraikela,9.08,Number of Condom pieces distributed,TOTAL,7445.0,7021.0,5622.0,32594.0,8479.0,7329.0,9025.0,8522.0,5973.0,2494.0,3488.0,2294.0,100286.0
Saraikela,9.09,Number of Centchroman (weekly) pills given,TOTAL,109.0,110.0,65.0,162.0,448.0,125.0,236.0,98.0,66.0,31.0,20.0,27.0,1497.0
Saraikela,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,73.0,25.0,22.0,85.0,65.0,139.0,80.0,134.0,102.0,145.0,109.0,213.0,1192.0
Saraikela,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,1.0,2.0,24.0,0.0,1.0,4.0,0.0,0.0,0.0,32.0
Saraikela,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,38.0,15.0,25.0,1.0,2.0,7.0,7.0,29.0,0.0,125.0
Saraikela,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,4.0,0.0,0.0,0.0,6.0
Saraikela,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,6.0,0.0,2.0,9.0,1.0,4.0,0.0,1.0,0.0,23.0
Saraikela,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,2.0,5.0,6.0,4.0,4.0,8.0,7.0,4.0,6.0,5.0,8.0,-1.0
Saraikela,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1329.0,1835.0,1933.0,2277.0,2101.0,1840.0,2045.0,2094.0,1939.0,1885.0,1132.0,1799.0,22209.0
Saraikela,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1265.0,1782.0,1757.0,1995.0,1965.0,1995.0,2142.0,1928.0,1950.0,2149.0,2033.0,1926.0,22887.0
Saraikela,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1446.0,1673.0,1810.0,1762.0,1844.0,1891.0,2149.0,2036.0,1832.0,1949.0,2049.0,2139.0,22580.0
Saraikela,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1545.0,1816.0,1730.0,1764.0,1732.0,1789.0,1955.0,2059.0,1914.0,1857.0,1842.0,2370.0,22373.0
Saraikela,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Saraikela,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Saraikela,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Saraikela,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,684.0,1009.0,960.0,1128.0,990.0,841.0,1167.0,1132.0,870.0,970.0,743.0,687.0,11181.0
Saraikela,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1167.0,1808.0,1748.0,1981.0,1976.0,1806.0,2160.0,1809.0,1652.0,1852.0,1835.0,1407.0,21201.0
Saraikela,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1364.0,1700.0,1802.0,1772.0,1824.0,1741.0,2143.0,1881.0,1594.0,1782.0,1907.0,1498.0,21008.0
Saraikela,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1423.0,1833.0,1746.0,1800.0,1743.0,1645.0,1941.0,1859.0,1670.0,1684.0,1674.0,1655.0,20673.0
Saraikela,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,56.0,0.0,19.0,11.0,0.0,65.0,115.0,146.0,109.0,130.0,112.0,5.0,768.0
Saraikela,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,110.0,115.0,164.0,92.0,94.0,77.0,112.0,144.0,90.0,128.0,1393.0,1551.0,4070.0
Saraikela,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,19.0,0.0,21.0,3.0,0.0,10.0,0.0,7.0,0.0,0.0,131.0,866.0,1057.0
Saraikela,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,17.0,0.0,25.0,27.0,0.0,6.0,10.0,31.0,0.0,6.0,19.0,49.0,190.0
Saraikela,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2456.0,2498.0,2170.0,2158.0,2181.0,1854.0,2023.0,1589.0,3002.0,1744.0,1777.0,1980.0,25432.0
Saraikela,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,19.0,2.0,0.0,11.0,0.0,11.0,0.0,17.0,0.0,0.0,60.0
Saraikela,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Saraikela,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1249.0,1295.0,1099.0,1082.0,1113.0,928.0,1014.0,795.0,1572.0,888.0,898.0,1011.0,12944.0
Saraikela,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1142.0,1195.0,1047.0,1049.0,1046.0,901.0,999.0,785.0,1424.0,800.0,838.0,944.0,12170.0
Saraikela,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2391.0,2490.0,2146.0,2131.0,2159.0,1829.0,2013.0,1580.0,2996.0,1688.0,1736.0,1955.0,25114.0
Saraikela,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1260.0,1682.0,1652.0,1551.0,1566.0,1375.0,1483.0,1469.0,1257.0,1626.0,1693.0,1955.0,18569.0
Saraikela,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1182.0,1679.0,1666.0,1518.0,1523.0,1259.0,1476.0,1322.0,1093.0,1485.0,1506.0,1348.0,17057.0
Saraikela,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,165.0,224.0,166.0,166.0,140.0,100.0,128.0,123.0,112.0,131.0,99.0,137.0,1691.0
Saraikela,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,163.0,211.0,182.0,196.0,140.0,100.0,100.0,118.0,102.0,104.0,106.0,152.0,1674.0
Saraikela,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,328.0,435.0,348.0,362.0,280.0,200.0,228.0,241.0,214.0,235.0,205.0,289.0,3365.0
Saraikela,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,97.0,1.0,89.0,116.0,149.0,113.0,116.0,92.0,69.0,133.0,84.0,168.0,1227.0
Saraikela,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,962.0,791.0,895.0,896.0,945.0,917.0,956.0,916.0,841.0,895.0,972.0,939.0,10925.0
Saraikela,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,878.0,962.0,990.0,971.0,954.0,920.0,1190.0,914.0,944.0,878.0,926.0,976.0,11503.0
Saraikela,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,19.0,29.0,39.0,25.0,20.0,16.0,26.0,23.0,22.0,24.0,19.0,32.0,294.0
Saraikela,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,3.0,6.0,11.0,20.0,21.0,16.0,11.0,0.0,3.0,19.0,17.0,127.0
Saraikela,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1218.0,1269.0,1307.0,1284.0,1276.0,1282.0,1294.0,1254.0,1295.0,1289.0,1311.0,1329.0,15408.0
Saraikela,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1168.0,1240.0,1265.0,1270.0,1245.0,1274.0,1276.0,1217.0,1274.0,1250.0,1230.0,1313.0,15022.0
Saraikela,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1057.0,1152.0,1160.0,1168.0,1151.0,1180.0,1191.0,1143.0,1207.0,1078.0,1093.0,1151.0,13731.0
Saraikela,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1412.0,1559.0,873.0,1464.0,4042.0,1922.0,1748.0,1400.0,1147.0,1325.0,2536.0,2012.0,21440.0
Saraikela,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,829.0,463.0,268.0,1285.0,9389.0,4496.0,556.0,429.0,273.0,208.0,22699.0,2174.0,43069.0
Saraikela,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,668.0,168.0,60.0,947.0,9787.0,5162.0,367.0,312.0,173.0,147.0,19364.0,1909.0,39064.0
Saraikela,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,23.0
Saraikela,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Saraikela,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,3.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
Saraikela,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,21.0,15.0,56.0,80.0,75.0,40.0,32.0,15.0,11.0,9.0,10.0,37.0,401.0
Saraikela,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,206.0,120.0,156.0,335.0,337.0,330.0,255.0,165.0,145.0,122.0,153.0,119.0,2443.0
Saraikela,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,53.0,42.0,127.0,618.0,636.0,117.0,145.0,96.0,72.0,70.0,105.0,79.0,2160.0
Saraikela,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,4.0,0.0,0.0,2.0,17.0,0.0,0.0,0.0,4.0,2.0,29.0
Saraikela,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1115.0,1115.0
Saraikela,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1115.0,1115.0
Saraikela,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,190.0,190.0
Saraikela,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,2.0,2.0,2.0,2.0,2.0,3.0,2.0,5.0,5.0,4.0,2.0,-1.0
Saraikela,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,2.0,5.0,5.0,4.0,4.0,5.0,6.0,6.0,5.0,5.0,4.0,-1.0
Saraikela,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,588.0,817.0,659.0,745.0,894.0,872.0,794.0,800.0,957.0,926.0,935.0,967.0,-1.0
Saraikela,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,6.0,6.0,5.0,6.0,5.0,6.0,4.0,7.0,8.0,5.0,6.0,-1.0
Saraikela,14.05,Number of RKS meetings held during the month,TOTAL,9.0,5.0,8.0,20.0,16.0,14.0,16.0,16.0,12.0,8.0,17.0,12.0,153.0
Saraikela,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,7.0,7.0,9.0,10.0,9.0,7.0,11.0,10.0,12.0,11.0,7.0,10.0,-1.0
Saraikela,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,23.0,46.0,33.0,55.0,56.0,49.0,75.0,60.0,73.0,51.0,65.0,48.0,634.0
Saraikela,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,3.0,3.0,2.0,1.0,-1.0
Saraikela,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,1.0,2.0,2.0,1.0,2.0,1.0,1.0,0.0,0.0,0.0,1.0,-1.0
Saraikela,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2.0,4.0,50.0,211.0,4.0,2.0,4.0,3.0,130.0,12.0,6.0,10.0,438.0
Saraikela,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,239.0,253.0,12.0,32.0,1565.0,77.0,89.0,82.0,15.0,8.0,6.0,5.0,2383.0
Saraikela,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,4.0,8.0,39.0,311.0,10.0,5.0,8.0,5.0,201.0,13.0,7.0,8.0,619.0
Saraikela,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,475.0,401.0,177.0,242.0,1242.0,269.0,288.0,331.0,251.0,240.0,397.0,208.0,4521.0
Saraikela,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,6.0,12.0,89.0,522.0,14.0,7.0,12.0,8.0,331.0,25.0,13.0,18.0,1057.0
Saraikela,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,714.0,654.0,189.0,274.0,2807.0,346.0,377.0,413.0,266.0,248.0,403.0,213.0,6904.0
Saraikela,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,0.0,3.0,4.0,4.0,0.0,0.0,2.0,2.0,0.0,0.0,1.0,17.0
Saraikela,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,2.0,0.0,2.0,0.0,7.0
Saraikela,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,1.0,0.0,3.0,4.0,4.0,3.0,0.0,2.0,4.0,0.0,2.0,1.0,24.0
Saraikela,14.11,In-Patient Head Count at midnight,TOTAL,209.0,203.0,569.0,736.0,881.0,304.0,675.0,584.0,528.0,470.0,545.0,510.0,6214.0
Saraikela,14.12.1,OPD attendance (All),TOTAL,22582.0,21751.0,23033.0,31275.0,27427.0,27555.0,26494.0,33126.0,22185.0,23344.0,23967.0,23083.0,305822.0
Saraikela,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,67.0,0.0,0.0,0.0,0.0,67.0
Saraikela,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Saraikela,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,0.0,9.0,6.0,13.0,12.0,15.0,18.0,86.0,76.0,73.0,56.0,51.0,415.0
Saraikela,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,2.0,2.0,2.0,1.0,0.0,0.0,8.0
Saraikela,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,13.0,65.0,71.0,41.0,0.0,0.0,191.0
Saraikela,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,2.0,1.0,1.0,0.0,0.0,0.0,5.0
Saraikela,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,950.0,865.0,973.0,1336.0,1063.0,1193.0,4548.0,2914.0,1098.0,1397.0,1527.0,1285.0,19149.0
Saraikela,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,33.0,35.0,32.0,51.0,44.0,22.0,62.0,28.0,31.0,22.0,28.0,30.0,418.0
Saraikela,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,110.0,8.0,133.0,22.0,134.0,129.0,71.0,118.0,104.0,143.0,309.0,280.0,1561.0
Saraikela,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,27.0,10.0,100.0,16.0,93.0,40.0,0.0,10.0,12.0,0.0,0.0,308.0
Saraikela,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,49.0,0.0,116.0,147.0,266.0,107.0,148.0,40.0,132.0,160.0,180.0,92.0,1437.0
Saraikela,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,26.0,12.0,53.0,17.0,67.0,11.0,0.0,11.0,0.0,0.0,0.0,197.0
Saraikela,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,142.0,16.0,173.0,71.0,42.0,85.0,124.0,108.0,128.0,128.0,287.0,188.0,1492.0
Saraikela,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,26.0,23.0,116.0,59.0,12.0,42.0,0.0,45.0,41.0,0.0,0.0,364.0
Saraikela,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,301.0,24.0,422.0,240.0,442.0,321.0,343.0,266.0,364.0,431.0,776.0,560.0,4490.0
Saraikela,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,79.0,45.0,269.0,92.0,172.0,93.0,0.0,66.0,53.0,0.0,0.0,869.0
Saraikela,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,2.0,17.0,21.0,15.0,2.0,22.0,42.0,69.0,60.0,68.0,318.0
Saraikela,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,2.0,0.0,2.0,46.0,69.0,4.0,3.0,36.0,24.0,48.0,59.0,52.0,345.0
Saraikela,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,12.0,10.0,12.0,0.0,0.0,54.0,0.0,24.0,87.0,23.0,30.0,28.0,280.0
Saraikela,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,14.0,10.0,16.0,63.0,90.0,73.0,5.0,82.0,153.0,140.0,149.0,148.0,943.0
Saraikela,15.4.1,Number of blood smears examined for Malaria,TOTAL,5026.0,5063.0,5494.0,6002.0,5425.0,5376.0,4395.0,4258.0,4861.0,4702.0,5878.0,5818.0,62298.0
Saraikela,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,51.0,60.0,55.0,32.0,44.0,57.0,27.0,33.0,46.0,28.0,36.0,40.0,509.0
Saraikela,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,109.0,88.0,96.0,93.0,83.0,67.0,72.0,293.0,371.0,145.0,80.0,122.0,1619.0
Saraikela,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,12710.0,25210.0,33210.0,38710.0,38710.0,25980.0,23700.0,26580.0,24210.0,23510.0,17010.0,23010.0,312550.0
Saraikela,16.1.1,Stock position of DPT vaccines,2. Stocks Received,30000.0,20000.0,25000.0,10000.0,0.0,10000.0,16000.0,10000.0,10000.0,12000.0,10000.0,20000.0,173000.0
Saraikela,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Saraikela,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,17500.0,12000.0,19500.0,10000.0,12730.0,12280.0,13120.0,12370.0,10700.0,18500.0,4000.0,18500.0,161200.0
Saraikela,16.1.1,Stock position of DPT vaccines,5. Total Stock,25210.0,33210.0,38710.0,38710.0,25980.0,23700.0,26580.0,24210.0,23510.0,17010.0,23010.0,24510.0,324350.0
Saraikela,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1380.0,23380.0,13880.0,19500.0,12900.0,6700.0,6720.0,5300.0,7680.0,2180.0,0.0,0.0,99620.0
Saraikela,16.1.2,Stock position of OPV vaccines,2. Stocks Received,60000.0,10000.0,40000.0,10000.0,24000.0,20000.0,20000.0,20000.0,10000.0,20000.0,200600.0,1540.0,436140.0
Saraikela,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Saraikela,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,38000.0,19500.0,34380.0,16600.0,30200.0,19980.0,21420.0,17620.0,15500.0,22180.0,200600.0,0.0,435980.0
Saraikela,16.1.2,Stock position of OPV vaccines,5. Total Stock,23380.0,13880.0,19500.0,12900.0,6700.0,6720.0,5300.0,7680.0,2180.0,0.0,0.0,1540.0,99780.0
Saraikela,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,6840.0,15340.0,21740.0,22240.0,27340.0,11550.0,9960.0,17170.0,15270.0,16070.0,12570.0,24070.0,200160.0
Saraikela,16.1.3,Stock position of TT vaccines,2. Stocks Received,25000.0,15000.0,20000.0,12000.0,0.0,10000.0,19000.0,10000.0,10000.0,15000.0,15000.0,10000.0,161000.0
Saraikela,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Saraikela,16.1.3,Stock position of TT vaccines,4. Stock Distributed,16500.0,8600.0,19500.0,6900.0,15790.0,11590.0,11790.0,11900.0,9200.0,18500.0,3500.0,17000.0,150770.0
Saraikela,16.1.3,Stock position of TT vaccines,5. Total Stock,15340.0,21740.0,22240.0,27340.0,11550.0,9960.0,17170.0,15270.0,16070.0,12570.0,24070.0,17070.0,210390.0
Saraikela,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3320.0,2320.0,9320.0,11320.0,12420.0,3730.0,4820.0,5850.0,5540.0,5340.0,0.0,3500.0,67480.0
Saraikela,16.1.5,Stock position of BCG vaccines,2. Stocks Received,12000.0,15000.0,15000.0,10000.0,0.0,14000.0,10000.0,10000.0,10000.0,0.0,5000.0,7000.0,108000.0
Saraikela,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Saraikela,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,13000.0,8000.0,13000.0,8900.0,8690.0,12910.0,8970.0,10310.0,10200.0,5340.0,1500.0,10500.0,111320.0
Saraikela,16.1.5,Stock position of BCG vaccines,5. Total Stock,2320.0,9320.0,11320.0,12420.0,3730.0,4820.0,5850.0,5540.0,5340.0,0.0,3500.0,0.0,64160.0
Saraikela,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4500.0,2250.0,6250.0,4000.0,6500.0,2165.0,2670.0,690.0,22225.0,20725.0,20725.0,18815.0,111515.0
Saraikela,16.1.6,Stock position of Measles vaccines,2. Stocks Received,6000.0,10000.0,5000.0,5000.0,2500.0,7000.0,0.0,88000.0,149000.0,0.0,0.0,0.0,272500.0
Saraikela,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,8250.0,6000.0,7250.0,2500.0,6835.0,6495.0,1980.0,66465.0,150500.0,0.0,1910.0,1050.0,259235.0
Saraikela,16.1.6,Stock position of Measles vaccines,5. Total Stock,2250.0,6250.0,4000.0,6500.0,2165.0,2670.0,690.0,22225.0,20725.0,20725.0,18815.0,17765.0,124780.0
Saraikela,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,0.0,150.0,150.0,8450.0,7850.0,16600.0
Saraikela,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,2000.0,0.0,26900.0,0.0,0.0,28900.0
Saraikela,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Saraikela,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,1850.0,0.0,18600.0,600.0,3700.0,24750.0
Saraikela,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150.0,150.0,8450.0,7850.0,4150.0,20750.0
Saraikela,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,2200.0,,,,,,,2200.0
Saraikela,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,2200.0,,,,,,,2200.0
Saraikela,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,58000.0,,,,,,,58000.0
Saraikela,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,58000.0,,,,,,,58000.0
Saraikela,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,12000.0,,,,,,,12000.0
Saraikela,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,12000.0,,,,,,,12000.0
Saraikela,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,2250.0,,,,,,2250.0
Saraikela,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,2250.0,0.0,,,,,,2250.0
Saraikela,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,0.0,2250.0,,,,,,2250.0
Saraikela,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,2250.0,0.0,0.0,0.0,0.0,0.0,0.0,2250.0
Saraikela,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,25.0,25.0,25.0,25.0,349.0,74.0,523.0
Saraikela,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,318.0,0.0,0.0,0.0,2324.0,0.0,0.0,2642.0
Saraikela,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Saraikela,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,293.0,,0.0,0.0,2000.0,275.0,74.0,2642.0
Saraikela,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,25.0,25.0,25.0,25.0,349.0,74.0,0.0,523.0
Saraikela,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Saraikela,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Saraikela,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Saraikela,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Saraikela,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saraikela,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3900.0,3600.0,2500.0,2100.0,4700.0,3300.0,5000.0,5800.0,5800.0,6200.0,4000.0,4900.0,51800.0
Saraikela,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2400.0,0.0,3300.0,5000.0,0.0,4000.0,3000.0,3000.0,3000.0,0.0,1500.0,2100.0,27300.0
Saraikela,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Saraikela,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2700.0,1100.0,3700.0,2400.0,1400.0,2300.0,2200.0,3000.0,2600.0,2200.0,600.0,2400.0,26600.0
Saraikela,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3600.0,2500.0,2100.0,4700.0,3300.0,5000.0,5800.0,5800.0,6200.0,4000.0,4900.0,4600.0,52500.0
Saraikela,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,20900.0,22100.0,41700.0,31700.0,31700.0,21700.0,37700.0,29700.0,71300.0,26300.0,26300.0,19900.0,381000.0
Saraikela,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,10000.0,30000.0,0.0,28000.0,0.0,20000.0,0.0,214000.0,9600.0,0.0,0.0,0.0,311600.0
Saraikela,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Saraikela,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,8800.0,10400.0,10000.0,28000.0,10000.0,4000.0,8000.0,172400.0,54600.0,0.0,6400.0,0.0,312600.0
Saraikela,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,22100.0,41700.0,31700.0,31700.0,21700.0,37700.0,29700.0,71300.0,26300.0,26300.0,19900.0,19900.0,380000.0
Saraikela,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,6600.0,8000.0,6400.0,5400.0,5400.0,4900.0,4900.0,4200.0,14000.0,7200.0,7200.0,7200.0,81400.0
Saraikela,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,0.0,0.0,0.0,0.0,0.0,0.0,44800.0,4000.0,0.0,0.0,0.0,51200.0
Saraikela,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Saraikela,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1000.0,1600.0,1000.0,0.0,500.0,0.0,700.0,35000.0,10800.0,0.0,0.0,0.0,50600.0
Saraikela,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,8000.0,6400.0,5400.0,5400.0,4900.0,4900.0,4200.0,14000.0,7200.0,7200.0,7200.0,7200.0,82000.0
Saraikela,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,1.0,2.0,8.0,3.0,2.0,5.0,10.0,3.0,7.0,4.0,2.0,49.0
Saraikela,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,1.0,,,1.0
Saraikela,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Saraikela,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,1.0,1.0,,,2.0
Saraikela,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Saraikela,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,,,,,1.0
Saraikela,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,1.0,,,,,,,,1.0
Saraikela,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,1.0,1.0,,2.0,,,,,,,5.0
Saraikela,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,,1.0,,,,,,2.0,1.0,5.0
Saraikela,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,,1.0,1.0,1.0,2.0,,,,,2.0,1.0,10.0
Saraikela,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,2.0,1.0,1.0,,,,1.0,,,1.0,6.0
Saraikela,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,4.0,,,,,1.0,,,1.0,,,6.0
Saraikela,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,4.0,2.0,1.0,1.0,,1.0,,1.0,1.0,,1.0,12.0
Saraikela,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,3.0,,,3.0,,,,,6.0
Saraikela,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saraikela,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,3.0,,,3.0,,,,,6.0
Saraikela,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Saraikela,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saraikela,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,1.0,1.0
Saraikela,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,2.0,,,,,,,,,,2.0
Saraikela,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,1.0,1.0,,,,,2.0
Saraikela,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,2.0,,,,1.0,1.0,,,,,4.0
Saraikela,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Saraikela,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saraikela,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Saraikela,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,1.0,1.0,2.0,2.0,,,7.0,4.0,2.0,6.0,3.0,29.0
Saraikela,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,,3.0,,1.0,2.0,,1.0,,1.0,,9.0
Saraikela,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,2.0,1.0,5.0,2.0,1.0,2.0,7.0,5.0,2.0,7.0,3.0,38.0
Saraikela,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,1.0,,1.0,,,,,2.0
Saraikela,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Saraikela,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,1.0,,1.0,,,,,3.0
Saraikela,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,,,1.0,2.0,1.0,1.0,,,,,6.0
Saraikela,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,1.0,,1.0,,1.0,,3.0
Saraikela,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,,1.0,2.0,2.0,1.0,1.0,,1.0,,9.0
Saraikela,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Saraikela,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,4.0,4.0,,,,1.0,1.0,1.0,1.0,12.0
Saraikela,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,1.0,1.0,,,1.0,,,,3.0
Saraikela,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,4.0,5.0,1.0,,,3.0,1.0,1.0,1.0,16.0
Saraikela,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,1.0,1.0,1.0,,,3.0
Saraikela,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,1.0,1.0,1.0,,,3.0
Saraikela,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Saraikela,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,1.0,,2.0,2.0,2.0,,,7.0
Saraikela,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,,1.0,,,,,,,,2.0
Saraikela,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,1.0,4.0,2.0,1.0,1.0,1.0,1.0,1.0,,,13.0
Saraikela,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,1.0,,,,1.0,,,1.0,,,2.0,7.0
Saraikela,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,3.0,1.0,4.0,3.0,2.0,1.0,1.0,2.0,1.0,,2.0,22.0
Saraikela,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Saraikela,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Saraikela,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Saraikela,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Saraikela,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,,1.0,2.0,,1.0,1.0,1.0,1.0,1.0,1.0,10.0
Saraikela,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,2.0,,2.0,1.0,1.0,,2.0,1.0,1.0,1.0,11.0
Saraikela,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,1.0,2.0,1.0,4.0,2.0,2.0,1.0,3.0,2.0,2.0,2.0,22.0
Saraikela,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,2.0,,1.0,,2.0,,,,,1.0,6.0
Saraikela,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Saraikela,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,,2.0,,1.0,,2.0,,,,,1.0,7.0
Saraikela,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Saraikela,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Saraikela,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Saraikela,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,,,,,,,,3.0,1.0,,5.0
Saraikela,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Saraikela,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,,,,,,,,3.0,1.0,,5.0
Saraikela,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,1.0,1.0,,,,2.0
Saraikela,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Saraikela,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,1.0,1.0,,,,2.0
Saraikela,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,,1.0,,,,,,,2.0
Saraikela,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Saraikela,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,,1.0,,,,,,,2.0
Saraikela,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,1.0,,,1.0,1.0,,4.0
Saraikela,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,1.0,,,1.0
Saraikela,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,1.0,,,2.0,1.0,,5.0
Saraikela,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,3.0,,1.0,,3.0,4.0,,1.0,1.0,2.0,1.0,17.0
Saraikela,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,1.0,,,,1.0,,,,,,2.0
Saraikela,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,3.0,1.0,1.0,,3.0,5.0,,1.0,1.0,2.0,1.0,19.0
Saraikela,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,1.0,,,1.0,,,,,,2.0
Saraikela,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,2.0,3.0,3.0,3.0,1.0,2.0,4.0,4.0,2.0,2.0,2.0,28.0
Saraikela,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,2.0,,,,1.0,,,,,1.0,4.0
Saraikela,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,2.0,5.0,4.0,3.0,1.0,4.0,4.0,4.0,2.0,2.0,3.0,34.0
Saraikela,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Saraikela,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,2.0,,,,1.0,1.0,,,,,5.0
Saraikela,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,,,,,2.0,,,,,,3.0
Saraikela,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,1.0,2.0,,,1.0,3.0,1.0,,,,,9.0
Saraikela,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,1.0,1.0,,,,,,3.0
Saraikela,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,2.0,2.0,4.0,,,,,,,,,8.0
Saraikela,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,2.0,2.0,4.0,1.0,1.0,1.0,,,,,,11.0
Saraikela,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,4.0,2.0,1.0,1.0,3.0,,2.0,2.0,1.0,,17.0
Saraikela,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,,3.0,2.0,1.0,,,,,2.0,1.0,10.0
Saraikela,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,2.0,4.0,5.0,3.0,2.0,3.0,,2.0,2.0,3.0,1.0,27.0
Saraikela,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Saraikela,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,2.0,1.0,3.0,,1.0,,2.0,4.0,1.0,2.0,17.0
Saraikela,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,1.0,6.0,3.0,3.0,1.0,,,2.0,2.0,,1.0,19.0
Saraikela,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,2.0,8.0,4.0,6.0,1.0,1.0,,4.0,6.0,1.0,3.0,36.0
Saraikela,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,1.0,,,,1.0,1.0,,,4.0
Saraikela,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,3.0,6.0,3.0,8.0,3.0,1.0,3.0,6.0,8.0,2.0,4.0,47.0
Saraikela,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,1.0,2.0,6.0,13.0,3.0,2.0,1.0,6.0,7.0,3.0,2.0,47.0
Saraikela,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,1.0,4.0,8.0,10.0,22.0,6.0,3.0,4.0,13.0,16.0,5.0,6.0,98.0
Simdega,1.1,Total number of pregnant women Registered for ANC,TOTAL,1218.0,1184.0,1059.0,1229.0,992.0,1178.0,1161.0,973.0,1287.0,1239.0,1135.0,1227.0,13882.0
Simdega,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,244.0,175.0,168.0,213.0,152.0,192.0,221.0,146.0,168.0,170.0,134.0,189.0,2172.0
Simdega,1.2,Number of Pregnant women registered under JSY,TOTAL,1177.0,1161.0,1031.0,1210.0,963.0,1160.0,1126.0,967.0,1268.0,1196.0,1108.0,1213.0,13580.0
Simdega,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,737.0,848.0,782.0,795.0,790.0,802.0,797.0,884.0,928.0,895.0,828.0,968.0,10054.0
Simdega,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1070.0,1068.0,970.0,1119.0,922.0,1053.0,1016.0,914.0,1211.0,1167.0,1072.0,1166.0,12748.0
Simdega,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,897.0,1054.0,963.0,856.0,1034.0,871.0,941.0,957.0,1069.0,1050.0,1020.0,1097.0,11809.0
Simdega,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,998.0,854.0,704.0,792.0,476.0,698.0,1221.0,921.0,1223.0,1871.0,993.0,1213.0,11964.0
Simdega,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,13.0,35.0,31.0,24.0,41.0,33.0,42.0,18.0,44.0,69.0,65.0,46.0,461.0
Simdega,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Simdega,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,93.0,88.0,96.0,76.0,95.0,82.0,107.0,73.0,149.0,113.0,123.0,136.0,1231.0
Simdega,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Simdega,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Simdega,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,132.0,144.0,174.0,132.0,142.0,151.0,136.0,136.0,148.0,125.0,129.0,136.0,1685.0
Simdega,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,156.0,190.0,202.0,230.0,259.0,178.0,227.0,176.0,214.0,214.0,198.0,215.0,2459.0
Simdega,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,288.0,334.0,376.0,362.0,401.0,329.0,363.0,312.0,362.0,339.0,327.0,351.0,4144.0
Simdega,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,210.0,263.0,259.0,275.0,311.0,249.0,278.0,228.0,230.0,244.0,241.0,251.0,3039.0
Simdega,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,16.0,12.0,14.0,19.0,25.0,43.0,46.0,22.0,25.0,44.0,33.0,15.0,314.0
Simdega,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,678.0,593.0,464.0,569.0,598.0,543.0,596.0,829.0,772.0,652.0,774.0,785.0,7853.0
Simdega,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,657.0,570.0,464.0,560.0,588.0,523.0,589.0,779.0,635.0,608.0,773.0,784.0,7530.0
Simdega,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,640.0,570.0,461.0,538.0,583.0,503.0,587.0,776.0,770.0,643.0,754.0,759.0,7584.0
Simdega,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,517.0,470.0,397.0,441.0,466.0,403.0,388.0,628.0,575.0,591.0,501.0,561.0,5938.0
Simdega,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,3.0,0.0,7.0,2.0,2.0,0.0,11.0,2.0,7.0,4.0,2.0,0.0,40.0
Simdega,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Simdega,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Simdega,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Simdega,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Simdega,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Simdega,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Simdega,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Simdega,4.1.1.a,Number of male live births,TOTAL,507.0,504.0,441.0,464.0,508.0,447.0,504.0,560.0,553.0,509.0,559.0,605.0,6161.0
Simdega,4.1.1.b,Number of female live births,TOTAL,468.0,471.0,399.0,462.0,488.0,423.0,449.0,562.0,589.0,491.0,535.0,526.0,5863.0
Simdega,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,975.0,975.0,840.0,926.0,996.0,870.0,953.0,1122.0,1142.0,1000.0,1094.0,1131.0,12024.0
Simdega,4.1.2,Number of still births,TOTAL,28.0,24.0,10.0,16.0,24.0,34.0,20.0,52.0,47.0,35.0,31.0,20.0,341.0
Simdega,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,18.0,21.0,17.0,19.0,19.0,26.0,26.0,20.0,19.0,22.0,14.0,16.0,237.0
Simdega,4.2.1,Number of Newborns weighed at birth,TOTAL,857.0,849.0,695.0,755.0,814.0,775.0,780.0,1009.0,989.0,805.0,935.0,950.0,10213.0
Simdega,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,37.0,24.0,33.0,48.0,28.0,35.0,37.0,46.0,62.0,29.0,45.0,46.0,470.0
Simdega,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,891.0,896.0,774.0,864.0,926.0,826.0,848.0,1058.0,1057.0,918.0,1035.0,1078.0,11171.0
Simdega,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Simdega,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Simdega,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Simdega,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Simdega,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,220.0,387.0,292.0,384.0,353.0,340.0,430.0,316.0,306.0,308.0,442.0,480.0,4258.0
Simdega,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,209.0,243.0,219.0,323.0,274.0,249.0,290.0,264.0,309.0,286.0,402.0,413.0,3481.0
Simdega,6.3,PNC maternal complications attended,TOTAL,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Simdega,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Simdega,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Simdega,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,10.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,5.0,0.0,36.0,55.0
Simdega,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,9.0,1.0,0.0,0.0,0.0,20.0,0.0,0.0,3.0,12.0,0.0,163.0,208.0
Simdega,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,19.0,2.0,0.0,0.0,0.0,21.0,0.0,0.0,5.0,17.0,0.0,199.0,263.0
Simdega,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,6.0
Simdega,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,10.0,25.0,23.0,299.0,25.0,74.0,16.0,15.0,45.0,20.0,78.0,29.0,659.0
Simdega,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,4.0,5.0,51.0,9.0,13.0,1.0,2.0,1.0,20.0,10.0,9.0,128.0
Simdega,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Simdega,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,15.0,29.0,28.0,351.0,34.0,87.0,17.0,18.0,46.0,42.0,88.0,38.0,793.0
Simdega,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Simdega,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,14.0,1.0,14.0,6.0,0.0,2.0,21.0,24.0,21.0,10.0,113.0
Simdega,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,0.0,0.0,0.0,0.0,0.0
Simdega,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Simdega,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,14.0,1.0,14.0,6.0,0.0,2.0,21.0,24.0,21.0,10.0,113.0
Simdega,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Simdega,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,2.0,0.0,11.0
Simdega,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,9.0,20.0,21.0,164.0,13.0,73.0,21.0,13.0,83.0,131.0,163.0,48.0,759.0
Simdega,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,7.0,1.0,4.0,39.0,1.0,6.0,14.0,14.0,21.0,67.0,63.0,24.0,261.0
Simdega,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Simdega,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,21.0,21.0,25.0,203.0,14.0,79.0,35.0,27.0,104.0,202.0,228.0,72.0,1031.0
Simdega,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Simdega,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Simdega,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,0.0,0.0,0.0,0.0,0.0
Simdega,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Simdega,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Simdega,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Simdega,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,194.0,201.0,249.0,1026.0,523.0,193.0,185.0,155.0,212.0,323.0,406.0,243.0,3910.0
Simdega,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,16.0,15.0,15.0,46.0,6.0,11.0,8.0,4.0,3.0,15.0,20.0,25.0,184.0
Simdega,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,35.0,51.0,13.0,320.0,46.0,305.0,286.0,32.0,59.0,54.0,50.0,38.0,1289.0
Simdega,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,12.0,21.0,23.0,58.0,13.0,24.0,27.0,18.0,8.0,10.0,32.0,19.0,265.0
Simdega,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Simdega,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,257.0,288.0,300.0,1450.0,588.0,533.0,506.0,209.0,282.0,402.0,508.0,325.0,5648.0
Simdega,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Simdega,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Simdega,9.06,Number of IUCD removals,TOTAL,97.0,71.0,56.0,157.0,147.0,124.0,101.0,87.0,146.0,202.0,126.0,81.0,1395.0
Simdega,9.07,Number of Oral Pills cycles distributed,TOTAL,4056.0,3887.0,4082.0,7400.0,7126.0,7339.0,8316.0,4938.0,6775.0,9363.0,12409.0,7964.0,83655.0
Simdega,9.08,Number of Condom pieces distributed,TOTAL,38875.0,38120.0,50324.0,86015.0,58578.0,58982.0,55615.0,46290.0,78584.0,72792.0,47943.0,36170.0,668288.0
Simdega,9.09,Number of Centchroman (weekly) pills given,TOTAL,2.0,242.0,40.0,29.0,24.0,2.0,2.0,25.0,372.0,0.0,4.0,6.0,748.0
Simdega,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,10.0,13.0,36.0,46.0,41.0,110.0,98.0,113.0,97.0,86.0,112.0,94.0,856.0
Simdega,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,1.0,0.0,4.0,18.0,7.0,2.0,0.0,1.0,4.0,2.0,8.0,0.0,47.0
Simdega,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,2.0,0.0,0.0,11.0,0.0,2.0,2.0,1.0,16.0,17.0,19.0,3.0,73.0
Simdega,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,3.0,2.0,1.0,13.0
Simdega,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,7.0,0.0,0.0,0.0,3.0,3.0,3.0,7.0,1.0,24.0
Simdega,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,6.0,6.0,9.0,6.0,6.0,6.0,8.0,7.0,6.0,4.0,6.0,-1.0
Simdega,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,885.0,901.0,801.0,896.0,902.0,842.0,707.0,992.0,1013.0,891.0,933.0,999.0,10762.0
Simdega,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,995.0,1124.0,1025.0,968.0,878.0,934.0,861.0,932.0,1203.0,1026.0,1023.0,1015.0,11984.0
Simdega,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1038.0,1165.0,1083.0,1029.0,1032.0,865.0,826.0,919.0,1173.0,1056.0,1035.0,1060.0,12281.0
Simdega,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1106.0,1160.0,1086.0,970.0,1019.0,980.0,761.0,828.0,1161.0,1011.0,949.0,1098.0,12129.0
Simdega,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Simdega,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Simdega,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Simdega,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,514.0,587.0,463.0,474.0,543.0,520.0,466.0,693.0,762.0,611.0,602.0,690.0,6925.0
Simdega,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,984.0,1124.0,1024.0,951.0,881.0,934.0,857.0,931.0,1194.0,1049.0,1024.0,1013.0,11966.0
Simdega,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1033.0,1165.0,1083.0,1028.0,1030.0,856.0,824.0,915.0,1172.0,1088.0,1024.0,1036.0,12254.0
Simdega,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1098.0,1160.0,1080.0,967.0,1015.0,975.0,747.0,945.0,1181.0,1042.0,951.0,1093.0,12254.0
Simdega,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,9.0,0.0,0.0,9.0,13.0,8.0,0.0,27.0,165.0,127.0,358.0
Simdega,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,36.0,16.0,47.0,16.0,18.0,63.0,66.0,14.0,118.0,357.0,513.0,1264.0
Simdega,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,80.0,428.0,516.0
Simdega,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,14.0,215.0,235.0
Simdega,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1696.0,1427.0,1105.0,867.0,1161.0,1094.0,902.0,2621.0,1127.0,1220.0,1083.0,959.0,15262.0
Simdega,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,0.0,0.0,11.0,0.0,1.0,0.0,0.0,3.0,7.0,22.0
Simdega,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Simdega,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,784.0,688.0,551.0,400.0,582.0,500.0,449.0,1289.0,505.0,467.0,434.0,414.0,7063.0
Simdega,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,748.0,661.0,538.0,414.0,537.0,477.0,448.0,1299.0,464.0,425.0,445.0,450.0,6906.0
Simdega,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1532.0,1349.0,1089.0,814.0,1119.0,977.0,897.0,2588.0,969.0,892.0,879.0,864.0,13969.0
Simdega,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,838.0,892.0,880.0,776.0,946.0,815.0,715.0,810.0,787.0,761.0,951.0,854.0,10025.0
Simdega,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,841.0,888.0,876.0,775.0,946.0,823.0,715.0,814.0,781.0,760.0,954.0,852.0,10025.0
Simdega,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,182.0,279.0,245.0,262.0,229.0,207.0,178.0,165.0,118.0,217.0,226.0,116.0,2424.0
Simdega,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,169.0,256.0,236.0,252.0,234.0,223.0,207.0,184.0,123.0,238.0,240.0,136.0,2498.0
Simdega,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,351.0,535.0,481.0,514.0,463.0,430.0,385.0,349.0,241.0,455.0,466.0,252.0,4922.0
Simdega,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,101.0,115.0,79.0,103.0,150.0,157.0,102.0,144.0,79.0,98.0,131.0,164.0,1423.0
Simdega,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,446.0,561.0,517.0,427.0,479.0,378.0,334.0,519.0,421.0,396.0,375.0,359.0,5212.0
Simdega,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,386.0,477.0,535.0,489.0,525.0,428.0,357.0,399.0,467.0,427.0,430.0,398.0,5318.0
Simdega,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,17.0,30.0,17.0,15.0,20.0,22.0,20.0,14.0,12.0,23.0,19.0,14.0,223.0
Simdega,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,3.0,2.0,5.0,5.0,8.0,13.0,3.0,4.0,7.0,8.0,3.0,61.0
Simdega,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,696.0,816.0,714.0,716.0,711.0,689.0,658.0,920.0,878.0,848.0,758.0,768.0,9172.0
Simdega,10.4.2,Number of Immunisation sessions held during the month,TOTAL,573.0,716.0,660.0,620.0,654.0,638.0,569.0,720.0,806.0,737.0,700.0,687.0,8080.0
Simdega,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,539.0,667.0,594.0,558.0,585.0,592.0,525.0,659.0,727.0,687.0,621.0,591.0,7345.0
Simdega,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1516.0,1224.0,837.0,645.0,1714.0,1081.0,844.0,756.0,767.0,761.0,1972.0,1022.0,13139.0
Simdega,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,352.0,419.0,238.0,273.0,5461.0,1077.0,443.0,135.0,152.0,88.0,4649.0,2782.0,16069.0
Simdega,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,379.0,362.0,208.0,241.0,6151.0,1291.0,400.0,76.0,51.0,25.0,5298.0,4417.0,18899.0
Simdega,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,0.0,0.0,17.0
Simdega,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Simdega,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,60.0,52.0,13.0,38.0,50.0,60.0,16.0,11.0,36.0,37.0,41.0,22.0,436.0
Simdega,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,157.0,173.0,220.0,172.0,136.0,185.0,127.0,134.0,179.0,196.0,147.0,106.0,1932.0
Simdega,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,359.0,234.0,140.0,208.0,167.0,415.0,239.0,286.0,430.0,357.0,163.0,155.0,3153.0
Simdega,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,42.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,51.0,0.0,0.0,143.0
Simdega,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,103.0,0.0,0.0,0.0,0.0,103.0
Simdega,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,103.0,0.0,0.0,0.0,0.0,103.0
Simdega,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1546.0,0.0,0.0,0.0,0.0,1546.0
Simdega,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,5.0,4.0,2.0,4.0,2.0,4.0,3.0,3.0,5.0,3.0,3.0,-1.0
Simdega,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,2.0,3.0,4.0,3.0,1.0,3.0,2.0,3.0,2.0,1.0,1.0,-1.0
Simdega,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,509.0,545.0,591.0,570.0,621.0,503.0,485.0,445.0,564.0,614.0,619.0,599.0,-1.0
Simdega,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,6.0,7.0,7.0,7.0,6.0,6.0,5.0,4.0,4.0,6.0,5.0,-1.0
Simdega,14.05,Number of RKS meetings held during the month,TOTAL,4.0,2.0,1.0,2.0,1.0,0.0,0.0,2.0,1.0,0.0,2.0,2.0,17.0
Simdega,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,7.0,6.0,7.0,7.0,6.0,9.0,8.0,5.0,7.0,8.0,7.0,-1.0
Simdega,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,54.0,62.0,35.0,39.0,16.0,25.0,8.0,68.0,6.0,44.0,36.0,36.0,429.0
Simdega,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,5.0,5.0,4.0,4.0,3.0,4.0,3.0,3.0,4.0,4.0,4.0,-1.0
Simdega,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,6.0,3.0,2.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,-1.0
Simdega,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,86.0,20.0,145.0,38.0,30.0,85.0,7.0,54.0,62.0,93.0,101.0,111.0,832.0
Simdega,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,482.0,36.0,356.0,235.0,170.0,179.0,31.0,60.0,105.0,190.0,242.0,228.0,2314.0
Simdega,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,125.0,17.0,118.0,30.0,24.0,146.0,6.0,78.0,88.0,42.0,46.0,45.0,765.0
Simdega,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,586.0,57.0,469.0,262.0,197.0,210.0,37.0,190.0,162.0,166.0,235.0,205.0,2776.0
Simdega,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,211.0,37.0,263.0,68.0,54.0,231.0,13.0,132.0,150.0,135.0,147.0,156.0,1597.0
Simdega,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1068.0,93.0,825.0,497.0,367.0,389.0,68.0,250.0,267.0,356.0,477.0,433.0,5090.0
Simdega,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,4.0
Simdega,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,2.0,1.0,1.0,3.0,0.0,0.0,1.0,0.0,1.0,0.0,9.0
Simdega,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,3.0,1.0,1.0,3.0,0.0,0.0,2.0,0.0,3.0,0.0,13.0
Simdega,14.11,In-Patient Head Count at midnight,TOTAL,62.0,29.0,83.0,108.0,51.0,75.0,17.0,76.0,116.0,174.0,144.0,119.0,1054.0
Simdega,14.12.1,OPD attendance (All),TOTAL,15978.0,16069.0,29673.0,35174.0,39912.0,30276.0,27281.0,18625.0,16819.0,28049.0,30311.0,27758.0,315925.0
Simdega,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,0.0,0.0,22.0
Simdega,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Simdega,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,38.0,19.0,39.0,116.0,13.0,53.0,15.0,10.0,0.0,101.0,64.0,49.0,517.0
Simdega,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,19.0,22.0,19.0,22.0,0.0,0.0,0.0,54.0,62.0,52.0,250.0
Simdega,14.14.c,Number of Adolescents counselled,TOTAL,39.0,54.0,215.0,44.0,14.0,101.0,23.0,35.0,14.0,27.0,21.0,26.0,613.0
Simdega,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,480.0,316.0,642.0,410.0,346.0,421.0,1066.0,1625.0,888.0,1016.0,898.0,939.0,9047.0
Simdega,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,3.0,7.0,12.0,5.0,4.0,10.0,19.0,14.0,133.0,12.0,19.0,16.0,254.0
Simdega,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,0.0,1.0,29.0,2.0,0.0,2.0,2.0,1.0,128.0,27.0,3.0,20.0,215.0
Simdega,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Simdega,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,0.0,0.0,12.0,4.0,0.0,4.0,4.0,0.0,90.0,0.0,0.0,6.0,120.0
Simdega,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,0.0,14.0,93.0,29.0,21.0,33.0,160.0,107.0,120.0,13.0,79.0,86.0,755.0
Simdega,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,0.0,15.0,134.0,35.0,21.0,39.0,166.0,108.0,338.0,40.0,82.0,112.0,1090.0
Simdega,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Simdega,15.2,Number of Widal tests conducted,Number tested,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Simdega,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,39.0,0.0,0.0,0.0,0.0,0.0,43.0,0.0,0.0,0.0,82.0
Simdega,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,65.0,0.0,0.0,0.0,65.0
Simdega,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,0.0,22.0,0.0,0.0,0.0,0.0,0.0,19.0,2.0,0.0,0.0,43.0
Simdega,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0.0,0.0,61.0,0.0,0.0,0.0,0.0,0.0,127.0,2.0,0.0,0.0,190.0
Simdega,15.4.1,Number of blood smears examined for Malaria,TOTAL,1201.0,1318.0,1181.0,2270.0,1794.0,3967.0,3818.0,5222.0,2714.0,4030.0,3306.0,4355.0,35176.0
Simdega,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,45.0,44.0,41.0,52.0,15.0,63.0,41.0,43.0,149.0,19.0,10.0,47.0,569.0
Simdega,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,136.0,64.0,73.0,136.0,159.0,510.0,325.0,571.0,517.0,423.0,205.0,220.0,3339.0
Simdega,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,18950.0,11750.0,16350.0,23150.0,16950.0,23670.0,23670.0,33470.0,24970.0,19770.0,18270.0,11270.0,242240.0
Simdega,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,16000.0,16000.0,0.0,14000.0,10440.0,16000.0,10000.0,0.0,5000.0,0.0,,87440.0
Simdega,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Simdega,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,7200.0,11400.0,9200.0,6200.0,7280.0,10440.0,6200.0,18500.0,5200.0,6500.0,7000.0,3030.0,98150.0
Simdega,16.1.1,Stock position of DPT vaccines,5. Total Stock,11750.0,16350.0,23150.0,16950.0,23670.0,23670.0,33470.0,24970.0,19770.0,18270.0,11270.0,8240.0,231530.0
Simdega,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Simdega,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Simdega,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Simdega,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Simdega,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,21560.0,14060.0,18380.0,25180.0,19000.0,26560.0,23180.0,22860.0,16580.0,16580.0,30080.0,21020.0,255040.0
Simdega,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,16000.0,16000.0,0.0,14000.0,0.0,0.0,0.0,0.0,20000.0,103000.0,,169000.0
Simdega,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Simdega,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7500.0,11680.0,9200.0,6180.0,6440.0,3380.0,320.0,6280.0,0.0,6500.0,112060.0,9200.0,178740.0
Simdega,16.1.2,Stock position of OPV vaccines,5. Total Stock,14060.0,18380.0,25180.0,19000.0,26560.0,23180.0,22860.0,16580.0,16580.0,30080.0,21020.0,11820.0,245300.0
Simdega,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,15530.0,10330.0,9830.0,15330.0,10830.0,14830.0,12830.0,15830.0,11330.0,6830.0,5830.0,5830.0,135160.0
Simdega,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,7000.0,10000.0,0.0,7000.0,0.0,8000.0,0.0,0.0,5000.0,,,37000.0
Simdega,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Simdega,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5200.0,7500.0,4500.0,4500.0,3000.0,2000.0,5000.0,4500.0,4500.0,6000.0,,3000.0,49700.0
Simdega,16.1.3,Stock position of TT vaccines,5. Total Stock,10330.0,9830.0,15330.0,10830.0,14830.0,12830.0,15830.0,11330.0,6830.0,5830.0,5830.0,2830.0,122460.0
Simdega,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,12780.0,9320.0,9020.0,11720.0,8000.0,4700.0,3630.0,7130.0,4830.0,92630.0,88130.0,81630.0,333520.0
Simdega,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,6000.0,8000.0,0.0,1000.0,0.0,8000.0,8000.0,90000.0,,,,121000.0
Simdega,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Simdega,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,3460.0,6300.0,5300.0,3720.0,4300.0,1070.0,4500.0,10300.0,2200.0,4500.0,6500.0,81630.0,133780.0
Simdega,16.1.5,Stock position of BCG vaccines,5. Total Stock,9320.0,9020.0,11720.0,8000.0,4700.0,3630.0,7130.0,4830.0,92630.0,88130.0,81630.0,0.0,320740.0
Simdega,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,7395.0,5045.0,1985.0,30.0,4755.0,7260.0,5870.0,4250.0,20540.0,16740.0,17415.0,15565.0,106850.0
Simdega,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,0.0,6500.0,5000.0,0.0,0.0,142250.0,5000.0,2500.0,,,161250.0
Simdega,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Simdega,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2350.0,3060.0,1955.0,1775.0,2495.0,1390.0,1620.0,125960.0,8800.0,1825.0,1850.0,1975.0,155055.0
Simdega,16.1.6,Stock position of Measles vaccines,5. Total Stock,5045.0,1985.0,30.0,4755.0,7260.0,5870.0,4250.0,20540.0,16740.0,17415.0,15565.0,13590.0,113045.0
Simdega,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,12700.0,10000.0,22700.0
Simdega,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,18400.0,,,18400.0
Simdega,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,,0.0
Simdega,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,5700.0,2700.0,2800.0,11200.0
Simdega,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12700.0,10000.0,7200.0,29900.0
Simdega,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,1050.0,2100.0,2100.0,3025.0,1925.0,1925.0,1925.0,1925.0,15975.0
Simdega,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1200.0,1200.0,0.0,1125.0,0.0,,,,,3525.0
Simdega,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Simdega,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,150.0,150.0,0.0,200.0,1100.0,,,,,1600.0
Simdega,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,1050.0,2100.0,2100.0,3025.0,1925.0,1925.0,1925.0,1925.0,1925.0,17900.0
Simdega,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15120.0,,,0.0,7500.0,22620.0
Simdega,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,500.0,18648.0,0.0,,,18500.0,,37648.0
Simdega,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,,,,0.0
Simdega,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,,500.0,3528.0,15120.0,,,11000.0,0.0,30148.0
Simdega,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,15120.0,0.0,0.0,0.0,7500.0,7500.0,30120.0
Simdega,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,2000.0,800.0,0.0,,3800.0
Simdega,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,10800.0,1000.0,0.0,,,,11800.0
Simdega,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Simdega,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,9800.0,0.0,1200.0,800.0,,,11800.0
Simdega,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,2000.0,800.0,0.0,0.0,0.0,3800.0
Simdega,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1050.0,1050.0,1050.0,1050.0,1050.0,5250.0
Simdega,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,3350.0,0.0,,,,,3350.0
Simdega,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Simdega,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,2300.0,0.0,,,,,2300.0
Simdega,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1050.0,1050.0,1050.0,1050.0,1050.0,1050.0,6300.0
Simdega,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,14614000.0,14214000.0,9214000.0,5114000.0,4704000.0,4704000.0,52564000.0
Simdega,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,15970000.0,0.0,0.0,,,,,15970000.0
Simdega,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Simdega,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,1356000.0,200000.0,5000000.0,4100000.0,410000.0,,,11066000.0
Simdega,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,14614000.0,14414000.0,9214000.0,5114000.0,4704000.0,4704000.0,4704000.0,57468000.0
Simdega,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,,,,,,,0.0
Simdega,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,1367.0,1367.0
Simdega,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,1382.0,,1382.0
Simdega,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,15.0,,15.0
Simdega,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1367.0,1367.0,2734.0
Simdega,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Simdega,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Simdega,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Simdega,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1400.0,600.0,0.0,2100.0,1450.0,3450.0,4150.0,6250.0,5050.0,6450.0,5150.0,5150.0,41200.0
Simdega,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,2800.0,0.0,3000.0,1300.0,3000.0,0.0,2700.0,0.0,,0.0,12800.0
Simdega,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Simdega,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,800.0,600.0,700.0,650.0,1000.0,600.0,900.0,1200.0,1300.0,1300.0,0.0,2400.0,11450.0
Simdega,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,600.0,0.0,2100.0,1450.0,3450.0,4150.0,6250.0,5050.0,6450.0,5150.0,5150.0,2750.0,42550.0
Simdega,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,34797.0,20997.0,15997.0,21397.0,10397.0,28400.0,30003.0,42003.0,36803.0,44203.0,45803.0,45803.0,376603.0
Simdega,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,19000.0,20000.0,0.0,28000.0,28000.0,24000.0,,20000.0,20000.0,,0.0,159000.0
Simdega,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0
Simdega,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,13800.0,24000.0,14600.0,11000.0,9997.0,26397.0,12000.0,5200.0,12600.0,18400.0,0.0,27200.0,175194.0
Simdega,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,20997.0,15997.0,21397.0,10397.0,28400.0,30003.0,42003.0,36803.0,44203.0,45803.0,45803.0,18603.0,360409.0
Simdega,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4664.0,3842.0,3112.0,2232.0,1530.0,561.0,561.0,561.0,3020.0,870.0,1370.0,1370.0,23693.0
Simdega,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,600.0,0.0,0.0,0.0,0.0,0.0,2459.0,0.0,500.0,,0.0,3559.0
Simdega,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0
Simdega,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,822.0,1330.0,880.0,702.0,969.0,0.0,0.0,0.0,2150.0,0.0,0.0,0.0,6853.0
Simdega,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3842.0,3112.0,2232.0,1530.0,561.0,561.0,561.0,3020.0,870.0,1370.0,1370.0,1370.0,20399.0
Simdega,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,,,,2.0,,,,,3.0
Simdega,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,1.0,,,1.0
Simdega,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Simdega,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,1.0,,,1.0
Simdega,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Simdega,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Simdega,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Simdega,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,1.0,,,1.0
Simdega,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Simdega,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,1.0,,,1.0
Simdega,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,1.0,,1.0,,,2.0
Simdega,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,1.0,,,2.0
Simdega,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,1.0,,1.0,,2.0,,,4.0
Simdega,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,1.0,3.0,,,1.0,1.0,6.0
Simdega,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,1.0,,,,,,1.0
Simdega,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,2.0,3.0,,,1.0,1.0,7.0
Simdega,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Simdega,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Simdega,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Simdega,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,2.0,,,3.0,2.0,7.0
Simdega,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,,2.0,,3.0,,,,6.0
Simdega,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,1.0,,2.0,2.0,3.0,,3.0,2.0,13.0
Simdega,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Simdega,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Simdega,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Simdega,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,1.0,,,,,,,1.0,1.0,,,4.0
Simdega,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,,,,,,3.0,1.0,1.0,,6.0
Simdega,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,1.0,,,,,,,4.0,2.0,1.0,,10.0
Simdega,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Simdega,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Simdega,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Simdega,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Simdega,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Simdega,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,,,,1.0,,,,,,2.0
Simdega,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Simdega,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Simdega,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Simdega,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Simdega,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Simdega,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Simdega,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,2.0,,,,2.0,,4.0
Simdega,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Simdega,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,2.0,,,,2.0,,4.0
Simdega,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Simdega,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Simdega,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Simdega,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Simdega,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Simdega,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Simdega,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Simdega,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Simdega,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Simdega,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Simdega,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Simdega,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Simdega,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Simdega,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Simdega,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,1.0,,,,,1.0
Simdega,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Simdega,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Simdega,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Simdega,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,1.0,1.0,2.0
Simdega,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Simdega,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,1.0,1.0,2.0
Simdega,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Simdega,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Simdega,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,1.0,,,,,,1.0
Simdega,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,,,,2.0,,1.0,,,1.0,5.0
Simdega,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,1.0,,1.0,,,,,,,,2.0
Simdega,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,2.0,,1.0,,2.0,,1.0,,,1.0,7.0
Simdega,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,1.0,,1.0,,1.0,,2.0,5.0
Simdega,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Simdega,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,1.0,1.0,,1.0,,1.0,,2.0,6.0
Simdega,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,1.0,,,,1.0,,2.0
Simdega,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Simdega,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,1.0,,,,1.0,,2.0
Simdega,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Simdega,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Simdega,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,1.0,1.0
Simdega,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Simdega,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Simdega,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,,,,,,,,,,1.0,,2.0
Simdega,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Simdega,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Simdega,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,,,,,,,,,,1.0,,2.0
Simdega,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,,,,,,,,1.0,,2.0,,4.0
Simdega,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Simdega,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,1.0,1.0,,,1.0,,3.0,2.0,6.0,1.0,3.0,18.0
Simdega,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,1.0,1.0,,,2.0
Simdega,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,1.0,1.0,,,1.0,,3.0,3.0,7.0,1.0,3.0,20.0
